data_1bld_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bld _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.74 170.58 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.114 1.21 . . . . 0.0 110.109 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HZ1' ' CB ' ' A' ' 30' ' ' LYS . 6.4 mtmp? -142.78 132.42 23.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.458 HH11 ' HG3' ' A' ' 31' ' ' ARG . 5.3 mtm-85 -84.83 122.52 29.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.64 98.94 10.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 109.485 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -97.85 117.15 31.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.5 t -82.18 137.71 34.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -26.38 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.956 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.7 m-20 -74.43 105.01 5.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 109.801 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.53 5.85 88.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.73 83.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 46.3 m-85 -142.32 137.52 30.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -1.083 . . . . 0.0 109.505 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 29.1 m-85 -94.46 145.96 24.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.556 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -80.26 145.3 32.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.255 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' CG ' ' A' ' 57' ' ' ASP . 2.9 ttt180 -148.4 122.29 9.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.499 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -90.04 109.1 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.172 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -66.13 152.26 94.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.147 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.85 -28.88 79.12 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.203 1.269 . . . . 0.0 110.242 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.82 6.55 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.29 -31.97 3.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -47.65 120.99 3.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -1.12 . . . . 0.0 109.461 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.34 129.77 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -147.87 -159.62 1.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.57 151.61 23.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.8 151.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' LYS . 25.1 mtm180 -77.66 -31.39 52.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 56' ' ' SER . 2.2 mm-40 -50.52 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.555 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -76.38 -1.29 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.4 p -91.37 -20.2 22.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -44.47 107.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 0.0 109.462 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.55 5.54 0.33 Allowed 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 120.797 0.998 . . . . 0.0 110.54 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.1 m80 -93.39 -18.19 22.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.77 -3.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -74.82 84.62 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.25 134.93 33.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -91.65 104.92 17.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.336 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.2 mp -92.38 152.69 19.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.68 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.13 149.16 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.39 149.39 22.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -149.03 143.04 25.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 52.95 -119.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.377 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -147.45 113.24 5.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.74 -18.46 55.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.51 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -1.163 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.42 131.17 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 109.437 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -92.42 118.29 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.24 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -145.56 144.77 30.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.46 137.52 13.64 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.98 -68.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -1.132 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 t -66.62 -48.88 68.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.91 -24.38 66.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.38 46.43 26.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.915 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.04 149.36 34.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -93.16 137.46 32.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -65.14 143.84 57.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.896 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.22 18.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.591 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.6 ttm -95.22 150.47 20.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -92.64 -170.01 2.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.4 mp0 -93.46 -32.02 14.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -79.89 -37.63 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 142.55 -5.01 2.03 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -73.26 117.87 15.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 10.9 mp -91.76 133.14 35.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 3.0 pp -149.96 172.95 14.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.87 164.84 13.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.414 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -150.02 169.74 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -84.01 -35.83 23.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -94.13 138.69 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.1 p -90.26 117.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.424 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 11.0 p -103.08 173.62 6.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -15.64 23.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.339 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.83 51.24 1.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 98' ' ' THR . 7.7 m -140.89 5.23 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -93.12 160.46 14.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -150.0 114.85 5.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -65.41 118.83 9.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -93.4 98.18 11.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.13 100.34 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.337 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 tt -77.6 129.45 35.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.71 -171.34 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -91.34 2.96 56.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.9 m-80 -94.78 24.78 4.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.21 -2.35 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.975 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.6 m-85 -91.55 -175.79 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 109.491 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 146' ' ' ILE . 5.2 m120 -146.95 158.13 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.565 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 p -134.29 118.38 17.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.64 -0.662 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.03 105.28 17.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -92.91 142.61 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.355 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 t -71.36 147.81 47.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -88.77 -66.67 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 tptp -49.1 -18.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.6 m-85 -144.31 77.69 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 82.3 p -66.01 5.96 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 3.9 m -89.52 5.38 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.526 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 5.3 m-90 -148.39 170.45 17.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.028 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 17.0 m-85 -137.09 162.67 32.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.96 122.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.12 138.17 17.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.35 171.94 8.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -87.64 -115.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -143.18 7.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 109.546 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.22 11.23 8.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.57 64.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -93.13 159.23 15.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 38.1 p90 -91.15 120.06 31.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -69.88 132.28 45.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -47.8 150.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.297 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -70.94 -10.43 68.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -91.03 -32.22 15.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.155 . . . . 0.0 109.52 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -81.16 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.4 p -79.4 156.32 27.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.14 -179.75 38.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.91 171.48 3.7 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.894 1.729 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.29 -50.54 3.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.07 134.28 40.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 14.1 mtmt -83.96 6.52 21.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.587 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -65.05 -6.46 8.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 113' ' ' ASN . 21.0 pt -90.45 -6.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.16 97.51 9.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -98.86 159.65 14.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.6 tp -139.13 71.53 40.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.504 -0.748 . . . . 0.0 108.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.83 116.45 3.45 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.877 1.718 . . . . 0.0 110.715 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.8 mtt -95.99 121.2 37.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 0.0 109.168 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.9 t -69.23 135.72 50.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 109.479 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.51 168.53 2.13 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.134 1.223 . . . . 0.0 110.097 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -138.9 139.84 38.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -91.52 120.07 32.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 mt -84.63 101.98 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -95.56 115.83 27.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.544 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.89 111.31 17.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.213 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -59.09 -30.39 68.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.6 m-80 -78.64 105.23 9.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 110.122 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 81.65 4.63 90.31 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 86.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.1 m-85 -142.66 134.5 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -94.14 123.84 37.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.79 141.83 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.491 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 25.4 ttt180 -147.28 117.93 7.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.5 mt -93.17 110.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -71.75 151.81 93.35 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.145 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.0 Cg_exo -57.04 -27.83 75.68 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.126 1.218 . . . . 0.0 110.238 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -74.95 0.45 15.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -29.62 7.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.59 114.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -1.153 . . . . 0.0 109.429 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.56 129.95 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 109.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 2.9 p30 -166.46 151.01 7.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.99 159.0 24.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 m -146.17 148.63 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -1.17 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -76.82 -9.84 58.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.43 84.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.477 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 2.51 3.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.89 -20.37 20.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.4 OUTLIER -49.89 111.2 1.95 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.67 5.38 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.663 0.909 . . . . 0.0 110.245 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' ASP . 47.3 m80 -94.24 -14.79 25.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.35 9.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 59' ' ' HIS . 2.9 mmmm -91.12 88.0 6.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.08 134.99 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.638 ' NE2' ' HZ2' ' A' ' 75' ' ' LYS . 26.0 tt0 -95.03 110.23 22.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.2 mp -95.47 144.57 25.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.813 . . . . 0.0 109.491 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.86 134.16 47.35 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 121.79 31.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.59 -85.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.6 mt-10 -94.86 149.57 21.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.883 . . . . 0.0 109.318 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.7 mtt-85 -57.58 84.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 140.82 -1.83 2.07 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -138.86 145.57 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -1.046 . . . . 0.0 109.414 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.9 133.83 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -94.61 127.07 40.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.452 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 mt -93.41 144.49 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HZ2' ' NE2' ' A' ' 63' ' ' GLN . 8.8 ttpt -146.52 143.47 28.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.68 135.59 12.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.92 -83.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -1.141 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.9 t -48.88 -43.99 39.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.88 65.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 49.65 50.14 18.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.4 mtp180 -146.0 147.08 31.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.95 127.29 36.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.9 144.85 31.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 109.33 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.17 170.14 16.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.416 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.419 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -144.16 134.65 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.5 -169.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -91.75 -11.16 37.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.413 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -92.6 -42.54 9.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.86 -9.97 1.38 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -66.98 127.56 33.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -1.167 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mp -93.47 134.51 35.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.462 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.7 pp -150.07 143.74 25.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.897 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.96 158.47 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.763 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.71 161.85 38.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.98 -47.35 37.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 m -85.07 139.42 31.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.23 152.16 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -148.01 -163.65 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.489 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -55.39 -51.64 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 85' ' ' MET . 71.7 mt-10 -74.2 77.23 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 36.9 m -155.2 -33.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 38.2 m-85 -84.68 156.05 21.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 68.4 m-85 -145.08 122.85 11.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.17 119.82 8.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.1 146.42 24.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.065 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 118.94 9.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.368 -0.832 . . . . 0.0 109.677 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.11 119.86 31.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.251 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.92 -178.74 6.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 m -86.43 -12.14 49.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 54.6 m-80 -89.48 16.94 6.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 1.0 OUTLIER 65.2 57.75 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.649 -0.657 . . . . 0.0 110.323 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 60.1 m-85 -145.49 123.42 12.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.581 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.7 OUTLIER -89.96 124.48 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.736 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.8 p -97.74 168.8 10.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.752 . . . . 0.0 109.382 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -143.59 105.87 4.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 134.38 38.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -63.94 131.41 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.141 -0.974 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 120' ' ' TYR . 40.7 ttp180 -69.22 -69.88 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.626 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.518 ' NZ ' ' OH ' ' A' ' 120' ' ' TYR . 17.8 tttt -51.65 -10.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.518 ' OH ' ' NZ ' ' A' ' 119' ' ' LYS . 36.3 m-85 -147.01 69.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -65.9 4.96 0.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.1 m -95.08 9.38 39.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.587 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.21 139.15 17.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.7 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -100.2 156.43 17.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.98 128.99 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.208 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.04 149.27 26.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.764 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -102.03 176.24 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.602 -0.686 . . . . 0.0 109.458 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -95.08 -167.42 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -11.2 30.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 1.6 t -91.47 0.12 57.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.47 -2.53 70.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.4 mp0 -84.97 176.41 8.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 32.6 p90 -92.8 120.4 33.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.63 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -71.02 136.09 48.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.97 164.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.061 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -93.17 -1.7 66.76 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -97.33 -20.82 17.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.245 -1.15 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -90.06 -4.91 57.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 p -79.51 155.23 28.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.004 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.63 178.71 42.92 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.4 Cg_endo -60.97 169.58 5.76 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.925 1.75 . . . . 0.0 110.274 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 -20.51 2.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 145' ' ' ALA . 10.2 mt-30 -90.16 109.51 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -1.15 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 15.9 mtmt -65.05 2.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.35 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -65.06 -9.13 19.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.1 pt -94.54 5.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.482 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.0 mt -94.67 85.67 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -94.9 169.64 9.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.227 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.73 70.43 30.56 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.41 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.89 104.13 0.37 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.848 1.699 . . . . 0.0 110.411 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.4 mtt -95.12 125.59 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.3 t -70.02 132.62 46.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.95 165.3 8.66 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.118 1.212 . . . . 0.0 110.45 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -147.26 122.14 9.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -86.27 122.62 30.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.85 101.08 12.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -91.95 124.34 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.286 -0.883 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.55 127.52 35.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.421 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -74.7 -19.56 60.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.669 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.21 105.16 15.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.73 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.69 5.14 90.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 84.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.5 m-85 -143.64 135.68 26.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -1.107 . . . . 0.0 109.518 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.48 129.43 43.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 tp -55.47 144.77 24.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.953 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.471 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 17.0 ttt180 -149.08 114.63 5.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.581 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.85 114.27 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.269 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.508 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 66.8 m-70 -69.34 151.27 96.95 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.034 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.526 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.8 Cg_endo -57.27 -27.92 77.32 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.301 1.334 . . . . 0.0 110.764 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.96 -3.0 29.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 109.742 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.69 -13.29 65.47 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -67.83 126.1 28.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.043 -1.269 . . . . 0.0 109.243 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.72 135.7 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 17.8 p-10 -153.93 -163.8 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.53 146.2 16.17 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.44 153.26 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -94.21 2.3 55.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.376 -0.828 . . . . 0.0 109.275 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 56' ' ' SER . 4.3 mm-40 -78.81 86.61 4.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.482 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -61.68 -5.17 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 54' ' ' GLU . 17.8 t -87.16 25.75 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.039 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -112.71 95.97 35.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.26 0.7 0.63 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.864 1.043 . . . . 0.0 110.271 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 57' ' ' ASP . 45.3 m80 -78.48 -26.77 46.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -70.37 -1.75 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.281 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -75.66 88.33 2.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.255 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.77 135.43 33.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.573 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 16.0 tp60 -89.85 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 10.6 mp -94.32 128.23 40.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -114.21 147.08 39.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.18 139.71 30.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' GLU . 1.9 tm-20 -145.55 129.36 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.263 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . 2.1 tt0 52.16 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 109.285 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -96.24 118.92 33.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.815 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.37 19.0 31.46 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -147.84 146.94 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.62 137.34 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -93.68 116.38 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.65 144.33 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -145.6 145.87 31.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.05 131.5 10.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.24 -85.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.44 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -50.18 -22.85 1.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.08 -26.64 19.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 51.19 52.21 15.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.949 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.633 HH21 ' HZ2' ' A' ' 95' ' ' LYS . 91.4 mtt180 -149.9 147.71 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.362 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -91.49 132.72 36.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.3 tp -63.36 147.77 50.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.226 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.03 132.83 15.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.409 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 11.1 ttm -100.87 132.71 46.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.408 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -90.98 169.3 11.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.084 -1.01 . . . . 0.0 109.533 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.55 -23.51 58.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.2 -3.97 48.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.96 71.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -79.77 118.23 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.334 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.2 mp -91.39 134.84 34.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.488 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.405 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -145.71 -174.13 4.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.471 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.67 154.6 49.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.319 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -145.85 170.16 17.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.633 ' HZ2' HH21 ' A' ' 81' ' ' ARG . 0.8 OUTLIER -81.54 -35.0 30.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 132.84 35.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.83 164.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -147.3 -173.1 4.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.0 -14.39 59.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 85' ' ' MET . 25.8 mt-10 -90.89 8.58 34.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.7 m -92.54 -5.88 50.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 56.1 m-85 -94.32 153.2 18.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 85.0 m-85 -149.1 121.67 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -55.66 114.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.323 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.45 95.1 9.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -94.18 118.96 32.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.433 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 tt -93.39 123.4 36.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 110' ' ' ASN . 14.6 mt-10 -90.8 161.68 15.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -67.89 3.81 1.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -93.02 20.26 6.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.02 -1.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.0 m-85 -98.07 141.31 31.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.629 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.9 OUTLIER -94.47 166.12 12.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.605 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 5.5 p -144.62 112.11 6.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.326 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.83 135.65 33.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 124' ' ' TYR . 3.2 ttm180 -127.13 145.75 50.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -68.85 146.03 53.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.708 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -88.53 -72.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.9 tttp -50.65 -10.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 20.4 m-85 -145.25 68.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.516 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 71.8 p -64.37 5.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.639 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.4 m -89.9 9.29 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.6 m-90 -150.3 141.16 22.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 109.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 116' ' ' ARG . 71.4 m-85 -104.09 165.7 10.88 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.711 . . . . 0.0 109.569 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.3 t -94.54 121.3 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.79 144.38 21.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.149 -0.969 . . . . 0.0 109.558 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.83 -175.93 3.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.462 -0.773 . . . . 0.0 109.478 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -93.78 -119.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -146.35 8.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.534 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.39 6.46 7.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.09 12.86 51.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.4 p90 -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -70.95 142.62 51.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.505 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 6.1 tp -63.71 -153.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.505 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -109.12 -43.66 1.17 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -61.39 -22.51 65.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 109.725 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -89.8 -15.63 31.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.59 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.6 p -90.1 154.49 19.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.532 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.85 179.72 38.32 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.68 169.01 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.888 1.725 . . . . 0.0 110.187 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.03 -58.09 3.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 134.45 54.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -1.153 . . . . 0.0 109.441 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -83.6 5.77 23.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.13 -7.13 11.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.575 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.14 -6.73 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.1 85.16 5.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -89.87 169.24 11.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.6 tp -142.32 70.08 22.01 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.809 . . . . 0.0 109.418 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.98 103.5 0.29 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.844 1.696 . . . . 0.0 110.356 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.3 mtt -97.73 119.12 35.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.761 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.7 t -70.0 119.09 13.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.384 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.46 177.62 0.21 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 121.267 1.312 . . . . 0.0 110.25 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.25 138.44 25.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.2 mtt-85 -92.66 120.97 33.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 0.0 109.321 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.82 102.01 12.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -93.5 118.95 31.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.98 101.4 12.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.649 ' HZ1' ' HH ' ' A' ' 112' ' ' TYR . 29.5 tttt -51.78 -34.51 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.691 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 5.1 m-80 -73.73 105.18 4.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.994 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.03 4.31 89.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.65 85.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.9 m-85 -142.72 133.77 25.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.496 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -95.39 123.68 39.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.3 tp -54.29 146.21 15.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.276 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 24.5 ttt180 -149.25 117.51 6.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.8 mt -92.87 130.94 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.172 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -91.71 151.4 42.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.163 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.491 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.47 -27.46 82.08 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.304 1.336 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -74.83 12.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.702 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 45' ' ' PRO . . . 84.92 -41.11 3.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.32 153.75 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.37 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -138.11 141.93 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.341 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 3.9 p-10 -153.85 -150.02 0.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -146.2 148.08 19.52 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.56 149.57 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -1.12 . . . . 0.0 109.466 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 53' ' ' ARG . 20.5 mtm-85 -90.25 -15.79 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.27 103.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.43 44.42 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -144.19 20.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.265 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.4 m-20 -105.77 104.97 51.39 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.74 2.66 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.786 0.991 . . . . 0.0 110.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.3 m80 -82.63 -5.75 58.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.257 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt -90.23 -5.18 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -76.64 86.53 3.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.12 134.92 34.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.84 114.08 26.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.838 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.4 mp -93.2 113.14 25.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.0 143.07 26.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.92 120.93 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -95.0 -42.43 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.2 mt-10 -151.77 158.78 43.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.466 -0.772 . . . . 0.0 109.296 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -60.75 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 141.93 -2.82 1.93 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.35 142.43 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -1.122 . . . . 0.0 109.596 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.91 130.7 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 109.239 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -91.51 131.13 37.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -89.95 142.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -146.96 121.77 9.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.573 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 139.56 27.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.2 t -75.06 -87.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -47.18 -33.33 5.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.491 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.44 -29.64 47.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 50.8 53.98 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.3 mtt180 -146.88 148.79 32.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -91.5 132.07 36.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.39 142.62 58.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.06 148.81 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 ttp -106.7 143.89 34.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.421 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.645 ' HZ2' ' NH2' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.15 148.9 25.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.34 -19.06 7.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.401 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.5 p30 -87.65 -44.65 11.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.81 -9.59 1.37 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.645 ' NH2' ' HZ2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -71.65 128.65 36.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -1.148 . . . . 0.0 109.449 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.8 mp -95.06 135.34 36.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.43 -173.72 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.28 42.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.455 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -146.97 155.84 42.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -71.32 -19.09 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.44 139.92 30.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.25 107.81 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.491 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 66.9 p -94.68 156.09 16.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.37 -23.92 6.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -93.93 53.09 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.491 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 97.0 m -134.24 -2.18 2.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 87.4 m-85 -95.44 153.98 17.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 71.2 m-85 -146.04 121.13 10.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.01 93.92 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 115' ' ' TYR . 31.4 tt0 -78.15 93.19 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -93.47 137.85 32.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.85 140.46 29.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.361 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.84 -171.72 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 111' ' ' ASN . 43.1 t -93.78 -33.28 13.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -74.27 20.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.142 -0.973 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.5 m-20 65.24 56.05 1.04 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.714 . . . . 0.0 109.916 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.649 ' HH ' ' HZ1' ' A' ' 35' ' ' LYS . 47.2 m-85 -142.42 137.31 30.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.393 -0.817 . . . . 0.0 109.286 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.91 153.99 20.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.5 p -137.18 114.92 11.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 109.239 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 105' ' ' GLU . 98.5 m-85 -89.93 104.5 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.506 ' NH2' ' O ' ' A' ' 121' ' ' THR . 23.8 ttt180 -93.92 134.37 36.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.205 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.9 t -60.95 153.36 25.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 120' ' ' TYR . 56.3 ttt180 -90.83 -77.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -51.13 -9.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.525 ' C ' ' H ' ' A' ' 122' ' ' SER . 32.3 m-85 -138.85 59.33 1.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.506 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 26.5 p -59.55 -0.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.737 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.6 m -90.04 10.07 25.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 3.3 m-90 -155.13 144.01 20.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.849 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 28.0 m-85 -104.85 167.21 9.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.658 -0.652 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.0 128.32 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -152.57 145.64 24.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.28 178.86 5.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 109.447 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -96.23 -167.9 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 109.401 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -93.24 -13.47 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 109.42 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -93.46 2.32 56.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.41 0.32 67.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -85.06 172.26 11.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -1.144 . . . . 0.0 109.512 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 37.8 p90 -92.63 120.22 32.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -71.99 131.59 43.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.3 tp -47.98 155.04 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.309 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.84 -1.45 58.98 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 139' ' ' THR . 60.1 p -92.79 -58.25 2.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -55.15 -7.62 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 137' ' ' SER . 11.4 p -85.57 155.44 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.81 39.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.98 170.79 4.37 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.905 1.736 . . . . 0.0 110.162 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.01 -51.18 4.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.75 135.05 50.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -1.106 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.5 mtpp -84.81 1.61 46.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 109.565 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.64 -3.58 0.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.693 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 144' ' ' LYS . 20.3 pt -98.13 2.61 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 109.681 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.451 ' CD1' ' HZ3' ' A' ' 144' ' ' LYS . 79.3 mt -90.48 110.23 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -117.23 168.28 10.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.51 70.17 17.5 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.318 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.33 105.98 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.794 1.662 . . . . 0.0 110.387 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.7 mtt -97.59 118.61 34.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 109.397 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.5 t -62.19 145.81 52.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.868 . . . . 0.0 109.498 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.2 165.96 6.45 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.229 1.286 . . . . 0.0 110.364 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -146.36 127.02 14.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.0 109.198 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -84.96 124.52 31.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 mt -84.8 98.25 10.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -92.76 119.66 32.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -86.89 112.23 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -63.34 -17.36 62.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.64 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.8 m-80 -88.03 104.92 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.91 4.79 89.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.12 84.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 47.1 m-85 -142.98 130.94 21.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.13 120.65 34.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.83 144.41 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.259 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.474 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 33.2 ttt180 -147.78 120.58 8.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -95.73 130.82 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.795 . . . . 0.0 109.11 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -91.29 150.89 42.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.49 -25.63 74.76 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.244 1.296 . . . . 0.0 110.312 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.1 p30 -74.92 7.56 3.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.7 -41.83 2.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.8 mmm180 -47.28 157.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.488 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.77 134.17 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.4 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -146.09 -150.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.24 149.92 22.11 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -145.79 145.99 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -1.118 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.4 -6.46 58.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.49 108.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.486 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 21.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.36 -20.24 3.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.642 . . . . 0.0 109.692 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -44.75 108.19 0.71 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 109.62 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.09 5.26 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 110.152 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 57' ' ' ASP . 50.0 m80 -93.71 -3.14 52.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.68 -1.48 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 14.7 mmtt -78.14 86.25 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.93 130.85 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.82 111.4 22.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.9 mp -90.25 153.58 20.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.902 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -144.9 130.96 19.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.338 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 123.77 28.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.572 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.15 -95.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -89.48 -173.9 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 112.4 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.43 24.65 20.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 t -145.92 142.54 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.63 125.79 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.523 -0.735 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -93.51 128.26 39.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.54 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.78 149.62 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HZ1' ' HH ' ' A' ' 82' ' ' TYR . 14.6 tttp -146.51 134.34 21.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.23 136.25 18.25 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 60.1 t -77.98 -57.01 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -1.154 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -17.82 48.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.43 -23.55 19.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 2.2 m120 51.13 49.64 20.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -146.43 148.52 32.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.624 ' HH ' ' HZ1' ' A' ' 75' ' ' LYS . 75.1 m-85 -91.63 132.81 36.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.545 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 tp -65.02 139.55 58.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.25 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.74 134.92 18.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.0 ttp -95.12 126.38 40.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.66 -175.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.14 -16.41 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 25.4 p-10 -90.2 -40.21 12.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.55 -9.26 1.41 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 90' ' ' ARG . 1.8 mtt-85 -73.55 123.62 24.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -1.165 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.8 mp -92.56 132.95 36.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.3 pp -148.7 -172.67 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.611 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.445 ' C ' ' HG ' ' A' ' 94' ' ' SER . . . -139.1 158.07 44.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.291 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.445 ' HG ' ' C ' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -146.02 170.04 17.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -84.6 -37.31 21.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 m -85.01 149.64 25.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 98' ' ' THR . 54.8 t -77.21 162.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.385 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.461 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 71.6 p -147.27 177.81 8.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -76.14 -26.34 56.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 27.0 mp0 -92.87 19.64 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.98 -11.8 30.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 66.2 m-85 -93.17 159.55 15.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 76.0 m-85 -148.78 116.18 6.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -54.89 142.35 29.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -125.15 141.64 51.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -146.96 142.02 27.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.97 137.35 35.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.31 -175.92 3.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.2 p -94.67 38.28 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 112' ' ' TYR . 59.1 m-80 -146.86 31.14 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 m120 60.99 -1.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 110' ' ' ASN . 40.6 m-85 -95.12 126.83 40.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.435 ' N ' ' ND2' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -93.67 168.83 10.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -137.64 161.47 36.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.731 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -137.8 109.87 7.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.72 149.17 22.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -75.52 162.79 28.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 120' ' ' TYR . 1.7 ttt-85 -93.5 -77.95 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.885 . . . . 0.0 109.303 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.2 tptt -51.24 -9.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.547 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 118' ' ' ARG . 10.7 m-85 -141.97 59.68 1.47 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.435 -0.791 . . . . 0.0 109.374 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p -62.07 0.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 120' ' ' TYR . 12.3 m -90.17 15.0 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.522 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 11.1 m-90 -155.14 143.56 20.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 109.713 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.0 m-85 -107.54 158.76 16.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.663 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -84.77 131.16 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.303 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.62 -175.75 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.55 161.52 37.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.772 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.21 173.74 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.8 19.15 7.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' A' ' 130' ' ' THR . 0.2 OUTLIER -125.12 16.63 8.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.74 -0.6 . . . . 0.0 109.384 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.47 42.87 47.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -134.68 154.8 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.944 . . . . 0.0 109.323 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -80.87 120.17 24.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.76 127.67 33.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.8 tp -50.35 142.57 10.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.75 14.55 2.58 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 135' ' ' LEU . 84.7 p -102.61 -38.65 7.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.508 -0.995 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -90.11 -8.65 50.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 p -69.91 145.21 52.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 109.495 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.11 -179.76 42.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.8 Cg_endo -61.07 -174.71 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.924 1.749 . . . . 0.0 110.164 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.27 -35.23 0.94 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 141' ' ' PRO . 18.2 mm-40 -93.14 134.52 35.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -1.131 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 39.4 mtmt -78.51 -0.49 29.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.19 -7.05 1.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -95.32 1.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 109.652 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.2 mt -90.99 110.06 21.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -116.79 165.36 13.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.1 tp -144.4 70.75 15.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 109.21 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -62.23 112.78 1.65 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.89 1.727 . . . . 0.0 110.617 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 35.3 mtt -96.72 129.69 44.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.342 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.4 t -70.11 128.71 37.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.538 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.11 176.13 0.27 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 120.99 1.127 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -144.89 175.06 10.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.469 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.8 mtm-85 -125.35 117.48 23.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.83 102.0 12.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 109.575 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -94.47 117.9 30.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.26 99.38 11.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -51.5 -35.01 38.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.736 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 12.1 m-80 -71.86 105.05 3.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.751 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.4 4.56 89.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.25 83.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.4 m-85 -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -93.51 119.73 32.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.11 138.72 37.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -147.44 123.64 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 109.715 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.1 mt -93.96 118.08 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -69.3 150.92 97.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.092 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.0 Cg_endo -58.86 -23.96 69.91 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.175 1.25 . . . . 0.0 110.542 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.64 -15.47 51.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.67 -34.01 4.56 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.27 114.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.243 . . . . 0.0 109.497 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.42 143.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -170.15 -150.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.58 156.47 26.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 m -145.7 139.13 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -1.077 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.9 mtm-85 -76.61 6.52 5.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -94.87 103.45 15.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -81.59 6.35 15.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.2 t -90.24 7.29 38.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 59' ' ' HIS . 5.8 m-20 -93.01 113.53 60.11 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.051 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.88 2.6 0.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.675 0.917 . . . . 0.0 110.216 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 57' ' ' ASP . 42.4 m80 -84.57 -20.47 31.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.82 0.07 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 22.3 mttt -87.58 87.55 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.524 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.42 135.22 33.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -91.1 117.1 29.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -90.51 158.66 16.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.51 138.84 26.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.311 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.91 157.99 16.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.01 -91.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.16 -155.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -88.64 105.02 17.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.5 -7.8 77.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.76 136.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.88 126.94 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -94.74 130.94 41.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -0.824 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.35 151.87 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.64 ' HZ1' ' HH ' ' A' ' 82' ' ' TYR . 2.3 tttp -150.06 145.54 26.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.516 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.03 138.96 17.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 40.2 t -75.74 -62.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -1.134 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.438 ' OG ' ' CD2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -73.84 -46.89 42.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.26 68.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.416 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.94 49.7 20.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 11.9 mtt180 -141.99 150.03 40.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.64 ' HH ' ' HZ1' ' A' ' 75' ' ' LYS . 81.6 m-85 -92.33 130.07 38.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.93 150.99 46.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.34 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.65 32.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.6 ttm -126.8 134.92 50.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -92.58 178.4 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -78.13 -34.19 50.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.21 -3.43 20.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.49 66.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -80.54 119.01 22.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.442 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 7.9 mp -93.4 134.52 35.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 4.3 pp -148.74 164.95 32.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.82 157.78 16.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.06 149.42 30.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -73.03 -31.95 64.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -92.96 142.04 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.3 t -79.25 156.43 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.453 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.474 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 46.2 p -146.88 156.75 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.34 -29.71 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.409 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -93.92 57.71 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.474 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 67.9 m -140.95 3.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -101.19 160.25 14.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.466 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.98 112.07 4.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -60.06 126.04 25.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.626 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -95.55 93.48 7.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.46 HH11 ' NH1' ' A' ' 116' ' ' ARG . 60.1 ttt180 -89.89 125.16 35.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.57 132.33 36.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.79 -173.22 3.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.97 -7.0 50.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -93.73 24.11 4.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 63.59 -5.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 109.889 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 110' ' ' ASN . 51.0 m-85 -91.64 128.51 37.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.124 -0.985 . . . . 0.0 109.26 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -89.91 166.91 13.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.913 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 p -141.85 122.91 14.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 109.177 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -92.57 110.97 22.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.767 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.46 ' NH1' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.75 137.82 37.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.273 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.87 157.98 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -93.78 -64.39 1.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 109.587 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -53.74 -49.73 67.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.678 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.57 ' C ' ' H ' ' A' ' 122' ' ' SER . 7.0 m-85 -110.47 68.87 0.68 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.7 -0.625 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.8 p -59.76 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.8 m -89.14 10.37 22.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.085 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.3 m-90 -149.69 141.7 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 109.696 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.5 m-85 -109.22 150.81 27.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.688 -0.632 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.24 131.3 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.307 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.03 171.52 15.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.556 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.7 mt -132.13 165.15 24.7 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -93.37 -172.71 3.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -93.0 -13.25 28.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 9.92 35.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.59 6.02 86.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -92.43 166.54 12.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 37.7 p90 -92.74 120.21 32.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -69.83 131.65 44.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.7 tp -47.55 135.5 11.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.278 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.12 2.85 1.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 135' ' ' LEU . 59.8 p -92.21 -38.76 11.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 109.56 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -79.79 -5.0 54.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.1 p -77.25 149.62 35.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.477 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.43 179.73 45.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.94 164.83 13.23 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 121.873 1.715 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.65 -43.16 3.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 143' ' ' GLN . 1.6 mp0 -68.35 132.42 47.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -1.115 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -84.81 -5.25 59.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.69 -0.73 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 144' ' ' LYS . 10.8 pt -99.97 6.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.99 110.05 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.643 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -119.6 168.0 11.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.659 -0.65 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -142.8 70.43 19.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -61.97 105.87 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.68 141.56 32.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.513 -0.742 . . . . 0.0 109.319 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.709 ' HG ' ' H ' ' A' ' 153' ' ' ALA . 43.8 t -70.04 173.47 6.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.709 ' H ' ' HG ' ' A' ' 152' ' ' SER . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.2 175.02 1.17 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.22 1.28 . . . . 0.0 110.321 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -145.28 175.35 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 4.2 mtm-85 -133.58 119.98 20.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.532 -0.73 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mt -84.57 102.35 12.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.584 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -96.48 115.89 28.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 t -83.26 106.03 14.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.513 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -28.33 24.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.685 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.2 m-80 -77.47 105.09 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.615 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.35 4.88 87.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.57 62.67 3.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -111.64 132.46 54.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.639 -0.918 . . . . 0.0 109.785 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -93.02 115.73 28.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.844 . . . . 0.0 109.265 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.6 tp -48.77 143.1 5.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 34.0 ttt180 -149.57 118.31 6.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -89.94 106.17 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.193 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -67.02 151.21 97.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 0.0 109.038 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.1 Cg_exo -57.16 -26.18 68.06 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.045 1.163 . . . . 0.0 110.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -75.21 -0.15 18.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.51 -30.46 6.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -52.8 121.55 7.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -92.57 138.33 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -165.37 151.35 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.81 159.41 22.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.03 141.77 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -86.37 16.08 4.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 56' ' ' SER . 6.3 mt-10 -94.93 88.32 5.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.621 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -62.03 -5.2 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 54' ' ' GLU . 11.1 p -90.99 31.02 1.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.848 . . . . 0.0 109.08 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 59' ' ' HIS . 30.2 m-20 -113.87 93.5 29.51 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.96 1.6 0.42 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 120.94 1.094 . . . . 0.0 110.382 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 57' ' ' ASP . 37.2 m80 -81.41 -15.61 54.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.69 2.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -76.43 82.12 3.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 109.147 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.86 135.07 33.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.166 -0.959 . . . . 0.0 109.391 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.94 104.18 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -90.79 148.31 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 125.35 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.69 28.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.86 -76.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.459 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -94.62 -90.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 -31.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.529 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.25 -18.88 6.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.98 147.81 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -1.104 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.3 127.43 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.469 -0.769 . . . . 0.0 109.453 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.8 m -93.22 112.11 23.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.6 mt -91.91 144.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -144.24 145.66 32.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.454 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.33 135.27 12.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.04 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 109.428 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.5 t -61.42 -47.26 86.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -27.76 69.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.888 . . . . 0.0 109.472 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.8 m120 51.34 50.58 18.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.7 mtt180 -149.84 147.96 28.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.04 129.34 36.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.8 tp -57.65 145.14 35.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.57 170.09 17.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.01 140.17 29.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -87.08 170.37 11.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.76 -14.09 61.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 3.1 p30 -83.11 -47.45 11.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 144.52 -7.56 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -72.43 125.37 27.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.526 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.1 mp -92.23 138.12 31.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.02 -171.63 3.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.755 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.28 159.45 42.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.446 -0.784 . . . . 0.0 109.272 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.5 t -146.69 170.09 17.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -83.85 -35.16 24.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -92.18 135.04 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 12.0 p -83.82 106.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.47 ' H ' ' HG1' ' A' ' 98' ' ' THR . 12.6 p -95.14 -179.11 4.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 109.471 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -16.68 63.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -93.54 48.0 1.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -139.9 3.27 2.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 84.1 m-85 -95.75 162.07 13.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 87.0 m-85 -150.03 114.38 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -59.12 112.96 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.06 141.74 37.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -137.78 90.83 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.549 -0.719 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.0 tp -68.19 126.72 30.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.373 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.03 -172.5 3.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -93.9 -13.43 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.2 m120 -88.0 28.97 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 109.489 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER 60.19 -0.15 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.2 m-85 -95.26 126.97 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.655 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.4 OUTLIER -93.23 166.21 12.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.636 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.8 p -144.6 120.77 10.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.315 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -90.69 113.8 25.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -96.38 144.95 26.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.435 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -70.81 153.88 42.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 120' ' ' TYR . 47.8 ttt180 -91.69 -75.72 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.604 ' NZ ' ' HH ' ' A' ' 120' ' ' TYR . 50.8 tttm -51.37 -9.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HH ' ' NZ ' ' A' ' 119' ' ' LYS . 20.5 m-85 -141.78 62.52 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -62.06 2.04 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.683 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 120' ' ' TYR . 48.7 m -90.91 11.31 23.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.05 142.35 19.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.6 m-85 -106.76 170.04 8.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.4 t -90.73 126.75 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -151.58 148.37 27.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.11 172.61 6.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.551 -0.718 . . . . 0.0 109.44 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -93.95 -169.48 2.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.449 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -92.78 -12.31 31.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 t -93.69 -4.01 51.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 9.92 59.92 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -92.75 141.17 28.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.133 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 26.0 p90 -62.03 120.14 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.77 126.69 30.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.9 tp -47.78 140.92 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.36 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.35 -4.9 39.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -87.82 -28.34 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -1.18 . . . . 0.0 109.436 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.92 -4.93 57.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.6 p -70.45 162.03 29.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 179.99 22.61 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.01 167.3 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.94 1.76 . . . . 0.0 110.17 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.32 -48.39 2.64 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -79.51 129.27 34.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -1.186 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -82.64 2.8 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.92 -2.73 2.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.3 pt -93.28 1.34 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.47 87.65 7.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.387 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.66 162.94 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.6 tp -138.46 71.83 44.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.92 103.76 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.911 1.741 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.26 35.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.2 t -70.03 175.17 4.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.458 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.14 160.07 16.98 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 121.066 1.177 . . . . 0.0 110.126 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -140.43 138.4 34.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.465 -0.772 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.2 mtm-85 -88.57 129.06 35.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.9 mt -93.91 101.09 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -95.1 121.67 36.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 t -88.56 105.13 17.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -15.24 8.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 16.3 m120 -86.38 104.38 15.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 75.31 4.94 75.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.7 89.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.8 m-85 -145.64 130.78 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -1.13 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -93.59 123.82 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.65 136.55 56.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.928 . . . . 0.0 109.219 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 57' ' ' ASP . 40.4 ttp180 -146.04 118.03 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.637 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mt -92.62 126.31 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -87.4 152.02 51.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.14 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.63 -26.59 65.69 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.236 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.95 1.7 12.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.965 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -25.09 10.88 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -57.55 114.96 2.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -1.19 . . . . 0.0 109.384 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.26 142.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -171.35 151.92 3.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.8 155.29 23.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 m -146.43 155.08 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.23 9.07 35.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.53 102.17 14.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -83.38 -4.96 58.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.358 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -78.74 13.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.25 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.507 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -105.59 104.93 50.73 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.84 1.06 0.91 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 120.77 0.98 . . . . 0.0 110.2 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 57' ' ' ASP . 40.6 m80 -76.15 -26.69 56.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.273 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -65.65 -5.33 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -75.9 87.41 2.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.92 135.23 33.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.857 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 6.8 tt0 -89.73 114.32 25.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.325 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.9 mp -86.6 153.07 22.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.0 109.628 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -144.68 131.91 20.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.93 119.78 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.57 -73.2 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -90.56 -143.85 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.482 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -93.94 -26.62 16.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.78 -9.38 2.54 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.45 104.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -1.204 . . . . 0.0 109.38 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.08 177.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.537 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -145.82 118.44 8.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.04 149.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' NZ ' ' NE2' ' A' ' 63' ' ' GLN . 11.0 tttm -146.59 144.35 29.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.44 133.65 11.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.4 -74.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -61.75 -26.03 67.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.95 -26.6 31.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 51.11 50.0 19.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -147.76 146.95 29.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -94.5 134.37 37.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.92 143.49 57.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.223 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.37 134.21 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.9 ttm -97.63 139.33 33.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.385 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -92.1 173.87 7.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.427 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -77.67 -27.09 50.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 6.4 p-10 -73.19 -49.4 28.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.486 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 145.67 -13.19 1.76 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -72.62 123.61 23.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.567 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.2 mp -92.36 137.15 32.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -147.87 -172.41 4.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.71 45.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.349 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 m -145.88 153.48 40.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CG ' ' NH1' ' A' ' 81' ' ' ARG . 9.1 mtmp? -68.62 -29.77 68.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.529 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.48 148.33 23.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.3 t -92.37 149.54 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.428 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 38.2 p -146.51 157.43 43.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.45 -17.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 44.82 1.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.428 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 3.8 m -144.62 8.12 1.31 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 81.1 m-85 -100.0 159.7 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 75.3 m-85 -149.37 140.53 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.49 125.61 33.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 109.448 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -90.25 135.04 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.281 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -141.3 126.03 17.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.387 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tt -92.51 125.45 37.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.292 -0.88 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -90.67 -173.87 3.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.408 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 m -93.34 63.85 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 112' ' ' TYR . 34.1 p30 -169.26 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.36 -7.52 0.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 110' ' ' ASN . 50.3 m-85 -93.75 135.85 34.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -95.38 166.44 11.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.785 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 22.9 p -139.82 119.9 13.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -98.75 117.07 32.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -95.05 161.47 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 109.272 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.56 159.77 30.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.871 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.66 -61.84 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.399 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -83.28 -36.44 24.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' SER . 16.5 m-85 -89.29 50.54 1.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -49.0 -14.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -90.03 17.54 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 13.1 m-90 -155.05 141.33 18.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.913 . . . . 0.0 109.62 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.4 m-85 -112.04 169.98 8.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.683 -0.636 . . . . 0.0 109.587 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.75 133.17 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.377 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 154.86 33.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.8 mt -115.66 172.75 6.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.4 -169.23 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -94.97 -17.04 22.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.33 3.34 55.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.525 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.81 2.91 66.55 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.4 163.47 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -1.177 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 33.7 p90 -79.23 120.27 23.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 0.0 109.489 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -72.05 128.66 36.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.6 tp -47.83 140.65 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.95 22.35 1.21 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.3 p -115.08 -27.25 7.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.598 -0.942 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -90.02 -9.27 49.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.682 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 p -69.97 152.28 44.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.22 -179.14 40.47 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.1 151.81 75.95 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.85 1.7 . . . . 0.0 110.185 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.43 -28.3 9.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -86.74 119.76 27.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -73.56 -3.45 27.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.78 -3.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -96.43 2.96 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.05 110.12 21.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.51 163.13 17.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 109.434 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.4 tp -137.79 72.34 48.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.49 -0.756 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.63 108.0 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.836 1.691 . . . . 0.0 110.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.458 -0.776 . . . . 0.0 109.584 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.4 t -70.16 147.65 49.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.231 -0.918 . . . . 0.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.461 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.43 164.07 11.6 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.187 1.258 . . . . 0.0 110.431 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -149.11 129.91 14.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.9 mtt-85 -87.34 117.18 25.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.83 99.73 11.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -94.82 121.48 36.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.0 t -91.28 113.28 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.269 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' CD ' ' HH ' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -62.29 -19.96 63.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 0.0 109.617 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.6 m-80 -82.86 104.99 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.17 4.96 87.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.1 86.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 43.8 m-85 -143.49 131.36 21.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 109.651 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -94.33 119.06 32.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.6 tp -47.8 140.78 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 44.5 ttt180 -145.97 115.98 7.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.01 104.15 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.066 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -64.89 150.55 94.73 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.109 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.7 Cg_endo -57.68 -26.67 73.99 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.142 1.228 . . . . 0.0 110.057 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -75.45 3.15 9.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.83 -30.74 5.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -50.48 114.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -1.152 . . . . 0.0 109.358 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.7 142.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.471 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -173.4 154.6 2.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.54 160.11 25.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -148.1 141.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -1.115 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.7 mtm-85 -84.54 2.12 42.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.95 112.97 20.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 109.771 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -85.21 -5.83 59.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.71 27.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' HIS . 88.3 m-20 -115.16 90.44 23.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.65 1.95 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.035 1.157 . . . . 0.0 110.64 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' ASP . 44.2 m80 -80.12 -10.74 59.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.279 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -79.81 -2.19 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -75.64 87.85 2.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.83 135.92 33.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -88.94 106.19 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.274 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -91.86 153.46 19.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.95 135.94 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.533 -0.729 . . . . 0.0 109.039 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 153.09 28.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -150.15 146.62 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.81 . . . . 0.0 109.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 53.06 -146.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 62.15 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.674 -0.642 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.28 1.67 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.48 156.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -1.095 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 5.6 m -145.32 123.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.355 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 m -93.32 123.98 36.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 mt -97.08 145.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.454 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.401 ' NZ ' ' OH ' ' A' ' 82' ' ' TYR . 40.2 tttt -146.75 152.15 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.47 132.09 11.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -73.52 -62.61 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -40.26 62.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 109.532 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.73 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 51.72 44.71 29.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.785 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 43.4 mtp180 -141.58 144.23 34.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' OH ' ' NZ ' ' A' ' 75' ' ' LYS . 81.1 m-85 -89.92 136.47 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.6 tp -64.13 149.47 47.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.119 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 131.37 14.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 50.6 ttm -97.67 132.58 43.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 109.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -91.5 176.02 6.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -83.29 -22.62 32.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.432 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 23.8 p30 -77.16 -4.76 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.948 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.89 4.61 65.0 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -88.77 122.16 31.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -1.175 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.0 mp -93.34 132.12 37.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.86 178.02 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.03 163.26 17.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.748 -0.595 . . . . 0.0 109.418 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -150.24 161.61 42.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.368 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -79.37 -34.57 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.75 164.55 13.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.15 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.456 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 74.8 p -147.52 177.14 9.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -22.5 62.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.15 13.26 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.495 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 88.8 m -93.69 -9.97 35.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 69.4 m-85 -96.21 153.18 17.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 73.8 m-85 -146.35 137.18 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -77.17 124.19 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -0.984 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.44 145.35 24.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 108' ' ' GLU . 19.3 ttp180 -147.51 116.32 6.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.04 134.26 34.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 106' ' ' ARG . 3.7 mm-40 -93.07 176.7 6.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.1 p -85.2 -4.02 59.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -93.38 28.48 2.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.28 -4.64 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.538 ' HH ' ' CD ' ' A' ' 35' ' ' LYS . 36.8 m-85 -88.95 -172.13 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -146.81 167.67 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.77 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 p -142.98 169.49 17.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -0.76 . . . . 0.0 109.184 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -145.27 110.7 5.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -92.58 140.18 29.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.364 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -61.63 147.69 44.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -75.87 -57.93 3.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -75.61 -42.25 52.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.508 ' C ' ' H ' ' A' ' 122' ' ' SER . 44.3 m-85 -92.91 52.69 1.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.0 p -53.81 -5.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.813 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.2 m -89.92 10.23 24.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.68 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.16 146.09 22.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.811 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -104.65 165.27 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 109.573 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.0 118.76 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -152.56 143.62 23.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.982 . . . . 0.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.31 175.4 6.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.431 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -91.01 -142.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.341 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -128.77 -16.83 4.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.66 . . . . 0.0 109.519 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 130' ' ' THR . 1.2 t -94.85 37.79 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.35 51.72 56.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -142.63 162.01 36.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -1.054 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.7 p90 -92.17 120.28 32.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.444 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.53 129.73 40.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 137' ' ' SER . 8.1 tp -55.42 157.9 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.152 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -80.28 24.31 3.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 135' ' ' LEU . 51.8 p -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.957 . . . . 0.0 109.539 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -89.64 -5.14 57.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.654 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 74.5 p -76.18 155.12 34.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.19 -179.93 35.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.73 179.61 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.857 1.705 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.91 -50.98 3.74 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.66 135.1 41.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 7.8 mtpt -83.99 7.44 18.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.86 -6.25 7.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.67 -2.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.9 mt -88.16 90.48 8.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -97.58 167.94 10.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 0.0 109.418 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -140.44 70.35 32.49 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.3 101.37 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.777 1.651 . . . . 0.0 110.507 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.3 mtt -96.71 129.18 44.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.1 t -70.08 140.54 52.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.972 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.78 150.3 71.9 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.979 1.119 . . . . 0.0 110.228 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -138.26 141.21 39.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.178 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -94.93 128.17 41.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -84.91 124.66 31.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -115.23 114.46 25.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.0 t -86.82 106.02 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -47.55 -35.32 8.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.43 -0.794 . . . . 0.0 109.922 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.08 105.04 2.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.21 5.55 76.99 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.33 54.04 10.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.95 134.02 45.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.594 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 24.6 m-85 -93.8 117.06 29.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.15 136.94 23.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.244 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 5.9 ttt180 -147.54 124.51 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.749 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.65 122.44 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.086 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.77 151.38 73.81 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 109.173 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.529 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.8 Cg_endo -59.14 -23.41 69.08 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.176 1.251 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.4 p30 -74.98 3.26 8.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.52 3.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 mmm180 -46.94 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 109.534 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -141.38 134.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.394 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -166.9 152.13 7.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.41 21.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.73 144.86 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -1.137 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . 19.9 mmm-85 -64.93 -36.6 84.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -85.43 -1.31 56.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.428 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.1 p -94.03 15.2 17.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.1 m-20 -92.01 114.57 62.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.157 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.9 -2.14 2.0 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 120.601 0.867 . . . . 0.0 110.113 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.455 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.0 m80 -79.49 -28.8 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.312 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.57 -6.32 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.424 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -74.84 86.82 2.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mt -90.15 135.26 33.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -89.7 109.31 20.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.3 mp -87.67 156.56 19.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.628 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -140.68 -175.24 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.476 -0.765 . . . . 0.0 109.279 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.09 144.24 51.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.683 . . . . 0.0 109.523 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.3 mm-40 -145.46 144.41 30.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 48.17 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.085 -1.01 . . . . 0.0 109.22 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.88 62.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.78 -18.29 1.43 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLU . 21.4 t -92.51 119.25 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.236 . . . . 0.0 109.678 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.12 179.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.339 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 m -145.87 116.87 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.62 145.51 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.92 129.23 12.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.41 133.86 12.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.94 -74.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -1.167 . . . . 0.0 109.53 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.5 m -47.13 -52.56 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.97 -22.37 65.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.9 m120 51.76 38.75 23.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 33.4 mtt180 -137.03 154.76 50.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.441 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -94.28 134.72 36.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.26 144.93 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.19 132.43 15.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.0 ttp -98.7 142.38 30.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.815 . . . . 0.0 109.555 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -94.93 177.93 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.53 -12.59 48.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.28 -2.54 58.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.85 64.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -88.81 118.58 28.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -1.118 . . . . 0.0 109.499 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.1 mp -92.36 132.17 36.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.4 pp -146.08 -170.45 3.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.848 . . . . 0.0 109.464 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.97 151.72 44.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 109.476 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -145.43 170.06 17.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -83.87 -23.38 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 t -92.44 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.46 94.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.558 ' N ' ' SG ' ' A' ' 101' ' ' CYS . 3.3 p -76.45 -175.72 3.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.04 -11.23 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 9.16 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 98' ' ' THR . 3.7 m -94.32 -0.35 55.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.579 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 96.7 m-85 -94.94 151.15 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -0.841 . . . . 0.0 109.716 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.4 m-85 -147.55 134.82 20.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -80.17 159.35 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.98 . . . . 0.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -123.71 139.83 53.6 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.16 77.84 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.83 151.99 10.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.29 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -129.4 168.72 15.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.661 -0.649 . . . . 0.0 109.324 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.7 p -77.2 58.05 1.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 112' ' ' TYR . 40.8 p30 -155.3 17.79 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 63.51 -7.75 0.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.526 -0.734 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 110' ' ' ASN . 49.9 m-85 -95.35 128.65 42.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.86 170.16 10.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.61 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 p -144.32 111.8 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -102.19 126.69 49.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -116.18 157.16 25.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 109.634 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.569 ' HG ' ' N ' ' A' ' 118' ' ' ARG . 4.4 t -65.15 160.61 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.873 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 117' ' ' SER . 53.9 ttt180 -90.7 -73.99 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 8.4 tptm -58.11 -9.72 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -136.39 57.77 1.76 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.529 -0.732 . . . . 0.0 109.445 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.8 p -61.26 1.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.687 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.6 m -89.96 11.52 20.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.99 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 14.5 m-90 -146.92 132.71 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -98.65 153.0 19.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.596 -0.69 . . . . 0.0 109.946 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.76 134.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.39 171.42 19.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.5 mt -132.32 172.03 12.96 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -94.49 -163.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -93.79 -24.94 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.707 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -77.22 -1.35 29.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.05 69.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.5 mp0 -85.11 179.1 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 31.6 p90 -94.11 120.77 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.67 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.611 ' NZ ' ' NE2' ' A' ' 143' ' ' GLN . 26.0 tttt -69.72 138.66 53.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 137' ' ' SER . 15.2 tp -47.65 142.56 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.0 19.3 1.27 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.3 p -115.18 -27.0 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.914 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -90.06 -4.94 57.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.749 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 p -70.89 135.93 48.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.45 179.72 47.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.6 Cg_endo -61.23 179.08 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.88 1.72 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.8 -30.75 1.28 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.611 ' NE2' ' NZ ' ' A' ' 134' ' ' LYS . 15.1 mt-30 -92.48 134.08 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.18 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 1.85 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.36 -11.59 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.2 pt -92.59 -2.8 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.6 mt -88.63 86.79 7.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 109.503 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -91.29 164.43 13.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.56 70.48 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.35 109.97 1.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.803 1.669 . . . . 0.0 110.303 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.0 mtt -98.04 128.37 44.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -68.57 160.57 29.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.647 -0.658 . . . . 0.0 109.393 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 166.46 7.62 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.075 1.183 . . . . 0.0 110.27 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -143.51 127.27 17.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.215 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -84.9 124.67 31.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.543 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.52 104.87 16.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -99.09 126.68 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.509 -0.744 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 43.8 t -89.45 130.74 35.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.19 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -79.8 -15.7 56.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.21 104.82 17.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.67 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.56 4.94 89.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.4 88.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 44.7 m-85 -145.42 132.17 20.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.733 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -94.73 120.69 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.402 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.4 tp -47.53 142.64 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 12.8 ttt180 -150.32 114.74 5.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 117.32 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.476 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 90.8 m-70 -79.71 150.24 72.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.913 . . . . 0.0 109.031 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.5 -23.96 58.92 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.075 1.183 . . . . 0.0 110.259 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 4.8 p30 -75.01 -2.49 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.72 -31.51 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 46' ' ' ASP . 3.2 mtm-85 -56.76 117.7 4.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -1.153 . . . . 0.0 109.528 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.09 140.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.491 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 43.0 p30 -164.14 153.27 13.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.06 160.44 24.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -146.84 149.77 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -1.155 . . . . 0.0 109.478 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -80.78 4.6 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 57' ' ' ASP . 20.7 tt0 -88.01 91.6 8.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.383 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -77.84 48.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 p -163.49 20.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.715 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -77.7 141.36 64.44 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.991 . . . . 0.0 108.991 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.89 22.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.191 1.261 . . . . 0.0 111.073 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.5 m80 -132.61 -10.2 3.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.173 -0.954 . . . . 0.0 109.99 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.3 -3.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.046 -1.033 . . . . 0.0 109.338 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.95 86.7 7.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.01 135.0 33.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -93.59 110.5 22.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.07 136.47 26.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.77 123.17 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.13 -30.12 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -165.45 -159.93 0.44 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 10.5 ptt180 -89.18 118.54 28.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.01 66.96 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 t -145.75 99.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -1.09 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 ' C ' ' HG ' ' A' ' 73' ' ' SER . 2.4 m -93.19 174.83 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 72' ' ' VAL . 9.1 m -145.48 119.72 9.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.67 147.59 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.594 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.55 ' HZ3' ' HH ' ' A' ' 82' ' ' TYR . 14.8 tttt -147.01 132.01 18.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.374 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.91 132.9 12.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.52 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -1.155 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 t -53.83 -47.56 70.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.7 70.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.35 46.35 26.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -136.09 142.63 44.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.55 ' HH ' ' HZ3' ' A' ' 75' ' ' LYS . 57.6 m-85 -89.93 116.4 27.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 tp -50.69 149.7 3.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.18 128.34 11.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.7 ttm -94.16 138.11 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -83.44 166.88 17.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -20.57 60.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.46 ' CG ' ' HE ' ' A' ' 90' ' ' ARG . 1.7 p30 -87.02 -45.14 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 147.69 -10.67 1.26 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' HE ' ' CG ' ' A' ' 88' ' ' ASP . 75.5 mtm180 -68.65 122.01 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -1.2 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mp -90.87 129.55 36.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 3.6 pp -147.53 150.93 35.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.264 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.2 157.32 16.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.748 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.85 146.21 27.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.454 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -70.99 -21.43 62.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 t -89.69 151.59 21.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.16 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -147.43 162.01 39.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -11.55 31.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.46 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 120' ' ' TYR . 23.3 mt-10 -94.12 4.96 53.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -91.52 -8.81 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.498 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 90.3 m-85 -95.03 153.03 17.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 69.2 m-85 -145.69 127.02 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.93 116.21 5.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.64 89.2 7.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.275 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.95 127.7 36.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.1 134.21 35.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -93.77 -177.78 4.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -93.63 40.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.5 m120 -148.15 30.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.57 -0.39 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.531 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.7 m-85 -97.36 125.34 41.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 0.0 109.284 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.2 m-20 -94.54 167.18 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 109.855 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -142.61 122.13 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.448 -0.782 . . . . 0.0 109.235 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -94.2 115.14 27.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 151.93 20.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.65 152.3 35.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.105 -0.997 . . . . 0.0 109.591 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -87.59 -75.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 21.7 tptt -49.69 -10.97 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 10.7 m-85 -143.91 66.37 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -64.71 5.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' TYR . 33.6 m -91.59 10.49 27.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.692 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -151.35 144.62 24.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 24.1 m-85 -108.26 166.25 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.35 132.94 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.85 166.28 33.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -132.7 175.77 9.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 0.0 109.336 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -95.21 -169.64 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.389 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.43 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 6.6 ptm180 -91.65 -12.72 33.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.68 1.44 56.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.4 64.88 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -85.34 161.84 19.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.8 p90 -91.98 120.51 32.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.511 ' HZ3' ' C ' ' A' ' 138' ' ' LYS . 13.8 ttpp -72.98 134.92 44.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.404 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.7 tp -47.3 136.79 8.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.888 . . . . 0.0 109.224 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.92 -8.75 74.17 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -83.45 -29.62 27.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.492 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.511 ' C ' ' HZ3' ' A' ' 134' ' ' LYS . 8.5 mtpp -89.98 -4.8 57.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 5.3 p -69.87 153.87 42.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.64 -179.75 43.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.94 162.62 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.803 1.669 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.57 -29.46 7.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.28 127.74 34.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -1.145 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -84.1 -2.88 57.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.23 -5.13 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.425 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.57 0.45 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.95 91.86 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -95.77 167.59 11.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.656 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.72 73.54 54.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.291 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.38 106.49 0.49 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.861 1.707 . . . . 0.0 110.608 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.1 mtp -97.41 130.24 44.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.463 -0.773 . . . . 0.0 109.409 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.5 t -70.04 137.01 50.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.47 164.0 6.07 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.096 1.197 . . . . 0.0 110.266 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -136.61 136.68 39.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.603 -0.685 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.8 mtt-85 -87.46 121.87 30.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.482 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.6 mt -86.6 97.67 10.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.25 120.46 33.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.61 107.17 19.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.15 -22.07 60.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.9 m-80 -80.13 96.42 6.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.928 . . . . 0.0 109.488 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 85.7 4.62 85.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 84.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -143.02 132.4 23.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -1.041 . . . . 0.0 109.515 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -94.13 124.67 38.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.81 140.25 48.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.28 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -147.41 121.48 9.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.6 mt -94.36 121.53 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 89.1 m-70 -86.44 150.29 51.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.029 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -57.98 -22.41 54.86 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.105 1.203 . . . . 0.0 110.109 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 14.1 p30 -75.04 1.04 14.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -39.33 3.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.463 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.1 mtm-85 -54.51 119.91 5.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -102.02 130.58 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -149.71 163.5 37.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.399 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.16 157.5 23.35 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -146.07 141.96 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -1.12 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -79.79 3.89 18.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm-40 -91.14 91.85 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 56.26 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -149.94 9.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.017 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' HIS . 2.6 p-10 -92.07 140.06 24.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.55 6.36 0.2 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.935 1.09 . . . . 0.0 110.564 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' ASP . 78.0 m80 -94.76 -34.54 12.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.78 -6.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 109.414 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 84.47 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.91 135.12 33.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tm0? -91.67 112.72 24.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.114 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 10.2 mp -92.47 152.03 19.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.657 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -138.03 123.99 20.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.585 -0.697 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.1 134.18 35.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -100.28 -89.65 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 109.349 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.19 -155.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.38 54.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 165.15 -30.32 0.22 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.95 154.89 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 109.537 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.32 166.25 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -137.16 124.75 22.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.33 148.29 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -148.08 129.95 15.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.61 138.0 16.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.17 -68.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -58.0 -54.36 47.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.77 67.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 50.66 51.75 16.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.602 ' HE ' ' HZ2' ' A' ' 95' ' ' LYS . 91.1 mtt180 -147.6 149.2 32.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.87 130.21 36.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.21 141.54 58.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 109.268 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 156.25 41.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 tpp -112.29 143.75 42.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.67 -0.644 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -80.17 -169.31 2.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -19.11 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.3 p30 -91.14 -38.47 12.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 109.62 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.14 -7.87 1.88 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -70.05 127.51 33.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 7.7 mp -91.9 139.02 31.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.04 -175.95 5.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.579 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.34 155.06 46.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -145.64 170.02 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HZ2' ' HE ' ' A' ' 81' ' ' ARG . 9.9 mttm -80.38 -42.38 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 126.68 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 10.4 p -65.53 120.09 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 3.2 p -92.21 -174.1 3.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 101' ' ' CYS . 52.7 t0 -80.03 -31.97 39.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.79 16.52 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.464 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.495 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 64.4 m -94.85 1.72 55.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.6 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.1 m-85 -96.76 148.66 22.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 61.6 m-85 -145.92 115.59 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.309 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -60.85 117.02 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.087 -1.008 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -81.09 148.29 29.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.582 ' NH2' HH21 ' A' ' 116' ' ' ARG . 36.0 ttp180 -148.2 108.95 4.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.97 121.23 34.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -90.22 -177.67 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.428 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 3.31 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -91.03 18.24 6.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.463 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.46 -0.67 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.1 m-85 -99.17 136.28 39.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.72 162.65 13.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.771 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.5 p -143.41 122.8 13.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -95.26 109.17 21.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.856 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.582 HH21 ' NH2' ' A' ' 106' ' ' ARG . 37.9 ttm180 -93.36 149.22 21.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.983 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -80.19 167.74 19.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -93.78 -87.1 0.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.412 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -48.54 -13.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 118' ' ' ARG . 6.1 m-85 -126.26 56.8 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.9 p -57.91 -19.75 32.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.727 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.9 m -89.55 19.95 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.917 -1.114 . . . . 0.0 108.989 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -139.83 151.89 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.512 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 28.3 m-85 -131.54 152.57 50.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.712 . . . . 0.0 109.522 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.09 135.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.2 -178.45 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.11 165.96 26.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.87 175.33 7.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -87.02 -13.12 45.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 1.01 57.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.55 7.75 61.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -92.59 166.22 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 27.8 p90 -83.19 120.25 25.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 135' ' ' LEU . 38.9 tttm -71.51 137.42 48.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 5.7 tp -61.65 -152.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -127.71 -36.87 0.47 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.52 ' OG ' ' NZ ' ' A' ' 138' ' ' LYS . 27.0 p -52.91 -29.93 31.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.221 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.52 ' NZ ' ' OG ' ' A' ' 137' ' ' SER . 2.4 mptp? -90.18 -20.08 23.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 70.4 p -69.93 136.7 50.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.51 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.14 179.81 48.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.74 153.97 58.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.874 1.716 . . . . 0.0 110.238 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.19 32.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -1.115 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 2.4 mtmp? -74.92 -7.76 54.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.12 -3.21 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -99.8 6.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.89 110.2 22.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.841 . . . . 0.0 109.614 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.14 163.72 16.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.684 -0.635 . . . . 0.0 109.402 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 tp -141.43 70.92 26.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.466 -0.771 . . . . 0.0 109.243 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.9 109.3 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.923 1.749 . . . . 0.0 110.559 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.2 mtt -95.92 125.7 40.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.1 t -68.72 141.57 55.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.562 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.72 167.72 3.81 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.138 1.225 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -145.77 133.46 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.232 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -85.03 120.96 27.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 mt -84.91 95.97 9.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -91.79 115.03 27.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.0 t -81.83 125.12 30.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -78.96 -14.88 58.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.903 . . . . 0.0 109.761 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 29.9 m-80 -88.32 92.49 9.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 93.02 4.92 64.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.75 82.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.4 m-85 -142.7 132.97 24.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.364 -1.08 . . . . 0.0 109.552 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -93.55 129.4 39.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.96 146.46 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 6.8 ttt180 -145.52 159.12 43.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.51 104.97 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.23 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.9 m-70 -66.92 150.58 97.75 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.079 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.2 Cg_exo -57.07 -24.05 55.95 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.157 1.238 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 23.8 p30 -74.98 -1.7 23.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.82 -32.04 6.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -52.15 119.94 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -1.209 . . . . 0.0 109.458 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.4 150.43 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 109.507 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 16.3 p-10 -174.57 151.35 1.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.92 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 155.25 21.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.87 139.54 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.0 mtm-85 -71.52 -7.12 45.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.04 98.04 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -84.98 7.15 22.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 t -91.34 -20.12 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -63.58 116.14 23.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.128 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.36 0.39 1.03 Allowed 'Trans proline' 0 C--O 1.213 -0.737 0 C-N-CA 120.632 0.888 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' ASP . 49.4 m80 -77.72 -6.63 54.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.86 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -87.63 6.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.3 87.41 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -91.77 135.28 34.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -89.75 105.39 17.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.51 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.5 mp -89.7 153.04 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -144.7 137.92 26.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.73 122.96 32.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -95.47 -76.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -95.96 -124.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -92.7 -76.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 5.44 81.24 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.08 140.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.9 m -141.02 127.32 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.303 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -91.47 121.1 32.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.611 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.32 145.12 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.321 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -146.84 143.81 28.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.13 139.98 18.81 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.449 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 58.5 t -80.02 -58.24 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -1.164 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.5 -43.78 18.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.12 67.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 3.1 m-80 51.25 50.84 18.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.57 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 94.1 mtt180 -148.5 149.3 31.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -93.17 129.79 39.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.937 . . . . 0.0 109.585 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.4 142.6 51.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.17 133.35 18.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.1 ttm -92.43 145.53 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -92.99 -177.34 4.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 21.2 mm-40 -79.62 -40.43 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.7 p30 -69.95 -37.14 75.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 135.8 1.75 2.94 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 90' ' ' ARG . 3.9 mtm-85 -76.45 119.15 19.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.5 mp -92.8 134.87 34.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.17 178.04 9.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.708 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.88 158.12 19.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.687 -0.633 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -150.06 134.46 17.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -54.84 -49.97 69.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -85.0 130.55 34.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.521 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -85.66 160.43 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 p -147.49 -172.98 4.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -13.0 62.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -95.91 50.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.1 m -147.43 9.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 63.0 m-85 -96.16 152.67 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.672 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.7 m-85 -150.25 115.77 5.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.897 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -57.56 152.56 14.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.42 137.34 54.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -142.8 134.52 26.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.438 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.17 128.57 46.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 109.679 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -86.33 171.42 11.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.277 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -76.21 -5.04 45.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.58 17.91 10.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.01 61.71 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -0.778 . . . . 0.0 110.205 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.452 ' C ' ' ND2' ' A' ' 113' ' ' ASN . 48.7 m-85 -144.6 -171.93 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 112' ' ' TYR . 4.3 m-80 -147.91 114.55 6.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 109.804 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -95.36 124.06 39.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.264 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -96.32 109.16 21.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -97.57 147.54 24.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.192 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 t -78.99 158.88 27.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.22 -78.01 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.449 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -47.86 -34.81 9.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.2 m-85 -112.22 65.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.6 p -64.08 3.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' TYR . 54.4 m -93.47 11.72 27.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.2 161.24 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 19.4 m-85 -123.91 169.91 11.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -87.92 122.52 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.48 144.45 22.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.615 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -95.86 -176.29 3.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -94.33 -108.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.86 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -148.17 -35.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 109.457 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -81.25 10.54 5.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.68 10.62 60.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -93.93 166.82 11.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -1.172 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -89.99 120.45 31.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.428 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -69.83 139.08 53.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.4 tp -58.64 141.94 50.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -66.46 5.16 2.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 135' ' ' LEU . 96.4 p -93.48 -32.37 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -90.0 -16.95 28.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.554 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.8 p -69.91 161.41 30.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.36 179.33 31.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.1 Cg_endo -61.7 178.38 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.88 1.72 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 -33.21 0.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 141' ' ' PRO . 17.2 mt-30 -87.65 128.11 35.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -1.207 . . . . 0.0 109.601 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 146' ' ' ILE . 37.8 mtmt -74.96 -2.82 28.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.16 -3.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.45 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.511 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.1 pt -97.49 3.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.1 109.95 21.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -116.05 163.75 15.46 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.1 tp -140.85 72.41 28.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.141 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.55 115.18 2.5 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.853 1.702 . . . . 0.0 110.711 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.4 mtt -97.13 121.84 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.8 t -69.98 139.86 52.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.254 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.61 150.6 60.03 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 121.13 1.22 . . . . 0.0 110.289 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -143.31 141.86 31.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.198 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' NH2' ' O ' ' A' ' 55' ' ' LYS . 7.8 mtp180 -92.97 128.28 38.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -85.03 128.78 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -115.31 114.51 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.1 105.7 17.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -48.51 -35.14 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 109.908 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 105.01 3.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 109.715 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.02 5.91 85.41 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.27 52.49 13.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -99.17 137.64 37.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.492 -1.005 . . . . 0.0 109.746 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -95.61 112.12 23.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.3 tp -46.51 145.18 1.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.661 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 64.0 ttt180 -144.26 154.26 42.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.679 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -134.74 127.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -91.65 149.41 39.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.124 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -58.26 -22.02 55.21 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.241 1.294 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.82 -11.62 60.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 109.677 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.84 15.02 38.06 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -93.8 115.55 27.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.107 -1.231 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.87 131.4 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -148.32 -163.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.383 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.86 127.18 2.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.72 155.61 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.468 -1.019 . . . . 0.0 108.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LYS . 16.7 mtm-85 -91.64 -16.42 27.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.986 -1.071 . . . . 0.0 109.451 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.8 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' ARG . 18.4 pttp -83.48 -2.71 56.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.88 10.02 20.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.142 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -104.56 106.03 52.71 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.56 2.48 0.52 Allowed 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 120.744 0.963 . . . . 0.0 110.273 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.5 m80 -76.99 -28.01 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -72.27 -8.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.83 92.05 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -91.31 135.61 33.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.22 108.95 19.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.224 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 8.9 mp -91.26 153.15 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -147.88 133.99 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.303 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 169.25 18.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 67' ' ' GLU . 3.1 tm-20 -145.04 -34.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -154.01 -163.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.487 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 80.7 mtm180 -84.88 58.82 5.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.575 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.47 -26.84 1.68 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.64 138.6 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -1.181 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.97 179.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.276 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 m -145.38 121.84 11.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.635 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.9 mt -93.96 147.7 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -146.46 140.09 25.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.399 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.48 138.71 19.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 41.2 t -80.0 -68.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.47 -15.6 59.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.7 24.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 77' ' ' VAL . 44.5 m-20 51.16 45.69 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.594 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 73.1 mtt180 -147.43 148.06 30.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -94.61 130.95 40.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -60.4 147.83 39.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.294 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.02 137.15 19.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.636 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.8 ttm -100.43 132.41 45.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.467 -0.771 . . . . 0.0 109.341 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -78.82 157.46 28.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -21.08 66.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 2.7 p-10 -84.77 -42.58 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.36 -7.48 1.8 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -72.54 122.3 21.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 109.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.6 mp -92.59 129.79 38.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -146.59 -174.58 4.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.01 154.07 44.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -146.46 163.93 34.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -70.14 -33.01 71.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.92 127.3 34.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 8.4 p -82.64 85.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.6 p -68.3 -167.26 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 101' ' ' CYS . 55.3 m-20 -80.0 -26.81 39.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.81 7.34 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.521 ' H ' ' C ' ' A' ' 99' ' ' ASP . 85.8 m -96.72 -3.04 43.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -86.64 149.87 24.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -150.03 117.74 6.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.451 ' CB ' ' HE ' ' A' ' 116' ' ' ARG . 33.0 m-85 -64.06 128.09 34.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -97.89 134.99 40.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -145.05 131.33 19.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.558 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.9 tp -95.91 120.16 35.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.63 170.88 12.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.4 t -78.29 53.27 1.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 112' ' ' TYR . 11.2 t-20 -150.84 22.86 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.25 0.23 0.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 109.568 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.6 m-85 -101.78 138.13 39.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -90.71 164.01 14.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.71 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 p -142.44 117.95 10.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -98.43 118.63 35.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.416 -0.802 . . . . 0.0 109.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HE ' ' CB ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -102.07 148.07 25.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.549 -0.72 . . . . 0.0 109.301 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -73.66 156.25 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 120' ' ' TYR . 1.1 ttt-85 -89.76 -77.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 5.7 tptt -48.35 -12.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 12.0 m-85 -143.82 67.12 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -65.27 5.02 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 120' ' ' TYR . 37.0 m -90.39 9.75 27.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.578 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -151.51 142.77 23.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.8 m-85 -110.65 163.84 13.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 109.561 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -80.82 138.46 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.04 -177.67 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -142.64 169.21 18.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -95.07 -178.12 4.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -11.45 32.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 1.9 t -93.58 2.64 56.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.75 4.93 67.04 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.6 mp0 -93.32 169.7 10.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.129 . . . . 0.0 109.473 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.5 p90 -92.54 120.46 33.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.425 ' HZ2' ' NE2' ' A' ' 143' ' ' GLN . 8.6 tttt -69.78 135.59 49.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.3 tp -47.65 123.78 6.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.222 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.47 -23.97 29.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.2 p -80.17 -20.79 43.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -1.195 . . . . 0.0 109.647 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -90.07 -8.89 50.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 45.2 p -73.02 157.75 36.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.68 179.74 42.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 172.11 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.876 1.717 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.99 -37.95 2.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.425 ' NE2' ' HZ2' ' A' ' 134' ' ' LYS . 59.8 mt-30 -83.55 131.88 34.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -1.19 . . . . 0.0 109.418 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.35 -0.49 50.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.81 3.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.56 2.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.32 90.62 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.14 166.99 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -146.21 71.03 13.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.242 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.3 112.9 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.842 1.694 . . . . 0.0 110.501 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.9 mtt -103.86 142.65 34.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.3 t -69.94 149.86 47.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.02 116.63 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 120.862 1.041 . . . . 0.0 110.165 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.1 143.18 26.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.392 -0.818 . . . . 0.0 109.666 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.2 mtt-85 -87.43 135.86 33.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.21 120.59 26.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 109.764 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -109.53 107.47 17.59 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -76.47 103.32 6.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -45.35 -31.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.0 m-80 -66.95 105.14 1.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.02 4.65 36.14 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.21 83.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -124.42 128.73 49.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.932 . . . . 0.0 109.255 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -90.31 114.07 26.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.216 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.9 tp -48.91 141.67 7.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 57' ' ' ASP . 39.8 ttp180 -147.55 112.48 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.2 mt -89.96 112.75 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -74.35 151.93 87.78 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.121 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.7 Cg_exo -56.92 -26.42 67.55 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.163 1.242 . . . . 0.0 110.24 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.46 0.37 17.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.56 4.36 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.3 mtm-85 -50.63 115.24 1.4 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.13 146.09 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 14.0 p30 -169.06 148.13 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.26 151.53 20.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -146.35 153.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -89.91 -0.7 57.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.28 88.1 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -68.91 -5.04 18.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 22.65 1.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -110.18 99.92 41.79 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.61 3.62 0.36 Allowed 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 120.912 1.075 . . . . 0.0 110.522 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.526 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.9 m80 -84.23 -4.64 58.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.65 1.85 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -77.01 100.45 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.29 135.2 43.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.79 107.33 19.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -85.85 150.72 24.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.532 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.04 132.93 16.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.4 135.44 33.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 -38.32 8.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.639 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -151.34 -117.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -83.85 -110.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.687 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.53 6.26 17.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.76 129.89 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.42 ' C ' ' HG ' ' A' ' 73' ' ' SER . 3.0 m -138.79 168.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 109.507 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.42 ' HG ' ' C ' ' A' ' 72' ' ' VAL . 2.3 m -142.47 118.99 10.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.448 -0.783 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.07 152.33 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -148.65 117.99 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.506 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 131.91 51.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.08 -60.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -68.2 -34.28 75.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.17 -21.92 33.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 51.25 55.21 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 6.6 mtp180 -146.8 149.29 33.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.399 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -94.97 129.63 41.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.06 139.66 58.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.267 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.82 133.31 16.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.0 ttp -97.12 133.0 42.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 88' ' ' ASP . 32.8 mmtt -73.45 164.24 26.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.893 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.78 24.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 86' ' ' LYS . 1.1 p30 -130.24 -42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.663 -0.648 . . . . 0.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.41 -9.61 1.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.2 mtt-85 -78.53 115.93 18.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -1.162 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.5 mp -92.67 131.02 38.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.412 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.94 -171.83 3.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.16 151.43 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 109.383 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.21 151.33 38.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.481 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -63.86 -28.92 70.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.77 127.38 38.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.94 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 p -148.25 -165.37 2.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -68.01 -19.43 64.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.961 . . . . 0.0 109.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.63 54.1 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 58.3 m -146.71 9.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -94.32 156.41 16.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.89 105.56 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -58.39 103.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.512 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -87.06 94.56 9.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -89.92 126.85 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.454 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.29 132.26 34.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.56 -178.92 4.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -89.15 -11.41 43.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.1 m-20 -89.59 28.55 1.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER 60.42 -0.7 0.25 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.75 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.2 m-85 -95.48 130.14 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.92 169.97 10.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.3 p -142.39 120.45 12.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.791 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -93.15 99.05 11.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -93.49 145.15 24.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -72.02 155.57 40.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.6 ttt180 -92.45 -76.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.6 -9.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 118' ' ' ARG . 13.4 m-85 -140.47 60.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 40.1 p -61.0 0.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' TYR . 4.0 m -90.51 10.68 24.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.08 142.33 19.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -105.55 170.13 8.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.0 t -90.68 69.95 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.01 141.59 28.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.5 mt -95.97 179.6 5.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -92.65 -171.68 2.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -93.64 -11.77 30.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 2.51 55.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.43 0.4 67.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -88.43 171.01 10.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.6 p90 -89.6 120.41 30.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -70.14 139.34 52.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.68 125.07 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.226 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.45 -16.5 7.04 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.3 p -90.1 -20.45 23.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.053 -1.263 . . . . 0.0 109.58 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -89.98 -11.03 42.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.2 p -69.93 175.07 4.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.83 25.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.2 170.95 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.893 1.729 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.91 -55.07 2.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -75.15 134.87 41.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 33.9 mtmt -82.76 4.39 25.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.21 -3.85 0.99 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.1 pt -93.12 -9.63 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 mt -81.87 91.64 6.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -94.07 157.28 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.5 tp -138.12 71.95 47.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.21 115.0 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.775 1.65 . . . . 0.0 110.732 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.3 mtt -97.43 130.59 44.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 109.22 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.0 t -68.32 144.31 54.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 15.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.48 156.7 30.05 Favored 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.236 1.291 . . . . 0.0 110.341 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 28' ' ' ASP . 20.3 mttm -141.12 133.77 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.436 -0.79 . . . . 0.0 109.424 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.612 ' NH1' ' NZ ' ' A' ' 61' ' ' LYS . 1.1 mtt-85 -90.76 133.86 34.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.65 126.35 38.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -115.19 119.46 36.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.5 t -93.82 106.66 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.09 -35.04 10.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.656 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.595 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -67.95 103.28 1.45 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.92 4.93 83.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 55.16 8.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -102.14 143.05 32.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.978 . . . . 0.0 109.795 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.02 110.14 22.46 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp -46.95 144.66 2.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.119 -0.988 . . . . 0.0 109.716 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -143.55 155.4 44.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.89 131.83 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.199 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -93.17 149.68 37.86 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.067 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.06 -21.75 52.15 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.224 1.283 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -74.85 4.79 5.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -38.54 3.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -48.1 164.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.7 t -137.83 148.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.587 -0.696 . . . . 0.0 109.258 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' ' CG1' ' A' ' 52' ' ' VAL . 3.1 p-10 -154.17 -160.02 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 131' ' ' GLY . . . -143.1 126.38 2.82 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.407 ' CG1' ' OD2' ' A' ' 50' ' ' ASP . 1.8 m -142.55 151.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.456 -1.026 . . . . 0.0 108.457 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 55' ' ' LYS . 35.4 mtm180 -89.04 -21.54 23.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.091 -1.006 . . . . 0.0 109.341 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -44.93 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.764 . . . . 0.0 109.705 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' ARG . 6.9 pttp -81.27 1.33 32.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.3 p -88.28 5.12 43.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.214 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -99.27 110.35 57.85 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.177 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.73 3.18 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.717 0.944 . . . . 0.0 110.238 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -74.85 -33.23 62.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.334 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.96 0.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.459 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.612 ' NZ ' ' NH1' ' A' ' 31' ' ' ARG . 8.6 tptt -77.1 96.71 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.453 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 131.75 45.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.503 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.02 109.54 20.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -92.61 150.01 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.553 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.73 137.9 21.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.1 160.21 25.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.952 . . . . 0.0 109.581 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -142.94 -84.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.79 -151.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -85.87 117.72 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 -3.11 13.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.41 139.34 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -1.16 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.5 m -140.86 128.23 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.535 -0.728 . . . . 0.0 109.577 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 m -94.47 118.74 32.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.06 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 82' ' ' TYR . 58.4 tttp -145.71 144.18 30.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.44 134.17 12.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.47 -77.75 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -27.18 7.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.95 -25.46 20.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.0 m120 50.99 48.3 23.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -146.37 150.76 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 75' ' ' LYS . 80.9 m-85 -94.86 127.8 41.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.3 147.92 24.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.88 167.87 22.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.467 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.0 ttm -134.17 141.12 46.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.675 -0.64 . . . . 0.0 109.407 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -92.84 160.79 14.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.46 -29.41 70.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -45.53 26.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.08 -6.72 1.81 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.541 ' NH1' ' HH ' ' A' ' 133' ' ' TYR . 2.1 mmt180 -63.84 120.08 11.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -1.222 . . . . 0.0 109.471 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -150.16 -175.31 5.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.08 150.6 38.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.315 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -146.6 156.52 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -73.44 -18.56 61.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -93.25 112.97 25.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.442 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.96 142.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.464 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.2 p -147.31 -163.35 1.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.58 -14.8 63.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.504 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -94.07 42.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 64.6 m -144.03 6.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 60.7 m-85 -94.36 151.44 19.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 96.0 m-85 -150.22 111.94 4.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CD2' ' NH1' ' A' ' 116' ' ' ARG . 32.2 m-85 -54.89 157.81 3.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.27 95.26 4.41 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 109.307 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -89.96 108.57 19.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.66 117.86 30.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.93 -175.58 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -1.25 57.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 112' ' ' TYR . 41.3 t-20 -91.44 27.49 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.95 -3.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 109.88 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.9 m-85 -94.31 156.49 16.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.242 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -123.9 165.38 17.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 109.758 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -141.0 120.13 12.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.321 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -89.9 107.77 19.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.479 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.513 ' NH1' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -99.07 133.65 43.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.499 -0.751 . . . . 0.0 109.133 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t -61.41 161.8 8.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.968 . . . . 0.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -95.45 -79.12 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 0.0 109.199 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -50.33 -11.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 118' ' ' ARG . 6.1 m-85 -130.19 52.53 2.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 79.9 p -52.72 -12.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.3 m -93.51 20.51 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.928 . . . . 0.0 109.635 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -152.29 130.75 12.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.72 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.5 m-85 -103.99 167.97 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.581 -0.699 . . . . 0.0 109.591 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.52 148.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.887 . . . . 0.0 109.362 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.58 -177.96 6.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.5 mt -144.86 171.28 14.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -90.27 174.03 7.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -93.79 11.71 28.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -125.08 5.55 7.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.7 -0.625 . . . . 0.0 109.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 95.27 0.28 63.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -85.09 172.95 10.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -1.166 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.541 ' HH ' ' NH1' ' A' ' 90' ' ' ARG . 20.9 p90 -93.62 120.55 34.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.592 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -72.71 132.82 44.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.364 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.72 158.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.76 -39.01 18.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -67.49 -15.37 63.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -1.159 . . . . 0.0 109.585 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -90.02 -5.05 57.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -74.38 165.68 24.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.57 179.47 21.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.86 168.71 6.74 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.849 1.7 . . . . 0.0 110.237 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.87 -47.9 2.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.14 131.52 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.595 ' CB ' HD22 ' A' ' 36' ' ' ASN . 36.3 mtmt -85.1 -1.94 57.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.522 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.18 -0.14 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.529 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.6 pt -93.66 -10.45 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.599 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 91.47 8.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.35 168.39 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.6 tp -144.27 70.44 16.09 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.58 112.97 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.796 1.664 . . . . 0.0 110.305 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 29.8 mtt -98.12 115.61 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.307 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.5 t -65.16 157.32 29.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.1 166.43 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.215 1.277 . . . . 0.0 110.525 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -150.02 131.05 14.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.235 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.53 118.73 28.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 mt -84.92 100.65 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -98.6 125.42 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.472 -0.767 . . . . 0.0 109.571 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.66 121.46 33.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -15.13 62.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.705 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.597 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -84.66 105.07 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 53' ' ' ARG . . . 75.87 4.91 78.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.67 88.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.2 m-85 -144.84 132.97 21.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -1.076 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -94.92 131.56 40.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.388 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.77 143.52 57.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.268 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 57' ' ' ASP . 42.5 ttt180 -146.47 119.32 8.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.669 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.13 120.22 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -82.93 151.74 64.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.38 -27.29 75.05 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.121 1.214 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 p30 -74.91 0.88 14.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -25.11 11.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -55.95 114.96 2.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -1.154 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -92.69 142.1 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.406 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 12.7 p-10 -170.91 150.09 3.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.09 155.23 22.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.67 140.57 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 37' ' ' GLY . 8.5 mmt180 -69.27 -12.54 61.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.78 98.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' O ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.12 -5.49 59.34 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.264 -0.897 . . . . 0.0 108.943 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -97.09 23.74 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -102.85 107.55 55.12 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.187 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.5 -3.28 3.21 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 120.718 0.945 . . . . 0.0 110.154 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -76.04 -25.64 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.271 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.49 -5.52 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -76.09 87.27 2.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.959 . . . . 0.0 109.424 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.38 33.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -89.62 111.19 22.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.256 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -91.3 148.97 21.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.718 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 73' ' ' SER . 7.4 tt0 -145.36 148.25 33.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.87 163.68 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 102' ' ' PHE . 3.2 tt0 -138.01 -51.13 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.489 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -147.77 -139.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -91.51 101.26 13.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.0 -14.63 52.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.03 106.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -1.174 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 103' ' ' PHE . 3.3 m -95.74 -178.0 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 65' ' ' GLN . 5.9 m -144.84 112.39 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.37 -0.831 . . . . 0.0 109.236 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.97 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.65 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -146.27 143.68 29.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.398 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.29 142.42 16.39 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.93 -87.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 109.368 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -47.6 -39.68 17.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.42 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.445 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 51.25 53.95 12.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.672 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -147.17 156.25 42.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.92 130.37 40.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.76 143.12 51.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.91 170.2 18.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 ttp -139.29 122.08 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.487 -0.758 . . . . 0.0 109.372 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -59.57 -175.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.26 -11.75 45.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -92.55 -38.02 12.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 143.44 -9.45 2.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -66.36 124.55 23.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.401 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 11.0 mp -92.71 134.33 35.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -150.09 -171.53 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.599 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.64 150.39 40.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.26 147.78 31.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -66.33 -17.3 64.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.895 . . . . 0.0 109.543 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -90.24 140.81 29.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.493 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.98 94.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.2 p -91.71 157.02 17.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.428 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.97 -21.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.87 48.52 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.2 m -138.61 1.02 2.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.455 -0.778 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 67' ' ' GLU . 99.2 m-85 -98.79 159.75 14.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.84 . . . . 0.0 109.412 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.2 m-85 -150.13 115.65 5.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.593 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.03 149.38 12.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.25 90.09 3.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -94.87 126.04 39.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.18 125.79 39.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -92.59 170.09 10.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.432 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -79.81 62.95 4.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 112' ' ' TYR . 13.0 p30 -159.94 21.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.488 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.4 -6.77 0.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 110.037 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.3 m-85 -97.62 134.55 40.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 109.365 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.4 170.01 9.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.877 . . . . 0.0 109.822 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -140.27 114.62 9.24 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -90.63 115.33 27.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.876 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 150.9 22.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.556 -0.715 . . . . 0.0 109.161 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.3 163.44 20.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.896 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -94.83 -61.65 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 109.242 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.51 -54.07 23.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -96.1 62.62 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 p -56.89 2.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 120' ' ' TYR . 19.4 m -89.33 15.17 9.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.898 -1.126 . . . . 0.0 109.443 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.04 146.55 23.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 14.4 m-85 -104.71 169.45 8.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.17 125.61 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.55 156.4 42.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.1 mt -112.75 -178.36 3.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.771 -0.581 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.99 -129.45 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.533 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HE ' ' C ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -139.84 4.52 2.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.502 -0.749 . . . . 0.0 109.408 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.31 14.82 8.32 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.61 6.46 60.91 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -92.91 162.74 13.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -1.121 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.0 p90 -93.32 120.3 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.666 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.666 ' NZ ' HE21 ' A' ' 143' ' ' GLN . 22.7 ttmt -70.03 135.41 49.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.493 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -47.66 160.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.27 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.3 24.52 7.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.7 p -115.07 -45.73 2.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.701 -0.882 . . . . 0.0 109.574 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -4.86 28.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.684 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -73.16 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.66 179.46 31.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.95 171.57 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.885 1.723 . . . . 0.0 110.237 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.26 -44.34 3.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.666 HE21 ' NZ ' ' A' ' 134' ' ' LYS . 2.5 mm100 -85.39 133.82 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.461 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.597 ' CB ' HD22 ' A' ' 36' ' ' ASN . 36.9 mtmt -81.39 3.95 22.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.25 -9.95 5.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 pt -92.56 1.82 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 71.1 mt -94.3 90.56 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.398 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.56 168.65 10.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 tp -141.02 70.61 28.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.329 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.54 103.83 0.41 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.8 1.667 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.6 mtt -95.4 125.35 39.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.354 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.4 t -70.02 135.33 49.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.416 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.45 167.24 2.85 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.204 1.269 . . . . 0.0 110.244 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -140.7 127.0 19.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -86.76 124.95 33.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -84.72 102.03 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.94 116.2 23.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.21 61.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.691 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.5 m-80 -90.0 105.21 17.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.37 4.91 87.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 84.17 0.02 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.63 134.68 30.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.413 -1.051 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -95.25 133.35 39.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.9 tp -67.53 143.25 56.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.209 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 1.5 ttt180 -155.99 125.05 6.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.98 . . . . 0.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.1 mt -94.13 127.17 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.256 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.519 ' CE1' ' NH1' ' A' ' 42' ' ' ARG . 86.8 m-70 -83.58 148.86 56.08 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.7 Cg_endo -59.25 -21.12 58.59 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.203 1.268 . . . . 0.0 110.466 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.71 7.73 2.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.708 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.63 -39.29 3.13 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -52.0 162.04 0.51 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -1.141 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.4 141.35 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.46 -0.775 . . . . 0.0 109.366 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' OD1' ' NE2' ' A' ' 44' ' ' HIS . 39.4 p-10 -159.46 -149.77 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.88 155.94 26.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.49 139.13 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -1.068 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -77.83 -17.78 57.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.18 110.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 34.65 0.55 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -129.63 -20.4 3.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.655 -0.653 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -45.48 108.71 0.82 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.837 . . . . 0.0 109.485 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.86 5.44 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.674 0.916 . . . . 0.0 110.152 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 47.6 m80 -94.13 -15.42 24.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -70.05 -4.72 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.506 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 32.0 mtpt -76.94 79.38 3.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.06 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.86 110.41 21.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -87.72 159.0 18.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -141.28 176.33 8.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.222 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.64 142.07 48.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.608 -0.682 . . . . 0.0 109.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.19 143.0 28.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 50.81 -127.22 2.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -147.81 137.8 22.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.23 10.33 81.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.25 143.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.476 -1.014 . . . . 0.0 109.324 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.83 -176.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.479 -0.763 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -141.53 126.34 18.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -95.48 148.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.36 136.75 23.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.41 136.81 15.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 51.3 t -74.97 -86.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -1.198 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -47.51 -53.63 13.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.359 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.55 63.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.9 m120 51.08 45.24 28.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 0.0 109.55 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -137.24 145.67 43.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 109.332 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.95 129.41 36.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.887 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.45 150.19 19.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.74 26.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 109.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.7 ttm -137.47 126.86 24.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.378 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -91.4 -173.04 3.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.92 -29.47 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.9 1.18 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.07 78.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.578 ' NH1' ' HH ' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -91.27 117.67 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.1 mp -90.04 137.34 32.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.13 177.46 9.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.736 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.18 164.64 12.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.692 -0.63 . . . . 0.0 109.417 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -149.33 159.13 44.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 109.509 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -88.44 -0.5 57.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.93 123.75 16.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.496 -0.753 . . . . 0.0 109.423 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.07 154.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -150.93 168.39 24.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -47.51 -24.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.9 49.27 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -143.38 5.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -97.4 157.61 15.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -150.01 112.94 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' ARG . 34.1 m-85 -54.92 149.14 12.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.98 . . . . 0.0 109.231 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.96 92.14 3.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.657 -0.652 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 114' ' ' THR . 10.5 ttp180 -91.47 120.19 32.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.68 126.56 32.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.91 -177.19 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.7 m -93.67 55.92 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.568 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 17.2 p-10 -165.78 31.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.95 -4.29 0.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.6 m-85 -91.31 127.61 36.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.72 167.21 11.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 14.2 p -136.17 120.57 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.85 104.18 16.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -98.45 145.82 26.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.38 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -62.56 161.34 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 0.0 109.277 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -87.15 -61.67 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.68 -44.38 56.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.533 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -92.63 57.91 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -58.25 -0.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.5 m -89.71 11.81 18.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.07 -1.019 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.03 152.59 29.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 11.4 m-85 -120.65 163.19 18.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.63 130.06 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.23 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.86 143.49 21.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.96 167.78 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -93.75 -165.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.86 -10.16 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -4.77 53.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.97 34.22 9.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.3 176.38 5.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.769 -0.842 . . . . 0.0 109.374 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.578 ' HH ' ' NH1' ' A' ' 90' ' ' ARG . 34.8 p90 -87.02 120.06 27.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -71.39 131.84 43.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.533 ' CD2' ' HG ' ' A' ' 137' ' ' SER . 13.7 tp -52.15 140.5 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.52 4.08 1.61 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.533 ' HG ' ' CD2' ' A' ' 135' ' ' LEU . 88.9 p -91.89 -34.61 14.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.17 . . . . 0.0 109.604 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.02 -10.76 43.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 p -70.0 145.33 51.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.5 178.96 38.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.49 166.54 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.938 1.759 . . . . 0.0 110.222 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.62 -50.47 2.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -80.41 135.08 36.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 40.6 mtmt -85.01 9.28 15.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.07 -2.54 2.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.4 pt -97.13 -3.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 109.521 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.93 91.75 8.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.632 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.54 165.51 12.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.1 tp -141.87 70.45 24.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.392 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.16 104.9 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.752 1.635 . . . . 0.0 110.36 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.7 mtt -95.31 136.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 130.4 42.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.1 153.61 57.27 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.148 1.232 . . . . 0.0 110.384 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -137.41 124.46 21.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.462 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -85.26 118.97 25.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.638 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.01 100.91 11.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -94.58 125.17 39.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.7 t -90.18 123.27 33.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -72.44 -13.91 61.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.3 m-80 -90.34 105.12 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.98 5.8 88.88 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.47 85.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 43.6 m-85 -143.15 136.21 27.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -1.089 . . . . 0.0 109.568 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -98.13 122.76 41.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.403 -0.811 . . . . 0.0 109.493 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.13 145.53 20.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.179 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 59' ' ' HIS . 20.2 ttt180 -150.63 128.62 11.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.06 131.35 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.451 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 49.9 m-70 -90.5 152.09 44.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.105 -0.997 . . . . 0.0 109.193 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.56 -27.34 76.38 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.198 1.265 . . . . 0.0 110.368 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -74.88 9.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.525 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -33.73 3.28 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -47.51 166.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -1.176 . . . . 0.0 109.405 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.44 134.01 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 32.8 p-10 -159.4 155.93 27.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.33 152.19 20.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.64 149.13 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -1.108 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -82.25 -10.07 59.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.51 83.78 0.41 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -84.66 49.63 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.552 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.95 6.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 109.914 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.5 m-20 -96.58 139.57 21.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.039 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.21 -4.37 3.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.022 1.148 . . . . 0.0 110.317 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CB ' ' NE ' ' A' ' 42' ' ' ARG . 70.1 m80 -75.0 -25.79 59.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.911 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.41 -1.95 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.322 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 11.7 mmtp -83.96 87.0 7.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.93 135.64 33.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.42 104.37 16.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.341 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.7 mp -90.82 154.8 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.22 141.25 35.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.74 136.08 33.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -140.57 122.18 15.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 60.01 164.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 108.935 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.77 32.97 0.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.77 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.23 16.76 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.742 -1.218 . . . . 0.0 110.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.54 155.67 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -1.231 . . . . 0.0 109.575 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.07 130.02 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 109.118 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -92.84 125.33 37.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.828 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -104.05 142.61 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.757 . . . . 0.0 109.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -147.23 151.57 36.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.75 139.42 14.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 54.4 t -78.24 -65.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -71.92 -42.54 66.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.6 65.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 49.98 51.29 16.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -146.06 145.98 30.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.377 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -89.8 133.55 34.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.579 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 44.1 tp -63.56 146.82 52.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.55 132.7 16.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.1 ttm -97.51 120.16 37.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.96 176.54 9.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.32 -26.33 30.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.18 -2.62 22.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 92.48 -14.98 63.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.6 mtt-85 -71.43 123.33 22.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.478 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.6 mp -90.2 136.2 33.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.414 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.1 pp -146.4 -175.44 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.65 158.7 43.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 p -145.17 170.11 16.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.321 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -79.97 -36.9 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -93.23 126.0 38.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 14.6 p -71.06 118.85 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 p -97.88 161.57 13.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.66 -21.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.37 55.47 2.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -139.29 3.69 2.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 79.3 m-85 -96.87 162.89 13.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 92.5 m-85 -150.15 121.94 8.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -62.18 97.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.17 95.37 2.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' O ' ' OG1' ' A' ' 114' ' ' THR . 66.2 ttt180 -92.51 123.64 35.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.75 134.32 35.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.24 -170.69 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -95.81 -17.54 21.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.659 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 4.1 p30 -94.39 26.0 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.769 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 71.52 2.61 4.34 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.726 -0.609 . . . . 0.0 110.697 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -90.29 140.58 29.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.918 -1.114 . . . . 0.0 109.443 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -95.4 164.16 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 3.2 p -141.8 119.89 12.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -91.77 105.47 17.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -96.15 145.5 25.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -68.34 148.8 50.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -80.55 -56.73 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -70.01 -46.64 64.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.536 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.1 m-85 -95.94 59.44 2.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -57.03 -2.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.624 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.9 m -89.85 10.34 24.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.678 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.08 153.02 30.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 13.8 m-85 -117.02 168.98 9.77 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.303 0.573 . . . . 0.0 109.464 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.78 133.24 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.87 177.48 9.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.1 158.36 39.86 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -93.19 170.63 9.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -78.49 -11.93 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 t -91.87 26.1 2.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.532 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.77 50.01 69.31 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -137.47 167.01 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.974 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.2 p90 -90.33 120.58 31.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -69.63 132.62 46.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.04 160.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -78.62 -0.61 80.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.1 p -95.01 -47.23 6.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -1.12 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -72.46 -6.74 45.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -69.95 153.52 43.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.417 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.01 -179.87 28.21 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 143' ' ' GLN . 3.9 Cg_exo -60.33 -174.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.779 1.652 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.57 -43.1 1.81 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' A' ' 145' ' ' ALA . 56.6 mm-40 -92.21 119.46 31.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.54 ' CB ' HD22 ' A' ' 36' ' ' ASN . 36.6 mtpt -71.05 4.53 2.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -63.24 -9.2 10.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.349 -0.844 . . . . 0.0 109.542 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -93.15 0.53 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.525 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.5 mt -92.35 91.39 7.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.39 168.84 10.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.5 tp -143.07 70.43 18.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.16 107.7 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.791 1.661 . . . . 0.0 110.246 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.0 mtt -93.88 111.13 22.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.805 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 t -66.2 145.37 55.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 179.939 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.8 175.57 0.29 Allowed 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 121.251 1.301 . . . . 0.0 110.243 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -146.28 175.11 10.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 31' ' ' ARG . 17.9 mtm-85 -131.01 128.1 39.67 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mt -84.45 111.0 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.774 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -101.42 114.52 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.81 108.31 17.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.491 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.737 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.25 105.0 8.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.65 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . . . 72.3 7.05 66.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 73.98 0.27 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -118.27 129.88 55.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.73 -0.865 . . . . 0.0 109.571 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.82 113.2 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.2 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.8 tp -49.07 133.83 18.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 109.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 57' ' ' ASP . 41.2 ttp180 -142.5 122.98 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.7 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.54 133.76 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.202 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -89.92 151.24 45.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.09 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.15 -18.15 28.23 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.161 1.24 . . . . 0.0 110.516 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.89 -7.88 54.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.19 55.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -94.05 163.09 13.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -1.132 . . . . 0.0 109.363 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.66 126.59 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.568 -0.707 . . . . 0.0 109.315 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.61 149.99 24.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.27 151.85 22.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.25 146.12 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -1.149 . . . . 0.0 109.704 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 37' ' ' GLY . 28.2 mtt-85 -77.02 1.16 18.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.01 88.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -85.11 33.37 0.54 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.602 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -143.64 21.8 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -94.66 124.41 55.02 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.041 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.1 1.86 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.668 0.912 . . . . 0.0 110.28 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.4 m80 -94.07 -13.81 26.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.54 9.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.612 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -93.26 87.48 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -90.1 135.16 33.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -89.82 110.33 21.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.4 mp -93.01 118.51 31.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.14 146.57 27.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.305 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 139.36 30.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' GLU . 28.1 tt0 -146.64 142.05 27.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . 1.5 mt-10 48.3 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -100.97 113.28 26.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 109.541 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.63 25.56 17.78 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.75 152.54 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -1.103 . . . . 0.0 109.418 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.7 m -144.49 133.41 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -92.08 118.75 31.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.554 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.89 138.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -147.04 139.6 24.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.66 142.36 20.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.44 -72.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -45.19 91.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.31 -27.35 68.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.96 50.15 19.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.89 150.05 35.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -95.29 134.31 38.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.323 -0.861 . . . . 0.0 109.766 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.249 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.08 148.5 29.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 47.2 ttm -106.27 132.91 51.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.371 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -72.45 -170.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.0 -45.54 26.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.707 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 1.4 p-10 -69.96 -82.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.511 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -171.18 24.61 0.09 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -89.61 124.27 34.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.2 mp -94.01 128.7 40.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.81 -173.53 4.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.2 152.55 46.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.404 -0.81 . . . . 0.0 109.487 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.61 155.03 42.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -61.09 -36.81 80.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 99.0 p -84.93 137.55 33.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.451 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 12.0 p -89.08 118.12 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.9 p -93.98 -169.82 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 101' ' ' CYS . 1.7 m-20 -80.06 -30.75 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.99 15.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.448 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.515 ' H ' ' C ' ' A' ' 99' ' ' ASP . 93.8 m -95.1 -9.32 33.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -86.74 148.8 25.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.935 . . . . 0.0 109.435 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.27 116.48 7.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -59.51 122.43 14.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.93 97.79 9.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 116.82 29.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.76 120.3 31.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.7 -171.29 3.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.5 p -93.37 -4.35 51.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.7 m-20 -93.06 25.84 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.55 -1.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.79 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.2 m-85 -95.93 130.94 42.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -91.61 163.05 14.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.742 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 p -139.09 114.66 9.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.124 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -89.84 114.71 26.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.806 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.82 139.82 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.295 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -67.68 137.01 55.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.5 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 120' ' ' TYR . 25.5 ttt180 -77.98 -70.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.589 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 3.2 tptt -51.55 -10.08 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 27.6 m-85 -146.2 70.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.7 p -64.88 4.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 120' ' ' TYR . 11.2 m -94.25 10.23 34.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.88 . . . . 0.0 109.603 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 10.4 m-90 -154.97 137.37 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 22.6 m-85 -100.98 165.39 11.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.574 -0.704 . . . . 0.0 109.388 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.67 125.86 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -152.2 143.4 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -95.39 176.21 6.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -93.07 173.19 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -84.92 -4.84 59.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.434 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.94 -5.16 48.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.26 -0.66 55.95 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.584 ' NE2' ' N ' ' A' ' 132' ' ' GLN . 1.5 mp0 -93.13 172.6 8.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -1.184 . . . . 0.0 109.532 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.9 p90 -91.61 120.22 32.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -70.2 131.84 44.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.2 tp -48.5 160.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.11 2.05 53.05 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' THR . 84.5 p -93.69 -68.17 0.82 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' N ' ' OG ' ' A' ' 137' ' ' SER . 12.3 mptt -48.18 -14.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 137' ' ' SER . 22.3 p -69.93 150.36 46.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.42 179.84 30.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.51 158.46 31.86 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.69 -28.78 8.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 145' ' ' ALA . 74.8 mm-40 -90.4 113.89 25.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -65.93 -2.25 3.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.99 -10.36 28.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.67 2.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.4 mt -91.01 87.31 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.99 159.62 15.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.672 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.5 tp -140.84 70.91 29.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.018 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 109.35 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.888 1.726 . . . . 0.0 110.641 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 20.6 mtt -97.5 130.94 44.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.397 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' A' ' 153' ' ' ALA . 41.0 t -70.08 167.99 16.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.134 -0.979 . . . . 0.0 109.171 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.606 ' N ' ' HG ' ' A' ' 152' ' ' SER . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.07 160.1 13.54 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.988 1.125 . . . . 0.0 110.174 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -122.47 174.16 7.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.7 mtm-85 -136.84 110.89 8.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -84.06 101.28 11.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.22 115.68 27.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.7 t -78.87 111.43 15.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.576 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -20.2 66.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.3 m-80 -88.13 100.93 13.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.597 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 86.71 4.55 82.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 84.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 48.7 m-85 -142.2 131.3 23.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -1.062 . . . . 0.0 109.477 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -92.64 121.92 34.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.47 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.0 145.25 13.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 22.4 ttt180 -148.7 158.95 44.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.576 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.6 mt -136.27 123.37 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -88.15 149.69 45.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.116 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.89 -23.72 60.82 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.294 1.33 . . . . 0.0 110.699 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.476 ' OD2' ' CD ' ' A' ' 48' ' ' ARG . 36.4 p-10 -74.63 3.87 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.739 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.42 -35.31 4.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' CD ' ' OD2' ' A' ' 46' ' ' ASP . 27.0 mtp180 -47.8 152.86 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.92 144.18 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.468 -0.77 . . . . 0.0 109.428 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -167.04 -146.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.91 161.12 28.25 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.8 m -147.1 138.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.465 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.462 HH11 ' HG3' ' A' ' 53' ' ' ARG . 4.5 mtm-85 -82.25 5.43 20.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.38 106.61 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -84.0 38.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.96 17.5 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -99.13 110.16 56.92 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.795 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 1.63 0.63 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.68 0.92 . . . . 0.0 110.127 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.518 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.1 m80 -80.6 -13.29 59.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.391 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.21 -0.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.18 87.48 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.97 131.68 35.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.454 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -89.98 102.95 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.7 mp -86.21 149.66 24.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.98 139.1 28.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.69 111.74 22.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -92.11 -91.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -84.34 180.0 7.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.8 mtt-85 -76.62 110.7 11.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.41 26.02 26.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.52 96.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -1.127 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.87 126.65 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 m -94.31 129.02 41.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.443 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.78 146.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.96 117.68 8.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.46 48.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 55.2 t -80.0 -80.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -1.086 . . . . 0.0 109.435 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -35.01 71.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.79 -25.83 61.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.479 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 5.0 m-80 51.21 52.69 14.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.8 mtt-85 -147.63 143.32 27.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.9 126.78 35.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -59.88 147.49 38.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.51 170.14 17.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -140.03 128.89 23.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -73.12 -169.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -92.78 -17.5 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.4 p30 -85.44 -40.87 15.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.49 2.16 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -70.56 126.35 29.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.9 mp -93.09 138.47 31.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.05 -176.56 5.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' C ' ' HG ' ' A' ' 94' ' ' SER . . . -142.89 157.1 44.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.446 ' HG ' ' C ' ' A' ' 93' ' ' ALA . 13.4 m -145.49 170.14 16.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.831 . . . . 0.0 109.415 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -42.88 33.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 p -89.43 142.86 27.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.5 p -85.23 116.99 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.417 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -96.01 178.88 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -22.81 67.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -94.08 54.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.814 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.2 m -137.43 0.56 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 83.9 m-85 -94.87 153.17 17.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.386 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 82.2 m-85 -147.84 120.14 8.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -59.74 154.19 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -125.25 97.24 5.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.684 -0.635 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.98 116.74 28.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.89 112.33 24.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -84.89 167.72 15.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.883 . . . . 0.0 109.528 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.0 t -81.49 66.39 7.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -167.58 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.49 -7.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.517 -0.739 . . . . 0.0 110.057 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.584 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 54.8 m-85 -98.32 120.12 38.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -93.25 170.05 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.833 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 p -134.08 121.64 21.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.344 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.44 105.01 16.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 121' ' ' THR . 27.9 ttt180 -94.78 147.06 23.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.855 . . . . 0.0 109.454 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -74.01 158.26 34.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -93.67 -75.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 10.4 tptm -51.44 -9.93 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 122' ' ' SER . 11.1 m-85 -142.97 63.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.467 -0.771 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.521 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 30.2 p -63.27 2.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.52 ' H ' ' C ' ' A' ' 120' ' ' TYR . 57.8 m -91.01 11.97 21.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.06 145.27 21.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 116' ' ' ARG . 27.9 m-85 -109.96 168.16 9.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.741 -0.6 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.7 t -92.93 131.43 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.4 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -148.26 -172.54 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -138.49 149.8 45.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.334 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -61.09 -102.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.5 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 31.3 ptt180 -173.76 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.417 -0.802 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.8 t -92.53 22.11 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.75 6.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -136.4 158.7 43.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.956 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 31.0 p90 -95.02 120.46 35.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.816 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -69.74 135.26 49.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 137' ' ' SER . 8.2 tp -58.06 157.34 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.279 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -79.39 22.19 3.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 138' ' ' LYS . 3.5 p -98.57 -60.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.362 -1.081 . . . . 0.0 109.554 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.546 ' H ' ' HG ' ' A' ' 137' ' ' SER . 12.3 mttp -71.93 -7.5 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -70.12 146.84 50.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.89 179.77 42.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.84 172.71 2.71 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.864 1.709 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.1 -42.11 2.5 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -72.52 134.68 45.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.0 mtpp -85.09 -4.13 59.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.48 -3.72 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 144' ' ' LYS . 3.0 pt -99.2 -3.23 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.446 ' CD1' ' HZ3' ' A' ' 144' ' ' LYS . 60.2 mt -82.24 93.95 7.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.26 161.06 13.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.808 . . . . 0.0 109.529 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.4 tp -133.32 75.73 69.74 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.672 . . . . 0.0 109.23 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.25 111.08 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.712 1.608 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.3 mtt -96.37 114.99 26.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.6 t -70.2 129.07 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.414 179.936 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.09 174.41 0.33 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.115 1.21 . . . . 0.0 110.08 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -147.22 131.04 17.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.9 mtt-85 -85.89 121.18 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.056 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.5 104.91 14.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.98 117.14 33.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.585 -0.697 . . . . 0.0 109.6 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.39 116.45 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.164 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -65.48 -24.5 67.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.06 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.82 105.14 14.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 83.24 4.34 89.69 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.41 83.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 47.8 m-85 -141.48 140.53 33.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -1.103 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -100.88 134.24 44.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.13 144.12 52.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 41.1 ttp180 -152.82 129.1 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -103.33 136.28 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.525 ' NE2' ' OD1' ' A' ' 50' ' ' ASP . 5.5 m-70 -91.73 148.89 38.16 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.066 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.14 -17.66 46.93 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.095 1.197 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 7.4 p30 -74.84 -10.48 59.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.776 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 15.15 29.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.6 mtt-85 -92.65 167.44 11.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -1.19 . . . . 0.0 109.333 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.7 t -142.94 117.73 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.402 -0.811 . . . . 0.0 109.274 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 44' ' ' HIS . 4.3 p-10 -158.23 160.29 36.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.637 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.11 152.99 20.94 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.7 155.06 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.481 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -75.26 -30.66 60.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.461 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' OE2' ' OD1' ' A' ' 57' ' ' ASP . 2.6 mt-10 -47.26 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 53' ' ' ARG . 8.8 pttp -85.24 33.82 0.56 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.946 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -165.23 43.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.09 -1.006 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -94.2 156.88 38.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.957 . . . . 0.0 109.188 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -66.15 22.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 121.508 1.472 . . . . 0.0 111.051 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.533 ' H ' ' C ' ' A' ' 57' ' ' ASP . 61.7 m80 -141.71 -15.51 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.029 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -64.81 -5.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -88.39 90.81 8.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -89.96 135.38 33.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 64' ' ' LEU . 2.4 tp-100 -89.67 106.49 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.52 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 10.6 mp -86.92 155.59 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.72 121.8 12.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.847 . . . . 0.0 109.246 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.83 157.57 26.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.93 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -148.06 135.42 20.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 50.75 -112.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -153.52 124.64 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.11 -17.87 35.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.29 146.02 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.669 -0.9 . . . . 0.0 109.332 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 m -146.43 175.34 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -143.97 128.77 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.73 147.84 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.565 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 5.7 tttp -147.49 134.27 20.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.62 130.85 10.3 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.36 -74.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -1.13 . . . . 0.0 109.496 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.1 t -66.42 -45.25 80.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -27.55 39.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 78' ' ' SER . 11.2 m120 49.79 47.48 22.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -147.28 144.67 29.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.436 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 70.7 m-85 -90.15 131.69 35.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.602 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 43.9 tp -61.33 142.63 56.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.206 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.29 134.49 19.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 53.7 ttm -96.65 126.58 41.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.395 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -72.25 178.8 3.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 -31.59 45.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -70.98 -48.26 54.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.06 -9.11 1.52 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -71.27 124.71 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.489 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.3 mp -92.74 133.87 35.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.59 177.78 8.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.83 156.64 26.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.626 . . . . 0.0 109.373 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -145.34 162.91 36.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -82.98 -39.79 20.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.1 t -92.63 122.76 35.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.14 154.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -147.53 -177.12 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -22.55 64.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -87.68 44.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 22.0 m -143.17 5.45 1.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 59.7 m-85 -93.42 151.89 19.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 0.0 109.563 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 84.1 m-85 -150.16 110.59 4.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.882 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -56.96 155.14 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.137 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -125.19 95.35 4.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.369 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' NH2' ' OE1' ' A' ' 108' ' ' GLU . 6.2 ttp180 -90.76 132.36 35.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.21 132.45 36.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' OE1' ' NH2' ' A' ' 106' ' ' ARG . 4.5 mm-40 -88.35 -174.67 4.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -16.46 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.908 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.404 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 5.7 m-80 -93.44 24.24 4.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 64.11 57.32 1.28 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 110.056 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 52.7 m-85 -143.02 126.39 16.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.257 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.73 120.36 34.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.8 p -98.1 129.06 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.405 -0.809 . . . . 0.0 109.224 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -95.89 113.03 24.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -100.81 144.89 29.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.378 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -76.24 139.95 41.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 109.582 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 120' ' ' TYR . 1.2 ttt-85 -76.47 -70.63 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -51.37 -9.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.409 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' ARG . 49.7 m-85 -143.86 68.22 1.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.5 p -67.06 3.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 120' ' ' TYR . 73.5 m -95.63 10.55 36.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.82 . . . . 0.0 109.652 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 5.1 m-90 -155.13 145.18 21.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.848 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.3 m-85 -112.01 161.47 16.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.75 -0.594 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.74 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.199 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 -171.37 3.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.808 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -140.78 159.46 42.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.523 -0.736 . . . . 0.0 109.3 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -87.56 -173.54 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.86 -15.53 26.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.613 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.424 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 1.5 t -89.09 3.5 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.05 76.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.446 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 3.6 mp0 -86.11 174.76 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -1.175 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 35.5 p90 -95.02 120.43 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.68 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -69.85 135.42 49.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.396 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -49.31 149.35 2.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.245 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.21 0.28 59.66 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 35.7 p -93.99 -37.96 11.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -1.123 . . . . 0.0 109.553 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -76.82 -8.2 56.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -71.95 160.32 32.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 153.3 179.69 28.98 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -61.11 -176.62 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.922 1.748 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.46 -36.78 0.98 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 145' ' ' ALA . 5.2 mt-30 -93.34 113.46 25.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -1.084 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 146' ' ' ILE . 19.5 mtmt -65.83 2.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.6 2.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.644 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.482 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.6 pt -100.66 6.35 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.35 94.81 8.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -98.3 164.3 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.811 . . . . 0.0 109.37 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -142.01 70.82 23.66 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.841 . . . . 0.0 109.52 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.81 107.84 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.929 1.753 . . . . 0.0 110.324 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 8.8 mtt -96.18 128.99 43.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.516 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.9 t -70.12 153.2 43.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.565 ' CB ' HH22 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.14 171.45 2.27 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.21 1.273 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -145.15 126.93 15.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.04 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.5 mtt-85 -84.81 117.09 23.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.653 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.63 99.07 10.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.97 124.2 36.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 t -90.51 120.31 31.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.212 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -67.94 -14.87 63.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 8.3 m-20 -88.63 105.22 17.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.642 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.21 4.94 87.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.85 86.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.2 m-85 -144.77 138.26 27.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.302 -1.116 . . . . 0.0 109.65 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.48 121.63 38.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.0 109.423 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 tp -49.36 150.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -156.61 119.51 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 mt -92.55 129.18 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.191 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.99 151.99 45.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.5 Cg_endo -57.8 -26.75 75.12 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.27 1.313 . . . . 0.0 110.378 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -74.79 10.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' PRO . . . 84.92 -37.41 2.98 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.8 mtt-85 -47.17 154.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -1.187 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.7 t -134.16 130.42 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -146.24 -149.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.42 150.44 22.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.16 144.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.46 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -77.64 -16.67 58.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -59.97 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.384 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.12 12.36 3.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.554 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -108.92 10.91 26.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 109.597 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -95.05 123.48 57.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.18 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.13 4.92 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 120.636 0.891 . . . . 0.0 110.331 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.54 ' H ' ' C ' ' A' ' 57' ' ' ASP . 24.1 m80 -82.53 -38.41 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.879 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -65.52 4.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.577 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 59' ' ' HIS . 14.5 mttt -87.24 84.08 7.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.37 134.28 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.83 108.23 19.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.371 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.4 mp -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -144.2 144.51 31.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.412 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.27 126.36 36.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.948 . . . . 0.0 109.505 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -97.48 -30.21 13.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -153.67 -171.88 4.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -0.926 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -82.95 23.53 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.579 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.63 23.72 0.1 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.31 151.0 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.2 127.18 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -94.5 122.22 36.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.583 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 mt -94.4 145.75 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -147.37 130.78 16.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.32 133.81 13.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 88.4 t -76.19 -65.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -1.15 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -61.64 -34.19 75.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.64 34.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 31.6 m120 50.97 50.82 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -148.11 148.53 30.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -89.95 134.89 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.5 tp -65.09 147.75 52.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.65 170.3 17.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.7 ttm -139.11 129.05 25.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.529 -0.732 . . . . 0.0 109.409 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -75.07 178.71 5.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.39 -7.84 59.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.7 p30 -92.72 -46.29 7.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.33 -9.16 1.46 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -71.93 127.86 33.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.9 mp -91.68 139.16 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.08 -176.06 5.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.57 160.08 40.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.291 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 76.8 p -147.14 170.02 18.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -80.98 -36.86 30.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.403 ' H ' ' HG ' ' A' ' 96' ' ' SER . 6.9 p -91.23 126.17 36.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.7 p -72.98 116.31 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.51 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.7 p -93.64 -170.16 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.92 -10.85 59.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -93.78 12.55 25.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 59.2 m -95.68 8.93 42.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.627 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -97.74 148.65 23.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 63.2 m-85 -150.13 113.37 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -55.26 152.02 8.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 108.928 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -125.07 94.71 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' OG1' ' A' ' 114' ' ' THR . 23.8 ttp180 -92.69 128.42 38.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.936 . . . . 0.0 109.4 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.29 137.99 32.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 112' ' ' TYR . 2.5 mp0 -92.67 -178.34 4.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -94.24 47.74 1.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -156.14 23.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 65.13 49.77 1.95 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.53 -0.731 . . . . 0.0 110.012 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' ' OE2' ' A' ' 108' ' ' GLU . 52.3 m-85 -140.63 129.87 23.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.6 OUTLIER -94.6 154.6 17.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.631 -179.826 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 23.3 p -131.38 119.32 21.51 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -93.32 107.74 19.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -101.53 148.12 25.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.294 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -72.57 157.11 38.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.965 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.96 -76.52 0.48 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -51.29 -10.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 122' ' ' SER . 31.2 m-85 -142.89 63.78 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 p -63.32 3.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.775 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.7 m -89.86 11.68 19.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.606 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.14 145.36 22.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 109.839 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.2 m-85 -113.79 167.51 10.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.766 -0.584 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.49 129.37 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.32 149.38 26.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.656 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 19.7 mt -107.11 176.56 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.535 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.46 -166.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 109.28 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -17.29 23.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.366 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.1 1.96 55.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.423 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.25 12.21 56.46 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -93.52 142.63 27.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -1.192 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 24.5 p90 -69.09 120.67 15.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 127' ' ' LEU . 2.8 ttpm? -69.65 130.5 42.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -47.5 148.34 1.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.38 -31.68 81.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -77.46 -15.55 59.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -1.174 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -89.31 -4.96 57.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.0 p -87.33 156.68 19.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 167.34 179.94 40.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.9 Cg_endo -60.93 166.52 10.29 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.866 1.711 . . . . 0.0 110.231 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.32 1.9 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 141' ' ' PRO . 1.9 mt-30 -75.25 106.46 6.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.402 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 146' ' ' ILE . 18.1 mtmm -66.42 -3.0 5.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.593 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -61.5 -6.27 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.408 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.402 ' H ' ' C ' ' A' ' 144' ' ' LYS . 4.9 pt -93.75 -1.52 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.497 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.11 90.35 8.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -94.92 167.98 11.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.7 tp -144.49 73.87 15.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.446 -0.784 . . . . 0.0 109.251 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.97 115.16 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.75 1.633 . . . . 0.0 110.629 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.0 mtt -96.33 107.01 19.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -63.97 147.02 53.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.75 168.66 2.2 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 121.147 1.231 . . . . 0.0 110.168 179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -144.86 128.75 17.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.825 . . . . 0.0 109.376 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.35 118.82 25.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.86 98.84 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 40' ' ' PHE . 37.3 t80 -94.98 122.13 37.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.685 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.24 131.48 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.184 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.57 -18.78 58.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.756 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 3.0 m120 -82.15 105.08 12.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 109.608 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.84 4.92 88.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 84.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.6 m-85 -143.17 134.95 26.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -1.112 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 22.8 m-85 -96.68 126.27 41.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.7 tp -51.22 149.3 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.35 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 17.7 ttt180 -158.26 116.02 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.0 mt -91.81 128.97 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.236 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -89.44 151.64 46.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 0.0 109.055 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.18 -24.02 64.72 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.113 1.208 . . . . 0.0 110.254 179.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -74.9 2.5 10.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.602 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.4 -32.25 5.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -47.36 162.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -1.114 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -143.6 128.33 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -155.99 -150.28 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.419 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.38 27.7 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.73 149.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -1.083 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -81.92 -15.72 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 99.87 3.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.379 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -80.61 12.26 3.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -92.26 -20.11 21.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.542 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.7 OUTLIER -60.02 115.01 11.23 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.256 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.94 3.45 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.633 0.889 . . . . 0.0 110.185 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.7 m80 -85.07 -12.33 53.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.4 9.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -92.53 84.57 5.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.27 134.48 34.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.59 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -91.65 109.77 21.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -93.56 114.88 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -99.01 142.85 29.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.6 161.56 14.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -145.21 -102.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.31 -154.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -90.43 106.61 18.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.88 -9.19 73.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.82 133.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.1 129.03 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.382 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.1 m -93.65 123.76 37.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.87 141.47 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.565 ' HZ3' ' HH ' ' A' ' 82' ' ' TYR . 79.1 tttt -146.13 146.65 30.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.69 14.84 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.94 -46.25 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -1.163 . . . . 0.0 109.558 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.67 -43.37 11.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.23 66.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 51.31 49.16 21.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.3 mtt180 -147.99 147.5 29.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.565 ' HH ' ' HZ3' ' A' ' 75' ' ' LYS . 80.2 m-85 -93.32 135.26 34.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.3 tp -64.95 145.19 56.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.203 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.86 135.34 18.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.9 ttm -98.18 138.89 34.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.455 -0.778 . . . . 0.0 109.453 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -92.48 178.0 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -80.54 -25.49 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.6 p30 -83.16 -1.56 53.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.475 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 93.69 2.26 65.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -78.36 115.18 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.6 mp -90.63 132.24 35.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.55 -172.04 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.483 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.31 152.66 47.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -145.03 170.01 16.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -83.47 -23.49 32.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 63.5 m -93.12 151.85 19.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.64 113.8 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -93.18 177.02 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.46 -17.74 61.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 22.9 mp0 -93.17 16.67 12.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.3 m -92.94 -7.18 46.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 68.1 m-85 -93.01 153.41 18.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 74.1 m-85 -146.47 116.38 7.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -56.11 159.4 3.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -125.13 141.77 51.9 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 97.86 3.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.72 131.33 42.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.39 -170.87 2.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.842 . . . . 0.0 109.385 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.87 -4.65 52.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.465 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -94.48 26.42 3.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.44 -0.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.4 m-85 -93.7 137.21 33.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.84 165.81 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 109.757 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.8 p -143.92 119.38 10.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.434 -0.791 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.66 113.54 25.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.75 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -97.21 143.23 28.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 109.302 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -60.67 162.18 6.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 109.383 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -92.68 -62.88 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -48.1 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.541 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.1 m-85 -93.89 60.46 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 80.4 p -56.96 -0.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.56 11.38 19.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.01 146.47 23.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.769 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.2 m-85 -109.31 169.82 8.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.656 -0.652 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.65 133.55 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.372 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.35 -175.69 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.09 165.82 26.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -94.24 177.72 5.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -92.88 -14.15 28.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.3 t -93.32 32.69 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.6 50.96 60.88 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -142.26 166.53 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -1.078 . . . . 0.0 109.513 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -90.62 120.25 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.656 ' HZ2' ' NE2' ' A' ' 143' ' ' GLN . 55.0 tttt -69.88 132.48 46.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.9 tp -53.34 134.45 39.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.0 109.352 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.57 -0.55 1.99 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.7 p -93.04 -29.65 15.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.586 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -89.73 -4.88 57.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.3 p -72.98 144.1 47.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.15 -179.96 45.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.05 169.92 5.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.883 1.722 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.25 -53.61 3.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.656 ' NE2' ' HZ2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -73.53 134.74 43.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -1.172 . . . . 0.0 109.523 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 7.67 16.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.437 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.439 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -64.1 -9.37 16.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.2 pt -90.14 -5.51 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.351 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.1 90.03 8.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -94.78 164.55 12.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.8 tp -141.82 70.98 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 106.35 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.953 1.769 . . . . 0.0 110.448 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.9 mtt -95.95 123.45 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.312 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.7 t -67.41 157.67 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.963 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 168.02 3.09 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.098 1.199 . . . . 0.0 110.247 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -141.96 139.0 32.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.362 -0.836 . . . . 0.0 109.249 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.465 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -89.91 122.26 32.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.1 mt -84.95 97.24 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.621 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -95.75 113.8 25.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.31 118.07 23.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 109.377 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.85 -16.5 63.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.472 HD22 ' CB ' ' A' ' 144' ' ' LYS . 14.2 m120 -86.31 104.13 15.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.01 4.84 89.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 83.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -142.82 132.57 23.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.358 -1.083 . . . . 0.0 109.533 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.79 114.96 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.6 tp -47.65 143.09 4.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.591 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 17.1 ttt180 -150.15 117.1 5.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 126.34 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.137 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -87.97 152.02 50.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.23 -22.77 58.79 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.126 1.217 . . . . 0.0 110.266 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -74.75 8.8 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.23 -36.18 3.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.4 mtt-85 -47.15 164.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -138.35 123.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -152.61 151.38 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.84 162.77 25.42 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -146.69 148.97 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -1.127 . . . . 0.0 109.549 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -82.18 10.26 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.425 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -93.71 94.84 8.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.627 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -75.33 -5.14 43.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 p -94.48 16.72 14.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -91.14 114.28 61.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.14 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.88 2.5 0.58 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.615 0.877 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.591 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 42.8 m80 -86.29 -11.38 52.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.47 -4.73 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -76.65 83.76 3.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.947 . . . . 0.0 109.406 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.75 135.1 33.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.17 113.07 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -92.17 153.78 19.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.416 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -145.55 149.72 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.88 150.71 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.12 130.84 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.43 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 50.84 -107.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 6.7 ptm180 -154.91 129.79 9.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.77 29.12 73.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.95 96.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -1.16 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.58 129.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 0.0 109.596 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -92.69 121.69 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -89.95 148.44 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -148.77 140.98 24.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.73 145.64 20.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -79.5 -86.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -47.36 -55.07 9.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -30.33 64.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 78' ' ' SER . 73.9 m-80 51.32 44.62 28.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 30.2 mtt180 -137.2 145.26 43.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.56 -0.713 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.17 136.21 33.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 55.2 tp -63.73 151.5 41.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.277 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.4 158.08 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 41.5 ttm -139.26 130.45 26.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 86' ' ' LYS . 3.1 mptp? -94.18 -171.22 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.44 -15.39 25.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.56 -5.51 59.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 94.36 7.78 60.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.15 108.21 17.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 6.3 mp -94.18 131.55 39.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 2.8 pp -150.07 173.14 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.03 159.62 15.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.702 . . . . 0.0 109.497 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -150.13 163.4 38.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.0 109.454 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -88.55 -34.18 17.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -93.66 130.71 39.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 10.7 p -81.93 103.5 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.42 ' C ' ' N ' ' A' ' 100' ' ' GLU . 69.7 p -96.0 165.2 12.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.43 -17.77 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.42 ' N ' ' C ' ' A' ' 98' ' ' THR . 2.5 mp0 -92.72 49.61 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -143.4 6.49 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -96.66 154.23 17.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 0.0 109.464 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 90.0 m-85 -150.02 115.68 5.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.95 152.27 7.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.201 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -125.13 89.86 3.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.626 . . . . 0.0 109.4 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -89.92 120.87 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.358 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 tp -91.6 119.92 31.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.311 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -84.92 -172.84 4.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 111' ' ' ASN . 13.0 p -92.78 -20.27 20.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.2 m120 -74.32 25.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.562 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.3 m120 60.65 -0.7 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.726 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 110' ' ' ASN . 46.4 m-85 -98.71 133.45 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.1 m120 -93.14 170.14 9.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 p -141.25 113.26 7.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.429 -0.795 . . . . 0.0 109.277 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -89.96 105.98 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 121' ' ' THR . 13.7 ttt180 -96.17 151.04 19.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -76.13 155.62 34.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -91.24 -74.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.4 tptt -52.34 -9.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.656 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 17.5 m-85 -142.96 67.19 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.371 -0.83 . . . . 0.0 109.495 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.523 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 23.4 p -65.12 5.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 120' ' ' TYR . 68.0 m -89.73 7.16 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.745 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.1 m-90 -154.62 167.59 29.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.76 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 12.7 m-85 -131.52 168.28 17.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.727 -0.608 . . . . 0.0 109.375 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.0 t -86.07 125.5 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 109.338 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.11 163.57 39.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.0 mt -119.56 161.69 20.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -79.27 -99.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.154 -0.966 . . . . 0.0 109.492 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.91 -36.7 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.463 ' CG2' ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -78.27 10.33 3.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 6.54 67.94 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.9 mp0 -84.82 167.54 15.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.536 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.5 p90 -93.73 120.1 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.619 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -69.91 126.42 29.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.7 tp -46.73 145.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -71.28 8.23 5.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.7 p -91.0 -34.65 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.428 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -90.0 -7.43 54.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 p -70.27 151.78 44.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 158.11 -179.31 33.9 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.95 169.99 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.848 1.699 . . . . 0.0 110.137 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.47 -49.63 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.577 ' N ' HE21 ' A' ' 143' ' ' GLN . 3.9 mm-40 -72.44 131.58 42.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' CB ' HD22 ' A' ' 36' ' ' ASN . 3.5 mtpt -85.02 3.68 37.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -2.53 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.556 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.2 pt -97.29 -3.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.84 99.39 9.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 109.53 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.37 159.29 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.08 72.17 46.98 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.64 117.67 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.824 1.683 . . . . 0.0 110.538 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 15.1 mtt -96.54 127.19 42.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 0.0 109.263 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 t -70.09 161.82 29.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.961 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.7 171.73 1.87 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.177 1.251 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -138.54 130.88 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.217 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.6 mtm-85 -84.99 116.95 23.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.78 95.66 9.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.184 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -91.47 116.2 28.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 t -83.61 105.0 14.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 109.169 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -57.65 -23.61 52.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.601 -179.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 15.4 m-80 -78.15 104.95 9.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 77.79 4.73 85.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.54 86.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' CZ ' ' NH1' ' A' ' 53' ' ' ARG . 48.3 m-85 -144.26 135.46 25.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 109.285 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -92.34 137.27 32.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.9 tp -75.4 143.42 42.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -146.48 122.52 10.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.04 107.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.447 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 61.1 m-70 -66.95 151.95 96.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.098 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.04 -29.57 74.74 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.118 1.212 . . . . 0.0 110.398 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.97 5.59 4.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.461 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 -26.27 5.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -51.53 115.99 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -1.145 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.63 127.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 7.2 p-10 -154.13 152.25 30.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.32 25.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.1 152.49 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 109.531 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.607 ' NH1' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -76.13 -27.87 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.277 179.847 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -47.86 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -85.19 25.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.733 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 p -152.15 35.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.026 . . . . 0.0 109.991 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.41 140.02 25.41 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 108.911 179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.11 -4.68 4.07 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 121.1 1.2 . . . . 0.0 110.453 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 61' ' ' LYS . 69.4 m80 -94.49 -23.66 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.241 -179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.1 8.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.4 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 59' ' ' HIS . 3.2 mmmm -94.4 87.86 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 109.425 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -93.84 135.08 35.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.618 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.24 109.53 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -93.84 151.06 19.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.27 150.4 36.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' OE1' ' A' ' 65' ' ' GLN . . . -94.31 150.76 19.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.78 -83.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.552 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.32 -147.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -92.29 127.03 37.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.412 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.55 33.99 68.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.57 101.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.69 -0.888 . . . . 0.0 109.372 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.1 m -103.09 126.03 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.686 . . . . 0.0 109.494 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 m -89.84 122.99 33.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.93 148.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -146.15 139.99 26.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.9 133.6 11.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 26.1 t -77.79 -72.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -39.97 96.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.61 63.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 18.5 m-80 50.95 50.82 18.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -147.44 147.97 30.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -91.54 127.93 37.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.58 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.64 149.82 20.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.366 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.25 18.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttm -138.29 131.37 30.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.0 109.433 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -85.86 -166.46 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -90.1 -33.88 16.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.56 -1.74 11.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.89 70.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.22 125.99 29.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -1.215 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.2 mp -92.13 135.83 33.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.42 -173.06 4.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.46 158.94 43.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.78 169.94 18.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -82.49 -27.98 31.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.8 m -92.87 160.13 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.516 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.1 t -92.83 156.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.482 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 72.1 p -147.35 160.06 42.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.59 -16.19 35.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -93.99 8.17 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.482 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 76.8 m -93.5 -4.57 50.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 109.79 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 93.5 m-85 -92.2 159.92 15.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 91.7 m-85 -150.94 119.13 6.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.32 147.57 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.974 -1.079 . . . . 0.0 109.334 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -125.33 97.77 5.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.674 -0.641 . . . . 0.0 109.318 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.72 128.42 41.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.568 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.5 tp -94.67 121.51 36.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.166 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.77 -175.72 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -92.98 -25.06 18.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.635 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -74.17 18.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 109' ' ' SER . 2.5 m120 63.92 65.17 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -144.92 -168.87 3.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.133 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -146.64 113.34 6.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.755 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -94.62 111.71 23.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.264 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.51 109.01 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -100.27 150.88 22.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.75 166.89 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.555 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -95.3 -57.82 2.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.388 179.913 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -82.08 -49.29 10.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.582 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.1 m-85 -91.7 61.25 4.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -57.11 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 0.0 110.711 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 120' ' ' TYR . 45.6 m -89.02 11.02 19.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.78 -1.2 . . . . 0.0 109.619 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.4 m-90 -152.48 159.38 43.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 21.2 m-85 -123.06 169.83 10.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.716 -0.615 . . . . 0.0 109.413 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.55 133.27 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.13 178.09 9.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 109.673 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.0 157.68 46.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.646 -0.659 . . . . 0.0 109.383 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -93.94 -166.58 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.334 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -93.87 -10.08 35.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.5 t -90.1 -7.86 52.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.97 60.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -93.77 173.95 7.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -1.11 . . . . 0.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 38.4 p90 -92.6 120.35 32.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -70.01 136.4 50.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.8 tp -59.78 127.49 32.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -49.16 -10.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.4 p -75.51 -36.55 60.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -1.211 . . . . 0.0 109.642 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -89.96 -5.19 56.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.675 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.5 p -83.7 138.73 33.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.9 179.5 48.65 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.96 165.62 11.83 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.874 1.716 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.34 -58.87 3.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 145' ' ' ALA . 26.2 mm-40 -70.75 120.83 16.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -1.191 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 19.1 mtmm -63.51 1.68 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -60.1 -4.66 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -99.86 4.75 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.86 109.82 21.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -113.0 162.06 16.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.6 tp -140.2 70.69 34.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.73 111.37 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.93 1.753 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.1 mtt -94.37 99.88 12.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.325 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 t -56.75 133.41 54.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.977 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.07 172.04 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.197 1.265 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -148.03 128.1 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.16 120.47 26.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.78 104.81 15.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.671 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -104.47 123.08 46.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.54 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.44 136.86 32.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HZ2' ' HZ1' ' A' ' 144' ' ' LYS . 12.5 ttpt -82.4 -25.77 33.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.95 105.07 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.38 4.93 89.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.45 87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.0 m-85 -143.81 136.44 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -1.067 . . . . 0.0 109.689 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -95.54 124.6 39.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.318 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.52 144.43 26.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.151 -0.968 . . . . 0.0 109.149 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -148.01 119.77 8.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.743 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -94.44 128.37 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.082 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -91.66 151.89 42.8 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.216 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.35 -27.79 77.11 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.178 1.252 . . . . 0.0 110.317 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -74.91 1.84 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.63 -31.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -50.2 118.5 3.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.463 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 148.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -169.57 -162.9 0.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.32 158.48 27.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.87 143.6 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -1.087 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -74.39 -1.39 20.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.66 92.55 8.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -85.17 56.42 3.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.2 p -155.49 13.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 110.096 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.6 m-20 -93.25 145.68 30.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.983 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.56 0.82 1.25 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.106 1.204 . . . . 0.0 110.338 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' ' 61' ' ' LYS . 77.5 m80 -91.35 -29.21 17.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 110.187 -179.233 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -69.16 4.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.971 -1.08 . . . . 0.0 109.351 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 59' ' ' HIS . 10.7 mtpt -93.02 82.87 4.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -93.39 134.04 36.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.387 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -94.04 123.27 37.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -91.94 156.34 17.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -144.94 125.04 13.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.04 165.29 22.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.56 -98.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.391 -0.818 . . . . 0.0 109.206 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.67 -172.62 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.049 -1.032 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 10.9 mpt_? -72.96 107.74 5.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.9 68.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.5 t -92.97 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.22 170.63 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.505 ' OG ' ' CD2' ' A' ' 102' ' ' PHE . 4.6 m -148.94 134.99 19.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.1 mt -93.14 155.94 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.36 139.8 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.62 127.33 9.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.94 -61.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.461 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -27.05 68.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.88 -23.98 21.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 51.66 51.2 17.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -148.08 145.96 28.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -96.03 125.09 40.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -58.98 145.1 42.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.244 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.1 130.83 14.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.435 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 ttm -90.5 104.25 16.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.91 166.46 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.527 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -78.51 -22.07 47.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -73.63 -5.85 43.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.95 -7.75 70.12 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.408 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -77.95 123.91 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.344 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.8 mp -89.77 124.26 34.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.209 -0.932 . . . . 0.0 109.128 179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.1 pp -148.43 -170.33 3.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 109.611 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.16 161.13 39.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 p -146.49 153.19 40.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -59.11 -38.37 79.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.87 157.67 20.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 t -93.1 117.45 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.542 ' H ' ' HG ' ' A' ' 101' ' ' CYS . 60.7 p -89.19 173.01 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.46 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -94.13 24.89 4.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.558 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.542 ' HG ' ' H ' ' A' ' 98' ' ' THR . 18.0 m -93.87 -8.81 39.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.583 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' OG ' ' A' ' 73' ' ' SER . 77.8 m-85 -93.99 158.56 15.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.593 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 86.7 m-85 -148.13 116.58 6.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.35 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -55.1 124.56 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -88.48 147.94 24.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -148.1 120.13 8.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.515 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.9 131.0 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -175.69 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -90.96 -4.48 56.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.466 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 112' ' ' TYR . 12.8 m-80 -93.48 27.89 2.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.501 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 63.64 -7.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.488 -0.758 . . . . 0.0 110.126 179.807 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.5 m-85 -84.14 -173.06 4.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.27 167.12 24.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -142.43 169.96 16.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.301 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -143.83 110.93 5.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.359 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -94.94 145.52 24.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.5 ' HG ' ' N ' ' A' ' 118' ' ' ARG . 4.4 t -63.98 162.12 14.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' N ' ' HG ' ' A' ' 117' ' ' SER . 1.7 ttt-85 -92.36 -63.71 1.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.714 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -64.9 -47.8 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.731 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.5 m-85 -99.59 63.85 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.57 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -59.76 2.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.9 m -89.81 14.02 13.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.041 -1.037 . . . . 0.0 109.772 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.07 145.75 22.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.948 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -107.71 166.93 10.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.36 125.49 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.67 159.06 40.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.8 mt -108.1 179.39 4.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.658 -0.651 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -95.24 -112.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.479 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -147.38 -32.59 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 -179.889 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -79.31 3.6 17.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.492 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.64 56.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -94.12 167.5 11.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -86.64 120.36 27.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.67 ' HZ2' HE21 ' A' ' 143' ' ' GLN . 63.8 tttt -69.84 133.71 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.9 tp -59.15 138.04 57.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.227 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -70.95 11.9 2.39 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 135' ' ' LEU . 99.4 p -94.57 -37.78 11.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -1.15 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -88.78 -6.05 57.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.3 p -70.97 158.01 37.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.508 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 161.35 -179.47 36.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.89 159.5 29.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.883 1.722 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.43 -27.48 9.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.67 HE21 ' HZ2' ' A' ' 134' ' ' LYS . 38.2 mt-30 -84.82 128.28 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HZ1' ' HZ2' ' A' ' 35' ' ' LYS . 6.7 mtmp? -82.78 -3.75 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.419 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.84 41.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pt -84.76 2.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.62 90.52 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.83 166.91 11.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.6 tp -141.93 70.42 24.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.722 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.01 105.75 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.791 1.661 . . . . 0.0 110.418 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.6 mtt -94.81 125.36 39.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.378 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 137.57 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.517 179.967 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.01 154.96 41.51 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.178 1.252 . . . . 0.0 110.243 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -124.67 122.61 37.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.95 118.62 24.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.82 102.89 13.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.586 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -95.82 123.45 39.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.322 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -91.88 117.56 29.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.4 -14.68 57.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.0 m-20 -83.4 105.02 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.32 4.86 65.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.92 75.65 0.21 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.41 133.0 51.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.698 -0.883 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.77 117.86 30.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.6 tp -48.74 137.58 12.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.249 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 7.2 ttt180 -148.23 119.97 8.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.645 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.8 113.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.103 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -76.18 149.47 82.17 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.525 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.1 Cg_endo -58.52 -24.05 67.63 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.13 1.22 . . . . 0.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 18.6 p30 -74.9 2.22 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.39 -33.76 4.61 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.14 114.75 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.4 125.03 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 4.7 p-10 -155.37 -152.96 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -144.07 161.34 27.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.29 142.63 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 109.505 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -77.1 1.48 17.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.31 83.84 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 55.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 m -145.43 6.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 109.872 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 59' ' ' HIS . 28.2 m-20 -94.27 138.93 22.34 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.91 . . . . 0.0 109.12 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -1.36 1.76 Allowed 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 121.069 1.179 . . . . 0.0 110.373 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 78.1 m80 -83.37 -22.12 32.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 110.036 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -75.95 7.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -95.81 87.36 4.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.44 135.27 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.11 109.6 21.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 109.266 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.7 mp -90.85 154.46 19.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -139.03 142.04 38.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.495 -0.753 . . . . 0.0 109.143 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.26 28.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.551 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 69' ' ' ARG . 1.1 tp10 -144.42 143.42 30.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 51.4 -90.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.405 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.0 ttm180 -147.82 -91.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.85 9.16 57.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.59 97.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -1.193 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.42 126.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -94.85 130.18 41.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.56 150.1 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.558 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -148.84 130.27 14.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.75 135.74 14.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.05 -80.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -1.103 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.7 t -47.66 -57.27 5.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.74 -25.81 63.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.9 m120 51.24 45.54 27.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -136.98 148.66 47.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.327 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -91.02 130.84 36.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.1 138.03 58.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.139 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.0 144.59 25.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.35 144.16 28.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.767 . . . . 0.0 109.357 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.9 174.18 11.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -78.69 -15.88 57.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.29 -42.51 9.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.517 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.13 -8.93 1.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -75.15 125.94 30.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -1.105 . . . . 0.0 109.501 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.5 mp -92.63 141.22 28.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.928 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.22 -171.31 3.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.91 114.79 12.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 109.328 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 p -98.2 170.09 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -38.4 14.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.448 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.34 159.73 15.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 t -93.02 149.11 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 p -147.1 172.46 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -47.88 -35.79 11.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 19.4 mt-10 -88.73 67.03 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 74.6 m -153.39 15.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 46.4 m-85 -124.6 158.4 33.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.706 -0.621 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 35.1 m-85 -144.74 122.9 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.398 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.59 109.48 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' OE2' ' CE1' ' A' ' 115' ' ' TYR . 37.4 tt0 -85.64 150.2 24.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -146.42 98.36 3.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.24 131.9 48.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.48 -166.82 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.339 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 111' ' ' ASN . 74.4 m -94.64 -20.9 19.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.786 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.0 OUTLIER -80.23 25.92 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.2 m120 62.94 -7.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.463 -0.773 . . . . 0.0 110.466 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 110' ' ' ASN . 42.7 m-85 -89.9 135.75 33.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.881 -1.137 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 113' ' ' ASN . 1.0 OUTLIER -93.75 168.74 10.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.1 p -143.66 122.69 12.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.458 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 85.1 m-85 -94.19 114.94 27.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 19.0 ttt180 -98.19 142.57 29.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 120' ' ' TYR . 34.7 ttt180 -94.99 -72.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -54.64 -9.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.7 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.538 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.8 m-85 -140.9 60.79 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 16.8 p -58.33 -1.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.726 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.88 10.3 24.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.53 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.08 142.49 19.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 109.737 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.9 m-85 -106.48 169.7 8.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.7 t -89.52 134.51 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.44 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.63 162.19 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.557 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.05 161.27 23.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -85.85 -170.02 2.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -92.44 -29.71 16.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -73.75 1.62 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.48 66.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -86.69 168.65 13.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -1.158 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.2 p90 -92.21 120.2 32.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 143' ' ' GLN . 48.1 tttt -69.94 135.76 49.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -47.54 160.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.202 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.83 16.81 55.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.9 p -115.07 -27.74 7.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.683 -0.892 . . . . 0.0 109.638 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -87.64 -4.98 58.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.694 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 p -70.71 166.69 20.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 154.26 179.58 29.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.93 166.35 10.57 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.85 1.7 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.81 -56.12 2.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.8 mt-30 -70.35 133.91 47.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 109.464 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.486 ' C ' HD22 ' A' ' 36' ' ' ASN . 15.3 mtpp -85.14 3.84 37.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.594 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.75 -4.24 1.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 144' ' ' LYS . 24.2 pt -93.99 -4.36 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -0.845 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.67 107.97 17.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.02 162.77 16.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.1 tp -140.29 71.18 33.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.96 105.09 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.901 1.734 . . . . 0.0 110.435 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.4 mtm -100.68 128.96 46.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.791 . . . . 0.0 109.408 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 t -70.22 120.75 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.999 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.54 171.64 1.31 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.233 1.289 . . . . 0.0 110.278 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -149.98 139.41 21.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.3 mtm-85 -92.98 114.47 27.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.5 mt -85.0 91.25 8.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -86.29 125.52 33.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.5 t -89.68 123.67 33.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.688 ' HZ2' ' HZ1' ' A' ' 144' ' ' LYS . 4.8 ttpt -72.5 -14.55 61.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.573 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -86.2 104.99 16.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.797 -179.66 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.53 6.23 80.31 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.38 77.68 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -134.29 138.15 44.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.598 -0.942 . . . . 0.0 109.606 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -96.47 158.81 15.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 tp -85.23 139.21 31.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -146.33 111.69 5.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.9 mt -89.85 133.89 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.194 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.524 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.8 m-70 -89.01 149.65 43.71 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 109.184 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.4 Cg_endo -59.94 -23.27 72.16 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.166 1.244 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -15.3 57.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.818 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.78 -37.12 3.39 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.5 mtt-85 -46.4 114.89 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -1.159 . . . . 0.0 109.79 -179.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -100.1 128.56 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.531 -0.731 . . . . 0.0 109.459 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 3.1 p30 -155.69 -150.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -146.89 163.63 28.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.42 154.46 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -81.1 -14.35 57.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE1' ' OG ' ' A' ' 56' ' ' SER . 6.3 mm-40 -78.95 87.6 4.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -81.99 17.84 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 109.421 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' OE1' ' A' ' 54' ' ' GLU . 13.3 p -100.58 3.32 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.86 133.71 28.65 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 109.164 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -4.16 4.21 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.84 1.026 . . . . 0.0 110.257 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -74.83 -10.95 59.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' LYS . 3.2 pt -89.26 -7.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.35 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -80.0 90.16 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.88 135.2 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.96 104.92 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.3 mp -89.13 153.34 21.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.44 126.93 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.94 121.92 26.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.97 -29.37 14.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.492 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.03 -167.59 2.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -82.42 -0.79 47.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.92 28.92 1.27 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 t -145.49 145.12 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -1.101 . . . . 0.0 109.431 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.01 121.67 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -93.28 123.34 36.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.451 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.1 mt -91.44 147.46 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -145.8 132.53 19.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.85 137.65 17.6 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.78 -65.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.471 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 t -63.3 -49.8 72.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.918 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.06 -21.55 66.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 47.65 45.0 17.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.842 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 40.7 mtp180 -141.08 146.82 37.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.464 -0.773 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.84 136.8 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.03 149.23 45.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.24 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.64 129.26 13.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 ttm -96.41 130.85 43.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.88 -175.38 4.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -92.72 -23.47 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 p30 -82.78 -40.35 20.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 143.57 -7.92 2.02 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -75.57 120.64 21.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.555 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.6 mp -92.42 136.34 33.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.1 pp -147.01 -171.9 3.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.14 164.36 30.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.371 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 m -149.92 170.02 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -83.09 -46.16 13.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.8 116.03 28.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -52.1 165.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.6 p -147.1 -173.05 4.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.405 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -25.68 62.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.4 59.16 3.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.2 m -147.25 10.11 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.9 m-85 -94.93 152.18 18.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.1 m-85 -150.04 116.59 5.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -69.31 127.42 33.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.01 96.52 10.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.701 ' HE ' HH22 ' A' ' 116' ' ' ARG . 0.0 OUTLIER -91.96 114.31 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.2 128.54 34.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -91.71 -177.44 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -92.62 45.06 1.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.9 m-20 -146.89 28.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.27 -0.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.897 . . . . 0.0 109.711 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.6 m-85 -96.61 130.98 43.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.373 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.56 168.71 11.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.4 p -145.8 119.6 9.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.12 106.31 18.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.701 HH22 ' HE ' ' A' ' 106' ' ' ARG . 33.5 ttm180 -93.87 146.5 23.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 118' ' ' ARG . 4.5 t -72.21 151.73 42.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' N ' ' HG ' ' A' ' 117' ' ' SER . 12.9 ttt180 -91.29 -75.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 13.9 tttp -51.14 -9.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.863 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 118' ' ' ARG . 14.7 m-85 -143.08 64.06 1.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.7 p -62.11 1.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' TYR . 15.4 m -89.97 11.33 20.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.493 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.04 140.54 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.943 . . . . 0.0 109.783 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.479 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 26.8 m-85 -106.37 165.4 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -91.41 119.88 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.56 147.17 27.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.56 178.36 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -95.53 -169.45 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -93.77 -13.87 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.9 8.37 39.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.427 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.33 3.65 84.35 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.85 173.14 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -1.128 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.0 p90 -92.82 120.32 33.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -69.95 131.49 44.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.395 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.7 tp -47.34 133.16 12.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -58.97 -2.3 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.0 p -92.36 -57.43 2.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.193 . . . . 0.0 109.498 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 137' ' ' SER . 23.1 mtpp -61.05 -8.19 3.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 136' ' ' GLY . 11.6 p -71.06 158.14 36.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.81 179.65 34.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.97 175.77 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.833 1.688 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.63 -56.14 5.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.86 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -1.151 . . . . 0.0 109.357 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.688 ' HZ1' ' HZ2' ' A' ' 35' ' ' LYS . 8.6 mtmp? -85.03 3.48 38.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.43 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -65.12 -10.47 31.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.588 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -5.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -83.94 87.98 7.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -92.94 167.75 11.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.5 70.63 32.12 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.446 -0.784 . . . . 0.0 109.391 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.38 99.6 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.852 1.701 . . . . 0.0 110.335 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.6 mtm -96.25 122.3 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.425 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.7 t -62.23 148.66 44.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.498 -179.951 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.02 157.65 24.2 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.264 1.309 . . . . 0.0 110.204 179.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -135.8 131.97 36.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.679 . . . . 0.0 109.19 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -84.96 118.67 24.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.526 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.87 98.01 10.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 117.61 30.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.99 102.58 12.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.31 -27.97 50.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 14.8 m120 -76.95 103.2 6.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.21 4.73 89.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.97 85.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.2 m-85 -143.39 132.82 23.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.078 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -93.28 129.02 39.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.53 142.25 55.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 109.245 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 48.5 ttt180 -146.85 115.62 6.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.65 115.5 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.284 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -75.42 151.74 85.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.007 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.05 -28.79 71.35 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 121.202 1.268 . . . . 0.0 110.468 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.56 4.06 10.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.87 -31.44 5.29 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -46.96 114.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -1.112 . . . . 0.0 109.519 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.23 129.53 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -155.61 149.89 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 155.39 22.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.54 152.92 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -82.51 -12.0 58.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.534 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.33 101.57 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.96 -5.01 59.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -20.19 22.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.536 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -51.95 112.3 3.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.925 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.57 3.72 0.45 Allowed 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 120.638 0.892 . . . . 0.0 110.129 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 57' ' ' ASP . 41.9 m80 -86.92 -15.25 39.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -76.76 -2.37 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -82.48 86.02 6.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.02 135.28 33.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.45 108.48 19.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -94.08 149.14 21.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.707 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -141.62 134.54 28.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.371 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.76 131.68 38.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -97.13 -76.72 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -95.85 -121.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -94.03 -96.6 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.1 3.38 46.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.0 125.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -1.188 . . . . 0.0 109.424 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.76 169.59 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 109.452 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -142.88 128.42 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.7 149.74 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -147.12 117.93 7.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.56 130.1 11.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.88 -74.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -1.121 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -49.12 -55.31 12.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.38 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -26.82 67.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.392 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m120 51.34 50.31 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 93' ' ' ALA . 8.7 mtp180 -146.68 147.2 30.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.948 . . . . 0.0 109.598 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.18 130.98 36.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.15 140.94 58.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.01 139.65 21.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -97.45 131.46 44.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.47 -0.769 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -73.2 -174.19 1.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.78 -16.79 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.5 p30 -90.23 -38.86 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.04 -10.88 2.31 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -72.8 124.8 26.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.1 mp -93.32 137.74 32.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -149.74 -174.23 4.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 179.931 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' ' 81' ' ' ARG . . . -143.67 132.18 22.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.295 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -110.24 168.77 9.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -84.51 -1.13 55.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.14 136.77 52.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.723 -0.611 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.468 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 14.9 p -80.98 109.02 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 p -97.53 179.12 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.415 -0.803 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.13 -21.58 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -93.09 53.16 1.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 51.0 m -141.61 5.6 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.8 . . . . 0.0 109.529 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 77.3 m-85 -93.2 153.52 18.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.9 m-85 -149.03 115.1 5.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -61.62 107.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -86.54 94.1 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -94.98 124.1 38.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.43 133.23 35.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.613 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 110' ' ' ASN . 2.1 mt-10 -94.71 151.2 19.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.513 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 m -63.58 1.9 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.496 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 112' ' ' TYR . 36.1 t-20 -93.38 25.77 3.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER 61.64 -3.63 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.887 179.98 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.1 m-85 -94.59 -174.87 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 112' ' ' TYR . 3.9 m-80 -147.64 164.83 32.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 p -143.82 120.63 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -93.8 105.43 17.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -93.25 139.16 30.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -70.27 147.93 49.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 120' ' ' TYR . 45.6 ttt180 -81.75 -73.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.0 tptt -51.64 -9.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 118' ' ' ARG . 13.6 m-85 -139.12 68.6 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.713 . . . . 0.0 109.176 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.3 p -63.75 -16.36 60.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.4 m -89.92 18.85 5.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.983 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -148.47 123.54 10.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.848 . . . . 0.0 109.636 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 35.4 m-85 -100.7 164.48 11.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.18 139.64 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.02 -175.25 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -141.14 166.39 24.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -94.21 177.86 5.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -91.69 -7.52 49.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 109.315 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.81 -0.68 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.4 -0.54 65.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -90.42 166.3 13.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 109.369 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.532 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 21.6 p90 -85.42 120.08 26.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.35 123.0 20.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.4 tp -47.92 160.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.178 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 139' ' ' THR . . . -77.02 -42.41 19.87 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -59.03 -17.58 26.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.689 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.31 -9.72 46.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.802 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 54.7 p -80.51 177.51 8.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -0.975 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.8 178.69 22.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -60.77 165.41 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.864 1.709 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.16 -37.6 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 141' ' ' PRO . 7.0 mm100 -66.52 121.82 16.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -1.142 . . . . 0.0 109.501 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 21.1 mtmt -80.97 -7.85 59.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.75 -6.46 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.3 pt -95.06 8.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.603 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.14 98.39 10.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.04 164.67 11.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.66 -0.65 . . . . 0.0 109.495 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -141.93 70.29 24.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.41 -0.806 . . . . 0.0 109.389 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.58 107.73 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.88 1.72 . . . . 0.0 110.478 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.1 mtt -98.41 117.14 32.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.501 -0.749 . . . . 0.0 109.38 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.3 t -69.95 142.65 52.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -70.19 1.12 5.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -48.43 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.917 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . 162.57 -164.62 35.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.63 -98.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' O ' ' OG1' ' A' ' 7' ' ' THR . 6.9 mt -145.43 142.37 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 6' ' ' ILE . 1.6 p 61.48 143.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.03 127.58 12.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 7.7 mt -90.11 -32.15 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 112.025 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.8 Cg_endo -68.98 98.54 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.689 0.926 . . . . 0.0 110.208 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.94 161.5 2.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.39 68.15 53.88 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.564 -0.71 . . . . 0.0 110.028 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.25 161.73 25.9 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.642 1.561 . . . . 0.0 110.217 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 48.43 73.26 0.22 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.62 -13.79 6.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.97 -85.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' C ' ' HG ' ' A' ' 18' ' ' SER . . . 69.17 36.72 80.5 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.426 ' HG ' ' C ' ' A' ' 17' ' ' GLY . 2.3 p 47.51 86.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.63 107.97 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.81 -35.07 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -89.96 -47.18 0.39 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.284 -0.885 . . . . 0.0 110.746 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.3 Cg_endo -66.62 168.08 17.5 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 120.995 1.13 . . . . 0.0 109.795 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.71 135.17 67.64 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.639 1.559 . . . . 0.0 110.137 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' ND1' ' A' ' 25' ' ' HIS . . . 171.54 -5.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 24' ' ' GLY . 64.1 m-70 -146.68 8.83 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -1.118 . . . . 0.0 109.647 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -95.6 29.64 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -27.24 16.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.51 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -114.8 152.62 46.57 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.74 170.58 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.114 1.21 . . . . 0.0 110.109 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.476 ' HZ1' ' CB ' ' A' ' 30' ' ' LYS . 6.4 mtmp? -142.78 132.42 23.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.458 HH11 ' HG3' ' A' ' 31' ' ' ARG . 5.3 mtm-85 -84.83 122.52 29.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.64 98.94 10.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 109.485 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -97.85 117.15 31.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.5 t -82.18 137.71 34.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -26.38 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.956 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.7 m-20 -74.43 105.01 5.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 109.801 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.53 5.85 88.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.73 83.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 46.3 m-85 -142.32 137.52 30.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -1.083 . . . . 0.0 109.505 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 29.1 m-85 -94.46 145.96 24.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.556 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -80.26 145.3 32.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.255 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.408 HH11 ' CG ' ' A' ' 57' ' ' ASP . 2.9 ttt180 -148.4 122.29 9.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.499 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -90.04 109.1 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.172 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -66.13 152.26 94.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.147 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.85 -28.88 79.12 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.203 1.269 . . . . 0.0 110.242 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.82 6.55 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.29 -31.97 3.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -47.65 120.99 3.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -1.12 . . . . 0.0 109.461 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.34 129.77 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.411 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -147.87 -159.62 1.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.57 151.61 23.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.8 151.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' LYS . 25.1 mtm180 -77.66 -31.39 52.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 56' ' ' SER . 2.2 mm-40 -50.52 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.555 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -76.38 -1.29 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.4 p -91.37 -20.2 22.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -44.47 107.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 0.0 109.462 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.55 5.54 0.33 Allowed 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 120.797 0.998 . . . . 0.0 110.54 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.1 m80 -93.39 -18.19 22.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.77 -3.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -74.82 84.62 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.25 134.93 33.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -91.65 104.92 17.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.336 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.2 mp -92.38 152.69 19.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.68 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.13 149.16 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.39 149.39 22.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -149.03 143.04 25.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 52.95 -119.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.377 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -147.45 113.24 5.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.74 -18.46 55.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -92.51 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -1.163 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.7 m -146.42 131.17 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 109.437 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -92.42 118.29 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.24 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -145.56 144.77 30.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.46 137.52 13.64 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.98 -68.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -1.132 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 t -66.62 -48.88 68.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.91 -24.38 66.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.38 46.43 26.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.915 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.04 149.36 34.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -93.16 137.46 32.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.4 tp -65.14 143.84 57.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.896 . . . . 0.0 109.29 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.22 18.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.591 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.6 ttm -95.22 150.47 20.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -92.64 -170.01 2.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.4 mp0 -93.46 -32.02 14.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -79.89 -37.63 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 142.55 -5.01 2.03 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -73.26 117.87 15.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 10.9 mp -91.76 133.14 35.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 3.0 pp -149.96 172.95 14.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -114.87 164.84 13.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.414 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -150.02 169.74 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -84.01 -35.83 23.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -94.13 138.69 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.1 p -90.26 117.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.424 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 11.0 p -103.08 173.62 6.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -15.64 23.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.339 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.83 51.24 1.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.424 ' SG ' ' O ' ' A' ' 98' ' ' THR . 7.7 m -140.89 5.23 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -93.12 160.46 14.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -150.0 114.85 5.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -65.41 118.83 9.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -93.4 98.18 11.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.13 100.34 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.337 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.4 tt -77.6 129.45 35.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.71 -171.34 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -91.34 2.96 56.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.9 m-80 -94.78 24.78 4.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.21 -2.35 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.975 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.6 m-85 -91.55 -175.79 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 109.491 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 146' ' ' ILE . 5.2 m120 -146.95 158.13 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.565 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 p -134.29 118.38 17.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.64 -0.662 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.03 105.28 17.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -92.91 142.61 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.355 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 t -71.36 147.81 47.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -88.77 -66.67 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 tptp -49.1 -18.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.6 m-85 -144.31 77.69 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 82.3 p -66.01 5.96 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 3.9 m -89.52 5.38 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.526 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 5.3 m-90 -148.39 170.45 17.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.028 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 17.0 m-85 -137.09 162.67 32.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.96 122.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.12 138.17 17.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.35 171.94 8.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -87.64 -115.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -143.18 7.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 109.546 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.22 11.23 8.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.57 64.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -93.13 159.23 15.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 38.1 p90 -91.15 120.06 31.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -69.88 132.28 45.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -47.8 150.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.297 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -70.94 -10.43 68.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.1 p -91.03 -32.22 15.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.155 . . . . 0.0 109.52 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -81.16 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.4 p -79.4 156.32 27.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.14 -179.75 38.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.91 171.48 3.7 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.894 1.729 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.29 -50.54 3.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.07 134.28 40.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 14.1 mtmt -83.96 6.52 21.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.587 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -65.05 -6.46 8.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 113' ' ' ASN . 21.0 pt -90.45 -6.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.16 97.51 9.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -98.86 159.65 14.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.6 tp -139.13 71.53 40.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.504 -0.748 . . . . 0.0 108.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.83 116.45 3.45 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.877 1.718 . . . . 0.0 110.715 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.8 mtt -95.99 121.2 37.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 0.0 109.168 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.9 t -69.23 135.72 50.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.92 57.15 4.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -74.5 -85.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.41 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.64 176.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.95 -99.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . 62.67 172.72 1.74 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 56' ' ' SER . 56.4 mm-40 -74.49 -46.87 36.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.18 172.38 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.803 . . . . 0.0 109.455 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -59.57 174.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' THR . 51.7 m 47.36 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -75.6 -47.15 4.16 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.223 -0.923 . . . . 0.0 110.682 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.7 Cg_endo -67.46 95.88 0.4 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.091 1.194 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' LEU . . . -105.69 51.11 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.524 -0.735 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ALA . 6.1 mt -38.43 102.81 0.25 Allowed Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.58 86.05 0.28 Allowed 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 120.769 0.979 . . . . 0.0 110.044 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 16' ' ' GLY . 3.5 mm-40 45.26 80.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.01 0.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 14' ' ' GLU . . . -81.34 -34.38 26.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.28 121.35 7.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.09 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.464 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.97 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 -81.28 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 109.522 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -146.89 62.91 7.89 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.467 -0.771 . . . . 0.0 109.936 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.58 113.57 2.01 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 121.735 1.624 . . . . 0.0 110.274 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.74 98.1 0.34 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 120.76 0.973 . . . . 0.0 109.928 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 25' ' ' HIS . . . -174.35 48.11 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 96.6 m-70 -157.15 46.52 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -1.127 . . . . 0.0 109.359 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -137.8 5.58 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -36.2 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.526 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.97 152.69 46.77 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.51 168.53 2.13 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.134 1.223 . . . . 0.0 110.097 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -138.9 139.84 38.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -91.52 120.07 32.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 mt -84.63 101.98 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -95.56 115.83 27.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.544 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.89 111.31 17.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.213 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -59.09 -30.39 68.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.6 m-80 -78.64 105.23 9.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 110.122 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 81.65 4.63 90.31 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 86.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.1 m-85 -142.66 134.5 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -94.14 123.84 37.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.7 tp -57.79 141.83 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.321 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 25.4 ttt180 -147.28 117.93 7.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.5 mt -93.17 110.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -71.75 151.81 93.35 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.145 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.0 Cg_exo -57.04 -27.83 75.68 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.126 1.218 . . . . 0.0 110.238 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -74.95 0.45 15.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -29.62 7.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.59 114.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -1.153 . . . . 0.0 109.429 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.56 129.95 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 109.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 2.9 p30 -166.46 151.01 7.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.99 159.0 24.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 m -146.17 148.63 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -1.17 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -76.82 -9.84 58.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.43 84.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.477 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 2.51 3.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.429 ' O ' ' OE2' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -92.89 -20.37 20.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.4 OUTLIER -49.89 111.2 1.95 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.67 5.38 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.663 0.909 . . . . 0.0 110.245 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' ASP . 47.3 m80 -94.24 -14.79 25.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.35 9.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 59' ' ' HIS . 2.9 mmmm -91.12 88.0 6.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.08 134.99 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.638 ' NE2' ' HZ2' ' A' ' 75' ' ' LYS . 26.0 tt0 -95.03 110.23 22.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.2 mp -95.47 144.57 25.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.813 . . . . 0.0 109.491 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.86 134.16 47.35 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 121.79 31.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.59 -85.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.6 mt-10 -94.86 149.57 21.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.883 . . . . 0.0 109.318 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.7 mtt-85 -57.58 84.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 140.82 -1.83 2.07 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -138.86 145.57 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -1.046 . . . . 0.0 109.414 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.9 133.83 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -94.61 127.07 40.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.452 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 mt -93.41 144.49 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HZ2' ' NE2' ' A' ' 63' ' ' GLN . 8.8 ttpt -146.52 143.47 28.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.68 135.59 12.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.92 -83.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -1.141 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.9 t -48.88 -43.99 39.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.88 65.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 49.65 50.14 18.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.4 mtp180 -146.0 147.08 31.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.95 127.29 36.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.9 144.85 31.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 109.33 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.17 170.14 16.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.416 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.419 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -144.16 134.65 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.5 -169.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -91.75 -11.16 37.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.413 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -92.6 -42.54 9.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.86 -9.97 1.38 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -66.98 127.56 33.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -1.167 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mp -93.47 134.51 35.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.7 pp -150.07 143.74 25.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.897 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.96 158.47 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.763 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.71 161.85 38.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.98 -47.35 37.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 m -85.07 139.42 31.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.23 152.16 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -148.01 -163.65 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.489 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -55.39 -51.64 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 85' ' ' MET . 71.7 mt-10 -74.2 77.23 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 36.9 m -155.2 -33.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 38.2 m-85 -84.68 156.05 21.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 68.4 m-85 -145.08 122.85 11.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.17 119.82 8.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.1 146.42 24.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.065 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 118.94 9.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.368 -0.832 . . . . 0.0 109.677 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.11 119.86 31.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.251 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.92 -178.74 6.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 m -86.43 -12.14 49.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 54.6 m-80 -89.48 16.94 6.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 1.0 OUTLIER 65.2 57.75 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.649 -0.657 . . . . 0.0 110.323 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 60.1 m-85 -145.49 123.42 12.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.581 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.7 OUTLIER -89.96 124.48 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.736 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.8 p -97.74 168.8 10.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.752 . . . . 0.0 109.382 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -143.59 105.87 4.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 134.38 38.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -63.94 131.41 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.141 -0.974 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' A' ' 120' ' ' TYR . 40.7 ttp180 -69.22 -69.88 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.626 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.518 ' NZ ' ' OH ' ' A' ' 120' ' ' TYR . 17.8 tttt -51.65 -10.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.518 ' OH ' ' NZ ' ' A' ' 119' ' ' LYS . 36.3 m-85 -147.01 69.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -65.9 4.96 0.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.1 m -95.08 9.38 39.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.587 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.21 139.15 17.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.7 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -100.2 156.43 17.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.98 128.99 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.208 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.04 149.27 26.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.764 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -102.03 176.24 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.602 -0.686 . . . . 0.0 109.458 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -95.08 -167.42 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -11.2 30.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 1.6 t -91.47 0.12 57.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.47 -2.53 70.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.4 mp0 -84.97 176.41 8.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 32.6 p90 -92.8 120.4 33.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.63 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -71.02 136.09 48.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.97 164.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.061 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -93.17 -1.7 66.76 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -97.33 -20.82 17.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.245 -1.15 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -90.06 -4.91 57.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 p -79.51 155.23 28.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.004 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.63 178.71 42.92 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.4 Cg_endo -60.97 169.58 5.76 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.925 1.75 . . . . 0.0 110.274 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 -20.51 2.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 145' ' ' ALA . 10.2 mt-30 -90.16 109.51 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -1.15 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 15.9 mtmt -65.05 2.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.35 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -65.06 -9.13 19.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.1 pt -94.54 5.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.482 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 87.0 mt -94.67 85.67 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -94.9 169.64 9.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.227 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.73 70.43 30.56 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.41 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.89 104.13 0.37 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.848 1.699 . . . . 0.0 110.411 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.4 mtt -95.12 125.59 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.3 t -70.02 132.62 46.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.8 57.04 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -63.11 -61.46 2.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.469 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.344 0.592 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.71 -102.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 26.3 mm-40 -92.96 74.25 4.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.533 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.09 -142.67 18.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -90.02 -101.92 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -1.116 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.442 ' O ' ' OG1' ' A' ' 7' ' ' THR . 0.4 OUTLIER -91.78 -166.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 6' ' ' ILE . 1.6 p 64.07 49.82 2.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.562 -0.711 . . . . 0.0 109.752 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -81.09 -3.17 51.06 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 108.974 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.4 tp -116.35 88.01 22.01 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.36 99.52 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 121.084 1.189 . . . . 0.0 110.457 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.55 -168.78 2.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 tp -142.27 68.64 21.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 109.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.2 89.07 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.772 1.648 . . . . 0.0 110.014 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 179.53 100.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.025 . . . . 0.0 109.445 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -20.54 66.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' SER . . . 68.19 -77.87 0.23 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' O ' ' OG ' ' A' ' 18' ' ' SER . . . -61.38 79.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m -168.19 95.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.426 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.93 60.16 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.11 92.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -1.082 . . . . 0.0 109.742 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 45.49 68.05 3.68 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.63 113.78 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.777 1.651 . . . . 0.0 109.963 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 124.8 14.73 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.715 0.943 . . . . 0.0 109.991 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 147.02 -57.67 0.5 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.83 6.1 1.3 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 109.413 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 24' ' ' GLY . 78.1 m-85 -85.83 16.6 3.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.171 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -92.16 35.6 0.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.847 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.81 148.72 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 108.841 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.95 165.3 8.66 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.118 1.212 . . . . 0.0 110.45 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -147.26 122.14 9.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -86.27 122.62 30.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.85 101.08 12.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -91.95 124.34 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.286 -0.883 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.55 127.52 35.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.421 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -74.7 -19.56 60.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.669 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.21 105.16 15.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.73 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.69 5.14 90.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 84.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.5 m-85 -143.64 135.68 26.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -1.107 . . . . 0.0 109.518 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.48 129.43 43.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 tp -55.47 144.77 24.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.953 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.471 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 17.0 ttt180 -149.08 114.63 5.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.581 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.85 114.27 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.269 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.508 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 66.8 m-70 -69.34 151.27 96.95 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.034 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.8 Cg_endo -57.27 -27.92 77.32 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.301 1.334 . . . . 0.0 110.764 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.96 -3.0 29.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 109.742 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.69 -13.29 65.47 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -67.83 126.1 28.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.043 -1.269 . . . . 0.0 109.243 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.72 135.7 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 17.8 p-10 -153.93 -163.8 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.53 146.2 16.17 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.44 153.26 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -94.21 2.3 55.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.376 -0.828 . . . . 0.0 109.275 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' C ' ' H ' ' A' ' 56' ' ' SER . 4.3 mm-40 -78.81 86.61 4.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.482 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 3' ' ' GLU . 15.8 ptmt -61.68 -5.17 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 54' ' ' GLU . 17.8 t -87.16 25.75 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.039 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -112.71 95.97 35.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.26 0.7 0.63 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.864 1.043 . . . . 0.0 110.271 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 57' ' ' ASP . 45.3 m80 -78.48 -26.77 46.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -70.37 -1.75 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.281 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -75.66 88.33 2.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.255 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.77 135.43 33.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.573 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 16.0 tp60 -89.85 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 10.6 mp -94.32 128.23 40.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -114.21 147.08 39.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.18 139.71 30.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' GLU . 1.9 tm-20 -145.55 129.36 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.263 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . 2.1 tt0 52.16 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 109.285 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -96.24 118.92 33.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.815 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.37 19.0 31.46 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -147.84 146.94 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.62 137.34 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -93.68 116.38 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.65 144.33 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -145.6 145.87 31.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.05 131.5 10.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.24 -85.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.44 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.8 t -50.18 -22.85 1.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.08 -26.64 19.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 51.19 52.21 15.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.949 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.633 HH21 ' HZ2' ' A' ' 95' ' ' LYS . 91.4 mtt180 -149.9 147.71 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.362 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -91.49 132.72 36.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.3 tp -63.36 147.77 50.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.226 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.03 132.83 15.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.409 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 11.1 ttm -100.87 132.71 46.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.408 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -90.98 169.3 11.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.084 -1.01 . . . . 0.0 109.533 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.55 -23.51 58.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.2 -3.97 48.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.96 71.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -79.77 118.23 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.334 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.2 mp -91.39 134.84 34.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.488 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.405 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -145.71 -174.13 4.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.471 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.67 154.6 49.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.319 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -145.85 170.16 17.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.633 ' HZ2' HH21 ' A' ' 81' ' ' ARG . 0.8 OUTLIER -81.54 -35.0 30.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 132.84 35.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.83 164.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -147.3 -173.1 4.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.0 -14.39 59.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 85' ' ' MET . 25.8 mt-10 -90.89 8.58 34.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.7 m -92.54 -5.88 50.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 56.1 m-85 -94.32 153.2 18.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 85.0 m-85 -149.1 121.67 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -55.66 114.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.323 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.45 95.1 9.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -94.18 118.96 32.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.433 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 tt -93.39 123.4 36.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.457 ' C ' ' H ' ' A' ' 110' ' ' ASN . 14.6 mt-10 -90.8 161.68 15.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.451 ' H ' ' HG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -67.89 3.81 1.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -93.02 20.26 6.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.02 -1.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.0 m-85 -98.07 141.31 31.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.629 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.9 OUTLIER -94.47 166.12 12.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.605 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 5.5 p -144.62 112.11 6.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.326 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.83 135.65 33.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 124' ' ' TYR . 3.2 ttm180 -127.13 145.75 50.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -68.85 146.03 53.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.708 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -88.53 -72.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.9 tttp -50.65 -10.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 20.4 m-85 -145.25 68.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.516 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 71.8 p -64.37 5.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.639 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.4 m -89.9 9.29 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.6 m-90 -150.3 141.16 22.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 109.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 116' ' ' ARG . 71.4 m-85 -104.09 165.7 10.88 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.711 . . . . 0.0 109.569 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.3 t -94.54 121.3 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.79 144.38 21.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.149 -0.969 . . . . 0.0 109.558 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.83 -175.93 3.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.462 -0.773 . . . . 0.0 109.478 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -93.78 -119.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -146.35 8.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.534 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.39 6.46 7.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.367 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.09 12.86 51.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.4 p90 -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -70.95 142.62 51.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.505 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 6.1 tp -63.71 -153.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -109.12 -43.66 1.17 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -61.39 -22.51 65.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 109.725 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -89.8 -15.63 31.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.59 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.6 p -90.1 154.49 19.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.532 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.85 179.72 38.32 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.68 169.01 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.888 1.725 . . . . 0.0 110.187 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.03 -58.09 3.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 134.45 54.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -1.153 . . . . 0.0 109.441 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -83.6 5.77 23.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.13 -7.13 11.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.575 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.14 -6.73 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.1 mt -80.1 85.16 5.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -89.87 169.24 11.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.6 tp -142.32 70.08 22.01 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.809 . . . . 0.0 109.418 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.98 103.5 0.29 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.844 1.696 . . . . 0.0 110.356 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.3 mtt -97.73 119.12 35.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.761 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.7 t -70.0 119.09 13.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.84 55.3 3.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.384 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -56.38 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.494 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.41 148.13 4.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -77.87 104.9 8.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' GLU . . . -92.93 -44.96 3.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -54.08 -172.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -1.184 . . . . 0.0 109.54 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.0 mt -82.79 119.35 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -49.47 100.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 m -144.82 61.59 1.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.208 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.477 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.1 mt -56.09 -49.36 93.59 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.196 -0.94 . . . . 0.0 110.744 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.3 Cg_endo -65.25 -173.0 0.25 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 120.887 1.058 . . . . 0.0 110.062 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -173.44 113.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tp -165.04 67.82 1.27 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.885 . . . . 0.0 109.725 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.51 154.86 66.08 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.732 1.621 . . . . 0.0 110.126 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 48.72 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -63.69 -26.68 68.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.71 82.34 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.84 106.6 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 p -170.89 68.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' PHE . . . 148.73 -44.29 0.76 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 19' ' ' GLY . . . 71.59 -13.2 0.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -1.106 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -157.47 66.66 3.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.19 114.27 2.58 Favored 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.837 1.691 . . . . 0.0 110.11 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.53 176.69 2.05 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.734 0.956 . . . . 0.0 110.154 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 47.11 50.56 15.93 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.662 ' CD2' ' HZ3' ' A' ' 30' ' ' LYS . 18.8 t60 -130.38 -9.17 4.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.648 -0.913 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.431 ' C ' ' H ' ' A' ' 28' ' ' ASP . 55.9 m-85 -78.22 34.6 0.2 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.422 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 25' ' ' HIS . 15.2 tttm -66.02 0.33 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.523 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 26' ' ' PHE . 7.1 m-20 -149.61 152.2 34.55 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.051 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.46 177.62 0.21 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 121.267 1.312 . . . . 0.0 110.25 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.662 ' HZ3' ' CD2' ' A' ' 25' ' ' HIS . 43.0 mttm -146.25 138.44 25.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.2 mtt-85 -92.66 120.97 33.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 0.0 109.321 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.82 102.01 12.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -93.5 118.95 31.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.98 101.4 12.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.649 ' HZ1' ' HH ' ' A' ' 112' ' ' TYR . 29.5 tttt -51.78 -34.51 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.691 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 5.1 m-80 -73.73 105.18 4.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.994 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.03 4.31 89.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.65 85.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.9 m-85 -142.72 133.77 25.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.496 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -95.39 123.68 39.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.3 tp -54.29 146.21 15.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.276 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 24.5 ttt180 -149.25 117.51 6.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.8 mt -92.87 130.94 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.172 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -91.71 151.4 42.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.163 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.47 -27.46 82.08 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.304 1.336 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -74.83 12.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.702 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 45' ' ' PRO . . . 84.92 -41.11 3.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.574 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.32 153.75 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.37 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -138.11 141.93 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.341 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 3.9 p-10 -153.85 -150.02 0.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -146.2 148.08 19.52 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.56 149.57 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -1.12 . . . . 0.0 109.466 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 53' ' ' ARG . 20.5 mtm-85 -90.25 -15.79 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.27 103.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.43 44.42 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -144.19 20.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.265 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.4 m-20 -105.77 104.97 51.39 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.74 2.66 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.786 0.991 . . . . 0.0 110.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.3 m80 -82.63 -5.75 58.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.257 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt -90.23 -5.18 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -76.64 86.53 3.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.12 134.92 34.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.84 114.08 26.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.838 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.499 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.4 mp -93.2 113.14 25.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.0 143.07 26.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.92 120.93 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -95.0 -42.43 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.2 mt-10 -151.77 158.78 43.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.466 -0.772 . . . . 0.0 109.296 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -60.75 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 141.93 -2.82 1.93 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.35 142.43 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -1.122 . . . . 0.0 109.596 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.91 130.7 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 109.239 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -91.51 131.13 37.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -89.95 142.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -146.96 121.77 9.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.573 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 139.56 27.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.2 t -75.06 -87.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.547 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.1 t -47.18 -33.33 5.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.491 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.44 -29.64 47.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 50.8 53.98 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.3 mtt180 -146.88 148.79 32.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -91.5 132.07 36.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.39 142.62 58.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.06 148.81 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.9 ttp -106.7 143.89 34.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.421 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.645 ' HZ2' ' NH2' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.15 148.9 25.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.34 -19.06 7.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.401 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.5 p30 -87.65 -44.65 11.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.81 -9.59 1.37 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.645 ' NH2' ' HZ2' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -71.65 128.65 36.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -1.148 . . . . 0.0 109.449 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.8 mp -95.06 135.34 36.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.43 -173.72 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.28 42.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.455 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -146.97 155.84 42.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -71.32 -19.09 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.44 139.92 30.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.25 107.81 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.491 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 66.9 p -94.68 156.09 16.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.37 -23.92 6.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -93.93 53.09 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.491 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 97.0 m -134.24 -2.18 2.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 87.4 m-85 -95.44 153.98 17.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 71.2 m-85 -146.04 121.13 10.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.01 93.92 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 115' ' ' TYR . 31.4 tt0 -78.15 93.19 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -93.47 137.85 32.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.85 140.46 29.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.361 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.84 -171.72 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 111' ' ' ASN . 43.1 t -93.78 -33.28 13.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -74.27 20.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.142 -0.973 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.515 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.5 m-20 65.24 56.05 1.04 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.714 . . . . 0.0 109.916 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.649 ' HH ' ' HZ1' ' A' ' 35' ' ' LYS . 47.2 m-85 -142.42 137.31 30.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.393 -0.817 . . . . 0.0 109.286 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.91 153.99 20.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 12.5 p -137.18 114.92 11.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 109.239 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 105' ' ' GLU . 98.5 m-85 -89.93 104.5 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.506 ' NH2' ' O ' ' A' ' 121' ' ' THR . 23.8 ttt180 -93.92 134.37 36.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.205 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.9 t -60.95 153.36 25.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' C ' ' H ' ' A' ' 120' ' ' TYR . 56.3 ttt180 -90.83 -77.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -51.13 -9.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.525 ' C ' ' H ' ' A' ' 122' ' ' SER . 32.3 m-85 -138.85 59.33 1.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.506 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 26.5 p -59.55 -0.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.737 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.525 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.6 m -90.04 10.07 25.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 3.3 m-90 -155.13 144.01 20.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.849 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 28.0 m-85 -104.85 167.21 9.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.658 -0.652 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.0 128.32 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -152.57 145.64 24.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.28 178.86 5.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 109.447 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -96.23 -167.9 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 109.401 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -93.24 -13.47 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 109.42 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -93.46 2.32 56.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.41 0.32 67.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -85.06 172.26 11.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -1.144 . . . . 0.0 109.512 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 37.8 p90 -92.63 120.22 32.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -71.99 131.59 43.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.3 tp -47.98 155.04 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.309 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.84 -1.45 58.98 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 139' ' ' THR . 60.1 p -92.79 -58.25 2.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -55.15 -7.62 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.489 ' H ' ' C ' ' A' ' 137' ' ' SER . 11.4 p -85.57 155.44 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.81 39.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.98 170.79 4.37 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.905 1.736 . . . . 0.0 110.162 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.01 -51.18 4.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.75 135.05 50.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -1.106 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.5 mtpp -84.81 1.61 46.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 109.565 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.64 -3.58 0.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.693 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 144' ' ' LYS . 20.3 pt -98.13 2.61 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 109.681 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.451 ' CD1' ' HZ3' ' A' ' 144' ' ' LYS . 79.3 mt -90.48 110.23 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -117.23 168.28 10.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.51 70.17 17.5 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.318 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.33 105.98 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.794 1.662 . . . . 0.0 110.387 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.7 mtt -97.59 118.61 34.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 109.397 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.5 t -62.19 145.81 52.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -90.78 58.63 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.868 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.49 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.58 -79.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 11.9 mp0 48.8 35.24 6.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.67 168.12 27.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.29 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.439 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 137.11 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -88.22 59.6 5.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -146.7 60.9 1.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -59.48 -47.71 97.32 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.898 . . . . 0.0 110.794 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.1 Cg_endo -66.52 113.18 2.61 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 120.988 1.126 . . . . 0.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.7 149.65 2.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.6 67.52 51.7 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.81 112.36 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.653 1.568 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 49.26 88.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -66.59 -31.75 72.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 47.24 -122.88 7.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.7 -146.27 50.28 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m 61.37 56.14 2.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -1.144 . . . . 0.0 109.525 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.14 -85.47 0.16 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.93 -106.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -174.01 70.44 0.33 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.22 168.0 15.15 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.716 1.611 . . . . 0.0 109.85 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.92 -170.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.668 1.579 . . . . 0.0 110.189 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.17 77.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.76 14.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -1.083 . . . . 0.0 109.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.557 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 55.0 m-85 -128.67 31.08 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -93.05 18.28 9.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -150.1 151.98 32.93 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.098 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.2 165.96 6.45 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.229 1.286 . . . . 0.0 110.364 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.557 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 57.8 mttt -146.36 127.02 14.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.0 109.198 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -84.96 124.52 31.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.3 mt -84.8 98.25 10.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -92.76 119.66 32.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -86.89 112.23 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -63.34 -17.36 62.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.64 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.8 m-80 -88.03 104.92 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.91 4.79 89.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.12 84.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 47.1 m-85 -142.98 130.94 21.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.13 120.65 34.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.83 144.41 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.259 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.474 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 33.2 ttt180 -147.78 120.58 8.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 76.0 mt -95.73 130.82 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.795 . . . . 0.0 109.11 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -91.29 150.89 42.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.49 -25.63 74.76 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.244 1.296 . . . . 0.0 110.312 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.1 p30 -74.92 7.56 3.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.7 -41.83 2.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.8 mmm180 -47.28 157.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.488 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.2 t -138.77 134.17 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.4 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -146.09 -150.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.24 149.92 22.11 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -145.79 145.99 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -1.118 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.4 -6.46 58.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.49 108.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.486 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 21.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.36 -20.24 3.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.642 . . . . 0.0 109.692 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -44.75 108.19 0.71 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 109.62 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.09 5.26 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 110.152 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 57' ' ' ASP . 50.0 m80 -93.71 -3.14 52.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.68 -1.48 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 14.7 mmtt -78.14 86.25 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.93 130.85 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.82 111.4 22.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.9 mp -90.25 153.58 20.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.902 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -144.9 130.96 19.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.338 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 123.77 28.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.572 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.15 -95.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -89.48 -173.9 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 112.4 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.43 24.65 20.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 t -145.92 142.54 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.63 125.79 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.523 -0.735 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -93.51 128.26 39.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.54 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.78 149.62 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HZ1' ' HH ' ' A' ' 82' ' ' TYR . 14.6 tttp -146.51 134.34 21.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.23 136.25 18.25 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 60.1 t -77.98 -57.01 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -1.154 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -17.82 48.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.43 -23.55 19.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 2.2 m120 51.13 49.64 20.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -146.43 148.52 32.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.624 ' HH ' ' HZ1' ' A' ' 75' ' ' LYS . 75.1 m-85 -91.63 132.81 36.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.545 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 tp -65.02 139.55 58.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.25 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.74 134.92 18.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.0 ttp -95.12 126.38 40.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.66 -175.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.14 -16.41 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 25.4 p-10 -90.2 -40.21 12.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.55 -9.26 1.41 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 90' ' ' ARG . 1.8 mtt-85 -73.55 123.62 24.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -1.165 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.8 mp -92.56 132.95 36.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.3 pp -148.7 -172.67 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.611 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.445 ' C ' ' HG ' ' A' ' 94' ' ' SER . . . -139.1 158.07 44.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.291 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.445 ' HG ' ' C ' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -146.02 170.04 17.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -84.6 -37.31 21.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 m -85.01 149.64 25.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 98' ' ' THR . 54.8 t -77.21 162.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.385 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.461 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 71.6 p -147.27 177.81 8.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -76.14 -26.34 56.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 27.0 mp0 -92.87 19.64 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.1 m -93.98 -11.8 30.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 66.2 m-85 -93.17 159.55 15.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 76.0 m-85 -148.78 116.18 6.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -54.89 142.35 29.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -125.15 141.64 51.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -146.96 142.02 27.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.97 137.35 35.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.31 -175.92 3.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.2 p -94.67 38.28 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 112' ' ' TYR . 59.1 m-80 -146.86 31.14 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 m120 60.99 -1.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 110' ' ' ASN . 40.6 m-85 -95.12 126.83 40.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.435 ' N ' ' ND2' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -93.67 168.83 10.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -137.64 161.47 36.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.731 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -137.8 109.87 7.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.72 149.17 22.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -75.52 162.79 28.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 120' ' ' TYR . 1.7 ttt-85 -93.5 -77.95 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.885 . . . . 0.0 109.303 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.2 tptt -51.24 -9.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.547 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 118' ' ' ARG . 10.7 m-85 -141.97 59.68 1.47 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.435 -0.791 . . . . 0.0 109.374 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p -62.07 0.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 120' ' ' TYR . 12.3 m -90.17 15.0 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.522 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 11.1 m-90 -155.14 143.56 20.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 109.713 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.0 m-85 -107.54 158.76 16.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.663 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -84.77 131.16 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.303 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.62 -175.75 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.657 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.55 161.52 37.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.772 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.21 173.74 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.8 19.15 7.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' A' ' 130' ' ' THR . 0.2 OUTLIER -125.12 16.63 8.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.74 -0.6 . . . . 0.0 109.384 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.47 42.87 47.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -134.68 154.8 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.944 . . . . 0.0 109.323 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -80.87 120.17 24.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.76 127.67 33.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.8 tp -50.35 142.57 10.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.75 14.55 2.58 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 135' ' ' LEU . 84.7 p -102.61 -38.65 7.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.508 -0.995 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -90.11 -8.65 50.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 41.0 p -69.91 145.21 52.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 109.495 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.11 -179.76 42.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.8 Cg_endo -61.07 -174.71 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.924 1.749 . . . . 0.0 110.164 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.27 -35.23 0.94 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' A' ' 141' ' ' PRO . 18.2 mm-40 -93.14 134.52 35.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -1.131 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 39.4 mtmt -78.51 -0.49 29.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.19 -7.05 1.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.404 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -95.32 1.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 109.652 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.2 mt -90.99 110.06 21.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -116.79 165.36 13.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.1 tp -144.4 70.75 15.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 109.21 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -62.23 112.78 1.65 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.89 1.727 . . . . 0.0 110.617 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 35.3 mtt -96.72 129.69 44.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.342 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.4 t -70.11 128.71 37.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.38 53.76 2.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.538 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -93.18 -66.73 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.498 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.372 0.606 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.03 -91.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 53.98 34.45 19.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.2 130.97 1.4 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.64 178.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -1.136 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -70.77 73.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.4 p -88.95 156.2 19.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' LEU . 27.0 p -75.51 -3.7 35.58 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 109.567 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' THR . 6.0 mp 58.23 158.23 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.13 115.13 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.124 1.216 . . . . 0.0 110.138 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.14 -166.92 2.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -140.6 69.41 31.47 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.58 -0.7 . . . . 0.0 109.422 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.23 -165.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.793 1.662 . . . . 0.0 110.317 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' GLY . 3.5 mt-10 -76.89 53.86 0.96 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 109.52 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 25.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 14' ' ' GLU . . . -47.95 125.91 12.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.31 70.58 0.33 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.5 p -93.2 59.79 3.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.434 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.12 -86.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -153.27 35.28 0.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 3.2 p90 39.2 67.43 2.41 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.807 -0.558 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.8 168.39 10.36 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.597 1.531 . . . . 0.0 109.872 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.16 111.67 0.88 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.696 1.598 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.38 4.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -146.59 9.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -1.107 . . . . 0.0 109.456 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.71 11.21 32.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 9.51 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -149.94 149.77 28.46 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 108.806 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.11 176.13 0.27 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 120.99 1.127 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -144.89 175.06 10.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.469 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.8 mtm-85 -125.35 117.48 23.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.83 102.0 12.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 109.575 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -94.47 117.9 30.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.26 99.38 11.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -51.5 -35.01 38.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.736 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 12.1 m-80 -71.86 105.05 3.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.751 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.4 4.56 89.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.25 83.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.4 m-85 -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -93.51 119.73 32.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.11 138.72 37.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -147.44 123.64 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 109.715 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.1 mt -93.96 118.08 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -69.3 150.92 97.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.092 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.0 Cg_endo -58.86 -23.96 69.91 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.175 1.25 . . . . 0.0 110.542 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.64 -15.47 51.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.67 -34.01 4.56 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.27 114.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.243 . . . . 0.0 109.497 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.42 143.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -170.15 -150.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.58 156.47 26.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 m -145.7 139.13 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -1.077 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.9 mtm-85 -76.61 6.52 5.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -94.87 103.45 15.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -81.59 6.35 15.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.2 t -90.24 7.29 38.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 59' ' ' HIS . 5.8 m-20 -93.01 113.53 60.11 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.051 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.88 2.6 0.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.675 0.917 . . . . 0.0 110.216 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 57' ' ' ASP . 42.4 m80 -84.57 -20.47 31.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.82 0.07 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 22.3 mttt -87.58 87.55 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.524 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.42 135.22 33.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -91.1 117.1 29.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -90.51 158.66 16.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.51 138.84 26.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.311 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.91 157.99 16.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.01 -91.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.16 -155.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -88.64 105.02 17.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.5 -7.8 77.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.76 136.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.88 126.94 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -94.74 130.94 41.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -0.824 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.35 151.87 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.64 ' HZ1' ' HH ' ' A' ' 82' ' ' TYR . 2.3 tttp -150.06 145.54 26.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.516 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.03 138.96 17.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 40.2 t -75.74 -62.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -1.134 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.438 ' OG ' ' CD2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -73.84 -46.89 42.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.26 68.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.416 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.94 49.7 20.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 11.9 mtt180 -141.99 150.03 40.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.64 ' HH ' ' HZ1' ' A' ' 75' ' ' LYS . 81.6 m-85 -92.33 130.07 38.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.93 150.99 46.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.34 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.65 32.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.6 ttm -126.8 134.92 50.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -92.58 178.4 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -78.13 -34.19 50.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.21 -3.43 20.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.49 66.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -80.54 119.01 22.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.442 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 7.9 mp -93.4 134.52 35.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 4.3 pp -148.74 164.95 32.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.82 157.78 16.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.06 149.42 30.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -73.03 -31.95 64.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -92.96 142.04 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.3 t -79.25 156.43 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.453 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.474 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 46.2 p -146.88 156.75 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.34 -29.71 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.409 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -93.92 57.71 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.474 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 67.9 m -140.95 3.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -101.19 160.25 14.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.466 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.98 112.07 4.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -60.06 126.04 25.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.626 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -95.55 93.48 7.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.46 HH11 ' NH1' ' A' ' 116' ' ' ARG . 60.1 ttt180 -89.89 125.16 35.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.57 132.33 36.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.79 -173.22 3.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.97 -7.0 50.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -93.73 24.11 4.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 63.59 -5.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 109.889 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 110' ' ' ASN . 51.0 m-85 -91.64 128.51 37.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.124 -0.985 . . . . 0.0 109.26 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -89.91 166.91 13.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.913 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 p -141.85 122.91 14.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 109.177 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -92.57 110.97 22.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.767 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.46 ' NH1' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.75 137.82 37.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.273 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.87 157.98 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -93.78 -64.39 1.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 109.587 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -53.74 -49.73 67.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.678 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.57 ' C ' ' H ' ' A' ' 122' ' ' SER . 7.0 m-85 -110.47 68.87 0.68 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.7 -0.625 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.8 p -59.76 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.8 m -89.14 10.37 22.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.085 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.3 m-90 -149.69 141.7 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 109.696 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.5 m-85 -109.22 150.81 27.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.688 -0.632 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.24 131.3 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.307 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.03 171.52 15.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.556 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.7 mt -132.13 165.15 24.7 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -93.37 -172.71 3.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -93.0 -13.25 28.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 9.92 35.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.59 6.02 86.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -92.43 166.54 12.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 37.7 p90 -92.74 120.21 32.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -69.83 131.65 44.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.7 tp -47.55 135.5 11.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.278 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.12 2.85 1.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 135' ' ' LEU . 59.8 p -92.21 -38.76 11.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 109.56 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -79.79 -5.0 54.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.1 p -77.25 149.62 35.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.477 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.43 179.73 45.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.94 164.83 13.23 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 121.873 1.715 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.65 -43.16 3.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 143' ' ' GLN . 1.6 mp0 -68.35 132.42 47.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -1.115 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -84.81 -5.25 59.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.69 -0.73 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 144' ' ' LYS . 10.8 pt -99.97 6.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.99 110.05 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.643 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -119.6 168.0 11.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.659 -0.65 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -142.8 70.43 19.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -61.97 105.87 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.68 141.56 32.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.513 -0.742 . . . . 0.0 109.319 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.709 ' HG ' ' H ' ' A' ' 153' ' ' ALA . 43.8 t -70.04 173.47 6.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.709 ' H ' ' HG ' ' A' ' 152' ' ' SER . . . -146.7 65.6 1.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -75.93 -76.79 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.479 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.66 173.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.72 89.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.9 133.63 6.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 1.2 mp0 -46.84 -24.83 0.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -1.098 . . . . 0.0 109.398 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 7' ' ' THR . 2.8 mp -131.17 168.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.693 -0.629 . . . . 0.0 109.419 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.467 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 11.7 t -138.59 -170.93 2.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 8' ' ' THR . 95.6 m 51.39 46.62 26.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.294 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -70.53 -47.89 17.73 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 110.957 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 3.2 Cg_exo -64.67 109.74 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 120.977 1.118 . . . . 0.0 110.239 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.09 -167.22 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.386 -0.821 . . . . 0.0 109.357 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.67 68.02 36.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.34 -169.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.75 1.634 . . . . 0.0 110.238 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -84.87 57.45 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.903 . . . . 0.0 109.448 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.24 -16.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . 83.92 -103.19 2.55 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.78 57.74 1.49 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.34 37.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -1.216 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 39.99 40.27 1.67 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.32 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.025 -1.279 . . . . 0.0 110.103 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 44.27 68.35 3.21 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.775 . . . . 0.0 110.202 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 3.9 Cg_exo -56.96 -44.51 43.88 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.779 1.652 . . . . 0.0 112.798 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 22' ' ' PRO . 3.6 Cg_exo -65.58 105.86 0.81 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 120.833 1.022 . . . . 0.0 110.257 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.38 -17.39 0.12 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.504 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -94.53 60.99 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -1.095 . . . . 0.0 109.296 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.455 ' C ' ' H ' ' A' ' 28' ' ' ASP . 38.7 m-85 -73.26 35.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 25' ' ' HIS . 0.2 OUTLIER -74.94 16.57 0.29 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.778 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 26' ' ' PHE . 4.0 m-20 -148.71 148.8 29.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.888 . . . . 0.0 109.125 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.2 175.02 1.17 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.22 1.28 . . . . 0.0 110.321 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -145.28 175.35 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 4.2 mtm-85 -133.58 119.98 20.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.532 -0.73 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mt -84.57 102.35 12.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.584 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -96.48 115.89 28.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 t -83.26 106.03 14.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.513 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -28.33 24.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.685 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.2 m-80 -77.47 105.09 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.615 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.35 4.88 87.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.57 62.67 3.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -111.64 132.46 54.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.639 -0.918 . . . . 0.0 109.785 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -93.02 115.73 28.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.844 . . . . 0.0 109.265 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.6 tp -48.77 143.1 5.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 0.0 109.292 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 34.0 ttt180 -149.57 118.31 6.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -89.94 106.17 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.193 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -67.02 151.21 97.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 0.0 109.038 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.1 Cg_exo -57.16 -26.18 68.06 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.045 1.163 . . . . 0.0 110.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -75.21 -0.15 18.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.51 -30.46 6.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -52.8 121.55 7.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.1 t -92.57 138.33 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -165.37 151.35 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.81 159.41 22.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.03 141.77 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -86.37 16.08 4.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 56' ' ' SER . 6.3 mt-10 -94.93 88.32 5.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.621 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -62.03 -5.2 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' H ' ' C ' ' A' ' 54' ' ' GLU . 11.1 p -90.99 31.02 1.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.848 . . . . 0.0 109.08 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 59' ' ' HIS . 30.2 m-20 -113.87 93.5 29.51 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.96 1.6 0.42 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 120.94 1.094 . . . . 0.0 110.382 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 57' ' ' ASP . 37.2 m80 -81.41 -15.61 54.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.69 2.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -76.43 82.12 3.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 109.147 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -89.86 135.07 33.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.166 -0.959 . . . . 0.0 109.391 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.94 104.18 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -90.79 148.31 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 125.35 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.69 28.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.86 -76.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.459 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -94.62 -90.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.54 -31.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.529 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.25 -18.88 6.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.98 147.81 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -1.104 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.3 127.43 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.469 -0.769 . . . . 0.0 109.453 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.8 m -93.22 112.11 23.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.6 mt -91.91 144.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -144.24 145.66 32.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.454 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.33 135.27 12.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.04 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 109.428 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.5 t -61.42 -47.26 86.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -27.76 69.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.888 . . . . 0.0 109.472 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.8 m120 51.34 50.58 18.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.7 mtt180 -149.84 147.96 28.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.04 129.34 36.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.8 tp -57.65 145.14 35.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.57 170.09 17.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.449 ' SD ' ' CD1' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.01 140.17 29.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -87.08 170.37 11.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.76 -14.09 61.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 3.1 p30 -83.11 -47.45 11.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 144.52 -7.56 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -72.43 125.37 27.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.1 mp -92.23 138.12 31.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.02 -171.63 3.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.755 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.28 159.45 42.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.446 -0.784 . . . . 0.0 109.272 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.5 t -146.69 170.09 17.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -83.85 -35.16 24.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -92.18 135.04 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 12.0 p -83.82 106.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.47 ' H ' ' HG1' ' A' ' 98' ' ' THR . 12.6 p -95.14 -179.11 4.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 109.471 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -16.68 63.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -93.54 48.0 1.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -139.9 3.27 2.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 84.1 m-85 -95.75 162.07 13.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 87.0 m-85 -150.03 114.38 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -59.12 112.96 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.06 141.74 37.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -137.78 90.83 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.549 -0.719 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.0 tp -68.19 126.72 30.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.373 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.03 -172.5 3.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -93.9 -13.43 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.2 m120 -88.0 28.97 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 109.489 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER 60.19 -0.15 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.2 m-85 -95.26 126.97 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.655 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.4 OUTLIER -93.23 166.21 12.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.636 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.8 p -144.6 120.77 10.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.315 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -90.69 113.8 25.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -96.38 144.95 26.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.435 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -70.81 153.88 42.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 120' ' ' TYR . 47.8 ttt180 -91.69 -75.72 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.604 ' NZ ' ' HH ' ' A' ' 120' ' ' TYR . 50.8 tttm -51.37 -9.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HH ' ' NZ ' ' A' ' 119' ' ' LYS . 20.5 m-85 -141.78 62.52 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -62.06 2.04 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.683 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 120' ' ' TYR . 48.7 m -90.91 11.31 23.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.05 142.35 19.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.6 m-85 -106.76 170.04 8.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.4 t -90.73 126.75 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -151.58 148.37 27.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.11 172.61 6.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.551 -0.718 . . . . 0.0 109.44 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -93.95 -169.48 2.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.449 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -92.78 -12.31 31.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 t -93.69 -4.01 51.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 9.92 59.92 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -92.75 141.17 28.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.133 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 26.0 p90 -62.03 120.14 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.77 126.69 30.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.9 tp -47.78 140.92 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.36 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.35 -4.9 39.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -87.82 -28.34 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -1.18 . . . . 0.0 109.436 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.92 -4.93 57.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 28.6 p -70.45 162.03 29.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.574 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 179.99 22.61 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.01 167.3 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.94 1.76 . . . . 0.0 110.17 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.32 -48.39 2.64 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -79.51 129.27 34.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -1.186 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -82.64 2.8 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.92 -2.73 2.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.3 pt -93.28 1.34 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.47 87.65 7.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.387 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.66 162.94 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.6 tp -138.46 71.83 44.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.92 103.76 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.911 1.741 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.26 35.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.2 t -70.03 175.17 4.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.41 77.64 1.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -93.77 -81.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.429 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.29 130.54 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.38 -99.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.84 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -172.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -1.184 . . . . 0.0 109.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 81.27 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 m 50.91 87.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -82.95 128.62 34.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.373 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 ' CD2' ' C ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -163.42 160.27 18.01 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 108.647 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.65 145.14 96.63 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.292 1.328 . . . . 0.0 110.237 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.59 91.53 2.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.604 -0.685 . . . . 0.0 109.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -74.31 -47.56 5.87 Favored Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 121.314 -0.866 . . . . 0.0 110.752 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.5 Cg_endo -67.34 96.58 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.025 1.15 . . . . 0.0 110.056 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.64 46.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -104.76 -19.53 13.9 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.59 19.51 0.49 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 15' ' ' ASP . . . -177.79 -130.15 1.36 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.0 t -101.26 -123.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.345 1.069 . . . . 0.0 109.119 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.47 56.07 0.49 Allowed Glycine 0 C--N 1.28 -2.581 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -147.0 -111.96 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.393 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -179.3 68.95 0.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 109.629 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.94 168.14 16.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.661 1.574 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.16 -171.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.639 1.559 . . . . 0.0 110.149 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.25 78.87 0.09 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.627 ' CD2' ' HZ3' ' A' ' 30' ' ' LYS . 16.5 t60 -172.13 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.13 33.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.626 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.22 10.23 22.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.77 149.58 24.18 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 108.91 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.14 160.07 16.98 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 121.066 1.177 . . . . 0.0 110.126 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.627 ' HZ3' ' CD2' ' A' ' 25' ' ' HIS . 21.7 mttt -140.43 138.4 34.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.465 -0.772 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.457 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.2 mtm-85 -88.57 129.06 35.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.9 mt -93.91 101.09 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -95.1 121.67 36.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 t -88.56 105.13 17.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -15.24 8.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 16.3 m120 -86.38 104.38 15.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 75.31 4.94 75.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.7 89.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.8 m-85 -145.64 130.78 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -1.13 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -93.59 123.82 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.65 136.55 56.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.928 . . . . 0.0 109.219 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 57' ' ' ASP . 40.4 ttp180 -146.04 118.03 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.637 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mt -92.62 126.31 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -87.4 152.02 51.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.14 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.63 -26.59 65.69 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.236 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.95 1.7 12.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.965 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -25.09 10.88 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -57.55 114.96 2.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -1.19 . . . . 0.0 109.384 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.26 142.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -171.35 151.92 3.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.8 155.29 23.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 m -146.43 155.08 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.23 9.07 35.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.53 102.17 14.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -83.38 -4.96 58.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.358 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -78.74 13.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.25 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -105.59 104.93 50.73 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.84 1.06 0.91 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 120.77 0.98 . . . . 0.0 110.2 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.496 ' H ' ' C ' ' A' ' 57' ' ' ASP . 40.6 m80 -76.15 -26.69 56.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.273 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -65.65 -5.33 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -75.9 87.41 2.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.92 135.23 33.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.857 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 6.8 tt0 -89.73 114.32 25.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.325 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.9 mp -86.6 153.07 22.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.0 109.628 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -144.68 131.91 20.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.93 119.78 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.57 -73.2 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -90.56 -143.85 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.482 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -93.94 -26.62 16.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.78 -9.38 2.54 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.45 104.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -1.204 . . . . 0.0 109.38 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.08 177.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.537 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -145.82 118.44 8.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.04 149.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' NZ ' ' NE2' ' A' ' 63' ' ' GLN . 11.0 tttm -146.59 144.35 29.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.44 133.65 11.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.4 -74.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -61.75 -26.03 67.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.95 -26.6 31.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 51.11 50.0 19.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -147.76 146.95 29.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -94.5 134.37 37.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.92 143.49 57.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.223 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.37 134.21 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.9 ttm -97.63 139.33 33.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.385 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -92.1 173.87 7.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.427 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -77.67 -27.09 50.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 6.4 p-10 -73.19 -49.4 28.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.486 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 145.67 -13.19 1.76 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -72.62 123.61 23.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.567 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.2 mp -92.36 137.15 32.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -147.87 -172.41 4.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.09 156.71 45.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.349 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 m -145.88 153.48 40.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CG ' ' NH1' ' A' ' 81' ' ' ARG . 9.1 mtmp? -68.62 -29.77 68.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.529 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.48 148.33 23.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.3 t -92.37 149.54 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.428 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 38.2 p -146.51 157.43 43.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.45 -17.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 44.82 1.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 3.8 m -144.62 8.12 1.31 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 81.1 m-85 -100.0 159.7 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 75.3 m-85 -149.37 140.53 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.49 125.61 33.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 109.448 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -90.25 135.04 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.281 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -141.3 126.03 17.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.387 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tt -92.51 125.45 37.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.292 -0.88 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -90.67 -173.87 3.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.408 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 m -93.34 63.85 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 112' ' ' TYR . 34.1 p30 -169.26 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.36 -7.52 0.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 110' ' ' ASN . 50.3 m-85 -93.75 135.85 34.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -95.38 166.44 11.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.785 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 22.9 p -139.82 119.9 13.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -98.75 117.07 32.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -95.05 161.47 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 109.272 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.56 159.77 30.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.871 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.66 -61.84 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.399 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -83.28 -36.44 24.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' SER . 16.5 m-85 -89.29 50.54 1.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -49.0 -14.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -90.03 17.54 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 13.1 m-90 -155.05 141.33 18.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.913 . . . . 0.0 109.62 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.4 m-85 -112.04 169.98 8.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.683 -0.636 . . . . 0.0 109.587 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.75 133.17 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.377 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 154.86 33.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.8 mt -115.66 172.75 6.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.4 -169.23 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -94.97 -17.04 22.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.33 3.34 55.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.525 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.81 2.91 66.55 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.4 163.47 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -1.177 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 33.7 p90 -79.23 120.27 23.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 0.0 109.489 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -72.05 128.66 36.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.6 tp -47.83 140.65 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.95 22.35 1.21 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.3 p -115.08 -27.25 7.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.598 -0.942 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -90.02 -9.27 49.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.682 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 p -69.97 152.28 44.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.22 -179.14 40.47 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.1 151.81 75.95 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.85 1.7 . . . . 0.0 110.185 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.43 -28.3 9.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -86.74 119.76 27.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -73.56 -3.45 27.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.78 -3.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -96.43 2.96 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.05 110.12 21.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.51 163.13 17.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 109.434 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.4 tp -137.79 72.34 48.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.49 -0.756 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.63 108.0 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.836 1.691 . . . . 0.0 110.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.458 -0.776 . . . . 0.0 109.584 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.4 t -70.16 147.65 49.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.231 -0.918 . . . . 0.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.64 58.29 4.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.461 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -55.02 -65.6 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.403 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.475 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 tpp . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -88.77 167.74 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 50.87 -96.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.478 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' GLU . . . 170.62 -160.42 33.05 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLY . 19.9 pt-20 35.95 -155.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.067 -0.666 . . . . 0.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -75.53 130.0 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.452 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -91.74 51.75 1.91 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -144.84 67.69 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -59.05 -47.85 97.78 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.852 . . . . 0.0 110.61 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.9 Cg_endo -66.72 110.96 2.01 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.04 1.16 . . . . 0.0 110.103 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.53 153.81 3.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 tp -169.39 67.95 0.63 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.24 179.38 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.773 1.649 . . . . 0.0 110.278 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 1.6 mp0 49.81 81.74 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -95.77 -30.14 13.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.15 132.76 45.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.65 124.41 3.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -151.52 65.82 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -1.098 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.35 -101.27 0.27 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -81.56 -105.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -177.52 69.51 0.22 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.44 168.18 13.43 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.654 1.569 . . . . 0.0 109.864 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.5 95.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.525 1.484 . . . . 0.0 110.163 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.7 -85.47 1.76 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -157.27 53.64 0.49 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 109.425 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -66.31 5.94 0.49 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -79.33 40.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -148.22 151.68 37.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.43 164.07 11.6 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.187 1.258 . . . . 0.0 110.431 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -149.11 129.91 14.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.9 mtt-85 -87.34 117.18 25.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.83 99.73 11.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.564 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -94.82 121.48 36.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.0 t -91.28 113.28 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.269 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' CD ' ' HH ' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -62.29 -19.96 63.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 0.0 109.617 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.424 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.6 m-80 -82.86 104.99 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.17 4.96 87.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.1 86.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 43.8 m-85 -143.49 131.36 21.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 109.651 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -94.33 119.06 32.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.6 tp -47.8 140.78 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 44.5 ttt180 -145.97 115.98 7.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.01 104.15 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.066 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -64.89 150.55 94.73 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.109 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.7 Cg_endo -57.68 -26.67 73.99 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.142 1.228 . . . . 0.0 110.057 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -75.45 3.15 9.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.83 -30.74 5.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -50.48 114.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -1.152 . . . . 0.0 109.358 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.7 142.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.471 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -173.4 154.6 2.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.54 160.11 25.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -148.1 141.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -1.115 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.7 mtm-85 -84.54 2.12 42.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.95 112.97 20.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 109.771 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -85.21 -5.83 59.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.71 27.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' HIS . 88.3 m-20 -115.16 90.44 23.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.65 1.95 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.035 1.157 . . . . 0.0 110.64 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.529 ' H ' ' C ' ' A' ' 57' ' ' ASP . 44.2 m80 -80.12 -10.74 59.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.279 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -79.81 -2.19 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -75.64 87.85 2.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.83 135.92 33.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -88.94 106.19 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.274 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -91.86 153.46 19.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.95 135.94 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.533 -0.729 . . . . 0.0 109.039 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 153.09 28.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -150.15 146.62 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.81 . . . . 0.0 109.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 53.06 -146.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 62.15 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.674 -0.642 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.28 1.67 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 90.1 t -93.48 156.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -1.095 . . . . 0.0 109.484 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' O ' ' CG2' ' A' ' 72' ' ' VAL . 5.6 m -145.32 123.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.355 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 m -93.32 123.98 36.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 mt -97.08 145.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.454 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.401 ' NZ ' ' OH ' ' A' ' 82' ' ' TYR . 40.2 tttt -146.75 152.15 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.464 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.47 132.09 11.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -73.52 -62.61 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -40.26 62.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 109.532 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.73 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 51.72 44.71 29.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.785 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 43.4 mtp180 -141.58 144.23 34.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' OH ' ' NZ ' ' A' ' 75' ' ' LYS . 81.1 m-85 -89.92 136.47 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.6 tp -64.13 149.47 47.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.119 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 131.37 14.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 50.6 ttm -97.67 132.58 43.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 109.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -91.5 176.02 6.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -83.29 -22.62 32.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.432 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 23.8 p30 -77.16 -4.76 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.948 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.89 4.61 65.0 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -88.77 122.16 31.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -1.175 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.0 mp -93.34 132.12 37.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.86 178.02 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.03 163.26 17.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.748 -0.595 . . . . 0.0 109.418 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -150.24 161.61 42.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.368 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -79.37 -34.57 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.75 164.55 13.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.2 t -90.15 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.456 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 74.8 p -147.52 177.14 9.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -22.5 62.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.15 13.26 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.495 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 88.8 m -93.69 -9.97 35.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 69.4 m-85 -96.21 153.18 17.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 73.8 m-85 -146.35 137.18 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -77.17 124.19 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -0.984 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.44 145.35 24.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.481 HH21 ' CD ' ' A' ' 108' ' ' GLU . 19.3 ttp180 -147.51 116.32 6.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.04 134.26 34.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.481 ' CD ' HH21 ' A' ' 106' ' ' ARG . 3.7 mm-40 -93.07 176.7 6.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.1 p -85.2 -4.02 59.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.0 OUTLIER -93.38 28.48 2.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.28 -4.64 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.538 ' HH ' ' CD ' ' A' ' 35' ' ' LYS . 36.8 m-85 -88.95 -172.13 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -146.81 167.67 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.77 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 p -142.98 169.49 17.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -0.76 . . . . 0.0 109.184 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -145.27 110.7 5.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -92.58 140.18 29.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.364 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -61.63 147.69 44.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -75.87 -57.93 3.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.591 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -75.61 -42.25 52.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.508 ' C ' ' H ' ' A' ' 122' ' ' SER . 44.3 m-85 -92.91 52.69 1.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.0 p -53.81 -5.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.813 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.2 m -89.92 10.23 24.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.68 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.16 146.09 22.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.811 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -104.65 165.27 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 109.573 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.0 118.76 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -152.56 143.62 23.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.982 . . . . 0.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.31 175.4 6.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.431 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -91.01 -142.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.341 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -128.77 -16.83 4.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.66 . . . . 0.0 109.519 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 130' ' ' THR . 1.2 t -94.85 37.79 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.35 51.72 56.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -142.63 162.01 36.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -1.054 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.7 p90 -92.17 120.28 32.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.444 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.53 129.73 40.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 137' ' ' SER . 8.1 tp -55.42 157.9 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.152 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -80.28 24.31 3.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 135' ' ' LEU . 51.8 p -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.957 . . . . 0.0 109.539 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -89.64 -5.14 57.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.654 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 74.5 p -76.18 155.12 34.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.19 -179.93 35.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.73 179.61 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.857 1.705 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.91 -50.98 3.74 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.66 135.1 41.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 7.8 mtpt -83.99 7.44 18.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.86 -6.25 7.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.67 -2.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.9 mt -88.16 90.48 8.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -97.58 167.94 10.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 0.0 109.418 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -140.44 70.35 32.49 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.3 101.37 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.777 1.651 . . . . 0.0 110.507 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.3 mtt -96.71 129.18 44.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.1 t -70.08 140.54 52.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.17 53.18 2.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HZ1' ' CE1' ' A' ' 25' ' ' HIS . 0.2 OUTLIER -75.04 -83.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.46 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.84 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.915 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.91 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.72 154.44 0.88 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -89.22 -83.78 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -80.34 166.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.123 -0.985 . . . . 0.0 109.355 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' ILE . 1.7 p -48.03 172.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.24 -28.54 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.36 151.51 40.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 108.663 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 139.21 89.59 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.943 1.096 . . . . 0.0 110.125 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' LEU . . . -96.19 47.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.39 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 11' ' ' ALA . 5.4 mt 40.94 69.96 1.76 Allowed Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.91 -0.494 . . . . 0.0 110.242 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.84 72.79 0.33 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.773 1.649 . . . . 0.0 109.979 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 46.31 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.023 -1.048 . . . . 0.0 109.69 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -37.22 12.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.78 84.02 0.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -149.79 -157.12 7.55 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 m -151.72 77.93 1.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -1.144 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.62 59.76 0.3 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.19 -90.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -1.139 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -59.67 -47.61 97.18 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.1 Cg_endo -66.7 168.04 17.77 Favored 'Trans proline' 0 C--N 1.321 -0.901 0 C-N-CA 120.994 1.129 . . . . 0.0 109.736 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -56.96 156.17 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.57 1.513 . . . . 0.0 110.242 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.5 -25.71 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -145.83 57.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -1.082 . . . . 0.0 109.391 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.73 42.57 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.352 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 3.4 ttpt -139.61 21.96 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.89 149.21 27.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.798 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.78 150.3 71.9 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.979 1.119 . . . . 0.0 110.228 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -138.26 141.21 39.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.178 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -94.93 128.17 41.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.9 mt -84.91 124.66 31.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -115.23 114.46 25.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.0 t -86.82 106.02 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -47.55 -35.32 8.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.43 -0.794 . . . . 0.0 109.922 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.08 105.04 2.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.21 5.55 76.99 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.33 54.04 10.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.95 134.02 45.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.594 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 24.6 m-85 -93.8 117.06 29.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.15 136.94 23.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.244 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 5.9 ttt180 -147.54 124.51 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.749 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.65 122.44 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.086 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.77 151.38 73.81 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 109.173 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.529 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.8 Cg_endo -59.14 -23.41 69.08 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.176 1.251 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.4 p30 -74.98 3.26 8.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.52 3.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 mmm180 -46.94 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 109.534 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -141.38 134.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.394 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -166.9 152.13 7.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.41 21.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.73 144.86 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -1.137 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . 19.9 mmm-85 -64.93 -36.6 84.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -85.43 -1.31 56.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.428 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.1 p -94.03 15.2 17.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.1 m-20 -92.01 114.57 62.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.157 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.9 -2.14 2.0 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 120.601 0.867 . . . . 0.0 110.113 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.455 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.0 m80 -79.49 -28.8 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.312 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.57 -6.32 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.424 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -74.84 86.82 2.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mt -90.15 135.26 33.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -89.7 109.31 20.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.3 mp -87.67 156.56 19.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.628 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -140.68 -175.24 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.476 -0.765 . . . . 0.0 109.279 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.09 144.24 51.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.683 . . . . 0.0 109.523 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.3 mm-40 -145.46 144.41 30.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 48.17 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.085 -1.01 . . . . 0.0 109.22 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.88 62.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.78 -18.29 1.43 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLU . 21.4 t -92.51 119.25 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.236 . . . . 0.0 109.678 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -94.12 179.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.339 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 m -145.87 116.87 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.62 145.51 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.92 129.23 12.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.41 133.86 12.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.94 -74.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -1.167 . . . . 0.0 109.53 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.5 m -47.13 -52.56 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.97 -22.37 65.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.9 m120 51.76 38.75 23.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 33.4 mtt180 -137.03 154.76 50.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.441 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -94.28 134.72 36.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.26 144.93 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.19 132.43 15.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.0 ttp -98.7 142.38 30.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.815 . . . . 0.0 109.555 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -94.93 177.93 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.53 -12.59 48.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.28 -2.54 58.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.85 64.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -88.81 118.58 28.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -1.118 . . . . 0.0 109.499 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.1 mp -92.36 132.17 36.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.4 pp -146.08 -170.45 3.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.848 . . . . 0.0 109.464 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.97 151.72 44.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 109.476 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -145.43 170.06 17.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -83.87 -23.38 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 t -92.44 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -82.46 94.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.558 ' N ' ' SG ' ' A' ' 101' ' ' CYS . 3.3 p -76.45 -175.72 3.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.04 -11.23 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 9.16 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 98' ' ' THR . 3.7 m -94.32 -0.35 55.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.579 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 96.7 m-85 -94.94 151.15 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -0.841 . . . . 0.0 109.716 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.4 m-85 -147.55 134.82 20.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -80.17 159.35 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.98 . . . . 0.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -123.71 139.83 53.6 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.16 77.84 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.83 151.99 10.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.29 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -129.4 168.72 15.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.661 -0.649 . . . . 0.0 109.324 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.7 p -77.2 58.05 1.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 112' ' ' TYR . 40.8 p30 -155.3 17.79 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 63.51 -7.75 0.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.526 -0.734 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 110' ' ' ASN . 49.9 m-85 -95.35 128.65 42.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.86 170.16 10.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.61 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 p -144.32 111.8 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -102.19 126.69 49.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -116.18 157.16 25.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 109.634 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.569 ' HG ' ' N ' ' A' ' 118' ' ' ARG . 4.4 t -65.15 160.61 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.873 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 117' ' ' SER . 53.9 ttt180 -90.7 -73.99 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 8.4 tptm -58.11 -9.72 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -136.39 57.77 1.76 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.529 -0.732 . . . . 0.0 109.445 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 21.8 p -61.26 1.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.687 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.6 m -89.96 11.52 20.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.99 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 14.5 m-90 -146.92 132.71 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -98.65 153.0 19.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.596 -0.69 . . . . 0.0 109.946 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.76 134.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.39 171.42 19.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.5 mt -132.32 172.03 12.96 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -94.49 -163.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -93.79 -24.94 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.707 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 132' ' ' GLN . 0.2 OUTLIER -77.22 -1.35 29.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.05 69.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.5 mp0 -85.11 179.1 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 31.6 p90 -94.11 120.77 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.67 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.611 ' NZ ' ' NE2' ' A' ' 143' ' ' GLN . 26.0 tttt -69.72 138.66 53.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 137' ' ' SER . 15.2 tp -47.65 142.56 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.0 19.3 1.27 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.3 p -115.18 -27.0 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.914 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -90.06 -4.94 57.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.749 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 p -70.89 135.93 48.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.45 179.72 47.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.492 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.6 Cg_endo -61.23 179.08 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.88 1.72 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.8 -30.75 1.28 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.611 ' NE2' ' NZ ' ' A' ' 134' ' ' LYS . 15.1 mt-30 -92.48 134.08 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.18 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.06 1.85 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.36 -11.59 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.2 pt -92.59 -2.8 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.6 mt -88.63 86.79 7.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 109.503 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -91.29 164.43 13.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.56 70.48 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.35 109.97 1.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.803 1.669 . . . . 0.0 110.303 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.0 mtt -98.04 128.37 44.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -68.57 160.57 29.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.97 72.88 1.48 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.647 -0.658 . . . . 0.0 109.393 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -75.55 -69.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.476 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.84 128.63 1.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.11 121.53 12.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.37 -178.41 39.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.24 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -91.62 178.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.493 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.55 104.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.406 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -77.93 -76.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tp 54.28 68.44 2.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 151.4 85.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.713 1.609 . . . . 0.0 110.219 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 175.89 87.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mp 42.32 70.39 1.76 Allowed Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.574 -0.704 . . . . 0.0 110.039 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.85 136.17 47.8 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.854 1.702 . . . . 0.0 110.173 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 47.43 74.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.29 88.02 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.21 56.26 0.24 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.99 153.11 25.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -163.16 52.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -1.138 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.29 -78.55 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.43 -110.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 p90 -150.43 67.62 8.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.96 168.31 12.39 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.643 1.562 . . . . 0.0 109.809 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.36 157.26 22.62 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.603 1.535 . . . . 0.0 110.038 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.18 -113.48 0.33 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.477 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -93.48 43.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.136 . . . . 0.0 109.646 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -75.01 18.48 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.395 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 25' ' ' HIS . 24.0 tttm -93.88 10.3 33.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.871 . . . . 0.0 109.661 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -114.9 149.52 42.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 166.46 7.62 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.075 1.183 . . . . 0.0 110.27 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -143.51 127.27 17.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.215 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -84.9 124.67 31.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.543 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.52 104.87 16.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -99.09 126.68 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.509 -0.744 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 43.8 t -89.45 130.74 35.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.19 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -79.8 -15.7 56.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.21 104.82 17.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.67 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.56 4.94 89.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.4 88.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 44.7 m-85 -145.42 132.17 20.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.733 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -94.73 120.69 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.402 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.4 tp -47.53 142.64 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 12.8 ttt180 -150.32 114.74 5.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 117.32 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.476 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 90.8 m-70 -79.71 150.24 72.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.913 . . . . 0.0 109.031 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.5 -23.96 58.92 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.075 1.183 . . . . 0.0 110.259 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 4.8 p30 -75.01 -2.49 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.72 -31.51 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' NH1' ' OD2' ' A' ' 46' ' ' ASP . 3.2 mtm-85 -56.76 117.7 4.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -1.153 . . . . 0.0 109.528 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.8 t -94.09 140.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.491 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 43.0 p30 -164.14 153.27 13.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.06 160.44 24.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -146.84 149.77 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -1.155 . . . . 0.0 109.478 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -80.78 4.6 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 57' ' ' ASP . 20.7 tt0 -88.01 91.6 8.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.383 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -77.84 48.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 p -163.49 20.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.715 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -77.7 141.36 64.44 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.991 . . . . 0.0 108.991 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.89 22.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.191 1.261 . . . . 0.0 111.073 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.5 m80 -132.61 -10.2 3.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.173 -0.954 . . . . 0.0 109.99 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.3 -3.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.046 -1.033 . . . . 0.0 109.338 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.95 86.7 7.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.01 135.0 33.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -93.59 110.5 22.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.07 136.47 26.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.77 123.17 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.13 -30.12 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -165.45 -159.93 0.44 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 10.5 ptt180 -89.18 118.54 28.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.01 66.96 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 t -145.75 99.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -1.09 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 ' C ' ' HG ' ' A' ' 73' ' ' SER . 2.4 m -93.19 174.83 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 72' ' ' VAL . 9.1 m -145.48 119.72 9.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.324 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.67 147.59 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.594 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' HZ3' ' HH ' ' A' ' 82' ' ' TYR . 14.8 tttt -147.01 132.01 18.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.374 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.91 132.9 12.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.0 t -72.52 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -1.155 . . . . 0.0 109.454 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.7 t -53.83 -47.56 70.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.7 70.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.35 46.35 26.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -136.09 142.63 44.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 109.305 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.55 ' HH ' ' HZ3' ' A' ' 75' ' ' LYS . 57.6 m-85 -89.93 116.4 27.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.2 tp -50.69 149.7 3.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.18 128.34 11.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.7 ttm -94.16 138.11 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -83.44 166.88 17.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -20.57 60.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.46 ' CG ' ' HE ' ' A' ' 90' ' ' ARG . 1.7 p30 -87.02 -45.14 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 147.69 -10.67 1.26 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' HE ' ' CG ' ' A' ' 88' ' ' ASP . 75.5 mtm180 -68.65 122.01 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -1.2 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.9 mp -90.87 129.55 36.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 3.6 pp -147.53 150.93 35.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.264 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.2 157.32 16.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.748 . . . . 0.0 109.504 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.85 146.21 27.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.454 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -70.99 -21.43 62.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 t -89.69 151.59 21.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.16 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -147.43 162.01 39.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -11.55 31.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.46 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE2' ' OH ' ' A' ' 120' ' ' TYR . 23.3 mt-10 -94.12 4.96 53.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.556 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -91.52 -8.81 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.498 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 90.3 m-85 -95.03 153.03 17.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 69.2 m-85 -145.69 127.02 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.93 116.21 5.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.64 89.2 7.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.275 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.95 127.7 36.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.1 134.21 35.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -93.77 -177.78 4.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -93.63 40.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.5 m120 -148.15 30.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.57 -0.39 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.531 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.7 m-85 -97.36 125.34 41.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 0.0 109.284 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.2 m-20 -94.54 167.18 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 109.855 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -142.61 122.13 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.448 -0.782 . . . . 0.0 109.235 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -94.2 115.14 27.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 151.93 20.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.65 152.3 35.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.105 -0.997 . . . . 0.0 109.591 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -87.59 -75.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 21.7 tptt -49.69 -10.97 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 10.7 m-85 -143.91 66.37 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -64.71 5.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' TYR . 33.6 m -91.59 10.49 27.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.692 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -151.35 144.62 24.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 24.1 m-85 -108.26 166.25 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.35 132.94 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.85 166.28 33.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -132.7 175.77 9.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 0.0 109.336 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -95.21 -169.64 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.389 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.43 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 6.6 ptm180 -91.65 -12.72 33.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.68 1.44 56.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.4 64.88 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -85.34 161.84 19.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 109.509 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.8 p90 -91.98 120.51 32.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.511 ' HZ3' ' C ' ' A' ' 138' ' ' LYS . 13.8 ttpp -72.98 134.92 44.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.404 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.7 tp -47.3 136.79 8.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.888 . . . . 0.0 109.224 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.92 -8.75 74.17 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -83.45 -29.62 27.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.492 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.511 ' C ' ' HZ3' ' A' ' 134' ' ' LYS . 8.5 mtpp -89.98 -4.8 57.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 5.3 p -69.87 153.87 42.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.64 -179.75 43.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.94 162.62 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.803 1.669 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.57 -29.46 7.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.28 127.74 34.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -1.145 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -84.1 -2.88 57.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.23 -5.13 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.425 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.57 0.45 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.95 91.86 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -95.77 167.59 11.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.656 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.72 73.54 54.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.291 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.38 106.49 0.49 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.861 1.707 . . . . 0.0 110.608 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.1 mtp -97.41 130.24 44.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.463 -0.773 . . . . 0.0 109.409 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.5 t -70.04 137.01 50.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.76 58.19 4.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.93 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.492 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.324 0.583 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.91 102.51 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -92.66 99.45 12.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.475 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.74 56.16 3.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 47.2 -103.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 6' ' ' ILE . 9.5 mm -90.65 101.44 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.1 p -56.58 -173.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.457 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.4 ' HG1' ' HZ1' ' A' ' 55' ' ' LYS . 87.7 m -92.17 57.78 3.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.26 152.49 58.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.13 153.23 33.72 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.13 1.22 . . . . 0.0 110.222 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.42 156.61 43.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 15' ' ' ASP . 7.1 tp -171.07 68.14 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.99 159.64 45.4 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.924 1.749 . . . . 0.0 110.475 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER 45.49 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.779 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.0 OUTLIER 36.33 -87.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.218 0.532 . . . . 0.0 110.722 179.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . -164.65 -29.64 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.05 -166.56 6.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m 47.38 71.12 0.35 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.74 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.22 26.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -1.109 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -76.46 -49.66 2.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.02 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 1.4 Cg_endo -66.81 167.35 19.71 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 120.779 0.986 . . . . 0.0 109.786 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.78 122.21 10.89 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.593 1.529 . . . . 0.0 109.984 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.29 20.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -145.76 8.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -1.15 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -109.02 4.89 23.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.641 -0.662 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -6.94 59.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.421 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.19 149.8 36.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.799 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.47 164.0 6.07 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.096 1.197 . . . . 0.0 110.266 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -136.61 136.68 39.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.603 -0.685 . . . . 0.0 109.266 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.8 mtt-85 -87.46 121.87 30.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.482 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.6 mt -86.6 97.67 10.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.25 120.46 33.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.61 107.17 19.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.15 -22.07 60.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.9 m-80 -80.13 96.42 6.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.928 . . . . 0.0 109.488 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 85.7 4.62 85.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 84.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -143.02 132.4 23.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -1.041 . . . . 0.0 109.515 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -94.13 124.67 38.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.2 tp -56.81 140.25 48.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.28 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -147.41 121.48 9.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.6 mt -94.36 121.53 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 89.1 m-70 -86.44 150.29 51.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.029 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -57.98 -22.41 54.86 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.105 1.203 . . . . 0.0 110.109 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 14.1 p30 -75.04 1.04 14.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -39.33 3.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.463 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.1 mtm-85 -54.51 119.91 5.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.5 t -102.02 130.58 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -149.71 163.5 37.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.399 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.16 157.5 23.35 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -146.07 141.96 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -1.12 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -79.79 3.89 18.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm-40 -91.14 91.85 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' HZ1' ' HG1' ' A' ' 8' ' ' THR . 0.0 OUTLIER -85.29 56.26 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.507 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -149.94 9.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.017 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' HIS . 2.6 p-10 -92.07 140.06 24.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.55 6.36 0.2 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.935 1.09 . . . . 0.0 110.564 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.521 ' H ' ' C ' ' A' ' 57' ' ' ASP . 78.0 m80 -94.76 -34.54 12.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.78 -6.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 109.414 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 84.47 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.91 135.12 33.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tm0? -91.67 112.72 24.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.114 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.47 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 10.2 mp -92.47 152.03 19.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.657 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -138.03 123.99 20.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.585 -0.697 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.1 134.18 35.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -100.28 -89.65 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 109.349 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.19 -155.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.38 54.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 165.15 -30.32 0.22 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.95 154.89 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 109.537 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.32 166.25 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -137.16 124.75 22.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.33 148.29 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -148.08 129.95 15.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.61 138.0 16.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.17 -68.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -58.0 -54.36 47.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.77 67.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 50.66 51.75 16.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.602 ' HE ' ' HZ2' ' A' ' 95' ' ' LYS . 91.1 mtt180 -147.6 149.2 32.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.87 130.21 36.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.21 141.54 58.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 109.268 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 156.25 41.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 tpp -112.29 143.75 42.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.67 -0.644 . . . . 0.0 109.383 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -80.17 -169.31 2.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -19.11 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.3 p30 -91.14 -38.47 12.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 109.62 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.14 -7.87 1.88 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -70.05 127.51 33.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 7.7 mp -91.9 139.02 31.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -150.04 -175.95 5.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.579 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.34 155.06 46.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -145.64 170.02 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.602 ' HZ2' ' HE ' ' A' ' 81' ' ' ARG . 9.9 mttm -80.38 -42.38 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 126.68 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.438 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 10.4 p -65.53 120.09 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.495 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 3.2 p -92.21 -174.1 3.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 0.0 109.497 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 101' ' ' CYS . 52.7 t0 -80.03 -31.97 39.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.79 16.52 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.464 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.495 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 64.4 m -94.85 1.72 55.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.6 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.1 m-85 -96.76 148.66 22.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 61.6 m-85 -145.92 115.59 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.309 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -60.85 117.02 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.087 -1.008 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -81.09 148.29 29.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.582 ' NH2' HH21 ' A' ' 116' ' ' ARG . 36.0 ttp180 -148.2 108.95 4.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.97 121.23 34.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -90.22 -177.67 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.428 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 3.31 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -91.03 18.24 6.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.463 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.46 -0.67 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.515 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.1 m-85 -99.17 136.28 39.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.72 162.65 13.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.771 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.5 p -143.41 122.8 13.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -95.26 109.17 21.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.856 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.582 HH21 ' NH2' ' A' ' 106' ' ' ARG . 37.9 ttm180 -93.36 149.22 21.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.983 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -80.19 167.74 19.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -93.78 -87.1 0.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.412 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -48.54 -13.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 118' ' ' ARG . 6.1 m-85 -126.26 56.8 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 52.9 p -57.91 -19.75 32.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.727 . . . . 0.0 110.418 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.9 m -89.55 19.95 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.917 -1.114 . . . . 0.0 108.989 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -139.83 151.89 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.512 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 28.3 m-85 -131.54 152.57 50.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.712 . . . . 0.0 109.522 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.09 135.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.2 -178.45 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.11 165.96 26.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.87 175.33 7.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -87.02 -13.12 45.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.09 1.01 57.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.55 7.75 61.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -92.59 166.22 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 27.8 p90 -83.19 120.25 25.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 135' ' ' LEU . 38.9 tttm -71.51 137.42 48.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 5.7 tp -61.65 -152.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -127.71 -36.87 0.47 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.52 ' OG ' ' NZ ' ' A' ' 138' ' ' LYS . 27.0 p -52.91 -29.93 31.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.221 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.52 ' NZ ' ' OG ' ' A' ' 137' ' ' SER . 2.4 mptp? -90.18 -20.08 23.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 70.4 p -69.93 136.7 50.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.51 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.14 179.81 48.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.74 153.97 58.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.874 1.716 . . . . 0.0 110.238 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.19 32.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -1.115 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 2.4 mtmp? -74.92 -7.76 54.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.12 -3.21 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -99.8 6.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.89 110.2 22.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.841 . . . . 0.0 109.614 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.14 163.72 16.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.684 -0.635 . . . . 0.0 109.402 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 tp -141.43 70.92 26.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.466 -0.771 . . . . 0.0 109.243 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.9 109.3 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.923 1.749 . . . . 0.0 110.559 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.2 mtt -95.92 125.7 40.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.1 t -68.72 141.57 55.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.562 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.47 56.7 2.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -60.57 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.444 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.92 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 51.37 -125.95 2.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.91 -177.3 46.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -65.68 -109.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.49 ' H ' HH22 ' A' ' 31' ' ' ARG . 71.2 mt -73.53 140.47 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.567 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -56.99 164.91 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.579 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.68 -81.32 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.84 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.1 mt 51.57 76.53 0.53 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.155 -0.965 . . . . 0.0 109.704 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.1 -175.18 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.704 1.602 . . . . 0.0 110.2 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.66 78.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER 179.26 -50.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.611 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.1 Cg_endo -65.34 120.76 8.03 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 120.827 1.018 . . . . 0.0 110.301 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 48.61 88.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.18 91.4 6.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.25 44.74 3.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.0 48.84 0.56 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 p -146.15 63.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 109.609 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 21' ' ' PHE . . . -81.8 -100.79 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 22.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.188 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.0 m-85 53.48 63.03 8.66 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 110.091 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.82 158.6 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.425 1.417 . . . . 0.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.18 103.17 0.35 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.329 1.353 . . . . 0.0 109.926 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.06 -82.33 0.05 OUTLIER Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.3 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.439 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 23.4 m-70 -100.98 66.18 1.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.315 -1.109 . . . . 0.0 109.888 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 35.7 m-85 -122.58 4.81 9.56 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -95.71 23.84 5.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.448 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -147.56 152.36 41.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 109.202 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.72 167.72 3.81 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.138 1.225 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.439 ' NZ ' ' O ' ' A' ' 25' ' ' HIS . 54.7 mttt -145.77 133.46 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.232 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.49 HH22 ' H ' ' A' ' 6' ' ' ILE . 23.4 mtt180 -85.03 120.96 27.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 mt -84.91 95.97 9.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -91.79 115.03 27.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.0 t -81.83 125.12 30.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -78.96 -14.88 58.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.903 . . . . 0.0 109.761 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 29.9 m-80 -88.32 92.49 9.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 93.02 4.92 64.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.75 82.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.4 m-85 -142.7 132.97 24.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.364 -1.08 . . . . 0.0 109.552 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -93.55 129.4 39.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.96 146.46 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 6.8 ttt180 -145.52 159.12 43.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.51 104.97 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.23 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.9 m-70 -66.92 150.58 97.75 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.079 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.2 Cg_exo -57.07 -24.05 55.95 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.157 1.238 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 23.8 p30 -74.98 -1.7 23.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.82 -32.04 6.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -52.15 119.94 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -1.209 . . . . 0.0 109.458 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.4 150.43 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 109.507 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 16.3 p-10 -174.57 151.35 1.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.92 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 155.25 21.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.87 139.54 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.0 mtm-85 -71.52 -7.12 45.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.04 98.04 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -84.98 7.15 22.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 t -91.34 -20.12 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -63.58 116.14 23.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.128 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.36 0.39 1.03 Allowed 'Trans proline' 0 C--O 1.213 -0.737 0 C-N-CA 120.632 0.888 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.492 ' H ' ' C ' ' A' ' 57' ' ' ASP . 49.4 m80 -77.72 -6.63 54.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.86 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -87.63 6.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.3 87.41 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -91.77 135.28 34.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -89.75 105.39 17.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.51 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.477 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 9.5 mp -89.7 153.04 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -144.7 137.92 26.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.73 122.96 32.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -95.47 -76.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -95.96 -124.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -92.7 -76.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 5.44 81.24 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.08 140.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.9 m -141.02 127.32 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.303 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -91.47 121.1 32.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.611 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.32 145.12 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.321 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -146.84 143.81 28.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.13 139.98 18.81 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.449 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 58.5 t -80.02 -58.24 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -1.164 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.5 -43.78 18.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.12 67.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 3.1 m-80 51.25 50.84 18.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.57 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 94.1 mtt180 -148.5 149.3 31.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -93.17 129.79 39.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.937 . . . . 0.0 109.585 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.4 142.6 51.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.17 133.35 18.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.1 ttm -92.43 145.53 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -92.99 -177.34 4.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 21.2 mm-40 -79.62 -40.43 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.7 p30 -69.95 -37.14 75.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 135.8 1.75 2.94 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 90' ' ' ARG . 3.9 mtm-85 -76.45 119.15 19.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.5 mp -92.8 134.87 34.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.17 178.04 9.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.708 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.88 158.12 19.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.687 -0.633 . . . . 0.0 109.449 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -150.06 134.46 17.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -54.84 -49.97 69.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -85.0 130.55 34.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.521 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -85.66 160.43 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 p -147.49 -172.98 4.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -13.0 62.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -95.91 50.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.1 m -147.43 9.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 63.0 m-85 -96.16 152.67 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.672 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.7 m-85 -150.25 115.77 5.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.897 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -57.56 152.56 14.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.42 137.34 54.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -142.8 134.52 26.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.438 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.17 128.57 46.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 109.679 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -86.33 171.42 11.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.277 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -76.21 -5.04 45.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.58 17.91 10.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.01 61.71 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -0.778 . . . . 0.0 110.205 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.452 ' C ' ' ND2' ' A' ' 113' ' ' ASN . 48.7 m-85 -144.6 -171.93 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 112' ' ' TYR . 4.3 m-80 -147.91 114.55 6.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 109.804 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -95.36 124.06 39.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.264 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -96.32 109.16 21.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -97.57 147.54 24.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.192 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 t -78.99 158.88 27.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.22 -78.01 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.449 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -47.86 -34.81 9.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.2 m-85 -112.22 65.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 67.6 p -64.08 3.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' TYR . 54.4 m -93.47 11.72 27.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.2 161.24 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 19.4 m-85 -123.91 169.91 11.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -87.92 122.52 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.48 144.45 22.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.615 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -95.86 -176.29 3.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -94.33 -108.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.86 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -148.17 -35.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 109.457 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -81.25 10.54 5.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.68 10.62 60.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -93.93 166.82 11.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -1.172 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -89.99 120.45 31.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.428 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -69.83 139.08 53.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.4 tp -58.64 141.94 50.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -66.46 5.16 2.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 135' ' ' LEU . 96.4 p -93.48 -32.37 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -90.0 -16.95 28.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.554 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 38.8 p -69.91 161.41 30.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.36 179.33 31.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.1 Cg_endo -61.7 178.38 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.88 1.72 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 -33.21 0.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.508 ' H ' ' C ' ' A' ' 141' ' ' PRO . 17.2 mt-30 -87.65 128.11 35.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -1.207 . . . . 0.0 109.601 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 146' ' ' ILE . 37.8 mtmt -74.96 -2.82 28.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.16 -3.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.45 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.511 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.1 pt -97.49 3.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.1 109.95 21.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -116.05 163.75 15.46 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.1 tp -140.85 72.41 28.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.141 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.55 115.18 2.5 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.853 1.702 . . . . 0.0 110.711 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.4 mtt -97.13 121.84 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.8 t -69.98 139.86 52.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.254 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.85 56.5 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -64.22 -84.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.449 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . -89.66 -33.89 16.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 2' ' ' ALA . 39.8 mt-10 -57.88 -162.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.658 ' N ' ' HZ3' ' A' ' 55' ' ' LYS . . . -151.22 -137.73 2.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' ILE . 5.1 mt-10 -93.42 160.56 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -1.143 . . . . 0.0 109.501 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' GLU . 3.3 mt 46.21 94.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.5 m -144.94 60.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' LEU . 5.3 t -146.38 44.29 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' THR . 9.6 mt 60.39 148.77 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.46 176.14 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.016 1.144 . . . . 0.0 110.315 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.41 -171.48 3.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.72 67.81 12.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.66 -171.74 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.714 1.61 . . . . 0.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.28 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -58.98 -57.16 14.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.389 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.67 84.8 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.04 26.04 16.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.33 101.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.3 108.4 0.22 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.74 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -1.089 . . . . 0.0 109.702 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 2.0 t80 -143.98 59.05 6.6 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 0.0 110.42 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HD3' ' N ' ' A' ' 21' ' ' PHE . 1.5 Cg_endo -63.84 168.19 12.42 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.604 1.536 . . . . 0.0 109.836 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.63 -169.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.517 1.478 . . . . 0.0 109.765 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.527 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 154.34 -105.87 0.28 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.467 ' CE1' ' HZ2' ' A' ' 154' ' ' LYS . 32.9 m-70 -73.44 28.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -1.162 . . . . 0.0 109.791 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 24' ' ' GLY . 71.1 m-85 -92.48 27.52 2.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -145.25 -7.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -114.79 152.44 46.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.61 150.6 60.03 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 121.13 1.22 . . . . 0.0 110.289 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -143.31 141.86 31.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.198 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' NH2' ' O ' ' A' ' 55' ' ' LYS . 7.8 mtp180 -92.97 128.28 38.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.3 mt -85.03 128.78 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -115.31 114.51 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.1 105.7 17.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -48.51 -35.14 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 109.908 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 105.01 3.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 109.715 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.02 5.91 85.41 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.27 52.49 13.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -99.17 137.64 37.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.492 -1.005 . . . . 0.0 109.746 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -95.61 112.12 23.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.3 tp -46.51 145.18 1.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.661 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 64.0 ttt180 -144.26 154.26 42.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.679 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -134.74 127.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -91.65 149.41 39.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.124 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -58.26 -22.02 55.21 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.241 1.294 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.82 -11.62 60.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 109.677 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.84 15.02 38.06 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -93.8 115.55 27.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.107 -1.231 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.87 131.4 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -148.32 -163.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.383 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.86 127.18 2.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.72 155.61 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.468 -1.019 . . . . 0.0 108.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LYS . 16.7 mtm-85 -91.64 -16.42 27.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.986 -1.071 . . . . 0.0 109.451 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.8 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HZ3' ' N ' ' A' ' 4' ' ' GLY . 18.4 pttp -83.48 -2.71 56.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.88 10.02 20.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.142 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.519 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -104.56 106.03 52.71 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.56 2.48 0.52 Allowed 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 120.744 0.963 . . . . 0.0 110.273 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.5 m80 -76.99 -28.01 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -72.27 -8.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.83 92.05 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mt -91.31 135.61 33.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.22 108.95 19.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.224 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 8.9 mp -91.26 153.15 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -147.88 133.99 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.303 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 169.25 18.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 67' ' ' GLU . 3.1 tm-20 -145.04 -34.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -154.01 -163.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.487 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 80.7 mtm180 -84.88 58.82 5.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.575 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.47 -26.84 1.68 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.64 138.6 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -1.181 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.97 179.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.276 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 m -145.38 121.84 11.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.635 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.9 mt -93.96 147.7 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -146.46 140.09 25.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.399 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.48 138.71 19.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 41.2 t -80.0 -68.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.47 -15.6 59.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.7 24.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 77' ' ' VAL . 44.5 m-20 51.16 45.69 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.594 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 73.1 mtt180 -147.43 148.06 30.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -94.61 130.95 40.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -60.4 147.83 39.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.294 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.02 137.15 19.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.636 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.8 ttm -100.43 132.41 45.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.467 -0.771 . . . . 0.0 109.341 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -78.82 157.46 28.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -21.08 66.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 2.7 p-10 -84.77 -42.58 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.36 -7.48 1.8 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -72.54 122.3 21.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 109.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.6 mp -92.59 129.79 38.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -146.59 -174.58 4.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.01 154.07 44.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -146.46 163.93 34.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -70.14 -33.01 71.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.92 127.3 34.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.464 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 8.4 p -82.64 85.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.6 p -68.3 -167.26 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 101' ' ' CYS . 55.3 m-20 -80.0 -26.81 39.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.81 7.34 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.521 ' H ' ' C ' ' A' ' 99' ' ' ASP . 85.8 m -96.72 -3.04 43.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -86.64 149.87 24.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -150.03 117.74 6.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.451 ' CB ' ' HE ' ' A' ' 116' ' ' ARG . 33.0 m-85 -64.06 128.09 34.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -97.89 134.99 40.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -145.05 131.33 19.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.558 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.9 tp -95.91 120.16 35.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.63 170.88 12.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.4 t -78.29 53.27 1.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 112' ' ' TYR . 11.2 t-20 -150.84 22.86 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.25 0.23 0.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 109.568 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.6 m-85 -101.78 138.13 39.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -90.71 164.01 14.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.71 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 p -142.44 117.95 10.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -98.43 118.63 35.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.416 -0.802 . . . . 0.0 109.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.451 ' HE ' ' CB ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -102.07 148.07 25.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.549 -0.72 . . . . 0.0 109.301 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -73.66 156.25 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 120' ' ' TYR . 1.1 ttt-85 -89.76 -77.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 5.7 tptt -48.35 -12.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 12.0 m-85 -143.82 67.12 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -65.27 5.02 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 120' ' ' TYR . 37.0 m -90.39 9.75 27.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.578 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -151.51 142.77 23.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.8 m-85 -110.65 163.84 13.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 109.561 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -80.82 138.46 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.04 -177.67 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -142.64 169.21 18.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -95.07 -178.12 4.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -11.45 32.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 1.9 t -93.58 2.64 56.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.75 4.93 67.04 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.6 mp0 -93.32 169.7 10.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.129 . . . . 0.0 109.473 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.5 p90 -92.54 120.46 33.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.425 ' HZ2' ' NE2' ' A' ' 143' ' ' GLN . 8.6 tttt -69.78 135.59 49.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.3 tp -47.65 123.78 6.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.222 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.47 -23.97 29.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.2 p -80.17 -20.79 43.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -1.195 . . . . 0.0 109.647 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -90.07 -8.89 50.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 45.2 p -73.02 157.75 36.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.68 179.74 42.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 172.11 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.876 1.717 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.99 -37.95 2.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' NE2' ' HZ2' ' A' ' 134' ' ' LYS . 59.8 mt-30 -83.55 131.88 34.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -1.19 . . . . 0.0 109.418 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.35 -0.49 50.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.02 -8.81 3.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.55 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.56 2.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.9 mt -93.32 90.62 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.14 166.99 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -146.21 71.03 13.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.242 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.3 112.9 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.842 1.694 . . . . 0.0 110.501 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.9 mtt -103.86 142.65 34.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.406 ' HG ' ' HZ1' ' A' ' 154' ' ' LYS . 38.3 t -69.94 149.86 47.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.0 59.06 3.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' HZ2' ' CE1' ' A' ' 25' ' ' HIS . 53.2 mttp -73.31 -69.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.271 0.558 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.59 -98.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 50.96 -169.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.68 -107.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 7' ' ' THR . 11.8 pm0 -85.58 -165.25 1.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 7' ' ' THR . 3.1 mt -59.49 81.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.425 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 70.39 142.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -157.37 52.59 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -91.69 152.08 42.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.3 161.24 9.51 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.1 1.2 . . . . 0.0 110.158 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.66 177.48 2.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.27 68.67 10.37 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.31 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 110.257 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -77.29 53.66 1.04 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -80.23 40.85 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.26 29.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.44 -55.94 2.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -169.33 70.44 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -1.19 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.93 108.82 0.58 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.62 -39.59 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -93.46 -47.65 0.29 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 110.738 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.4 Cg_endo -66.29 167.92 17.3 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.004 1.136 . . . . 0.0 109.902 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.55 -169.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.676 1.584 . . . . 0.0 110.244 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.1 -48.14 3.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -96.21 61.89 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -1.071 . . . . 0.0 109.325 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -139.97 4.84 2.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.563 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -85.72 48.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -162.78 94.81 1.17 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 0.0 109.106 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.02 116.63 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 120.862 1.041 . . . . 0.0 110.165 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.1 143.18 26.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.392 -0.818 . . . . 0.0 109.666 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.2 mtt-85 -87.43 135.86 33.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.21 120.59 26.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 109.764 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -109.53 107.47 17.59 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -76.47 103.32 6.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -45.35 -31.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.0 m-80 -66.95 105.14 1.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.02 4.65 36.14 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.21 83.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -124.42 128.73 49.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.932 . . . . 0.0 109.255 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -90.31 114.07 26.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.216 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.9 tp -48.91 141.67 7.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 57' ' ' ASP . 39.8 ttp180 -147.55 112.48 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.2 mt -89.96 112.75 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -74.35 151.93 87.78 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.121 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.7 Cg_exo -56.92 -26.42 67.55 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.163 1.242 . . . . 0.0 110.24 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.46 0.37 17.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.56 4.36 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.3 mtm-85 -50.63 115.24 1.4 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.13 146.09 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 14.0 p30 -169.06 148.13 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.26 151.53 20.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -146.35 153.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -89.91 -0.7 57.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.28 88.1 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -68.91 -5.04 18.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 22.65 1.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -110.18 99.92 41.79 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.61 3.62 0.36 Allowed 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 120.912 1.075 . . . . 0.0 110.522 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.526 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.9 m80 -84.23 -4.64 58.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.65 1.85 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -77.01 100.45 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.29 135.2 43.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.79 107.33 19.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -85.85 150.72 24.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.532 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.04 132.93 16.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.4 135.44 33.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 -38.32 8.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.639 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -151.34 -117.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -83.85 -110.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.687 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.53 6.26 17.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.76 129.89 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.42 ' C ' ' HG ' ' A' ' 73' ' ' SER . 3.0 m -138.79 168.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 109.507 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.42 ' HG ' ' C ' ' A' ' 72' ' ' VAL . 2.3 m -142.47 118.99 10.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.448 -0.783 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.8 mt -91.07 152.33 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -148.65 117.99 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.506 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 131.91 51.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.08 -60.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -68.2 -34.28 75.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.17 -21.92 33.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 51.25 55.21 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 6.6 mtp180 -146.8 149.29 33.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.399 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -94.97 129.63 41.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.06 139.66 58.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.267 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.82 133.31 16.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.0 ttp -97.12 133.0 42.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 88' ' ' ASP . 32.8 mmtt -73.45 164.24 26.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.893 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.78 24.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 86' ' ' LYS . 1.1 p30 -130.24 -42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.663 -0.648 . . . . 0.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.41 -9.61 1.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.2 mtt-85 -78.53 115.93 18.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -1.162 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.5 mp -92.67 131.02 38.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.412 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.94 -171.83 3.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -141.16 151.43 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 109.383 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.21 151.33 38.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.481 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -63.86 -28.92 70.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.77 127.38 38.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.94 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 p -148.25 -165.37 2.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -68.01 -19.43 64.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.961 . . . . 0.0 109.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.63 54.1 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 58.3 m -146.71 9.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -94.32 156.41 16.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.89 105.56 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -58.39 103.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.512 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -87.06 94.56 9.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -89.92 126.85 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.454 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.29 132.26 34.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.56 -178.92 4.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -89.15 -11.41 43.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.1 m-20 -89.59 28.55 1.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER 60.42 -0.7 0.25 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.75 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.2 m-85 -95.48 130.14 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.92 169.97 10.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.3 p -142.39 120.45 12.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.791 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -93.15 99.05 11.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -93.49 145.15 24.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -72.02 155.57 40.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.6 ttt180 -92.45 -76.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.6 -9.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 118' ' ' ARG . 13.4 m-85 -140.47 60.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 40.1 p -61.0 0.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' TYR . 4.0 m -90.51 10.68 24.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.08 142.33 19.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -105.55 170.13 8.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.0 t -90.68 69.95 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -94.01 141.59 28.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.5 mt -95.97 179.6 5.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -92.65 -171.68 2.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -93.64 -11.77 30.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 2.51 55.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.43 0.4 67.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -88.43 171.01 10.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.6 p90 -89.6 120.41 30.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -70.14 139.34 52.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.68 125.07 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.226 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.45 -16.5 7.04 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.3 p -90.1 -20.45 23.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.053 -1.263 . . . . 0.0 109.58 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -89.98 -11.03 42.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.2 p -69.93 175.07 4.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.83 25.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.2 170.95 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.893 1.729 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.91 -55.07 2.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -75.15 134.87 41.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 33.9 mtmt -82.76 4.39 25.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.21 -3.85 0.99 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.1 pt -93.12 -9.63 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 mt -81.87 91.64 6.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -94.07 157.28 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.5 tp -138.12 71.95 47.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.21 115.0 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.775 1.65 . . . . 0.0 110.732 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.3 mtt -97.43 130.59 44.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 109.22 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.0 t -68.32 144.31 54.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.1 53.43 2.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.22 -77.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.324 0.583 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.69 115.75 22.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.7 mt-10 -91.6 97.31 10.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 58.62 158.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.62 -120.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -1.179 . . . . 0.0 109.437 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.38 107.35 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.478 ' H ' ' HG1' ' A' ' 7' ' ' THR . 1.8 p -62.42 139.03 58.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 109.189 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -145.86 156.42 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.637 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.92 98.23 41.09 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.31 115.56 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.68 0 C-N-CA 120.924 1.082 . . . . 0.0 110.543 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.1 52.11 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.482 -0.761 . . . . 0.0 109.176 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.16 68.74 2.53 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.499 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.95 156.84 60.17 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.697 1.598 . . . . 0.0 110.273 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.45 90.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.486 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -77.48 52.93 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . -55.37 -43.51 84.79 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . 62.02 119.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 73.18 102.16 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -1.114 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.18 91.6 2.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.29 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -1.037 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -95.79 -46.17 0.26 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.441 -0.787 . . . . 0.0 111.036 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 3.9 Cg_exo -65.45 167.89 15.82 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 109.96 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.82 170.51 1.38 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.64 1.56 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.34 -20.37 0.08 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -177.45 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -1.183 . . . . 0.0 109.469 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -87.51 17.15 4.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 41.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 15.3 m-20 -150.3 152.07 32.58 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.48 156.7 30.05 Favored 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.236 1.291 . . . . 0.0 110.341 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 28' ' ' ASP . 20.3 mttm -141.12 133.77 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.436 -0.79 . . . . 0.0 109.424 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.612 ' NH1' ' NZ ' ' A' ' 61' ' ' LYS . 1.1 mtt-85 -90.76 133.86 34.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.65 126.35 38.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -115.19 119.46 36.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.5 t -93.82 106.66 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.09 -35.04 10.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.656 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.595 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -67.95 103.28 1.45 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.92 4.93 83.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 55.16 8.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -102.14 143.05 32.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.978 . . . . 0.0 109.795 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.02 110.14 22.46 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.6 tp -46.95 144.66 2.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.119 -0.988 . . . . 0.0 109.716 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -143.55 155.4 44.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.89 131.83 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.199 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -93.17 149.68 37.86 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.067 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.06 -21.75 52.15 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.224 1.283 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -74.85 4.79 5.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -38.54 3.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -48.1 164.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.7 t -137.83 148.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.587 -0.696 . . . . 0.0 109.258 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' ' CG1' ' A' ' 52' ' ' VAL . 3.1 p-10 -154.17 -160.02 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 131' ' ' GLY . . . -143.1 126.38 2.82 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.407 ' CG1' ' OD2' ' A' ' 50' ' ' ASP . 1.8 m -142.55 151.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.456 -1.026 . . . . 0.0 108.457 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 55' ' ' LYS . 35.4 mtm180 -89.04 -21.54 23.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.091 -1.006 . . . . 0.0 109.341 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -44.93 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.764 . . . . 0.0 109.705 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' ARG . 6.9 pttp -81.27 1.33 32.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.3 p -88.28 5.12 43.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.214 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -99.27 110.35 57.85 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.177 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.73 3.18 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.717 0.944 . . . . 0.0 110.238 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -74.85 -33.23 62.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.334 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.96 0.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.459 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.612 ' NZ ' ' NH1' ' A' ' 31' ' ' ARG . 8.6 tptt -77.1 96.71 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.453 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 131.75 45.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.503 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.02 109.54 20.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -92.61 150.01 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.553 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.73 137.9 21.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.1 160.21 25.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.952 . . . . 0.0 109.581 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -142.94 -84.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.79 -151.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -85.87 117.72 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 -3.11 13.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.41 139.34 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -1.16 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.5 m -140.86 128.23 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.535 -0.728 . . . . 0.0 109.577 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 m -94.47 118.74 32.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.06 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 82' ' ' TYR . 58.4 tttp -145.71 144.18 30.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.44 134.17 12.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.47 -77.75 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -27.18 7.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.95 -25.46 20.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.0 m120 50.99 48.3 23.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -146.37 150.76 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 75' ' ' LYS . 80.9 m-85 -94.86 127.8 41.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.3 147.92 24.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.88 167.87 22.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.467 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.0 ttm -134.17 141.12 46.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.675 -0.64 . . . . 0.0 109.407 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -92.84 160.79 14.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.46 -29.41 70.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -45.53 26.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.08 -6.72 1.81 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' NH1' ' HH ' ' A' ' 133' ' ' TYR . 2.1 mmt180 -63.84 120.08 11.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -1.222 . . . . 0.0 109.471 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -150.16 -175.31 5.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.08 150.6 38.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.315 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -146.6 156.52 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -73.44 -18.56 61.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -93.25 112.97 25.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.442 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.96 142.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.464 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.2 p -147.31 -163.35 1.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.58 -14.8 63.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.504 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -94.07 42.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 64.6 m -144.03 6.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 60.7 m-85 -94.36 151.44 19.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 96.0 m-85 -150.22 111.94 4.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CD2' ' NH1' ' A' ' 116' ' ' ARG . 32.2 m-85 -54.89 157.81 3.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.27 95.26 4.41 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 109.307 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -89.96 108.57 19.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.66 117.86 30.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.93 -175.58 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -1.25 57.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 112' ' ' TYR . 41.3 t-20 -91.44 27.49 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.95 -3.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 109.88 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.9 m-85 -94.31 156.49 16.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.242 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -123.9 165.38 17.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 109.758 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -141.0 120.13 12.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.321 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -89.9 107.77 19.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.479 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.513 ' NH1' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -99.07 133.65 43.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.499 -0.751 . . . . 0.0 109.133 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t -61.41 161.8 8.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.968 . . . . 0.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -95.45 -79.12 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 0.0 109.199 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -50.33 -11.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' H ' ' C ' ' A' ' 118' ' ' ARG . 6.1 m-85 -130.19 52.53 2.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 79.9 p -52.72 -12.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.3 m -93.51 20.51 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.928 . . . . 0.0 109.635 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -152.29 130.75 12.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.72 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.5 m-85 -103.99 167.97 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.581 -0.699 . . . . 0.0 109.591 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.52 148.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.887 . . . . 0.0 109.362 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.58 -177.96 6.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.5 mt -144.86 171.28 14.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -90.27 174.03 7.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -93.79 11.71 28.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -125.08 5.55 7.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.7 -0.625 . . . . 0.0 109.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 95.27 0.28 63.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -85.09 172.95 10.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -1.166 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.541 ' HH ' ' NH1' ' A' ' 90' ' ' ARG . 20.9 p90 -93.62 120.55 34.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.592 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -72.71 132.82 44.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.364 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.72 158.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.76 -39.01 18.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -67.49 -15.37 63.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -1.159 . . . . 0.0 109.585 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -90.02 -5.05 57.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -74.38 165.68 24.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.57 179.47 21.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.86 168.71 6.74 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.849 1.7 . . . . 0.0 110.237 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.87 -47.9 2.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.14 131.52 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.595 ' CB ' HD22 ' A' ' 36' ' ' ASN . 36.3 mtmt -85.1 -1.94 57.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.522 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.18 -0.14 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.529 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.6 pt -93.66 -10.45 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.599 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 91.47 8.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.35 168.39 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.6 tp -144.27 70.44 16.09 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.58 112.97 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.796 1.664 . . . . 0.0 110.305 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 29.8 mtt -98.12 115.61 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.307 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.5 t -65.16 157.32 29.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.99 56.21 3.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -56.13 -58.02 9.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.26 -96.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -142.77 -91.69 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.29 -176.67 14.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' ILE . 8.6 mt-10 -90.15 134.35 34.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 7' ' ' THR . 74.0 mt 53.09 172.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.541 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.465 ' N ' ' CG2' ' A' ' 6' ' ' ILE . 3.2 p -77.64 165.86 23.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 109.541 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.14 147.73 3.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' ALA . 4.4 mp -138.13 149.01 62.21 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.3 Cg_endo -58.47 76.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 120.985 1.123 . . . . 0.0 110.243 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 43.15 65.68 0.92 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.17 -47.46 0.39 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 110.779 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.2 Cg_endo -66.49 167.1 19.7 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.09 1.193 . . . . 0.0 110.205 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' GLY . 10.5 tt0 64.33 50.35 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER 41.84 -90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.737 -0.602 . . . . 0.0 110.128 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . 149.86 11.82 0.11 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' O ' ' OG ' ' A' ' 18' ' ' SER . . . -68.21 -175.47 9.6 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 17' ' ' GLY . 2.0 m 177.13 79.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.45 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.32 -58.79 5.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -145.78 9.68 1.17 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -1.087 . . . . 0.0 109.461 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 2.7 p90 38.09 67.19 2.17 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.822 -0.549 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.35 168.18 11.63 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.645 1.563 . . . . 0.0 109.853 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.63 168.53 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.614 1.543 . . . . 0.0 110.171 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.15 39.46 6.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -166.69 30.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -1.152 . . . . 0.0 109.5 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -135.86 28.28 3.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.553 -0.717 . . . . 0.0 109.323 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 3.0 56.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -114.86 151.94 45.96 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.1 166.43 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.215 1.277 . . . . 0.0 110.525 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -150.02 131.05 14.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.235 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.53 118.73 28.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 mt -84.92 100.65 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -98.6 125.42 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.472 -0.767 . . . . 0.0 109.571 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.66 121.46 33.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -15.13 62.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.705 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.597 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -84.66 105.07 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 53' ' ' ARG . . . 75.87 4.91 78.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.67 88.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.2 m-85 -144.84 132.97 21.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -1.076 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -94.92 131.56 40.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.388 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.77 143.52 57.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.268 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 57' ' ' ASP . 42.5 ttt180 -146.47 119.32 8.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.669 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.13 120.22 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -82.93 151.74 64.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.38 -27.29 75.05 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.121 1.214 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 p30 -74.91 0.88 14.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -25.11 11.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -55.95 114.96 2.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -1.154 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -92.69 142.1 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.406 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 12.7 p-10 -170.91 150.09 3.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.09 155.23 22.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.67 140.57 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 37' ' ' GLY . 8.5 mmt180 -69.27 -12.54 61.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.78 98.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' O ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.12 -5.49 59.34 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.264 -0.897 . . . . 0.0 108.943 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -97.09 23.74 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -102.85 107.55 55.12 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.187 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.5 -3.28 3.21 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 120.718 0.945 . . . . 0.0 110.154 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -76.04 -25.64 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.271 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.49 -5.52 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -76.09 87.27 2.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.959 . . . . 0.0 109.424 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.38 33.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -89.62 111.19 22.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.256 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -91.3 148.97 21.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.718 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 73' ' ' SER . 7.4 tt0 -145.36 148.25 33.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.87 163.68 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 102' ' ' PHE . 3.2 tt0 -138.01 -51.13 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.489 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -147.77 -139.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -91.51 101.26 13.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.0 -14.63 52.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.03 106.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -1.174 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 103' ' ' PHE . 3.3 m -95.74 -178.0 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 65' ' ' GLN . 5.9 m -144.84 112.39 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.37 -0.831 . . . . 0.0 109.236 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.97 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.65 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -146.27 143.68 29.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.398 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.29 142.42 16.39 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.93 -87.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 109.368 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 t -47.6 -39.68 17.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.42 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.445 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 51.25 53.95 12.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.672 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -147.17 156.25 42.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.92 130.37 40.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.76 143.12 51.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.91 170.2 18.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 ttp -139.29 122.08 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.487 -0.758 . . . . 0.0 109.372 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -59.57 -175.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.26 -11.75 45.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -92.55 -38.02 12.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 143.44 -9.45 2.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -66.36 124.55 23.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.401 ' CD1' ' O ' ' A' ' 89' ' ' GLY . 11.0 mp -92.71 134.33 35.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -150.09 -171.53 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.599 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.64 150.39 40.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.26 147.78 31.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -66.33 -17.3 64.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.895 . . . . 0.0 109.543 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -90.24 140.81 29.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.493 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 t -92.98 94.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.2 p -91.71 157.02 17.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.428 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.97 -21.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.87 48.52 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.2 m -138.61 1.02 2.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.455 -0.778 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 67' ' ' GLU . 99.2 m-85 -98.79 159.75 14.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.84 . . . . 0.0 109.412 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.2 m-85 -150.13 115.65 5.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.593 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.03 149.38 12.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.25 90.09 3.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -94.87 126.04 39.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.18 125.79 39.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -92.59 170.09 10.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.432 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -79.81 62.95 4.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 112' ' ' TYR . 13.0 p30 -159.94 21.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.488 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.4 -6.77 0.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 110.037 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.3 m-85 -97.62 134.55 40.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 109.365 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.4 170.01 9.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.877 . . . . 0.0 109.822 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -140.27 114.62 9.24 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -90.63 115.33 27.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.876 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 150.9 22.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.556 -0.715 . . . . 0.0 109.161 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.3 163.44 20.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.896 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -94.83 -61.65 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 109.242 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.51 -54.07 23.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -96.1 62.62 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 p -56.89 2.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 120' ' ' TYR . 19.4 m -89.33 15.17 9.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.898 -1.126 . . . . 0.0 109.443 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.04 146.55 23.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 14.4 m-85 -104.71 169.45 8.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.17 125.61 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.55 156.4 42.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.1 mt -112.75 -178.36 3.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.771 -0.581 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.99 -129.45 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.533 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.415 ' HE ' ' C ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -139.84 4.52 2.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.502 -0.749 . . . . 0.0 109.408 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.31 14.82 8.32 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.61 6.46 60.91 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -92.91 162.74 13.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -1.121 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.0 p90 -93.32 120.3 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.666 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.666 ' NZ ' HE21 ' A' ' 143' ' ' GLN . 22.7 ttmt -70.03 135.41 49.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.493 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -47.66 160.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.27 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.3 24.52 7.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.7 p -115.07 -45.73 2.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.701 -0.882 . . . . 0.0 109.574 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -4.86 28.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.684 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -73.16 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.66 179.46 31.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.95 171.57 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.885 1.723 . . . . 0.0 110.237 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.26 -44.34 3.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.666 HE21 ' NZ ' ' A' ' 134' ' ' LYS . 2.5 mm100 -85.39 133.82 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.461 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.597 ' CB ' HD22 ' A' ' 36' ' ' ASN . 36.9 mtmt -81.39 3.95 22.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.25 -9.95 5.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 pt -92.56 1.82 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 71.1 mt -94.3 90.56 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.398 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.56 168.65 10.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 tp -141.02 70.61 28.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.329 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.54 103.83 0.41 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.8 1.667 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.6 mtt -95.4 125.35 39.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.354 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.4 t -70.02 135.33 49.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 61.98 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -54.9 -77.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.424 -179.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.61 123.88 7.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 2.5 mp0 -88.18 -169.91 2.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 50.49 95.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.22 -98.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.48 ' CG1' ' NH2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -89.64 -176.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -66.18 178.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.592 ' CG2' ' H ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -145.6 -98.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.592 ' H ' ' CG2' ' A' ' 8' ' ' THR . 11.8 mt 60.18 148.86 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.559 -0.713 . . . . 0.0 109.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.13 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.991 1.127 . . . . 0.0 110.188 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 156.5 30.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 179.18 -50.76 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 110.573 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.2 Cg_endo -64.62 144.65 85.11 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 120.717 0.945 . . . . 0.0 110.111 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 49.65 74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.5 -28.29 23.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 48.95 -130.63 23.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -155.26 -40.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -145.69 48.47 1.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.347 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.11 66.39 0.24 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.45 -79.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 109.688 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 2.3 p90 -153.99 67.14 5.74 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.852 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.61 167.78 11.05 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.565 1.51 . . . . 0.0 109.65 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 25' ' ' HIS . 2.5 Cg_endo -58.45 173.96 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.667 1.578 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.13 3.08 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.603 ' NE2' ' NZ ' ' A' ' 30' ' ' LYS . 81.6 t60 -87.59 -23.07 24.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -1.173 . . . . 0.0 109.473 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -93.02 31.23 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.614 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -73.27 -28.6 62.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.349 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.91 152.64 46.67 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.45 167.24 2.85 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.204 1.269 . . . . 0.0 110.244 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.603 ' NZ ' ' NE2' ' A' ' 25' ' ' HIS . 16.5 mtpt -140.7 127.0 19.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 109.352 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' NH2' ' CG1' ' A' ' 6' ' ' ILE . 53.6 mtt180 -86.76 124.95 33.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -84.72 102.03 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.94 116.2 23.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.21 61.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.691 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.5 m-80 -90.0 105.21 17.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.37 4.91 87.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 84.17 0.02 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.63 134.68 30.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.413 -1.051 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -95.25 133.35 39.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 39.9 tp -67.53 143.25 56.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.209 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 1.5 ttt180 -155.99 125.05 6.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.98 . . . . 0.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.1 mt -94.13 127.17 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.256 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.519 ' CE1' ' NH1' ' A' ' 42' ' ' ARG . 86.8 m-70 -83.58 148.86 56.08 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.7 Cg_endo -59.25 -21.12 58.59 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.203 1.268 . . . . 0.0 110.466 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.71 7.73 2.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.708 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.63 -39.29 3.13 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -52.0 162.04 0.51 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -1.141 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.0 t -139.4 141.35 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.46 -0.775 . . . . 0.0 109.366 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' OD1' ' NE2' ' A' ' 44' ' ' HIS . 39.4 p-10 -159.46 -149.77 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.88 155.94 26.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.49 139.13 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -1.068 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -77.83 -17.78 57.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.18 110.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 34.65 0.55 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -129.63 -20.4 3.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.655 -0.653 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -45.48 108.71 0.82 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.837 . . . . 0.0 109.485 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.86 5.44 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.674 0.916 . . . . 0.0 110.152 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.617 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 47.6 m80 -94.13 -15.42 24.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -70.05 -4.72 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.506 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 32.0 mtpt -76.94 79.38 3.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.06 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.86 110.41 21.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -87.72 159.0 18.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -141.28 176.33 8.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.222 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.64 142.07 48.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.608 -0.682 . . . . 0.0 109.574 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.19 143.0 28.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 50.81 -127.22 2.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -147.81 137.8 22.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.23 10.33 81.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.25 143.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.476 -1.014 . . . . 0.0 109.324 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.83 -176.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.479 -0.763 . . . . 0.0 109.559 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -141.53 126.34 18.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -95.48 148.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.36 136.75 23.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.41 136.81 15.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 51.3 t -74.97 -86.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -1.198 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -47.51 -53.63 13.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.359 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.55 63.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.9 m120 51.08 45.24 28.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 0.0 109.55 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -137.24 145.67 43.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 109.332 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.95 129.41 36.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.887 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.45 150.19 19.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.74 26.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 109.476 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.7 ttm -137.47 126.86 24.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.378 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -91.4 -173.04 3.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.92 -29.47 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.9 1.18 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.07 78.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.578 ' NH1' ' HH ' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -91.27 117.67 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.537 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.1 mp -90.04 137.34 32.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.13 177.46 9.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.736 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.18 164.64 12.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.692 -0.63 . . . . 0.0 109.417 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -149.33 159.13 44.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 109.509 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -88.44 -0.5 57.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.93 123.75 16.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.496 -0.753 . . . . 0.0 109.423 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.07 154.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -150.93 168.39 24.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -47.51 -24.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.9 49.27 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -143.38 5.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -97.4 157.61 15.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -150.01 112.94 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' ARG . 34.1 m-85 -54.92 149.14 12.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.98 . . . . 0.0 109.231 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.96 92.14 3.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.657 -0.652 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 114' ' ' THR . 10.5 ttp180 -91.47 120.19 32.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.68 126.56 32.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.91 -177.19 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.7 m -93.67 55.92 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.568 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 17.2 p-10 -165.78 31.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.95 -4.29 0.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.6 m-85 -91.31 127.61 36.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.72 167.21 11.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 14.2 p -136.17 120.57 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.85 104.18 16.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -98.45 145.82 26.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.38 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -62.56 161.34 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 0.0 109.277 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -87.15 -61.67 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.68 -44.38 56.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.533 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -92.63 57.91 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -58.25 -0.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.5 m -89.71 11.81 18.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.07 -1.019 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.03 152.59 29.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 11.4 m-85 -120.65 163.19 18.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.63 130.06 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.23 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.86 143.49 21.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.96 167.78 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -93.75 -165.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.86 -10.16 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -4.77 53.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.97 34.22 9.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.3 176.38 5.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.769 -0.842 . . . . 0.0 109.374 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.578 ' HH ' ' NH1' ' A' ' 90' ' ' ARG . 34.8 p90 -87.02 120.06 27.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -71.39 131.84 43.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.533 ' CD2' ' HG ' ' A' ' 137' ' ' SER . 13.7 tp -52.15 140.5 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.52 4.08 1.61 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.533 ' HG ' ' CD2' ' A' ' 135' ' ' LEU . 88.9 p -91.89 -34.61 14.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.17 . . . . 0.0 109.604 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.02 -10.76 43.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 p -70.0 145.33 51.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.5 178.96 38.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.49 166.54 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.938 1.759 . . . . 0.0 110.222 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.62 -50.47 2.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -80.41 135.08 36.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 40.6 mtmt -85.01 9.28 15.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.07 -2.54 2.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.4 pt -97.13 -3.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 109.521 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.93 91.75 8.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.632 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.54 165.51 12.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.1 tp -141.87 70.45 24.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.392 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.16 104.9 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.752 1.635 . . . . 0.0 110.36 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.7 mtt -95.31 136.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 130.4 42.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.47 59.73 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.535 ' CB ' ' HZ1' ' A' ' 154' ' ' LYS . 7.8 mtpm? -55.08 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.494 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.43 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.28 35.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.93 83.34 5.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.81 136.27 2.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE2' ' NE ' ' A' ' 31' ' ' ARG . 4.7 mp0 -82.56 -142.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -1.176 . . . . 0.0 109.502 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -66.19 86.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.424 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -53.12 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -92.2 16.16 12.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.478 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 3.3 mm? 57.29 150.44 0.06 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.99 142.0 96.45 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 120.825 1.017 . . . . 0.0 110.066 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.27 -175.98 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.183 -0.948 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -148.12 69.95 10.87 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.359 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.49 -163.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.823 1.682 . . . . 0.0 110.382 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -76.24 52.64 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.456 -0.777 . . . . 0.0 109.749 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.44 -26.92 29.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.5 -63.1 1.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.45 -160.03 48.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 p -149.02 53.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -1.174 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.61 37.58 0.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.61 90.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -1.096 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.514 ' CZ ' ' O ' ' A' ' 105' ' ' GLU . 52.6 m-85 45.69 67.98 3.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.893 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.61 114.06 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.775 1.65 . . . . 0.0 109.857 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.61 115.25 2.78 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 120.7 0.934 . . . . 0.0 110.158 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.58 -21.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -159.83 91.58 0.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -1.154 . . . . 0.0 109.519 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -144.11 19.08 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.509 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -94.77 21.16 7.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 0.0 109.683 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -114.9 149.23 42.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.1 153.61 57.27 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.148 1.232 . . . . 0.0 110.384 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -137.41 124.46 21.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' NE ' ' OE2' ' A' ' 5' ' ' GLU . 2.1 mtm-85 -85.26 118.97 25.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.638 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.01 100.91 11.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -94.58 125.17 39.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.7 t -90.18 123.27 33.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -72.44 -13.91 61.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.3 m-80 -90.34 105.12 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.98 5.8 88.88 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.47 85.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 43.6 m-85 -143.15 136.21 27.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -1.089 . . . . 0.0 109.568 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -98.13 122.76 41.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.403 -0.811 . . . . 0.0 109.493 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.13 145.53 20.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.179 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 59' ' ' HIS . 20.2 ttt180 -150.63 128.62 11.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.06 131.35 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 49.9 m-70 -90.5 152.09 44.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.105 -0.997 . . . . 0.0 109.193 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.56 -27.34 76.38 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.198 1.265 . . . . 0.0 110.368 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -74.88 9.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.525 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -33.73 3.28 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -47.51 166.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -1.176 . . . . 0.0 109.405 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.44 134.01 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 32.8 p-10 -159.4 155.93 27.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.33 152.19 20.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.64 149.13 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -1.108 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -82.25 -10.07 59.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.51 83.78 0.41 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -84.66 49.63 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.552 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.95 6.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 109.914 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.5 m-20 -96.58 139.57 21.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.039 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.21 -4.37 3.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.022 1.148 . . . . 0.0 110.317 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CB ' ' NE ' ' A' ' 42' ' ' ARG . 70.1 m80 -75.0 -25.79 59.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.911 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.41 -1.95 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.322 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 11.7 mmtp -83.96 87.0 7.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.93 135.64 33.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.42 104.37 16.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.341 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.7 mp -90.82 154.8 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.22 141.25 35.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.74 136.08 33.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -140.57 122.18 15.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 60.01 164.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 108.935 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.77 32.97 0.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.77 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.23 16.76 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.742 -1.218 . . . . 0.0 110.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.54 155.67 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -1.231 . . . . 0.0 109.575 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.07 130.02 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 109.118 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -92.84 125.33 37.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.828 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -104.05 142.61 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.757 . . . . 0.0 109.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -147.23 151.57 36.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.75 139.42 14.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 54.4 t -78.24 -65.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -71.92 -42.54 66.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.6 65.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 49.98 51.29 16.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -146.06 145.98 30.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.377 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -89.8 133.55 34.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.579 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 44.1 tp -63.56 146.82 52.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.55 132.7 16.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.1 ttm -97.51 120.16 37.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.96 176.54 9.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.32 -26.33 30.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.18 -2.62 22.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 92.48 -14.98 63.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.6 mtt-85 -71.43 123.33 22.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.478 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.6 mp -90.2 136.2 33.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.1 pp -146.4 -175.44 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.65 158.7 43.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 p -145.17 170.11 16.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.321 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -79.97 -36.9 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -93.23 126.0 38.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 14.6 p -71.06 118.85 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 p -97.88 161.57 13.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.66 -21.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.37 55.47 2.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -139.29 3.69 2.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 79.3 m-85 -96.87 162.89 13.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 92.5 m-85 -150.15 121.94 8.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -62.18 97.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 34.9 tt0 -73.17 95.37 2.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' O ' ' OG1' ' A' ' 114' ' ' THR . 66.2 ttt180 -92.51 123.64 35.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.75 134.32 35.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.24 -170.69 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -95.81 -17.54 21.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.659 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 4.1 p30 -94.39 26.0 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.769 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 71.52 2.61 4.34 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.726 -0.609 . . . . 0.0 110.697 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -90.29 140.58 29.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.918 -1.114 . . . . 0.0 109.443 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -95.4 164.16 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 3.2 p -141.8 119.89 12.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -91.77 105.47 17.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -96.15 145.5 25.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -68.34 148.8 50.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -80.55 -56.73 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -70.01 -46.64 64.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.536 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.1 m-85 -95.94 59.44 2.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -57.03 -2.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.624 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.9 m -89.85 10.34 24.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.678 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.08 153.02 30.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 13.8 m-85 -117.02 168.98 9.77 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.303 0.573 . . . . 0.0 109.464 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.78 133.24 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.87 177.48 9.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.1 158.36 39.86 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -93.19 170.63 9.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -78.49 -11.93 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.7 t -91.87 26.1 2.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.532 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.77 50.01 69.31 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -137.47 167.01 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.974 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.2 p90 -90.33 120.58 31.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -69.63 132.62 46.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.8 tp -54.04 160.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -78.62 -0.61 80.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.1 p -95.01 -47.23 6.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -1.12 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -72.46 -6.74 45.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -69.95 153.52 43.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.417 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.01 -179.87 28.21 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 143' ' ' GLN . 3.9 Cg_exo -60.33 -174.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.779 1.652 . . . . 0.0 110.2 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.57 -43.1 1.81 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.415 ' C ' ' H ' ' A' ' 145' ' ' ALA . 56.6 mm-40 -92.21 119.46 31.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.54 ' CB ' HD22 ' A' ' 36' ' ' ASN . 36.6 mtpt -71.05 4.53 2.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -63.24 -9.2 10.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.349 -0.844 . . . . 0.0 109.542 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -93.15 0.53 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.525 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.5 mt -92.35 91.39 7.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.39 168.84 10.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.5 tp -143.07 70.43 18.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.16 107.7 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.791 1.661 . . . . 0.0 110.246 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.0 mtt -93.88 111.13 22.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.805 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 t -66.2 145.37 55.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.08 56.21 3.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -74.84 -83.45 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.526 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.419 ' O ' ' OG1' ' A' ' 8' ' ' THR . 9.6 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.5 161.08 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.98 103.47 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.91 134.68 2.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -92.02 -81.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -1.202 . . . . 0.0 109.587 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -99.16 135.44 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -58.04 -161.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.519 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 94.6 m 53.33 96.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -44.87 153.12 0.51 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.288 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.65 173.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.23 1.286 . . . . 0.0 110.542 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -179.12 -167.52 0.11 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mt -142.41 70.81 21.64 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.517 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 14' ' ' GLU . 2.2 Cg_endo -65.49 114.04 2.73 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.858 1.705 . . . . 0.0 110.165 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 14.5 tt0 71.0 101.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.366 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.06 -26.04 0.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 47.09 74.91 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.22 108.86 0.31 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 p -171.15 55.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -1.143 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.75 -87.82 0.12 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' C ' ' CD1' ' A' ' 21' ' ' PHE . . . -146.3 -110.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.13 . . . . 0.0 109.412 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 20' ' ' ALA . 72.7 m-85 -152.37 67.51 6.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.775 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.15 167.8 13.68 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.591 1.527 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.82 152.67 55.63 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.594 1.53 . . . . 0.0 110.097 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 143.02 -52.33 0.64 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 63.4 m-70 -75.08 28.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.128 . . . . 0.0 109.538 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 24' ' ' GLY . 52.1 m-85 -131.92 29.72 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.74 . . . . 0.0 109.224 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -95.21 -14.96 23.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.793 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -150.27 152.52 33.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.338 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.8 175.57 0.29 Allowed 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 121.251 1.301 . . . . 0.0 110.243 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 25' ' ' HIS . 9.6 mttp -146.28 175.11 10.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 31' ' ' ARG . 17.9 mtm-85 -131.01 128.1 39.67 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.4 mt -84.45 111.0 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.774 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -101.42 114.52 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.81 108.31 17.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.491 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.737 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.25 105.0 8.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.65 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . . . 72.3 7.05 66.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 73.98 0.27 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -118.27 129.88 55.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.73 -0.865 . . . . 0.0 109.571 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.82 113.2 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.2 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.8 tp -49.07 133.83 18.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 109.187 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.507 HH11 ' CG ' ' A' ' 57' ' ' ASP . 41.2 ttp180 -142.5 122.98 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.7 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.54 133.76 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.202 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -89.92 151.24 45.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.09 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.15 -18.15 28.23 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.161 1.24 . . . . 0.0 110.516 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.89 -7.88 54.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.19 55.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -94.05 163.09 13.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -1.132 . . . . 0.0 109.363 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.66 126.59 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.568 -0.707 . . . . 0.0 109.315 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.61 149.99 24.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.27 151.85 22.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.25 146.12 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -1.149 . . . . 0.0 109.704 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 37' ' ' GLY . 28.2 mtt-85 -77.02 1.16 18.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.01 88.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -85.11 33.37 0.54 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.602 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -143.64 21.8 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -94.66 124.41 55.02 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.041 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.1 1.86 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.668 0.912 . . . . 0.0 110.28 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.4 m80 -94.07 -13.81 26.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.54 9.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.612 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -93.26 87.48 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -90.1 135.16 33.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -89.82 110.33 21.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.4 mp -93.01 118.51 31.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.14 146.57 27.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.305 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 139.36 30.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' GLU . 28.1 tt0 -146.64 142.05 27.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . 1.5 mt-10 48.3 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -100.97 113.28 26.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 109.541 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.63 25.56 17.78 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.75 152.54 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -1.103 . . . . 0.0 109.418 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.7 m -144.49 133.41 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -92.08 118.75 31.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.554 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.89 138.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -147.04 139.6 24.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.66 142.36 20.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.44 -72.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -45.19 91.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.31 -27.35 68.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.96 50.15 19.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.89 150.05 35.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -95.29 134.31 38.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.323 -0.861 . . . . 0.0 109.766 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.249 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.08 148.5 29.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 47.2 ttm -106.27 132.91 51.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.371 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -72.45 -170.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.0 -45.54 26.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.707 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 1.4 p-10 -69.96 -82.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.511 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -171.18 24.61 0.09 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -89.61 124.27 34.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.2 mp -94.01 128.7 40.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.81 -173.53 4.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.2 152.55 46.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.404 -0.81 . . . . 0.0 109.487 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.61 155.03 42.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -61.09 -36.81 80.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 99.0 p -84.93 137.55 33.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.451 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 12.0 p -89.08 118.12 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.9 p -93.98 -169.82 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 101' ' ' CYS . 1.7 m-20 -80.06 -30.75 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.99 15.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.448 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.515 ' H ' ' C ' ' A' ' 99' ' ' ASP . 93.8 m -95.1 -9.32 33.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -86.74 148.8 25.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.935 . . . . 0.0 109.435 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.27 116.48 7.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -59.51 122.43 14.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.93 97.79 9.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 116.82 29.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.76 120.3 31.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.7 -171.29 3.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.5 p -93.37 -4.35 51.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.7 m-20 -93.06 25.84 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.55 -1.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.79 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.2 m-85 -95.93 130.94 42.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -91.61 163.05 14.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.742 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 p -139.09 114.66 9.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.124 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -89.84 114.71 26.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.806 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.82 139.82 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.295 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -67.68 137.01 55.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.5 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.479 ' C ' ' H ' ' A' ' 120' ' ' TYR . 25.5 ttt180 -77.98 -70.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.589 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 3.2 tptt -51.55 -10.08 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 27.6 m-85 -146.2 70.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.7 p -64.88 4.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 120' ' ' TYR . 11.2 m -94.25 10.23 34.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.88 . . . . 0.0 109.603 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 10.4 m-90 -154.97 137.37 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 22.6 m-85 -100.98 165.39 11.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.574 -0.704 . . . . 0.0 109.388 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.67 125.86 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -152.2 143.4 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -95.39 176.21 6.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -93.07 173.19 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -84.92 -4.84 59.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.434 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.94 -5.16 48.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.26 -0.66 55.95 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.584 ' NE2' ' N ' ' A' ' 132' ' ' GLN . 1.5 mp0 -93.13 172.6 8.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -1.184 . . . . 0.0 109.532 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.9 p90 -91.61 120.22 32.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -70.2 131.84 44.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.2 tp -48.5 160.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.11 2.05 53.05 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' THR . 84.5 p -93.69 -68.17 0.82 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' N ' ' OG ' ' A' ' 137' ' ' SER . 12.3 mptt -48.18 -14.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 137' ' ' SER . 22.3 p -69.93 150.36 46.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.42 179.84 30.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.51 158.46 31.86 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.69 -28.78 8.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.407 ' C ' ' H ' ' A' ' 145' ' ' ALA . 74.8 mm-40 -90.4 113.89 25.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.411 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -65.93 -2.25 3.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.99 -10.36 28.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.67 2.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.499 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.4 mt -91.01 87.31 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.99 159.62 15.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.672 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.5 tp -140.84 70.91 29.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.018 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 109.35 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.888 1.726 . . . . 0.0 110.641 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 20.6 mtt -97.5 130.94 44.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.397 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.606 ' HG ' ' N ' ' A' ' 153' ' ' ALA . 41.0 t -70.08 167.99 16.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.134 -0.979 . . . . 0.0 109.171 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.606 ' N ' ' HG ' ' A' ' 152' ' ' SER . . . -84.9 50.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.413 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -93.79 -73.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.433 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.513 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.97 146.71 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.25 -131.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.68 132.54 0.09 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -66.19 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -1.158 . . . . 0.0 109.502 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 mp -78.32 139.63 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.2 p -51.94 160.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -77.37 -60.37 2.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.486 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 8' ' ' THR . 6.3 mp 57.84 157.62 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.16 174.8 0.4 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.173 1.249 . . . . 0.0 110.144 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.28 -172.43 4.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 15' ' ' ASP . 1.5 tt 52.25 69.04 2.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.451 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.15 177.37 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.56 51.81 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 12' ' ' LEU . 1.2 m-20 -71.54 94.89 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . -172.77 58.59 0.15 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . 58.05 161.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 166.91 105.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -1.114 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.2 -79.07 0.07 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -150.7 81.05 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -1.178 . . . . 0.0 109.53 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.492 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 2.9 p90 37.17 66.47 2.12 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.997 -0.439 . . . . 0.0 110.597 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.9 168.13 12.64 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.561 1.507 . . . . 0.0 109.766 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.62 103.01 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.583 1.522 . . . . 0.0 110.213 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' O ' ' ND1' ' A' ' 25' ' ' HIS . . . 148.88 47.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 24' ' ' GLY . 46.7 m-70 -155.96 16.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -120.14 27.25 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -93.01 10.82 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.07 149.93 26.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 108.822 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.07 160.1 13.54 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.988 1.125 . . . . 0.0 110.174 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -122.47 174.16 7.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.7 mtm-85 -136.84 110.89 8.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -84.06 101.28 11.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.927 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.22 115.68 27.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.7 t -78.87 111.43 15.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.576 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -20.2 66.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.3 m-80 -88.13 100.93 13.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.597 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 86.71 4.55 82.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 84.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 48.7 m-85 -142.2 131.3 23.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -1.062 . . . . 0.0 109.477 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -92.64 121.92 34.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.47 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.2 tp -53.0 145.25 13.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.0 109.187 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 22.4 ttt180 -148.7 158.95 44.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.576 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.6 mt -136.27 123.37 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -88.15 149.69 45.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.116 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.89 -23.72 60.82 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.294 1.33 . . . . 0.0 110.699 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' OD2' ' CD ' ' A' ' 48' ' ' ARG . 36.4 p-10 -74.63 3.87 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.739 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.42 -35.31 4.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' CD ' ' OD2' ' A' ' 46' ' ' ASP . 27.0 mtp180 -47.8 152.86 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.92 144.18 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.468 -0.77 . . . . 0.0 109.428 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -167.04 -146.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.91 161.12 28.25 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.8 m -147.1 138.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.465 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.462 HH11 ' HG3' ' A' ' 53' ' ' ARG . 4.5 mtm-85 -82.25 5.43 20.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.38 106.61 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -84.0 38.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.96 17.5 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -99.13 110.16 56.92 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.795 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 1.63 0.63 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.68 0.92 . . . . 0.0 110.127 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.518 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.1 m80 -80.6 -13.29 59.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.391 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.21 -0.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.18 87.48 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.97 131.68 35.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.454 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -89.98 102.95 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.7 mp -86.21 149.66 24.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.98 139.1 28.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.69 111.74 22.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -92.11 -91.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -84.34 180.0 7.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.8 mtt-85 -76.62 110.7 11.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.41 26.02 26.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.52 96.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -1.127 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.87 126.65 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 m -94.31 129.02 41.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.443 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.78 146.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.96 117.68 8.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.46 48.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 55.2 t -80.0 -80.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -1.086 . . . . 0.0 109.435 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.6 -35.01 71.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.79 -25.83 61.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.479 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 5.0 m-80 51.21 52.69 14.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.8 mtt-85 -147.63 143.32 27.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.9 126.78 35.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -59.88 147.49 38.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.51 170.14 17.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -140.03 128.89 23.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -73.12 -169.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -92.78 -17.5 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.4 p30 -85.44 -40.87 15.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.49 2.16 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -70.56 126.35 29.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.9 mp -93.09 138.47 31.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.05 -176.56 5.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' C ' ' HG ' ' A' ' 94' ' ' SER . . . -142.89 157.1 44.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.446 ' HG ' ' C ' ' A' ' 93' ' ' ALA . 13.4 m -145.49 170.14 16.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.831 . . . . 0.0 109.415 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -42.88 33.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 p -89.43 142.86 27.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.5 p -85.23 116.99 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.417 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -96.01 178.88 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -22.81 67.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -94.08 54.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.814 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.2 m -137.43 0.56 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 83.9 m-85 -94.87 153.17 17.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.386 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 82.2 m-85 -147.84 120.14 8.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -59.74 154.19 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -125.25 97.24 5.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.684 -0.635 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.98 116.74 28.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.89 112.33 24.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -84.89 167.72 15.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.883 . . . . 0.0 109.528 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.0 t -81.49 66.39 7.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.584 ' ND2' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -167.58 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.49 -7.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.517 -0.739 . . . . 0.0 110.057 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.584 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 54.8 m-85 -98.32 120.12 38.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -93.25 170.05 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.833 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 p -134.08 121.64 21.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.344 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.44 105.01 16.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 121' ' ' THR . 27.9 ttt180 -94.78 147.06 23.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.855 . . . . 0.0 109.454 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -74.01 158.26 34.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.584 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -93.67 -75.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 10.4 tptm -51.44 -9.93 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 122' ' ' SER . 11.1 m-85 -142.97 63.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.467 -0.771 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.521 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 30.2 p -63.27 2.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.52 ' H ' ' C ' ' A' ' 120' ' ' TYR . 57.8 m -91.01 11.97 21.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.06 145.27 21.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 116' ' ' ARG . 27.9 m-85 -109.96 168.16 9.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.741 -0.6 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.7 t -92.93 131.43 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.4 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -148.26 -172.54 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -138.49 149.8 45.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.334 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -61.09 -102.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.5 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 31.3 ptt180 -173.76 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.417 -0.802 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.8 t -92.53 22.11 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.616 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.75 6.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -136.4 158.7 43.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.956 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 31.0 p90 -95.02 120.46 35.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.816 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -69.74 135.26 49.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 137' ' ' SER . 8.2 tp -58.06 157.34 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.279 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -79.39 22.19 3.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 138' ' ' LYS . 3.5 p -98.57 -60.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.362 -1.081 . . . . 0.0 109.554 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.546 ' H ' ' HG ' ' A' ' 137' ' ' SER . 12.3 mttp -71.93 -7.5 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.7 p -70.12 146.84 50.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.89 179.77 42.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.84 172.71 2.71 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.864 1.709 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.1 -42.11 2.5 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -72.52 134.68 45.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.0 mtpp -85.09 -4.13 59.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.48 -3.72 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 144' ' ' LYS . 3.0 pt -99.2 -3.23 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.446 ' CD1' ' HZ3' ' A' ' 144' ' ' LYS . 60.2 mt -82.24 93.95 7.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.26 161.06 13.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.808 . . . . 0.0 109.529 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.4 tp -133.32 75.73 69.74 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.672 . . . . 0.0 109.23 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.25 111.08 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.712 1.608 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.3 mtt -96.37 114.99 26.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.57 ' CB ' ' HZ3' ' A' ' 154' ' ' LYS . 9.6 t -70.2 129.07 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.94 56.34 3.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.57 ' HZ3' ' CB ' ' A' ' 152' ' ' SER . 63.4 mttp -66.78 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.493 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.28 0.562 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.74 120.73 9.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -82.15 135.92 35.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.461 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLU . . . 93.49 51.51 2.16 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLY . 1.4 pm0 29.48 -131.62 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.313 -0.522 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 7' ' ' THR . 2.4 mp -78.46 115.66 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 6' ' ' ILE . 11.8 p 51.94 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 8' ' ' THR . 8.3 t -165.34 94.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.55 151.85 44.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 108.956 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.97 99.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.07 1.18 . . . . 0.0 110.133 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.29 143.4 47.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.82 68.07 9.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.68 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.86 131.66 33.94 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.736 1.624 . . . . 0.0 110.176 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 16' ' ' GLY . 2.2 mp0 52.59 91.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -54.23 -7.42 0.14 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -145.4 -49.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 46.8 -93.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 20' ' ' ALA . 20.6 m -146.58 51.25 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 109.425 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 20' ' ' ALA . . . 66.02 -6.13 1.66 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 69.86 101.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -1.166 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.436 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 177.98 -51.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 110.801 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 3.9 Cg_exo -62.46 167.87 10.67 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 120.65 0.9 . . . . 0.0 109.829 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.73 -168.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.687 1.591 . . . . 0.0 110.368 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.28 -48.54 1.19 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -93.85 44.89 1.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.486 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.91 14.23 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -94.09 23.91 4.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.695 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -162.8 152.56 13.29 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.09 174.41 0.33 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.115 1.21 . . . . 0.0 110.08 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -147.22 131.04 17.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.9 mtt-85 -85.89 121.18 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.056 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.5 104.91 14.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.98 117.14 33.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.585 -0.697 . . . . 0.0 109.6 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.39 116.45 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.164 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -65.48 -24.5 67.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.06 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.82 105.14 14.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 83.24 4.34 89.69 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.41 83.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 47.8 m-85 -141.48 140.53 33.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -1.103 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -100.88 134.24 44.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.7 tp -70.13 144.12 52.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 41.1 ttp180 -152.82 129.1 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -103.33 136.28 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.525 ' NE2' ' OD1' ' A' ' 50' ' ' ASP . 5.5 m-70 -91.73 148.89 38.16 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.066 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.14 -17.66 46.93 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.095 1.197 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 7.4 p30 -74.84 -10.48 59.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.776 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 15.15 29.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.6 mtt-85 -92.65 167.44 11.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -1.19 . . . . 0.0 109.333 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.7 t -142.94 117.73 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.402 -0.811 . . . . 0.0 109.274 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' OD1' ' NE2' ' A' ' 44' ' ' HIS . 4.3 p-10 -158.23 160.29 36.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.637 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.11 152.99 20.94 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.7 155.06 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.481 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -75.26 -30.66 60.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.461 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' OE2' ' OD1' ' A' ' 57' ' ' ASP . 2.6 mt-10 -47.26 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 53' ' ' ARG . 8.8 pttp -85.24 33.82 0.56 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.946 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -165.23 43.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.09 -1.006 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -94.2 156.88 38.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.957 . . . . 0.0 109.188 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -66.15 22.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 121.508 1.472 . . . . 0.0 111.051 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.533 ' H ' ' C ' ' A' ' 57' ' ' ASP . 61.7 m80 -141.71 -15.51 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.029 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -64.81 -5.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -88.39 90.81 8.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -89.96 135.38 33.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 64' ' ' LEU . 2.4 tp-100 -89.67 106.49 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.52 ' N ' ' OE1' ' A' ' 63' ' ' GLN . 10.6 mp -86.92 155.59 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.72 121.8 12.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.847 . . . . 0.0 109.246 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.83 157.57 26.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.93 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -148.06 135.42 20.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 50.75 -112.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -153.52 124.64 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.11 -17.87 35.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.29 146.02 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.669 -0.9 . . . . 0.0 109.332 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 m -146.43 175.34 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -143.97 128.77 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.73 147.84 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.565 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 5.7 tttp -147.49 134.27 20.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.62 130.85 10.3 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.36 -74.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -1.13 . . . . 0.0 109.496 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.1 t -66.42 -45.25 80.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -27.55 39.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 78' ' ' SER . 11.2 m120 49.79 47.48 22.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -147.28 144.67 29.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.436 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 70.7 m-85 -90.15 131.69 35.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.602 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 43.9 tp -61.33 142.63 56.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.206 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.29 134.49 19.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 53.7 ttm -96.65 126.58 41.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.395 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -72.25 178.8 3.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 -31.59 45.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -70.98 -48.26 54.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.06 -9.11 1.52 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -71.27 124.71 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.489 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.3 mp -92.74 133.87 35.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.59 177.78 8.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -116.83 156.64 26.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.626 . . . . 0.0 109.373 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -145.34 162.91 36.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -82.98 -39.79 20.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.1 t -92.63 122.76 35.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.14 154.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -147.53 -177.12 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -22.55 64.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -87.68 44.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 22.0 m -143.17 5.45 1.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 59.7 m-85 -93.42 151.89 19.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 0.0 109.563 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 84.1 m-85 -150.16 110.59 4.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.882 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -56.96 155.14 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.137 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -125.19 95.35 4.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.369 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' NH2' ' OE1' ' A' ' 108' ' ' GLU . 6.2 ttp180 -90.76 132.36 35.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.21 132.45 36.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' OE1' ' NH2' ' A' ' 106' ' ' ARG . 4.5 mm-40 -88.35 -174.67 4.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -16.46 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.908 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.404 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 5.7 m-80 -93.44 24.24 4.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 64.11 57.32 1.28 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 110.056 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 52.7 m-85 -143.02 126.39 16.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.257 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.73 120.36 34.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 66.8 p -98.1 129.06 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.405 -0.809 . . . . 0.0 109.224 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -95.89 113.03 24.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -100.81 144.89 29.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.378 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -76.24 139.95 41.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 109.582 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 120' ' ' TYR . 1.2 ttt-85 -76.47 -70.63 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -51.37 -9.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.409 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' ARG . 49.7 m-85 -143.86 68.22 1.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.5 p -67.06 3.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 120' ' ' TYR . 73.5 m -95.63 10.55 36.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.82 . . . . 0.0 109.652 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 5.1 m-90 -155.13 145.18 21.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.848 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.3 m-85 -112.01 161.47 16.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.75 -0.594 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.74 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.199 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 -171.37 3.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.808 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -140.78 159.46 42.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.523 -0.736 . . . . 0.0 109.3 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -87.56 -173.54 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.86 -15.53 26.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.613 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.424 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 1.5 t -89.09 3.5 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.05 76.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.446 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 3.6 mp0 -86.11 174.76 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -1.175 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 35.5 p90 -95.02 120.43 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.68 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -69.85 135.42 49.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.396 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -49.31 149.35 2.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.245 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.21 0.28 59.66 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 35.7 p -93.99 -37.96 11.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -1.123 . . . . 0.0 109.553 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -76.82 -8.2 56.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -71.95 160.32 32.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 153.3 179.69 28.98 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -61.11 -176.62 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.922 1.748 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.46 -36.78 0.98 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.494 ' C ' ' H ' ' A' ' 145' ' ' ALA . 5.2 mt-30 -93.34 113.46 25.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -1.084 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 146' ' ' ILE . 19.5 mtmt -65.83 2.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.6 2.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.644 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.482 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.6 pt -100.66 6.35 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.35 94.81 8.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -98.3 164.3 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.811 . . . . 0.0 109.37 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -142.01 70.82 23.66 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.841 . . . . 0.0 109.52 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.81 107.84 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.929 1.753 . . . . 0.0 110.324 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 8.8 mtt -96.18 128.99 43.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.516 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.9 t -70.12 153.2 43.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.565 ' CB ' HH22 ' A' ' 31' ' ' ARG . . . -91.36 58.84 3.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.53 -78.57 0.41 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.503 -179.973 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.264 0.554 . . . . 0.0 109.528 . . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.71 129.15 13.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.23 -0.919 . . . . 0.0 109.517 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.85 99.48 12.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.02 -18.7 74.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -140.36 -168.48 2.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -1.01 . . . . 0.0 109.351 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.32 99.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -92.52 116.54 29.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.539 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.4 t -147.53 -3.28 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp 46.77 68.8 3.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.765 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.07 99.01 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.799 1.666 . . . . 0.0 110.21 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.79 58.23 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.596 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 178.65 -37.26 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.584 -0.697 . . . . 0.0 111.308 179.561 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 1.8 Cg_endo -70.01 127.0 13.78 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 120.488 0.792 . . . . 0.0 110.277 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 51.32 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.05 -8.53 23.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.91 -113.02 3.87 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.92 -149.64 5.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -84.69 52.63 2.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -1.111 . . . . 0.0 109.501 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.15 88.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.88 8.09 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.429 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 12.7 m-85 46.46 66.88 4.95 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.37 113.95 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 121.767 1.645 . . . . 0.0 110.073 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.88 109.9 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.778 0.985 . . . . 0.0 110.096 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.03 -64.82 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -88.68 27.3 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.667 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.572 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 24.7 m-85 -87.04 10.11 17.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.415 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 12.8 tttm -93.43 34.45 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 109.506 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.83 151.92 36.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.073 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.14 171.45 2.27 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.21 1.273 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.572 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 30.2 mttt -145.15 126.93 15.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.04 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.5 mtt-85 -84.81 117.09 23.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.653 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.63 99.07 10.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.97 124.2 36.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 t -90.51 120.31 31.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.212 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -67.94 -14.87 63.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 8.3 m-20 -88.63 105.22 17.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.642 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.21 4.94 87.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.85 86.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.2 m-85 -144.77 138.26 27.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.302 -1.116 . . . . 0.0 109.65 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.48 121.63 38.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.0 109.423 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 41.4 tp -49.36 150.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -156.61 119.51 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 mt -92.55 129.18 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.191 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.99 151.99 45.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' GLY . 2.5 Cg_endo -57.8 -26.75 75.12 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.27 1.313 . . . . 0.0 110.378 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -74.79 10.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 45' ' ' PRO . . . 84.92 -37.41 2.98 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.8 mtt-85 -47.17 154.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -1.187 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.7 t -134.16 130.42 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -146.24 -149.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.42 150.44 22.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.16 144.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.46 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -77.64 -16.67 58.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -59.97 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.384 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.12 12.36 3.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.554 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -108.92 10.91 26.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 109.597 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -95.05 123.48 57.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.18 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.13 4.92 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 120.636 0.891 . . . . 0.0 110.331 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.54 ' H ' ' C ' ' A' ' 57' ' ' ASP . 24.1 m80 -82.53 -38.41 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.879 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -65.52 4.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.577 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 59' ' ' HIS . 14.5 mttt -87.24 84.08 7.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.37 134.28 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.83 108.23 19.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.371 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.4 mp -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -144.2 144.51 31.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.412 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.27 126.36 36.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.948 . . . . 0.0 109.505 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -97.48 -30.21 13.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -153.67 -171.88 4.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -0.926 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -82.95 23.53 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.579 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.63 23.72 0.1 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.31 151.0 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.2 127.18 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -94.5 122.22 36.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.583 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.3 mt -94.4 145.75 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -147.37 130.78 16.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.32 133.81 13.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 88.4 t -76.19 -65.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -1.15 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -61.64 -34.19 75.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.64 34.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 31.6 m120 50.97 50.82 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -148.11 148.53 30.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -89.95 134.89 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.5 tp -65.09 147.75 52.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.65 170.3 17.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.7 ttm -139.11 129.05 25.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.529 -0.732 . . . . 0.0 109.409 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -75.07 178.71 5.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.39 -7.84 59.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.7 p30 -92.72 -46.29 7.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.33 -9.16 1.46 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -71.93 127.86 33.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.9 mp -91.68 139.16 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.08 -176.06 5.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.57 160.08 40.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.291 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 76.8 p -147.14 170.02 18.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -80.98 -36.86 30.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.403 ' H ' ' HG ' ' A' ' 96' ' ' SER . 6.9 p -91.23 126.17 36.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.7 p -72.98 116.31 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.51 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.7 p -93.64 -170.16 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.92 -10.85 59.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -93.78 12.55 25.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 59.2 m -95.68 8.93 42.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.627 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -97.74 148.65 23.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 63.2 m-85 -150.13 113.37 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -55.26 152.02 8.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 108.928 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' OE2' ' CE1' ' A' ' 21' ' ' PHE . 10.6 tt0 -125.07 94.71 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' OG1' ' A' ' 114' ' ' THR . 23.8 ttp180 -92.69 128.42 38.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.936 . . . . 0.0 109.4 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.29 137.99 32.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.423 ' OE2' ' O ' ' A' ' 112' ' ' TYR . 2.5 mp0 -92.67 -178.34 4.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -94.24 47.74 1.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -156.14 23.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 65.13 49.77 1.95 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.53 -0.731 . . . . 0.0 110.012 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' ' OE2' ' A' ' 108' ' ' GLU . 52.3 m-85 -140.63 129.87 23.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.6 OUTLIER -94.6 154.6 17.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.631 -179.826 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 23.3 p -131.38 119.32 21.51 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -93.32 107.74 19.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -101.53 148.12 25.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.294 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -72.57 157.11 38.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.965 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.96 -76.52 0.48 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -51.29 -10.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 122' ' ' SER . 31.2 m-85 -142.89 63.78 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 p -63.32 3.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.775 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.7 m -89.86 11.68 19.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.606 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.14 145.36 22.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 109.839 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.2 m-85 -113.79 167.51 10.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.766 -0.584 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.49 129.37 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.32 149.38 26.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.656 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 19.7 mt -107.11 176.56 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.535 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.46 -166.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 109.28 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -17.29 23.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.366 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.1 1.96 55.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.423 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.25 12.21 56.46 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -93.52 142.63 27.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -1.192 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 24.5 p90 -69.09 120.67 15.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 127' ' ' LEU . 2.8 ttpm? -69.65 130.5 42.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -47.5 148.34 1.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.403 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.38 -31.68 81.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -77.46 -15.55 59.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -1.174 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -89.31 -4.96 57.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.0 p -87.33 156.68 19.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 167.34 179.94 40.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.9 Cg_endo -60.93 166.52 10.29 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.866 1.711 . . . . 0.0 110.231 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.32 1.9 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 141' ' ' PRO . 1.9 mt-30 -75.25 106.46 6.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.402 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 146' ' ' ILE . 18.1 mtmm -66.42 -3.0 5.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.593 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -61.5 -6.27 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.408 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.402 ' H ' ' C ' ' A' ' 144' ' ' LYS . 4.9 pt -93.75 -1.52 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.497 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.11 90.35 8.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -94.92 167.98 11.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.7 tp -144.49 73.87 15.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.446 -0.784 . . . . 0.0 109.251 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.97 115.16 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.75 1.633 . . . . 0.0 110.629 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.0 mtt -96.33 107.01 19.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -63.97 147.02 53.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.99 56.76 4.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -55.21 -86.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.535 179.98 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.315 0.578 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 -15.71 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -59.73 167.93 1.91 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.92 172.08 42.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.05 -106.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 8' ' ' THR . 9.5 mm -90.93 105.31 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.536 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -47.95 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -79.42 87.2 5.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 11' ' ' ALA . 83.4 mt -84.51 150.57 57.22 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 108.657 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 2.5 Cg_endo -56.7 87.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.98 1.12 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 10' ' ' PRO . . . 165.4 73.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 109.227 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.648 ' CD1' ' H ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -101.15 163.23 18.35 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.37 -0.831 . . . . 0.0 108.946 -179.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.39 101.36 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.458 1.439 . . . . 0.0 110.222 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -162.45 51.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -96.35 -31.55 12.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 0.0 109.386 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 86.63 1.35 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.09 152.01 24.17 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -77.78 52.27 1.01 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -1.12 . . . . 0.0 109.459 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.29 15.02 36.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 -112.45 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -1.081 . . . . 0.0 109.216 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 21' ' ' PHE . 13.6 p90 -165.41 66.87 1.16 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.804 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.76 167.93 11.05 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.587 1.524 . . . . 0.0 109.837 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.63 133.74 58.56 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.637 1.558 . . . . 0.0 110.204 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 25' ' ' HIS . . . 149.21 27.93 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 91.5 m-70 -156.64 56.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -140.87 14.94 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -92.5 -16.84 25.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.84 152.63 46.61 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.75 168.66 2.2 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 121.147 1.231 . . . . 0.0 110.168 179.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -144.86 128.75 17.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.825 . . . . 0.0 109.376 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.35 118.82 25.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.7 mt -84.86 98.84 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 40' ' ' PHE . 37.3 t80 -94.98 122.13 37.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.685 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.24 131.48 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.184 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.57 -18.78 58.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.756 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 3.0 m120 -82.15 105.08 12.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 109.608 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.84 4.92 88.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 84.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.6 m-85 -143.17 134.95 26.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -1.112 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 22.8 m-85 -96.68 126.27 41.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 49.7 tp -51.22 149.3 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.35 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 17.7 ttt180 -158.26 116.02 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.0 mt -91.81 128.97 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.236 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -89.44 151.64 46.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 0.0 109.055 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.18 -24.02 64.72 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.113 1.208 . . . . 0.0 110.254 179.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -74.9 2.5 10.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.602 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.4 -32.25 5.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -47.36 162.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -1.114 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -143.6 128.33 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -155.99 -150.28 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.419 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.38 27.7 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.73 149.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -1.083 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -81.92 -15.72 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 99.87 3.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.379 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -80.61 12.26 3.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -92.26 -20.11 21.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.542 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.7 OUTLIER -60.02 115.01 11.23 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.256 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.94 3.45 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.633 0.889 . . . . 0.0 110.185 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.7 m80 -85.07 -12.33 53.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.4 9.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -92.53 84.57 5.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.27 134.48 34.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.59 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -91.65 109.77 21.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -93.56 114.88 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -99.01 142.85 29.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.6 161.56 14.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -145.21 -102.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.31 -154.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -90.43 106.61 18.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.88 -9.19 73.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.82 133.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.1 129.03 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.382 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.1 m -93.65 123.76 37.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.87 141.47 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.565 ' HZ3' ' HH ' ' A' ' 82' ' ' TYR . 79.1 tttt -146.13 146.65 30.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.69 14.84 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.1 t -79.94 -46.25 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -1.163 . . . . 0.0 109.558 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.67 -43.37 11.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.23 66.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 51.31 49.16 21.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.3 mtt180 -147.99 147.5 29.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.565 ' HH ' ' HZ3' ' A' ' 75' ' ' LYS . 80.2 m-85 -93.32 135.26 34.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.3 tp -64.95 145.19 56.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.203 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.86 135.34 18.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.9 ttm -98.18 138.89 34.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.455 -0.778 . . . . 0.0 109.453 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -92.48 178.0 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -80.54 -25.49 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.6 p30 -83.16 -1.56 53.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.475 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 93.69 2.26 65.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -78.36 115.18 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.6 mp -90.63 132.24 35.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.55 -172.04 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.483 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.31 152.66 47.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -145.03 170.01 16.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -83.47 -23.49 32.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 63.5 m -93.12 151.85 19.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.64 113.8 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -93.18 177.02 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.46 -17.74 61.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 22.9 mp0 -93.17 16.67 12.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.3 m -92.94 -7.18 46.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 68.1 m-85 -93.01 153.41 18.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 74.1 m-85 -146.47 116.38 7.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -56.11 159.4 3.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -125.13 141.77 51.9 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 97.86 3.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.72 131.33 42.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.39 -170.87 2.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.842 . . . . 0.0 109.385 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.87 -4.65 52.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.465 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -94.48 26.42 3.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.44 -0.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.4 m-85 -93.7 137.21 33.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.84 165.81 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 109.757 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.8 p -143.92 119.38 10.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.434 -0.791 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.66 113.54 25.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.75 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -97.21 143.23 28.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 109.302 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -60.67 162.18 6.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 109.383 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -92.68 -62.88 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -48.1 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.541 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.1 m-85 -93.89 60.46 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 80.4 p -56.96 -0.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.56 11.38 19.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.01 146.47 23.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.769 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.2 m-85 -109.31 169.82 8.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.656 -0.652 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.65 133.55 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.372 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.35 -175.69 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.09 165.82 26.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -94.24 177.72 5.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -92.88 -14.15 28.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.3 t -93.32 32.69 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.6 50.96 60.88 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -142.26 166.53 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -1.078 . . . . 0.0 109.513 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -90.62 120.25 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.656 ' HZ2' ' NE2' ' A' ' 143' ' ' GLN . 55.0 tttt -69.88 132.48 46.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.489 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.9 tp -53.34 134.45 39.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.0 109.352 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.57 -0.55 1.99 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.7 p -93.04 -29.65 15.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.586 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -89.73 -4.88 57.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.3 p -72.98 144.1 47.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.15 -179.96 45.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.05 169.92 5.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.883 1.722 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.25 -53.61 3.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.656 ' NE2' ' HZ2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -73.53 134.74 43.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -1.172 . . . . 0.0 109.523 179.959 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.44 7.67 16.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.437 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.439 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -64.1 -9.37 16.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.2 pt -90.14 -5.51 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.351 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.1 90.03 8.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -94.78 164.55 12.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.8 tp -141.82 70.98 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 109.17 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 106.35 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.953 1.769 . . . . 0.0 110.448 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.9 mtt -95.95 123.45 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.312 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.7 t -67.41 157.67 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.29 82.69 1.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -62.37 -66.06 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.499 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.81 24.53 1.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -92.2 116.06 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.14 -81.53 0.05 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -146.84 -94.33 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.137 . . . . 0.0 109.408 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.62 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -62.71 177.56 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 109.3 -179.958 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -147.1 62.38 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.339 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.9 t -145.19 66.17 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -57.22 -48.84 96.69 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 110.708 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.5 Cg_endo -65.04 -169.57 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 120.918 1.079 . . . . 0.0 110.059 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.99 86.18 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.329 -0.857 . . . . 0.0 109.541 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -89.23 -47.54 0.41 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.249 -0.907 . . . . 0.0 110.679 179.927 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.8 Cg_endo -67.47 113.97 3.1 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.085 1.19 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.65 97.68 0.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.0 -85.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.83 71.14 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.05 -129.44 3.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.2 t 50.43 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -1.185 . . . . 0.0 109.466 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.71 -63.45 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -129.19 -11.17 4.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.657 -0.908 . . . . 0.0 109.555 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 3.2 p90 38.05 66.94 2.25 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.74 -0.6 . . . . 0.0 110.445 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.71 168.24 10.48 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.533 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.19 145.22 87.88 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.61 1.54 . . . . 0.0 110.177 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.34 -74.6 0.22 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -66.63 -6.6 15.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -1.153 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.36 41.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.96 13.57 5.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.698 -0.626 . . . . 0.0 109.327 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.55 149.64 29.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.893 . . . . 0.0 108.781 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 168.02 3.09 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.098 1.199 . . . . 0.0 110.247 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -141.96 139.0 32.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.362 -0.836 . . . . 0.0 109.249 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.465 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -89.91 122.26 32.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.1 mt -84.95 97.24 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.621 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -95.75 113.8 25.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.31 118.07 23.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 109.377 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.85 -16.5 63.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.472 HD22 ' CB ' ' A' ' 144' ' ' LYS . 14.2 m120 -86.31 104.13 15.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.01 4.84 89.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 83.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -142.82 132.57 23.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.358 -1.083 . . . . 0.0 109.533 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.79 114.96 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.6 tp -47.65 143.09 4.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.591 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 17.1 ttt180 -150.15 117.1 5.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 126.34 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.137 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -87.97 152.02 50.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.23 -22.77 58.79 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.126 1.217 . . . . 0.0 110.266 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -74.75 8.8 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.23 -36.18 3.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.4 mtt-85 -47.15 164.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -138.35 123.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -152.61 151.38 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.84 162.77 25.42 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -146.69 148.97 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -1.127 . . . . 0.0 109.549 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -82.18 10.26 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.425 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -93.71 94.84 8.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.627 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -75.33 -5.14 43.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 p -94.48 16.72 14.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -91.14 114.28 61.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.14 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.88 2.5 0.58 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.615 0.877 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.591 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 42.8 m80 -86.29 -11.38 52.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.47 -4.73 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -76.65 83.76 3.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.947 . . . . 0.0 109.406 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.75 135.1 33.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.17 113.07 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -92.17 153.78 19.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.416 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -145.55 149.72 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.88 150.71 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.12 130.84 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.43 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 50.84 -107.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 6.7 ptm180 -154.91 129.79 9.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.77 29.12 73.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.95 96.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -1.16 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.58 129.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 0.0 109.596 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -92.69 121.69 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -89.95 148.44 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -148.77 140.98 24.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.73 145.64 20.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -79.5 -86.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.2 OUTLIER -47.36 -55.07 9.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -30.33 64.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 78' ' ' SER . 73.9 m-80 51.32 44.62 28.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 30.2 mtt180 -137.2 145.26 43.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.56 -0.713 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.17 136.21 33.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.461 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 55.2 tp -63.73 151.5 41.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.277 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.4 158.08 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 41.5 ttm -139.26 130.45 26.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.495 ' N ' ' CD ' ' A' ' 86' ' ' LYS . 3.1 mptp? -94.18 -171.22 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.44 -15.39 25.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.56 -5.51 59.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 94.36 7.78 60.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -85.15 108.21 17.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 6.3 mp -94.18 131.55 39.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 2.8 pp -150.07 173.14 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -105.03 159.62 15.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.702 . . . . 0.0 109.497 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -150.13 163.4 38.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.0 109.454 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -88.55 -34.18 17.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -93.66 130.71 39.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 10.7 p -81.93 103.5 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.42 ' C ' ' N ' ' A' ' 100' ' ' GLU . 69.7 p -96.0 165.2 12.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.43 -17.77 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.42 ' N ' ' C ' ' A' ' 98' ' ' THR . 2.5 mp0 -92.72 49.61 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -143.4 6.49 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -96.66 154.23 17.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 0.0 109.464 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 90.0 m-85 -150.02 115.68 5.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.95 152.27 7.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.201 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -125.13 89.86 3.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.626 . . . . 0.0 109.4 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -89.92 120.87 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.358 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 tp -91.6 119.92 31.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.311 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -84.92 -172.84 4.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 111' ' ' ASN . 13.0 p -92.78 -20.27 20.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.2 m120 -74.32 25.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.562 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.524 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.3 m120 60.65 -0.7 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.726 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 110' ' ' ASN . 46.4 m-85 -98.71 133.45 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.1 m120 -93.14 170.14 9.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 p -141.25 113.26 7.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.429 -0.795 . . . . 0.0 109.277 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -89.96 105.98 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 121' ' ' THR . 13.7 ttt180 -96.17 151.04 19.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -76.13 155.62 34.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -91.24 -74.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.4 tptt -52.34 -9.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.656 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 17.5 m-85 -142.96 67.19 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.371 -0.83 . . . . 0.0 109.495 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.523 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 23.4 p -65.12 5.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 120' ' ' TYR . 68.0 m -89.73 7.16 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.745 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.1 m-90 -154.62 167.59 29.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.76 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 12.7 m-85 -131.52 168.28 17.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.727 -0.608 . . . . 0.0 109.375 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.0 t -86.07 125.5 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 109.338 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.11 163.57 39.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.0 mt -119.56 161.69 20.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -79.27 -99.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.154 -0.966 . . . . 0.0 109.492 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.91 -36.7 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.463 ' CG2' ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -78.27 10.33 3.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 6.54 67.94 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.9 mp0 -84.82 167.54 15.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.536 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.5 p90 -93.73 120.1 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.619 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -69.91 126.42 29.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.7 tp -46.73 145.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -71.28 8.23 5.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.7 p -91.0 -34.65 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.428 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -90.0 -7.43 54.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 p -70.27 151.78 44.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 158.11 -179.31 33.9 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.95 169.99 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.848 1.699 . . . . 0.0 110.137 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.47 -49.63 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.577 ' N ' HE21 ' A' ' 143' ' ' GLN . 3.9 mm-40 -72.44 131.58 42.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' CB ' HD22 ' A' ' 36' ' ' ASN . 3.5 mtpt -85.02 3.68 37.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.44 -2.53 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.556 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.2 pt -97.29 -3.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.798 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.84 99.39 9.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 109.53 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.37 159.29 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.08 72.17 46.98 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.64 117.67 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.824 1.683 . . . . 0.0 110.538 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 15.1 mtt -96.54 127.19 42.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 0.0 109.263 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 t -70.09 161.82 29.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.59 85.09 1.63 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -72.87 -65.12 0.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.493 179.948 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.6 -134.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.445 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 47.58 67.08 0.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.5 141.2 0.39 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.31 174.39 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -1.166 . . . . 0.0 109.462 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.16 95.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -148.7 151.61 35.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.515 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 7' ' ' THR . 56.5 m -166.39 -1.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.215 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.9 mt -123.78 80.31 56.06 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 12' ' ' LEU . 6.2 Cg_exo -61.21 -170.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.395 1.397 . . . . 0.0 110.37 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.94 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.831 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 10' ' ' PRO . 4.8 tp -171.46 66.82 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.34 -168.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.744 1.629 . . . . 0.0 110.215 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -171.28 70.26 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 12.4 t70 -150.31 6.63 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.3 -116.86 5.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.22 1.08 0.5 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -88.61 57.51 4.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 20' ' ' ALA . . . -168.07 25.46 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 19' ' ' GLY . . . 69.46 24.4 5.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -1.121 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 56.8 67.9 2.4 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.718 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.48 168.13 11.94 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.647 1.565 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.17 146.4 81.75 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.535 1.49 . . . . 0.0 110.204 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.25 -38.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -147.58 13.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -1.143 . . . . 0.0 109.526 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.2 21.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 25' ' ' HIS . 9.5 mttm -93.32 -13.73 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.617 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -114.9 152.31 46.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.7 171.73 1.87 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.177 1.251 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -138.54 130.88 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.217 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.6 mtm-85 -84.99 116.95 23.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.78 95.66 9.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.184 179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -91.47 116.2 28.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 t -83.61 105.0 14.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 109.169 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -57.65 -23.61 52.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.601 -179.71 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 15.4 m-80 -78.15 104.95 9.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 77.79 4.73 85.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.54 86.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' CZ ' ' NH1' ' A' ' 53' ' ' ARG . 48.3 m-85 -144.26 135.46 25.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 109.285 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -92.34 137.27 32.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.9 tp -75.4 143.42 42.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.9 ttm180 -146.48 122.52 10.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.04 107.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 61.1 m-70 -66.95 151.95 96.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.098 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.04 -29.57 74.74 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.118 1.212 . . . . 0.0 110.398 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.97 5.59 4.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.461 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 -26.27 5.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -51.53 115.99 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -1.145 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.63 127.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 7.2 p-10 -154.13 152.25 30.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.32 25.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.1 152.49 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 109.531 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.607 ' NH1' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -76.13 -27.87 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.277 179.847 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -47.86 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -85.19 25.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.733 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 p -152.15 35.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.026 . . . . 0.0 109.991 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.41 140.02 25.41 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 108.911 179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.11 -4.68 4.07 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 121.1 1.2 . . . . 0.0 110.453 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 61' ' ' LYS . 69.4 m80 -94.49 -23.66 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.241 -179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -69.1 8.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.4 -179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 59' ' ' HIS . 3.2 mmmm -94.4 87.86 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 109.425 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.2 mt -93.84 135.08 35.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.618 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.24 109.53 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -93.84 151.06 19.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.27 150.4 36.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' OE1' ' A' ' 65' ' ' GLN . . . -94.31 150.76 19.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.78 -83.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.552 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.32 -147.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -92.29 127.03 37.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.412 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.55 33.99 68.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.57 101.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.69 -0.888 . . . . 0.0 109.372 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.1 m -103.09 126.03 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.686 . . . . 0.0 109.494 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 m -89.84 122.99 33.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.93 148.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -146.15 139.99 26.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.9 133.6 11.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 26.1 t -77.79 -72.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -39.97 96.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.61 63.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 18.5 m-80 50.95 50.82 18.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -147.44 147.97 30.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -91.54 127.93 37.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.58 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.64 149.82 20.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.366 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.32 170.25 18.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 23.9 ttm -138.29 131.37 30.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.0 109.433 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -85.86 -166.46 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -90.1 -33.88 16.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.56 -1.74 11.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.89 70.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.22 125.99 29.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -1.215 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 9.2 mp -92.13 135.83 33.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.42 -173.06 4.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.46 158.94 43.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.78 169.94 18.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -82.49 -27.98 31.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.8 m -92.87 160.13 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.516 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.1 t -92.83 156.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.482 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 72.1 p -147.35 160.06 42.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.59 -16.19 35.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -93.99 8.17 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.482 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 76.8 m -93.5 -4.57 50.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 109.79 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 93.5 m-85 -92.2 159.92 15.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 91.7 m-85 -150.94 119.13 6.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.32 147.57 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.974 -1.079 . . . . 0.0 109.334 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -125.33 97.77 5.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.674 -0.641 . . . . 0.0 109.318 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.72 128.42 41.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.568 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 17.5 tp -94.67 121.51 36.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.166 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.77 -175.72 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.51 ' C ' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -92.98 -25.06 18.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.635 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -74.17 18.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 109' ' ' SER . 2.5 m120 63.92 65.17 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -144.92 -168.87 3.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.133 179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -146.64 113.34 6.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.755 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -94.62 111.71 23.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.264 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.51 109.01 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -100.27 150.88 22.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.75 166.89 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.555 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -95.3 -57.82 2.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.388 179.913 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -82.08 -49.29 10.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.582 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.1 m-85 -91.7 61.25 4.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -57.11 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 0.0 110.711 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 120' ' ' TYR . 45.6 m -89.02 11.02 19.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.78 -1.2 . . . . 0.0 109.619 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.4 m-90 -152.48 159.38 43.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 21.2 m-85 -123.06 169.83 10.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.716 -0.615 . . . . 0.0 109.413 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.55 133.27 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.13 178.09 9.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 109.673 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.0 157.68 46.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.646 -0.659 . . . . 0.0 109.383 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -93.94 -166.58 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.334 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -93.87 -10.08 35.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.5 t -90.1 -7.86 52.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.97 60.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -93.77 173.95 7.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -1.11 . . . . 0.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 38.4 p90 -92.6 120.35 32.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -70.01 136.4 50.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.8 tp -59.78 127.49 32.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -49.16 -10.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 135' ' ' LEU . 21.4 p -75.51 -36.55 60.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -1.211 . . . . 0.0 109.642 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -89.96 -5.19 56.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.675 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.5 p -83.7 138.73 33.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.9 179.5 48.65 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.96 165.62 11.83 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.874 1.716 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.34 -58.87 3.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.505 ' C ' ' H ' ' A' ' 145' ' ' ALA . 26.2 mm-40 -70.75 120.83 16.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -1.191 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 19.1 mtmm -63.51 1.68 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -60.1 -4.66 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -99.86 4.75 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.86 109.82 21.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -113.0 162.06 16.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.6 tp -140.2 70.69 34.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.73 111.37 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.93 1.753 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.1 mtt -94.37 99.88 12.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.325 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 t -56.75 133.41 54.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.05 59.47 3.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -54.97 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.492 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.57 114.52 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER -91.18 59.14 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 179.988 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . -61.69 -144.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.64 -83.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 7' ' ' THR . 2.7 mp -98.0 62.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 1.2 p 48.49 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.838 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 m -140.06 108.48 5.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 109.433 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -103.55 163.85 16.61 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.822 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -57.22 109.51 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.383 1.389 . . . . 0.0 110.296 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.69 -172.45 3.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.23 68.35 5.31 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 109.668 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.3 149.64 90.74 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.784 1.656 . . . . 0.0 110.241 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -174.78 90.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -91.36 -28.08 17.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.936 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 55.03 2.82 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.34 -109.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 20' ' ' ALA . 3.3 t 59.2 55.9 4.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 109.445 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.05 -39.28 2.04 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 18' ' ' SER . . . 67.27 1.22 2.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -1.11 . . . . 0.0 109.488 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -82.57 -47.45 0.89 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 110.728 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.1 Cg_endo -66.93 168.05 18.15 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.96 1.107 . . . . 0.0 109.777 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.23 -170.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.648 1.565 . . . . 0.0 110.216 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.24 35.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -158.0 21.65 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.34 40.25 3.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.259 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -90.92 16.19 9.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -154.91 152.09 24.7 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.187 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.07 172.04 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.197 1.265 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -148.03 128.1 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.16 120.47 26.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.78 104.81 15.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.671 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -104.47 123.08 46.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.54 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.44 136.86 32.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HZ2' ' HZ1' ' A' ' 144' ' ' LYS . 12.5 ttpt -82.4 -25.77 33.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.95 105.07 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.38 4.93 89.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.45 87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.0 m-85 -143.81 136.44 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -1.067 . . . . 0.0 109.689 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -95.54 124.6 39.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.318 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.52 144.43 26.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.151 -0.968 . . . . 0.0 109.149 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -148.01 119.77 8.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.743 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -94.44 128.37 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.082 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -91.66 151.89 42.8 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.216 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.35 -27.79 77.11 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.178 1.252 . . . . 0.0 110.317 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -74.91 1.84 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.63 -31.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -50.2 118.5 3.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.463 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 148.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -169.57 -162.9 0.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.32 158.48 27.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.87 143.6 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -1.087 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -74.39 -1.39 20.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.66 92.55 8.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -85.17 56.42 3.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.2 p -155.49 13.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 110.096 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.6 m-20 -93.25 145.68 30.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.983 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.56 0.82 1.25 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.106 1.204 . . . . 0.0 110.338 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' ' 61' ' ' LYS . 77.5 m80 -91.35 -29.21 17.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 110.187 -179.233 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -69.16 4.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.971 -1.08 . . . . 0.0 109.351 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' H ' ' C ' ' A' ' 59' ' ' HIS . 10.7 mtpt -93.02 82.87 4.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -93.39 134.04 36.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.387 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -94.04 123.27 37.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.6 mp -91.94 156.34 17.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -144.94 125.04 13.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.04 165.29 22.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.56 -98.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.391 -0.818 . . . . 0.0 109.206 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -84.67 -172.62 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.049 -1.032 . . . . 0.0 109.393 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 10.9 mpt_? -72.96 107.74 5.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.9 68.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.5 t -92.97 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.22 170.63 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.505 ' OG ' ' CD2' ' A' ' 102' ' ' PHE . 4.6 m -148.94 134.99 19.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.1 mt -93.14 155.94 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.36 139.8 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.62 127.33 9.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.94 -61.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.461 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -27.05 68.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.88 -23.98 21.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 51.66 51.2 17.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -148.08 145.96 28.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -96.03 125.09 40.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -58.98 145.1 42.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.244 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.1 130.83 14.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.435 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 ttm -90.5 104.25 16.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.91 166.46 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.527 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -78.51 -22.07 47.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -73.63 -5.85 43.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.95 -7.75 70.12 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -77.95 123.91 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.344 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.8 mp -89.77 124.26 34.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.209 -0.932 . . . . 0.0 109.128 179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.41 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.1 pp -148.43 -170.33 3.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 109.611 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.16 161.13 39.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 p -146.49 153.19 40.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -59.11 -38.37 79.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.87 157.67 20.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 t -93.1 117.45 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.542 ' H ' ' HG ' ' A' ' 101' ' ' CYS . 60.7 p -89.19 173.01 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.46 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -94.13 24.89 4.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.558 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.542 ' HG ' ' H ' ' A' ' 98' ' ' THR . 18.0 m -93.87 -8.81 39.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.583 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' OG ' ' A' ' 73' ' ' SER . 77.8 m-85 -93.99 158.56 15.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.593 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 86.7 m-85 -148.13 116.58 6.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.35 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -55.1 124.56 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -88.48 147.94 24.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -148.1 120.13 8.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.515 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.9 131.0 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -175.69 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -90.96 -4.48 56.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.466 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 112' ' ' TYR . 12.8 m-80 -93.48 27.89 2.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.501 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 63.64 -7.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.488 -0.758 . . . . 0.0 110.126 179.807 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.5 m-85 -84.14 -173.06 4.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.27 167.12 24.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -142.43 169.96 16.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.301 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -143.83 110.93 5.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.359 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -94.94 145.52 24.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.5 ' HG ' ' N ' ' A' ' 118' ' ' ARG . 4.4 t -63.98 162.12 14.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' N ' ' HG ' ' A' ' 117' ' ' SER . 1.7 ttt-85 -92.36 -63.71 1.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.714 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -64.9 -47.8 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.731 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.5 m-85 -99.59 63.85 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.57 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.0 p -59.76 2.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.9 m -89.81 14.02 13.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.041 -1.037 . . . . 0.0 109.772 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.07 145.75 22.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.948 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -107.71 166.93 10.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.36 125.49 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.67 159.06 40.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.8 mt -108.1 179.39 4.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.658 -0.651 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -95.24 -112.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.479 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -147.38 -32.59 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 -179.889 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -79.31 3.6 17.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.492 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.64 56.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -94.12 167.5 11.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -86.64 120.36 27.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.67 ' HZ2' HE21 ' A' ' 143' ' ' GLN . 63.8 tttt -69.84 133.71 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.9 tp -59.15 138.04 57.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.227 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -70.95 11.9 2.39 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 135' ' ' LEU . 99.4 p -94.57 -37.78 11.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -1.15 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -88.78 -6.05 57.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.3 p -70.97 158.01 37.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.508 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 161.35 -179.47 36.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.89 159.5 29.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.883 1.722 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.43 -27.48 9.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.67 HE21 ' HZ2' ' A' ' 134' ' ' LYS . 38.2 mt-30 -84.82 128.28 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HZ1' ' HZ2' ' A' ' 35' ' ' LYS . 6.7 mtmp? -82.78 -3.75 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.419 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.84 41.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pt -84.76 2.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.7 mt -91.62 90.52 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.83 166.91 11.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.6 tp -141.93 70.42 24.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.722 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.01 105.75 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.791 1.661 . . . . 0.0 110.418 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.6 mtt -94.81 125.36 39.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.378 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 137.57 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.26 56.8 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.517 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 154' ' ' LYS . 9.7 mtpm? -81.67 -57.34 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.561 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.296 0.569 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.13 -50.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 53.57 85.17 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' GLU . . . -79.03 65.38 3.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 48.15 -173.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.154 . . . . 0.0 109.446 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -49.67 142.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.24 121.6 3.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.82 127.29 31.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.54 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.51 116.78 66.78 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 108.963 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 -178.4 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.563 0.842 . . . . 0.0 110.211 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.44 52.86 0.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.877 . . . . 0.0 109.65 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -89.69 -47.42 0.4 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 179.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.2 Cg_endo -68.69 86.9 0.44 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 120.994 1.129 . . . . 0.0 109.894 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 53.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.359 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -24.05 63.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.87 6.04 73.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.87 17.85 14.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -90.5 58.42 3.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.141 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.65 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.29 -76.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -143.16 68.66 17.79 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.52 114.23 2.62 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.728 1.618 . . . . 0.0 109.843 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.48 99.89 0.21 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.693 0.929 . . . . 0.0 110.154 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.54 36.21 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.561 ' CE1' ' HZ3' ' A' ' 154' ' ' LYS . 84.2 t60 -146.4 53.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -1.125 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -140.23 33.2 1.91 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 109.396 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -95.52 19.03 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.825 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.85 149.29 25.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 109.051 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.01 154.96 41.51 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.178 1.252 . . . . 0.0 110.243 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -124.67 122.61 37.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.95 118.62 24.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.82 102.89 13.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.586 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -95.82 123.45 39.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.322 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -91.88 117.56 29.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.4 -14.68 57.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.0 m-20 -83.4 105.02 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.32 4.86 65.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.92 75.65 0.21 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.41 133.0 51.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.698 -0.883 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.77 117.86 30.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 36.6 tp -48.74 137.58 12.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.249 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 7.2 ttt180 -148.23 119.97 8.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.645 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.8 113.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.103 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -76.18 149.47 82.17 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.525 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.1 Cg_endo -58.52 -24.05 67.63 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.13 1.22 . . . . 0.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 18.6 p30 -74.9 2.22 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.39 -33.76 4.61 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.14 114.75 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.4 125.03 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 4.7 p-10 -155.37 -152.96 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -144.07 161.34 27.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.29 142.63 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 109.505 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -77.1 1.48 17.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.31 83.84 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 55.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 m -145.43 6.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 109.872 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' C ' ' H ' ' A' ' 59' ' ' HIS . 28.2 m-20 -94.27 138.93 22.34 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.91 . . . . 0.0 109.12 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -1.36 1.76 Allowed 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 121.069 1.179 . . . . 0.0 110.373 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 78.1 m80 -83.37 -22.12 32.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 110.036 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -75.95 7.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -95.81 87.36 4.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.44 135.27 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.11 109.6 21.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 109.266 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.7 mp -90.85 154.46 19.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -139.03 142.04 38.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.495 -0.753 . . . . 0.0 109.143 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.26 28.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.551 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 69' ' ' ARG . 1.1 tp10 -144.42 143.42 30.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 51.4 -90.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.405 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.0 ttm180 -147.82 -91.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.85 9.16 57.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.59 97.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -1.193 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.42 126.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -94.85 130.18 41.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.56 150.1 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.558 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -148.84 130.27 14.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.75 135.74 14.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.05 -80.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -1.103 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.7 t -47.66 -57.27 5.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.74 -25.81 63.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.9 m120 51.24 45.54 27.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -136.98 148.66 47.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.327 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -91.02 130.84 36.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.1 138.03 58.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.139 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.0 144.59 25.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.35 144.16 28.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.767 . . . . 0.0 109.357 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.9 174.18 11.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -78.69 -15.88 57.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.29 -42.51 9.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.517 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.13 -8.93 1.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -75.15 125.94 30.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -1.105 . . . . 0.0 109.501 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.52 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.5 mp -92.63 141.22 28.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.928 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.22 -171.31 3.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -135.91 114.79 12.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 109.328 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 p -98.2 170.09 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -38.4 14.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.448 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.34 159.73 15.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 t -93.02 149.11 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 p -147.1 172.46 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -47.88 -35.79 11.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 19.4 mt-10 -88.73 67.03 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 74.6 m -153.39 15.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 46.4 m-85 -124.6 158.4 33.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.706 -0.621 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 35.1 m-85 -144.74 122.9 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.398 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.59 109.48 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' OE2' ' CE1' ' A' ' 115' ' ' TYR . 37.4 tt0 -85.64 150.2 24.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -146.42 98.36 3.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.24 131.9 48.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.48 -166.82 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.339 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 111' ' ' ASN . 74.4 m -94.64 -20.9 19.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.786 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.0 OUTLIER -80.23 25.92 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.2 m120 62.94 -7.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.463 -0.773 . . . . 0.0 110.466 179.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 110' ' ' ASN . 42.7 m-85 -89.9 135.75 33.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.881 -1.137 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.59 ' N ' HD21 ' A' ' 113' ' ' ASN . 1.0 OUTLIER -93.75 168.74 10.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.733 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.1 p -143.66 122.69 12.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.458 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 85.1 m-85 -94.19 114.94 27.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 19.0 ttt180 -98.19 142.57 29.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 179.748 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.437 ' C ' ' H ' ' A' ' 120' ' ' TYR . 34.7 ttt180 -94.99 -72.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -54.64 -9.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.7 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.538 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.8 m-85 -140.9 60.79 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 16.8 p -58.33 -1.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.726 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.88 10.3 24.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.53 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.08 142.49 19.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 109.737 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.9 m-85 -106.48 169.7 8.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.7 t -89.52 134.51 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.44 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -147.63 162.19 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.557 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.05 161.27 23.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -85.85 -170.02 2.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -92.44 -29.71 16.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -73.75 1.62 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.48 66.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -86.69 168.65 13.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -1.158 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.2 p90 -92.21 120.2 32.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.517 ' NZ ' ' OE1' ' A' ' 143' ' ' GLN . 48.1 tttt -69.94 135.76 49.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.5 tp -47.54 160.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.202 -180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.83 16.81 55.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.9 p -115.07 -27.74 7.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.683 -0.892 . . . . 0.0 109.638 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -87.64 -4.98 58.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.694 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 p -70.71 166.69 20.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 154.26 179.58 29.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.93 166.35 10.57 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.85 1.7 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.81 -56.12 2.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.8 mt-30 -70.35 133.91 47.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 109.464 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.486 ' C ' HD22 ' A' ' 36' ' ' ASN . 15.3 mtpp -85.14 3.84 37.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.594 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.75 -4.24 1.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 144' ' ' LYS . 24.2 pt -93.99 -4.36 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -0.845 . . . . 0.0 109.557 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.67 107.97 17.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.02 162.77 16.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.1 tp -140.29 71.18 33.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.96 105.09 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.901 1.734 . . . . 0.0 110.435 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.4 mtm -100.68 128.96 46.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.791 . . . . 0.0 109.408 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 t -70.22 120.75 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.08 59.89 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.561 ' HZ3' ' CE1' ' A' ' 25' ' ' HIS . 50.9 mttm -55.01 -91.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.451 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.09 100.0 3.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 1.6 mm-40 -57.64 105.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.551 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.09 -151.41 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -1.181 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.469 ' CG2' ' N ' ' A' ' 7' ' ' THR . 95.2 mt -84.57 166.02 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 9' ' ' LEU . 8.5 p -47.54 141.76 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.73 16.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' H ' ' C ' ' A' ' 7' ' ' THR . 9.1 mt -92.01 152.39 42.79 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 108.86 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.57 -175.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.119 1.212 . . . . 0.0 110.163 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.27 151.82 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 mt -139.93 68.48 35.61 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.463 -0.773 . . . . 0.0 109.607 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.43 -171.86 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.74 1.626 . . . . 0.0 110.219 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 57.35 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.88 -30.47 70.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.16 -106.09 0.36 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -172.64 34.49 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -146.99 65.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -1.139 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.59 36.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.1 21.85 6.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -1.117 . . . . 0.0 109.529 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.502 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -77.67 -48.47 2.26 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.314 -0.866 . . . . 0.0 110.789 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 1.7 Cg_endo -67.12 168.08 18.39 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 120.909 1.073 . . . . 0.0 109.747 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.79 133.52 56.69 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.644 1.563 . . . . 0.0 110.055 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.18 -45.63 0.03 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 27' ' ' LYS . 4.9 p80 -146.82 28.66 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.464 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.569 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 51.2 m-85 -72.56 16.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 25' ' ' HIS . 12.3 mttp -90.75 30.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -149.01 152.18 36.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.027 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.54 171.64 1.31 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.233 1.289 . . . . 0.0 110.278 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.569 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 83.7 mttt -149.98 139.41 21.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.3 mtm-85 -92.98 114.47 27.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.5 mt -85.0 91.25 8.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -86.29 125.52 33.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.5 t -89.68 123.67 33.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.688 ' HZ2' ' HZ1' ' A' ' 144' ' ' LYS . 4.8 ttpt -72.5 -14.55 61.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.573 HD22 ' CB ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -86.2 104.99 16.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.797 -179.66 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.53 6.23 80.31 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.38 77.68 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -134.29 138.15 44.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.598 -0.942 . . . . 0.0 109.606 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -96.47 158.81 15.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 17.9 tp -85.23 139.21 31.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -146.33 111.69 5.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.9 mt -89.85 133.89 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.194 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.524 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.8 m-70 -89.01 149.65 43.71 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 109.184 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.4 Cg_endo -59.94 -23.27 72.16 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.166 1.244 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -15.3 57.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.818 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.78 -37.12 3.39 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.5 mtt-85 -46.4 114.89 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -1.159 . . . . 0.0 109.79 -179.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -100.1 128.56 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.531 -0.731 . . . . 0.0 109.459 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 3.1 p30 -155.69 -150.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -146.89 163.63 28.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.42 154.46 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -81.1 -14.35 57.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' OE1' ' OG ' ' A' ' 56' ' ' SER . 6.3 mm-40 -78.95 87.6 4.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -81.99 17.84 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 109.421 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' OG ' ' OE1' ' A' ' 54' ' ' GLU . 13.3 p -100.58 3.32 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.86 133.71 28.65 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 109.164 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -4.16 4.21 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.84 1.026 . . . . 0.0 110.257 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -74.83 -10.95 59.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' LYS . 3.2 pt -89.26 -7.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.35 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -80.0 90.16 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.88 135.2 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.96 104.92 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.3 mp -89.13 153.34 21.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.44 126.93 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.94 121.92 26.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.97 -29.37 14.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.492 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.03 -167.59 2.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -82.42 -0.79 47.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.92 28.92 1.27 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 t -145.49 145.12 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -1.101 . . . . 0.0 109.431 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.01 121.67 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 109.521 179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -93.28 123.34 36.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.451 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.1 mt -91.44 147.46 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -145.8 132.53 19.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.85 137.65 17.6 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.78 -65.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.471 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 t -63.3 -49.8 72.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.918 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.06 -21.55 66.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 47.65 45.0 17.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.842 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 40.7 mtp180 -141.08 146.82 37.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.464 -0.773 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.84 136.8 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.03 149.23 45.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.24 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.64 129.26 13.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 ttm -96.41 130.85 43.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.88 -175.38 4.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -92.72 -23.47 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 p30 -82.78 -40.35 20.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 143.57 -7.92 2.02 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -75.57 120.64 21.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.555 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 8.6 mp -92.42 136.34 33.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 1.1 pp -147.01 -171.9 3.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.14 164.36 30.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.371 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 m -149.92 170.02 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -83.09 -46.16 13.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.8 116.03 28.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -52.1 165.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.6 p -147.1 -173.05 4.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.405 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -25.68 62.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.4 59.16 3.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.2 m -147.25 10.11 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.9 m-85 -94.93 152.18 18.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.1 m-85 -150.04 116.59 5.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -69.31 127.42 33.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.01 96.52 10.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.701 ' HE ' HH22 ' A' ' 116' ' ' ARG . 0.0 OUTLIER -91.96 114.31 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.2 128.54 34.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -91.71 -177.44 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -92.62 45.06 1.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.9 m-20 -146.89 28.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.27 -0.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.897 . . . . 0.0 109.711 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.6 m-85 -96.61 130.98 43.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.373 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.56 168.71 11.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.4 p -145.8 119.6 9.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.12 106.31 18.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.701 HH22 ' HE ' ' A' ' 106' ' ' ARG . 33.5 ttm180 -93.87 146.5 23.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 118' ' ' ARG . 4.5 t -72.21 151.73 42.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.374 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' N ' ' HG ' ' A' ' 117' ' ' SER . 12.9 ttt180 -91.29 -75.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 13.9 tttp -51.14 -9.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.863 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 118' ' ' ARG . 14.7 m-85 -143.08 64.06 1.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.7 p -62.11 1.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 120' ' ' TYR . 15.4 m -89.97 11.33 20.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.493 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.04 140.54 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.943 . . . . 0.0 109.783 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.479 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 26.8 m-85 -106.37 165.4 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -91.41 119.88 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -150.56 147.17 27.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.56 178.36 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -95.53 -169.45 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -93.77 -13.87 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.9 8.37 39.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.427 179.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.33 3.65 84.35 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.85 173.14 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -1.128 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.0 p90 -92.82 120.32 33.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -69.95 131.49 44.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.395 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 137' ' ' SER . 13.7 tp -47.34 133.16 12.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -58.97 -2.3 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 135' ' ' LEU . 22.0 p -92.36 -57.43 2.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.193 . . . . 0.0 109.498 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 137' ' ' SER . 23.1 mtpp -61.05 -8.19 3.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 136' ' ' GLY . 11.6 p -71.06 158.14 36.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.81 179.65 34.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.97 175.77 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.833 1.688 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.63 -56.14 5.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.86 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -1.151 . . . . 0.0 109.357 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.688 ' HZ1' ' HZ2' ' A' ' 35' ' ' LYS . 8.6 mtmp? -85.03 3.48 38.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.43 ' N ' ' OD1' ' A' ' 36' ' ' ASN . . . -65.12 -10.47 31.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.588 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -5.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -83.94 87.98 7.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -92.94 167.75 11.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.5 70.63 32.12 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.446 -0.784 . . . . 0.0 109.391 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.38 99.6 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.852 1.701 . . . . 0.0 110.335 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.6 mtm -96.25 122.3 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.425 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.7 t -62.23 148.66 44.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.51 57.05 4.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -74.45 -85.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.441 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.478 179.989 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.96 -87.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.69 -170.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.18 -66.01 1.74 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 6' ' ' ILE . 11.1 tt0 -158.42 -141.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -1.109 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.4 ' H ' ' CG ' ' A' ' 5' ' ' GLU . 8.0 mt -47.39 149.67 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.13 153.28 18.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -91.11 57.21 3.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 11' ' ' ALA . 1.2 mt -51.43 150.04 6.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.808 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.23 76.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.051 1.167 . . . . 0.0 110.238 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 42.4 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.133 -0.979 . . . . 0.0 110.199 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.54 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -91.61 -47.07 0.35 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.0 Cg_endo -66.86 97.23 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.035 1.156 . . . . 0.0 110.17 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -172.83 83.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.37 -41.02 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.6 -147.51 18.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.84 -179.78 27.81 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.3 m -134.75 -126.88 0.16 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.37 1.081 . . . . 0.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.22 -57.75 5.49 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 -88.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -1.136 . . . . 0.0 109.338 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.72 64.91 8.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.865 . . . . 0.0 109.916 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.79 167.9 16.41 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.451 1.434 . . . . 0.0 109.754 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -61.32 92.14 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.636 1.557 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 23' ' ' PRO . . . -61.99 -128.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.642 ' CD2' ' H ' ' A' ' 25' ' ' HIS . 0.1 OUTLIER -99.8 64.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.544 -0.974 . . . . 0.0 109.349 -179.959 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -88.14 4.92 43.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -99.43 -13.64 19.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.78 -179.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -114.75 152.32 46.24 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.664 . . . . 0.0 109.247 -179.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.02 157.65 24.2 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.264 1.309 . . . . 0.0 110.204 179.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -135.8 131.97 36.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.679 . . . . 0.0 109.19 179.785 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -84.96 118.67 24.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.526 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 23.9 mt -84.87 98.01 10.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 117.61 30.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.99 102.58 12.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.31 -27.97 50.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 14.8 m120 -76.95 103.2 6.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.21 4.73 89.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.97 85.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.2 m-85 -143.39 132.82 23.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.078 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -93.28 129.02 39.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.8 tp -60.53 142.25 55.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 109.245 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 48.5 ttt180 -146.85 115.62 6.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.65 115.5 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.284 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -75.42 151.74 85.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.007 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.05 -28.79 71.35 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 121.202 1.268 . . . . 0.0 110.468 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.56 4.06 10.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.87 -31.44 5.29 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -46.96 114.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -1.112 . . . . 0.0 109.519 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.23 129.53 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -155.61 149.89 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 155.39 22.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.54 152.92 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -82.51 -12.0 58.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.534 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.33 101.57 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.96 -5.01 59.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -20.19 22.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.536 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -51.95 112.3 3.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.925 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.57 3.72 0.45 Allowed 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 120.638 0.892 . . . . 0.0 110.129 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.52 ' H ' ' C ' ' A' ' 57' ' ' ASP . 41.9 m80 -86.92 -15.25 39.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -76.76 -2.37 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -82.48 86.02 6.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.02 135.28 33.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.45 108.48 19.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.434 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 10.5 mp -94.08 149.14 21.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.707 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -141.62 134.54 28.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.371 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.76 131.68 38.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -97.13 -76.72 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -95.85 -121.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -94.03 -96.6 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.1 3.38 46.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.0 125.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -1.188 . . . . 0.0 109.424 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.76 169.59 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 109.452 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -142.88 128.42 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.7 149.74 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -147.12 117.93 7.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.56 130.1 11.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.88 -74.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -1.121 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 t -49.12 -55.31 12.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.38 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -26.82 67.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.392 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m120 51.34 50.31 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 93' ' ' ALA . 8.7 mtp180 -146.68 147.2 30.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.948 . . . . 0.0 109.598 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.18 130.98 36.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.15 140.94 58.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.01 139.65 21.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -97.45 131.46 44.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.47 -0.769 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -73.2 -174.19 1.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.78 -16.79 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.5 p30 -90.23 -38.86 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.04 -10.88 2.31 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -72.8 124.8 26.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 91' ' ' LEU . 10.1 mp -93.32 137.74 32.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -149.74 -174.23 4.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 179.931 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' ' 81' ' ' ARG . . . -143.67 132.18 22.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.295 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -110.24 168.77 9.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -84.51 -1.13 55.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.14 136.77 52.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.723 -0.611 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.468 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 14.9 p -80.98 109.02 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 p -97.53 179.12 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.415 -0.803 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.13 -21.58 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -93.09 53.16 1.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 51.0 m -141.61 5.6 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.8 . . . . 0.0 109.529 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 77.3 m-85 -93.2 153.52 18.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.9 m-85 -149.03 115.1 5.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -61.62 107.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -86.54 94.1 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -94.98 124.1 38.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.43 133.23 35.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.613 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 110' ' ' ASN . 2.1 mt-10 -94.71 151.2 19.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.513 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 m -63.58 1.9 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.496 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 112' ' ' TYR . 36.1 t-20 -93.38 25.77 3.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER 61.64 -3.63 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.887 179.98 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.1 m-85 -94.59 -174.87 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 112' ' ' TYR . 3.9 m-80 -147.64 164.83 32.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 p -143.82 120.63 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -93.8 105.43 17.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -93.25 139.16 30.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -70.27 147.93 49.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 120' ' ' TYR . 45.6 ttt180 -81.75 -73.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.0 tptt -51.64 -9.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 118' ' ' ARG . 13.6 m-85 -139.12 68.6 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.713 . . . . 0.0 109.176 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.3 p -63.75 -16.36 60.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.4 m -89.92 18.85 5.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.983 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -148.47 123.54 10.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.848 . . . . 0.0 109.636 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 35.4 m-85 -100.7 164.48 11.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.18 139.64 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.02 -175.25 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -141.14 166.39 24.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -94.21 177.86 5.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -91.69 -7.52 49.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 109.315 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.81 -0.68 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.4 -0.54 65.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -90.42 166.3 13.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 109.369 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.532 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 21.6 p90 -85.42 120.08 26.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.35 123.0 20.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.4 tp -47.92 160.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.178 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.424 ' O ' ' OG1' ' A' ' 139' ' ' THR . . . -77.02 -42.41 19.87 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -59.03 -17.58 26.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.689 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.31 -9.72 46.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.802 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 54.7 p -80.51 177.51 8.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -0.975 . . . . 0.0 109.565 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.8 178.69 22.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.439 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -60.77 165.41 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.864 1.709 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.16 -37.6 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 141' ' ' PRO . 7.0 mm100 -66.52 121.82 16.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -1.142 . . . . 0.0 109.501 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 21.1 mtmt -80.97 -7.85 59.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.75 -6.46 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.436 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.3 pt -95.06 8.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.603 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.14 98.39 10.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.04 164.67 11.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.66 -0.65 . . . . 0.0 109.495 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -141.93 70.29 24.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.41 -0.806 . . . . 0.0 109.389 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.58 107.73 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.88 1.72 . . . . 0.0 110.478 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.1 mtt -98.41 117.14 32.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.501 -0.749 . . . . 0.0 109.38 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.427 ' CB ' ' ND1' ' A' ' 25' ' ' HIS . 31.3 t -69.95 142.65 52.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.04 58.86 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -55.43 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.95 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.74 170.58 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.114 1.21 . . . . 0.0 110.109 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HE3' HD22 ' A' ' 64' ' ' LEU . 6.4 mtmp? -142.78 132.42 23.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 5.3 mtm-85 -84.83 122.52 29.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.64 98.94 10.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 109.485 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -97.85 117.15 31.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.5 t -82.18 137.71 34.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -26.38 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.956 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.7 m-20 -74.43 105.01 5.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 109.801 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.53 5.85 88.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.73 83.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 46.3 m-85 -142.32 137.52 30.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -1.083 . . . . 0.0 109.505 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 29.1 m-85 -94.46 145.96 24.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.556 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -80.26 145.3 32.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.255 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.417 HH11 ' CG ' ' A' ' 57' ' ' ASP . 2.9 ttt180 -148.4 122.29 9.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.499 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -90.04 109.1 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.172 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -66.13 152.26 94.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.147 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.85 -28.88 79.12 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.203 1.269 . . . . 0.0 110.242 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.82 6.55 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.29 -31.97 3.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -47.65 120.99 3.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -1.12 . . . . 0.0 109.461 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.533 HG21 ' CD1' ' A' ' 83' ' ' LEU . 62.5 t -91.34 129.77 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -147.87 -159.62 1.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.57 151.61 23.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.8 151.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' LYS . 25.1 mtm180 -77.66 -31.39 52.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 56' ' ' SER . 2.2 mm-40 -50.52 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.555 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -76.38 -1.29 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.4 p -91.37 -20.2 22.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -44.47 107.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 0.0 109.462 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.55 5.54 0.33 Allowed 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 120.797 0.998 . . . . 0.0 110.54 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.1 m80 -93.39 -18.19 22.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.77 -3.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -74.82 84.62 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.25 134.93 33.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -91.65 104.92 17.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.336 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.38 152.69 19.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.68 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.13 149.16 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.39 149.39 22.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -149.03 143.04 25.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 52.95 -119.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.377 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -147.45 113.24 5.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.74 -18.46 55.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 72' ' ' VAL . 69.0 t -92.51 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -1.163 . . . . 0.0 109.477 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 72' ' ' VAL . 19.7 m -146.42 131.17 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -92.42 118.29 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.24 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -145.56 144.77 30.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.46 137.52 13.64 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.98 -68.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -1.132 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 t -66.62 -48.88 68.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.91 -24.38 66.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.38 46.43 26.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.915 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.04 149.36 34.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -93.16 137.46 32.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.533 ' CD1' HG21 ' A' ' 49' ' ' VAL . 57.4 tp -65.14 143.84 57.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.896 . . . . 0.0 109.29 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.22 18.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.591 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.6 ttm -95.22 150.47 20.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -92.64 -170.01 2.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.592 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.4 mp0 -93.46 -32.02 14.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -79.89 -37.63 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 142.55 -5.01 2.03 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -73.26 117.87 15.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -91.76 133.14 35.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.0 pp -149.96 172.95 14.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.598 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -114.87 164.84 13.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.414 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -150.02 169.74 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -84.01 -35.83 23.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -94.13 138.69 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.1 p -90.26 117.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.403 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 11.0 p -103.08 173.62 6.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -15.64 23.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.339 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.83 51.24 1.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 98' ' ' THR . 7.7 m -140.89 5.23 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -93.12 160.46 14.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -150.0 114.85 5.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -65.41 118.83 9.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -93.4 98.18 11.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.611 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.13 100.34 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.337 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 113' ' ' ASN . 4.4 tt -77.6 129.45 35.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.71 -171.34 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -91.34 2.96 56.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.9 m-80 -94.78 24.78 4.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.21 -2.35 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.975 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.6 m-85 -91.55 -175.79 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 109.491 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.499 HD21 HD12 ' A' ' 107' ' ' LEU . 5.2 m120 -146.95 158.13 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.565 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 p -134.29 118.38 17.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.64 -0.662 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.03 105.28 17.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -92.91 142.61 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.355 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 t -71.36 147.81 47.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -88.77 -66.67 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 tptp -49.1 -18.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.6 m-85 -144.31 77.69 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 82.3 p -66.01 5.96 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 3.9 m -89.52 5.38 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.526 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 5.3 m-90 -148.39 170.45 17.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.028 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 17.0 m-85 -137.09 162.67 32.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.96 122.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.688 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -153.12 138.17 17.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.35 171.94 8.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -87.64 -115.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -143.18 7.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 109.546 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.22 11.23 8.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.57 64.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -93.13 159.23 15.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 38.1 p90 -91.15 120.06 31.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -69.88 132.28 45.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.638 ' O ' HG23 ' A' ' 139' ' ' THR . 13.5 tp -47.8 150.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -70.94 -10.43 68.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.557 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.1 p -91.03 -32.22 15.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.155 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -81.16 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 135' ' ' LEU . 70.4 p -79.4 156.32 27.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.14 -179.75 38.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.91 171.48 3.7 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.894 1.729 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.29 -50.54 3.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.07 134.28 40.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 14.1 mtmt -83.96 6.52 21.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.688 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.05 -6.46 8.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 113' ' ' ASN . 21.0 pt -90.45 -6.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.16 97.51 9.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -98.86 159.65 14.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.6 tp -139.13 71.53 40.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.504 -0.748 . . . . 0.0 108.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HB2' ' HZ2' ' A' ' 30' ' ' LYS . 5.9 Cg_exo -61.83 116.45 3.45 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.877 1.718 . . . . 0.0 110.715 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.8 mtt -95.99 121.2 37.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 0.0 109.168 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.9 t -69.23 135.72 50.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 109.479 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.51 168.53 2.13 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.134 1.223 . . . . 0.0 110.097 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.9 mtmt -138.9 139.84 38.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -91.52 120.07 32.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 22.8 mt -84.63 101.98 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -95.56 115.83 27.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.544 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.89 111.31 17.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.213 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -59.09 -30.39 68.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.63 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.0 m120 -78.64 105.23 9.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 110.122 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 81.65 4.63 90.31 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 86.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.1 m-85 -142.66 134.5 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -94.14 123.84 37.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 51.7 tp -57.79 141.83 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.491 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 25.4 ttt180 -147.28 117.93 7.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.5 mt -93.17 110.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -71.75 151.81 93.35 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.145 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.0 Cg_exo -57.04 -27.83 75.68 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.126 1.218 . . . . 0.0 110.238 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -74.95 0.45 15.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -29.62 7.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.59 114.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -1.153 . . . . 0.0 109.429 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.56 129.95 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 109.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 2.9 p30 -166.46 151.01 7.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.99 159.0 24.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 m -146.17 148.63 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -1.17 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -76.82 -9.84 58.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.43 84.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.477 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 2.51 3.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.89 -20.37 20.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -49.89 111.2 1.95 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.67 5.38 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.663 0.909 . . . . 0.0 110.245 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 47.3 m80 -94.24 -14.79 25.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.35 9.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 59' ' ' HIS . 2.9 mmmm -91.12 88.0 6.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' A' ' 32' ' ' LEU . 11.0 mt -90.08 134.99 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -95.03 110.23 22.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.581 HD22 ' HE2' ' A' ' 30' ' ' LYS . 10.2 mp -95.47 144.57 25.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.813 . . . . 0.0 109.491 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.86 134.16 47.35 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 121.79 31.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.59 -85.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.6 mt-10 -94.86 149.57 21.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.883 . . . . 0.0 109.318 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.7 mtt-85 -57.58 84.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 140.82 -1.83 2.07 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -138.86 145.57 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -1.046 . . . . 0.0 109.414 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.7 m -138.9 133.83 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -94.61 127.07 40.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.452 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 mt -93.41 144.49 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -146.52 143.47 28.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.68 135.59 12.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.92 -83.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -1.141 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.9 t -48.88 -43.99 39.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.88 65.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 49.65 50.14 18.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.4 mtp180 -146.0 147.08 31.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.95 127.29 36.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.9 144.85 31.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 109.33 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -145.17 170.14 16.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.16 134.65 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.5 -169.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -91.75 -11.16 37.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.413 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -92.6 -42.54 9.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA3' ' H ' ' A' ' 136' ' ' GLY . . . 146.86 -9.97 1.38 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -66.98 127.56 33.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -1.167 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.9 mp -93.47 134.51 35.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.7 pp -150.07 143.74 25.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.897 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.96 158.47 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.763 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.71 161.85 38.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.98 -47.35 37.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 m -85.07 139.42 31.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.23 152.16 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -148.01 -163.65 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.489 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -55.39 -51.64 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 85' ' ' MET . 71.7 mt-10 -74.2 77.23 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 36.9 m -155.2 -33.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 38.2 m-85 -84.68 156.05 21.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 68.4 m-85 -145.08 122.85 11.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.17 119.82 8.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.1 146.42 24.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.065 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 118.94 9.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.368 -0.832 . . . . 0.0 109.677 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.11 119.86 31.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.251 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.92 -178.74 6.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 m -86.43 -12.14 49.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 54.6 m-80 -89.48 16.94 6.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.2 57.75 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.649 -0.657 . . . . 0.0 110.323 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 60.1 m-85 -145.49 123.42 12.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -89.96 124.48 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.736 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.8 p -97.74 168.8 10.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.752 . . . . 0.0 109.382 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -143.59 105.87 4.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 134.38 38.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -63.94 131.41 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.141 -0.974 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 120' ' ' TYR . 40.7 ttp180 -69.22 -69.88 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.626 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 17.8 tttt -51.65 -10.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 122' ' ' SER . 36.3 m-85 -147.01 69.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -65.9 4.96 0.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.1 m -95.08 9.38 39.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.587 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.21 139.15 17.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.7 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -100.2 156.43 17.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.98 128.99 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.208 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.04 149.27 26.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -102.03 176.24 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.602 -0.686 . . . . 0.0 109.458 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -95.08 -167.42 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -11.2 30.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 132' ' ' GLN . 1.6 t -91.47 0.12 57.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.47 -2.53 70.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.4 mp0 -84.97 176.41 8.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 32.6 p90 -92.8 120.4 33.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.63 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -71.02 136.09 48.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.97 164.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.061 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -93.17 -1.7 66.76 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -97.33 -20.82 17.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.245 -1.15 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -90.06 -4.91 57.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 p -79.51 155.23 28.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.004 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.63 178.71 42.92 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.4 Cg_endo -60.97 169.58 5.76 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.925 1.75 . . . . 0.0 110.274 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 -20.51 2.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' A' ' 145' ' ' ALA . 10.2 mt-30 -90.16 109.51 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -1.15 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.63 ' HB2' HD22 ' A' ' 36' ' ' ASN . 15.9 mtmt -65.05 2.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.35 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.06 -9.13 19.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.1 pt -94.54 5.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.482 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 144' ' ' LYS . 87.0 mt -94.67 85.67 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -94.9 169.64 9.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.227 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.73 70.43 30.56 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.41 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.89 104.13 0.37 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.848 1.699 . . . . 0.0 110.411 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.4 mtt -95.12 125.59 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.3 t -70.02 132.62 46.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.95 165.3 8.66 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.118 1.212 . . . . 0.0 110.45 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -147.26 122.14 9.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -86.27 122.62 30.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.85 101.08 12.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -91.95 124.34 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.286 -0.883 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.55 127.52 35.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.421 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -74.7 -19.56 60.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.669 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.21 105.16 15.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.73 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.69 5.14 90.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 84.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.5 m-85 -143.64 135.68 26.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -1.107 . . . . 0.0 109.518 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.48 129.43 43.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 tp -55.47 144.77 24.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.953 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.471 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 17.0 ttt180 -149.08 114.63 5.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.581 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.85 114.27 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.269 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.508 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 66.8 m-70 -69.34 151.27 96.95 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.034 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.526 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.8 Cg_endo -57.27 -27.92 77.32 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.301 1.334 . . . . 0.0 110.764 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.96 -3.0 29.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 109.742 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.69 -13.29 65.47 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -67.83 126.1 28.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.043 -1.269 . . . . 0.0 109.243 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.72 135.7 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 17.8 p-10 -153.93 -163.8 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.53 146.2 16.17 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.44 153.26 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -94.21 2.3 55.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.376 -0.828 . . . . 0.0 109.275 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.81 86.61 4.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.482 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -61.68 -5.17 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 t -87.16 25.75 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.039 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.471 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-20 -112.71 95.97 35.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.26 0.7 0.63 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.864 1.043 . . . . 0.0 110.271 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.52 ' CD2' ' HG ' ' A' ' 78' ' ' SER . 45.3 m80 -78.48 -26.77 46.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -70.37 -1.75 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.281 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -75.66 88.33 2.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.255 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.77 135.43 33.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.573 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -89.85 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.464 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -94.32 128.23 40.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -114.21 147.08 39.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.18 139.71 30.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' GLU . 1.9 tm-20 -145.55 129.36 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.263 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . 2.1 tt0 52.16 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 109.285 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -96.24 118.92 33.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.815 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.37 19.0 31.46 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -147.84 146.94 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.62 137.34 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -93.68 116.38 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.65 144.33 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -145.6 145.87 31.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.05 131.5 10.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.24 -85.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.44 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.52 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 22.8 t -50.18 -22.85 1.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.08 -26.64 19.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 51.19 52.21 15.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.949 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.62 HH21 ' HZ1' ' A' ' 95' ' ' LYS . 91.4 mtt180 -149.9 147.71 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.362 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -91.49 132.72 36.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.3 tp -63.36 147.77 50.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.226 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -150.03 132.83 15.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.409 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 11.1 ttm -100.87 132.71 46.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.408 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 92' ' ' LEU . 11.1 mmtm -90.98 169.3 11.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.084 -1.01 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.55 -23.51 58.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.2 -3.97 48.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.96 71.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -79.77 118.23 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.334 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -91.39 134.84 34.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.488 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -145.71 -174.13 4.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.471 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.67 154.6 49.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.319 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -145.85 170.16 17.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.62 ' HZ1' HH21 ' A' ' 81' ' ' ARG . 0.8 OUTLIER -81.54 -35.0 30.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 132.84 35.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.83 164.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -147.3 -173.1 4.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.0 -14.39 59.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 85' ' ' MET . 25.8 mt-10 -90.89 8.58 34.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.7 m -92.54 -5.88 50.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 56.1 m-85 -94.32 153.2 18.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 85.0 m-85 -149.1 121.67 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -55.66 114.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.323 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.45 95.1 9.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -94.18 118.96 32.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.433 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 tt -93.39 123.4 36.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' ASN . 14.6 mt-10 -90.8 161.68 15.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.89 3.81 1.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -93.02 20.26 6.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.02 -1.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.0 m-85 -98.07 141.31 31.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -94.47 166.12 12.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 5.5 p -144.62 112.11 6.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.326 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.83 135.65 33.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 124' ' ' TYR . 3.2 ttm180 -127.13 145.75 50.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -68.85 146.03 53.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.708 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -88.53 -72.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.9 tttp -50.65 -10.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 20.4 m-85 -145.25 68.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.516 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 71.8 p -64.37 5.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.639 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.4 m -89.9 9.29 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.6 m-90 -150.3 141.16 22.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 109.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 116' ' ' ARG . 71.4 m-85 -104.09 165.7 10.88 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.711 . . . . 0.0 109.569 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.3 t -94.54 121.3 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.79 144.38 21.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.149 -0.969 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.83 -175.93 3.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.462 -0.773 . . . . 0.0 109.478 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -93.78 -119.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -146.35 8.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.534 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -125.39 6.46 7.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.09 12.86 51.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HG2' HG23 ' A' ' 130' ' ' THR . 84.4 mm-40 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.4 p90 -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -70.95 142.62 51.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 6.1 tp -63.71 -153.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -109.12 -43.66 1.17 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -61.39 -22.51 65.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 109.725 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -89.8 -15.63 31.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.59 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 135' ' ' LEU . 80.6 p -90.1 154.49 19.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.85 179.72 38.32 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.68 169.01 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.888 1.725 . . . . 0.0 110.187 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.03 -58.09 3.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 134.45 54.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -1.153 . . . . 0.0 109.441 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HB3' HD12 ' A' ' 147' ' ' LEU . 31.5 mtmt -83.6 5.77 23.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.13 -7.13 11.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.575 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.14 -6.73 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 144' ' ' LYS . 63.1 mt -80.1 85.16 5.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -89.87 169.24 11.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.6 tp -142.32 70.08 22.01 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.809 . . . . 0.0 109.418 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.98 103.5 0.29 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.844 1.696 . . . . 0.0 110.356 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.3 mtt -97.73 119.12 35.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.761 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.7 t -70.0 119.09 13.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.384 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.46 177.62 0.21 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 121.267 1.312 . . . . 0.0 110.25 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.25 138.44 25.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.2 mtt-85 -92.66 120.97 33.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 0.0 109.321 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.82 102.01 12.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -93.5 118.95 31.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.98 101.4 12.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -51.78 -34.51 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.691 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 5.1 m-80 -73.73 105.18 4.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.994 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.03 4.31 89.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.65 85.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.9 m-85 -142.72 133.77 25.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.496 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -95.39 123.68 39.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.3 tp -54.29 146.21 15.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.276 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 24.5 ttt180 -149.25 117.51 6.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.8 mt -92.87 130.94 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.172 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -91.71 151.4 42.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.163 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.491 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.47 -27.46 82.08 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.304 1.336 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -74.83 12.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.702 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -41.11 3.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.32 153.75 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.37 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -138.11 141.93 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.341 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 3.9 p-10 -153.85 -150.02 0.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -146.2 148.08 19.52 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.56 149.57 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -1.12 . . . . 0.0 109.466 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 53' ' ' ARG . 20.5 mtm-85 -90.25 -15.79 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.27 103.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.43 44.42 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -144.19 20.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.265 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.4 m-20 -105.77 104.97 51.39 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.74 2.66 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.786 0.991 . . . . 0.0 110.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.3 m80 -82.63 -5.75 58.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.257 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt -90.23 -5.18 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -76.64 86.53 3.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.12 134.92 34.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.84 114.08 26.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.838 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -93.2 113.14 25.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.0 143.07 26.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.92 120.93 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -95.0 -42.43 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.2 mt-10 -151.77 158.78 43.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.466 -0.772 . . . . 0.0 109.296 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -60.75 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 141.93 -2.82 1.93 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.35 142.43 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -1.122 . . . . 0.0 109.596 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.91 130.7 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 109.239 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -91.51 131.13 37.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -89.95 142.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -146.96 121.77 9.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.573 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 139.56 27.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 78' ' ' SER . 79.2 t -75.06 -87.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.547 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 77' ' ' VAL . 13.1 t -47.18 -33.33 5.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.44 -29.64 47.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 50.8 53.98 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.3 mtt180 -146.88 148.79 32.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -91.5 132.07 36.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.39 142.62 58.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.06 148.81 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.9 ttp -106.7 143.89 34.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HZ3' HH21 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.15 148.9 25.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.34 -19.06 7.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.401 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.5 p30 -87.65 -44.65 11.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.81 -9.59 1.37 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 ' HZ3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -71.65 128.65 36.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -1.148 . . . . 0.0 109.449 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -95.06 135.34 36.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.43 -173.72 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.28 42.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.455 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -146.97 155.84 42.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -71.32 -19.09 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.44 139.92 30.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 97' ' ' VAL . 4.5 t -86.25 107.81 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -94.68 156.09 16.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.37 -23.92 6.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -93.93 53.09 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 97.0 m -134.24 -2.18 2.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 87.4 m-85 -95.44 153.98 17.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 71.2 m-85 -146.04 121.13 10.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.01 93.92 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 115' ' ' TYR . 31.4 tt0 -78.15 93.19 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -93.47 137.85 32.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.85 140.46 29.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.361 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.84 -171.72 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' ASN . 43.1 t -93.78 -33.28 13.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -74.27 20.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.142 -0.973 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.5 m-20 65.24 56.05 1.04 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.714 . . . . 0.0 109.916 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -142.42 137.31 30.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.393 -0.817 . . . . 0.0 109.286 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.91 153.99 20.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 146' ' ' ILE . 12.5 p -137.18 114.92 11.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 105' ' ' GLU . 98.5 m-85 -89.93 104.5 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.506 ' NH2' ' O ' ' A' ' 121' ' ' THR . 23.8 ttt180 -93.92 134.37 36.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.205 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.9 t -60.95 153.36 25.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 120' ' ' TYR . 56.3 ttt180 -90.83 -77.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -51.13 -9.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 122' ' ' SER . 32.3 m-85 -138.85 59.33 1.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.506 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 26.5 p -59.55 -0.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.737 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.6 m -90.04 10.07 25.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 3.3 m-90 -155.13 144.01 20.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.849 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 28.0 m-85 -104.85 167.21 9.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.658 -0.652 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.0 128.32 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.57 145.64 24.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.632 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.28 178.86 5.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 109.447 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -96.23 -167.9 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 109.401 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -93.24 -13.47 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 109.42 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -93.46 2.32 56.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.41 0.32 67.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -85.06 172.26 11.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -1.144 . . . . 0.0 109.512 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 37.8 p90 -92.63 120.22 32.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -71.99 131.59 43.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.496 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.3 tp -47.98 155.04 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.309 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.84 -1.45 58.98 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.496 ' OG ' HD23 ' A' ' 135' ' ' LEU . 60.1 p -92.79 -58.25 2.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -55.15 -7.62 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 137' ' ' SER . 11.4 p -85.57 155.44 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.81 39.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.98 170.79 4.37 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.905 1.736 . . . . 0.0 110.162 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.01 -51.18 4.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.75 135.05 50.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -1.106 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.5 mtpp -84.81 1.61 46.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 109.565 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.64 -3.58 0.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.693 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 114' ' ' THR . 20.3 pt -98.13 2.61 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 109.681 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 144' ' ' LYS . 79.3 mt -90.48 110.23 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -117.23 168.28 10.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.51 70.17 17.5 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.318 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.33 105.98 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.794 1.662 . . . . 0.0 110.387 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.7 mtt -97.59 118.61 34.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 109.397 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.5 t -62.19 145.81 52.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.868 . . . . 0.0 109.498 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.2 165.96 6.45 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.229 1.286 . . . . 0.0 110.364 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HD2' HD22 ' A' ' 64' ' ' LEU . 57.8 mttt -146.36 127.02 14.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.0 109.198 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -84.96 124.52 31.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 41' ' ' LEU . 23.3 mt -84.8 98.25 10.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -92.76 119.66 32.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -86.89 112.23 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -63.34 -17.36 62.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.64 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.8 m-80 -88.03 104.92 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.91 4.79 89.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.12 84.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 47.1 m-85 -142.98 130.94 21.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.13 120.65 34.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 32' ' ' LEU . 49.1 tp -50.83 144.41 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.259 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.474 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 33.2 ttt180 -147.78 120.58 8.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 49' ' ' VAL . 76.0 mt -95.73 130.82 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.795 . . . . 0.0 109.11 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -91.29 150.89 42.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.49 -25.63 74.76 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.244 1.296 . . . . 0.0 110.312 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.1 p30 -74.92 7.56 3.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.7 -41.83 2.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.8 mmm180 -47.28 157.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.488 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 43' ' ' ILE . 84.2 t -138.77 134.17 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.4 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -146.09 -150.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.24 149.92 22.11 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -145.79 145.99 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -1.118 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.4 -6.46 58.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.49 108.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.486 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 21.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.36 -20.24 3.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.642 . . . . 0.0 109.692 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -44.75 108.19 0.71 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 109.62 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.09 5.26 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 110.152 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' ASP . 50.0 m80 -93.71 -3.14 52.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.68 -1.48 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 14.7 mmtt -78.14 86.25 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.93 130.85 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.82 111.4 22.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -90.25 153.58 20.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.902 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -144.9 130.96 19.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.338 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 123.77 28.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.572 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.15 -95.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -89.48 -173.9 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 112.4 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.43 24.65 20.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 t -145.92 142.54 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' VAL . 31.3 m -140.63 125.79 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.523 -0.735 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -93.51 128.26 39.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.54 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.78 149.62 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 14.6 tttp -146.51 134.34 21.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.23 136.25 18.25 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 60.1 t -77.98 -57.01 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -1.154 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -17.82 48.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.43 -23.55 19.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 51.13 49.64 20.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.423 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -146.43 148.52 32.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.551 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 75.1 m-85 -91.63 132.81 36.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.545 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 tp -65.02 139.55 58.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.25 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.74 134.92 18.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.579 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -95.12 126.38 40.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.66 -175.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.14 -16.41 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -90.2 -40.21 12.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.55 -9.26 1.41 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 90' ' ' ARG . 1.8 mtt-85 -73.55 123.62 24.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -1.165 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -92.56 132.95 36.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.3 pp -148.7 -172.67 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.611 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.07 44.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.291 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 170.04 17.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -84.6 -37.31 21.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 m -85.01 149.64 25.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 98' ' ' THR . 54.8 t -77.21 162.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.385 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.531 ' N ' HG12 ' A' ' 97' ' ' VAL . 71.6 p -147.27 177.81 8.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -76.14 -26.34 56.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 27.0 mp0 -92.87 19.64 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 2.1 m -93.98 -11.8 30.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 66.2 m-85 -93.17 159.55 15.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 76.0 m-85 -148.78 116.18 6.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -54.89 142.35 29.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -125.15 141.64 51.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -146.96 142.02 27.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.97 137.35 35.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.31 -175.92 3.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.2 p -94.67 38.28 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 59.1 m-80 -146.86 31.14 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 m120 60.99 -1.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 40.6 m-85 -95.12 126.83 40.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.67 168.83 10.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -137.64 161.47 36.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.731 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -137.8 109.87 7.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.72 149.17 22.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -75.52 162.79 28.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.7 ttt-85 -93.5 -77.95 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.885 . . . . 0.0 109.303 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.2 tptt -51.24 -9.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.547 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.7 m-85 -141.97 59.68 1.47 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.435 -0.791 . . . . 0.0 109.374 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p -62.07 0.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 12.3 m -90.17 15.0 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.522 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 11.1 m-90 -155.14 143.56 20.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 109.713 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.0 m-85 -107.54 158.76 16.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.663 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -84.77 131.16 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.303 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.62 -175.75 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.55 161.52 37.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.772 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.21 173.74 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.8 19.15 7.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 16.63 8.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.74 -0.6 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.47 42.87 47.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -134.68 154.8 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.944 . . . . 0.0 109.323 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -80.87 120.17 24.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.76 127.67 33.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.678 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.8 tp -50.35 142.57 10.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.75 14.55 2.58 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 135' ' ' LEU . 84.7 p -102.61 -38.65 7.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.508 -0.995 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -90.11 -8.65 50.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 135' ' ' LEU . 41.0 p -69.91 145.21 52.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 109.495 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.11 -179.76 42.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.8 Cg_endo -61.07 -174.71 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.924 1.749 . . . . 0.0 110.164 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.27 -35.23 0.94 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 141' ' ' PRO . 18.2 mm-40 -93.14 134.52 35.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -1.131 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 39.4 mtmt -78.51 -0.49 29.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.19 -7.05 1.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.2 pt -95.32 1.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 109.652 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.2 mt -90.99 110.06 21.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -116.79 165.36 13.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.1 tp -144.4 70.75 15.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 109.21 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -62.23 112.78 1.65 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.89 1.727 . . . . 0.0 110.617 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 35.3 mtt -96.72 129.69 44.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.342 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.4 t -70.11 128.71 37.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.538 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.11 176.13 0.27 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 120.99 1.127 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.6 ' HD2' HD22 ' A' ' 64' ' ' LEU . 47.0 mttt -144.89 175.06 10.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.8 mtm-85 -125.35 117.48 23.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' CD1' HD12 ' A' ' 62' ' ' LEU . 20.7 mt -84.83 102.0 12.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -94.47 117.9 30.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.26 99.38 11.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -51.5 -35.01 38.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.736 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 12.1 m-80 -71.86 105.05 3.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.751 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.4 4.56 89.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.25 83.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.4 m-85 -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -93.51 119.73 32.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.11 138.72 37.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -147.44 123.64 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 109.715 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.1 mt -93.96 118.08 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -69.3 150.92 97.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.092 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.0 Cg_endo -58.86 -23.96 69.91 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.175 1.25 . . . . 0.0 110.542 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.64 -15.47 51.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.67 -34.01 4.56 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -47.27 114.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.243 . . . . 0.0 109.497 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.42 143.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -170.15 -150.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.58 156.47 26.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 m -145.7 139.13 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -1.077 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.492 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.9 mtm-85 -76.61 6.52 5.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -94.87 103.45 15.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -81.59 6.35 15.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.2 t -90.24 7.29 38.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' HIS . 5.8 m-20 -93.01 113.53 60.11 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.051 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.88 2.6 0.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.675 0.917 . . . . 0.0 110.216 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.474 ' CE1' ' OG ' ' A' ' 78' ' ' SER . 59.6 m-70 -84.57 -20.47 31.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.82 0.07 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 22.3 mttt -87.58 87.55 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.524 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.1 mt -90.42 135.22 33.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -91.1 117.1 29.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.6 HD22 ' HD2' ' A' ' 30' ' ' LYS . 10.6 mp -90.51 158.66 16.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.51 138.84 26.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.311 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.91 157.99 16.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.01 -91.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.16 -155.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -88.64 105.02 17.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.5 -7.8 77.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.76 136.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.88 126.94 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -94.74 130.94 41.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -0.824 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.35 151.87 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -150.06 145.54 26.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.03 138.96 17.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 40.2 t -75.74 -62.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -1.134 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.474 ' OG ' ' CE1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -73.84 -46.89 42.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.26 68.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.416 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.94 49.7 20.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 11.9 mtt180 -141.99 150.03 40.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -92.33 130.07 38.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.93 150.99 46.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.34 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.65 32.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.6 ttm -126.8 134.92 50.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -92.58 178.4 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -78.13 -34.19 50.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.21 -3.43 20.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.49 66.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.422 ' C ' HD12 ' A' ' 91' ' ' LEU . 58.0 mtm180 -80.54 119.01 22.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.442 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.9 mp -93.4 134.52 35.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 92' ' ' LEU . 4.3 pp -148.74 164.95 32.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.82 157.78 16.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.06 149.42 30.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -73.03 -31.95 64.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -92.96 142.04 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.3 t -79.25 156.43 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.453 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 46.2 p -146.88 156.75 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.34 -29.71 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.409 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -93.92 57.71 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.472 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 67.9 m -140.95 3.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -101.19 160.25 14.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.466 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.98 112.07 4.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -60.06 126.04 25.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.626 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -95.55 93.48 7.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.474 HH11 ' NH1' ' A' ' 116' ' ' ARG . 60.1 ttt180 -89.89 125.16 35.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.57 132.33 36.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.79 -173.22 3.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.97 -7.0 50.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -93.73 24.11 4.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 63.59 -5.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 109.889 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 110' ' ' ASN . 51.0 m-85 -91.64 128.51 37.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.124 -0.985 . . . . 0.0 109.26 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -89.91 166.91 13.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.913 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 p -141.85 122.91 14.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 109.177 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -92.57 110.97 22.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.767 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.474 ' NH1' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.75 137.82 37.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.273 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.87 157.98 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -93.78 -64.39 1.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 109.587 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -53.74 -49.73 67.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.678 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 122' ' ' SER . 7.0 m-85 -110.47 68.87 0.68 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.7 -0.625 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 121' ' ' THR . 14.8 p -59.76 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.8 m -89.14 10.37 22.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.085 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.3 m-90 -149.69 141.7 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 109.696 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.5 m-85 -109.22 150.81 27.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.688 -0.632 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.24 131.3 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.307 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.03 171.52 15.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.7 mt -132.13 165.15 24.7 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -93.37 -172.71 3.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -93.0 -13.25 28.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 9.92 35.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.59 6.02 86.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -92.43 166.54 12.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 37.7 p90 -92.74 120.21 32.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -69.83 131.65 44.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.661 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.55 135.5 11.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.278 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.12 2.85 1.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.661 ' OG ' HD23 ' A' ' 135' ' ' LEU . 59.8 p -92.21 -38.76 11.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 109.56 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -79.79 -5.0 54.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.1 p -77.25 149.62 35.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.477 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.43 179.73 45.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.94 164.83 13.23 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 121.873 1.715 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.65 -43.16 3.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 143' ' ' GLN . 1.6 mp0 -68.35 132.42 47.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -1.115 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -84.81 -5.25 59.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.69 -0.73 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 10.8 pt -99.97 6.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.99 110.05 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.643 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -119.6 168.0 11.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.659 -0.65 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -142.8 70.43 19.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -61.97 105.87 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.68 141.56 32.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.513 -0.742 . . . . 0.0 109.319 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -70.04 173.47 6.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.2 175.02 1.17 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.22 1.28 . . . . 0.0 110.321 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -145.28 175.35 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 4.2 mtm-85 -133.58 119.98 20.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.532 -0.73 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.57 102.35 12.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.584 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -96.48 115.89 28.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 t -83.26 106.03 14.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.513 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -28.33 24.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.685 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.2 m-80 -77.47 105.09 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.615 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.35 4.88 87.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.57 62.67 3.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -111.64 132.46 54.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.639 -0.918 . . . . 0.0 109.785 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -93.02 115.73 28.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.844 . . . . 0.0 109.265 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.513 HD23 HD12 ' A' ' 32' ' ' LEU . 41.6 tp -48.77 143.1 5.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 0.0 109.292 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 34.0 ttt180 -149.57 118.31 6.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -89.94 106.17 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.193 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -67.02 151.21 97.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 0.0 109.038 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.1 Cg_exo -57.16 -26.18 68.06 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.045 1.163 . . . . 0.0 110.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -75.21 -0.15 18.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.51 -30.46 6.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -52.8 121.55 7.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 83' ' ' LEU . 95.1 t -92.57 138.33 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -165.37 151.35 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.81 159.41 22.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.03 141.77 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -86.37 16.08 4.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.93 88.32 5.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.621 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -62.03 -5.2 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 p -90.99 31.02 1.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.848 . . . . 0.0 109.08 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 30.2 m-20 -113.87 93.5 29.51 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.96 1.6 0.42 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 120.94 1.094 . . . . 0.0 110.382 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.486 ' H ' ' C ' ' A' ' 57' ' ' ASP . 37.2 m80 -81.41 -15.61 54.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.69 2.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -76.43 82.12 3.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 109.147 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.1 mt -89.86 135.07 33.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.166 -0.959 . . . . 0.0 109.391 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.94 104.18 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -90.79 148.31 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 125.35 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.69 28.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.86 -76.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.459 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -94.62 -90.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -142.54 -31.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.529 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.25 -18.88 6.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.98 147.81 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -1.104 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.3 127.43 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.469 -0.769 . . . . 0.0 109.453 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.8 m -93.22 112.11 23.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.6 mt -91.91 144.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -144.24 145.66 32.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.454 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.33 135.27 12.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.04 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 109.428 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.555 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 2.5 t -61.42 -47.26 86.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -27.76 69.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.888 . . . . 0.0 109.472 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 78' ' ' SER . 41.5 m-80 51.34 50.58 18.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.7 mtt180 -149.84 147.96 28.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.04 129.34 36.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 49' ' ' VAL . 40.8 tp -57.65 145.14 35.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.57 170.09 17.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.01 140.17 29.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -87.08 170.37 11.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.76 -14.09 61.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 3.1 p30 -83.11 -47.45 11.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 144.52 -7.56 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -72.43 125.37 27.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -92.23 138.12 31.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.02 -171.63 3.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.755 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.28 159.45 42.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.446 -0.784 . . . . 0.0 109.272 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.5 t -146.69 170.09 17.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -83.85 -35.16 24.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -92.18 135.04 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -83.82 106.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.6 p -95.14 -179.11 4.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -16.68 63.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -93.54 48.0 1.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -139.9 3.27 2.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 84.1 m-85 -95.75 162.07 13.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 87.0 m-85 -150.03 114.38 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -59.12 112.96 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.06 141.74 37.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -137.78 90.83 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.549 -0.719 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.0 tp -68.19 126.72 30.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.373 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.03 -172.5 3.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -93.9 -13.43 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.2 m120 -88.0 28.97 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 109.489 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER 60.19 -0.15 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.2 m-85 -95.26 126.97 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 2.1 m120 -93.23 166.21 12.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.636 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.8 p -144.6 120.77 10.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.315 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -90.69 113.8 25.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -96.38 144.95 26.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.435 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -70.81 153.88 42.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.466 ' C ' ' H ' ' A' ' 120' ' ' TYR . 47.8 ttt180 -91.69 -75.72 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -51.37 -9.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 122' ' ' SER . 20.5 m-85 -141.78 62.52 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -62.06 2.04 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.683 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 120' ' ' TYR . 48.7 m -90.91 11.31 23.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.408 ' HD1' ' HG1' ' A' ' 139' ' ' THR . 2.4 m-90 -155.05 142.35 19.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.6 m-85 -106.76 170.04 8.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.4 t -90.73 126.75 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -151.58 148.37 27.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.51 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.11 172.61 6.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.551 -0.718 . . . . 0.0 109.44 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -93.95 -169.48 2.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.449 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -92.78 -12.31 31.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 t -93.69 -4.01 51.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 9.92 59.92 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -92.75 141.17 28.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.133 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 26.0 p90 -62.03 120.14 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.77 126.69 30.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.58 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -47.78 140.92 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.36 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.35 -4.9 39.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.6 p -87.82 -28.34 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -1.18 . . . . 0.0 109.436 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.92 -4.93 57.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.408 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 28.6 p -70.45 162.03 29.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.574 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 179.99 22.61 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.01 167.3 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.94 1.76 . . . . 0.0 110.17 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.32 -48.39 2.64 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -79.51 129.27 34.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -1.186 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -82.64 2.8 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.736 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.92 -2.73 2.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 pt -93.28 1.34 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.47 87.65 7.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.387 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.66 162.94 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.6 tp -138.46 71.83 44.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.92 103.76 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.911 1.741 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.26 35.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.2 t -70.03 175.17 4.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.458 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.14 160.07 16.98 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 121.066 1.177 . . . . 0.0 110.126 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.51 ' HD2' HD22 ' A' ' 64' ' ' LEU . 21.7 mttt -140.43 138.4 34.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.465 -0.772 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.2 mtm-85 -88.57 129.06 35.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.9 mt -93.91 101.09 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -95.1 121.67 36.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 t -88.56 105.13 17.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -15.24 8.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 22.9 m-80 -86.38 104.38 15.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 75.31 4.94 75.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.7 89.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.8 m-85 -145.64 130.78 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -1.13 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -93.59 123.82 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.65 136.55 56.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.928 . . . . 0.0 109.219 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 57' ' ' ASP . 40.4 ttp180 -146.04 118.03 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.637 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mt -92.62 126.31 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -87.4 152.02 51.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.14 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.63 -26.59 65.69 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.236 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.95 1.7 12.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.965 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -25.09 10.88 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -57.55 114.96 2.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -1.19 . . . . 0.0 109.384 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.26 142.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -171.35 151.92 3.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.8 155.29 23.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 m -146.43 155.08 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.402 HH11 ' HB3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -92.23 9.07 35.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.53 102.17 14.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -83.38 -4.96 58.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.358 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -78.74 13.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.25 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -105.59 104.93 50.73 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.84 1.06 0.91 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 120.77 0.98 . . . . 0.0 110.2 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 57' ' ' ASP . 40.6 m80 -76.15 -26.69 56.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.273 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -65.65 -5.33 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -75.9 87.41 2.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.92 135.23 33.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.857 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -89.73 114.32 25.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -86.6 153.07 22.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.0 109.628 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -144.68 131.91 20.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.93 119.78 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.57 -73.2 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -90.56 -143.85 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.482 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -93.94 -26.62 16.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.78 -9.38 2.54 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.45 104.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -1.204 . . . . 0.0 109.38 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.08 177.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.537 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -145.82 118.44 8.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.04 149.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -146.59 144.35 29.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.44 133.65 11.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.4 -74.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -61.75 -26.03 67.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.95 -26.6 31.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 51.11 50.0 19.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -147.76 146.95 29.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -94.5 134.37 37.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.92 143.49 57.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.223 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.37 134.21 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.9 ttm -97.63 139.33 33.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.385 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HE3' HD21 ' A' ' 92' ' ' LEU . 25.4 mmtt -92.1 173.87 7.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.427 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -77.67 -27.09 50.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 6.4 p-10 -73.19 -49.4 28.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.486 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 145.67 -13.19 1.76 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -72.62 123.61 23.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.567 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -92.36 137.15 32.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -147.87 -172.41 4.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.09 156.71 45.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 m -145.88 153.48 40.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CG ' ' NH1' ' A' ' 81' ' ' ARG . 9.1 mtmp? -68.62 -29.77 68.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.529 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.48 148.33 23.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.3 t -92.37 149.54 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.428 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 38.2 p -146.51 157.43 43.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.45 -17.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 44.82 1.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.428 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 3.8 m -144.62 8.12 1.31 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 81.1 m-85 -100.0 159.7 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 75.3 m-85 -149.37 140.53 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.49 125.61 33.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 109.448 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -90.25 135.04 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.281 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -141.3 126.03 17.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.387 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tt -92.51 125.45 37.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.292 -0.88 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -90.67 -173.87 3.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.408 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 m -93.34 63.85 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 34.1 p30 -169.26 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.36 -7.52 0.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 50.3 m-85 -93.75 135.85 34.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -95.38 166.44 11.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.785 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 22.9 p -139.82 119.9 13.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -98.75 117.07 32.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -95.05 161.47 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 109.272 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.56 159.77 30.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.871 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.66 -61.84 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.399 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -83.28 -36.44 24.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' SER . 16.5 m-85 -89.29 50.54 1.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -49.0 -14.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -90.03 17.54 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 13.1 m-90 -155.05 141.33 18.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.913 . . . . 0.0 109.62 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.4 m-85 -112.04 169.98 8.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.683 -0.636 . . . . 0.0 109.587 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.75 133.17 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.377 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.01 154.86 33.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HA ' ' H ' ' A' ' 134' ' ' LYS . 31.8 mt -115.66 172.75 6.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.4 -169.23 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -94.97 -17.04 22.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -91.33 3.34 55.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.525 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.81 2.91 66.55 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.4 163.47 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -1.177 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 33.7 p90 -79.23 120.27 23.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 0.0 109.489 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 127' ' ' LEU . 16.8 tttt -72.05 128.66 36.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.581 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.6 tp -47.83 140.65 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.95 22.35 1.21 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.581 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.08 -27.25 7.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.598 -0.942 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -90.02 -9.27 49.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.682 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 p -69.97 152.28 44.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.22 -179.14 40.47 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.1 151.81 75.95 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.85 1.7 . . . . 0.0 110.185 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.43 -28.3 9.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -86.74 119.76 27.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.576 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -73.56 -3.45 27.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.78 -3.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -96.43 2.96 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.05 110.12 21.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.51 163.13 17.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 109.434 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.4 tp -137.79 72.34 48.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.49 -0.756 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.63 108.0 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.836 1.691 . . . . 0.0 110.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.458 -0.776 . . . . 0.0 109.584 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.4 t -70.16 147.65 49.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.231 -0.918 . . . . 0.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.461 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.43 164.07 11.6 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.187 1.258 . . . . 0.0 110.431 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -149.11 129.91 14.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.9 mtt-85 -87.34 117.18 25.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD12 HD23 ' A' ' 41' ' ' LEU . 19.0 mt -84.83 99.73 11.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.564 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -94.82 121.48 36.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.0 t -91.28 113.28 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.269 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.29 -19.96 63.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 0.0 109.617 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.452 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.6 m-80 -82.86 104.99 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.17 4.96 87.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.1 86.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 43.8 m-85 -143.49 131.36 21.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 109.651 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -94.33 119.06 32.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 32' ' ' LEU . 46.6 tp -47.8 140.78 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.271 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 44.5 ttt180 -145.97 115.98 7.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.01 104.15 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.066 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -64.89 150.55 94.73 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.109 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.7 Cg_endo -57.68 -26.67 73.99 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.142 1.228 . . . . 0.0 110.057 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -75.45 3.15 9.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.83 -30.74 5.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -50.48 114.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -1.152 . . . . 0.0 109.358 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.7 142.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.471 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -173.4 154.6 2.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.54 160.11 25.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -148.1 141.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -1.115 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.7 mtm-85 -84.54 2.12 42.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.95 112.97 20.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 109.771 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -85.21 -5.83 59.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.71 27.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' HIS . 88.3 m-20 -115.16 90.44 23.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.65 1.95 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.035 1.157 . . . . 0.0 110.64 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' ASP . 44.2 m80 -80.12 -10.74 59.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.279 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -79.81 -2.19 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -75.64 87.85 2.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.83 135.92 33.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -88.94 106.19 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.274 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.86 153.46 19.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.95 135.94 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.533 -0.729 . . . . 0.0 109.039 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 153.09 28.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -150.15 146.62 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.81 . . . . 0.0 109.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 53.06 -146.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 62.15 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.674 -0.642 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.28 1.67 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 72' ' ' VAL . 90.1 t -93.48 156.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -1.095 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 72' ' ' VAL . 5.6 m -145.32 123.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.355 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 m -93.32 123.98 36.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 mt -97.08 145.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.454 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -146.75 152.15 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.464 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.47 132.09 11.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -73.52 -62.61 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -40.26 62.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 109.532 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.73 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 51.72 44.71 29.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.785 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 43.4 mtp180 -141.58 144.23 34.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.92 136.47 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.6 tp -64.13 149.47 47.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.119 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 131.37 14.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 50.6 ttm -97.67 132.58 43.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 109.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -91.5 176.02 6.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -83.29 -22.62 32.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.432 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 23.8 p30 -77.16 -4.76 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.948 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.89 4.61 65.0 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 91' ' ' LEU . 9.5 mtp180 -88.77 122.16 31.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -1.175 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.685 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.0 mp -93.34 132.12 37.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.86 178.02 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -119.03 163.26 17.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.748 -0.595 . . . . 0.0 109.418 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -150.24 161.61 42.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.368 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -79.37 -34.57 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.75 164.55 13.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 98' ' ' THR . 46.2 t -90.15 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.505 ' N ' HG12 ' A' ' 97' ' ' VAL . 74.8 p -147.52 177.14 9.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -22.5 62.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.15 13.26 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 88.8 m -93.69 -9.97 35.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 69.4 m-85 -96.21 153.18 17.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 73.8 m-85 -146.35 137.18 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -77.17 124.19 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -0.984 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.44 145.35 24.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 108' ' ' GLU . 19.3 ttp180 -147.51 116.32 6.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.04 134.26 34.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 106' ' ' ARG . 3.7 mm-40 -93.07 176.7 6.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.1 p -85.2 -4.02 59.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 112' ' ' TYR . 4.4 m120 -93.38 28.48 2.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.28 -4.64 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.8 m-85 -88.95 -172.13 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -146.81 167.67 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.77 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 p -142.98 169.49 17.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -0.76 . . . . 0.0 109.184 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -145.27 110.7 5.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -92.58 140.18 29.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.364 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -61.63 147.69 44.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 121' ' ' THR . 6.1 ttp180 -75.87 -57.93 3.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.591 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -75.61 -42.25 52.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 122' ' ' SER . 44.3 m-85 -92.91 52.69 1.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 118' ' ' ARG . 65.0 p -53.81 -5.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.813 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.2 m -89.92 10.23 24.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.68 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.16 146.09 22.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.811 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -104.65 165.27 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 109.573 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.0 118.76 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.56 143.62 23.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.982 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.31 175.4 6.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.431 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -91.01 -142.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.341 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -128.77 -16.83 4.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.66 . . . . 0.0 109.519 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.2 t -94.85 37.79 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.35 51.72 56.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -142.63 162.01 36.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -1.054 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.7 p90 -92.17 120.28 32.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.444 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.53 129.73 40.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.668 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.1 tp -55.42 157.9 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.152 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -80.28 24.31 3.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.668 ' OG ' HD23 ' A' ' 135' ' ' LEU . 51.8 p -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.957 . . . . 0.0 109.539 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -89.64 -5.14 57.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.654 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 135' ' ' LEU . 74.5 p -76.18 155.12 34.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.19 -179.93 35.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.73 179.61 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.857 1.705 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.91 -50.98 3.74 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.66 135.1 41.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.452 ' CB ' HD21 ' A' ' 36' ' ' ASN . 7.8 mtpt -83.99 7.44 18.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.86 -6.25 7.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.67 -2.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 144' ' ' LYS . 61.9 mt -88.16 90.48 8.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -97.58 167.94 10.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 0.0 109.418 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -140.44 70.35 32.49 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.3 101.37 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.777 1.651 . . . . 0.0 110.507 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.3 mtt -96.71 129.18 44.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.1 t -70.08 140.54 52.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.412 ' HB1' HH22 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.78 150.3 71.9 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.979 1.119 . . . . 0.0 110.228 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.8 mtmt -138.26 141.21 39.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.178 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -94.93 128.17 41.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' CD1' HD12 ' A' ' 62' ' ' LEU . 17.9 mt -84.91 124.66 31.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -115.23 114.46 25.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.0 t -86.82 106.02 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -47.55 -35.32 8.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.43 -0.794 . . . . 0.0 109.922 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.08 105.04 2.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.21 5.55 76.99 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.33 54.04 10.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.95 134.02 45.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.594 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 24.6 m-85 -93.8 117.06 29.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.15 136.94 23.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.244 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 5.9 ttt180 -147.54 124.51 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.749 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.65 122.44 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.086 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.77 151.38 73.81 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 109.173 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.529 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.8 Cg_endo -59.14 -23.41 69.08 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.176 1.251 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.4 p30 -74.98 3.26 8.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.52 3.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 mmm180 -46.94 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 109.534 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -141.38 134.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.394 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -166.9 152.13 7.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.41 21.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.73 144.86 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -1.137 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . 19.9 mmm-85 -64.93 -36.6 84.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -85.43 -1.31 56.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.428 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.1 p -94.03 15.2 17.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.1 m-20 -92.01 114.57 62.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.157 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.9 -2.14 2.0 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 120.601 0.867 . . . . 0.0 110.113 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.0 m80 -79.49 -28.8 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.312 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.57 -6.32 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.424 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -74.84 86.82 2.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.424 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.3 mt -90.15 135.26 33.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -89.7 109.31 20.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -87.67 156.56 19.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.628 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -140.68 -175.24 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.476 -0.765 . . . . 0.0 109.279 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.09 144.24 51.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.683 . . . . 0.0 109.523 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.3 mm-40 -145.46 144.41 30.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 48.17 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.085 -1.01 . . . . 0.0 109.22 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.88 62.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.78 -18.29 1.43 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLU . 21.4 t -92.51 119.25 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.236 . . . . 0.0 109.678 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 103' ' ' PHE . 3.6 m -94.12 179.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.339 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 m -145.87 116.87 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.62 145.51 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.92 129.23 12.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.41 133.86 12.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.94 -74.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -1.167 . . . . 0.0 109.53 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.5 m -47.13 -52.56 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.97 -22.37 65.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.9 m120 51.76 38.75 23.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 33.4 mtt180 -137.03 154.76 50.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.441 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.459 ' CG ' HG22 ' A' ' 97' ' ' VAL . 79.5 m-85 -94.28 134.72 36.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.26 144.93 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.19 132.43 15.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.668 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -98.7 142.38 30.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.815 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 92' ' ' LEU . 4.9 mmtm -94.93 177.93 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.53 -12.59 48.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.28 -2.54 58.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.85 64.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -88.81 118.58 28.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -1.118 . . . . 0.0 109.499 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.1 mp -92.36 132.17 36.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.4 pp -146.08 -170.45 3.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.848 . . . . 0.0 109.464 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.97 151.72 44.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 109.476 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -145.43 170.06 17.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -83.87 -23.38 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 t -92.44 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 97' ' ' VAL . 25.2 t -82.46 94.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.558 ' N ' ' SG ' ' A' ' 101' ' ' CYS . 3.3 p -76.45 -175.72 3.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.04 -11.23 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 9.16 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 98' ' ' THR . 3.7 m -94.32 -0.35 55.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.579 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 96.7 m-85 -94.94 151.15 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -0.841 . . . . 0.0 109.716 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.4 m-85 -147.55 134.82 20.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -80.17 159.35 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.98 . . . . 0.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -123.71 139.83 53.6 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.16 77.84 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.83 151.99 10.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.29 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -129.4 168.72 15.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.661 -0.649 . . . . 0.0 109.324 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.7 p -77.2 58.05 1.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.501 ' C ' ' H ' ' A' ' 112' ' ' TYR . 40.8 p30 -155.3 17.79 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 63.51 -7.75 0.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.526 -0.734 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 110' ' ' ASN . 49.9 m-85 -95.35 128.65 42.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.86 170.16 10.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.61 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 p -144.32 111.8 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -102.19 126.69 49.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -116.18 157.16 25.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 109.634 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -65.15 160.61 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.873 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 121' ' ' THR . 53.9 ttt180 -90.7 -73.99 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 8.4 tptm -58.11 -9.72 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -136.39 57.77 1.76 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.529 -0.732 . . . . 0.0 109.445 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' ARG . 21.8 p -61.26 1.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.687 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.6 m -89.96 11.52 20.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.99 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 14.5 m-90 -146.92 132.71 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -98.65 153.0 19.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.596 -0.69 . . . . 0.0 109.946 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.76 134.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.39 171.42 19.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.5 mt -132.32 172.03 12.96 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 128' ' ' LYS . 14.5 mtpp -94.49 -163.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -93.79 -24.94 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.707 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -77.22 -1.35 29.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.05 69.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.5 mp0 -85.11 179.1 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 31.6 p90 -94.11 120.77 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.67 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' NZ ' ' OE1' ' A' ' 143' ' ' GLN . 26.0 tttt -69.72 138.66 53.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.571 HD23 ' OG ' ' A' ' 137' ' ' SER . 15.2 tp -47.65 142.56 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.0 19.3 1.27 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.571 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.18 -27.0 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.914 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -90.06 -4.94 57.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.749 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 p -70.89 135.93 48.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' N ' HE22 ' A' ' 143' ' ' GLN . . . -176.45 179.72 47.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.6 Cg_endo -61.23 179.08 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.88 1.72 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.8 -30.75 1.28 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.46 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 2.3 mt-30 -92.48 134.08 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.18 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -85.06 1.85 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.545 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.36 -11.59 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.2 pt -92.59 -2.8 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.6 mt -88.63 86.79 7.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 109.503 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -91.29 164.43 13.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.56 70.48 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.35 109.97 1.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.803 1.669 . . . . 0.0 110.303 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.0 mtt -98.04 128.37 44.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -68.57 160.57 29.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.647 -0.658 . . . . 0.0 109.393 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 166.46 7.62 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.075 1.183 . . . . 0.0 110.27 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HD2' HD22 ' A' ' 64' ' ' LEU . 39.3 mttp -143.51 127.27 17.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.215 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -84.9 124.67 31.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.543 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.52 104.87 16.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -99.09 126.68 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.509 -0.744 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 43.8 t -89.45 130.74 35.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.19 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -79.8 -15.7 56.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.0 OUTLIER -88.21 104.82 17.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.67 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.56 4.94 89.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.4 88.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 44.7 m-85 -145.42 132.17 20.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.733 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -94.73 120.69 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.402 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.4 tp -47.53 142.64 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 12.8 ttt180 -150.32 114.74 5.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 117.32 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.476 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 90.8 m-70 -79.71 150.24 72.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.913 . . . . 0.0 109.031 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.5 -23.96 58.92 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.075 1.183 . . . . 0.0 110.259 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 4.8 p30 -75.01 -2.49 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.72 -31.51 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.2 mtm-85 -56.76 117.7 4.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -1.153 . . . . 0.0 109.528 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 83' ' ' LEU . 48.8 t -94.09 140.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 43.0 p30 -164.14 153.27 13.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.06 160.44 24.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -146.84 149.77 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -1.155 . . . . 0.0 109.478 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -80.78 4.6 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 57' ' ' ASP . 20.7 tt0 -88.01 91.6 8.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.383 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -77.84 48.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 p -163.49 20.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.715 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -77.7 141.36 64.44 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.991 . . . . 0.0 108.991 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.89 22.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.191 1.261 . . . . 0.0 111.073 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.5 m80 -132.61 -10.2 3.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.173 -0.954 . . . . 0.0 109.99 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.3 -3.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.046 -1.033 . . . . 0.0 109.338 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.95 86.7 7.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.01 135.0 33.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -93.59 110.5 22.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.07 136.47 26.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.77 123.17 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.13 -30.12 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -165.45 -159.93 0.44 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 10.5 ptt180 -89.18 118.54 28.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.01 66.96 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 t -145.75 99.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -1.09 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -93.19 174.83 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 m -145.48 119.72 9.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.324 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.67 147.59 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.594 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -147.01 132.01 18.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.374 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.91 132.9 12.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 78' ' ' SER . 57.0 t -72.52 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -1.155 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 77' ' ' VAL . 24.7 t -53.83 -47.56 70.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.7 70.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.35 46.35 26.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 81' ' ' ARG . 2.8 mtt-85 -136.09 142.63 44.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 109.305 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -89.93 116.4 27.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 49' ' ' VAL . 49.2 tp -50.69 149.7 3.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.18 128.34 11.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.7 ttm -94.16 138.11 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -83.44 166.88 17.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -20.57 60.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.498 ' CG ' ' HE ' ' A' ' 90' ' ' ARG . 1.7 p30 -87.02 -45.14 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 147.69 -10.67 1.26 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HE ' ' CG ' ' A' ' 88' ' ' ASP . 75.5 mtm180 -68.65 122.01 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -1.2 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -90.87 129.55 36.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.698 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.6 pp -147.53 150.93 35.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.264 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -101.2 157.32 16.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.748 . . . . 0.0 109.504 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.85 146.21 27.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.454 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -70.99 -21.43 62.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 t -89.69 151.59 21.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.16 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -147.43 162.01 39.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -11.55 31.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.46 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -94.12 4.96 53.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -91.52 -8.81 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.498 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 90.3 m-85 -95.03 153.03 17.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 69.2 m-85 -145.69 127.02 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.93 116.21 5.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.64 89.2 7.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.275 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.95 127.7 36.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.1 134.21 35.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -93.77 -177.78 4.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -93.63 40.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.5 m120 -148.15 30.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.57 -0.39 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.7 m-85 -97.36 125.34 41.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 0.0 109.284 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.2 m-20 -94.54 167.18 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 109.855 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -142.61 122.13 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.448 -0.782 . . . . 0.0 109.235 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -94.2 115.14 27.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 151.93 20.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.65 152.3 35.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.105 -0.997 . . . . 0.0 109.591 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -87.59 -75.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 21.7 tptt -49.69 -10.97 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 10.7 m-85 -143.91 66.37 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -64.71 5.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 33.6 m -91.59 10.49 27.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.692 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -151.35 144.62 24.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 24.1 m-85 -108.26 166.25 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.35 132.94 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.85 166.28 33.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -132.7 175.77 9.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 0.0 109.336 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -95.21 -169.64 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.389 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.43 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 6.6 ptm180 -91.65 -12.72 33.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -93.68 1.44 56.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.4 64.88 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.42 ' HG2' HG23 ' A' ' 130' ' ' THR . 49.1 mm-40 -85.34 161.84 19.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 109.509 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.8 p90 -91.98 120.51 32.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.502 ' HZ2' ' HB2' ' A' ' 138' ' ' LYS . 13.8 ttpp -72.98 134.92 44.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.404 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.532 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.7 tp -47.3 136.79 8.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.888 . . . . 0.0 109.224 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.92 -8.75 74.17 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.532 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.0 p -83.45 -29.62 27.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.492 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 134' ' ' LYS . 8.5 mtpp -89.98 -4.8 57.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.424 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 5.3 p -69.87 153.87 42.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.64 -179.75 43.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.94 162.62 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.803 1.669 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.57 -29.46 7.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.28 127.74 34.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -1.145 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -84.1 -2.88 57.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.606 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -63.23 -5.13 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.425 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.57 0.45 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.95 91.86 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -95.77 167.59 11.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.656 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.72 73.54 54.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.291 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.38 106.49 0.49 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.861 1.707 . . . . 0.0 110.608 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.1 mtp -97.41 130.24 44.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.463 -0.773 . . . . 0.0 109.409 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.5 t -70.04 137.01 50.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.47 164.0 6.07 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.096 1.197 . . . . 0.0 110.266 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 64' ' ' LEU . 26.3 mtmt -136.61 136.68 39.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.603 -0.685 . . . . 0.0 109.266 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.8 mtt-85 -87.46 121.87 30.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.482 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.528 HD12 HD23 ' A' ' 41' ' ' LEU . 27.6 mt -86.6 97.67 10.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.25 120.46 33.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.61 107.17 19.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.15 -22.07 60.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.9 m-80 -80.13 96.42 6.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.928 . . . . 0.0 109.488 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 85.7 4.62 85.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 84.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -143.02 132.4 23.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -1.041 . . . . 0.0 109.515 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -94.13 124.67 38.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 32' ' ' LEU . 56.2 tp -56.81 140.25 48.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.28 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -147.41 121.48 9.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.418 HG23 HG22 ' A' ' 49' ' ' VAL . 62.6 mt -94.36 121.53 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 89.1 m-70 -86.44 150.29 51.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.029 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -57.98 -22.41 54.86 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.105 1.203 . . . . 0.0 110.109 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 14.1 p30 -75.04 1.04 14.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -39.33 3.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.479 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.1 mtm-85 -54.51 119.91 5.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 43' ' ' ILE . 39.5 t -102.02 130.58 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -149.71 163.5 37.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.399 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.16 157.5 23.35 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -146.07 141.96 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -1.12 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -79.79 3.89 18.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm-40 -91.14 91.85 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 56.26 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -149.94 9.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.017 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' HIS . 2.6 p-10 -92.07 140.06 24.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.55 6.36 0.2 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.935 1.09 . . . . 0.0 110.564 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . 78.0 m80 -94.76 -34.54 12.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.78 -6.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 109.414 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 84.47 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.91 135.12 33.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tm0? -91.67 112.72 24.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.114 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.47 152.03 19.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.657 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -138.03 123.99 20.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.585 -0.697 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.1 134.18 35.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -100.28 -89.65 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 109.349 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.19 -155.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.38 54.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 165.15 -30.32 0.22 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 72' ' ' VAL . 55.3 t -89.95 154.89 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 109.537 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 71' ' ' VAL . 18.0 m -142.32 166.25 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -137.16 124.75 22.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.33 148.29 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -148.08 129.95 15.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.61 138.0 16.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.17 -68.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -58.0 -54.36 47.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.77 67.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 50.66 51.75 16.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.631 ' HE ' ' HZ3' ' A' ' 95' ' ' LYS . 91.1 mtt180 -147.6 149.2 32.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.87 130.21 36.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.21 141.54 58.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 109.268 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 156.25 41.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.6 tpp -112.29 143.75 42.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.67 -0.644 . . . . 0.0 109.383 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -80.17 -169.31 2.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -19.11 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.3 p30 -91.14 -38.47 12.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 109.62 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.14 -7.87 1.88 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -70.05 127.51 33.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.7 mp -91.9 139.02 31.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -150.04 -175.95 5.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.579 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.34 155.06 46.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -145.64 170.02 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.631 ' HZ3' ' HE ' ' A' ' 81' ' ' ARG . 9.9 mttm -80.38 -42.38 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 126.68 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.4 p -65.53 120.09 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 p -92.21 -174.1 3.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 101' ' ' CYS . 52.7 t0 -80.03 -31.97 39.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.79 16.52 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.464 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' A' ' 99' ' ' ASP . 64.4 m -94.85 1.72 55.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.6 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.1 m-85 -96.76 148.66 22.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 61.6 m-85 -145.92 115.59 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.309 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -60.85 117.02 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.087 -1.008 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -81.09 148.29 29.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' NH2' HH21 ' A' ' 116' ' ' ARG . 36.0 ttp180 -148.2 108.95 4.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.97 121.23 34.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -90.22 -177.67 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.428 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 3.31 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -91.03 18.24 6.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.463 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.46 -0.67 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.1 m-85 -99.17 136.28 39.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -93.72 162.65 13.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.771 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.5 p -143.41 122.8 13.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -95.26 109.17 21.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.856 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.598 HH21 ' NH2' ' A' ' 106' ' ' ARG . 37.9 ttm180 -93.36 149.22 21.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.983 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -80.19 167.74 19.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -93.78 -87.1 0.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.412 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -48.54 -13.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -126.26 56.8 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 118' ' ' ARG . 52.9 p -57.91 -19.75 32.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.727 . . . . 0.0 110.418 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.9 m -89.55 19.95 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.917 -1.114 . . . . 0.0 108.989 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -139.83 151.89 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.512 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 28.3 m-85 -131.54 152.57 50.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.712 . . . . 0.0 109.522 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.09 135.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -154.2 -178.45 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.11 165.96 26.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.87 175.33 7.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -87.02 -13.12 45.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -93.09 1.01 57.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.55 7.75 61.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -92.59 166.22 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 27.8 p90 -83.19 120.25 25.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 135' ' ' LEU . 38.9 tttm -71.51 137.42 48.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.487 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 5.7 tp -61.65 -152.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -127.71 -36.87 0.47 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.466 ' HG ' ' HZ3' ' A' ' 138' ' ' LYS . 27.0 p -52.91 -29.93 31.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.221 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HZ3' ' HG ' ' A' ' 137' ' ' SER . 2.4 mptp? -90.18 -20.08 23.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.4 p -69.93 136.7 50.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.14 179.81 48.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.74 153.97 58.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.874 1.716 . . . . 0.0 110.238 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.19 32.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -1.115 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 2.4 mtmp? -74.92 -7.76 54.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -58.12 -3.21 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -99.8 6.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.89 110.2 22.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.841 . . . . 0.0 109.614 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.14 163.72 16.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.684 -0.635 . . . . 0.0 109.402 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 tp -141.43 70.92 26.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.466 -0.771 . . . . 0.0 109.243 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.9 109.3 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.923 1.749 . . . . 0.0 110.559 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.2 mtt -95.92 125.7 40.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.1 t -68.72 141.57 55.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.562 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.72 167.72 3.81 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.138 1.225 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.7 mttt -145.77 133.46 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.232 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -85.03 120.96 27.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 mt -84.91 95.97 9.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -91.79 115.03 27.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.0 t -81.83 125.12 30.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -78.96 -14.88 58.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.903 . . . . 0.0 109.761 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 29.9 m-80 -88.32 92.49 9.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 93.02 4.92 64.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.75 82.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.4 m-85 -142.7 132.97 24.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.364 -1.08 . . . . 0.0 109.552 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -93.55 129.4 39.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.96 146.46 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 6.8 ttt180 -145.52 159.12 43.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.51 104.97 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.23 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.9 m-70 -66.92 150.58 97.75 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.079 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.2 Cg_exo -57.07 -24.05 55.95 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.157 1.238 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 23.8 p30 -74.98 -1.7 23.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.82 -32.04 6.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -52.15 119.94 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -1.209 . . . . 0.0 109.458 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.4 150.43 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 109.507 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 16.3 p-10 -174.57 151.35 1.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.92 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 155.25 21.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.87 139.54 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.0 mtm-85 -71.52 -7.12 45.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.04 98.04 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -84.98 7.15 22.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 t -91.34 -20.12 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -63.58 116.14 23.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.128 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.36 0.39 1.03 Allowed 'Trans proline' 0 C--O 1.213 -0.737 0 C-N-CA 120.632 0.888 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . 49.4 m80 -77.72 -6.63 54.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.86 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -87.63 6.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.3 87.41 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -91.77 135.28 34.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.75 105.39 17.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.51 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.5 mp -89.7 153.04 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -144.7 137.92 26.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.73 122.96 32.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -95.47 -76.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -95.96 -124.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -92.7 -76.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 5.44 81.24 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.08 140.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 30.9 m -141.02 127.32 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -91.47 121.1 32.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.611 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.32 145.12 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.321 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -146.84 143.81 28.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.13 139.98 18.81 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.02 -58.24 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -1.164 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.5 -43.78 18.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.12 67.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 m120 51.25 50.84 18.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.57 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 94.1 mtt180 -148.5 149.3 31.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -93.17 129.79 39.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.937 . . . . 0.0 109.585 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.4 142.6 51.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.17 133.35 18.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.1 ttm -92.43 145.53 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HE3' HD21 ' A' ' 92' ' ' LEU . 17.2 mmtt -92.99 -177.34 4.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 21.2 mm-40 -79.62 -40.43 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.7 p30 -69.95 -37.14 75.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 135.8 1.75 2.94 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 90' ' ' ARG . 3.9 mtm-85 -76.45 119.15 19.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.8 134.87 34.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD21 ' HE3' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -149.17 178.04 9.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.708 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -111.88 158.12 19.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.687 -0.633 . . . . 0.0 109.449 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -150.06 134.46 17.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -54.84 -49.97 69.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -85.0 130.55 34.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.521 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -85.66 160.43 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 p -147.49 -172.98 4.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -13.0 62.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -95.91 50.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.1 m -147.43 9.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 63.0 m-85 -96.16 152.67 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.672 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.7 m-85 -150.25 115.77 5.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.897 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -57.56 152.56 14.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.42 137.34 54.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -142.8 134.52 26.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.438 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.17 128.57 46.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 109.679 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -86.33 171.42 11.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.277 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -76.21 -5.04 45.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.58 17.91 10.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.01 61.71 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -0.778 . . . . 0.0 110.205 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -144.6 -171.93 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -147.91 114.55 6.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 109.804 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -95.36 124.06 39.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.264 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -96.32 109.16 21.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -97.57 147.54 24.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.192 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 t -78.99 158.88 27.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.676 ' O ' HG23 ' A' ' 121' ' ' THR . 0.2 OUTLIER -93.22 -78.01 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.449 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -47.86 -34.81 9.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.2 m-85 -112.22 65.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 118' ' ' ARG . 67.6 p -64.08 3.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 120' ' ' TYR . 54.4 m -93.47 11.72 27.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.2 161.24 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 19.4 m-85 -123.91 169.91 11.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -87.92 122.52 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.48 144.45 22.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.615 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -95.86 -176.29 3.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -94.33 -108.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.86 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -148.17 -35.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 109.457 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -81.25 10.54 5.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.68 10.62 60.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -93.93 166.82 11.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -1.172 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -89.99 120.45 31.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.428 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -69.83 139.08 53.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.713 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.4 tp -58.64 141.94 50.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -66.46 5.16 2.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 135' ' ' LEU . 96.4 p -93.48 -32.37 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -90.0 -16.95 28.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.554 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 126' ' ' ALA . 38.8 p -69.91 161.41 30.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.36 179.33 31.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.1 Cg_endo -61.7 178.38 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.88 1.72 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 -33.21 0.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 141' ' ' PRO . 17.2 mt-30 -87.65 128.11 35.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -1.207 . . . . 0.0 109.601 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 37.8 mtmt -74.96 -2.82 28.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.16 -3.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.45 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.1 pt -97.49 3.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.1 109.95 21.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -116.05 163.75 15.46 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.1 tp -140.85 72.41 28.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.141 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.55 115.18 2.5 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.853 1.702 . . . . 0.0 110.711 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.4 mtt -97.13 121.84 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.8 t -69.98 139.86 52.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.254 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.61 150.6 60.03 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 121.13 1.22 . . . . 0.0 110.289 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HE2' HD22 ' A' ' 64' ' ' LEU . 40.4 mtmt -143.31 141.86 31.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.198 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' NH2' ' O ' ' A' ' 55' ' ' LYS . 7.8 mtp180 -92.97 128.28 38.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 HD23 ' A' ' 41' ' ' LEU . 17.3 mt -85.03 128.78 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -115.31 114.51 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.1 105.7 17.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -48.51 -35.14 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 109.908 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 105.01 3.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 109.715 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.02 5.91 85.41 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.27 52.49 13.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -99.17 137.64 37.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.492 -1.005 . . . . 0.0 109.746 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -95.61 112.12 23.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD12 ' A' ' 32' ' ' LEU . 37.3 tp -46.51 145.18 1.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 64.0 ttt180 -144.26 154.26 42.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.679 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -134.74 127.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -91.65 149.41 39.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.124 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -58.26 -22.02 55.21 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.241 1.294 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.82 -11.62 60.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 109.677 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.84 15.02 38.06 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -93.8 115.55 27.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.107 -1.231 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.87 131.4 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -148.32 -163.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.383 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.86 127.18 2.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.72 155.61 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.468 -1.019 . . . . 0.0 108.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LYS . 16.7 mtm-85 -91.64 -16.42 27.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.986 -1.071 . . . . 0.0 109.451 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.8 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' ARG . 18.4 pttp -83.48 -2.71 56.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.88 10.02 20.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.142 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -104.56 106.03 52.71 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.56 2.48 0.52 Allowed 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 120.744 0.963 . . . . 0.0 110.273 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.5 m80 -76.99 -28.01 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.456 HD11 ' NH2' ' A' ' 31' ' ' ARG . 2.2 pt -72.27 -8.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.83 92.05 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.448 HD12 HD11 ' A' ' 32' ' ' LEU . 8.2 mt -91.31 135.61 33.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.22 108.95 19.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.224 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.9 mp -91.26 153.15 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -147.88 133.99 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.303 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 169.25 18.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 67' ' ' GLU . 3.1 tm-20 -145.04 -34.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -154.01 -163.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 80.7 mtm180 -84.88 58.82 5.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.575 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.47 -26.84 1.68 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.64 138.6 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -1.181 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.97 179.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.276 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 m -145.38 121.84 11.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.635 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.9 mt -93.96 147.7 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -146.46 140.09 25.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.399 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.48 138.71 19.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 41.2 t -80.0 -68.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.47 -15.6 59.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.7 24.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 77' ' ' VAL . 44.5 m-20 51.16 45.69 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.594 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 73.1 mtt180 -147.43 148.06 30.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -94.61 130.95 40.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -60.4 147.83 39.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.294 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.02 137.15 19.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.636 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.8 ttm -100.43 132.41 45.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.467 -0.771 . . . . 0.0 109.341 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -78.82 157.46 28.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -21.08 66.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 2.7 p-10 -84.77 -42.58 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.36 -7.48 1.8 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -72.54 122.3 21.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 109.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -92.59 129.79 38.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -146.59 -174.58 4.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.01 154.07 44.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -146.46 163.93 34.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -70.14 -33.01 71.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.92 127.3 34.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 97' ' ' VAL . 8.4 p -82.64 85.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.6 p -68.3 -167.26 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 101' ' ' CYS . 55.3 m-20 -80.0 -26.81 39.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.81 7.34 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.473 ' H ' ' C ' ' A' ' 99' ' ' ASP . 85.8 m -96.72 -3.04 43.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -86.64 149.87 24.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -150.03 117.74 6.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CB ' ' HE ' ' A' ' 116' ' ' ARG . 33.0 m-85 -64.06 128.09 34.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -97.89 134.99 40.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -145.05 131.33 19.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.558 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.9 tp -95.91 120.16 35.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.63 170.88 12.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.4 t -78.29 53.27 1.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 112' ' ' TYR . 11.2 t-20 -150.84 22.86 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.25 0.23 0.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 109.568 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.6 m-85 -101.78 138.13 39.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -90.71 164.01 14.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.71 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 p -142.44 117.95 10.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -98.43 118.63 35.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.416 -0.802 . . . . 0.0 109.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -102.07 148.07 25.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.549 -0.72 . . . . 0.0 109.301 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -73.66 156.25 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 120' ' ' TYR . 1.1 ttt-85 -89.76 -77.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 5.7 tptt -48.35 -12.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 12.0 m-85 -143.82 67.12 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -65.27 5.02 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 37.0 m -90.39 9.75 27.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.578 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -151.51 142.77 23.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.8 m-85 -110.65 163.84 13.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 109.561 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -80.82 138.46 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -155.04 -177.67 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 127' ' ' LEU . 79.8 mt -142.64 169.21 18.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -95.07 -178.12 4.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -11.45 32.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 130' ' ' THR . 1.9 t -93.58 2.64 56.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.75 4.93 67.04 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.6 mp0 -93.32 169.7 10.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.129 . . . . 0.0 109.473 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.5 p90 -92.54 120.46 33.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -69.78 135.59 49.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.469 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.3 tp -47.65 123.78 6.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.47 -23.97 29.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.469 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.2 p -80.17 -20.79 43.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -1.195 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -90.07 -8.89 50.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 45.2 p -73.02 157.75 36.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.68 179.74 42.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 172.11 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.876 1.717 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.99 -37.95 2.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -83.55 131.88 34.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -1.19 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -83.35 -0.49 50.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.571 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.02 -8.81 3.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.56 2.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 144' ' ' LYS . 60.9 mt -93.32 90.62 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.14 166.99 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -146.21 71.03 13.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.242 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.3 112.9 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.842 1.694 . . . . 0.0 110.501 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.9 mtt -103.86 142.65 34.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.3 t -69.94 149.86 47.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.02 116.63 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 120.862 1.041 . . . . 0.0 110.165 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -95.1 143.18 26.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.392 -0.818 . . . . 0.0 109.666 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.2 mtt-85 -87.43 135.86 33.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.21 120.59 26.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 109.764 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -109.53 107.47 17.59 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -76.47 103.32 6.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -45.35 -31.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -66.95 105.14 1.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.02 4.65 36.14 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.21 83.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -124.42 128.73 49.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.932 . . . . 0.0 109.255 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -90.31 114.07 26.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.216 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.9 tp -48.91 141.67 7.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.526 HH11 ' CG ' ' A' ' 57' ' ' ASP . 39.8 ttp180 -147.55 112.48 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.2 mt -89.96 112.75 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -74.35 151.93 87.78 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.121 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.7 Cg_exo -56.92 -26.42 67.55 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.163 1.242 . . . . 0.0 110.24 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.46 0.37 17.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.56 4.36 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.3 mtm-85 -50.63 115.24 1.4 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.13 146.09 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 14.0 p30 -169.06 148.13 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.26 151.53 20.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -146.35 153.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -89.91 -0.7 57.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.28 88.1 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -68.91 -5.04 18.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 22.65 1.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.6 OUTLIER -110.18 99.92 41.79 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.61 3.62 0.36 Allowed 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 120.912 1.075 . . . . 0.0 110.522 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' A' ' 57' ' ' ASP . 56.0 m-70 -84.23 -4.64 58.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.65 1.85 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -77.01 100.45 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.29 135.2 43.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.79 107.33 19.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -85.85 150.72 24.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.532 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.04 132.93 16.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.4 135.44 33.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 -38.32 8.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.639 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -151.34 -117.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -83.85 -110.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.687 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.53 6.26 17.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.76 129.89 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.79 168.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -142.47 118.99 10.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.448 -0.783 . . . . 0.0 109.401 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 74' ' ' ILE . 4.8 mt -91.07 152.33 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -148.65 117.99 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.506 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 131.91 51.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.08 -60.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -68.2 -34.28 75.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.17 -21.92 33.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 51.25 55.21 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 6.6 mtp180 -146.8 149.29 33.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.399 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -94.97 129.63 41.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.06 139.66 58.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.267 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.82 133.31 16.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -97.12 133.0 42.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 88' ' ' ASP . 32.8 mmtt -73.45 164.24 26.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.893 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.78 24.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.1 p30 -130.24 -42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.663 -0.648 . . . . 0.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.41 -9.61 1.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.2 mtt-85 -78.53 115.93 18.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -1.162 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.67 131.02 38.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.412 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.94 -171.83 3.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.16 151.43 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 109.383 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.21 151.33 38.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.481 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -63.86 -28.92 70.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.77 127.38 38.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.94 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 p -148.25 -165.37 2.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -68.01 -19.43 64.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.961 . . . . 0.0 109.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.63 54.1 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 58.3 m -146.71 9.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -94.32 156.41 16.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.89 105.56 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -58.39 103.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.512 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -87.06 94.56 9.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -89.92 126.85 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.454 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.29 132.26 34.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.56 -178.92 4.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -89.15 -11.41 43.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.1 m-20 -89.59 28.55 1.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER 60.42 -0.7 0.25 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.75 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.2 m-85 -95.48 130.14 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.92 169.97 10.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.3 p -142.39 120.45 12.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.791 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -93.15 99.05 11.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -93.49 145.15 24.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -72.02 155.57 40.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.6 ttt180 -92.45 -76.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.6 -9.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 13.4 m-85 -140.47 60.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 40.1 p -61.0 0.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 4.0 m -90.51 10.68 24.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.08 142.33 19.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -105.55 170.13 8.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.0 t -90.68 69.95 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 145' ' ' ALA . . . -94.01 141.59 28.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.5 mt -95.97 179.6 5.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -92.65 -171.68 2.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -93.64 -11.77 30.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 2.51 55.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.43 0.4 67.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -88.43 171.01 10.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.6 p90 -89.6 120.41 30.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -70.14 139.34 52.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.483 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.4 tp -47.68 125.07 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.226 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.45 -16.5 7.04 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.483 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.3 p -90.1 -20.45 23.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.053 -1.263 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -89.98 -11.03 42.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.2 p -69.93 175.07 4.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.83 25.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.2 170.95 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.893 1.729 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.91 -55.07 2.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -75.15 134.87 41.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 146' ' ' ILE . 33.9 mtmt -82.76 4.39 25.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . . . -61.21 -3.85 0.99 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.1 pt -93.12 -9.63 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.9 mt -81.87 91.64 6.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -94.07 157.28 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.5 tp -138.12 71.95 47.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.21 115.0 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.775 1.65 . . . . 0.0 110.732 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.3 mtt -97.43 130.59 44.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 109.22 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.0 t -68.32 144.31 54.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' HH12 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.48 156.7 30.05 Favored 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.236 1.291 . . . . 0.0 110.341 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -141.12 133.77 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.436 -0.79 . . . . 0.0 109.424 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.1 mtt-85 -90.76 133.86 34.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.65 126.35 38.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -115.19 119.46 36.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.5 t -93.82 106.66 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.09 -35.04 10.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.656 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.593 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.7 m120 -67.95 103.28 1.45 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.92 4.93 83.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 55.16 8.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -102.14 143.05 32.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.978 . . . . 0.0 109.795 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.02 110.14 22.46 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 127' ' ' LEU . 13.6 tp -46.95 144.66 2.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.119 -0.988 . . . . 0.0 109.716 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -143.55 155.4 44.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.89 131.83 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.199 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -93.17 149.68 37.86 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.067 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.06 -21.75 52.15 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.224 1.283 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -74.85 4.79 5.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -38.54 3.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -48.1 164.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.7 t -137.83 148.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.587 -0.696 . . . . 0.0 109.258 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' ' CG1' ' A' ' 52' ' ' VAL . 3.1 p-10 -154.17 -160.02 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 131' ' ' GLY . . . -143.1 126.38 2.82 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.407 ' CG1' ' OD2' ' A' ' 50' ' ' ASP . 1.8 m -142.55 151.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.456 -1.026 . . . . 0.0 108.457 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 55' ' ' LYS . 35.4 mtm180 -89.04 -21.54 23.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.091 -1.006 . . . . 0.0 109.341 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -44.93 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.764 . . . . 0.0 109.705 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' ARG . 6.9 pttp -81.27 1.33 32.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.3 p -88.28 5.12 43.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.214 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -99.27 110.35 57.85 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.177 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.73 3.18 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.717 0.944 . . . . 0.0 110.238 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -74.85 -33.23 62.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.334 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.96 0.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.459 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.612 ' NZ ' ' NH1' ' A' ' 31' ' ' ARG . 8.6 tptt -77.1 96.71 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.453 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 131.75 45.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.503 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.02 109.54 20.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -92.61 150.01 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.553 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.73 137.9 21.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.1 160.21 25.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.952 . . . . 0.0 109.581 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -142.94 -84.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.79 -151.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -85.87 117.72 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 -3.11 13.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.41 139.34 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -1.16 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.5 m -140.86 128.23 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.535 -0.728 . . . . 0.0 109.577 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 m -94.47 118.74 32.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.06 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 82' ' ' TYR . 58.4 tttp -145.71 144.18 30.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.44 134.17 12.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.47 -77.75 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -27.18 7.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.95 -25.46 20.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.0 m120 50.99 48.3 23.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -146.37 150.76 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 75' ' ' LYS . 80.9 m-85 -94.86 127.8 41.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.3 147.92 24.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -145.88 167.87 22.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.0 ttm -134.17 141.12 46.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.675 -0.64 . . . . 0.0 109.407 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -92.84 160.79 14.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.46 -29.41 70.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -45.53 26.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.08 -6.72 1.81 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.52 ' NH1' ' OH ' ' A' ' 133' ' ' TYR . 2.1 mmt180 -63.84 120.08 11.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -1.222 . . . . 0.0 109.471 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.16 -175.31 5.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.08 150.6 38.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.315 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -146.6 156.52 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -73.44 -18.56 61.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.25 112.97 25.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.96 142.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.464 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.2 p -147.31 -163.35 1.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.58 -14.8 63.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.504 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -94.07 42.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 64.6 m -144.03 6.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 60.7 m-85 -94.36 151.44 19.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 96.0 m-85 -150.22 111.94 4.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CD2' ' NH1' ' A' ' 116' ' ' ARG . 32.2 m-85 -54.89 157.81 3.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.27 95.26 4.41 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 109.307 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -89.96 108.57 19.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.66 117.86 30.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.93 -175.58 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -1.25 57.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 41.3 t-20 -91.44 27.49 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.95 -3.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 109.88 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.9 m-85 -94.31 156.49 16.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.242 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -123.9 165.38 17.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 109.758 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -141.0 120.13 12.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.321 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -89.9 107.77 19.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.479 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.513 ' NH1' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -99.07 133.65 43.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.499 -0.751 . . . . 0.0 109.133 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t -61.41 161.8 8.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.968 . . . . 0.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -95.45 -79.12 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 0.0 109.199 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -50.33 -11.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -130.19 52.53 2.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 118' ' ' ARG . 79.9 p -52.72 -12.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 m -93.51 20.51 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.928 . . . . 0.0 109.635 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -152.29 130.75 12.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.72 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.5 m-85 -103.99 167.97 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.581 -0.699 . . . . 0.0 109.591 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.52 148.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.887 . . . . 0.0 109.362 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.58 -177.96 6.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 41' ' ' LEU . 29.5 mt -144.86 171.28 14.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -90.27 174.03 7.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -93.79 11.71 28.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -125.08 5.55 7.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.7 -0.625 . . . . 0.0 109.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 95.27 0.28 63.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -85.09 172.95 10.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -1.166 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 20.9 p90 -93.62 120.55 34.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.592 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -72.71 132.82 44.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.364 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.72 158.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.76 -39.01 18.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -67.49 -15.37 63.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -1.159 . . . . 0.0 109.585 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -90.02 -5.05 57.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -74.38 165.68 24.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.57 179.47 21.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.86 168.71 6.74 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.849 1.7 . . . . 0.0 110.237 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.87 -47.9 2.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.14 131.52 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.593 ' HB2' HD22 ' A' ' 36' ' ' ASN . 36.3 mtmt -85.1 -1.94 57.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.522 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.18 -0.14 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.6 pt -93.66 -10.45 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.599 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 91.47 8.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.35 168.39 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.6 tp -144.27 70.44 16.09 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.58 112.97 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.796 1.664 . . . . 0.0 110.305 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 29.8 mtt -98.12 115.61 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.307 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.5 t -65.16 157.32 29.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.1 166.43 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.215 1.277 . . . . 0.0 110.525 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HD2' HD22 ' A' ' 64' ' ' LEU . 36.8 mttp -150.02 131.05 14.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.235 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.53 118.73 28.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' CD1' HD12 ' A' ' 62' ' ' LEU . 24.0 mt -84.92 100.65 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -98.6 125.42 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.472 -0.767 . . . . 0.0 109.571 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.66 121.46 33.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -15.13 62.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.705 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.5 m120 -84.66 105.07 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 53' ' ' ARG . . . 75.87 4.91 78.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.67 88.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.2 m-85 -144.84 132.97 21.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -1.076 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -94.92 131.56 40.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.388 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.77 143.52 57.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.268 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 57' ' ' ASP . 42.5 ttt180 -146.47 119.32 8.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.669 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.13 120.22 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -82.93 151.74 64.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.38 -27.29 75.05 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.121 1.214 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 p30 -74.91 0.88 14.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -25.11 11.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -55.95 114.96 2.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -1.154 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -92.69 142.1 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.406 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 12.7 p-10 -170.91 150.09 3.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.09 155.23 22.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.67 140.57 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 37' ' ' GLY . 8.5 mmt180 -69.27 -12.54 61.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.78 98.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' O ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.12 -5.49 59.34 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.264 -0.897 . . . . 0.0 108.943 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -97.09 23.74 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -102.85 107.55 55.12 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.187 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.5 -3.28 3.21 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 120.718 0.945 . . . . 0.0 110.154 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -76.04 -25.64 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.271 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.49 -5.52 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -76.09 87.27 2.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.959 . . . . 0.0 109.424 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 32' ' ' LEU . 8.4 mt -89.92 135.38 33.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -89.62 111.19 22.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.256 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -91.3 148.97 21.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.718 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 73' ' ' SER . 7.4 tt0 -145.36 148.25 33.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.87 163.68 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 102' ' ' PHE . 3.2 tt0 -138.01 -51.13 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.489 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -147.77 -139.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -91.51 101.26 13.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.0 -14.63 52.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.03 106.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -1.174 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 103' ' ' PHE . 3.3 m -95.74 -178.0 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 65' ' ' GLN . 5.9 m -144.84 112.39 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.37 -0.831 . . . . 0.0 109.236 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.97 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.65 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -146.27 143.68 29.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.398 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.29 142.42 16.39 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 78' ' ' SER . 55.0 t -78.93 -87.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 109.368 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 77' ' ' VAL . 10.0 t -47.6 -39.68 17.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.42 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.445 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 51.25 53.95 12.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.672 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -147.17 156.25 42.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.92 130.37 40.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.76 143.12 51.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.559 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -147.91 170.2 18.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.5 ttp -139.29 122.08 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.487 -0.758 . . . . 0.0 109.372 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -59.57 -175.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.26 -11.75 45.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -92.55 -38.02 12.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 143.44 -9.45 2.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -66.36 124.55 23.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.64 HD11 ' SD ' ' A' ' 85' ' ' MET . 11.0 mp -92.71 134.33 35.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.09 -171.53 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.599 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.64 150.39 40.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.26 147.78 31.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -66.33 -17.3 64.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.895 . . . . 0.0 109.543 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -90.24 140.81 29.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.493 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 97' ' ' VAL . 24.9 t -92.98 94.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.48 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.2 p -91.71 157.02 17.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.428 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.97 -21.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.87 48.52 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.2 m -138.61 1.02 2.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.455 -0.778 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 67' ' ' GLU . 99.2 m-85 -98.79 159.75 14.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.84 . . . . 0.0 109.412 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.2 m-85 -150.13 115.65 5.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.593 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.03 149.38 12.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.25 90.09 3.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -94.87 126.04 39.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.18 125.79 39.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -92.59 170.09 10.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.432 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -79.81 62.95 4.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 13.0 p30 -159.94 21.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.488 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 63.4 -6.77 0.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 110.037 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.3 m-85 -97.62 134.55 40.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 109.365 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.4 170.01 9.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.877 . . . . 0.0 109.822 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -140.27 114.62 9.24 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -90.63 115.33 27.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.876 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 150.9 22.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.556 -0.715 . . . . 0.0 109.161 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.3 163.44 20.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.896 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -94.83 -61.65 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 109.242 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.51 -54.07 23.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -96.1 62.62 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 p -56.89 2.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 120' ' ' TYR . 19.4 m -89.33 15.17 9.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.898 -1.126 . . . . 0.0 109.443 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.04 146.55 23.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 14.4 m-85 -104.71 169.45 8.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.17 125.61 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.55 156.4 42.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.1 mt -112.75 -178.36 3.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.771 -0.581 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.99 -129.45 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.533 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -139.84 4.52 2.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.502 -0.749 . . . . 0.0 109.408 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.31 14.82 8.32 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.61 6.46 60.91 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -92.91 162.74 13.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -1.121 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.0 p90 -93.32 120.3 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.666 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.452 ' NZ ' ' OE1' ' A' ' 143' ' ' GLN . 22.7 ttmt -70.03 135.41 49.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.493 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.677 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.66 160.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.27 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.3 24.52 7.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.677 ' OG ' HD23 ' A' ' 135' ' ' LEU . 33.7 p -115.07 -45.73 2.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.701 -0.882 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -4.86 28.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.684 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -73.16 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.66 179.46 31.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.95 171.57 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.885 1.723 . . . . 0.0 110.237 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.26 -44.34 3.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 8.7 mm-40 -85.39 133.82 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.461 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.567 ' HB2' HD22 ' A' ' 36' ' ' ASN . 36.9 mtmt -81.39 3.95 22.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.25 -9.95 5.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 pt -92.56 1.82 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 144' ' ' LYS . 71.1 mt -94.3 90.56 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.398 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.56 168.65 10.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 tp -141.02 70.61 28.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.329 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.54 103.83 0.41 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.8 1.667 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.6 mtt -95.4 125.35 39.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.354 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.4 t -70.02 135.33 49.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.416 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.45 167.24 2.85 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.204 1.269 . . . . 0.0 110.244 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -140.7 127.0 19.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -86.76 124.95 33.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD12 HD23 ' A' ' 41' ' ' LEU . 10.9 mt -84.72 102.03 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.562 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.94 116.2 23.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.21 61.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.691 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.5 m-80 -90.0 105.21 17.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.37 4.91 87.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 84.17 0.02 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.63 134.68 30.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.413 -1.051 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -95.25 133.35 39.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 32' ' ' LEU . 39.9 tp -67.53 143.25 56.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.209 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.651 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 1.5 ttt180 -155.99 125.05 6.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.98 . . . . 0.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 49' ' ' VAL . 38.1 mt -94.13 127.17 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.256 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.792 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 86.8 m-70 -83.58 148.86 56.08 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.7 Cg_endo -59.25 -21.12 58.59 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.203 1.268 . . . . 0.0 110.466 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.71 7.73 2.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.708 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.63 -39.29 3.13 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -52.0 162.04 0.51 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -1.141 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 43' ' ' ILE . 70.0 t -139.4 141.35 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.46 -0.775 . . . . 0.0 109.366 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.792 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 39.4 p-10 -159.46 -149.77 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.88 155.94 26.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m -145.49 139.13 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -1.068 . . . . 0.0 109.401 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -77.83 -17.78 57.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.18 110.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 34.65 0.55 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -129.63 -20.4 3.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.655 -0.653 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -45.48 108.71 0.82 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.837 . . . . 0.0 109.485 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.86 5.44 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.674 0.916 . . . . 0.0 110.152 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.651 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 47.6 m80 -94.13 -15.42 24.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -70.05 -4.72 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.506 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.0 mtpt -76.94 79.38 3.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.06 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.86 110.41 21.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -87.72 159.0 18.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -141.28 176.33 8.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.222 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 72' ' ' VAL . . . -132.64 142.07 48.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.608 -0.682 . . . . 0.0 109.574 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.19 143.0 28.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 50.81 -127.22 2.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -147.81 137.8 22.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.23 10.33 81.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.25 143.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.476 -1.014 . . . . 0.0 109.324 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 66' ' ' ALA . 2.4 m -136.83 -176.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.479 -0.763 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -141.53 126.34 18.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -95.48 148.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.36 136.75 23.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.41 136.81 15.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 78' ' ' SER . 51.3 t -74.97 -86.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -1.198 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.558 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -47.51 -53.63 13.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.359 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.55 63.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 78' ' ' SER . 45.8 m-80 51.08 45.24 28.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 0.0 109.55 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -137.24 145.67 43.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 109.332 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.95 129.41 36.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.887 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.45 150.19 19.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -144.03 165.74 26.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 109.476 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.7 ttm -137.47 126.86 24.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.378 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -91.4 -173.04 3.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.92 -29.47 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.9 1.18 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.07 78.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -91.27 117.67 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -90.04 137.34 32.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.612 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.13 177.46 9.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.736 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.18 164.64 12.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.692 -0.63 . . . . 0.0 109.417 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -149.33 159.13 44.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 109.509 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -88.44 -0.5 57.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.93 123.75 16.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.496 -0.753 . . . . 0.0 109.423 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.07 154.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -150.93 168.39 24.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -47.51 -24.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.9 49.27 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -143.38 5.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -97.4 157.61 15.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -150.01 112.94 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' ARG . 34.1 m-85 -54.92 149.14 12.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.98 . . . . 0.0 109.231 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.96 92.14 3.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.657 -0.652 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 114' ' ' THR . 10.5 ttp180 -91.47 120.19 32.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.68 126.56 32.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.91 -177.19 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.7 m -93.67 55.92 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.568 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 17.2 p-10 -165.78 31.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.95 -4.29 0.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.6 m-85 -91.31 127.61 36.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.72 167.21 11.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 14.2 p -136.17 120.57 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.85 104.18 16.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -98.45 145.82 26.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.38 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -62.56 161.34 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 0.0 109.277 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -87.15 -61.67 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.68 -44.38 56.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.504 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -92.63 57.91 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -58.25 -0.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.5 m -89.71 11.81 18.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.07 -1.019 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.03 152.59 29.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 11.4 m-85 -120.65 163.19 18.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.63 130.06 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.23 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.86 143.49 21.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.96 167.78 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -93.75 -165.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.86 -10.16 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -4.77 53.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.97 34.22 9.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.3 176.38 5.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.769 -0.842 . . . . 0.0 109.374 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.8 p90 -87.02 120.06 27.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -71.39 131.84 43.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.715 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -52.15 140.5 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.52 4.08 1.61 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.715 ' OG ' HD23 ' A' ' 135' ' ' LEU . 88.9 p -91.89 -34.61 14.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.17 . . . . 0.0 109.604 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.02 -10.76 43.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 p -70.0 145.33 51.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.5 178.96 38.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.49 166.54 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.938 1.759 . . . . 0.0 110.222 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.62 -50.47 2.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -80.41 135.08 36.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 40.6 mtmt -85.01 9.28 15.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.07 -2.54 2.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 pt -97.13 -3.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 109.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.93 91.75 8.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.632 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.54 165.51 12.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.1 tp -141.87 70.45 24.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.392 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.16 104.9 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.752 1.635 . . . . 0.0 110.36 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.7 mtt -95.31 136.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 130.4 42.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.1 153.61 57.27 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.148 1.232 . . . . 0.0 110.384 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -137.41 124.46 21.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -85.26 118.97 25.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.638 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.01 100.91 11.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -94.58 125.17 39.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.7 t -90.18 123.27 33.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -72.44 -13.91 61.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.1 m120 -90.34 105.12 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.98 5.8 88.88 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.47 85.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 43.6 m-85 -143.15 136.21 27.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -1.089 . . . . 0.0 109.568 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -98.13 122.76 41.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.403 -0.811 . . . . 0.0 109.493 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.13 145.53 20.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.179 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 59' ' ' HIS . 20.2 ttt180 -150.63 128.62 11.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.06 131.35 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.416 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 49.9 m-70 -90.5 152.09 44.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.105 -0.997 . . . . 0.0 109.193 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.56 -27.34 76.38 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.198 1.265 . . . . 0.0 110.368 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -74.88 9.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.525 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -33.73 3.28 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -47.51 166.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -1.176 . . . . 0.0 109.405 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.44 134.01 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 32.8 p-10 -159.4 155.93 27.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.33 152.19 20.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.64 149.13 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -1.108 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -82.25 -10.07 59.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.51 83.78 0.41 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -84.66 49.63 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.552 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.95 6.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 109.914 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 139.57 21.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.039 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.21 -4.37 3.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.022 1.148 . . . . 0.0 110.317 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CB ' ' NE ' ' A' ' 42' ' ' ARG . 70.1 m80 -75.0 -25.79 59.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.911 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.41 -1.95 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.322 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 77' ' ' VAL . 11.7 mmtp -83.96 87.0 7.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.93 135.64 33.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.42 104.37 16.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.341 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.82 154.8 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.22 141.25 35.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.74 136.08 33.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -140.57 122.18 15.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 60.01 164.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 108.935 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.77 32.97 0.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.77 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.23 16.76 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.742 -1.218 . . . . 0.0 110.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.54 155.67 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -1.231 . . . . 0.0 109.575 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' VAL . 4.3 m -144.07 130.02 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -92.84 125.33 37.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.828 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -104.05 142.61 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.757 . . . . 0.0 109.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -147.23 151.57 36.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.75 139.42 14.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 61' ' ' LYS . 54.4 t -78.24 -65.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -71.92 -42.54 66.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.6 65.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 49.98 51.29 16.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -146.06 145.98 30.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.377 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -89.8 133.55 34.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.579 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 44.1 tp -63.56 146.82 52.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.55 132.7 16.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.1 ttm -97.51 120.16 37.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.96 176.54 9.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.32 -26.33 30.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.18 -2.62 22.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 92.48 -14.98 63.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.6 mtt-85 -71.43 123.33 22.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.478 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -90.2 136.2 33.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.579 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -146.4 -175.44 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.65 158.7 43.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 p -145.17 170.11 16.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.321 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -79.97 -36.9 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -93.23 126.0 38.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -71.06 118.85 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 p -97.88 161.57 13.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.66 -21.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.37 55.47 2.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -139.29 3.69 2.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 79.3 m-85 -96.87 162.89 13.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 92.5 m-85 -150.15 121.94 8.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -62.18 97.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.17 95.37 2.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -92.51 123.64 35.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.75 134.32 35.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.24 -170.69 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -95.81 -17.54 21.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.659 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 4.1 p30 -94.39 26.0 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.769 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 71.52 2.61 4.34 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.726 -0.609 . . . . 0.0 110.697 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -90.29 140.58 29.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.918 -1.114 . . . . 0.0 109.443 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -95.4 164.16 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 p -141.8 119.89 12.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.332 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -91.77 105.47 17.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -96.15 145.5 25.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -68.34 148.8 50.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -80.55 -56.73 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -70.01 -46.64 64.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.1 m-85 -95.94 59.44 2.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -57.03 -2.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.9 m -89.85 10.34 24.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.678 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.08 153.02 30.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 13.8 m-85 -117.02 168.98 9.77 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.303 0.573 . . . . 0.0 109.464 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.78 133.24 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.87 177.48 9.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.1 158.36 39.86 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -93.19 170.63 9.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -78.49 -11.93 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 130' ' ' THR . 1.7 t -91.87 26.1 2.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.77 50.01 69.31 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -137.47 167.01 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.974 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.2 p90 -90.33 120.58 31.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -69.63 132.62 46.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 139' ' ' THR . 13.8 tp -54.04 160.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -78.62 -0.61 80.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.1 p -95.01 -47.23 6.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -1.12 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -72.46 -6.74 45.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 135' ' ' LEU . 3.1 p -69.95 153.52 43.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.01 -179.87 28.21 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.33 -174.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.779 1.652 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.57 -43.1 1.81 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -92.21 119.46 31.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.526 ' HB2' HD22 ' A' ' 36' ' ' ASN . 36.6 mtpt -71.05 4.53 2.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.24 -9.2 10.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.349 -0.844 . . . . 0.0 109.542 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -93.15 0.53 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.525 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 144' ' ' LYS . 70.5 mt -92.35 91.39 7.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.39 168.84 10.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.5 tp -143.07 70.43 18.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.16 107.7 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.791 1.661 . . . . 0.0 110.246 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.0 mtt -93.88 111.13 22.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.805 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 t -66.2 145.37 55.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 179.939 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.8 175.57 0.29 Allowed 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 121.251 1.301 . . . . 0.0 110.243 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -146.28 175.11 10.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.427 HH11 ' HG3' ' A' ' 31' ' ' ARG . 17.9 mtm-85 -131.01 128.1 39.67 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.45 111.0 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.774 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -101.42 114.52 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.81 108.31 17.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.491 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.737 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.1 m-80 -77.25 105.0 8.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.65 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . . . 72.3 7.05 66.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 73.98 0.27 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -118.27 129.88 55.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.73 -0.865 . . . . 0.0 109.571 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.82 113.2 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.2 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 32' ' ' LEU . 43.8 tp -49.07 133.83 18.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 109.187 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 57' ' ' ASP . 41.2 ttp180 -142.5 122.98 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.7 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.54 133.76 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.202 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -89.92 151.24 45.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.09 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.15 -18.15 28.23 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.161 1.24 . . . . 0.0 110.516 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.89 -7.88 54.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.19 55.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -94.05 163.09 13.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -1.132 . . . . 0.0 109.363 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 83' ' ' LEU . 74.5 t -129.66 126.59 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.568 -0.707 . . . . 0.0 109.315 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.61 149.99 24.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.27 151.85 22.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.25 146.12 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -1.149 . . . . 0.0 109.704 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 37' ' ' GLY . 28.2 mtt-85 -77.02 1.16 18.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.01 88.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -85.11 33.37 0.54 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.602 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -143.64 21.8 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.66 124.41 55.02 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.041 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.1 1.86 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.668 0.912 . . . . 0.0 110.28 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.4 m80 -94.07 -13.81 26.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.54 9.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.612 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -93.26 87.48 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -90.1 135.16 33.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -89.82 110.33 21.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.01 118.51 31.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.14 146.57 27.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.305 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 139.36 30.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' GLU . 28.1 tt0 -146.64 142.05 27.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . 1.5 mt-10 48.3 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -100.97 113.28 26.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 109.541 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.63 25.56 17.78 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.75 152.54 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -1.103 . . . . 0.0 109.418 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.7 m -144.49 133.41 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -92.08 118.75 31.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.554 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.89 138.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -147.04 139.6 24.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.66 142.36 20.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.44 -72.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -45.19 91.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.31 -27.35 68.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.96 50.15 19.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.421 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 5.5 mtp180 -145.89 150.05 35.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -95.29 134.31 38.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.323 -0.861 . . . . 0.0 109.766 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HG21 ' A' ' 49' ' ' VAL . 42.9 tp -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.249 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.08 148.5 29.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 47.2 ttm -106.27 132.91 51.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.371 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -72.45 -170.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.0 -45.54 26.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.707 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 1.4 p-10 -69.96 -82.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -171.18 24.61 0.09 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -89.61 124.27 34.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.2 mp -94.01 128.7 40.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.54 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.81 -173.53 4.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -140.2 152.55 46.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.404 -0.81 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.61 155.03 42.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -61.09 -36.81 80.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 99.0 p -84.93 137.55 33.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -89.08 118.12 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.9 p -93.98 -169.82 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 101' ' ' CYS . 1.7 m-20 -80.06 -30.75 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.99 15.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.448 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 99' ' ' ASP . 93.8 m -95.1 -9.32 33.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -86.74 148.8 25.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.935 . . . . 0.0 109.435 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.27 116.48 7.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -59.51 122.43 14.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.93 97.79 9.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 116.82 29.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.76 120.3 31.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' OE1' HG23 ' A' ' 114' ' ' THR . 19.4 mt-10 -84.7 -171.29 3.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.5 p -93.37 -4.35 51.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.7 m-20 -93.06 25.84 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.55 -1.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.79 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.2 m-85 -95.93 130.94 42.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -91.61 163.05 14.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.742 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.493 HG23 ' OE1' ' A' ' 108' ' ' GLU . 6.6 p -139.09 114.66 9.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.124 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -89.84 114.71 26.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.806 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.82 139.82 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.295 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -67.68 137.01 55.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.5 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 120' ' ' TYR . 25.5 ttt180 -77.98 -70.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.589 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 3.2 tptt -51.55 -10.08 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 27.6 m-85 -146.2 70.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.7 p -64.88 4.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 120' ' ' TYR . 11.2 m -94.25 10.23 34.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.88 . . . . 0.0 109.603 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 10.4 m-90 -154.97 137.37 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 22.6 m-85 -100.98 165.39 11.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.574 -0.704 . . . . 0.0 109.388 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.67 125.86 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.665 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -152.2 143.4 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -95.39 176.21 6.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -93.07 173.19 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -84.92 -4.84 59.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.434 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.94 -5.16 48.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.26 -0.66 55.95 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 2.0 mp0 -93.13 172.6 8.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -1.184 . . . . 0.0 109.532 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.9 p90 -91.61 120.22 32.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -70.2 131.84 44.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 139' ' ' THR . 13.2 tp -48.5 160.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.11 2.05 53.05 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' THR . 84.5 p -93.69 -68.17 0.82 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' N ' ' OG ' ' A' ' 137' ' ' SER . 12.3 mptt -48.18 -14.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 135' ' ' LEU . 22.3 p -69.93 150.36 46.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.42 179.84 30.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.51 158.46 31.86 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.69 -28.78 8.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -90.4 113.89 25.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.411 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -65.93 -2.25 3.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.665 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.99 -10.36 28.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 1.9 pt -90.67 2.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.499 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.4 mt -91.01 87.31 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.99 159.62 15.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.672 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 149' ' ' LEU . 19.5 tp -140.84 70.91 29.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.018 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 109.35 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.888 1.726 . . . . 0.0 110.641 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 20.6 mtt -97.5 130.94 44.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.397 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.0 t -70.08 167.99 16.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.134 -0.979 . . . . 0.0 109.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.413 -179.965 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.07 160.1 13.54 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.988 1.125 . . . . 0.0 110.174 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.69 ' HG3' HD22 ' A' ' 64' ' ' LEU . 24.8 mmtp -122.47 174.16 7.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.7 mtm-85 -136.84 110.89 8.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 41' ' ' LEU . 9.5 mt -84.06 101.28 11.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.927 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.22 115.68 27.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.7 t -78.87 111.43 15.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.576 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -20.2 66.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.3 m-80 -88.13 100.93 13.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.597 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 86.71 4.55 82.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 84.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 48.7 m-85 -142.2 131.3 23.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -1.062 . . . . 0.0 109.477 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -92.64 121.92 34.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.47 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 32' ' ' LEU . 49.2 tp -53.0 145.25 13.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.0 109.187 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 22.4 ttt180 -148.7 158.95 44.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.576 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.6 mt -136.27 123.37 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -88.15 149.69 45.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.116 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.89 -23.72 60.82 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.294 1.33 . . . . 0.0 110.699 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.476 ' OD2' ' CD ' ' A' ' 48' ' ' ARG . 36.4 p-10 -74.63 3.87 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.739 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.42 -35.31 4.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' CD ' ' OD2' ' A' ' 46' ' ' ASP . 27.0 mtp180 -47.8 152.86 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.92 144.18 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.468 -0.77 . . . . 0.0 109.428 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -167.04 -146.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.91 161.12 28.25 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.8 m -147.1 138.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.465 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 53' ' ' ARG . 4.5 mtm-85 -82.25 5.43 20.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.38 106.61 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -84.0 38.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.96 17.5 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -99.13 110.16 56.92 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.795 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 1.63 0.63 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.68 0.92 . . . . 0.0 110.127 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.1 m80 -80.6 -13.29 59.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.391 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.21 -0.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.18 87.48 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.97 131.68 35.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.454 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -89.98 102.95 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.69 HD22 ' HG3' ' A' ' 30' ' ' LYS . 10.7 mp -86.21 149.66 24.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.98 139.1 28.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.69 111.74 22.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -92.11 -91.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -84.34 180.0 7.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.8 mtt-85 -76.62 110.7 11.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.41 26.02 26.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.52 96.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -1.127 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.87 126.65 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 m -94.31 129.02 41.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.443 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.78 146.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.96 117.68 8.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.46 48.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 78' ' ' SER . 55.2 t -80.0 -80.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -1.086 . . . . 0.0 109.435 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -58.6 -35.01 71.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.79 -25.83 61.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.479 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 51.21 52.69 14.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.8 mtt-85 -147.63 143.32 27.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.9 126.78 35.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -59.88 147.49 38.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.51 170.14 17.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -140.03 128.89 23.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -73.12 -169.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -92.78 -17.5 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.4 p30 -85.44 -40.87 15.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.49 2.16 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -70.56 126.35 29.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -93.09 138.47 31.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.05 -176.56 5.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.89 157.1 44.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m -145.49 170.14 16.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.831 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -42.88 33.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 p -89.43 142.86 27.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.5 p -85.23 116.99 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.417 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -96.01 178.88 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -22.81 67.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -94.08 54.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.814 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.2 m -137.43 0.56 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 83.9 m-85 -94.87 153.17 17.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.386 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 82.2 m-85 -147.84 120.14 8.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -59.74 154.19 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -125.25 97.24 5.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.684 -0.635 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.98 116.74 28.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.89 112.33 24.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -84.89 167.72 15.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.883 . . . . 0.0 109.528 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.0 t -81.49 66.39 7.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 112' ' ' TYR . 33.0 p30 -167.58 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 63.49 -7.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.517 -0.739 . . . . 0.0 110.057 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 110' ' ' ASN . 54.8 m-85 -98.32 120.12 38.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -93.25 170.05 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.833 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 p -134.08 121.64 21.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.344 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.44 105.01 16.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 121' ' ' THR . 27.9 ttt180 -94.78 147.06 23.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.855 . . . . 0.0 109.454 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -74.01 158.26 34.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -93.67 -75.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 10.4 tptm -51.44 -9.93 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.1 m-85 -142.97 63.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.467 -0.771 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.521 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 30.2 p -63.27 2.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 57.8 m -91.01 11.97 21.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.06 145.27 21.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 116' ' ' ARG . 27.9 m-85 -109.96 168.16 9.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.741 -0.6 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.7 t -92.93 131.43 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.4 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -148.26 -172.54 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 95.5 mt -138.49 149.8 45.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -61.09 -102.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.5 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 31.3 ptt180 -173.76 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.417 -0.802 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 130' ' ' THR . 1.8 t -92.53 22.11 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.616 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.75 6.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -136.4 158.7 43.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.956 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 31.0 p90 -95.02 120.46 35.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.816 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -69.74 135.26 49.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.606 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.2 tp -58.06 157.34 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.279 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -79.39 22.19 3.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.606 ' OG ' HD23 ' A' ' 135' ' ' LEU . 3.5 p -98.57 -60.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.362 -1.081 . . . . 0.0 109.554 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -71.93 -7.5 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 135' ' ' LEU . 23.7 p -70.12 146.84 50.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.89 179.77 42.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.84 172.71 2.71 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.864 1.709 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.1 -42.11 2.5 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -72.52 134.68 45.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.0 mtpp -85.09 -4.13 59.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -61.48 -3.72 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 144' ' ' LYS . 3.0 pt -99.2 -3.23 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.2 mt -82.24 93.95 7.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 109.591 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.26 161.06 13.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.808 . . . . 0.0 109.529 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.4 tp -133.32 75.73 69.74 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.672 . . . . 0.0 109.23 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.25 111.08 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.712 1.608 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.3 mtt -96.37 114.99 26.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.6 t -70.2 129.07 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.414 179.936 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.09 174.41 0.33 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.115 1.21 . . . . 0.0 110.08 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' HD22 ' A' ' 64' ' ' LEU . 9.7 mtpp -147.22 131.04 17.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.9 mtt-85 -85.89 121.18 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.056 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 41' ' ' LEU . 19.7 mt -84.5 104.91 14.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.98 117.14 33.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.585 -0.697 . . . . 0.0 109.6 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.39 116.45 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.164 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -65.48 -24.5 67.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.06 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.82 105.14 14.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 83.24 4.34 89.69 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.41 83.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 47.8 m-85 -141.48 140.53 33.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -1.103 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -100.88 134.24 44.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 32' ' ' LEU . 44.7 tp -70.13 144.12 52.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 41.1 ttp180 -152.82 129.1 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -103.33 136.28 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.518 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 5.5 m-70 -91.73 148.89 38.16 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.066 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.14 -17.66 46.93 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.095 1.197 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 7.4 p30 -74.84 -10.48 59.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.776 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 15.15 29.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.6 mtt-85 -92.65 167.44 11.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -1.19 . . . . 0.0 109.333 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.7 t -142.94 117.73 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.402 -0.811 . . . . 0.0 109.274 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 4.3 p-10 -158.23 160.29 36.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.637 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.11 152.99 20.94 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.7 155.06 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.481 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -75.26 -30.66 60.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.461 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' OE2' ' OD1' ' A' ' 57' ' ' ASP . 2.6 mt-10 -47.26 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 53' ' ' ARG . 8.8 pttp -85.24 33.82 0.56 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.946 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -165.23 43.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.09 -1.006 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.2 156.88 38.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.957 . . . . 0.0 109.188 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -66.15 22.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 121.508 1.472 . . . . 0.0 111.051 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . 61.7 m80 -141.71 -15.51 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.029 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -64.81 -5.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -88.39 90.81 8.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.434 HD12 ' CD1' ' A' ' 32' ' ' LEU . 15.4 mt -89.96 135.38 33.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 64' ' ' LEU . 2.4 tp-100 -89.67 106.49 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -86.92 155.59 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.72 121.8 12.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.847 . . . . 0.0 109.246 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.83 157.57 26.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.93 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -148.06 135.42 20.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 50.75 -112.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -153.52 124.64 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.11 -17.87 35.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.29 146.02 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.669 -0.9 . . . . 0.0 109.332 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 m -146.43 175.34 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -143.97 128.77 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.73 147.84 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.565 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 5.7 tttp -147.49 134.27 20.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.62 130.85 10.3 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.36 -74.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -1.13 . . . . 0.0 109.496 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 2.1 t -66.42 -45.25 80.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -27.55 39.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 78' ' ' SER . 16.3 m-80 49.79 47.48 22.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.513 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 92.4 mtt180 -147.28 144.67 29.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 70.7 m-85 -90.15 131.69 35.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.602 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.33 142.63 56.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.206 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -148.29 134.49 19.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 53.7 ttm -96.65 126.58 41.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.395 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -72.25 178.8 3.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 -31.59 45.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -70.98 -48.26 54.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.06 -9.11 1.52 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -71.27 124.71 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.489 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.3 mp -92.74 133.87 35.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.553 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -147.59 177.78 8.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -116.83 156.64 26.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.626 . . . . 0.0 109.373 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -145.34 162.91 36.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -82.98 -39.79 20.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.1 t -92.63 122.76 35.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.14 154.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -147.53 -177.12 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -22.55 64.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -87.68 44.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 22.0 m -143.17 5.45 1.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 59.7 m-85 -93.42 151.89 19.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 0.0 109.563 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 84.1 m-85 -150.16 110.59 4.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.882 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -56.96 155.14 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.137 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -125.19 95.35 4.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.369 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' NH2' ' OE1' ' A' ' 108' ' ' GLU . 6.2 ttp180 -90.76 132.36 35.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.21 132.45 36.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' OE1' ' NH2' ' A' ' 106' ' ' ARG . 4.5 mm-40 -88.35 -174.67 4.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -16.46 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.908 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.404 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 5.7 m-80 -93.44 24.24 4.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 64.11 57.32 1.28 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 110.056 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 52.7 m-85 -143.02 126.39 16.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.257 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.73 120.36 34.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 146' ' ' ILE . 66.8 p -98.1 129.06 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.405 -0.809 . . . . 0.0 109.224 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -95.89 113.03 24.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -100.81 144.89 29.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.378 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -76.24 139.95 41.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 109.582 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.474 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.2 ttt-85 -76.47 -70.63 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -51.37 -9.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.409 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' N ' ' C ' ' A' ' 118' ' ' ARG . 49.7 m-85 -143.86 68.22 1.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.5 p -67.06 3.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 120' ' ' TYR . 73.5 m -95.63 10.55 36.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.82 . . . . 0.0 109.652 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 5.1 m-90 -155.13 145.18 21.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.848 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.3 m-85 -112.01 161.47 16.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.75 -0.594 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.74 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.199 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 -171.37 3.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.808 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 133' ' ' TYR . 19.4 mt -140.78 159.46 42.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.523 -0.736 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -87.56 -173.54 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.86 -15.53 26.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.613 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.542 HG23 ' OE1' ' A' ' 132' ' ' GLN . 1.5 t -89.09 3.5 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.05 76.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 130' ' ' THR . 3.6 mp0 -86.11 174.76 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -1.175 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 35.5 p90 -95.02 120.43 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.68 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -69.85 135.42 49.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.396 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -49.31 149.35 2.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.245 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.21 0.28 59.66 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 35.7 p -93.99 -37.96 11.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -1.123 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -76.82 -8.2 56.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -71.95 160.32 32.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 153.3 179.69 28.98 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -61.11 -176.62 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.922 1.748 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.46 -36.78 0.98 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 145' ' ' ALA . 5.2 mt-30 -93.34 113.46 25.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -1.084 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 146' ' ' ILE . 19.5 mtmt -65.83 2.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.6 2.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.644 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' THR . 5.6 pt -100.66 6.35 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.35 94.81 8.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -98.3 164.3 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.811 . . . . 0.0 109.37 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -142.01 70.82 23.66 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.841 . . . . 0.0 109.52 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.81 107.84 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.929 1.753 . . . . 0.0 110.324 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 8.8 mtt -96.18 128.99 43.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.516 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.9 t -70.12 153.2 43.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.578 ' CB ' HH22 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.14 171.45 2.27 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.21 1.273 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -145.15 126.93 15.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.04 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.5 mtt-85 -84.81 117.09 23.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.653 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 41' ' ' LEU . 18.7 mt -84.63 99.07 10.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.97 124.2 36.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 t -90.51 120.31 31.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.212 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -67.94 -14.87 63.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.63 105.22 17.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.642 -179.856 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.21 4.94 87.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.85 86.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.2 m-85 -144.77 138.26 27.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.302 -1.116 . . . . 0.0 109.65 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.48 121.63 38.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.0 109.423 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 32' ' ' LEU . 41.4 tp -49.36 150.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.203 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -156.61 119.51 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 mt -92.55 129.18 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.191 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.99 151.99 45.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.8 -26.75 75.12 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.27 1.313 . . . . 0.0 110.378 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -74.79 10.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -37.41 2.98 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.621 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.8 mtt-85 -47.17 154.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -1.187 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 83' ' ' LEU . 95.7 t -134.16 130.42 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -146.24 -149.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.42 150.44 22.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.16 144.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -77.64 -16.67 58.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -59.97 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.384 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.12 12.36 3.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.554 -179.908 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -108.92 10.91 26.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 109.597 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -95.05 123.48 57.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.18 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.13 4.92 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 120.636 0.891 . . . . 0.0 110.331 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 57' ' ' ASP . 24.1 m80 -82.53 -38.41 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.879 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -65.52 4.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.577 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 59' ' ' HIS . 14.5 mttt -87.24 84.08 7.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.37 134.28 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.83 108.23 19.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.371 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -144.2 144.51 31.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.412 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.27 126.36 36.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.948 . . . . 0.0 109.505 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -97.48 -30.21 13.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -153.67 -171.88 4.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -0.926 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -82.95 23.53 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.579 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.63 23.72 0.1 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.31 151.0 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.3 m -145.2 127.18 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -94.5 122.22 36.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.583 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 74' ' ' ILE . 8.3 mt -94.4 145.75 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -147.37 130.78 16.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.32 133.81 13.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.19 -65.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -1.15 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -61.64 -34.19 75.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.64 34.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 50.97 50.82 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -148.11 148.53 30.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -89.95 134.89 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 49' ' ' VAL . 39.5 tp -65.09 147.75 52.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.65 170.3 17.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.7 ttm -139.11 129.05 25.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.529 -0.732 . . . . 0.0 109.409 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -75.07 178.71 5.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.39 -7.84 59.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.7 p30 -92.72 -46.29 7.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.33 -9.16 1.46 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -71.93 127.86 33.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.9 mp -91.68 139.16 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.662 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.08 -176.06 5.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.57 160.08 40.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.291 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 76.8 p -147.14 170.02 18.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -80.98 -36.86 30.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 p -91.23 126.17 36.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.7 p -72.98 116.31 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.51 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.7 p -93.64 -170.16 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.92 -10.85 59.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -93.78 12.55 25.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 59.2 m -95.68 8.93 42.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.627 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -97.74 148.65 23.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 63.2 m-85 -150.13 113.37 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -55.26 152.02 8.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 108.928 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -125.07 94.71 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -92.69 128.42 38.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.936 . . . . 0.0 109.4 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.29 137.99 32.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.664 ' OE2' HG23 ' A' ' 114' ' ' THR . 2.5 mp0 -92.67 -178.34 4.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -94.24 47.74 1.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -156.14 23.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.13 49.77 1.95 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.53 -0.731 . . . . 0.0 110.012 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' ' OE2' ' A' ' 108' ' ' GLU . 52.3 m-85 -140.63 129.87 23.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.6 154.6 17.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.631 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.664 HG23 ' OE2' ' A' ' 108' ' ' GLU . 23.3 p -131.38 119.32 21.51 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -93.32 107.74 19.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -101.53 148.12 25.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.294 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -72.57 157.11 38.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.965 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.96 -76.52 0.48 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -51.29 -10.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 118' ' ' ARG . 31.2 m-85 -142.89 63.78 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 p -63.32 3.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.775 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.7 m -89.86 11.68 19.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.606 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.14 145.36 22.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 109.839 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.2 m-85 -113.79 167.51 10.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.766 -0.584 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.49 129.37 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.32 149.38 26.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 19.7 mt -107.11 176.56 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.535 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.46 -166.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 109.28 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -17.29 23.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.366 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.1 1.96 55.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.423 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.25 12.21 56.46 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -93.52 142.63 27.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -1.192 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 24.5 p90 -69.09 120.67 15.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 127' ' ' LEU . 2.8 ttpm? -69.65 130.5 42.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.418 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.5 148.34 1.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.38 -31.68 81.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.418 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -77.46 -15.55 59.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -1.174 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -89.31 -4.96 57.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.0 p -87.33 156.68 19.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 167.34 179.94 40.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.93 166.52 10.29 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.866 1.711 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.32 1.9 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.25 106.46 6.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -66.42 -3.0 5.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.528 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.585 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.5 -6.27 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.408 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 146' ' ' ILE . 4.9 pt -93.75 -1.52 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.497 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.11 90.35 8.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -94.92 167.98 11.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.7 tp -144.49 73.87 15.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.446 -0.784 . . . . 0.0 109.251 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.97 115.16 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.75 1.633 . . . . 0.0 110.629 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.0 mtt -96.33 107.01 19.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -63.97 147.02 53.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.75 168.66 2.2 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 121.147 1.231 . . . . 0.0 110.168 179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -144.86 128.75 17.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.825 . . . . 0.0 109.376 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.35 118.82 25.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 20.7 mt -84.86 98.84 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 40' ' ' PHE . 37.3 t80 -94.98 122.13 37.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.685 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.24 131.48 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.184 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.57 -18.78 58.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.756 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 3.0 m120 -82.15 105.08 12.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 109.608 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.84 4.92 88.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 84.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.6 m-85 -143.17 134.95 26.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -1.112 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 22.8 m-85 -96.68 126.27 41.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 49.7 tp -51.22 149.3 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.35 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 17.7 ttt180 -158.26 116.02 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.0 mt -91.81 128.97 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.236 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -89.44 151.64 46.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 0.0 109.055 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.18 -24.02 64.72 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.113 1.208 . . . . 0.0 110.254 179.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -74.9 2.5 10.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.602 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.4 -32.25 5.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -47.36 162.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -1.114 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -143.6 128.33 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -155.99 -150.28 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.419 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.38 27.7 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.73 149.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -1.083 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -81.92 -15.72 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 99.87 3.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.379 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -80.61 12.26 3.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -92.26 -20.11 21.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.542 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.7 OUTLIER -60.02 115.01 11.23 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.256 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.94 3.45 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.633 0.889 . . . . 0.0 110.185 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.4 m-70 -85.07 -12.33 53.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.4 9.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.9 mmmm -92.53 84.57 5.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.27 134.48 34.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.59 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.65 109.77 21.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.56 114.88 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -99.01 142.85 29.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.6 161.56 14.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -145.21 -102.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.31 -154.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -90.43 106.61 18.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.88 -9.19 73.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.82 133.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.1 129.03 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.382 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.1 m -93.65 123.76 37.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.87 141.47 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -146.13 146.65 30.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.69 14.84 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' LYS . 99.1 t -79.94 -46.25 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -1.163 . . . . 0.0 109.558 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.67 -43.37 11.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.23 66.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 51.31 49.16 21.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.3 mtt180 -147.99 147.5 29.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.32 135.26 34.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.3 tp -64.95 145.19 56.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.203 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.86 135.34 18.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.9 ttm -98.18 138.89 34.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.455 -0.778 . . . . 0.0 109.453 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HE2' HD21 ' A' ' 92' ' ' LEU . 10.4 mmtm -92.48 178.0 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 4.6 pm0 -80.54 -25.49 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.6 p30 -83.16 -1.56 53.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.475 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 93.69 2.26 65.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -78.36 115.18 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -90.63 132.24 35.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.549 HD21 ' HE2' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -146.55 -172.04 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.483 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.31 152.66 47.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -145.03 170.01 16.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -83.47 -23.49 32.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 63.5 m -93.12 151.85 19.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.64 113.8 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -93.18 177.02 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.46 -17.74 61.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 22.9 mp0 -93.17 16.67 12.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.3 m -92.94 -7.18 46.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 68.1 m-85 -93.01 153.41 18.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 74.1 m-85 -146.47 116.38 7.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -56.11 159.4 3.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -125.13 141.77 51.9 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 97.86 3.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.72 131.33 42.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.39 -170.87 2.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.842 . . . . 0.0 109.385 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.87 -4.65 52.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.465 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -94.48 26.42 3.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.44 -0.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.4 m-85 -93.7 137.21 33.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.84 165.81 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 109.757 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.8 p -143.92 119.38 10.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.434 -0.791 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.66 113.54 25.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.75 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -97.21 143.23 28.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 109.302 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -60.67 162.18 6.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 109.383 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 121' ' ' THR . 61.2 ttt180 -92.68 -62.88 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -48.1 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.1 m-85 -93.89 60.46 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 118' ' ' ARG . 80.4 p -56.96 -0.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.56 11.38 19.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.01 146.47 23.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.769 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.2 m-85 -109.31 169.82 8.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.656 -0.652 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.65 133.55 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.372 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.35 -175.69 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.09 165.82 26.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -94.24 177.72 5.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -92.88 -14.15 28.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.3 t -93.32 32.69 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.6 50.96 60.88 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -142.26 166.53 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -1.078 . . . . 0.0 109.513 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -90.62 120.25 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -69.88 132.48 46.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -53.34 134.45 39.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.0 109.352 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.57 -0.55 1.99 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -93.04 -29.65 15.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.586 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -89.73 -4.88 57.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.3 p -72.98 144.1 47.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.15 -179.96 45.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.05 169.92 5.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.883 1.722 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.25 -53.61 3.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -73.53 134.74 43.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -1.172 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -83.44 7.67 16.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.437 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.1 -9.37 16.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.2 pt -90.14 -5.51 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.351 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' ' 144' ' ' LYS . 52.3 mt -87.1 90.03 8.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -94.78 164.55 12.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 149' ' ' LEU . 39.8 tp -141.82 70.98 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 109.17 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 106.35 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.953 1.769 . . . . 0.0 110.448 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.9 mtt -95.95 123.45 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.312 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.7 t -67.41 157.67 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.963 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 168.02 3.09 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.098 1.199 . . . . 0.0 110.247 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.9 mttt -141.96 139.0 32.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.362 -0.836 . . . . 0.0 109.249 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -89.91 122.26 32.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.1 mt -84.95 97.24 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.621 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -95.75 113.8 25.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.31 118.07 23.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 109.377 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.85 -16.5 63.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 26.8 m-80 -86.31 104.13 15.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.01 4.84 89.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 83.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -142.82 132.57 23.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.358 -1.083 . . . . 0.0 109.533 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.79 114.96 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.6 tp -47.65 143.09 4.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 17.1 ttt180 -150.15 117.1 5.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 126.34 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.137 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -87.97 152.02 50.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.23 -22.77 58.79 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.126 1.217 . . . . 0.0 110.266 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -74.75 8.8 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.23 -36.18 3.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.4 mtt-85 -47.15 164.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -138.35 123.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -152.61 151.38 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.84 162.77 25.42 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -146.69 148.97 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -1.127 . . . . 0.0 109.549 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -82.18 10.26 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.425 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -93.71 94.84 8.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.714 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -75.33 -5.14 43.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 p -94.48 16.72 14.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -91.14 114.28 61.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.14 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.88 2.5 0.58 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.615 0.877 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 42.8 m80 -86.29 -11.38 52.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.47 -4.73 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 77' ' ' VAL . 20.8 mmtm -76.65 83.76 3.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.947 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.75 135.1 33.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -90.17 113.07 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -92.17 153.78 19.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.416 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -145.55 149.72 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.88 150.71 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.12 130.84 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.43 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 50.84 -107.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 6.7 ptm180 -154.91 129.79 9.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.77 29.12 73.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.95 96.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -1.16 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 72' ' ' VAL . 2.4 m -94.58 129.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -92.69 121.69 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -89.95 148.44 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -148.77 140.98 24.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.73 145.64 20.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 78' ' ' SER . 76.2 t -79.5 -86.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 109.488 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.464 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -47.36 -55.07 9.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -30.33 64.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 78' ' ' SER . 73.9 m-80 51.32 44.62 28.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 30.2 mtt180 -137.2 145.26 43.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.56 -0.713 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.17 136.21 33.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.416 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 55.2 tp -63.73 151.5 41.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.277 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.4 158.08 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.42 ' CE ' HD21 ' A' ' 91' ' ' LEU . 41.5 ttm -139.26 130.45 26.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HE3' HD21 ' A' ' 92' ' ' LEU . 3.1 mptp? -94.18 -171.22 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.44 -15.39 25.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.56 -5.51 59.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 94.36 7.78 60.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 91' ' ' LEU . 98.9 mtt180 -85.15 108.21 17.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.384 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.757 ' N ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -94.18 131.55 39.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.8 pp -150.07 173.14 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.567 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -105.03 159.62 15.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.702 . . . . 0.0 109.497 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -150.13 163.4 38.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.0 109.454 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -88.55 -34.18 17.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -93.66 130.71 39.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.7 p -81.93 103.5 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.42 ' C ' ' N ' ' A' ' 100' ' ' GLU . 69.7 p -96.0 165.2 12.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.43 -17.77 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.42 ' N ' ' C ' ' A' ' 98' ' ' THR . 2.5 mp0 -92.72 49.61 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -143.4 6.49 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -96.66 154.23 17.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 0.0 109.464 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 90.0 m-85 -150.02 115.68 5.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.95 152.27 7.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.201 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -125.13 89.86 3.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.626 . . . . 0.0 109.4 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -89.92 120.87 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.358 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 tp -91.6 119.92 31.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.311 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -84.92 -172.84 4.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 111' ' ' ASN . 13.0 p -92.78 -20.27 20.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.2 m120 -74.32 25.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.562 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.3 m120 60.65 -0.7 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.726 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 46.4 m-85 -98.71 133.45 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.1 m120 -93.14 170.14 9.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 p -141.25 113.26 7.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.429 -0.795 . . . . 0.0 109.277 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -89.96 105.98 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 121' ' ' THR . 13.7 ttt180 -96.17 151.04 19.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -76.13 155.62 34.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -91.24 -74.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.4 tptt -52.34 -9.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.656 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 17.5 m-85 -142.96 67.19 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.371 -0.83 . . . . 0.0 109.495 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.523 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 23.4 p -65.12 5.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 68.0 m -89.73 7.16 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.745 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.1 m-90 -154.62 167.59 29.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.76 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 12.7 m-85 -131.52 168.28 17.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.727 -0.608 . . . . 0.0 109.375 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.0 t -86.07 125.5 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 109.338 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.11 163.57 39.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.0 mt -119.56 161.69 20.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -79.27 -99.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.154 -0.966 . . . . 0.0 109.492 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.91 -36.7 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.735 HG23 ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -78.27 10.33 3.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 6.54 67.94 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.735 ' OE1' HG23 ' A' ' 130' ' ' THR . 1.9 mp0 -84.82 167.54 15.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.536 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.5 p90 -93.73 120.1 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.619 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -69.91 126.42 29.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -46.73 145.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -71.28 8.23 5.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -91.0 -34.65 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -90.0 -7.43 54.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 p -70.27 151.78 44.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 158.11 -179.31 33.9 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.95 169.99 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.848 1.699 . . . . 0.0 110.137 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.47 -49.63 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -72.44 131.58 42.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.578 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 3.5 mtpt -85.02 3.68 37.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.44 -2.53 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 23.2 pt -97.29 -3.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.798 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.84 99.39 9.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 109.53 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.37 159.29 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.08 72.17 46.98 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.64 117.67 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.824 1.683 . . . . 0.0 110.538 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 15.1 mtt -96.54 127.19 42.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 0.0 109.263 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 t -70.09 161.82 29.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.961 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.7 171.73 1.87 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.177 1.251 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -138.54 130.88 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.217 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.6 mtm-85 -84.99 116.95 23.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 41' ' ' LEU . 25.0 mt -84.78 95.66 9.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -91.47 116.2 28.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 t -83.61 105.0 14.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 109.169 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -57.65 -23.61 52.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.601 -179.71 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 15.4 m-80 -78.15 104.95 9.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 77.79 4.73 85.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.54 86.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' CZ ' ' NH1' ' A' ' 53' ' ' ARG . 48.3 m-85 -144.26 135.46 25.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 109.285 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -92.34 137.27 32.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 32' ' ' LEU . 50.9 tp -75.4 143.42 42.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.734 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 30.9 ttm180 -146.48 122.52 10.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.04 107.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.447 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 61.1 m-70 -66.95 151.95 96.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.098 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.04 -29.57 74.74 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.118 1.212 . . . . 0.0 110.398 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.97 5.59 4.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.461 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 -26.27 5.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -51.53 115.99 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -1.145 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.63 127.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 7.2 p-10 -154.13 152.25 30.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.32 25.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 42' ' ' ARG . 33.8 m -149.1 152.49 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.607 ' NH1' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -76.13 -27.87 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.277 179.847 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -47.86 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -85.19 25.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.733 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 p -152.15 35.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.026 . . . . 0.0 109.991 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.41 140.02 25.41 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 108.911 179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.11 -4.68 4.07 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 121.1 1.2 . . . . 0.0 110.453 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 61' ' ' LYS . 69.4 m80 -94.49 -23.66 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.241 -179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 60' ' ' ILE . 1.3 pt -69.1 8.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 59' ' ' HIS . 3.2 mmmm -94.4 87.86 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 109.425 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.2 mt -93.84 135.08 35.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.24 109.53 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.84 151.06 19.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.27 150.4 36.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' OE1' ' A' ' 65' ' ' GLN . . . -94.31 150.76 19.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.78 -83.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.552 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.32 -147.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -92.29 127.03 37.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.412 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.55 33.99 68.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.57 101.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.69 -0.888 . . . . 0.0 109.372 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.1 m -103.09 126.03 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.686 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 m -89.84 122.99 33.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.93 148.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -146.15 139.99 26.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.9 133.6 11.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 26.1 t -77.79 -72.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.4 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -62.88 -39.97 96.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.61 63.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 18.5 m-80 50.95 50.82 18.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -147.44 147.97 30.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -91.54 127.93 37.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.58 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.64 149.82 20.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.366 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.32 170.25 18.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.404 ' CE ' HD11 ' A' ' 91' ' ' LEU . 23.9 ttm -138.29 131.37 30.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.0 109.433 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -85.86 -166.46 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -90.1 -33.88 16.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.56 -1.74 11.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.89 70.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.22 125.99 29.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -1.215 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 mp -92.13 135.83 33.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.675 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -149.42 -173.06 4.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.46 158.94 43.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.78 169.94 18.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -82.49 -27.98 31.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.8 m -92.87 160.13 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.516 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.1 t -92.83 156.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 72.1 p -147.35 160.06 42.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.59 -16.19 35.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -93.99 8.17 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.5 -4.57 50.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 109.79 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 93.5 m-85 -92.2 159.92 15.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 91.7 m-85 -150.94 119.13 6.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.32 147.57 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.974 -1.079 . . . . 0.0 109.334 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -125.33 97.77 5.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.674 -0.641 . . . . 0.0 109.318 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.72 128.42 41.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.568 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 112' ' ' TYR . 17.5 tp -94.67 121.51 36.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.77 -175.72 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -92.98 -25.06 18.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.635 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -74.17 18.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 109' ' ' SER . 2.5 m120 63.92 65.17 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.401 ' O ' HD12 ' A' ' 107' ' ' LEU . 40.5 m-85 -144.92 -168.87 3.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.133 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -146.64 113.34 6.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.755 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -94.62 111.71 23.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.264 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.51 109.01 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -100.27 150.88 22.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.75 166.89 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -95.3 -57.82 2.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.388 179.913 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -82.08 -49.29 10.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.1 m-85 -91.7 61.25 4.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -57.11 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 0.0 110.711 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 120' ' ' TYR . 45.6 m -89.02 11.02 19.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.78 -1.2 . . . . 0.0 109.619 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.4 m-90 -152.48 159.38 43.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 21.2 m-85 -123.06 169.83 10.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.716 -0.615 . . . . 0.0 109.413 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.55 133.27 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -150.13 178.09 9.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 109.673 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.0 157.68 46.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.646 -0.659 . . . . 0.0 109.383 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -93.94 -166.58 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.334 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -93.87 -10.08 35.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.5 t -90.1 -7.86 52.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.97 60.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -93.77 173.95 7.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -1.11 . . . . 0.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 38.4 p90 -92.6 120.35 32.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -70.01 136.4 50.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 137' ' ' SER . 13.8 tp -59.78 127.49 32.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -49.16 -10.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 135' ' ' LEU . 21.4 p -75.51 -36.55 60.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -1.211 . . . . 0.0 109.642 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -89.96 -5.19 56.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.675 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.5 p -83.7 138.73 33.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.9 179.5 48.65 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.96 165.62 11.83 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.874 1.716 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.34 -58.87 3.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 145' ' ' ALA . 26.2 mm-40 -70.75 120.83 16.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -1.191 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 19.1 mtmm -63.51 1.68 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.1 -4.66 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -99.86 4.75 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.9 mt -91.86 109.82 21.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -113.0 162.06 16.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.6 tp -140.2 70.69 34.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.73 111.37 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.93 1.753 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.1 mtt -94.37 99.88 12.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.325 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 t -56.75 133.41 54.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.977 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.07 172.04 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.197 1.265 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 64' ' ' LEU . 34.9 mttm -148.03 128.1 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.16 120.47 26.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.78 104.81 15.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.671 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -104.47 123.08 46.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.54 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.44 136.86 32.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -82.4 -25.77 33.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.626 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.3 m120 -74.95 105.07 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.704 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.38 4.93 89.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.45 87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.0 m-85 -143.81 136.44 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -1.067 . . . . 0.0 109.689 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -95.54 124.6 39.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.318 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.52 144.43 26.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.151 -0.968 . . . . 0.0 109.149 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 19.6 ttt180 -148.01 119.77 8.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.743 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -94.44 128.37 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.082 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -91.66 151.89 42.8 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.216 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.35 -27.79 77.11 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.178 1.252 . . . . 0.0 110.317 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -74.91 1.84 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.63 -31.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -50.2 118.5 3.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.463 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 148.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -169.57 -162.9 0.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.32 158.48 27.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.87 143.6 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -1.087 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -74.39 -1.39 20.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.66 92.55 8.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -85.17 56.42 3.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.2 p -155.49 13.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 110.096 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.6 m-20 -93.25 145.68 30.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.983 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.56 0.82 1.25 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.106 1.204 . . . . 0.0 110.338 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 57' ' ' ASP . 77.5 m80 -91.35 -29.21 17.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 110.187 -179.233 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -69.16 4.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.971 -1.08 . . . . 0.0 109.351 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 59' ' ' HIS . 10.7 mtpt -93.02 82.87 4.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -93.39 134.04 36.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.387 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -94.04 123.27 37.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.94 156.34 17.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -144.94 125.04 13.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.04 165.29 22.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.56 -98.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.391 -0.818 . . . . 0.0 109.206 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 2.3 mt-10 -84.67 -172.62 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.049 -1.032 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 10.9 mpt_? -72.96 107.74 5.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.9 68.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 68' ' ' GLU . 12.5 t -92.97 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.22 170.63 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.505 ' OG ' ' CD2' ' A' ' 102' ' ' PHE . 4.6 m -148.94 134.99 19.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 75' ' ' LYS . 82.1 mt -93.14 155.94 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.501 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' N ' HG22 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -149.36 139.8 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.62 127.33 9.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.94 -61.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.461 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -27.05 68.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.88 -23.98 21.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 51.66 51.2 17.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -148.08 145.96 28.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.516 ' CG ' HG22 ' A' ' 97' ' ' VAL . 86.8 m-85 -96.03 125.09 40.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -58.98 145.1 42.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.244 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.1 130.83 14.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 ttm -90.5 104.25 16.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.546 ' HG3' HD21 ' A' ' 92' ' ' LEU . 23.6 mmtt -62.91 166.46 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.527 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -78.51 -22.07 47.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -73.63 -5.85 43.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.95 -7.75 70.12 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -77.95 123.91 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.344 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.8 mp -89.77 124.26 34.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.209 -0.932 . . . . 0.0 109.128 179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -148.43 -170.33 3.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 109.611 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.16 161.13 39.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 p -146.49 153.19 40.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -59.11 -38.37 79.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.87 157.67 20.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' CG ' ' A' ' 82' ' ' TYR . 28.1 t -93.1 117.45 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.7 p -89.19 173.01 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.46 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -94.13 24.89 4.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.558 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 18.0 m -93.87 -8.81 39.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.583 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' OG ' ' A' ' 73' ' ' SER . 77.8 m-85 -93.99 158.56 15.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.593 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 86.7 m-85 -148.13 116.58 6.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.35 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -55.1 124.56 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -88.48 147.94 24.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -148.1 120.13 8.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.515 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.9 131.0 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -175.69 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -90.96 -4.48 56.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.466 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 112' ' ' TYR . 12.8 m-80 -93.48 27.89 2.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.501 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 63.64 -7.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.488 -0.758 . . . . 0.0 110.126 179.807 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.5 m-85 -84.14 -173.06 4.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.27 167.12 24.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -142.43 169.96 16.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.301 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -143.83 110.93 5.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.359 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -94.94 145.52 24.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -63.98 162.12 14.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 121' ' ' THR . 1.7 ttt-85 -92.36 -63.71 1.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.714 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -64.9 -47.8 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.731 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.5 m-85 -99.59 63.85 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.57 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -59.76 2.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.9 m -89.81 14.02 13.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.041 -1.037 . . . . 0.0 109.772 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.07 145.75 22.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.948 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -107.71 166.93 10.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.36 125.49 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.67 159.06 40.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.8 mt -108.1 179.39 4.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.658 -0.651 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -95.24 -112.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CB ' HH11 ' A' ' 129' ' ' ARG . 0.0 OUTLIER -147.38 -32.59 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 -179.889 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -79.31 3.6 17.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.492 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.64 56.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -94.12 167.5 11.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -86.64 120.36 27.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -69.84 133.71 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -59.15 138.04 57.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.227 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -70.95 11.9 2.39 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.686 ' OG ' HD23 ' A' ' 135' ' ' LEU . 99.4 p -94.57 -37.78 11.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -1.15 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -88.78 -6.05 57.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.55 ' C ' HE22 ' A' ' 143' ' ' GLN . 32.3 p -70.97 158.01 37.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.496 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.675 ' N ' HE22 ' A' ' 143' ' ' GLN . . . 161.35 -179.47 36.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.89 159.5 29.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.883 1.722 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.43 -27.48 9.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.675 HE22 ' N ' ' A' ' 140' ' ' GLY . 7.5 mt-30 -84.82 128.28 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.626 ' HB2' HD22 ' A' ' 36' ' ' ASN . 6.7 mtmp? -82.78 -3.75 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.419 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.595 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.16 -14.84 41.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pt -84.76 2.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 144' ' ' LYS . 73.7 mt -91.62 90.52 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.83 166.91 11.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.6 tp -141.93 70.42 24.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.722 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.01 105.75 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.791 1.661 . . . . 0.0 110.418 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.6 mtt -94.81 125.36 39.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.378 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 137.57 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.517 179.967 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.01 154.96 41.51 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.178 1.252 . . . . 0.0 110.243 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -124.67 122.61 37.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.95 118.62 24.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 41' ' ' LEU . 16.2 mt -84.82 102.89 13.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.586 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -95.82 123.45 39.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.322 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -91.88 117.56 29.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.4 -14.68 57.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.0 m-20 -83.4 105.02 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.32 4.86 65.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.92 75.65 0.21 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.41 133.0 51.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.698 -0.883 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.77 117.86 30.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 32' ' ' LEU . 36.6 tp -48.74 137.58 12.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.249 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 7.2 ttt180 -148.23 119.97 8.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.645 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.8 113.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.103 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -76.18 149.47 82.17 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.525 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.1 Cg_endo -58.52 -24.05 67.63 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.13 1.22 . . . . 0.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 18.6 p30 -74.9 2.22 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.39 -33.76 4.61 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.14 114.75 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.4 125.03 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 4.7 p-10 -155.37 -152.96 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -144.07 161.34 27.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.29 142.63 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 109.505 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -77.1 1.48 17.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.31 83.84 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 55.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 m -145.43 6.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 109.872 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 59' ' ' HIS . 28.2 m-20 -94.27 138.93 22.34 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.91 . . . . 0.0 109.12 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -1.36 1.76 Allowed 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 121.069 1.179 . . . . 0.0 110.373 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.513 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 78.1 m80 -83.37 -22.12 32.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 110.036 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -75.95 7.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -95.81 87.36 4.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.44 135.27 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.11 109.6 21.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 109.266 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.85 154.46 19.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -139.03 142.04 38.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.495 -0.753 . . . . 0.0 109.143 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.26 28.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.551 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 69' ' ' ARG . 1.1 tp10 -144.42 143.42 30.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 51.4 -90.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.405 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.0 ttm180 -147.82 -91.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.85 9.16 57.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.59 97.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -1.193 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.42 126.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -94.85 130.18 41.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.56 150.1 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.558 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -148.84 130.27 14.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.75 135.74 14.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.05 -80.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -1.103 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.457 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 23.7 t -47.66 -57.27 5.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.74 -25.81 63.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 78' ' ' SER . 63.5 m-80 51.24 45.54 27.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -136.98 148.66 47.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.327 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -91.02 130.84 36.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.1 138.03 58.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.139 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.0 144.59 25.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.35 144.16 28.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.767 . . . . 0.0 109.357 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.9 174.18 11.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -78.69 -15.88 57.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.29 -42.51 9.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.517 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.13 -8.93 1.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' HD12 ' A' ' 91' ' ' LEU . 46.3 mtp180 -75.15 125.94 30.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -1.105 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.63 141.22 28.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.928 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.22 -171.31 3.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 179.922 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -135.91 114.79 12.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 p -98.2 170.09 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -38.4 14.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.448 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.34 159.73 15.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 t -93.02 149.11 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 p -147.1 172.46 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -47.88 -35.79 11.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 19.4 mt-10 -88.73 67.03 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 74.6 m -153.39 15.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 46.4 m-85 -124.6 158.4 33.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.706 -0.621 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 35.1 m-85 -144.74 122.9 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.398 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.59 109.48 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' OE2' ' CE1' ' A' ' 115' ' ' TYR . 37.4 tt0 -85.64 150.2 24.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -146.42 98.36 3.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.24 131.9 48.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.48 -166.82 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.339 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.4 m -94.64 -20.9 19.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.786 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 32.1 p30 -80.23 25.92 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 62.94 -7.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.463 -0.773 . . . . 0.0 110.466 179.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 42.7 m-85 -89.9 135.75 33.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.881 -1.137 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.75 168.74 10.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.1 p -143.66 122.69 12.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.458 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 85.1 m-85 -94.19 114.94 27.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 19.0 ttt180 -98.19 142.57 29.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.416 ' C ' ' N ' ' A' ' 120' ' ' TYR . 34.7 ttt180 -94.99 -72.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -54.64 -9.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.7 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.8 m-85 -140.9 60.79 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 16.8 p -58.33 -1.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.726 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.88 10.3 24.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.53 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.08 142.49 19.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 109.737 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.9 m-85 -106.48 169.7 8.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.7 t -89.52 134.51 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.44 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.63 162.19 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.05 161.27 23.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.522 ' HZ2' ' HG3' ' A' ' 134' ' ' LYS . 33.0 mttp -85.85 -170.02 2.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -92.44 -29.71 16.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -73.75 1.62 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.48 66.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -86.69 168.65 13.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -1.158 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.2 p90 -92.21 120.2 32.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HG3' ' HZ2' ' A' ' 128' ' ' LYS . 48.1 tttt -69.94 135.76 49.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.54 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.54 160.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.202 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.83 16.81 55.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.54 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.9 p -115.07 -27.74 7.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.683 -0.892 . . . . 0.0 109.638 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -87.64 -4.98 58.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.694 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 p -70.71 166.69 20.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 154.26 179.58 29.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.93 166.35 10.57 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.85 1.7 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.81 -56.12 2.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.48 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.8 mt-30 -70.35 133.91 47.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 109.464 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.503 ' C ' HD21 ' A' ' 36' ' ' ASN . 15.3 mtpp -85.14 3.84 37.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.594 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.75 -4.24 1.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.2 pt -93.99 -4.36 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -0.845 . . . . 0.0 109.557 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.67 107.97 17.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.02 162.77 16.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.1 tp -140.29 71.18 33.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.96 105.09 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.901 1.734 . . . . 0.0 110.435 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.4 mtm -100.68 128.96 46.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.791 . . . . 0.0 109.408 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 t -70.22 120.75 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.999 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.54 171.64 1.31 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.233 1.289 . . . . 0.0 110.278 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.51 ' HD2' HD22 ' A' ' 64' ' ' LEU . 83.7 mttt -149.98 139.41 21.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.3 mtm-85 -92.98 114.47 27.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.5 mt -85.0 91.25 8.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -86.29 125.52 33.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.5 t -89.68 123.67 33.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -72.5 -14.55 61.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.608 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -86.2 104.99 16.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.797 -179.66 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.53 6.23 80.31 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.38 77.68 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -134.29 138.15 44.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.598 -0.942 . . . . 0.0 109.606 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -96.47 158.81 15.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 41' ' ' LEU . 17.9 tp -85.23 139.21 31.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -146.33 111.69 5.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.9 mt -89.85 133.89 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.194 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.524 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.8 m-70 -89.01 149.65 43.71 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 109.184 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.4 Cg_endo -59.94 -23.27 72.16 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.166 1.244 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -15.3 57.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.818 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 117.78 -37.12 3.39 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.5 mtt-85 -46.4 114.89 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -1.159 . . . . 0.0 109.79 -179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 47' ' ' GLY . 97.3 t -100.1 128.56 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.531 -0.731 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 3.1 p30 -155.69 -150.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -146.89 163.63 28.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.42 154.46 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -81.1 -14.35 57.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.95 87.6 4.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -81.99 17.84 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 109.421 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 p -100.58 3.32 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.86 133.71 28.65 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 109.164 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -4.16 4.21 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.84 1.026 . . . . 0.0 110.257 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -74.83 -10.95 59.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' LYS . 3.2 pt -89.26 -7.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.35 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -80.0 90.16 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.88 135.2 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.96 104.92 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -89.13 153.34 21.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.44 126.93 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.94 121.92 26.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.97 -29.37 14.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.492 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.03 -167.59 2.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -82.42 -0.79 47.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.92 28.92 1.27 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 t -145.49 145.12 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -1.101 . . . . 0.0 109.431 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.1 m -143.01 121.67 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -93.28 123.34 36.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.451 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.1 mt -91.44 147.46 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -145.8 132.53 19.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.85 137.65 17.6 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.78 -65.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.471 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 t -63.3 -49.8 72.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.918 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.06 -21.55 66.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 47.65 45.0 17.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.842 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 40.7 mtp180 -141.08 146.82 37.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.464 -0.773 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.84 136.8 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.03 149.23 45.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.24 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.64 129.26 13.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 ttm -96.41 130.85 43.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.88 -175.38 4.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -92.72 -23.47 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 p30 -82.78 -40.35 20.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 143.57 -7.92 2.02 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -75.57 120.64 21.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.555 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -92.42 136.34 33.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -147.01 -171.9 3.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.14 164.36 30.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.371 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 m -149.92 170.02 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -83.09 -46.16 13.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.8 116.03 28.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -52.1 165.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.6 p -147.1 -173.05 4.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.405 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -25.68 62.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.4 59.16 3.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.2 m -147.25 10.11 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.9 m-85 -94.93 152.18 18.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.1 m-85 -150.04 116.59 5.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -69.31 127.42 33.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.01 96.52 10.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HE ' HH22 ' A' ' 116' ' ' ARG . 0.0 OUTLIER -91.96 114.31 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.2 128.54 34.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -91.71 -177.44 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -92.62 45.06 1.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.9 m-20 -146.89 28.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.27 -0.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.897 . . . . 0.0 109.711 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.6 m-85 -96.61 130.98 43.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.373 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.56 168.71 11.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.4 p -145.8 119.6 9.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.12 106.31 18.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.751 HH22 ' HE ' ' A' ' 106' ' ' ARG . 33.5 ttm180 -93.87 146.5 23.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -72.21 151.73 42.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.9 ttt180 -91.29 -75.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 13.9 tttp -51.14 -9.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.863 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 118' ' ' ARG . 14.7 m-85 -143.08 64.06 1.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.7 p -62.11 1.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 15.4 m -89.97 11.33 20.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.493 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.04 140.54 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.943 . . . . 0.0 109.783 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.479 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 26.8 m-85 -106.37 165.4 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -91.41 119.88 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.697 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -150.56 147.17 27.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.56 178.36 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -95.53 -169.45 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -93.77 -13.87 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -92.9 8.37 39.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.427 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.33 3.65 84.35 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.85 173.14 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -1.128 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.0 p90 -92.82 120.32 33.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -69.95 131.49 44.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.395 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.599 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.34 133.16 12.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -58.97 -2.3 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.599 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.0 p -92.36 -57.43 2.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.193 . . . . 0.0 109.498 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 137' ' ' SER . 23.1 mtpp -61.05 -8.19 3.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -71.06 158.14 36.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.81 179.65 34.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.97 175.77 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.833 1.688 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.63 -56.14 5.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.86 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -1.151 . . . . 0.0 109.357 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.608 ' CB ' HD21 ' A' ' 36' ' ' ASN . 8.6 mtmp? -85.03 3.48 38.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.697 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.12 -10.47 31.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.588 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -5.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -83.94 87.98 7.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -92.94 167.75 11.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.5 70.63 32.12 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.446 -0.784 . . . . 0.0 109.391 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.38 99.6 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.852 1.701 . . . . 0.0 110.335 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.6 mtm -96.25 122.3 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.425 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.7 t -62.23 148.66 44.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.498 -179.951 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.02 157.65 24.2 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.264 1.309 . . . . 0.0 110.204 179.466 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' HE2' HD22 ' A' ' 64' ' ' LEU . 2.4 mtmt -135.8 131.97 36.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.679 . . . . 0.0 109.19 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -84.96 118.67 24.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.526 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 41' ' ' LEU . 23.9 mt -84.87 98.01 10.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 117.61 30.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.99 102.58 12.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.31 -27.97 50.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 23.9 m-80 -76.95 103.2 6.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.21 4.73 89.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.97 85.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.2 m-85 -143.39 132.82 23.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.078 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -93.28 129.02 39.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD23 HD12 ' A' ' 32' ' ' LEU . 53.8 tp -60.53 142.25 55.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 109.245 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 48.5 ttt180 -146.85 115.62 6.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.65 115.5 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.284 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -75.42 151.74 85.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.007 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.05 -28.79 71.35 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 121.202 1.268 . . . . 0.0 110.468 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.56 4.06 10.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.87 -31.44 5.29 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -46.96 114.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -1.112 . . . . 0.0 109.519 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.23 129.53 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -155.61 149.89 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 155.39 22.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.54 152.92 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -82.51 -12.0 58.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.534 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.33 101.57 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.96 -5.01 59.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -20.19 22.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.536 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -51.95 112.3 3.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.925 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.57 3.72 0.45 Allowed 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 120.638 0.892 . . . . 0.0 110.129 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 41.9 m80 -86.92 -15.25 39.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -76.76 -2.37 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -82.48 86.02 6.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.02 135.28 33.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.45 108.48 19.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -94.08 149.14 21.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.707 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -141.62 134.54 28.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.371 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.76 131.68 38.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -97.13 -76.72 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -95.85 -121.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -94.03 -96.6 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.1 3.38 46.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.0 125.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -1.188 . . . . 0.0 109.424 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.76 169.59 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 109.452 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -142.88 128.42 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.7 149.74 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -147.12 117.93 7.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.56 130.1 11.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.88 -74.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -1.121 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.419 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 14.3 t -49.12 -55.31 12.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.38 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -26.82 67.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.392 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m120 51.34 50.31 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 93' ' ' ALA . 8.7 mtp180 -146.68 147.2 30.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.948 . . . . 0.0 109.598 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.18 130.98 36.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.15 140.94 58.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.01 139.65 21.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -97.45 131.46 44.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.47 -0.769 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -73.2 -174.19 1.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.78 -16.79 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.5 p30 -90.23 -38.86 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.04 -10.88 2.31 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -72.8 124.8 26.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.1 mp -93.32 137.74 32.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.556 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -149.74 -174.23 4.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 179.931 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' ' 81' ' ' ARG . . . -143.67 132.18 22.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.295 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -110.24 168.77 9.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -84.51 -1.13 55.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.14 136.77 52.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.723 -0.611 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.9 p -80.98 109.02 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 p -97.53 179.12 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.415 -0.803 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.13 -21.58 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -93.09 53.16 1.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 51.0 m -141.61 5.6 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.8 . . . . 0.0 109.529 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 77.3 m-85 -93.2 153.52 18.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.9 m-85 -149.03 115.1 5.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -61.62 107.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -86.54 94.1 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -94.98 124.1 38.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.671 HD12 HD22 ' A' ' 113' ' ' ASN . 3.9 tt -91.43 133.23 35.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.613 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 110' ' ' ASN . 2.1 mt-10 -94.71 151.2 19.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.513 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 m -63.58 1.9 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.496 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 36.1 t-20 -93.38 25.77 3.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER 61.64 -3.63 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.887 179.98 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.1 m-85 -94.59 -174.87 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.671 HD22 HD12 ' A' ' 107' ' ' LEU . 5.8 m120 -147.64 164.83 32.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 p -143.82 120.63 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -93.8 105.43 17.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -93.25 139.16 30.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -70.27 147.93 49.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 120' ' ' TYR . 45.6 ttt180 -81.75 -73.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.0 tptt -51.64 -9.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 13.6 m-85 -139.12 68.6 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.713 . . . . 0.0 109.176 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.3 p -63.75 -16.36 60.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.4 m -89.92 18.85 5.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.983 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -148.47 123.54 10.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.848 . . . . 0.0 109.636 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 35.4 m-85 -100.7 164.48 11.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.18 139.64 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.02 -175.25 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -141.14 166.39 24.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -94.21 177.86 5.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -91.69 -7.52 49.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 109.315 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.81 -0.68 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.4 -0.54 65.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -90.42 166.3 13.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 109.369 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.532 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 21.6 p90 -85.42 120.08 26.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.35 123.0 20.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 135' ' ' LEU . 13.4 tp -47.92 160.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.178 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.02 -42.41 19.87 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -59.03 -17.58 26.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.689 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.31 -9.72 46.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.802 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.7 p -80.51 177.51 8.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -0.975 . . . . 0.0 109.565 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.8 178.69 22.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.77 165.41 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.864 1.709 . . . . 0.0 110.16 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.16 -37.6 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -66.52 121.82 16.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -1.142 . . . . 0.0 109.501 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.571 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 21.1 mtmt -80.97 -7.85 59.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.75 -6.46 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.3 pt -95.06 8.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.603 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.14 98.39 10.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.04 164.67 11.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.66 -0.65 . . . . 0.0 109.495 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -141.93 70.29 24.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.41 -0.806 . . . . 0.0 109.389 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.58 107.73 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.88 1.72 . . . . 0.0 110.478 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.1 mtt -98.41 117.14 32.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.501 -0.749 . . . . 0.0 109.38 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.3 t -69.95 142.65 52.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -70.19 1.12 5.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -48.43 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.917 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . 162.57 -164.62 35.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.63 -98.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' C ' HG23 ' A' ' 7' ' ' THR . 6.9 mt -145.43 142.37 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 6' ' ' ILE . 1.6 p 61.48 143.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.03 127.58 12.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 7.7 mt -90.11 -32.15 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 112.025 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.8 Cg_endo -68.98 98.54 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.689 0.926 . . . . 0.0 110.208 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.94 161.5 2.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.39 68.15 53.88 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.564 -0.71 . . . . 0.0 110.028 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.25 161.73 25.9 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.642 1.561 . . . . 0.0 110.217 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 48.43 73.26 0.22 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.62 -13.79 6.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.97 -85.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.17 36.72 80.5 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 p 47.51 86.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.63 107.97 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.81 -35.07 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -89.96 -47.18 0.39 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.284 -0.885 . . . . 0.0 110.746 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.3 Cg_endo -66.62 168.08 17.5 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 120.995 1.13 . . . . 0.0 109.795 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.71 135.17 67.64 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.639 1.559 . . . . 0.0 110.137 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' ND1' ' A' ' 25' ' ' HIS . . . 171.54 -5.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 24' ' ' GLY . 64.1 m-70 -146.68 8.83 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -1.118 . . . . 0.0 109.647 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -95.6 29.64 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -27.24 16.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.51 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -114.8 152.62 46.57 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.74 170.58 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.114 1.21 . . . . 0.0 110.109 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HE3' HD22 ' A' ' 64' ' ' LEU . 6.4 mtmp? -142.78 132.42 23.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 5.3 mtm-85 -84.83 122.52 29.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.64 98.94 10.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 109.485 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -97.85 117.15 31.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.5 t -82.18 137.71 34.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -26.38 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.956 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.7 m-20 -74.43 105.01 5.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 109.801 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.53 5.85 88.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.73 83.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 46.3 m-85 -142.32 137.52 30.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -1.083 . . . . 0.0 109.505 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 29.1 m-85 -94.46 145.96 24.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.556 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -80.26 145.3 32.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.255 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.417 HH11 ' CG ' ' A' ' 57' ' ' ASP . 2.9 ttt180 -148.4 122.29 9.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.499 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -90.04 109.1 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.172 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -66.13 152.26 94.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.147 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.85 -28.88 79.12 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.203 1.269 . . . . 0.0 110.242 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.82 6.55 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.29 -31.97 3.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -47.65 120.99 3.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -1.12 . . . . 0.0 109.461 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.533 HG21 ' CD1' ' A' ' 83' ' ' LEU . 62.5 t -91.34 129.77 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -147.87 -159.62 1.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.57 151.61 23.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.8 151.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' LYS . 25.1 mtm180 -77.66 -31.39 52.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 56' ' ' SER . 2.2 mm-40 -50.52 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.555 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -76.38 -1.29 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.4 p -91.37 -20.2 22.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -44.47 107.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 0.0 109.462 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.55 5.54 0.33 Allowed 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 120.797 0.998 . . . . 0.0 110.54 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.1 m80 -93.39 -18.19 22.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.77 -3.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -74.82 84.62 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.25 134.93 33.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -91.65 104.92 17.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.336 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.38 152.69 19.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.68 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.13 149.16 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.39 149.39 22.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -149.03 143.04 25.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 52.95 -119.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.377 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -147.45 113.24 5.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.74 -18.46 55.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 72' ' ' VAL . 69.0 t -92.51 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -1.163 . . . . 0.0 109.477 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 72' ' ' VAL . 19.7 m -146.42 131.17 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -92.42 118.29 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.24 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -145.56 144.77 30.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.46 137.52 13.64 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.98 -68.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -1.132 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 t -66.62 -48.88 68.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.91 -24.38 66.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.38 46.43 26.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.915 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.04 149.36 34.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -93.16 137.46 32.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.533 ' CD1' HG21 ' A' ' 49' ' ' VAL . 57.4 tp -65.14 143.84 57.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.896 . . . . 0.0 109.29 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.22 18.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.591 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.6 ttm -95.22 150.47 20.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -92.64 -170.01 2.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.592 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.4 mp0 -93.46 -32.02 14.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -79.89 -37.63 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 142.55 -5.01 2.03 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -73.26 117.87 15.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -91.76 133.14 35.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.0 pp -149.96 172.95 14.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.598 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -114.87 164.84 13.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.414 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -150.02 169.74 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -84.01 -35.83 23.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -94.13 138.69 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.1 p -90.26 117.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.403 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 11.0 p -103.08 173.62 6.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -15.64 23.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.339 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.83 51.24 1.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 98' ' ' THR . 7.7 m -140.89 5.23 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -93.12 160.46 14.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -150.0 114.85 5.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -65.41 118.83 9.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -93.4 98.18 11.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.611 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.13 100.34 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.337 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 113' ' ' ASN . 4.4 tt -77.6 129.45 35.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.71 -171.34 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -91.34 2.96 56.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.9 m-80 -94.78 24.78 4.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.21 -2.35 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.975 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.6 m-85 -91.55 -175.79 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 109.491 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.499 HD21 HD12 ' A' ' 107' ' ' LEU . 5.2 m120 -146.95 158.13 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.565 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 p -134.29 118.38 17.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.64 -0.662 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.03 105.28 17.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -92.91 142.61 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.355 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 t -71.36 147.81 47.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -88.77 -66.67 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 tptp -49.1 -18.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.6 m-85 -144.31 77.69 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 82.3 p -66.01 5.96 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 3.9 m -89.52 5.38 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.526 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 5.3 m-90 -148.39 170.45 17.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.028 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 17.0 m-85 -137.09 162.67 32.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.96 122.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.688 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -153.12 138.17 17.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.35 171.94 8.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -87.64 -115.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -143.18 7.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 109.546 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.22 11.23 8.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.57 64.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -93.13 159.23 15.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 38.1 p90 -91.15 120.06 31.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -69.88 132.28 45.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.638 ' O ' HG23 ' A' ' 139' ' ' THR . 13.5 tp -47.8 150.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -70.94 -10.43 68.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.557 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.1 p -91.03 -32.22 15.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.155 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -81.16 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 135' ' ' LEU . 70.4 p -79.4 156.32 27.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.14 -179.75 38.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.91 171.48 3.7 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.894 1.729 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.29 -50.54 3.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.07 134.28 40.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 14.1 mtmt -83.96 6.52 21.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.688 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.05 -6.46 8.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 113' ' ' ASN . 21.0 pt -90.45 -6.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.16 97.51 9.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -98.86 159.65 14.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.6 tp -139.13 71.53 40.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.504 -0.748 . . . . 0.0 108.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HB2' ' HZ2' ' A' ' 30' ' ' LYS . 5.9 Cg_exo -61.83 116.45 3.45 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.877 1.718 . . . . 0.0 110.715 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.8 mtt -95.99 121.2 37.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 0.0 109.168 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.9 t -69.23 135.72 50.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.92 57.15 4.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -74.5 -85.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.41 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.64 176.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.95 -99.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . 62.67 172.72 1.74 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 56' ' ' SER . 56.4 mm-40 -74.49 -46.87 36.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.18 172.38 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.803 . . . . 0.0 109.455 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -59.57 174.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' THR . 51.7 m 47.36 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -75.6 -47.15 4.16 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.223 -0.923 . . . . 0.0 110.682 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.7 Cg_endo -67.46 95.88 0.4 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.091 1.194 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' LEU . . . -105.69 51.11 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.524 -0.735 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ALA . 6.1 mt -38.43 102.81 0.25 Allowed Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.58 86.05 0.28 Allowed 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 120.769 0.979 . . . . 0.0 110.044 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 16' ' ' GLY . 3.5 mm-40 45.26 80.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD1' HD22 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -63.01 0.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 14' ' ' GLU . . . -81.34 -34.38 26.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.28 121.35 7.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.09 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.464 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.97 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 -81.28 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 109.522 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -146.89 62.91 7.89 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.467 -0.771 . . . . 0.0 109.936 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.58 113.57 2.01 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 121.735 1.624 . . . . 0.0 110.274 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.74 98.1 0.34 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 120.76 0.973 . . . . 0.0 109.928 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 25' ' ' HIS . . . -174.35 48.11 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 96.6 m-70 -157.15 46.52 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -1.127 . . . . 0.0 109.359 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 90.9 m-85 -137.8 5.58 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.538 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -36.2 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.526 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.97 152.69 46.77 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.51 168.53 2.13 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.134 1.223 . . . . 0.0 110.097 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.9 mtmt -138.9 139.84 38.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -91.52 120.07 32.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 22.8 mt -84.63 101.98 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -95.56 115.83 27.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.544 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.89 111.31 17.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.213 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -59.09 -30.39 68.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.63 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.0 m120 -78.64 105.23 9.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 110.122 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 81.65 4.63 90.31 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 86.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.1 m-85 -142.66 134.5 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -94.14 123.84 37.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 51.7 tp -57.79 141.83 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 25.4 ttt180 -147.28 117.93 7.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.5 mt -93.17 110.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -71.75 151.81 93.35 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.145 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.0 Cg_exo -57.04 -27.83 75.68 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.126 1.218 . . . . 0.0 110.238 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -74.95 0.45 15.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -29.62 7.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.59 114.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -1.153 . . . . 0.0 109.429 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.56 129.95 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 109.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 2.9 p30 -166.46 151.01 7.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.99 159.0 24.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 m -146.17 148.63 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -1.17 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -76.82 -9.84 58.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.43 84.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.477 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 2.51 3.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.429 ' O ' ' OE2' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -92.89 -20.37 20.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -49.89 111.2 1.95 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.67 5.38 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.663 0.909 . . . . 0.0 110.245 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 47.3 m80 -94.24 -14.79 25.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.35 9.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 59' ' ' HIS . 2.9 mmmm -91.12 88.0 6.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' A' ' 32' ' ' LEU . 11.0 mt -90.08 134.99 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -95.03 110.23 22.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.581 HD22 ' HE2' ' A' ' 30' ' ' LYS . 10.2 mp -95.47 144.57 25.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.813 . . . . 0.0 109.491 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.86 134.16 47.35 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -88.98 121.79 31.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.59 -85.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.6 mt-10 -94.86 149.57 21.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.883 . . . . 0.0 109.318 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.7 mtt-85 -57.58 84.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 140.82 -1.83 2.07 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -138.86 145.57 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -1.046 . . . . 0.0 109.414 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.7 m -138.9 133.83 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -94.61 127.07 40.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.452 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 mt -93.41 144.49 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -146.52 143.47 28.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.68 135.59 12.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.92 -83.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -1.141 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.9 t -48.88 -43.99 39.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.88 65.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 49.65 50.14 18.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.4 mtp180 -146.0 147.08 31.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.95 127.29 36.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.9 144.85 31.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 109.33 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -145.17 170.14 16.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.16 134.65 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.5 -169.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -91.75 -11.16 37.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.413 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -92.6 -42.54 9.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA3' ' H ' ' A' ' 136' ' ' GLY . . . 146.86 -9.97 1.38 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -66.98 127.56 33.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -1.167 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.9 mp -93.47 134.51 35.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.7 pp -150.07 143.74 25.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.897 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.96 158.47 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.763 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.71 161.85 38.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.98 -47.35 37.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 m -85.07 139.42 31.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.23 152.16 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -148.01 -163.65 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.489 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -55.39 -51.64 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 85' ' ' MET . 71.7 mt-10 -74.2 77.23 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 36.9 m -155.2 -33.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 38.2 m-85 -84.68 156.05 21.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 68.4 m-85 -145.08 122.85 11.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.17 119.82 8.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.1 146.42 24.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.065 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 118.94 9.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.368 -0.832 . . . . 0.0 109.677 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.11 119.86 31.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.251 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.92 -178.74 6.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 m -86.43 -12.14 49.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 54.6 m-80 -89.48 16.94 6.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 65.2 57.75 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.649 -0.657 . . . . 0.0 110.323 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 60.1 m-85 -145.49 123.42 12.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -89.96 124.48 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.736 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.8 p -97.74 168.8 10.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.752 . . . . 0.0 109.382 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -143.59 105.87 4.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 134.38 38.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -63.94 131.41 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.141 -0.974 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 120' ' ' TYR . 40.7 ttp180 -69.22 -69.88 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.626 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 17.8 tttt -51.65 -10.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 122' ' ' SER . 36.3 m-85 -147.01 69.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -65.9 4.96 0.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.1 m -95.08 9.38 39.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.587 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.21 139.15 17.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.7 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -100.2 156.43 17.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.98 128.99 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.208 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.04 149.27 26.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -102.03 176.24 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.602 -0.686 . . . . 0.0 109.458 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -95.08 -167.42 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -11.2 30.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 132' ' ' GLN . 1.6 t -91.47 0.12 57.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.47 -2.53 70.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.4 mp0 -84.97 176.41 8.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 32.6 p90 -92.8 120.4 33.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.63 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -71.02 136.09 48.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.97 164.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.061 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -93.17 -1.7 66.76 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -97.33 -20.82 17.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.245 -1.15 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -90.06 -4.91 57.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 p -79.51 155.23 28.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.004 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.63 178.71 42.92 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.4 Cg_endo -60.97 169.58 5.76 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.925 1.75 . . . . 0.0 110.274 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 -20.51 2.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' A' ' 145' ' ' ALA . 10.2 mt-30 -90.16 109.51 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -1.15 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.63 ' HB2' HD22 ' A' ' 36' ' ' ASN . 15.9 mtmt -65.05 2.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.35 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.06 -9.13 19.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.1 pt -94.54 5.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.482 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 144' ' ' LYS . 87.0 mt -94.67 85.67 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -94.9 169.64 9.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.227 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.73 70.43 30.56 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.41 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.89 104.13 0.37 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.848 1.699 . . . . 0.0 110.411 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.4 mtt -95.12 125.59 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.3 t -70.02 132.62 46.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.8 57.04 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -63.11 -61.46 2.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.469 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.344 0.592 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.71 -102.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -92.96 74.25 4.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.533 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.09 -142.67 18.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -90.02 -101.92 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -1.116 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' C ' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -91.78 -166.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.515 HG23 ' C ' ' A' ' 6' ' ' ILE . 1.6 p 64.07 49.82 2.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.562 -0.711 . . . . 0.0 109.752 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -81.09 -3.17 51.06 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 108.974 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.4 tp -116.35 88.01 22.01 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.36 99.52 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 121.084 1.189 . . . . 0.0 110.457 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.55 -168.78 2.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 149' ' ' LEU . 1.2 tp -142.27 68.64 21.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 109.901 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.2 89.07 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.772 1.648 . . . . 0.0 110.014 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 179.53 100.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.025 . . . . 0.0 109.445 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -20.54 66.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' SER . . . 68.19 -77.87 0.23 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 18' ' ' SER . . . -61.38 79.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m -168.19 95.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.426 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.93 60.16 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.11 92.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -1.082 . . . . 0.0 109.742 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 45.49 68.05 3.68 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.63 113.78 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.777 1.651 . . . . 0.0 109.963 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 124.8 14.73 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.715 0.943 . . . . 0.0 109.991 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 147.02 -57.67 0.5 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -69.83 6.1 1.3 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 109.413 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.479 ' CG ' ' HB2' ' A' ' 66' ' ' ALA . 78.1 m-85 -85.83 16.6 3.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.171 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -92.16 35.6 0.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.847 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.81 148.72 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 108.841 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.95 165.3 8.66 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.118 1.212 . . . . 0.0 110.45 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -147.26 122.14 9.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -86.27 122.62 30.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.85 101.08 12.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -91.95 124.34 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.286 -0.883 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.55 127.52 35.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.421 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -74.7 -19.56 60.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.669 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.21 105.16 15.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.73 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.69 5.14 90.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 84.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.5 m-85 -143.64 135.68 26.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -1.107 . . . . 0.0 109.518 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.48 129.43 43.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 tp -55.47 144.77 24.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.953 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.471 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 17.0 ttt180 -149.08 114.63 5.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.581 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.85 114.27 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.269 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.508 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 66.8 m-70 -69.34 151.27 96.95 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.034 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.8 Cg_endo -57.27 -27.92 77.32 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.301 1.334 . . . . 0.0 110.764 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.96 -3.0 29.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 109.742 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.69 -13.29 65.47 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -67.83 126.1 28.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.043 -1.269 . . . . 0.0 109.243 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.72 135.7 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 17.8 p-10 -153.93 -163.8 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.53 146.2 16.17 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.44 153.26 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -94.21 2.3 55.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.376 -0.828 . . . . 0.0 109.275 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.81 86.61 4.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.482 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -61.68 -5.17 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 t -87.16 25.75 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.039 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.471 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-20 -112.71 95.97 35.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.26 0.7 0.63 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.864 1.043 . . . . 0.0 110.271 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.52 ' CD2' ' HG ' ' A' ' 78' ' ' SER . 45.3 m80 -78.48 -26.77 46.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -70.37 -1.75 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.281 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -75.66 88.33 2.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.255 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.77 135.43 33.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.573 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -89.85 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.464 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -94.32 128.23 40.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -114.21 147.08 39.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . . . -88.18 139.71 30.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.65 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' GLU . 1.9 tm-20 -145.55 129.36 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.263 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . 2.1 tt0 52.16 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 109.285 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -96.24 118.92 33.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.815 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.37 19.0 31.46 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -147.84 146.94 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.62 137.34 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -93.68 116.38 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.65 144.33 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -145.6 145.87 31.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.05 131.5 10.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.24 -85.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.44 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.52 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 22.8 t -50.18 -22.85 1.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.08 -26.64 19.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 51.19 52.21 15.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.949 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.62 HH21 ' HZ1' ' A' ' 95' ' ' LYS . 91.4 mtt180 -149.9 147.71 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.362 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -91.49 132.72 36.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.3 tp -63.36 147.77 50.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.226 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -150.03 132.83 15.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.409 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 11.1 ttm -100.87 132.71 46.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.408 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 92' ' ' LEU . 11.1 mmtm -90.98 169.3 11.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.084 -1.01 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.55 -23.51 58.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.2 -3.97 48.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.96 71.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -79.77 118.23 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.334 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -91.39 134.84 34.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.488 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -145.71 -174.13 4.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.471 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.67 154.6 49.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.319 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -145.85 170.16 17.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.62 ' HZ1' HH21 ' A' ' 81' ' ' ARG . 0.8 OUTLIER -81.54 -35.0 30.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 132.84 35.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.83 164.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -147.3 -173.1 4.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.0 -14.39 59.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 85' ' ' MET . 25.8 mt-10 -90.89 8.58 34.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.7 m -92.54 -5.88 50.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 56.1 m-85 -94.32 153.2 18.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 85.0 m-85 -149.1 121.67 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -55.66 114.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.323 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.45 95.1 9.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -94.18 118.96 32.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.433 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 tt -93.39 123.4 36.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' ASN . 14.6 mt-10 -90.8 161.68 15.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.89 3.81 1.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -93.02 20.26 6.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.02 -1.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.0 m-85 -98.07 141.31 31.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -94.47 166.12 12.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 5.5 p -144.62 112.11 6.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.326 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.83 135.65 33.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 124' ' ' TYR . 3.2 ttm180 -127.13 145.75 50.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -68.85 146.03 53.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.708 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -88.53 -72.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.9 tttp -50.65 -10.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 20.4 m-85 -145.25 68.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.516 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 71.8 p -64.37 5.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.639 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.4 m -89.9 9.29 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.6 m-90 -150.3 141.16 22.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 109.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 116' ' ' ARG . 71.4 m-85 -104.09 165.7 10.88 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.711 . . . . 0.0 109.569 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.3 t -94.54 121.3 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.79 144.38 21.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.149 -0.969 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.83 -175.93 3.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.462 -0.773 . . . . 0.0 109.478 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -93.78 -119.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -146.35 8.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.534 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -125.39 6.46 7.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.09 12.86 51.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HG2' HG23 ' A' ' 130' ' ' THR . 84.4 mm-40 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.4 p90 -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -70.95 142.62 51.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 6.1 tp -63.71 -153.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -109.12 -43.66 1.17 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -61.39 -22.51 65.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 109.725 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -89.8 -15.63 31.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.59 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 135' ' ' LEU . 80.6 p -90.1 154.49 19.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.85 179.72 38.32 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.68 169.01 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.888 1.725 . . . . 0.0 110.187 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.03 -58.09 3.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 134.45 54.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -1.153 . . . . 0.0 109.441 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HB3' HD12 ' A' ' 147' ' ' LEU . 31.5 mtmt -83.6 5.77 23.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.13 -7.13 11.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.575 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.14 -6.73 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 144' ' ' LYS . 63.1 mt -80.1 85.16 5.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -89.87 169.24 11.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 12' ' ' LEU . 21.6 tp -142.32 70.08 22.01 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.809 . . . . 0.0 109.418 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.98 103.5 0.29 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.844 1.696 . . . . 0.0 110.356 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.3 mtt -97.73 119.12 35.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.761 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.7 t -70.0 119.09 13.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.84 55.3 3.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.384 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -56.38 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.494 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.41 148.13 4.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -77.87 104.9 8.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' GLU . . . -92.93 -44.96 3.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -54.08 -172.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -1.184 . . . . 0.0 109.54 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.0 mt -82.79 119.35 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -49.47 100.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 m -144.82 61.59 1.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.208 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.477 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.1 mt -56.09 -49.36 93.59 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.196 -0.94 . . . . 0.0 110.744 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.3 Cg_endo -65.25 -173.0 0.25 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 120.887 1.058 . . . . 0.0 110.062 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' ' SD ' ' A' ' 151' ' ' MET . . . -173.44 113.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tp -165.04 67.82 1.27 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.885 . . . . 0.0 109.725 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.51 154.86 66.08 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.732 1.621 . . . . 0.0 110.126 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 48.72 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -63.69 -26.68 68.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.71 82.34 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.84 106.6 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 p -170.89 68.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . 148.73 -44.29 0.76 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 71.59 -13.2 0.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -1.106 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -157.47 66.66 3.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.19 114.27 2.58 Favored 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.837 1.691 . . . . 0.0 110.11 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.53 176.69 2.05 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.734 0.956 . . . . 0.0 110.154 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 47.11 50.56 15.93 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 25' ' ' HIS . 18.8 t60 -130.38 -9.17 4.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.648 -0.913 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 66' ' ' ALA . 55.9 m-85 -78.22 34.6 0.2 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.422 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 25' ' ' HIS . 15.2 tttm -66.02 0.33 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.523 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 26' ' ' PHE . 7.1 m-20 -149.61 152.2 34.55 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.051 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.46 177.62 0.21 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 121.267 1.312 . . . . 0.0 110.25 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HZ2' ' HB2' ' A' ' 152' ' ' SER . 43.0 mttm -146.25 138.44 25.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.2 mtt-85 -92.66 120.97 33.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 0.0 109.321 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.82 102.01 12.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -93.5 118.95 31.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.98 101.4 12.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -51.78 -34.51 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.691 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 5.1 m-80 -73.73 105.18 4.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.994 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.03 4.31 89.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.65 85.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.9 m-85 -142.72 133.77 25.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.496 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -95.39 123.68 39.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.3 tp -54.29 146.21 15.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.276 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 24.5 ttt180 -149.25 117.51 6.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.8 mt -92.87 130.94 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.172 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -91.71 151.4 42.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.163 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.47 -27.46 82.08 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.304 1.336 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -74.83 12.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.702 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -41.11 3.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.32 153.75 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.37 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -138.11 141.93 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.341 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 3.9 p-10 -153.85 -150.02 0.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -146.2 148.08 19.52 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.56 149.57 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -1.12 . . . . 0.0 109.466 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 53' ' ' ARG . 20.5 mtm-85 -90.25 -15.79 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.27 103.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.43 44.42 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -144.19 20.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.265 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.4 m-20 -105.77 104.97 51.39 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.74 2.66 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.786 0.991 . . . . 0.0 110.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.3 m80 -82.63 -5.75 58.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.257 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt -90.23 -5.18 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -76.64 86.53 3.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.12 134.92 34.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.84 114.08 26.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.838 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -93.2 113.14 25.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.0 143.07 26.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . . . -93.92 120.93 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -95.0 -42.43 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.2 mt-10 -151.77 158.78 43.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.466 -0.772 . . . . 0.0 109.296 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -60.75 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 141.93 -2.82 1.93 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.35 142.43 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -1.122 . . . . 0.0 109.596 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.91 130.7 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 109.239 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -91.51 131.13 37.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -89.95 142.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -146.96 121.77 9.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.573 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 139.56 27.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 78' ' ' SER . 79.2 t -75.06 -87.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.547 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 77' ' ' VAL . 13.1 t -47.18 -33.33 5.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.44 -29.64 47.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 50.8 53.98 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.3 mtt180 -146.88 148.79 32.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -91.5 132.07 36.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.39 142.62 58.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.06 148.81 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.9 ttp -106.7 143.89 34.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HZ3' HH21 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.15 148.9 25.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.34 -19.06 7.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.401 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.5 p30 -87.65 -44.65 11.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.81 -9.59 1.37 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 ' HZ3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -71.65 128.65 36.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -1.148 . . . . 0.0 109.449 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -95.06 135.34 36.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.43 -173.72 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.28 42.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.455 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -146.97 155.84 42.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -71.32 -19.09 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.44 139.92 30.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 97' ' ' VAL . 4.5 t -86.25 107.81 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -94.68 156.09 16.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.37 -23.92 6.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -93.93 53.09 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 97.0 m -134.24 -2.18 2.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 87.4 m-85 -95.44 153.98 17.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 71.2 m-85 -146.04 121.13 10.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.01 93.92 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 115' ' ' TYR . 31.4 tt0 -78.15 93.19 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -93.47 137.85 32.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.85 140.46 29.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.361 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.84 -171.72 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' ASN . 43.1 t -93.78 -33.28 13.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -74.27 20.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.142 -0.973 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.5 m-20 65.24 56.05 1.04 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.714 . . . . 0.0 109.916 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -142.42 137.31 30.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.393 -0.817 . . . . 0.0 109.286 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.91 153.99 20.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 146' ' ' ILE . 12.5 p -137.18 114.92 11.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 105' ' ' GLU . 98.5 m-85 -89.93 104.5 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.506 ' NH2' ' O ' ' A' ' 121' ' ' THR . 23.8 ttt180 -93.92 134.37 36.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.205 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.9 t -60.95 153.36 25.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 120' ' ' TYR . 56.3 ttt180 -90.83 -77.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -51.13 -9.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 122' ' ' SER . 32.3 m-85 -138.85 59.33 1.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.506 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 26.5 p -59.55 -0.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.737 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.6 m -90.04 10.07 25.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 3.3 m-90 -155.13 144.01 20.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.849 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 28.0 m-85 -104.85 167.21 9.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.658 -0.652 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.0 128.32 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.57 145.64 24.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.632 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.28 178.86 5.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 109.447 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -96.23 -167.9 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 109.401 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -93.24 -13.47 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 109.42 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -93.46 2.32 56.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.41 0.32 67.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -85.06 172.26 11.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -1.144 . . . . 0.0 109.512 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 37.8 p90 -92.63 120.22 32.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -71.99 131.59 43.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.496 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.3 tp -47.98 155.04 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.309 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.84 -1.45 58.98 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.496 ' OG ' HD23 ' A' ' 135' ' ' LEU . 60.1 p -92.79 -58.25 2.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -55.15 -7.62 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 137' ' ' SER . 11.4 p -85.57 155.44 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.81 39.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.98 170.79 4.37 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.905 1.736 . . . . 0.0 110.162 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.01 -51.18 4.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.75 135.05 50.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -1.106 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.5 mtpp -84.81 1.61 46.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 109.565 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.64 -3.58 0.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.693 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 114' ' ' THR . 20.3 pt -98.13 2.61 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 109.681 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 144' ' ' LYS . 79.3 mt -90.48 110.23 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -117.23 168.28 10.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.51 70.17 17.5 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.318 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.33 105.98 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.794 1.662 . . . . 0.0 110.387 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 11' ' ' ALA . 9.7 mtt -97.59 118.61 34.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 109.397 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.405 ' HB2' ' HZ2' ' A' ' 30' ' ' LYS . 46.5 t -62.19 145.81 52.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -90.78 58.63 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.868 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.49 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.58 -79.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 11.9 mp0 48.8 35.24 6.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.67 168.12 27.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.29 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.439 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 137.11 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -88.22 59.6 5.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -146.7 60.9 1.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -59.48 -47.71 97.32 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.898 . . . . 0.0 110.794 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.1 Cg_endo -66.52 113.18 2.61 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 120.988 1.126 . . . . 0.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.7 149.65 2.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.6 67.52 51.7 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.81 112.36 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.653 1.568 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 49.26 88.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -66.59 -31.75 72.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 47.24 -122.88 7.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.7 -146.27 50.28 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m 61.37 56.14 2.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -1.144 . . . . 0.0 109.525 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.14 -85.47 0.16 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.93 -106.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -174.01 70.44 0.33 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.22 168.0 15.15 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.716 1.611 . . . . 0.0 109.85 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.92 -170.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.668 1.579 . . . . 0.0 110.189 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.17 77.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.76 14.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -1.083 . . . . 0.0 109.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -128.67 31.08 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -93.05 18.28 9.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -150.1 151.98 32.93 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.098 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.2 165.96 6.45 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.229 1.286 . . . . 0.0 110.364 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HD2' HD22 ' A' ' 64' ' ' LEU . 57.8 mttt -146.36 127.02 14.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.0 109.198 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -84.96 124.52 31.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 41' ' ' LEU . 23.3 mt -84.8 98.25 10.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -92.76 119.66 32.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -86.89 112.23 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -63.34 -17.36 62.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.64 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.8 m-80 -88.03 104.92 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.91 4.79 89.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.12 84.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 47.1 m-85 -142.98 130.94 21.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.13 120.65 34.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 32' ' ' LEU . 49.1 tp -50.83 144.41 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.259 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.474 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 33.2 ttt180 -147.78 120.58 8.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 49' ' ' VAL . 76.0 mt -95.73 130.82 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.795 . . . . 0.0 109.11 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -91.29 150.89 42.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.49 -25.63 74.76 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.244 1.296 . . . . 0.0 110.312 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.1 p30 -74.92 7.56 3.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.7 -41.83 2.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.8 mmm180 -47.28 157.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.488 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 43' ' ' ILE . 84.2 t -138.77 134.17 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.4 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -146.09 -150.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.24 149.92 22.11 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -145.79 145.99 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -1.118 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.4 -6.46 58.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.49 108.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.486 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 21.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.36 -20.24 3.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.642 . . . . 0.0 109.692 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -44.75 108.19 0.71 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 109.62 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.09 5.26 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 110.152 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' ASP . 50.0 m80 -93.71 -3.14 52.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.68 -1.48 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 14.7 mmtt -78.14 86.25 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.93 130.85 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.82 111.4 22.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -90.25 153.58 20.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.902 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -144.9 130.96 19.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.338 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 123.77 28.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.572 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.15 -95.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -89.48 -173.9 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 112.4 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.43 24.65 20.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 t -145.92 142.54 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' VAL . 31.3 m -140.63 125.79 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.523 -0.735 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -93.51 128.26 39.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.54 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.78 149.62 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 14.6 tttp -146.51 134.34 21.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.23 136.25 18.25 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 60.1 t -77.98 -57.01 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -1.154 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -17.82 48.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.43 -23.55 19.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 51.13 49.64 20.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.423 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -146.43 148.52 32.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.551 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 75.1 m-85 -91.63 132.81 36.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.545 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 tp -65.02 139.55 58.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.25 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.74 134.92 18.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.579 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -95.12 126.38 40.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.66 -175.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.14 -16.41 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -90.2 -40.21 12.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.55 -9.26 1.41 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 90' ' ' ARG . 1.8 mtt-85 -73.55 123.62 24.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -1.165 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -92.56 132.95 36.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.3 pp -148.7 -172.67 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.611 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.07 44.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.291 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 170.04 17.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -84.6 -37.31 21.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 m -85.01 149.64 25.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 98' ' ' THR . 54.8 t -77.21 162.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.385 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.531 ' N ' HG12 ' A' ' 97' ' ' VAL . 71.6 p -147.27 177.81 8.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -76.14 -26.34 56.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 27.0 mp0 -92.87 19.64 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 2.1 m -93.98 -11.8 30.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 66.2 m-85 -93.17 159.55 15.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 76.0 m-85 -148.78 116.18 6.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -54.89 142.35 29.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -125.15 141.64 51.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -146.96 142.02 27.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.97 137.35 35.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.31 -175.92 3.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.2 p -94.67 38.28 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 59.1 m-80 -146.86 31.14 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 m120 60.99 -1.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 40.6 m-85 -95.12 126.83 40.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -93.67 168.83 10.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -137.64 161.47 36.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.731 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -137.8 109.87 7.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.72 149.17 22.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -75.52 162.79 28.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.7 ttt-85 -93.5 -77.95 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.885 . . . . 0.0 109.303 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.2 tptt -51.24 -9.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.547 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.7 m-85 -141.97 59.68 1.47 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.435 -0.791 . . . . 0.0 109.374 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p -62.07 0.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 12.3 m -90.17 15.0 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.522 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 11.1 m-90 -155.14 143.56 20.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 109.713 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.0 m-85 -107.54 158.76 16.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.663 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -84.77 131.16 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.303 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.62 -175.75 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.55 161.52 37.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.772 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.21 173.74 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.8 19.15 7.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 16.63 8.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.74 -0.6 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.47 42.87 47.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -134.68 154.8 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.944 . . . . 0.0 109.323 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -80.87 120.17 24.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.76 127.67 33.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.678 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.8 tp -50.35 142.57 10.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.75 14.55 2.58 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 135' ' ' LEU . 84.7 p -102.61 -38.65 7.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.508 -0.995 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -90.11 -8.65 50.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 135' ' ' LEU . 41.0 p -69.91 145.21 52.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 109.495 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.11 -179.76 42.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.8 Cg_endo -61.07 -174.71 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.924 1.749 . . . . 0.0 110.164 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.27 -35.23 0.94 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 141' ' ' PRO . 18.2 mm-40 -93.14 134.52 35.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -1.131 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 39.4 mtmt -78.51 -0.49 29.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.19 -7.05 1.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.2 pt -95.32 1.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 109.652 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.2 mt -90.99 110.06 21.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -116.79 165.36 13.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.1 tp -144.4 70.75 15.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 109.21 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -62.23 112.78 1.65 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.89 1.727 . . . . 0.0 110.617 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 35.3 mtt -96.72 129.69 44.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.342 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.4 t -70.11 128.71 37.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.38 53.76 2.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.538 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -93.18 -66.73 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.498 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.372 0.606 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.03 -91.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 53.98 34.45 19.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.2 130.97 1.4 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.64 178.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -1.136 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -70.77 73.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 ' OG1' HD12 ' A' ' 9' ' ' LEU . 76.4 p -88.95 156.2 19.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' LEU . 27.0 p -75.51 -3.7 35.58 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 109.567 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' THR . 6.0 mp 58.23 158.23 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.13 115.13 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.124 1.216 . . . . 0.0 110.138 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.14 -166.92 2.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -140.6 69.41 31.47 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.58 -0.7 . . . . 0.0 109.422 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.23 -165.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.793 1.662 . . . . 0.0 110.317 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' GLY . 3.5 mt-10 -76.89 53.86 0.96 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 109.52 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 25.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' GLU . . . -47.95 125.91 12.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.31 70.58 0.33 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.5 p -93.2 59.79 3.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.434 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.12 -86.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -153.27 35.28 0.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 3.2 p90 39.2 67.43 2.41 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.807 -0.558 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.8 168.39 10.36 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.597 1.531 . . . . 0.0 109.872 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.16 111.67 0.88 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.696 1.598 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.38 4.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -146.59 9.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -1.107 . . . . 0.0 109.456 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.71 11.21 32.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 9.51 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -149.94 149.77 28.46 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 108.806 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.11 176.13 0.27 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 120.99 1.127 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.6 ' HD2' HD22 ' A' ' 64' ' ' LEU . 47.0 mttt -144.89 175.06 10.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.8 mtm-85 -125.35 117.48 23.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' CD1' HD12 ' A' ' 62' ' ' LEU . 20.7 mt -84.83 102.0 12.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -94.47 117.9 30.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.26 99.38 11.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -51.5 -35.01 38.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.736 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 12.1 m-80 -71.86 105.05 3.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.751 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.4 4.56 89.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.25 83.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.4 m-85 -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -93.51 119.73 32.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.11 138.72 37.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -147.44 123.64 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 109.715 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.1 mt -93.96 118.08 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -69.3 150.92 97.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.092 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.0 Cg_endo -58.86 -23.96 69.91 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.175 1.25 . . . . 0.0 110.542 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.64 -15.47 51.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.67 -34.01 4.56 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -47.27 114.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.243 . . . . 0.0 109.497 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.42 143.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -170.15 -150.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.58 156.47 26.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 m -145.7 139.13 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -1.077 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.492 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.9 mtm-85 -76.61 6.52 5.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -94.87 103.45 15.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -81.59 6.35 15.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.2 t -90.24 7.29 38.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' HIS . 5.8 m-20 -93.01 113.53 60.11 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.051 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.88 2.6 0.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.675 0.917 . . . . 0.0 110.216 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.474 ' CE1' ' OG ' ' A' ' 78' ' ' SER . 59.6 m-70 -84.57 -20.47 31.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.82 0.07 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 22.3 mttt -87.58 87.55 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.524 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.1 mt -90.42 135.22 33.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -91.1 117.1 29.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.6 HD22 ' HD2' ' A' ' 30' ' ' LYS . 10.6 mp -90.51 158.66 16.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.51 138.84 26.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.311 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.91 157.99 16.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.01 -91.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.16 -155.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -88.64 105.02 17.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.5 -7.8 77.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.76 136.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.88 126.94 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -94.74 130.94 41.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -0.824 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.35 151.87 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -150.06 145.54 26.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.03 138.96 17.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 40.2 t -75.74 -62.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -1.134 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.474 ' OG ' ' CE1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -73.84 -46.89 42.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.26 68.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.416 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.94 49.7 20.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 11.9 mtt180 -141.99 150.03 40.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -92.33 130.07 38.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.93 150.99 46.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.34 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.65 32.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.6 ttm -126.8 134.92 50.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -92.58 178.4 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -78.13 -34.19 50.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.21 -3.43 20.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.49 66.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.422 ' C ' HD12 ' A' ' 91' ' ' LEU . 58.0 mtm180 -80.54 119.01 22.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.442 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.9 mp -93.4 134.52 35.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 92' ' ' LEU . 4.3 pp -148.74 164.95 32.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.82 157.78 16.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.06 149.42 30.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -73.03 -31.95 64.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -92.96 142.04 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.3 t -79.25 156.43 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.453 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 46.2 p -146.88 156.75 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.34 -29.71 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.409 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -93.92 57.71 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.472 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 67.9 m -140.95 3.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -101.19 160.25 14.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.466 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.98 112.07 4.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -60.06 126.04 25.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.626 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -95.55 93.48 7.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.474 HH11 ' NH1' ' A' ' 116' ' ' ARG . 60.1 ttt180 -89.89 125.16 35.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.57 132.33 36.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.79 -173.22 3.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.97 -7.0 50.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -93.73 24.11 4.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 63.59 -5.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 109.889 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 110' ' ' ASN . 51.0 m-85 -91.64 128.51 37.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.124 -0.985 . . . . 0.0 109.26 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -89.91 166.91 13.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.913 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 p -141.85 122.91 14.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 109.177 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -92.57 110.97 22.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.767 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.474 ' NH1' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.75 137.82 37.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.273 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.87 157.98 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -93.78 -64.39 1.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 109.587 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -53.74 -49.73 67.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.678 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 122' ' ' SER . 7.0 m-85 -110.47 68.87 0.68 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.7 -0.625 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 121' ' ' THR . 14.8 p -59.76 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.8 m -89.14 10.37 22.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.085 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.3 m-90 -149.69 141.7 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 109.696 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.5 m-85 -109.22 150.81 27.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.688 -0.632 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.24 131.3 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.307 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.03 171.52 15.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.7 mt -132.13 165.15 24.7 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -93.37 -172.71 3.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -93.0 -13.25 28.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 9.92 35.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.59 6.02 86.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -92.43 166.54 12.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 37.7 p90 -92.74 120.21 32.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -69.83 131.65 44.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.661 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.55 135.5 11.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.278 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.12 2.85 1.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.661 ' OG ' HD23 ' A' ' 135' ' ' LEU . 59.8 p -92.21 -38.76 11.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 109.56 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -79.79 -5.0 54.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.1 p -77.25 149.62 35.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.477 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.43 179.73 45.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.94 164.83 13.23 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 121.873 1.715 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.65 -43.16 3.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 143' ' ' GLN . 1.6 mp0 -68.35 132.42 47.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -1.115 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -84.81 -5.25 59.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.69 -0.73 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 10.8 pt -99.97 6.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.99 110.05 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.643 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -119.6 168.0 11.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.659 -0.65 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -142.8 70.43 19.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -61.97 105.87 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.68 141.56 32.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.513 -0.742 . . . . 0.0 109.319 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -70.04 173.47 6.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.7 65.6 1.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -75.93 -76.79 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.479 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.66 173.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.72 89.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.9 133.63 6.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 1.2 mp0 -46.84 -24.83 0.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -1.098 . . . . 0.0 109.398 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.63 HG22 ' N ' ' A' ' 7' ' ' THR . 2.8 mp -131.17 168.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.693 -0.629 . . . . 0.0 109.419 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.63 ' N ' HG22 ' A' ' 6' ' ' ILE . 11.7 t -138.59 -170.93 2.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 8' ' ' THR . 95.6 m 51.39 46.62 26.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.294 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -70.53 -47.89 17.73 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 110.957 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 3.2 Cg_exo -64.67 109.74 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 120.977 1.118 . . . . 0.0 110.239 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.09 -167.22 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.386 -0.821 . . . . 0.0 109.357 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.67 68.02 36.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.34 -169.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.75 1.634 . . . . 0.0 110.238 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -84.87 57.45 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.903 . . . . 0.0 109.448 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.24 -16.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . 83.92 -103.19 2.55 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.78 57.74 1.49 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.34 37.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -1.216 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 39.99 40.27 1.67 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.32 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.025 -1.279 . . . . 0.0 110.103 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 44.27 68.35 3.21 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.775 . . . . 0.0 110.202 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 3.9 Cg_exo -56.96 -44.51 43.88 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.779 1.652 . . . . 0.0 112.798 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 22' ' ' PRO . 3.6 Cg_exo -65.58 105.86 0.81 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 120.833 1.022 . . . . 0.0 110.257 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.38 -17.39 0.12 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -94.53 60.99 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -1.095 . . . . 0.0 109.296 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' A' ' 28' ' ' ASP . 38.7 m-85 -73.26 35.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 25' ' ' HIS . 0.2 OUTLIER -74.94 16.57 0.29 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.778 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 27' ' ' LYS . 4.0 m-20 -148.71 148.8 29.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.888 . . . . 0.0 109.125 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.2 175.02 1.17 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.22 1.28 . . . . 0.0 110.321 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -145.28 175.35 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 4.2 mtm-85 -133.58 119.98 20.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.532 -0.73 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.57 102.35 12.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.584 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -96.48 115.89 28.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 t -83.26 106.03 14.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.513 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -28.33 24.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.685 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.2 m-80 -77.47 105.09 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.615 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.35 4.88 87.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.57 62.67 3.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -111.64 132.46 54.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.639 -0.918 . . . . 0.0 109.785 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -93.02 115.73 28.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.844 . . . . 0.0 109.265 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.513 HD23 HD12 ' A' ' 32' ' ' LEU . 41.6 tp -48.77 143.1 5.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 0.0 109.292 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 34.0 ttt180 -149.57 118.31 6.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -89.94 106.17 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.193 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -67.02 151.21 97.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 0.0 109.038 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.1 Cg_exo -57.16 -26.18 68.06 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.045 1.163 . . . . 0.0 110.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -75.21 -0.15 18.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.51 -30.46 6.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -52.8 121.55 7.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 83' ' ' LEU . 95.1 t -92.57 138.33 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -165.37 151.35 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.81 159.41 22.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.03 141.77 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -86.37 16.08 4.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.93 88.32 5.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.621 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -62.03 -5.2 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 p -90.99 31.02 1.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.848 . . . . 0.0 109.08 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 30.2 m-20 -113.87 93.5 29.51 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.96 1.6 0.42 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 120.94 1.094 . . . . 0.0 110.382 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.486 ' H ' ' C ' ' A' ' 57' ' ' ASP . 37.2 m80 -81.41 -15.61 54.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.69 2.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -76.43 82.12 3.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 109.147 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.1 mt -89.86 135.07 33.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.166 -0.959 . . . . 0.0 109.391 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.94 104.18 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -90.79 148.31 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 125.35 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.69 28.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.86 -76.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.459 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -94.62 -90.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -142.54 -31.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.529 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.25 -18.88 6.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.98 147.81 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -1.104 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.3 127.43 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.469 -0.769 . . . . 0.0 109.453 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.8 m -93.22 112.11 23.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.6 mt -91.91 144.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -144.24 145.66 32.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.454 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.33 135.27 12.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.04 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 109.428 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.555 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 2.5 t -61.42 -47.26 86.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -27.76 69.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.888 . . . . 0.0 109.472 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.555 ' ND2' ' O ' ' A' ' 78' ' ' SER . 41.5 m-80 51.34 50.58 18.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.7 mtt180 -149.84 147.96 28.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.04 129.34 36.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 49' ' ' VAL . 40.8 tp -57.65 145.14 35.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.57 170.09 17.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.01 140.17 29.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -87.08 170.37 11.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.76 -14.09 61.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 3.1 p30 -83.11 -47.45 11.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 144.52 -7.56 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -72.43 125.37 27.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -92.23 138.12 31.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.02 -171.63 3.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.755 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.28 159.45 42.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.446 -0.784 . . . . 0.0 109.272 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.5 t -146.69 170.09 17.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -83.85 -35.16 24.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -92.18 135.04 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -83.82 106.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.6 p -95.14 -179.11 4.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -16.68 63.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -93.54 48.0 1.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -139.9 3.27 2.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 84.1 m-85 -95.75 162.07 13.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 87.0 m-85 -150.03 114.38 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -59.12 112.96 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.06 141.74 37.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -137.78 90.83 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.549 -0.719 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.0 tp -68.19 126.72 30.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.373 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.03 -172.5 3.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -93.9 -13.43 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.2 m120 -88.0 28.97 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 109.489 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER 60.19 -0.15 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.2 m-85 -95.26 126.97 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 2.1 m120 -93.23 166.21 12.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.636 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.8 p -144.6 120.77 10.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.315 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -90.69 113.8 25.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -96.38 144.95 26.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.435 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -70.81 153.88 42.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.466 ' C ' ' H ' ' A' ' 120' ' ' TYR . 47.8 ttt180 -91.69 -75.72 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -51.37 -9.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 122' ' ' SER . 20.5 m-85 -141.78 62.52 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -62.06 2.04 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.683 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 120' ' ' TYR . 48.7 m -90.91 11.31 23.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.408 ' HD1' ' HG1' ' A' ' 139' ' ' THR . 2.4 m-90 -155.05 142.35 19.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.6 m-85 -106.76 170.04 8.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.4 t -90.73 126.75 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -151.58 148.37 27.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.51 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.11 172.61 6.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.551 -0.718 . . . . 0.0 109.44 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -93.95 -169.48 2.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.449 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -92.78 -12.31 31.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 t -93.69 -4.01 51.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 9.92 59.92 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -92.75 141.17 28.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.133 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 26.0 p90 -62.03 120.14 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.77 126.69 30.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.58 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -47.78 140.92 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.36 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.35 -4.9 39.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.6 p -87.82 -28.34 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -1.18 . . . . 0.0 109.436 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.92 -4.93 57.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.408 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 28.6 p -70.45 162.03 29.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.574 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 179.99 22.61 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.01 167.3 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.94 1.76 . . . . 0.0 110.17 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.32 -48.39 2.64 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -79.51 129.27 34.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -1.186 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -82.64 2.8 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.736 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.92 -2.73 2.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 pt -93.28 1.34 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.47 87.65 7.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.387 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.66 162.94 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.6 tp -138.46 71.83 44.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.92 103.76 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.911 1.741 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.26 35.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.2 t -70.03 175.17 4.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.41 77.64 1.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -93.77 -81.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.429 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.29 130.54 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.38 -99.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.84 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -172.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -1.184 . . . . 0.0 109.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 81.27 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 7' ' ' THR . 14.0 m 50.91 87.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.579 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 8' ' ' THR . 8.8 t -82.95 128.62 34.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.373 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.873 HD23 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -163.42 160.27 18.01 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 108.647 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.65 145.14 96.63 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.292 1.328 . . . . 0.0 110.237 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.59 91.53 2.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.604 -0.685 . . . . 0.0 109.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -74.31 -47.56 5.87 Favored Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 121.314 -0.866 . . . . 0.0 110.752 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.5 Cg_endo -67.34 96.58 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.025 1.15 . . . . 0.0 110.056 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.64 46.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -104.76 -19.53 13.9 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.59 19.51 0.49 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 15' ' ' ASP . . . -177.79 -130.15 1.36 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.0 t -101.26 -123.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.345 1.069 . . . . 0.0 109.119 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.47 56.07 0.49 Allowed Glycine 0 C--N 1.28 -2.581 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -147.0 -111.96 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.393 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -179.3 68.95 0.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 109.629 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.94 168.14 16.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.661 1.574 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.16 -171.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.639 1.559 . . . . 0.0 110.149 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.25 78.87 0.09 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.618 ' CE1' ' NZ ' ' A' ' 30' ' ' LYS . 16.5 t60 -172.13 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.626 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 8.4 m-85 -88.13 33.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.626 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.22 10.23 22.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.77 149.58 24.18 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 108.91 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.14 160.07 16.98 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 121.066 1.177 . . . . 0.0 110.126 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.618 ' NZ ' ' CE1' ' A' ' 25' ' ' HIS . 21.7 mttt -140.43 138.4 34.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.465 -0.772 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.2 mtm-85 -88.57 129.06 35.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.9 mt -93.91 101.09 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -95.1 121.67 36.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 t -88.56 105.13 17.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -15.24 8.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 22.9 m-80 -86.38 104.38 15.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 75.31 4.94 75.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.7 89.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.8 m-85 -145.64 130.78 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -1.13 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -93.59 123.82 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.65 136.55 56.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.928 . . . . 0.0 109.219 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 57' ' ' ASP . 40.4 ttp180 -146.04 118.03 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.637 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mt -92.62 126.31 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -87.4 152.02 51.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.14 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.63 -26.59 65.69 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.236 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.95 1.7 12.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.965 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -25.09 10.88 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -57.55 114.96 2.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -1.19 . . . . 0.0 109.384 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.26 142.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -171.35 151.92 3.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.8 155.29 23.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 m -146.43 155.08 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 HH11 ' HB3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -92.23 9.07 35.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.53 102.17 14.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -83.38 -4.96 58.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.358 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -78.74 13.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.25 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -105.59 104.93 50.73 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.84 1.06 0.91 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 120.77 0.98 . . . . 0.0 110.2 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 57' ' ' ASP . 40.6 m80 -76.15 -26.69 56.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.273 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -65.65 -5.33 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -75.9 87.41 2.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.92 135.23 33.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.857 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -89.73 114.32 25.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -86.6 153.07 22.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.0 109.628 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -144.68 131.91 20.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.626 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . . . -88.93 119.78 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.57 -73.2 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -90.56 -143.85 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.482 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -93.94 -26.62 16.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.78 -9.38 2.54 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.45 104.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -1.204 . . . . 0.0 109.38 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.08 177.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.537 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -145.82 118.44 8.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.04 149.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -146.59 144.35 29.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.44 133.65 11.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.4 -74.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -61.75 -26.03 67.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.95 -26.6 31.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 51.11 50.0 19.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -147.76 146.95 29.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -94.5 134.37 37.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.92 143.49 57.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.223 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.37 134.21 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.9 ttm -97.63 139.33 33.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.385 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HE3' HD21 ' A' ' 92' ' ' LEU . 25.4 mmtt -92.1 173.87 7.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.427 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -77.67 -27.09 50.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 6.4 p-10 -73.19 -49.4 28.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.486 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 145.67 -13.19 1.76 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -72.62 123.61 23.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.567 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -92.36 137.15 32.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -147.87 -172.41 4.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.09 156.71 45.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 m -145.88 153.48 40.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CG ' ' NH1' ' A' ' 81' ' ' ARG . 9.1 mtmp? -68.62 -29.77 68.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.529 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.48 148.33 23.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.3 t -92.37 149.54 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.428 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 38.2 p -146.51 157.43 43.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.45 -17.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 44.82 1.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 3.8 m -144.62 8.12 1.31 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 81.1 m-85 -100.0 159.7 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 75.3 m-85 -149.37 140.53 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.49 125.61 33.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 109.448 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -90.25 135.04 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.281 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -141.3 126.03 17.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.387 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tt -92.51 125.45 37.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.292 -0.88 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -90.67 -173.87 3.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.408 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 m -93.34 63.85 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 34.1 p30 -169.26 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.36 -7.52 0.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 50.3 m-85 -93.75 135.85 34.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -95.38 166.44 11.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.785 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 22.9 p -139.82 119.9 13.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -98.75 117.07 32.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -95.05 161.47 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 109.272 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.56 159.77 30.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.871 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.66 -61.84 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.399 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -83.28 -36.44 24.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' SER . 16.5 m-85 -89.29 50.54 1.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -49.0 -14.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -90.03 17.54 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 13.1 m-90 -155.05 141.33 18.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.913 . . . . 0.0 109.62 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.4 m-85 -112.04 169.98 8.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.683 -0.636 . . . . 0.0 109.587 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.75 133.17 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.377 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.01 154.86 33.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HA ' ' H ' ' A' ' 134' ' ' LYS . 31.8 mt -115.66 172.75 6.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.4 -169.23 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -94.97 -17.04 22.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -91.33 3.34 55.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.525 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.81 2.91 66.55 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.4 163.47 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -1.177 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 33.7 p90 -79.23 120.27 23.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 0.0 109.489 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 127' ' ' LEU . 16.8 tttt -72.05 128.66 36.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.581 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.6 tp -47.83 140.65 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.95 22.35 1.21 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.581 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.08 -27.25 7.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.598 -0.942 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -90.02 -9.27 49.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.682 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 p -69.97 152.28 44.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.22 -179.14 40.47 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.1 151.81 75.95 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.85 1.7 . . . . 0.0 110.185 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.43 -28.3 9.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -86.74 119.76 27.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.576 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -73.56 -3.45 27.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.78 -3.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -96.43 2.96 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.05 110.12 21.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.51 163.13 17.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 109.434 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.4 tp -137.79 72.34 48.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.49 -0.756 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.63 108.0 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.836 1.691 . . . . 0.0 110.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.458 -0.776 . . . . 0.0 109.584 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.4 t -70.16 147.65 49.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.231 -0.918 . . . . 0.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.64 58.29 4.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.461 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -55.02 -65.6 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.403 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.475 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 tpp . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -88.77 167.74 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 50.87 -96.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.478 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' GLU . . . 170.62 -160.42 33.05 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLY . 19.9 pt-20 35.95 -155.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.067 -0.666 . . . . 0.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -75.53 130.0 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.452 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -91.74 51.75 1.91 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -144.84 67.69 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -59.05 -47.85 97.78 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.852 . . . . 0.0 110.61 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.9 Cg_endo -66.72 110.96 2.01 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.04 1.16 . . . . 0.0 110.103 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.53 153.81 3.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 tp -169.39 67.95 0.63 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.24 179.38 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.773 1.649 . . . . 0.0 110.278 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 1.6 mp0 49.81 81.74 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -95.77 -30.14 13.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.15 132.76 45.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.65 124.41 3.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -151.52 65.82 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -1.098 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.35 -101.27 0.27 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -81.56 -105.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -177.52 69.51 0.22 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.44 168.18 13.43 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.654 1.569 . . . . 0.0 109.864 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.5 95.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.525 1.484 . . . . 0.0 110.163 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.7 -85.47 1.76 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.487 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -157.27 53.64 0.49 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 109.425 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -66.31 5.94 0.49 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -79.33 40.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -148.22 151.68 37.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.43 164.07 11.6 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.187 1.258 . . . . 0.0 110.431 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -149.11 129.91 14.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.9 mtt-85 -87.34 117.18 25.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD12 HD23 ' A' ' 41' ' ' LEU . 19.0 mt -84.83 99.73 11.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.564 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -94.82 121.48 36.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.0 t -91.28 113.28 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.269 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.29 -19.96 63.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 0.0 109.617 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.452 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.6 m-80 -82.86 104.99 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.17 4.96 87.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.1 86.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 43.8 m-85 -143.49 131.36 21.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 109.651 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -94.33 119.06 32.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 32' ' ' LEU . 46.6 tp -47.8 140.78 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.271 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 44.5 ttt180 -145.97 115.98 7.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.01 104.15 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.066 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -64.89 150.55 94.73 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.109 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.7 Cg_endo -57.68 -26.67 73.99 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.142 1.228 . . . . 0.0 110.057 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -75.45 3.15 9.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.83 -30.74 5.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -50.48 114.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -1.152 . . . . 0.0 109.358 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.7 142.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.471 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -173.4 154.6 2.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.54 160.11 25.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -148.1 141.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -1.115 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.7 mtm-85 -84.54 2.12 42.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.95 112.97 20.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 109.771 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -85.21 -5.83 59.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.71 27.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' HIS . 88.3 m-20 -115.16 90.44 23.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.65 1.95 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.035 1.157 . . . . 0.0 110.64 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' ASP . 44.2 m80 -80.12 -10.74 59.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.279 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -79.81 -2.19 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -75.64 87.85 2.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.83 135.92 33.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -88.94 106.19 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.274 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.86 153.46 19.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.95 135.94 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.533 -0.729 . . . . 0.0 109.039 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 153.09 28.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -150.15 146.62 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.81 . . . . 0.0 109.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 53.06 -146.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 62.15 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.674 -0.642 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.28 1.67 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 72' ' ' VAL . 90.1 t -93.48 156.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -1.095 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 72' ' ' VAL . 5.6 m -145.32 123.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.355 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 m -93.32 123.98 36.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 mt -97.08 145.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.454 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -146.75 152.15 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.464 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.47 132.09 11.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -73.52 -62.61 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -40.26 62.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 109.532 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.73 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 51.72 44.71 29.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.785 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 43.4 mtp180 -141.58 144.23 34.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.92 136.47 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.6 tp -64.13 149.47 47.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.119 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 131.37 14.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 50.6 ttm -97.67 132.58 43.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 109.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -91.5 176.02 6.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -83.29 -22.62 32.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.432 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 23.8 p30 -77.16 -4.76 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.948 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.89 4.61 65.0 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 91' ' ' LEU . 9.5 mtp180 -88.77 122.16 31.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -1.175 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.685 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.0 mp -93.34 132.12 37.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.86 178.02 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -119.03 163.26 17.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.748 -0.595 . . . . 0.0 109.418 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -150.24 161.61 42.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.368 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -79.37 -34.57 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.75 164.55 13.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 98' ' ' THR . 46.2 t -90.15 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.505 ' N ' HG12 ' A' ' 97' ' ' VAL . 74.8 p -147.52 177.14 9.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -22.5 62.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.15 13.26 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 88.8 m -93.69 -9.97 35.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 69.4 m-85 -96.21 153.18 17.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 73.8 m-85 -146.35 137.18 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -77.17 124.19 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -0.984 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.44 145.35 24.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 108' ' ' GLU . 19.3 ttp180 -147.51 116.32 6.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.04 134.26 34.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 106' ' ' ARG . 3.7 mm-40 -93.07 176.7 6.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.1 p -85.2 -4.02 59.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 112' ' ' TYR . 4.4 m120 -93.38 28.48 2.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.28 -4.64 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.8 m-85 -88.95 -172.13 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -146.81 167.67 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.77 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 p -142.98 169.49 17.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -0.76 . . . . 0.0 109.184 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -145.27 110.7 5.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -92.58 140.18 29.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.364 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -61.63 147.69 44.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 121' ' ' THR . 6.1 ttp180 -75.87 -57.93 3.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.591 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -75.61 -42.25 52.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 122' ' ' SER . 44.3 m-85 -92.91 52.69 1.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 118' ' ' ARG . 65.0 p -53.81 -5.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.813 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.2 m -89.92 10.23 24.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.68 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.16 146.09 22.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.811 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -104.65 165.27 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 109.573 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.0 118.76 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.56 143.62 23.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.982 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.31 175.4 6.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.431 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -91.01 -142.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.341 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -128.77 -16.83 4.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.66 . . . . 0.0 109.519 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.2 t -94.85 37.79 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.35 51.72 56.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -142.63 162.01 36.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -1.054 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.7 p90 -92.17 120.28 32.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.444 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.53 129.73 40.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.668 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.1 tp -55.42 157.9 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.152 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -80.28 24.31 3.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.668 ' OG ' HD23 ' A' ' 135' ' ' LEU . 51.8 p -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.957 . . . . 0.0 109.539 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -89.64 -5.14 57.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.654 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 135' ' ' LEU . 74.5 p -76.18 155.12 34.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.19 -179.93 35.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.73 179.61 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.857 1.705 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.91 -50.98 3.74 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.66 135.1 41.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' CB ' HD21 ' A' ' 36' ' ' ASN . 7.8 mtpt -83.99 7.44 18.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.86 -6.25 7.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.67 -2.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 144' ' ' LYS . 61.9 mt -88.16 90.48 8.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -97.58 167.94 10.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 0.0 109.418 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -140.44 70.35 32.49 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.3 101.37 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.777 1.651 . . . . 0.0 110.507 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.3 mtt -96.71 129.18 44.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.1 t -70.08 140.54 52.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.412 ' HB1' HH22 ' A' ' 31' ' ' ARG . . . -92.17 53.18 2.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.04 -83.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.46 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.84 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.915 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.91 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.72 154.44 0.88 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -89.22 -83.78 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -80.34 166.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.123 -0.985 . . . . 0.0 109.355 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' ILE . 1.7 p -48.03 172.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.24 -28.54 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.9 OUTLIER -93.36 151.51 40.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 108.663 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 139.21 89.59 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.943 1.096 . . . . 0.0 110.125 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' LEU . . . -96.19 47.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.39 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 11' ' ' ALA . 5.4 mt 40.94 69.96 1.76 Allowed Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.91 -0.494 . . . . 0.0 110.242 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.84 72.79 0.33 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.773 1.649 . . . . 0.0 109.979 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 46.31 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.023 -1.048 . . . . 0.0 109.69 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -37.22 12.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.78 84.02 0.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -149.79 -157.12 7.55 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 m -151.72 77.93 1.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -1.144 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.62 59.76 0.3 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.19 -90.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -1.139 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -59.67 -47.61 97.18 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.1 Cg_endo -66.7 168.04 17.77 Favored 'Trans proline' 0 C--N 1.321 -0.901 0 C-N-CA 120.994 1.129 . . . . 0.0 109.736 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -56.96 156.17 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.57 1.513 . . . . 0.0 110.242 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.5 -25.71 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -145.83 57.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -1.082 . . . . 0.0 109.391 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.73 42.57 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.352 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 3.4 ttpt -139.61 21.96 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.89 149.21 27.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.798 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.78 150.3 71.9 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.979 1.119 . . . . 0.0 110.228 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.8 mtmt -138.26 141.21 39.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.178 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -94.93 128.17 41.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' CD1' HD12 ' A' ' 62' ' ' LEU . 17.9 mt -84.91 124.66 31.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -115.23 114.46 25.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.0 t -86.82 106.02 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -47.55 -35.32 8.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.43 -0.794 . . . . 0.0 109.922 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.08 105.04 2.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.21 5.55 76.99 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.33 54.04 10.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.95 134.02 45.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.594 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 24.6 m-85 -93.8 117.06 29.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.15 136.94 23.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.244 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 5.9 ttt180 -147.54 124.51 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.749 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.65 122.44 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.086 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.77 151.38 73.81 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 109.173 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.529 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.8 Cg_endo -59.14 -23.41 69.08 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.176 1.251 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.4 p30 -74.98 3.26 8.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.52 3.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 mmm180 -46.94 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 109.534 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -141.38 134.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.394 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -166.9 152.13 7.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.41 21.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.73 144.86 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -1.137 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . 19.9 mmm-85 -64.93 -36.6 84.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -85.43 -1.31 56.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.428 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.1 p -94.03 15.2 17.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.1 m-20 -92.01 114.57 62.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.157 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.9 -2.14 2.0 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 120.601 0.867 . . . . 0.0 110.113 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.0 m80 -79.49 -28.8 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.312 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.57 -6.32 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.424 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -74.84 86.82 2.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.424 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.3 mt -90.15 135.26 33.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -89.7 109.31 20.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -87.67 156.56 19.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.628 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -140.68 -175.24 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.476 -0.765 . . . . 0.0 109.279 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.09 144.24 51.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.683 . . . . 0.0 109.523 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.3 mm-40 -145.46 144.41 30.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 48.17 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.085 -1.01 . . . . 0.0 109.22 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.88 62.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.78 -18.29 1.43 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLU . 21.4 t -92.51 119.25 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.236 . . . . 0.0 109.678 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 103' ' ' PHE . 3.6 m -94.12 179.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.339 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 m -145.87 116.87 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.62 145.51 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.92 129.23 12.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.41 133.86 12.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.94 -74.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -1.167 . . . . 0.0 109.53 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.5 m -47.13 -52.56 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.97 -22.37 65.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.9 m120 51.76 38.75 23.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 33.4 mtt180 -137.03 154.76 50.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.441 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.459 ' CG ' HG22 ' A' ' 97' ' ' VAL . 79.5 m-85 -94.28 134.72 36.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.26 144.93 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.19 132.43 15.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.668 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -98.7 142.38 30.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.815 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 92' ' ' LEU . 4.9 mmtm -94.93 177.93 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.53 -12.59 48.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.28 -2.54 58.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.85 64.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -88.81 118.58 28.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -1.118 . . . . 0.0 109.499 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.1 mp -92.36 132.17 36.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.4 pp -146.08 -170.45 3.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.848 . . . . 0.0 109.464 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.97 151.72 44.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 109.476 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -145.43 170.06 17.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -83.87 -23.38 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 t -92.44 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 97' ' ' VAL . 25.2 t -82.46 94.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.558 ' N ' ' SG ' ' A' ' 101' ' ' CYS . 3.3 p -76.45 -175.72 3.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.04 -11.23 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 9.16 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 98' ' ' THR . 3.7 m -94.32 -0.35 55.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.579 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 96.7 m-85 -94.94 151.15 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -0.841 . . . . 0.0 109.716 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.4 m-85 -147.55 134.82 20.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -80.17 159.35 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.98 . . . . 0.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -123.71 139.83 53.6 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.16 77.84 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.83 151.99 10.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.29 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -129.4 168.72 15.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.661 -0.649 . . . . 0.0 109.324 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.7 p -77.2 58.05 1.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.501 ' C ' ' H ' ' A' ' 112' ' ' TYR . 40.8 p30 -155.3 17.79 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 63.51 -7.75 0.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.526 -0.734 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 110' ' ' ASN . 49.9 m-85 -95.35 128.65 42.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.86 170.16 10.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.61 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 p -144.32 111.8 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -102.19 126.69 49.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -116.18 157.16 25.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 109.634 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -65.15 160.61 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.873 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 121' ' ' THR . 53.9 ttt180 -90.7 -73.99 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 8.4 tptm -58.11 -9.72 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -136.39 57.77 1.76 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.529 -0.732 . . . . 0.0 109.445 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' ARG . 21.8 p -61.26 1.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.687 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.6 m -89.96 11.52 20.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.99 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 14.5 m-90 -146.92 132.71 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -98.65 153.0 19.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.596 -0.69 . . . . 0.0 109.946 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.76 134.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.39 171.42 19.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.5 mt -132.32 172.03 12.96 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 128' ' ' LYS . 14.5 mtpp -94.49 -163.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -93.79 -24.94 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.707 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -77.22 -1.35 29.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.05 69.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.5 mp0 -85.11 179.1 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 31.6 p90 -94.11 120.77 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.67 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' NZ ' ' OE1' ' A' ' 143' ' ' GLN . 26.0 tttt -69.72 138.66 53.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.571 HD23 ' OG ' ' A' ' 137' ' ' SER . 15.2 tp -47.65 142.56 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.0 19.3 1.27 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.571 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.18 -27.0 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.914 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -90.06 -4.94 57.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.749 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 p -70.89 135.93 48.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' N ' HE22 ' A' ' 143' ' ' GLN . . . -176.45 179.72 47.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.6 Cg_endo -61.23 179.08 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.88 1.72 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.8 -30.75 1.28 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 2.3 mt-30 -92.48 134.08 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.18 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -85.06 1.85 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.545 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.36 -11.59 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.2 pt -92.59 -2.8 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.6 mt -88.63 86.79 7.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 109.503 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -91.29 164.43 13.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.56 70.48 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.35 109.97 1.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.803 1.669 . . . . 0.0 110.303 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.0 mtt -98.04 128.37 44.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -68.57 160.57 29.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.97 72.88 1.48 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.647 -0.658 . . . . 0.0 109.393 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -75.55 -69.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.476 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.84 128.63 1.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.11 121.53 12.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.37 -178.41 39.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.24 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -91.62 178.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.493 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.55 104.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.406 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -77.93 -76.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tp 54.28 68.44 2.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 2.6 Cg_endo -63.31 151.4 85.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.713 1.609 . . . . 0.0 110.219 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 10' ' ' PRO . . . 175.89 87.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mp 42.32 70.39 1.76 Allowed Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.574 -0.704 . . . . 0.0 110.039 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.85 136.17 47.8 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.854 1.702 . . . . 0.0 110.173 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 47.43 74.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.29 88.02 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.21 56.26 0.24 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.99 153.11 25.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -163.16 52.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -1.138 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.29 -78.55 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.43 -110.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 p90 -150.43 67.62 8.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.96 168.31 12.39 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.643 1.562 . . . . 0.0 109.809 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.36 157.26 22.62 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.603 1.535 . . . . 0.0 110.038 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.18 -113.48 0.33 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.456 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -93.48 43.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.136 . . . . 0.0 109.646 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -75.01 18.48 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.395 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 25' ' ' HIS . 24.0 tttm -93.88 10.3 33.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.871 . . . . 0.0 109.661 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -114.9 149.52 42.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 166.46 7.62 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.075 1.183 . . . . 0.0 110.27 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HD2' HD22 ' A' ' 64' ' ' LEU . 39.3 mttp -143.51 127.27 17.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.215 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -84.9 124.67 31.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.543 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.52 104.87 16.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -99.09 126.68 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.509 -0.744 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 43.8 t -89.45 130.74 35.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.19 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -79.8 -15.7 56.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.0 OUTLIER -88.21 104.82 17.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.67 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.56 4.94 89.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.4 88.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 44.7 m-85 -145.42 132.17 20.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.733 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -94.73 120.69 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.402 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.4 tp -47.53 142.64 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 12.8 ttt180 -150.32 114.74 5.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 117.32 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.476 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 90.8 m-70 -79.71 150.24 72.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.913 . . . . 0.0 109.031 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.5 -23.96 58.92 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.075 1.183 . . . . 0.0 110.259 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 4.8 p30 -75.01 -2.49 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.72 -31.51 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.2 mtm-85 -56.76 117.7 4.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -1.153 . . . . 0.0 109.528 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 83' ' ' LEU . 48.8 t -94.09 140.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 43.0 p30 -164.14 153.27 13.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.06 160.44 24.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -146.84 149.77 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -1.155 . . . . 0.0 109.478 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -80.78 4.6 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 57' ' ' ASP . 20.7 tt0 -88.01 91.6 8.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.383 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -77.84 48.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 p -163.49 20.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.715 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -77.7 141.36 64.44 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.991 . . . . 0.0 108.991 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.89 22.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.191 1.261 . . . . 0.0 111.073 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.5 m80 -132.61 -10.2 3.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.173 -0.954 . . . . 0.0 109.99 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.3 -3.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.046 -1.033 . . . . 0.0 109.338 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.95 86.7 7.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.01 135.0 33.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -93.59 110.5 22.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.07 136.47 26.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.77 123.17 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.13 -30.12 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -165.45 -159.93 0.44 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 10.5 ptt180 -89.18 118.54 28.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.01 66.96 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 t -145.75 99.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -1.09 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -93.19 174.83 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 m -145.48 119.72 9.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.324 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.67 147.59 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.594 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -147.01 132.01 18.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.374 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.91 132.9 12.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 78' ' ' SER . 57.0 t -72.52 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -1.155 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 77' ' ' VAL . 24.7 t -53.83 -47.56 70.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.7 70.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.35 46.35 26.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 81' ' ' ARG . 2.8 mtt-85 -136.09 142.63 44.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 109.305 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -89.93 116.4 27.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 49' ' ' VAL . 49.2 tp -50.69 149.7 3.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.18 128.34 11.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.7 ttm -94.16 138.11 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -83.44 166.88 17.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -20.57 60.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.498 ' CG ' ' HE ' ' A' ' 90' ' ' ARG . 1.7 p30 -87.02 -45.14 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 147.69 -10.67 1.26 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HE ' ' CG ' ' A' ' 88' ' ' ASP . 75.5 mtm180 -68.65 122.01 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -1.2 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -90.87 129.55 36.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.698 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.6 pp -147.53 150.93 35.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.264 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -101.2 157.32 16.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.748 . . . . 0.0 109.504 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.85 146.21 27.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.454 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -70.99 -21.43 62.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 t -89.69 151.59 21.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.16 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -147.43 162.01 39.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -11.55 31.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.46 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -94.12 4.96 53.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -91.52 -8.81 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.498 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 90.3 m-85 -95.03 153.03 17.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 69.2 m-85 -145.69 127.02 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.93 116.21 5.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.64 89.2 7.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.275 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.95 127.7 36.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.1 134.21 35.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -93.77 -177.78 4.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -93.63 40.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.5 m120 -148.15 30.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.57 -0.39 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.7 m-85 -97.36 125.34 41.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 0.0 109.284 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.2 m-20 -94.54 167.18 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 109.855 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -142.61 122.13 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.448 -0.782 . . . . 0.0 109.235 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -94.2 115.14 27.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 151.93 20.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.65 152.3 35.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.105 -0.997 . . . . 0.0 109.591 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -87.59 -75.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 21.7 tptt -49.69 -10.97 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 10.7 m-85 -143.91 66.37 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -64.71 5.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 33.6 m -91.59 10.49 27.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.692 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -151.35 144.62 24.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 24.1 m-85 -108.26 166.25 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.35 132.94 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.85 166.28 33.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -132.7 175.77 9.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 0.0 109.336 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -95.21 -169.64 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.389 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.43 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 6.6 ptm180 -91.65 -12.72 33.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -93.68 1.44 56.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.4 64.88 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.42 ' HG2' HG23 ' A' ' 130' ' ' THR . 49.1 mm-40 -85.34 161.84 19.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 109.509 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.8 p90 -91.98 120.51 32.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.502 ' HZ2' ' HB2' ' A' ' 138' ' ' LYS . 13.8 ttpp -72.98 134.92 44.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.404 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.532 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.7 tp -47.3 136.79 8.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.888 . . . . 0.0 109.224 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.92 -8.75 74.17 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.532 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.0 p -83.45 -29.62 27.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.492 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 134' ' ' LYS . 8.5 mtpp -89.98 -4.8 57.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.424 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 5.3 p -69.87 153.87 42.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.64 -179.75 43.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.94 162.62 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.803 1.669 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.57 -29.46 7.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.28 127.74 34.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -1.145 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -84.1 -2.88 57.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.606 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -63.23 -5.13 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.425 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.57 0.45 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.95 91.86 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -95.77 167.59 11.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.656 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.72 73.54 54.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.291 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.38 106.49 0.49 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.861 1.707 . . . . 0.0 110.608 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.1 mtp -97.41 130.24 44.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.463 -0.773 . . . . 0.0 109.409 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.5 t -70.04 137.01 50.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.76 58.19 4.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.93 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.492 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.324 0.583 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.91 102.51 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -92.66 99.45 12.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.475 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.74 56.16 3.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 47.2 -103.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mm -90.65 101.44 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 ' H ' HG23 ' A' ' 7' ' ' THR . 9.1 p -56.58 -173.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 8' ' ' THR . 87.7 m -92.17 57.78 3.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.26 152.49 58.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.13 153.23 33.72 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.13 1.22 . . . . 0.0 110.222 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.42 156.61 43.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 15' ' ' ASP . 7.1 tp -171.07 68.14 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.99 159.64 45.4 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.924 1.749 . . . . 0.0 110.475 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER 45.49 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.779 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.0 OUTLIER 36.33 -87.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.218 0.532 . . . . 0.0 110.722 179.41 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . -164.65 -29.64 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.05 -166.56 6.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m 47.38 71.12 0.35 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.74 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.22 26.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -1.109 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -76.46 -49.66 2.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.02 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 1.4 Cg_endo -66.81 167.35 19.71 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 120.779 0.986 . . . . 0.0 109.786 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.78 122.21 10.89 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.593 1.529 . . . . 0.0 109.984 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.29 20.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -145.76 8.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -1.15 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 42.4 m-85 -109.02 4.89 23.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.641 -0.662 . . . . 0.0 109.429 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -6.94 59.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.421 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.19 149.8 36.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.799 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.47 164.0 6.07 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.096 1.197 . . . . 0.0 110.266 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 64' ' ' LEU . 26.3 mtmt -136.61 136.68 39.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.603 -0.685 . . . . 0.0 109.266 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.8 mtt-85 -87.46 121.87 30.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.482 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD12 HD23 ' A' ' 41' ' ' LEU . 27.6 mt -86.6 97.67 10.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.25 120.46 33.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.61 107.17 19.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.15 -22.07 60.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.9 m-80 -80.13 96.42 6.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.928 . . . . 0.0 109.488 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 85.7 4.62 85.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 84.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -143.02 132.4 23.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -1.041 . . . . 0.0 109.515 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -94.13 124.67 38.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 32' ' ' LEU . 56.2 tp -56.81 140.25 48.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.28 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -147.41 121.48 9.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.418 HG23 HG22 ' A' ' 49' ' ' VAL . 62.6 mt -94.36 121.53 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 89.1 m-70 -86.44 150.29 51.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.029 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -57.98 -22.41 54.86 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.105 1.203 . . . . 0.0 110.109 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 14.1 p30 -75.04 1.04 14.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -39.33 3.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.479 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.1 mtm-85 -54.51 119.91 5.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 43' ' ' ILE . 39.5 t -102.02 130.58 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -149.71 163.5 37.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.399 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.16 157.5 23.35 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -146.07 141.96 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -1.12 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -79.79 3.89 18.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm-40 -91.14 91.85 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 56.26 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -149.94 9.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.017 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' HIS . 2.6 p-10 -92.07 140.06 24.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.55 6.36 0.2 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.935 1.09 . . . . 0.0 110.564 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . 78.0 m80 -94.76 -34.54 12.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.78 -6.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 109.414 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 84.47 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.91 135.12 33.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tm0? -91.67 112.72 24.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.114 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.47 152.03 19.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.657 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -138.03 123.99 20.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.585 -0.697 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -81.1 134.18 35.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.622 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -100.28 -89.65 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 109.349 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.19 -155.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.38 54.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 165.15 -30.32 0.22 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 72' ' ' VAL . 55.3 t -89.95 154.89 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 109.537 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 71' ' ' VAL . 18.0 m -142.32 166.25 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -137.16 124.75 22.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.33 148.29 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -148.08 129.95 15.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.61 138.0 16.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.17 -68.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -58.0 -54.36 47.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.77 67.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 50.66 51.75 16.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.631 ' HE ' ' HZ3' ' A' ' 95' ' ' LYS . 91.1 mtt180 -147.6 149.2 32.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.87 130.21 36.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.21 141.54 58.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 109.268 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 156.25 41.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.6 tpp -112.29 143.75 42.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.67 -0.644 . . . . 0.0 109.383 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -80.17 -169.31 2.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -19.11 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.3 p30 -91.14 -38.47 12.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 109.62 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.14 -7.87 1.88 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -70.05 127.51 33.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.7 mp -91.9 139.02 31.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -150.04 -175.95 5.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.579 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.34 155.06 46.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -145.64 170.02 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.631 ' HZ3' ' HE ' ' A' ' 81' ' ' ARG . 9.9 mttm -80.38 -42.38 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 126.68 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.4 p -65.53 120.09 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 p -92.21 -174.1 3.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 101' ' ' CYS . 52.7 t0 -80.03 -31.97 39.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.79 16.52 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.464 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' A' ' 99' ' ' ASP . 64.4 m -94.85 1.72 55.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.6 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.1 m-85 -96.76 148.66 22.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 61.6 m-85 -145.92 115.59 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.309 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -60.85 117.02 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.087 -1.008 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -81.09 148.29 29.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' NH2' HH21 ' A' ' 116' ' ' ARG . 36.0 ttp180 -148.2 108.95 4.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.97 121.23 34.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -90.22 -177.67 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.428 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 3.31 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -91.03 18.24 6.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.463 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.46 -0.67 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.1 m-85 -99.17 136.28 39.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -93.72 162.65 13.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.771 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.5 p -143.41 122.8 13.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -95.26 109.17 21.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.856 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.598 HH21 ' NH2' ' A' ' 106' ' ' ARG . 37.9 ttm180 -93.36 149.22 21.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.983 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -80.19 167.74 19.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -93.78 -87.1 0.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.412 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -48.54 -13.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -126.26 56.8 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 118' ' ' ARG . 52.9 p -57.91 -19.75 32.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.727 . . . . 0.0 110.418 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.9 m -89.55 19.95 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.917 -1.114 . . . . 0.0 108.989 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -139.83 151.89 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.512 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 28.3 m-85 -131.54 152.57 50.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.712 . . . . 0.0 109.522 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.09 135.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -154.2 -178.45 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.11 165.96 26.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.87 175.33 7.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -87.02 -13.12 45.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -93.09 1.01 57.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.55 7.75 61.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -92.59 166.22 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 27.8 p90 -83.19 120.25 25.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 135' ' ' LEU . 38.9 tttm -71.51 137.42 48.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.487 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 5.7 tp -61.65 -152.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -127.71 -36.87 0.47 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.466 ' HG ' ' HZ3' ' A' ' 138' ' ' LYS . 27.0 p -52.91 -29.93 31.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.221 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HZ3' ' HG ' ' A' ' 137' ' ' SER . 2.4 mptp? -90.18 -20.08 23.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.4 p -69.93 136.7 50.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.14 179.81 48.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.74 153.97 58.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.874 1.716 . . . . 0.0 110.238 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.19 32.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -1.115 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 2.4 mtmp? -74.92 -7.76 54.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -58.12 -3.21 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -99.8 6.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.89 110.2 22.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.841 . . . . 0.0 109.614 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.14 163.72 16.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.684 -0.635 . . . . 0.0 109.402 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 tp -141.43 70.92 26.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.466 -0.771 . . . . 0.0 109.243 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.9 109.3 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.923 1.749 . . . . 0.0 110.559 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.2 mtt -95.92 125.7 40.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.1 t -68.72 141.57 55.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.562 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.47 56.7 2.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -60.57 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.444 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.92 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 51.37 -125.95 2.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.91 -177.3 46.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -65.68 -109.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.534 ' H ' HH22 ' A' ' 31' ' ' ARG . 71.2 mt -73.53 140.47 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.567 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -56.99 164.91 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.579 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -94.68 -81.32 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.84 . . . . 0.0 109.54 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 8' ' ' THR . 9.1 mt 51.57 76.53 0.53 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.155 -0.965 . . . . 0.0 109.704 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.1 -175.18 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.704 1.602 . . . . 0.0 110.2 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.66 78.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.498 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER 179.26 -50.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.611 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 2.1 Cg_endo -65.34 120.76 8.03 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 120.827 1.018 . . . . 0.0 110.301 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 48.61 88.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.18 91.4 6.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.25 44.74 3.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.0 48.84 0.56 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 p -146.15 63.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 109.609 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 21' ' ' PHE . . . -81.8 -100.79 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 22.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.188 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.0 m-85 53.48 63.03 8.66 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 110.091 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.82 158.6 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.425 1.417 . . . . 0.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.18 103.17 0.35 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.329 1.353 . . . . 0.0 109.926 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.06 -82.33 0.05 OUTLIER Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.3 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -100.98 66.18 1.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.315 -1.109 . . . . 0.0 109.888 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 35.7 m-85 -122.58 4.81 9.56 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -95.71 23.84 5.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.448 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -147.56 152.36 41.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 109.202 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.72 167.72 3.81 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.138 1.225 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.7 mttt -145.77 133.46 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.232 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.534 HH22 ' H ' ' A' ' 6' ' ' ILE . 23.4 mtt180 -85.03 120.96 27.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 mt -84.91 95.97 9.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -91.79 115.03 27.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.0 t -81.83 125.12 30.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -78.96 -14.88 58.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.903 . . . . 0.0 109.761 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 29.9 m-80 -88.32 92.49 9.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 93.02 4.92 64.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.75 82.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.4 m-85 -142.7 132.97 24.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.364 -1.08 . . . . 0.0 109.552 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -93.55 129.4 39.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.96 146.46 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 6.8 ttt180 -145.52 159.12 43.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.51 104.97 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.23 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.9 m-70 -66.92 150.58 97.75 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.079 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.2 Cg_exo -57.07 -24.05 55.95 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.157 1.238 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 23.8 p30 -74.98 -1.7 23.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.82 -32.04 6.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -52.15 119.94 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -1.209 . . . . 0.0 109.458 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.4 150.43 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 109.507 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 16.3 p-10 -174.57 151.35 1.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.92 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 155.25 21.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.87 139.54 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.0 mtm-85 -71.52 -7.12 45.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.04 98.04 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -84.98 7.15 22.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 t -91.34 -20.12 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -63.58 116.14 23.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.128 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.36 0.39 1.03 Allowed 'Trans proline' 0 C--O 1.213 -0.737 0 C-N-CA 120.632 0.888 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . 49.4 m80 -77.72 -6.63 54.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.86 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -87.63 6.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.3 87.41 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -91.77 135.28 34.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -89.75 105.39 17.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.51 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.5 mp -89.7 153.04 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -144.7 137.92 26.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.73 122.96 32.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -95.47 -76.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -95.96 -124.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -92.7 -76.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 5.44 81.24 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.08 140.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 30.9 m -141.02 127.32 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -91.47 121.1 32.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.611 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.32 145.12 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.321 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -146.84 143.81 28.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.13 139.98 18.81 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.02 -58.24 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -1.164 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.5 -43.78 18.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.12 67.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.4 m120 51.25 50.84 18.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.57 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 94.1 mtt180 -148.5 149.3 31.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -93.17 129.79 39.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.937 . . . . 0.0 109.585 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.4 142.6 51.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.17 133.35 18.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.1 ttm -92.43 145.53 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HE3' HD21 ' A' ' 92' ' ' LEU . 17.2 mmtt -92.99 -177.34 4.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 21.2 mm-40 -79.62 -40.43 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.7 p30 -69.95 -37.14 75.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 135.8 1.75 2.94 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 90' ' ' ARG . 3.9 mtm-85 -76.45 119.15 19.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.8 134.87 34.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD21 ' HE3' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -149.17 178.04 9.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.708 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -111.88 158.12 19.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.687 -0.633 . . . . 0.0 109.449 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -150.06 134.46 17.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -54.84 -49.97 69.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -85.0 130.55 34.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.521 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -85.66 160.43 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 p -147.49 -172.98 4.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -13.0 62.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -95.91 50.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.1 m -147.43 9.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 63.0 m-85 -96.16 152.67 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.672 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.7 m-85 -150.25 115.77 5.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.897 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -57.56 152.56 14.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.42 137.34 54.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -142.8 134.52 26.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.438 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.17 128.57 46.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 109.679 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -86.33 171.42 11.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.277 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -76.21 -5.04 45.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.58 17.91 10.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.01 61.71 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -0.778 . . . . 0.0 110.205 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -144.6 -171.93 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -147.91 114.55 6.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 109.804 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -95.36 124.06 39.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.264 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -96.32 109.16 21.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -97.57 147.54 24.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.192 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 t -78.99 158.88 27.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.676 ' O ' HG23 ' A' ' 121' ' ' THR . 0.2 OUTLIER -93.22 -78.01 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.449 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -47.86 -34.81 9.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.2 m-85 -112.22 65.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 118' ' ' ARG . 67.6 p -64.08 3.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 120' ' ' TYR . 54.4 m -93.47 11.72 27.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.2 161.24 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 19.4 m-85 -123.91 169.91 11.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -87.92 122.52 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.48 144.45 22.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.615 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -95.86 -176.29 3.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -94.33 -108.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.86 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -148.17 -35.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 109.457 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -81.25 10.54 5.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.68 10.62 60.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -93.93 166.82 11.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -1.172 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -89.99 120.45 31.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.428 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -69.83 139.08 53.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.713 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.4 tp -58.64 141.94 50.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -66.46 5.16 2.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 135' ' ' LEU . 96.4 p -93.48 -32.37 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -90.0 -16.95 28.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.554 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 126' ' ' ALA . 38.8 p -69.91 161.41 30.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.36 179.33 31.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.1 Cg_endo -61.7 178.38 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.88 1.72 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 -33.21 0.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 141' ' ' PRO . 17.2 mt-30 -87.65 128.11 35.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -1.207 . . . . 0.0 109.601 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 37.8 mtmt -74.96 -2.82 28.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.16 -3.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.45 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.1 pt -97.49 3.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.1 109.95 21.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -116.05 163.75 15.46 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.1 tp -140.85 72.41 28.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.141 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.55 115.18 2.5 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.853 1.702 . . . . 0.0 110.711 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.4 mtt -97.13 121.84 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.8 t -69.98 139.86 52.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.254 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.85 56.5 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -64.22 -84.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.449 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . -89.66 -33.89 16.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.604 ' OE2' HG21 ' A' ' 7' ' ' THR . 39.8 mt-10 -57.88 -162.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.76 ' N ' ' HZ1' ' A' ' 55' ' ' LYS . . . -151.22 -137.73 2.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' ILE . 5.1 mt-10 -93.42 160.56 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -1.143 . . . . 0.0 109.501 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' GLU . 3.3 mt 46.21 94.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.604 HG21 ' OE2' ' A' ' 3' ' ' GLU . 86.5 m -144.94 60.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' LEU . 5.3 t -146.38 44.29 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' THR . 9.6 mt 60.39 148.77 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.46 176.14 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.016 1.144 . . . . 0.0 110.315 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.41 -171.48 3.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.72 67.81 12.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.66 -171.74 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.714 1.61 . . . . 0.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.28 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -58.98 -57.16 14.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.389 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.67 84.8 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.04 26.04 16.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.33 101.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.3 108.4 0.22 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.74 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -1.089 . . . . 0.0 109.702 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 2.0 t80 -143.98 59.05 6.6 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 0.0 110.42 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 21' ' ' PHE . 1.5 Cg_endo -63.84 168.19 12.42 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.604 1.536 . . . . 0.0 109.836 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.63 -169.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.517 1.478 . . . . 0.0 109.765 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 154.34 -105.87 0.28 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.401 ' CD2' ' HZ3' ' A' ' 154' ' ' LYS . 11.4 m80 -73.44 28.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -1.162 . . . . 0.0 109.791 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 24' ' ' GLY . 71.1 m-85 -92.48 27.52 2.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -145.25 -7.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -114.79 152.44 46.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.61 150.6 60.03 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 121.13 1.22 . . . . 0.0 110.289 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HE2' HD22 ' A' ' 64' ' ' LEU . 40.4 mtmt -143.31 141.86 31.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.198 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' NH2' ' O ' ' A' ' 55' ' ' LYS . 7.8 mtp180 -92.97 128.28 38.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 HD23 ' A' ' 41' ' ' LEU . 17.3 mt -85.03 128.78 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -115.31 114.51 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.1 105.7 17.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -48.51 -35.14 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 109.908 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 105.01 3.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 109.715 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.02 5.91 85.41 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.27 52.49 13.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -99.17 137.64 37.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.492 -1.005 . . . . 0.0 109.746 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -95.61 112.12 23.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD12 ' A' ' 32' ' ' LEU . 37.3 tp -46.51 145.18 1.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 64.0 ttt180 -144.26 154.26 42.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.679 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -134.74 127.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -91.65 149.41 39.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.124 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -58.26 -22.02 55.21 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.241 1.294 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.82 -11.62 60.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 109.677 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.84 15.02 38.06 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -93.8 115.55 27.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.107 -1.231 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.87 131.4 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -148.32 -163.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.383 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.86 127.18 2.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.72 155.61 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.468 -1.019 . . . . 0.0 108.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LYS . 16.7 mtm-85 -91.64 -16.42 27.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.986 -1.071 . . . . 0.0 109.451 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.8 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.76 ' HZ1' ' N ' ' A' ' 4' ' ' GLY . 18.4 pttp -83.48 -2.71 56.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.88 10.02 20.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.142 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -104.56 106.03 52.71 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.56 2.48 0.52 Allowed 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 120.744 0.963 . . . . 0.0 110.273 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.5 m80 -76.99 -28.01 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.456 HD11 ' NH2' ' A' ' 31' ' ' ARG . 2.2 pt -72.27 -8.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.83 92.05 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.448 HD12 HD11 ' A' ' 32' ' ' LEU . 8.2 mt -91.31 135.61 33.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.22 108.95 19.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.224 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.9 mp -91.26 153.15 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -147.88 133.99 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.303 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 169.25 18.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 67' ' ' GLU . 3.1 tm-20 -145.04 -34.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -154.01 -163.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 80.7 mtm180 -84.88 58.82 5.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.575 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.47 -26.84 1.68 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.64 138.6 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -1.181 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.97 179.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.276 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 m -145.38 121.84 11.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.635 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.9 mt -93.96 147.7 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -146.46 140.09 25.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.399 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.48 138.71 19.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 41.2 t -80.0 -68.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.47 -15.6 59.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.7 24.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 77' ' ' VAL . 44.5 m-20 51.16 45.69 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.594 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 73.1 mtt180 -147.43 148.06 30.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -94.61 130.95 40.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -60.4 147.83 39.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.294 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.02 137.15 19.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.636 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.8 ttm -100.43 132.41 45.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.467 -0.771 . . . . 0.0 109.341 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -78.82 157.46 28.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -21.08 66.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 2.7 p-10 -84.77 -42.58 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.36 -7.48 1.8 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -72.54 122.3 21.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 109.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -92.59 129.79 38.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -146.59 -174.58 4.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.01 154.07 44.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -146.46 163.93 34.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -70.14 -33.01 71.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.92 127.3 34.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 97' ' ' VAL . 8.4 p -82.64 85.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.6 p -68.3 -167.26 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 101' ' ' CYS . 55.3 m-20 -80.0 -26.81 39.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.81 7.34 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.473 ' H ' ' C ' ' A' ' 99' ' ' ASP . 85.8 m -96.72 -3.04 43.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -86.64 149.87 24.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -150.03 117.74 6.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CB ' ' HE ' ' A' ' 116' ' ' ARG . 33.0 m-85 -64.06 128.09 34.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -97.89 134.99 40.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -145.05 131.33 19.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.558 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.9 tp -95.91 120.16 35.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.63 170.88 12.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.4 t -78.29 53.27 1.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 112' ' ' TYR . 11.2 t-20 -150.84 22.86 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.25 0.23 0.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 109.568 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.6 m-85 -101.78 138.13 39.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -90.71 164.01 14.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.71 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 p -142.44 117.95 10.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -98.43 118.63 35.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.416 -0.802 . . . . 0.0 109.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -102.07 148.07 25.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.549 -0.72 . . . . 0.0 109.301 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -73.66 156.25 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 120' ' ' TYR . 1.1 ttt-85 -89.76 -77.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 5.7 tptt -48.35 -12.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 12.0 m-85 -143.82 67.12 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -65.27 5.02 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 37.0 m -90.39 9.75 27.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.578 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -151.51 142.77 23.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.8 m-85 -110.65 163.84 13.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 109.561 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -80.82 138.46 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -155.04 -177.67 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 127' ' ' LEU . 79.8 mt -142.64 169.21 18.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -95.07 -178.12 4.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -11.45 32.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 130' ' ' THR . 1.9 t -93.58 2.64 56.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.75 4.93 67.04 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.6 mp0 -93.32 169.7 10.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.129 . . . . 0.0 109.473 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.5 p90 -92.54 120.46 33.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -69.78 135.59 49.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.469 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.3 tp -47.65 123.78 6.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.47 -23.97 29.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.469 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.2 p -80.17 -20.79 43.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -1.195 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -90.07 -8.89 50.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 45.2 p -73.02 157.75 36.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.68 179.74 42.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 172.11 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.876 1.717 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.99 -37.95 2.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -83.55 131.88 34.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -1.19 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -83.35 -0.49 50.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.571 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.02 -8.81 3.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.56 2.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 144' ' ' LYS . 60.9 mt -93.32 90.62 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.14 166.99 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -146.21 71.03 13.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.242 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.3 112.9 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.842 1.694 . . . . 0.0 110.501 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.9 mtt -103.86 142.65 34.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.3 t -69.94 149.86 47.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.0 59.06 3.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' HZ3' ' CD2' ' A' ' 25' ' ' HIS . 53.2 mttp -73.31 -69.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.271 0.558 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.59 -98.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 50.96 -169.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.68 -107.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.556 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 11.8 pm0 -85.58 -165.25 1.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 7' ' ' THR . 3.1 mt -59.49 81.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.425 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 70.39 142.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -157.37 52.59 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -91.69 152.08 42.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.3 161.24 9.51 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.1 1.2 . . . . 0.0 110.158 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.66 177.48 2.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.27 68.67 10.37 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.31 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 110.257 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -77.29 53.66 1.04 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -80.23 40.85 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.26 29.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.44 -55.94 2.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -169.33 70.44 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -1.19 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.93 108.82 0.58 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' H ' ' HD2' ' A' ' 22' ' ' PRO . . . -148.62 -39.59 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.509 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -93.46 -47.65 0.29 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 110.738 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.4 Cg_endo -66.29 167.92 17.3 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.004 1.136 . . . . 0.0 109.902 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.55 -169.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.676 1.584 . . . . 0.0 110.244 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.1 -48.14 3.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -96.21 61.89 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -1.071 . . . . 0.0 109.325 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 20.6 m-85 -139.97 4.84 2.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -85.72 48.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -162.78 94.81 1.17 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 0.0 109.106 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.02 116.63 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 120.862 1.041 . . . . 0.0 110.165 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -95.1 143.18 26.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.392 -0.818 . . . . 0.0 109.666 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.2 mtt-85 -87.43 135.86 33.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.21 120.59 26.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 109.764 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -109.53 107.47 17.59 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -76.47 103.32 6.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -45.35 -31.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -66.95 105.14 1.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.02 4.65 36.14 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.21 83.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -124.42 128.73 49.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.932 . . . . 0.0 109.255 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -90.31 114.07 26.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.216 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.9 tp -48.91 141.67 7.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.526 HH11 ' CG ' ' A' ' 57' ' ' ASP . 39.8 ttp180 -147.55 112.48 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.2 mt -89.96 112.75 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -74.35 151.93 87.78 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.121 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.7 Cg_exo -56.92 -26.42 67.55 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.163 1.242 . . . . 0.0 110.24 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.46 0.37 17.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.56 4.36 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.3 mtm-85 -50.63 115.24 1.4 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.13 146.09 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 14.0 p30 -169.06 148.13 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.26 151.53 20.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -146.35 153.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -89.91 -0.7 57.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.28 88.1 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -68.91 -5.04 18.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 22.65 1.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.6 OUTLIER -110.18 99.92 41.79 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.61 3.62 0.36 Allowed 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 120.912 1.075 . . . . 0.0 110.522 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' A' ' 57' ' ' ASP . 56.0 m-70 -84.23 -4.64 58.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.65 1.85 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -77.01 100.45 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.29 135.2 43.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.79 107.33 19.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -85.85 150.72 24.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.532 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.04 132.93 16.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -91.4 135.44 33.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 -38.32 8.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.639 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -151.34 -117.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -83.85 -110.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.687 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.53 6.26 17.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.76 129.89 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.79 168.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -142.47 118.99 10.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.448 -0.783 . . . . 0.0 109.401 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 74' ' ' ILE . 4.8 mt -91.07 152.33 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -148.65 117.99 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.506 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 131.91 51.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.08 -60.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -68.2 -34.28 75.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.17 -21.92 33.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 51.25 55.21 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 6.6 mtp180 -146.8 149.29 33.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.399 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -94.97 129.63 41.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.06 139.66 58.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.267 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.82 133.31 16.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -97.12 133.0 42.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 88' ' ' ASP . 32.8 mmtt -73.45 164.24 26.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.893 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.78 24.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.1 p30 -130.24 -42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.663 -0.648 . . . . 0.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.41 -9.61 1.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.2 mtt-85 -78.53 115.93 18.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -1.162 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.67 131.02 38.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.412 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.94 -171.83 3.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.16 151.43 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 109.383 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.21 151.33 38.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.481 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -63.86 -28.92 70.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.77 127.38 38.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.94 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 p -148.25 -165.37 2.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -68.01 -19.43 64.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.961 . . . . 0.0 109.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.63 54.1 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 58.3 m -146.71 9.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -94.32 156.41 16.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.89 105.56 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -58.39 103.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.512 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -87.06 94.56 9.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -89.92 126.85 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.454 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.29 132.26 34.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.56 -178.92 4.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -89.15 -11.41 43.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.1 m-20 -89.59 28.55 1.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER 60.42 -0.7 0.25 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.75 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.2 m-85 -95.48 130.14 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.92 169.97 10.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.3 p -142.39 120.45 12.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.791 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -93.15 99.05 11.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -93.49 145.15 24.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -72.02 155.57 40.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.6 ttt180 -92.45 -76.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.6 -9.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 13.4 m-85 -140.47 60.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 40.1 p -61.0 0.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 4.0 m -90.51 10.68 24.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.08 142.33 19.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -105.55 170.13 8.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.0 t -90.68 69.95 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 145' ' ' ALA . . . -94.01 141.59 28.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.5 mt -95.97 179.6 5.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -92.65 -171.68 2.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -93.64 -11.77 30.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 2.51 55.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.43 0.4 67.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -88.43 171.01 10.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.6 p90 -89.6 120.41 30.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -70.14 139.34 52.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.483 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.4 tp -47.68 125.07 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.226 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.45 -16.5 7.04 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.483 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.3 p -90.1 -20.45 23.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.053 -1.263 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -89.98 -11.03 42.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.2 p -69.93 175.07 4.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.83 25.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.2 170.95 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.893 1.729 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.91 -55.07 2.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -75.15 134.87 41.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 146' ' ' ILE . 33.9 mtmt -82.76 4.39 25.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . . . -61.21 -3.85 0.99 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.1 pt -93.12 -9.63 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.9 mt -81.87 91.64 6.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -94.07 157.28 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.5 tp -138.12 71.95 47.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.21 115.0 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.775 1.65 . . . . 0.0 110.732 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.3 mtt -97.43 130.59 44.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 109.22 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.0 t -68.32 144.31 54.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' HH12 ' A' ' 31' ' ' ARG . . . -85.1 53.43 2.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.22 -77.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.324 0.583 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.69 115.75 22.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.7 mt-10 -91.6 97.31 10.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 58.62 158.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.62 -120.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -1.179 . . . . 0.0 109.437 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.38 107.35 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -62.42 139.03 58.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 109.189 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -145.86 156.42 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.637 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.92 98.23 41.09 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.31 115.56 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.68 0 C-N-CA 120.924 1.082 . . . . 0.0 110.543 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.1 52.11 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.482 -0.761 . . . . 0.0 109.176 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.16 68.74 2.53 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.499 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.95 156.84 60.17 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.697 1.598 . . . . 0.0 110.273 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.45 90.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.486 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -77.48 52.93 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . -55.37 -43.51 84.79 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . 62.02 119.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 73.18 102.16 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -1.114 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.18 91.6 2.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.29 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -1.037 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -95.79 -46.17 0.26 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.441 -0.787 . . . . 0.0 111.036 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 3.9 Cg_exo -65.45 167.89 15.82 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 109.96 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.82 170.51 1.38 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.64 1.56 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.34 -20.37 0.08 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -177.45 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -1.183 . . . . 0.0 109.469 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -87.51 17.15 4.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 41.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.3 152.07 32.58 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.48 156.7 30.05 Favored 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.236 1.291 . . . . 0.0 110.341 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -141.12 133.77 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.436 -0.79 . . . . 0.0 109.424 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.1 mtt-85 -90.76 133.86 34.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.65 126.35 38.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -115.19 119.46 36.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.5 t -93.82 106.66 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.09 -35.04 10.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.656 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.593 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.7 m120 -67.95 103.28 1.45 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.92 4.93 83.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 55.16 8.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -102.14 143.05 32.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.978 . . . . 0.0 109.795 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.02 110.14 22.46 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 127' ' ' LEU . 13.6 tp -46.95 144.66 2.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.119 -0.988 . . . . 0.0 109.716 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -143.55 155.4 44.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.89 131.83 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.199 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -93.17 149.68 37.86 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.067 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.06 -21.75 52.15 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.224 1.283 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -74.85 4.79 5.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -38.54 3.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -48.1 164.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.7 t -137.83 148.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.587 -0.696 . . . . 0.0 109.258 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' ' CG1' ' A' ' 52' ' ' VAL . 3.1 p-10 -154.17 -160.02 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 131' ' ' GLY . . . -143.1 126.38 2.82 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.407 ' CG1' ' OD2' ' A' ' 50' ' ' ASP . 1.8 m -142.55 151.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.456 -1.026 . . . . 0.0 108.457 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 55' ' ' LYS . 35.4 mtm180 -89.04 -21.54 23.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.091 -1.006 . . . . 0.0 109.341 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -44.93 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.764 . . . . 0.0 109.705 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' ARG . 6.9 pttp -81.27 1.33 32.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.3 p -88.28 5.12 43.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.214 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -99.27 110.35 57.85 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.177 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.73 3.18 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.717 0.944 . . . . 0.0 110.238 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -74.85 -33.23 62.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.334 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.96 0.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.459 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.612 ' NZ ' ' NH1' ' A' ' 31' ' ' ARG . 8.6 tptt -77.1 96.71 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.453 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 131.75 45.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.503 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.02 109.54 20.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -92.61 150.01 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.553 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.73 137.9 21.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.1 160.21 25.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.952 . . . . 0.0 109.581 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -142.94 -84.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.79 -151.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -85.87 117.72 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 -3.11 13.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.41 139.34 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -1.16 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.5 m -140.86 128.23 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.535 -0.728 . . . . 0.0 109.577 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 m -94.47 118.74 32.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.06 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 82' ' ' TYR . 58.4 tttp -145.71 144.18 30.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.44 134.17 12.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.47 -77.75 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -27.18 7.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.95 -25.46 20.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.0 m120 50.99 48.3 23.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -146.37 150.76 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 75' ' ' LYS . 80.9 m-85 -94.86 127.8 41.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.3 147.92 24.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -145.88 167.87 22.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.0 ttm -134.17 141.12 46.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.675 -0.64 . . . . 0.0 109.407 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -92.84 160.79 14.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.46 -29.41 70.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -45.53 26.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.08 -6.72 1.81 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.52 ' NH1' ' OH ' ' A' ' 133' ' ' TYR . 2.1 mmt180 -63.84 120.08 11.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -1.222 . . . . 0.0 109.471 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.16 -175.31 5.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.08 150.6 38.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.315 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -146.6 156.52 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -73.44 -18.56 61.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.25 112.97 25.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.96 142.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.464 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.2 p -147.31 -163.35 1.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.58 -14.8 63.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.504 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -94.07 42.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 64.6 m -144.03 6.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 60.7 m-85 -94.36 151.44 19.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 96.0 m-85 -150.22 111.94 4.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CD2' ' NH1' ' A' ' 116' ' ' ARG . 32.2 m-85 -54.89 157.81 3.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.27 95.26 4.41 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 109.307 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -89.96 108.57 19.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.66 117.86 30.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.93 -175.58 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -1.25 57.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 41.3 t-20 -91.44 27.49 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.95 -3.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 109.88 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.9 m-85 -94.31 156.49 16.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.242 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -123.9 165.38 17.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 109.758 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -141.0 120.13 12.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.321 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -89.9 107.77 19.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.479 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.513 ' NH1' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -99.07 133.65 43.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.499 -0.751 . . . . 0.0 109.133 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t -61.41 161.8 8.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.968 . . . . 0.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -95.45 -79.12 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 0.0 109.199 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -50.33 -11.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -130.19 52.53 2.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 118' ' ' ARG . 79.9 p -52.72 -12.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 m -93.51 20.51 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.928 . . . . 0.0 109.635 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -152.29 130.75 12.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.72 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.5 m-85 -103.99 167.97 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.581 -0.699 . . . . 0.0 109.591 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.52 148.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.887 . . . . 0.0 109.362 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.58 -177.96 6.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 41' ' ' LEU . 29.5 mt -144.86 171.28 14.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -90.27 174.03 7.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -93.79 11.71 28.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -125.08 5.55 7.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.7 -0.625 . . . . 0.0 109.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 95.27 0.28 63.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -85.09 172.95 10.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -1.166 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 20.9 p90 -93.62 120.55 34.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.592 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -72.71 132.82 44.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.364 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.72 158.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.76 -39.01 18.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -67.49 -15.37 63.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -1.159 . . . . 0.0 109.585 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -90.02 -5.05 57.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -74.38 165.68 24.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.57 179.47 21.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.86 168.71 6.74 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.849 1.7 . . . . 0.0 110.237 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.87 -47.9 2.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -82.14 131.52 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.593 ' HB2' HD22 ' A' ' 36' ' ' ASN . 36.3 mtmt -85.1 -1.94 57.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.522 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.18 -0.14 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.6 pt -93.66 -10.45 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.599 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 91.47 8.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.35 168.39 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.6 tp -144.27 70.44 16.09 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.58 112.97 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.796 1.664 . . . . 0.0 110.305 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 29.8 mtt -98.12 115.61 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.307 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.5 t -65.16 157.32 29.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.99 56.21 3.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -56.13 -58.02 9.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.26 -96.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -142.77 -91.69 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.29 -176.67 14.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' ILE . 8.6 mt-10 -90.15 134.35 34.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 7' ' ' THR . 74.0 mt 53.09 172.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.541 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.666 ' N ' HG22 ' A' ' 6' ' ' ILE . 3.2 p -77.64 165.86 23.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 109.541 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.14 147.73 3.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' ALA . 4.4 mp -138.13 149.01 62.21 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.3 Cg_endo -58.47 76.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 120.985 1.123 . . . . 0.0 110.243 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 43.15 65.68 0.92 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.17 -47.46 0.39 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 110.779 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.2 Cg_endo -66.49 167.1 19.7 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.09 1.193 . . . . 0.0 110.205 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' GLY . 10.5 tt0 64.33 50.35 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER 41.84 -90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.737 -0.602 . . . . 0.0 110.128 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . 149.86 11.82 0.11 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.21 -175.47 9.6 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m 177.13 79.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.45 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.32 -58.79 5.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -145.78 9.68 1.17 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -1.087 . . . . 0.0 109.461 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 2.7 p90 38.09 67.19 2.17 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.822 -0.549 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.35 168.18 11.63 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.645 1.563 . . . . 0.0 109.853 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.63 168.53 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.614 1.543 . . . . 0.0 110.171 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.15 39.46 6.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -166.69 30.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -1.152 . . . . 0.0 109.5 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -135.86 28.28 3.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.553 -0.717 . . . . 0.0 109.323 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 3.0 56.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -114.86 151.94 45.96 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.1 166.43 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.215 1.277 . . . . 0.0 110.525 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HD2' HD22 ' A' ' 64' ' ' LEU . 36.8 mttp -150.02 131.05 14.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.235 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.53 118.73 28.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' CD1' HD12 ' A' ' 62' ' ' LEU . 24.0 mt -84.92 100.65 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -98.6 125.42 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.472 -0.767 . . . . 0.0 109.571 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.66 121.46 33.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -15.13 62.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.705 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.5 m120 -84.66 105.07 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 53' ' ' ARG . . . 75.87 4.91 78.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.67 88.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.2 m-85 -144.84 132.97 21.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -1.076 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -94.92 131.56 40.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.388 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.77 143.52 57.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.268 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 57' ' ' ASP . 42.5 ttt180 -146.47 119.32 8.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.669 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.13 120.22 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -82.93 151.74 64.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.38 -27.29 75.05 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.121 1.214 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 p30 -74.91 0.88 14.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -25.11 11.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -55.95 114.96 2.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -1.154 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -92.69 142.1 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.406 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 12.7 p-10 -170.91 150.09 3.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.09 155.23 22.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.67 140.57 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 37' ' ' GLY . 8.5 mmt180 -69.27 -12.54 61.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.78 98.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' O ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.12 -5.49 59.34 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.264 -0.897 . . . . 0.0 108.943 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -97.09 23.74 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -102.85 107.55 55.12 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.187 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.5 -3.28 3.21 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 120.718 0.945 . . . . 0.0 110.154 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -76.04 -25.64 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.271 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.49 -5.52 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -76.09 87.27 2.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.959 . . . . 0.0 109.424 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 32' ' ' LEU . 8.4 mt -89.92 135.38 33.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -89.62 111.19 22.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.256 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -91.3 148.97 21.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.718 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 73' ' ' SER . 7.4 tt0 -145.36 148.25 33.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.87 163.68 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 102' ' ' PHE . 3.2 tt0 -138.01 -51.13 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.489 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -147.77 -139.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -91.51 101.26 13.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.0 -14.63 52.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.03 106.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -1.174 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 103' ' ' PHE . 3.3 m -95.74 -178.0 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 65' ' ' GLN . 5.9 m -144.84 112.39 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.37 -0.831 . . . . 0.0 109.236 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.97 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.65 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -146.27 143.68 29.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.398 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.29 142.42 16.39 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 78' ' ' SER . 55.0 t -78.93 -87.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 109.368 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 77' ' ' VAL . 10.0 t -47.6 -39.68 17.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.42 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.445 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 51.25 53.95 12.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.672 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -147.17 156.25 42.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.92 130.37 40.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.76 143.12 51.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.559 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -147.91 170.2 18.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.5 ttp -139.29 122.08 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.487 -0.758 . . . . 0.0 109.372 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -59.57 -175.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.26 -11.75 45.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -92.55 -38.02 12.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 143.44 -9.45 2.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -66.36 124.55 23.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.64 HD11 ' SD ' ' A' ' 85' ' ' MET . 11.0 mp -92.71 134.33 35.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.09 -171.53 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.599 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.64 150.39 40.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.26 147.78 31.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -66.33 -17.3 64.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.895 . . . . 0.0 109.543 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -90.24 140.81 29.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.493 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 97' ' ' VAL . 24.9 t -92.98 94.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.48 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.2 p -91.71 157.02 17.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.428 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.97 -21.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.87 48.52 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.2 m -138.61 1.02 2.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.455 -0.778 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 67' ' ' GLU . 99.2 m-85 -98.79 159.75 14.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.84 . . . . 0.0 109.412 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.2 m-85 -150.13 115.65 5.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.593 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.03 149.38 12.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.25 90.09 3.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -94.87 126.04 39.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.18 125.79 39.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -92.59 170.09 10.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.432 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -79.81 62.95 4.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 13.0 p30 -159.94 21.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.488 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m120 63.4 -6.77 0.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 110.037 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.3 m-85 -97.62 134.55 40.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 109.365 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.4 170.01 9.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.877 . . . . 0.0 109.822 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -140.27 114.62 9.24 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -90.63 115.33 27.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.876 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 150.9 22.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.556 -0.715 . . . . 0.0 109.161 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.3 163.44 20.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.896 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -94.83 -61.65 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 109.242 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.51 -54.07 23.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -96.1 62.62 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 p -56.89 2.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 120' ' ' TYR . 19.4 m -89.33 15.17 9.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.898 -1.126 . . . . 0.0 109.443 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.04 146.55 23.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 14.4 m-85 -104.71 169.45 8.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.17 125.61 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.55 156.4 42.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.1 mt -112.75 -178.36 3.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.771 -0.581 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.99 -129.45 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.533 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -139.84 4.52 2.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.502 -0.749 . . . . 0.0 109.408 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.31 14.82 8.32 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.61 6.46 60.91 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -92.91 162.74 13.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -1.121 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.0 p90 -93.32 120.3 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.666 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.452 ' NZ ' ' OE1' ' A' ' 143' ' ' GLN . 22.7 ttmt -70.03 135.41 49.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.493 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.677 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.66 160.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.27 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.3 24.52 7.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.677 ' OG ' HD23 ' A' ' 135' ' ' LEU . 33.7 p -115.07 -45.73 2.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.701 -0.882 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -4.86 28.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.684 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -73.16 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.66 179.46 31.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.95 171.57 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.885 1.723 . . . . 0.0 110.237 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.26 -44.34 3.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 8.7 mm-40 -85.39 133.82 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.461 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.567 ' HB2' HD22 ' A' ' 36' ' ' ASN . 36.9 mtmt -81.39 3.95 22.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.25 -9.95 5.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 pt -92.56 1.82 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 144' ' ' LYS . 71.1 mt -94.3 90.56 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.398 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.56 168.65 10.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 tp -141.02 70.61 28.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.329 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.54 103.83 0.41 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.8 1.667 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.6 mtt -95.4 125.35 39.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.354 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.4 t -70.02 135.33 49.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 61.98 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -54.9 -77.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.403 ' OXT' HG21 ' A' ' 6' ' ' ILE . 41.8 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.424 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.61 123.88 7.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 2.5 mp0 -88.18 -169.91 2.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 50.49 95.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.22 -98.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.48 ' CG1' ' NH2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -89.64 -176.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -66.18 178.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -145.6 -98.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.798 ' H ' HG23 ' A' ' 8' ' ' THR . 11.8 mt 60.18 148.86 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.559 -0.713 . . . . 0.0 109.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.13 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.991 1.127 . . . . 0.0 110.188 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 156.5 30.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.48 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 179.18 -50.76 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 110.573 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 2.2 Cg_endo -64.62 144.65 85.11 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 120.717 0.945 . . . . 0.0 110.111 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 49.65 74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.5 -28.29 23.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 48.95 -130.63 23.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -155.26 -40.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -145.69 48.47 1.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.347 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.11 66.39 0.24 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' CD1' ' A' ' 21' ' ' PHE . . . -46.45 -79.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 109.688 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 2.3 p90 -153.99 67.14 5.74 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.852 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.61 167.78 11.05 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.565 1.51 . . . . 0.0 109.65 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' HIS . 2.5 Cg_endo -58.45 173.96 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.667 1.578 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.13 3.08 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 23' ' ' PRO . 81.6 t60 -87.59 -23.07 24.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -1.173 . . . . 0.0 109.473 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 7.4 m-85 -93.02 31.23 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.614 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -73.27 -28.6 62.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.349 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.91 152.64 46.67 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.45 167.24 2.85 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.204 1.269 . . . . 0.0 110.244 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -140.7 127.0 19.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' NH2' ' CG1' ' A' ' 6' ' ' ILE . 53.6 mtt180 -86.76 124.95 33.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD12 HD23 ' A' ' 41' ' ' LEU . 10.9 mt -84.72 102.03 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.562 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.94 116.2 23.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.21 61.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.691 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.5 m-80 -90.0 105.21 17.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.37 4.91 87.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 84.17 0.02 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.63 134.68 30.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.413 -1.051 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -95.25 133.35 39.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 32' ' ' LEU . 39.9 tp -67.53 143.25 56.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.209 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.651 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 1.5 ttt180 -155.99 125.05 6.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.98 . . . . 0.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 49' ' ' VAL . 38.1 mt -94.13 127.17 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.256 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.792 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 86.8 m-70 -83.58 148.86 56.08 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.7 Cg_endo -59.25 -21.12 58.59 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.203 1.268 . . . . 0.0 110.466 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.71 7.73 2.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.708 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.63 -39.29 3.13 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -52.0 162.04 0.51 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -1.141 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 43' ' ' ILE . 70.0 t -139.4 141.35 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.46 -0.775 . . . . 0.0 109.366 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.792 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 39.4 p-10 -159.46 -149.77 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.88 155.94 26.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m -145.49 139.13 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -1.068 . . . . 0.0 109.401 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -77.83 -17.78 57.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.18 110.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 34.65 0.55 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -129.63 -20.4 3.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.655 -0.653 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -45.48 108.71 0.82 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.837 . . . . 0.0 109.485 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.86 5.44 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.674 0.916 . . . . 0.0 110.152 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.651 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 47.6 m80 -94.13 -15.42 24.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -70.05 -4.72 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.506 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.0 mtpt -76.94 79.38 3.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.06 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.86 110.41 21.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -87.72 159.0 18.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -141.28 176.33 8.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.222 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . . . -132.64 142.07 48.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.608 -0.682 . . . . 0.0 109.574 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.19 143.0 28.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 50.81 -127.22 2.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -147.81 137.8 22.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.23 10.33 81.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.25 143.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.476 -1.014 . . . . 0.0 109.324 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 66' ' ' ALA . 2.4 m -136.83 -176.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.479 -0.763 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -141.53 126.34 18.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -95.48 148.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.36 136.75 23.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.41 136.81 15.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 78' ' ' SER . 51.3 t -74.97 -86.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -1.198 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.558 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -47.51 -53.63 13.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.359 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.55 63.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 78' ' ' SER . 45.8 m-80 51.08 45.24 28.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 0.0 109.55 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -137.24 145.67 43.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 109.332 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.95 129.41 36.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.887 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.45 150.19 19.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -144.03 165.74 26.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 109.476 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.7 ttm -137.47 126.86 24.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.378 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -91.4 -173.04 3.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.92 -29.47 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.9 1.18 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.07 78.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -91.27 117.67 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -90.04 137.34 32.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.612 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.13 177.46 9.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.736 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.18 164.64 12.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.692 -0.63 . . . . 0.0 109.417 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -149.33 159.13 44.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 109.509 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -88.44 -0.5 57.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.93 123.75 16.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.496 -0.753 . . . . 0.0 109.423 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.07 154.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -150.93 168.39 24.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -47.51 -24.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.9 49.27 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -143.38 5.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -97.4 157.61 15.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -150.01 112.94 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' ARG . 34.1 m-85 -54.92 149.14 12.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.98 . . . . 0.0 109.231 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.96 92.14 3.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.657 -0.652 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 114' ' ' THR . 10.5 ttp180 -91.47 120.19 32.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.68 126.56 32.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.91 -177.19 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.7 m -93.67 55.92 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.568 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 17.2 p-10 -165.78 31.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.95 -4.29 0.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.6 m-85 -91.31 127.61 36.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.72 167.21 11.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 14.2 p -136.17 120.57 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.85 104.18 16.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -98.45 145.82 26.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.38 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -62.56 161.34 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 0.0 109.277 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -87.15 -61.67 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.68 -44.38 56.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -92.63 57.91 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -58.25 -0.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.5 m -89.71 11.81 18.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.07 -1.019 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.03 152.59 29.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 11.4 m-85 -120.65 163.19 18.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.63 130.06 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.23 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.86 143.49 21.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.96 167.78 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -93.75 -165.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.86 -10.16 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -4.77 53.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.97 34.22 9.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.3 176.38 5.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.769 -0.842 . . . . 0.0 109.374 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.8 p90 -87.02 120.06 27.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -71.39 131.84 43.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.715 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -52.15 140.5 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.52 4.08 1.61 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.715 ' OG ' HD23 ' A' ' 135' ' ' LEU . 88.9 p -91.89 -34.61 14.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.17 . . . . 0.0 109.604 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.02 -10.76 43.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 p -70.0 145.33 51.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.5 178.96 38.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.49 166.54 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.938 1.759 . . . . 0.0 110.222 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.62 -50.47 2.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -80.41 135.08 36.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 40.6 mtmt -85.01 9.28 15.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.07 -2.54 2.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 pt -97.13 -3.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 109.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.93 91.75 8.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.632 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.54 165.51 12.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.1 tp -141.87 70.45 24.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.392 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.16 104.9 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.752 1.635 . . . . 0.0 110.36 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.7 mtt -95.31 136.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 130.4 42.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.47 59.73 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -55.08 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.494 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.43 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.28 35.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.93 83.34 5.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.81 136.27 2.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE2' ' NE ' ' A' ' 31' ' ' ARG . 4.7 mp0 -82.56 -142.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -1.176 . . . . 0.0 109.502 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -66.19 86.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.424 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -53.12 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -92.2 16.16 12.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.478 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.3 mm? 57.29 150.44 0.06 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.99 142.0 96.45 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 120.825 1.017 . . . . 0.0 110.066 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.27 -175.98 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.183 -0.948 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -148.12 69.95 10.87 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.359 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.49 -163.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.823 1.682 . . . . 0.0 110.382 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -76.24 52.64 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.456 -0.777 . . . . 0.0 109.749 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.44 -26.92 29.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.5 -63.1 1.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.45 -160.03 48.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 p -149.02 53.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -1.174 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.61 37.58 0.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.61 90.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -1.096 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.514 ' CZ ' ' O ' ' A' ' 105' ' ' GLU . 52.6 m-85 45.69 67.98 3.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.893 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.61 114.06 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.775 1.65 . . . . 0.0 109.857 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.61 115.25 2.78 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 120.7 0.934 . . . . 0.0 110.158 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.58 -21.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 91.58 0.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -1.154 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CG ' ' HB2' ' A' ' 66' ' ' ALA . 46.1 m-85 -144.11 19.08 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -94.77 21.16 7.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 0.0 109.683 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -114.9 149.23 42.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.1 153.61 57.27 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.148 1.232 . . . . 0.0 110.384 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -137.41 124.46 21.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' NE ' ' OE2' ' A' ' 5' ' ' GLU . 2.1 mtm-85 -85.26 118.97 25.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.638 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.01 100.91 11.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -94.58 125.17 39.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.7 t -90.18 123.27 33.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -72.44 -13.91 61.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.1 m120 -90.34 105.12 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.98 5.8 88.88 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.47 85.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 43.6 m-85 -143.15 136.21 27.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -1.089 . . . . 0.0 109.568 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -98.13 122.76 41.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.403 -0.811 . . . . 0.0 109.493 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.13 145.53 20.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.179 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 59' ' ' HIS . 20.2 ttt180 -150.63 128.62 11.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.06 131.35 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.416 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 49.9 m-70 -90.5 152.09 44.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.105 -0.997 . . . . 0.0 109.193 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.56 -27.34 76.38 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.198 1.265 . . . . 0.0 110.368 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -74.88 9.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.525 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -33.73 3.28 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -47.51 166.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -1.176 . . . . 0.0 109.405 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.44 134.01 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 32.8 p-10 -159.4 155.93 27.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.33 152.19 20.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.64 149.13 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -1.108 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -82.25 -10.07 59.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.51 83.78 0.41 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -84.66 49.63 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.552 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.95 6.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 109.914 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 139.57 21.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.039 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.21 -4.37 3.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.022 1.148 . . . . 0.0 110.317 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CB ' ' NE ' ' A' ' 42' ' ' ARG . 70.1 m80 -75.0 -25.79 59.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.911 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.41 -1.95 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.322 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 77' ' ' VAL . 11.7 mmtp -83.96 87.0 7.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.93 135.64 33.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.42 104.37 16.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.341 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.82 154.8 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.22 141.25 35.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . . . -90.74 136.08 33.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -140.57 122.18 15.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 60.01 164.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 108.935 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.77 32.97 0.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.77 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.23 16.76 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.742 -1.218 . . . . 0.0 110.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.54 155.67 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -1.231 . . . . 0.0 109.575 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' VAL . 4.3 m -144.07 130.02 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -92.84 125.33 37.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.828 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -104.05 142.61 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.757 . . . . 0.0 109.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -147.23 151.57 36.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.75 139.42 14.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 61' ' ' LYS . 54.4 t -78.24 -65.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -71.92 -42.54 66.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.6 65.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 49.98 51.29 16.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -146.06 145.98 30.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.377 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -89.8 133.55 34.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.579 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 44.1 tp -63.56 146.82 52.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.55 132.7 16.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.1 ttm -97.51 120.16 37.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.96 176.54 9.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.32 -26.33 30.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.18 -2.62 22.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 92.48 -14.98 63.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.6 mtt-85 -71.43 123.33 22.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.478 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -90.2 136.2 33.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.579 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -146.4 -175.44 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.65 158.7 43.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 p -145.17 170.11 16.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.321 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -79.97 -36.9 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -93.23 126.0 38.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -71.06 118.85 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 p -97.88 161.57 13.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.66 -21.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.37 55.47 2.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -139.29 3.69 2.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 79.3 m-85 -96.87 162.89 13.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 92.5 m-85 -150.15 121.94 8.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -62.18 97.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 34.9 tt0 -73.17 95.37 2.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -92.51 123.64 35.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.75 134.32 35.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.24 -170.69 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -95.81 -17.54 21.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.659 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 4.1 p30 -94.39 26.0 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.769 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 71.52 2.61 4.34 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.726 -0.609 . . . . 0.0 110.697 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -90.29 140.58 29.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.918 -1.114 . . . . 0.0 109.443 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -95.4 164.16 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 p -141.8 119.89 12.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.332 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -91.77 105.47 17.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -96.15 145.5 25.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -68.34 148.8 50.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -80.55 -56.73 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -70.01 -46.64 64.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.1 m-85 -95.94 59.44 2.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -57.03 -2.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.9 m -89.85 10.34 24.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.678 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.08 153.02 30.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 13.8 m-85 -117.02 168.98 9.77 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.303 0.573 . . . . 0.0 109.464 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.78 133.24 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.87 177.48 9.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.1 158.36 39.86 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -93.19 170.63 9.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -78.49 -11.93 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 130' ' ' THR . 1.7 t -91.87 26.1 2.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.77 50.01 69.31 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -137.47 167.01 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.974 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.2 p90 -90.33 120.58 31.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -69.63 132.62 46.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 139' ' ' THR . 13.8 tp -54.04 160.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -78.62 -0.61 80.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.1 p -95.01 -47.23 6.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -1.12 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -72.46 -6.74 45.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 135' ' ' LEU . 3.1 p -69.95 153.52 43.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.01 -179.87 28.21 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.33 -174.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.779 1.652 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.57 -43.1 1.81 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -92.21 119.46 31.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.526 ' HB2' HD22 ' A' ' 36' ' ' ASN . 36.6 mtpt -71.05 4.53 2.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.24 -9.2 10.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.349 -0.844 . . . . 0.0 109.542 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -93.15 0.53 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.525 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 144' ' ' LYS . 70.5 mt -92.35 91.39 7.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.39 168.84 10.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.5 tp -143.07 70.43 18.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.16 107.7 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.791 1.661 . . . . 0.0 110.246 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.0 mtt -93.88 111.13 22.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.805 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 t -66.2 145.37 55.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.08 56.21 3.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -74.84 -83.45 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.526 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.5 161.08 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.98 103.47 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.91 134.68 2.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -92.02 -81.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -1.202 . . . . 0.0 109.587 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -99.16 135.44 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -58.04 -161.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.519 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 7' ' ' THR . 94.6 m 53.33 96.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -44.87 153.12 0.51 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.288 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.65 173.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.23 1.286 . . . . 0.0 110.542 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -179.12 -167.52 0.11 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mt -142.41 70.81 21.64 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.517 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 14' ' ' GLU . 2.2 Cg_endo -65.49 114.04 2.73 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.858 1.705 . . . . 0.0 110.165 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 14.5 tt0 71.0 101.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.366 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.06 -26.04 0.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 47.09 74.91 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.22 108.86 0.31 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 p -171.15 55.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -1.143 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.75 -87.82 0.12 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' C ' ' CD1' ' A' ' 21' ' ' PHE . . . -146.3 -110.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.13 . . . . 0.0 109.412 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 20' ' ' ALA . 72.7 m-85 -152.37 67.51 6.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.775 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.15 167.8 13.68 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.591 1.527 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.82 152.67 55.63 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.594 1.53 . . . . 0.0 110.097 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 143.02 -52.33 0.64 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.509 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 63.4 m-70 -75.08 28.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.128 . . . . 0.0 109.538 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 52.1 m-85 -131.92 29.72 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.74 . . . . 0.0 109.224 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -95.21 -14.96 23.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.793 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -150.27 152.52 33.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.338 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.8 175.57 0.29 Allowed 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 121.251 1.301 . . . . 0.0 110.243 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 25' ' ' HIS . 9.6 mttp -146.28 175.11 10.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.427 HH11 ' HG3' ' A' ' 31' ' ' ARG . 17.9 mtm-85 -131.01 128.1 39.67 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.45 111.0 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.774 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -101.42 114.52 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.81 108.31 17.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.491 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.737 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.1 m-80 -77.25 105.0 8.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.65 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . . . 72.3 7.05 66.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 73.98 0.27 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -118.27 129.88 55.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.73 -0.865 . . . . 0.0 109.571 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.82 113.2 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.2 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 32' ' ' LEU . 43.8 tp -49.07 133.83 18.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 109.187 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 57' ' ' ASP . 41.2 ttp180 -142.5 122.98 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.7 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.54 133.76 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.202 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -89.92 151.24 45.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.09 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.15 -18.15 28.23 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.161 1.24 . . . . 0.0 110.516 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.89 -7.88 54.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.19 55.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -94.05 163.09 13.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -1.132 . . . . 0.0 109.363 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 83' ' ' LEU . 74.5 t -129.66 126.59 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.568 -0.707 . . . . 0.0 109.315 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.61 149.99 24.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.27 151.85 22.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.25 146.12 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -1.149 . . . . 0.0 109.704 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 37' ' ' GLY . 28.2 mtt-85 -77.02 1.16 18.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.01 88.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -85.11 33.37 0.54 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.602 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -143.64 21.8 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.66 124.41 55.02 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.041 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.1 1.86 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.668 0.912 . . . . 0.0 110.28 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.4 m80 -94.07 -13.81 26.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.54 9.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.612 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -93.26 87.48 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -90.1 135.16 33.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -89.82 110.33 21.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.01 118.51 31.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.14 146.57 27.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.305 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -88.98 139.36 30.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' GLU . 28.1 tt0 -146.64 142.05 27.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . 1.5 mt-10 48.3 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -100.97 113.28 26.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 109.541 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.63 25.56 17.78 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.75 152.54 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -1.103 . . . . 0.0 109.418 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.7 m -144.49 133.41 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -92.08 118.75 31.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.554 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.89 138.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -147.04 139.6 24.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.66 142.36 20.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.44 -72.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -45.19 91.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.31 -27.35 68.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.96 50.15 19.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 5.5 mtp180 -145.89 150.05 35.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -95.29 134.31 38.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.323 -0.861 . . . . 0.0 109.766 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HG21 ' A' ' 49' ' ' VAL . 42.9 tp -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.249 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.08 148.5 29.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 47.2 ttm -106.27 132.91 51.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.371 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -72.45 -170.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.0 -45.54 26.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.707 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 1.4 p-10 -69.96 -82.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -171.18 24.61 0.09 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -89.61 124.27 34.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.2 mp -94.01 128.7 40.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.54 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.81 -173.53 4.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -140.2 152.55 46.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.404 -0.81 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.61 155.03 42.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -61.09 -36.81 80.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 99.0 p -84.93 137.55 33.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -89.08 118.12 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.9 p -93.98 -169.82 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 101' ' ' CYS . 1.7 m-20 -80.06 -30.75 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.99 15.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.448 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 99' ' ' ASP . 93.8 m -95.1 -9.32 33.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -86.74 148.8 25.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.935 . . . . 0.0 109.435 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.27 116.48 7.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -59.51 122.43 14.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.93 97.79 9.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 116.82 29.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.76 120.3 31.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' OE1' HG23 ' A' ' 114' ' ' THR . 19.4 mt-10 -84.7 -171.29 3.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.5 p -93.37 -4.35 51.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.7 m-20 -93.06 25.84 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.55 -1.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.79 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.2 m-85 -95.93 130.94 42.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -91.61 163.05 14.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.742 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.493 HG23 ' OE1' ' A' ' 108' ' ' GLU . 6.6 p -139.09 114.66 9.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.124 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -89.84 114.71 26.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.806 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.82 139.82 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.295 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -67.68 137.01 55.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.5 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 120' ' ' TYR . 25.5 ttt180 -77.98 -70.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.589 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 3.2 tptt -51.55 -10.08 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 27.6 m-85 -146.2 70.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.7 p -64.88 4.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 120' ' ' TYR . 11.2 m -94.25 10.23 34.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.88 . . . . 0.0 109.603 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 10.4 m-90 -154.97 137.37 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 22.6 m-85 -100.98 165.39 11.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.574 -0.704 . . . . 0.0 109.388 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.67 125.86 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.665 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -152.2 143.4 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -95.39 176.21 6.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -93.07 173.19 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -84.92 -4.84 59.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.434 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.94 -5.16 48.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.26 -0.66 55.95 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 2.0 mp0 -93.13 172.6 8.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -1.184 . . . . 0.0 109.532 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.9 p90 -91.61 120.22 32.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -70.2 131.84 44.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 139' ' ' THR . 13.2 tp -48.5 160.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.11 2.05 53.05 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' THR . 84.5 p -93.69 -68.17 0.82 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' N ' ' OG ' ' A' ' 137' ' ' SER . 12.3 mptt -48.18 -14.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 135' ' ' LEU . 22.3 p -69.93 150.36 46.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.42 179.84 30.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.51 158.46 31.86 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.69 -28.78 8.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -90.4 113.89 25.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.411 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -65.93 -2.25 3.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.665 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.99 -10.36 28.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 1.9 pt -90.67 2.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.499 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.4 mt -91.01 87.31 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.99 159.62 15.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.672 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 149' ' ' LEU . 19.5 tp -140.84 70.91 29.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.018 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 109.35 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.888 1.726 . . . . 0.0 110.641 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 20.6 mtt -97.5 130.94 44.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.397 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.0 t -70.08 167.99 16.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.134 -0.979 . . . . 0.0 109.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.9 50.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -93.79 -73.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.433 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.513 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.97 146.71 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.25 -131.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.68 132.54 0.09 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -66.19 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -1.158 . . . . 0.0 109.502 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 6' ' ' ILE . 2.4 mp -78.32 139.63 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' HD13 ' A' ' 9' ' ' LEU . 79.2 p -51.94 160.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -77.37 -60.37 2.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.486 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.594 HD13 ' OG1' ' A' ' 7' ' ' THR . 6.3 mp 57.84 157.62 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.16 174.8 0.4 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.173 1.249 . . . . 0.0 110.144 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.28 -172.43 4.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 15' ' ' ASP . 1.5 tt 52.25 69.04 2.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.451 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.15 177.37 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.56 51.81 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 12' ' ' LEU . 1.2 m-20 -71.54 94.89 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . -172.77 58.59 0.15 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . 58.05 161.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 166.91 105.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -1.114 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.2 -79.07 0.07 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -150.7 81.05 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -1.178 . . . . 0.0 109.53 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.492 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 2.9 p90 37.17 66.47 2.12 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.997 -0.439 . . . . 0.0 110.597 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.9 168.13 12.64 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.561 1.507 . . . . 0.0 109.766 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.62 103.01 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.583 1.522 . . . . 0.0 110.213 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' O ' ' ND1' ' A' ' 25' ' ' HIS . . . 148.88 47.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 24' ' ' GLY . 46.7 m-70 -155.96 16.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 27.9 m-85 -120.14 27.25 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -93.01 10.82 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.07 149.93 26.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 108.822 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.07 160.1 13.54 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.988 1.125 . . . . 0.0 110.174 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.69 ' HG3' HD22 ' A' ' 64' ' ' LEU . 24.8 mmtp -122.47 174.16 7.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.7 mtm-85 -136.84 110.89 8.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 41' ' ' LEU . 9.5 mt -84.06 101.28 11.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.927 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.22 115.68 27.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.7 t -78.87 111.43 15.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.576 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -20.2 66.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.3 m-80 -88.13 100.93 13.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.597 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 86.71 4.55 82.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 84.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 48.7 m-85 -142.2 131.3 23.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -1.062 . . . . 0.0 109.477 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -92.64 121.92 34.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.47 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 32' ' ' LEU . 49.2 tp -53.0 145.25 13.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.0 109.187 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 22.4 ttt180 -148.7 158.95 44.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.576 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.6 mt -136.27 123.37 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -88.15 149.69 45.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.116 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.89 -23.72 60.82 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.294 1.33 . . . . 0.0 110.699 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' OD2' ' CD ' ' A' ' 48' ' ' ARG . 36.4 p-10 -74.63 3.87 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.739 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.42 -35.31 4.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' CD ' ' OD2' ' A' ' 46' ' ' ASP . 27.0 mtp180 -47.8 152.86 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.92 144.18 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.468 -0.77 . . . . 0.0 109.428 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -167.04 -146.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.91 161.12 28.25 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.8 m -147.1 138.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.465 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 53' ' ' ARG . 4.5 mtm-85 -82.25 5.43 20.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.38 106.61 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -84.0 38.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.96 17.5 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -99.13 110.16 56.92 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.795 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 1.63 0.63 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.68 0.92 . . . . 0.0 110.127 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.1 m80 -80.6 -13.29 59.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.391 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.21 -0.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.18 87.48 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.97 131.68 35.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.454 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -89.98 102.95 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.69 HD22 ' HG3' ' A' ' 30' ' ' LYS . 10.7 mp -86.21 149.66 24.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.98 139.1 28.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . . . -88.69 111.74 22.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -92.11 -91.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -84.34 180.0 7.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.8 mtt-85 -76.62 110.7 11.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.41 26.02 26.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.52 96.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -1.127 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.87 126.65 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 m -94.31 129.02 41.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.443 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.78 146.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.96 117.68 8.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.46 48.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 78' ' ' SER . 55.2 t -80.0 -80.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -1.086 . . . . 0.0 109.435 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -58.6 -35.01 71.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.79 -25.83 61.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.479 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 m120 51.21 52.69 14.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.8 mtt-85 -147.63 143.32 27.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.9 126.78 35.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -59.88 147.49 38.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.51 170.14 17.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -140.03 128.89 23.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -73.12 -169.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -92.78 -17.5 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.4 p30 -85.44 -40.87 15.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.49 2.16 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -70.56 126.35 29.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -93.09 138.47 31.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.05 -176.56 5.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.89 157.1 44.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m -145.49 170.14 16.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.831 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -42.88 33.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 p -89.43 142.86 27.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.5 p -85.23 116.99 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.417 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -96.01 178.88 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -22.81 67.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -94.08 54.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.814 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.2 m -137.43 0.56 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 83.9 m-85 -94.87 153.17 17.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.386 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 82.2 m-85 -147.84 120.14 8.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -59.74 154.19 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -125.25 97.24 5.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.684 -0.635 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.98 116.74 28.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.89 112.33 24.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -84.89 167.72 15.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.883 . . . . 0.0 109.528 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.0 t -81.49 66.39 7.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 112' ' ' TYR . 33.0 p30 -167.58 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 63.49 -7.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.517 -0.739 . . . . 0.0 110.057 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.506 ' H ' ' C ' ' A' ' 110' ' ' ASN . 54.8 m-85 -98.32 120.12 38.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -93.25 170.05 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.833 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 p -134.08 121.64 21.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.344 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.44 105.01 16.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 121' ' ' THR . 27.9 ttt180 -94.78 147.06 23.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.855 . . . . 0.0 109.454 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -74.01 158.26 34.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -93.67 -75.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 10.4 tptm -51.44 -9.93 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.1 m-85 -142.97 63.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.467 -0.771 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.521 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 30.2 p -63.27 2.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 57.8 m -91.01 11.97 21.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.06 145.27 21.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 116' ' ' ARG . 27.9 m-85 -109.96 168.16 9.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.741 -0.6 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.7 t -92.93 131.43 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.4 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -148.26 -172.54 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 95.5 mt -138.49 149.8 45.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -61.09 -102.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.5 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 31.3 ptt180 -173.76 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.417 -0.802 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 130' ' ' THR . 1.8 t -92.53 22.11 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.616 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.75 6.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -136.4 158.7 43.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.956 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 31.0 p90 -95.02 120.46 35.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.816 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -69.74 135.26 49.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.606 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.2 tp -58.06 157.34 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.279 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -79.39 22.19 3.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.606 ' OG ' HD23 ' A' ' 135' ' ' LEU . 3.5 p -98.57 -60.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.362 -1.081 . . . . 0.0 109.554 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -71.93 -7.5 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 135' ' ' LEU . 23.7 p -70.12 146.84 50.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.89 179.77 42.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.84 172.71 2.71 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.864 1.709 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.1 -42.11 2.5 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -72.52 134.68 45.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.0 mtpp -85.09 -4.13 59.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -61.48 -3.72 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 144' ' ' LYS . 3.0 pt -99.2 -3.23 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.2 mt -82.24 93.95 7.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 109.591 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.26 161.06 13.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.808 . . . . 0.0 109.529 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.4 tp -133.32 75.73 69.74 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.672 . . . . 0.0 109.23 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.25 111.08 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.712 1.608 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.3 mtt -96.37 114.99 26.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.497 ' CB ' ' HZ2' ' A' ' 154' ' ' LYS . 9.6 t -70.2 129.07 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.94 56.34 3.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.497 ' HZ2' ' CB ' ' A' ' 152' ' ' SER . 63.4 mttp -66.78 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.493 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.28 0.562 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.74 120.73 9.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -82.15 135.92 35.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.461 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLU . . . 93.49 51.51 2.16 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLY . 1.4 pm0 29.48 -131.62 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.313 -0.522 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.622 HG22 HG23 ' A' ' 7' ' ' THR . 2.4 mp -78.46 115.66 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.622 HG23 HG22 ' A' ' 6' ' ' ILE . 11.8 p 51.94 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 8' ' ' THR . 8.3 t -165.34 94.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.55 151.85 44.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 108.956 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.97 99.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.07 1.18 . . . . 0.0 110.133 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.29 143.4 47.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.82 68.07 9.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.68 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.86 131.66 33.94 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.736 1.624 . . . . 0.0 110.176 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 16' ' ' GLY . 2.2 mp0 52.59 91.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -54.23 -7.42 0.14 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -145.4 -49.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 46.8 -93.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 16' ' ' GLY . 20.6 m -146.58 51.25 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 109.425 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . 66.02 -6.13 1.66 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.86 101.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -1.166 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' H ' ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 177.98 -51.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 110.801 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 21' ' ' PHE . 3.9 Cg_exo -62.46 167.87 10.67 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 120.65 0.9 . . . . 0.0 109.829 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.73 -168.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.687 1.591 . . . . 0.0 110.368 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.28 -48.54 1.19 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -93.85 44.89 1.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.486 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.91 14.23 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -94.09 23.91 4.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.695 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -162.8 152.56 13.29 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.09 174.41 0.33 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.115 1.21 . . . . 0.0 110.08 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' HD22 ' A' ' 64' ' ' LEU . 9.7 mtpp -147.22 131.04 17.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.9 mtt-85 -85.89 121.18 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.056 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 41' ' ' LEU . 19.7 mt -84.5 104.91 14.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.98 117.14 33.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.585 -0.697 . . . . 0.0 109.6 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.39 116.45 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.164 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -65.48 -24.5 67.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.06 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.82 105.14 14.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 83.24 4.34 89.69 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.41 83.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 47.8 m-85 -141.48 140.53 33.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -1.103 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -100.88 134.24 44.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 32' ' ' LEU . 44.7 tp -70.13 144.12 52.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 41.1 ttp180 -152.82 129.1 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -103.33 136.28 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.518 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 5.5 m-70 -91.73 148.89 38.16 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.066 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.14 -17.66 46.93 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.095 1.197 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 7.4 p30 -74.84 -10.48 59.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.776 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 15.15 29.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.6 mtt-85 -92.65 167.44 11.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -1.19 . . . . 0.0 109.333 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.7 t -142.94 117.73 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.402 -0.811 . . . . 0.0 109.274 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 4.3 p-10 -158.23 160.29 36.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.637 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.11 152.99 20.94 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.7 155.06 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.481 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -75.26 -30.66 60.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.461 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' OE2' ' OD1' ' A' ' 57' ' ' ASP . 2.6 mt-10 -47.26 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 53' ' ' ARG . 8.8 pttp -85.24 33.82 0.56 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.946 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 1.1 t -165.23 43.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.09 -1.006 . . . . 0.0 110.007 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.2 156.88 38.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.957 . . . . 0.0 109.188 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -66.15 22.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 121.508 1.472 . . . . 0.0 111.051 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . 61.7 m80 -141.71 -15.51 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.029 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -64.81 -5.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -88.39 90.81 8.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.434 HD12 ' CD1' ' A' ' 32' ' ' LEU . 15.4 mt -89.96 135.38 33.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 64' ' ' LEU . 2.4 tp-100 -89.67 106.49 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -86.92 155.59 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.72 121.8 12.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.847 . . . . 0.0 109.246 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.83 157.57 26.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.93 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -148.06 135.42 20.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 50.75 -112.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -153.52 124.64 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.11 -17.87 35.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.29 146.02 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.669 -0.9 . . . . 0.0 109.332 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 m -146.43 175.34 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -143.97 128.77 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.73 147.84 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.565 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 5.7 tttp -147.49 134.27 20.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.62 130.85 10.3 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.36 -74.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -1.13 . . . . 0.0 109.496 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.468 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 2.1 t -66.42 -45.25 80.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -27.55 39.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 78' ' ' SER . 16.3 m-80 49.79 47.48 22.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.513 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 92.4 mtt180 -147.28 144.67 29.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 70.7 m-85 -90.15 131.69 35.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.602 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.33 142.63 56.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.206 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -148.29 134.49 19.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 53.7 ttm -96.65 126.58 41.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.395 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -72.25 178.8 3.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 -31.59 45.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -70.98 -48.26 54.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.06 -9.11 1.52 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -71.27 124.71 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.489 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.3 mp -92.74 133.87 35.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.553 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -147.59 177.78 8.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -116.83 156.64 26.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.626 . . . . 0.0 109.373 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -145.34 162.91 36.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -82.98 -39.79 20.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.1 t -92.63 122.76 35.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.14 154.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -147.53 -177.12 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -22.55 64.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -87.68 44.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 22.0 m -143.17 5.45 1.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 59.7 m-85 -93.42 151.89 19.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 0.0 109.563 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 84.1 m-85 -150.16 110.59 4.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.882 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -56.96 155.14 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.137 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -125.19 95.35 4.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.369 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' NH2' ' OE1' ' A' ' 108' ' ' GLU . 6.2 ttp180 -90.76 132.36 35.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.21 132.45 36.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' OE1' ' NH2' ' A' ' 106' ' ' ARG . 4.5 mm-40 -88.35 -174.67 4.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -16.46 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.908 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.404 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 5.7 m-80 -93.44 24.24 4.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 64.11 57.32 1.28 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 110.056 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 52.7 m-85 -143.02 126.39 16.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.257 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.73 120.36 34.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 146' ' ' ILE . 66.8 p -98.1 129.06 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.405 -0.809 . . . . 0.0 109.224 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -95.89 113.03 24.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -100.81 144.89 29.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.378 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -76.24 139.95 41.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 109.582 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.474 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.2 ttt-85 -76.47 -70.63 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -51.37 -9.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.409 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' N ' ' C ' ' A' ' 118' ' ' ARG . 49.7 m-85 -143.86 68.22 1.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.5 p -67.06 3.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 120' ' ' TYR . 73.5 m -95.63 10.55 36.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.82 . . . . 0.0 109.652 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 5.1 m-90 -155.13 145.18 21.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.848 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.3 m-85 -112.01 161.47 16.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.75 -0.594 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.74 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.199 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 -171.37 3.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.808 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 133' ' ' TYR . 19.4 mt -140.78 159.46 42.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.523 -0.736 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -87.56 -173.54 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.86 -15.53 26.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.613 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.542 HG23 ' OE1' ' A' ' 132' ' ' GLN . 1.5 t -89.09 3.5 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.05 76.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 130' ' ' THR . 3.6 mp0 -86.11 174.76 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -1.175 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 35.5 p90 -95.02 120.43 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.68 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -69.85 135.42 49.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.396 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -49.31 149.35 2.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.245 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.21 0.28 59.66 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 35.7 p -93.99 -37.96 11.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -1.123 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -76.82 -8.2 56.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -71.95 160.32 32.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 153.3 179.69 28.98 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -61.11 -176.62 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.922 1.748 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.46 -36.78 0.98 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 145' ' ' ALA . 5.2 mt-30 -93.34 113.46 25.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -1.084 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 146' ' ' ILE . 19.5 mtmt -65.83 2.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.6 2.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.644 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' THR . 5.6 pt -100.66 6.35 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.35 94.81 8.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -98.3 164.3 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.811 . . . . 0.0 109.37 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -142.01 70.82 23.66 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.841 . . . . 0.0 109.52 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.81 107.84 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.929 1.753 . . . . 0.0 110.324 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 8.8 mtt -96.18 128.99 43.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.516 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.9 t -70.12 153.2 43.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.578 ' CB ' HH22 ' A' ' 31' ' ' ARG . . . -91.36 58.84 3.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.53 -78.57 0.41 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.503 -179.973 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.264 0.554 . . . . 0.0 109.528 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.71 129.15 13.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.23 -0.919 . . . . 0.0 109.517 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.85 99.48 12.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.02 -18.7 74.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -140.36 -168.48 2.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -1.01 . . . . 0.0 109.351 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.32 99.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -92.52 116.54 29.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.539 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.4 t -147.53 -3.28 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp 46.77 68.8 3.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.765 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.07 99.01 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.799 1.666 . . . . 0.0 110.21 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.79 58.23 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.711 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 178.65 -37.26 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.584 -0.697 . . . . 0.0 111.308 179.561 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 1.8 Cg_endo -70.01 127.0 13.78 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 120.488 0.792 . . . . 0.0 110.277 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 51.32 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.05 -8.53 23.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.91 -113.02 3.87 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.92 -149.64 5.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -84.69 52.63 2.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -1.111 . . . . 0.0 109.501 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.15 88.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.88 8.09 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.429 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 12.7 m-85 46.46 66.88 4.95 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.37 113.95 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 121.767 1.645 . . . . 0.0 110.073 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.88 109.9 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.778 0.985 . . . . 0.0 110.096 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.03 -64.82 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.68 27.3 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.667 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.572 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 24.7 m-85 -87.04 10.11 17.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.415 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 12.8 tttm -93.43 34.45 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 109.506 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.83 151.92 36.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.073 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.14 171.45 2.27 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.21 1.273 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.572 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 30.2 mttt -145.15 126.93 15.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.04 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.5 mtt-85 -84.81 117.09 23.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.653 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 41' ' ' LEU . 18.7 mt -84.63 99.07 10.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.97 124.2 36.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 t -90.51 120.31 31.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.212 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -67.94 -14.87 63.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' OD1' ' N ' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -88.63 105.22 17.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.642 -179.856 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.21 4.94 87.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.85 86.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.2 m-85 -144.77 138.26 27.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.302 -1.116 . . . . 0.0 109.65 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.48 121.63 38.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.0 109.423 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 32' ' ' LEU . 41.4 tp -49.36 150.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.203 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -156.61 119.51 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 mt -92.55 129.18 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.191 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.99 151.99 45.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.8 -26.75 75.12 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.27 1.313 . . . . 0.0 110.378 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -74.79 10.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -37.41 2.98 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.621 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.8 mtt-85 -47.17 154.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -1.187 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 83' ' ' LEU . 95.7 t -134.16 130.42 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -146.24 -149.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.42 150.44 22.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.16 144.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -77.64 -16.67 58.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -59.97 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.384 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.12 12.36 3.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.554 -179.908 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -108.92 10.91 26.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 109.597 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -95.05 123.48 57.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.18 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.13 4.92 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 120.636 0.891 . . . . 0.0 110.331 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 57' ' ' ASP . 24.1 m80 -82.53 -38.41 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.879 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -65.52 4.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.577 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 59' ' ' HIS . 14.5 mttt -87.24 84.08 7.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.37 134.28 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.83 108.23 19.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.371 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -144.2 144.51 31.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.412 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.27 126.36 36.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.948 . . . . 0.0 109.505 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -97.48 -30.21 13.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -153.67 -171.88 4.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -0.926 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -82.95 23.53 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.579 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.63 23.72 0.1 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.31 151.0 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.3 m -145.2 127.18 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -94.5 122.22 36.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.583 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 74' ' ' ILE . 8.3 mt -94.4 145.75 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -147.37 130.78 16.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.32 133.81 13.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.19 -65.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -1.15 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -61.64 -34.19 75.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.64 34.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 50.97 50.82 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -148.11 148.53 30.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -89.95 134.89 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 49' ' ' VAL . 39.5 tp -65.09 147.75 52.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.65 170.3 17.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.7 ttm -139.11 129.05 25.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.529 -0.732 . . . . 0.0 109.409 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -75.07 178.71 5.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.39 -7.84 59.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.7 p30 -92.72 -46.29 7.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.33 -9.16 1.46 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -71.93 127.86 33.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.9 mp -91.68 139.16 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.08 -176.06 5.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.57 160.08 40.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.291 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 76.8 p -147.14 170.02 18.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -80.98 -36.86 30.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 p -91.23 126.17 36.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.7 p -72.98 116.31 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.51 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.7 p -93.64 -170.16 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.92 -10.85 59.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -93.78 12.55 25.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 59.2 m -95.68 8.93 42.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.627 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -97.74 148.65 23.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 63.2 m-85 -150.13 113.37 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -55.26 152.02 8.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 108.928 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' OE2' ' CE1' ' A' ' 21' ' ' PHE . 10.6 tt0 -125.07 94.71 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -92.69 128.42 38.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.936 . . . . 0.0 109.4 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.29 137.99 32.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.664 ' OE2' HG23 ' A' ' 114' ' ' THR . 2.5 mp0 -92.67 -178.34 4.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -94.24 47.74 1.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -156.14 23.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.13 49.77 1.95 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.53 -0.731 . . . . 0.0 110.012 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' ' OE2' ' A' ' 108' ' ' GLU . 52.3 m-85 -140.63 129.87 23.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.6 154.6 17.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.631 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.664 HG23 ' OE2' ' A' ' 108' ' ' GLU . 23.3 p -131.38 119.32 21.51 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -93.32 107.74 19.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -101.53 148.12 25.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.294 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -72.57 157.11 38.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.965 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.96 -76.52 0.48 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -51.29 -10.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 118' ' ' ARG . 31.2 m-85 -142.89 63.78 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 p -63.32 3.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.775 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.7 m -89.86 11.68 19.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.606 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.14 145.36 22.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 109.839 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.2 m-85 -113.79 167.51 10.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.766 -0.584 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.49 129.37 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.32 149.38 26.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 19.7 mt -107.11 176.56 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.535 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.46 -166.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 109.28 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -17.29 23.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.366 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.1 1.96 55.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.423 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.25 12.21 56.46 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -93.52 142.63 27.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -1.192 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 24.5 p90 -69.09 120.67 15.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 127' ' ' LEU . 2.8 ttpm? -69.65 130.5 42.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.418 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.5 148.34 1.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.38 -31.68 81.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.418 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -77.46 -15.55 59.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -1.174 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -89.31 -4.96 57.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.0 p -87.33 156.68 19.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 167.34 179.94 40.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.93 166.52 10.29 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.866 1.711 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.32 1.9 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.25 106.46 6.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -66.42 -3.0 5.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.528 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.585 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.5 -6.27 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.408 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 146' ' ' ILE . 4.9 pt -93.75 -1.52 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.497 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.11 90.35 8.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -94.92 167.98 11.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.7 tp -144.49 73.87 15.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.446 -0.784 . . . . 0.0 109.251 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.97 115.16 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.75 1.633 . . . . 0.0 110.629 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.0 mtt -96.33 107.01 19.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -63.97 147.02 53.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.99 56.76 4.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -55.21 -86.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.535 179.98 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.315 0.578 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 -15.71 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -59.73 167.93 1.91 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.92 172.08 42.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.05 -106.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 8' ' ' THR . 9.5 mm -90.93 105.31 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.536 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -47.95 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -79.42 87.2 5.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 11' ' ' ALA . 83.4 mt -84.51 150.57 57.22 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 108.657 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 2.5 Cg_endo -56.7 87.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.98 1.12 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 10' ' ' PRO . . . 165.4 73.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 109.227 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.963 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -101.15 163.23 18.35 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.37 -0.831 . . . . 0.0 108.946 -179.916 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.39 101.36 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.458 1.439 . . . . 0.0 110.222 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -162.45 51.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -96.35 -31.55 12.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 0.0 109.386 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 86.63 1.35 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.09 152.01 24.17 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -77.78 52.27 1.01 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -1.12 . . . . 0.0 109.459 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.29 15.02 36.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 -112.45 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -1.081 . . . . 0.0 109.216 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 21' ' ' PHE . 13.6 p90 -165.41 66.87 1.16 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.804 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.76 167.93 11.05 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.587 1.524 . . . . 0.0 109.837 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.63 133.74 58.56 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.637 1.558 . . . . 0.0 110.204 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 25' ' ' HIS . . . 149.21 27.93 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 91.5 m-70 -156.64 56.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -140.87 14.94 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -92.5 -16.84 25.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.84 152.63 46.61 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.75 168.66 2.2 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 121.147 1.231 . . . . 0.0 110.168 179.474 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -144.86 128.75 17.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.825 . . . . 0.0 109.376 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.35 118.82 25.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 20.7 mt -84.86 98.84 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 40' ' ' PHE . 37.3 t80 -94.98 122.13 37.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.685 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.24 131.48 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.184 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.57 -18.78 58.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.756 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 3.0 m120 -82.15 105.08 12.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 109.608 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.84 4.92 88.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 84.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.6 m-85 -143.17 134.95 26.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -1.112 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 22.8 m-85 -96.68 126.27 41.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 49.7 tp -51.22 149.3 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.35 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 17.7 ttt180 -158.26 116.02 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.0 mt -91.81 128.97 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.236 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -89.44 151.64 46.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 0.0 109.055 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.18 -24.02 64.72 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.113 1.208 . . . . 0.0 110.254 179.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -74.9 2.5 10.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.602 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.4 -32.25 5.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -47.36 162.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -1.114 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -143.6 128.33 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -155.99 -150.28 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.419 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.38 27.7 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.73 149.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -1.083 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -81.92 -15.72 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 99.87 3.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.379 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -80.61 12.26 3.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -92.26 -20.11 21.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.542 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.7 OUTLIER -60.02 115.01 11.23 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.256 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.94 3.45 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.633 0.889 . . . . 0.0 110.185 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.4 m-70 -85.07 -12.33 53.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.4 9.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.9 mmmm -92.53 84.57 5.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.27 134.48 34.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.59 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.65 109.77 21.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.56 114.88 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -99.01 142.85 29.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.6 161.56 14.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -145.21 -102.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.31 -154.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -90.43 106.61 18.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.88 -9.19 73.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.82 133.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.1 129.03 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.382 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.1 m -93.65 123.76 37.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.87 141.47 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -146.13 146.65 30.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.69 14.84 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' LYS . 99.1 t -79.94 -46.25 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -1.163 . . . . 0.0 109.558 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.67 -43.37 11.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.23 66.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 51.31 49.16 21.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.3 mtt180 -147.99 147.5 29.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.32 135.26 34.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.3 tp -64.95 145.19 56.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.203 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.86 135.34 18.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.9 ttm -98.18 138.89 34.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.455 -0.778 . . . . 0.0 109.453 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HE2' HD21 ' A' ' 92' ' ' LEU . 10.4 mmtm -92.48 178.0 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 4.6 pm0 -80.54 -25.49 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.6 p30 -83.16 -1.56 53.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.475 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 93.69 2.26 65.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -78.36 115.18 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -90.63 132.24 35.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.549 HD21 ' HE2' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -146.55 -172.04 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.483 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.31 152.66 47.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -145.03 170.01 16.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -83.47 -23.49 32.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 63.5 m -93.12 151.85 19.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.64 113.8 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -93.18 177.02 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.46 -17.74 61.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 22.9 mp0 -93.17 16.67 12.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.3 m -92.94 -7.18 46.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 68.1 m-85 -93.01 153.41 18.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 74.1 m-85 -146.47 116.38 7.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -56.11 159.4 3.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -125.13 141.77 51.9 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 97.86 3.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.72 131.33 42.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.39 -170.87 2.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.842 . . . . 0.0 109.385 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.87 -4.65 52.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.465 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -94.48 26.42 3.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.44 -0.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.4 m-85 -93.7 137.21 33.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.84 165.81 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 109.757 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.8 p -143.92 119.38 10.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.434 -0.791 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.66 113.54 25.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.75 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -97.21 143.23 28.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 109.302 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -60.67 162.18 6.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 109.383 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 121' ' ' THR . 61.2 ttt180 -92.68 -62.88 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -48.1 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.1 m-85 -93.89 60.46 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 118' ' ' ARG . 80.4 p -56.96 -0.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.56 11.38 19.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.01 146.47 23.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.769 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.2 m-85 -109.31 169.82 8.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.656 -0.652 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.65 133.55 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.372 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.35 -175.69 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.09 165.82 26.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -94.24 177.72 5.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -92.88 -14.15 28.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.3 t -93.32 32.69 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.6 50.96 60.88 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -142.26 166.53 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -1.078 . . . . 0.0 109.513 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -90.62 120.25 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -69.88 132.48 46.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -53.34 134.45 39.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.0 109.352 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.57 -0.55 1.99 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -93.04 -29.65 15.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.586 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -89.73 -4.88 57.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.3 p -72.98 144.1 47.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.15 -179.96 45.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.05 169.92 5.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.883 1.722 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.25 -53.61 3.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -73.53 134.74 43.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -1.172 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -83.44 7.67 16.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.437 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.1 -9.37 16.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.2 pt -90.14 -5.51 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.351 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' ' 144' ' ' LYS . 52.3 mt -87.1 90.03 8.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -94.78 164.55 12.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 149' ' ' LEU . 39.8 tp -141.82 70.98 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 109.17 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 106.35 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.953 1.769 . . . . 0.0 110.448 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.9 mtt -95.95 123.45 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.312 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.7 t -67.41 157.67 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.29 82.69 1.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -62.37 -66.06 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.499 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.81 24.53 1.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -92.2 116.06 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.14 -81.53 0.05 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -146.84 -94.33 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.137 . . . . 0.0 109.408 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -62.71 177.56 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 109.3 -179.958 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -147.1 62.38 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.339 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 8' ' ' THR . 5.9 t -145.19 66.17 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -57.22 -48.84 96.69 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 110.708 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.5 Cg_endo -65.04 -169.57 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 120.918 1.079 . . . . 0.0 110.059 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.99 86.18 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.329 -0.857 . . . . 0.0 109.541 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -89.23 -47.54 0.41 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.249 -0.907 . . . . 0.0 110.679 179.927 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.8 Cg_endo -67.47 113.97 3.1 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.085 1.19 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.65 97.68 0.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.0 -85.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.83 71.14 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.05 -129.44 3.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.2 t 50.43 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -1.185 . . . . 0.0 109.466 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.71 -63.45 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -129.19 -11.17 4.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.657 -0.908 . . . . 0.0 109.555 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 3.2 p90 38.05 66.94 2.25 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.74 -0.6 . . . . 0.0 110.445 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.71 168.24 10.48 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.533 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.19 145.22 87.88 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.61 1.54 . . . . 0.0 110.177 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.34 -74.6 0.22 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -66.63 -6.6 15.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -1.153 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.36 41.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.96 13.57 5.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.698 -0.626 . . . . 0.0 109.327 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.55 149.64 29.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.893 . . . . 0.0 108.781 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 168.02 3.09 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.098 1.199 . . . . 0.0 110.247 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.9 mttt -141.96 139.0 32.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.362 -0.836 . . . . 0.0 109.249 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -89.91 122.26 32.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.1 mt -84.95 97.24 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.621 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -95.75 113.8 25.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.31 118.07 23.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 109.377 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.85 -16.5 63.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.578 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 26.8 m-80 -86.31 104.13 15.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.01 4.84 89.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 83.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -142.82 132.57 23.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.358 -1.083 . . . . 0.0 109.533 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.79 114.96 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.6 tp -47.65 143.09 4.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 17.1 ttt180 -150.15 117.1 5.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 126.34 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.137 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -87.97 152.02 50.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.23 -22.77 58.79 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.126 1.217 . . . . 0.0 110.266 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -74.75 8.8 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.23 -36.18 3.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.4 mtt-85 -47.15 164.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -138.35 123.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -152.61 151.38 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.84 162.77 25.42 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -146.69 148.97 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -1.127 . . . . 0.0 109.549 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -82.18 10.26 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.425 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -93.71 94.84 8.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.714 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -75.33 -5.14 43.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 p -94.48 16.72 14.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -91.14 114.28 61.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.14 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.88 2.5 0.58 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.615 0.877 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 42.8 m80 -86.29 -11.38 52.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.47 -4.73 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 77' ' ' VAL . 20.8 mmtm -76.65 83.76 3.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.947 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.75 135.1 33.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -90.17 113.07 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -92.17 153.78 19.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.416 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -145.55 149.72 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.88 150.71 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.12 130.84 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.43 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 50.84 -107.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 6.7 ptm180 -154.91 129.79 9.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.77 29.12 73.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.95 96.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -1.16 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 72' ' ' VAL . 2.4 m -94.58 129.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -92.69 121.69 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -89.95 148.44 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -148.77 140.98 24.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.73 145.64 20.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 78' ' ' SER . 76.2 t -79.5 -86.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 109.488 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.464 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -47.36 -55.07 9.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -30.33 64.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 78' ' ' SER . 73.9 m-80 51.32 44.62 28.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 30.2 mtt180 -137.2 145.26 43.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.56 -0.713 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.17 136.21 33.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 55.2 tp -63.73 151.5 41.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.277 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.4 158.08 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.42 ' CE ' HD21 ' A' ' 91' ' ' LEU . 41.5 ttm -139.26 130.45 26.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HE3' HD21 ' A' ' 92' ' ' LEU . 3.1 mptp? -94.18 -171.22 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.44 -15.39 25.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.56 -5.51 59.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 94.36 7.78 60.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 91' ' ' LEU . 98.9 mtt180 -85.15 108.21 17.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.384 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.757 ' N ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -94.18 131.55 39.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.8 pp -150.07 173.14 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.567 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -105.03 159.62 15.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.702 . . . . 0.0 109.497 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -150.13 163.4 38.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.0 109.454 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -88.55 -34.18 17.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -93.66 130.71 39.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.7 p -81.93 103.5 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.42 ' C ' ' N ' ' A' ' 100' ' ' GLU . 69.7 p -96.0 165.2 12.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.43 -17.77 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.42 ' N ' ' C ' ' A' ' 98' ' ' THR . 2.5 mp0 -92.72 49.61 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -143.4 6.49 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -96.66 154.23 17.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 0.0 109.464 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 90.0 m-85 -150.02 115.68 5.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.95 152.27 7.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.201 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -125.13 89.86 3.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.626 . . . . 0.0 109.4 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -89.92 120.87 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.358 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 tp -91.6 119.92 31.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.311 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -84.92 -172.84 4.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 111' ' ' ASN . 13.0 p -92.78 -20.27 20.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.2 m120 -74.32 25.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.562 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.3 m120 60.65 -0.7 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.726 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 46.4 m-85 -98.71 133.45 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.1 m120 -93.14 170.14 9.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 p -141.25 113.26 7.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.429 -0.795 . . . . 0.0 109.277 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -89.96 105.98 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 121' ' ' THR . 13.7 ttt180 -96.17 151.04 19.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -76.13 155.62 34.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -91.24 -74.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.4 tptt -52.34 -9.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.656 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 17.5 m-85 -142.96 67.19 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.371 -0.83 . . . . 0.0 109.495 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.523 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 23.4 p -65.12 5.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 68.0 m -89.73 7.16 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.745 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.1 m-90 -154.62 167.59 29.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.76 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 12.7 m-85 -131.52 168.28 17.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.727 -0.608 . . . . 0.0 109.375 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.0 t -86.07 125.5 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 109.338 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.11 163.57 39.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.0 mt -119.56 161.69 20.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -79.27 -99.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.154 -0.966 . . . . 0.0 109.492 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.91 -36.7 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.735 HG23 ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -78.27 10.33 3.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 6.54 67.94 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.735 ' OE1' HG23 ' A' ' 130' ' ' THR . 1.9 mp0 -84.82 167.54 15.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.536 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.5 p90 -93.73 120.1 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.619 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -69.91 126.42 29.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -46.73 145.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -71.28 8.23 5.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -91.0 -34.65 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -90.0 -7.43 54.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 p -70.27 151.78 44.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 158.11 -179.31 33.9 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.95 169.99 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.848 1.699 . . . . 0.0 110.137 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.47 -49.63 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -72.44 131.58 42.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.578 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 3.5 mtpt -85.02 3.68 37.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.44 -2.53 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 23.2 pt -97.29 -3.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.798 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.84 99.39 9.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 109.53 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.37 159.29 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.08 72.17 46.98 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.64 117.67 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.824 1.683 . . . . 0.0 110.538 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 15.1 mtt -96.54 127.19 42.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 0.0 109.263 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 t -70.09 161.82 29.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.59 85.09 1.63 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -72.87 -65.12 0.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.493 179.948 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.6 -134.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.445 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 47.58 67.08 0.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.5 141.2 0.39 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.31 174.39 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -1.166 . . . . 0.0 109.462 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.16 95.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.7 151.61 35.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 8' ' ' THR . 56.5 m -166.39 -1.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.215 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.9 mt -123.78 80.31 56.06 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 12' ' ' LEU . 6.2 Cg_exo -61.21 -170.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.395 1.397 . . . . 0.0 110.37 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.94 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.831 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 10' ' ' PRO . 4.8 tp -171.46 66.82 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.34 -168.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.744 1.629 . . . . 0.0 110.215 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -171.28 70.26 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 12.4 t70 -150.31 6.63 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.3 -116.86 5.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.22 1.08 0.5 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -88.61 57.51 4.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -168.07 25.46 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.46 24.4 5.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -1.121 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 56.8 67.9 2.4 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.718 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.48 168.13 11.94 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.647 1.565 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.17 146.4 81.75 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.535 1.49 . . . . 0.0 110.204 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.25 -38.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -147.58 13.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -1.143 . . . . 0.0 109.526 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.2 21.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 25' ' ' HIS . 9.5 mttm -93.32 -13.73 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.617 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -114.9 152.31 46.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.7 171.73 1.87 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.177 1.251 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -138.54 130.88 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.217 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.6 mtm-85 -84.99 116.95 23.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 41' ' ' LEU . 25.0 mt -84.78 95.66 9.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -91.47 116.2 28.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 t -83.61 105.0 14.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 109.169 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -57.65 -23.61 52.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.601 -179.71 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 15.4 m-80 -78.15 104.95 9.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 77.79 4.73 85.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.54 86.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' CZ ' ' NH1' ' A' ' 53' ' ' ARG . 48.3 m-85 -144.26 135.46 25.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 109.285 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -92.34 137.27 32.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 32' ' ' LEU . 50.9 tp -75.4 143.42 42.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.734 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 30.9 ttm180 -146.48 122.52 10.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.04 107.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 61.1 m-70 -66.95 151.95 96.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.098 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.04 -29.57 74.74 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.118 1.212 . . . . 0.0 110.398 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.97 5.59 4.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.461 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 -26.27 5.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -51.53 115.99 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -1.145 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.63 127.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 7.2 p-10 -154.13 152.25 30.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.32 25.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 42' ' ' ARG . 33.8 m -149.1 152.49 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.607 ' NH1' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -76.13 -27.87 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.277 179.847 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -47.86 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -85.19 25.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.733 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 p -152.15 35.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.026 . . . . 0.0 109.991 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.41 140.02 25.41 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 108.911 179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.11 -4.68 4.07 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 121.1 1.2 . . . . 0.0 110.453 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 61' ' ' LYS . 69.4 m80 -94.49 -23.66 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.241 -179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 60' ' ' ILE . 1.3 pt -69.1 8.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 59' ' ' HIS . 3.2 mmmm -94.4 87.86 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 109.425 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.2 mt -93.84 135.08 35.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.24 109.53 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.84 151.06 19.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.27 150.4 36.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' OE1' ' A' ' 65' ' ' GLN . . . -94.31 150.76 19.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.78 -83.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.552 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.32 -147.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -92.29 127.03 37.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.412 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.55 33.99 68.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.57 101.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.69 -0.888 . . . . 0.0 109.372 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.1 m -103.09 126.03 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.686 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 m -89.84 122.99 33.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.93 148.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -146.15 139.99 26.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.9 133.6 11.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 26.1 t -77.79 -72.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.4 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -62.88 -39.97 96.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.61 63.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 18.5 m-80 50.95 50.82 18.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -147.44 147.97 30.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -91.54 127.93 37.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.58 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.64 149.82 20.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.366 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.32 170.25 18.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.404 ' CE ' HD11 ' A' ' 91' ' ' LEU . 23.9 ttm -138.29 131.37 30.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.0 109.433 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -85.86 -166.46 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -90.1 -33.88 16.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.56 -1.74 11.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.89 70.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.22 125.99 29.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -1.215 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 mp -92.13 135.83 33.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.675 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -149.42 -173.06 4.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.46 158.94 43.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.78 169.94 18.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -82.49 -27.98 31.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.8 m -92.87 160.13 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.516 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.1 t -92.83 156.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 72.1 p -147.35 160.06 42.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.59 -16.19 35.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -93.99 8.17 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.5 -4.57 50.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 109.79 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 93.5 m-85 -92.2 159.92 15.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 91.7 m-85 -150.94 119.13 6.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.32 147.57 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.974 -1.079 . . . . 0.0 109.334 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -125.33 97.77 5.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.674 -0.641 . . . . 0.0 109.318 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.72 128.42 41.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.568 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 112' ' ' TYR . 17.5 tp -94.67 121.51 36.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.77 -175.72 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -92.98 -25.06 18.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.635 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -74.17 18.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 109' ' ' SER . 2.5 m120 63.92 65.17 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.401 ' O ' HD12 ' A' ' 107' ' ' LEU . 40.5 m-85 -144.92 -168.87 3.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.133 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -146.64 113.34 6.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.755 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -94.62 111.71 23.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.264 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.51 109.01 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -100.27 150.88 22.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.75 166.89 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -95.3 -57.82 2.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.388 179.913 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -82.08 -49.29 10.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.1 m-85 -91.7 61.25 4.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -57.11 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 0.0 110.711 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 120' ' ' TYR . 45.6 m -89.02 11.02 19.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.78 -1.2 . . . . 0.0 109.619 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.4 m-90 -152.48 159.38 43.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 21.2 m-85 -123.06 169.83 10.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.716 -0.615 . . . . 0.0 109.413 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.55 133.27 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -150.13 178.09 9.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 109.673 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.0 157.68 46.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.646 -0.659 . . . . 0.0 109.383 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -93.94 -166.58 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.334 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -93.87 -10.08 35.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.5 t -90.1 -7.86 52.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.97 60.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -93.77 173.95 7.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -1.11 . . . . 0.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 38.4 p90 -92.6 120.35 32.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -70.01 136.4 50.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 137' ' ' SER . 13.8 tp -59.78 127.49 32.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -49.16 -10.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 135' ' ' LEU . 21.4 p -75.51 -36.55 60.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -1.211 . . . . 0.0 109.642 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -89.96 -5.19 56.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.675 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.5 p -83.7 138.73 33.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.9 179.5 48.65 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.96 165.62 11.83 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.874 1.716 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.34 -58.87 3.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 145' ' ' ALA . 26.2 mm-40 -70.75 120.83 16.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -1.191 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 19.1 mtmm -63.51 1.68 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.1 -4.66 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -99.86 4.75 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.9 mt -91.86 109.82 21.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -113.0 162.06 16.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.6 tp -140.2 70.69 34.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.73 111.37 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.93 1.753 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.1 mtt -94.37 99.88 12.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.325 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 t -56.75 133.41 54.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.05 59.47 3.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -54.97 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.492 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.57 114.52 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER -91.18 59.14 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 179.988 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . -61.69 -144.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.64 -83.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 6' ' ' ILE . 2.7 mp -98.0 62.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 1.2 p 48.49 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.838 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.517 ' C ' HD23 ' A' ' 9' ' ' LEU . 10.3 m -140.06 108.48 5.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 109.433 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.749 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -103.55 163.85 16.61 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.822 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -57.22 109.51 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.383 1.389 . . . . 0.0 110.296 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.69 -172.45 3.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.23 68.35 5.31 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 109.668 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.3 149.64 90.74 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.784 1.656 . . . . 0.0 110.241 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -174.78 90.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -91.36 -28.08 17.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.936 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 55.03 2.82 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.34 -109.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t 59.2 55.9 4.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . 79.05 -39.28 2.04 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 67.27 1.22 2.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -1.11 . . . . 0.0 109.488 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -82.57 -47.45 0.89 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 110.728 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.1 Cg_endo -66.93 168.05 18.15 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.96 1.107 . . . . 0.0 109.777 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.23 -170.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.648 1.565 . . . . 0.0 110.216 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.24 35.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -158.0 21.65 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.34 40.25 3.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.259 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -90.92 16.19 9.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -154.91 152.09 24.7 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.187 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.07 172.04 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.197 1.265 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 64' ' ' LEU . 34.9 mttm -148.03 128.1 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.16 120.47 26.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.78 104.81 15.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.671 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -104.47 123.08 46.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.54 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.44 136.86 32.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -82.4 -25.77 33.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.626 HD22 ' HB2' ' A' ' 144' ' ' LYS . 3.3 m120 -74.95 105.07 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.704 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.38 4.93 89.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.45 87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.0 m-85 -143.81 136.44 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -1.067 . . . . 0.0 109.689 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -95.54 124.6 39.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.318 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.52 144.43 26.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.151 -0.968 . . . . 0.0 109.149 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 19.6 ttt180 -148.01 119.77 8.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.743 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -94.44 128.37 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.082 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -91.66 151.89 42.8 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.216 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.35 -27.79 77.11 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.178 1.252 . . . . 0.0 110.317 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -74.91 1.84 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.63 -31.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -50.2 118.5 3.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.463 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 148.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -169.57 -162.9 0.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.32 158.48 27.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.87 143.6 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -1.087 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -74.39 -1.39 20.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.66 92.55 8.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -85.17 56.42 3.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.2 p -155.49 13.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 110.096 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.6 m-20 -93.25 145.68 30.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.983 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.56 0.82 1.25 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.106 1.204 . . . . 0.0 110.338 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 57' ' ' ASP . 77.5 m80 -91.35 -29.21 17.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 110.187 -179.233 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -69.16 4.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.971 -1.08 . . . . 0.0 109.351 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 59' ' ' HIS . 10.7 mtpt -93.02 82.87 4.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -93.39 134.04 36.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.387 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -94.04 123.27 37.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.94 156.34 17.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -144.94 125.04 13.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.04 165.29 22.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.56 -98.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.391 -0.818 . . . . 0.0 109.206 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 2.3 mt-10 -84.67 -172.62 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.049 -1.032 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 10.9 mpt_? -72.96 107.74 5.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.9 68.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 68' ' ' GLU . 12.5 t -92.97 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.22 170.63 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.505 ' OG ' ' CD2' ' A' ' 102' ' ' PHE . 4.6 m -148.94 134.99 19.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 75' ' ' LYS . 82.1 mt -93.14 155.94 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.501 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' N ' HG22 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -149.36 139.8 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.62 127.33 9.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.94 -61.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.461 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -27.05 68.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.88 -23.98 21.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 51.66 51.2 17.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -148.08 145.96 28.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.516 ' CG ' HG22 ' A' ' 97' ' ' VAL . 86.8 m-85 -96.03 125.09 40.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -58.98 145.1 42.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.244 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.1 130.83 14.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 ttm -90.5 104.25 16.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.546 ' HG3' HD21 ' A' ' 92' ' ' LEU . 23.6 mmtt -62.91 166.46 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.527 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -78.51 -22.07 47.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -73.63 -5.85 43.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.95 -7.75 70.12 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -77.95 123.91 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.344 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.8 mp -89.77 124.26 34.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.209 -0.932 . . . . 0.0 109.128 179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -148.43 -170.33 3.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 109.611 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.16 161.13 39.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 p -146.49 153.19 40.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -59.11 -38.37 79.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.87 157.67 20.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' CG ' ' A' ' 82' ' ' TYR . 28.1 t -93.1 117.45 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.7 p -89.19 173.01 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.46 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -94.13 24.89 4.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.558 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 18.0 m -93.87 -8.81 39.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.583 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' OG ' ' A' ' 73' ' ' SER . 77.8 m-85 -93.99 158.56 15.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.593 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 86.7 m-85 -148.13 116.58 6.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.35 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -55.1 124.56 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -88.48 147.94 24.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -148.1 120.13 8.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.515 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.9 131.0 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -175.69 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -90.96 -4.48 56.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.466 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 112' ' ' TYR . 12.8 m-80 -93.48 27.89 2.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.501 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 63.64 -7.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.488 -0.758 . . . . 0.0 110.126 179.807 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.5 m-85 -84.14 -173.06 4.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.27 167.12 24.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -142.43 169.96 16.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.301 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -143.83 110.93 5.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.359 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -94.94 145.52 24.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -63.98 162.12 14.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 121' ' ' THR . 1.7 ttt-85 -92.36 -63.71 1.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.714 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -64.9 -47.8 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.731 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.5 m-85 -99.59 63.85 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.57 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -59.76 2.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.9 m -89.81 14.02 13.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.041 -1.037 . . . . 0.0 109.772 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.07 145.75 22.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.948 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -107.71 166.93 10.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.36 125.49 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.67 159.06 40.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.8 mt -108.1 179.39 4.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.658 -0.651 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -95.24 -112.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CB ' HH11 ' A' ' 129' ' ' ARG . 0.0 OUTLIER -147.38 -32.59 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 -179.889 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -79.31 3.6 17.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.492 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.64 56.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -94.12 167.5 11.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -86.64 120.36 27.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -69.84 133.71 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -59.15 138.04 57.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.227 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -70.95 11.9 2.39 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.686 ' OG ' HD23 ' A' ' 135' ' ' LEU . 99.4 p -94.57 -37.78 11.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -1.15 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -88.78 -6.05 57.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.55 ' C ' HE22 ' A' ' 143' ' ' GLN . 32.3 p -70.97 158.01 37.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.496 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.675 ' N ' HE22 ' A' ' 143' ' ' GLN . . . 161.35 -179.47 36.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.89 159.5 29.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.883 1.722 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.43 -27.48 9.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.675 HE22 ' N ' ' A' ' 140' ' ' GLY . 7.5 mt-30 -84.82 128.28 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.626 ' HB2' HD22 ' A' ' 36' ' ' ASN . 6.7 mtmp? -82.78 -3.75 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.419 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.595 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.16 -14.84 41.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pt -84.76 2.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 144' ' ' LYS . 73.7 mt -91.62 90.52 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.83 166.91 11.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.6 tp -141.93 70.42 24.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.722 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.01 105.75 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.791 1.661 . . . . 0.0 110.418 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.6 mtt -94.81 125.36 39.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.378 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 137.57 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.26 56.8 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.517 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 154' ' ' LYS . 9.7 mtpm? -81.67 -57.34 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.561 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.296 0.569 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.13 -50.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 53.57 85.17 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' GLU . . . -79.03 65.38 3.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 48.15 -173.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.154 . . . . 0.0 109.446 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 6' ' ' ILE . 2.5 mp -49.67 142.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -47.24 121.6 3.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.82 127.29 31.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.54 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD13 ' HD2' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -94.51 116.78 66.78 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 108.963 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD2' HD13 ' A' ' 9' ' ' LEU . 5.0 Cg_exo -59.99 -178.4 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.563 0.842 . . . . 0.0 110.211 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.44 52.86 0.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.877 . . . . 0.0 109.65 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -89.69 -47.42 0.4 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 179.933 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.2 Cg_endo -68.69 86.9 0.44 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 120.994 1.129 . . . . 0.0 109.894 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 53.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.359 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -24.05 63.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.87 6.04 73.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.87 17.85 14.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -90.5 58.42 3.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.141 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.65 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.29 -76.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -143.16 68.66 17.79 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.52 114.23 2.62 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.728 1.618 . . . . 0.0 109.843 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.48 99.89 0.21 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.693 0.929 . . . . 0.0 110.154 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.54 36.21 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.518 ' CG ' ' O ' ' A' ' 25' ' ' HIS . 46.1 t-80 -146.4 53.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -1.125 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -140.23 33.2 1.91 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 109.396 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -95.52 19.03 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.825 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.85 149.29 25.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 109.051 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.01 154.96 41.51 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.178 1.252 . . . . 0.0 110.243 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -124.67 122.61 37.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.95 118.62 24.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 41' ' ' LEU . 16.2 mt -84.82 102.89 13.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.586 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -95.82 123.45 39.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.322 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -91.88 117.56 29.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.4 -14.68 57.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.0 m-20 -83.4 105.02 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.32 4.86 65.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.92 75.65 0.21 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.41 133.0 51.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.698 -0.883 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.77 117.86 30.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 32' ' ' LEU . 36.6 tp -48.74 137.58 12.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.249 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 7.2 ttt180 -148.23 119.97 8.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.645 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.8 113.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.103 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -76.18 149.47 82.17 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.525 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.1 Cg_endo -58.52 -24.05 67.63 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.13 1.22 . . . . 0.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 18.6 p30 -74.9 2.22 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.39 -33.76 4.61 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.14 114.75 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.4 125.03 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 4.7 p-10 -155.37 -152.96 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -144.07 161.34 27.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.29 142.63 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 109.505 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -77.1 1.48 17.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.31 83.84 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 55.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 m -145.43 6.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 109.872 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 59' ' ' HIS . 28.2 m-20 -94.27 138.93 22.34 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.91 . . . . 0.0 109.12 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -1.36 1.76 Allowed 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 121.069 1.179 . . . . 0.0 110.373 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 78.1 m80 -83.37 -22.12 32.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 110.036 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -75.95 7.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -95.81 87.36 4.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.44 135.27 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.11 109.6 21.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 109.266 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.85 154.46 19.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -139.03 142.04 38.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.495 -0.753 . . . . 0.0 109.143 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.26 28.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.551 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 69' ' ' ARG . 1.1 tp10 -144.42 143.42 30.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 51.4 -90.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.405 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.0 ttm180 -147.82 -91.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.85 9.16 57.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.59 97.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -1.193 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.42 126.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -94.85 130.18 41.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.56 150.1 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.558 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -148.84 130.27 14.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.75 135.74 14.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.05 -80.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -1.103 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.457 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 23.7 t -47.66 -57.27 5.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.74 -25.81 63.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 78' ' ' SER . 63.5 m-80 51.24 45.54 27.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.572 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -136.98 148.66 47.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.327 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -91.02 130.84 36.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.1 138.03 58.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.139 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.0 144.59 25.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.35 144.16 28.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.767 . . . . 0.0 109.357 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.9 174.18 11.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -78.69 -15.88 57.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.29 -42.51 9.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.517 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.13 -8.93 1.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' HD12 ' A' ' 91' ' ' LEU . 46.3 mtp180 -75.15 125.94 30.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -1.105 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.63 141.22 28.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.928 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.22 -171.31 3.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 179.922 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -135.91 114.79 12.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 p -98.2 170.09 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -38.4 14.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.448 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.34 159.73 15.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 t -93.02 149.11 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 p -147.1 172.46 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -47.88 -35.79 11.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 19.4 mt-10 -88.73 67.03 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 74.6 m -153.39 15.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 46.4 m-85 -124.6 158.4 33.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.706 -0.621 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 35.1 m-85 -144.74 122.9 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.398 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.59 109.48 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' OE2' ' CE1' ' A' ' 115' ' ' TYR . 37.4 tt0 -85.64 150.2 24.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -146.42 98.36 3.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.24 131.9 48.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -94.48 -166.82 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.339 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.4 m -94.64 -20.9 19.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.786 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 32.1 p30 -80.23 25.92 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 62.94 -7.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.463 -0.773 . . . . 0.0 110.466 179.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 42.7 m-85 -89.9 135.75 33.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.881 -1.137 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -93.75 168.74 10.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.1 p -143.66 122.69 12.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.458 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 85.1 m-85 -94.19 114.94 27.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 19.0 ttt180 -98.19 142.57 29.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 179.748 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.416 ' C ' ' N ' ' A' ' 120' ' ' TYR . 34.7 ttt180 -94.99 -72.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -54.64 -9.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.7 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.8 m-85 -140.9 60.79 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 16.8 p -58.33 -1.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.726 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.88 10.3 24.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.53 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.08 142.49 19.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 109.737 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.9 m-85 -106.48 169.7 8.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.7 t -89.52 134.51 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.44 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.63 162.19 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.05 161.27 23.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.522 ' HZ2' ' HG3' ' A' ' 134' ' ' LYS . 33.0 mttp -85.85 -170.02 2.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -92.44 -29.71 16.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -73.75 1.62 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.48 66.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -86.69 168.65 13.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -1.158 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.2 p90 -92.21 120.2 32.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HG3' ' HZ2' ' A' ' 128' ' ' LYS . 48.1 tttt -69.94 135.76 49.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.54 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.54 160.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.202 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.83 16.81 55.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.54 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.9 p -115.07 -27.74 7.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.683 -0.892 . . . . 0.0 109.638 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -87.64 -4.98 58.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.694 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 p -70.71 166.69 20.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 154.26 179.58 29.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.93 166.35 10.57 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.85 1.7 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.81 -56.12 2.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.48 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.8 mt-30 -70.35 133.91 47.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 109.464 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.503 ' C ' HD21 ' A' ' 36' ' ' ASN . 15.3 mtpp -85.14 3.84 37.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.594 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.75 -4.24 1.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.2 pt -93.99 -4.36 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -0.845 . . . . 0.0 109.557 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.67 107.97 17.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.02 162.77 16.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.1 tp -140.29 71.18 33.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.96 105.09 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.901 1.734 . . . . 0.0 110.435 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.4 mtm -100.68 128.96 46.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.791 . . . . 0.0 109.408 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 t -70.22 120.75 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.08 59.89 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.01 -91.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.451 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.09 100.0 3.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 1.6 mm-40 -57.64 105.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.551 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.09 -151.41 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -1.181 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 7' ' ' THR . 95.2 mt -84.57 166.02 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.614 ' N ' HG22 ' A' ' 6' ' ' ILE . 8.5 p -47.54 141.76 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER -72.73 16.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.98 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 7' ' ' THR . 9.1 mt -92.01 152.39 42.79 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 108.86 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.57 -175.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.119 1.212 . . . . 0.0 110.163 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.27 151.82 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 mt -139.93 68.48 35.61 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.463 -0.773 . . . . 0.0 109.607 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.43 -171.86 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.74 1.626 . . . . 0.0 110.219 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 57.35 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.88 -30.47 70.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.16 -106.09 0.36 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -172.64 34.49 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -146.99 65.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -1.139 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.59 36.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.1 21.85 6.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -1.117 . . . . 0.0 109.529 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.502 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -77.67 -48.47 2.26 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.314 -0.866 . . . . 0.0 110.789 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 1.7 Cg_endo -67.12 168.08 18.39 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 120.909 1.073 . . . . 0.0 109.747 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.79 133.52 56.69 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.644 1.563 . . . . 0.0 110.055 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.18 -45.63 0.03 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' C ' ' H ' ' A' ' 27' ' ' LYS . 18.1 p-80 -146.82 28.66 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.464 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 51.2 m-85 -72.56 16.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 25' ' ' HIS . 12.3 mttp -90.75 30.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -149.01 152.18 36.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.027 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.54 171.64 1.31 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.233 1.289 . . . . 0.0 110.278 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.554 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 83.7 mttt -149.98 139.41 21.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.3 mtm-85 -92.98 114.47 27.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.5 mt -85.0 91.25 8.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -86.29 125.52 33.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.5 t -89.68 123.67 33.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -72.5 -14.55 61.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.608 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -86.2 104.99 16.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.797 -179.66 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.53 6.23 80.31 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.38 77.68 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -134.29 138.15 44.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.598 -0.942 . . . . 0.0 109.606 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -96.47 158.81 15.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 41' ' ' LEU . 17.9 tp -85.23 139.21 31.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -146.33 111.69 5.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.9 mt -89.85 133.89 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.194 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.524 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.8 m-70 -89.01 149.65 43.71 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 109.184 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.4 Cg_endo -59.94 -23.27 72.16 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.166 1.244 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -15.3 57.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.818 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 117.78 -37.12 3.39 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.5 mtt-85 -46.4 114.89 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -1.159 . . . . 0.0 109.79 -179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 47' ' ' GLY . 97.3 t -100.1 128.56 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.531 -0.731 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 3.1 p30 -155.69 -150.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -146.89 163.63 28.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.42 154.46 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -81.1 -14.35 57.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.95 87.6 4.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -81.99 17.84 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 109.421 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 p -100.58 3.32 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.86 133.71 28.65 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 109.164 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -4.16 4.21 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.84 1.026 . . . . 0.0 110.257 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -74.83 -10.95 59.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' LYS . 3.2 pt -89.26 -7.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.35 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -80.0 90.16 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.88 135.2 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.96 104.92 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -89.13 153.34 21.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.44 126.93 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.94 121.92 26.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.97 -29.37 14.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.492 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.03 -167.59 2.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -82.42 -0.79 47.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.92 28.92 1.27 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 t -145.49 145.12 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -1.101 . . . . 0.0 109.431 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.1 m -143.01 121.67 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -93.28 123.34 36.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.451 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.1 mt -91.44 147.46 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -145.8 132.53 19.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.85 137.65 17.6 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.78 -65.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.471 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 t -63.3 -49.8 72.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.918 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.06 -21.55 66.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 47.65 45.0 17.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.842 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 40.7 mtp180 -141.08 146.82 37.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.464 -0.773 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.84 136.8 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.03 149.23 45.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.24 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.64 129.26 13.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 ttm -96.41 130.85 43.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.88 -175.38 4.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -92.72 -23.47 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 p30 -82.78 -40.35 20.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 143.57 -7.92 2.02 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -75.57 120.64 21.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.555 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -92.42 136.34 33.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -147.01 -171.9 3.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.14 164.36 30.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.371 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 m -149.92 170.02 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -83.09 -46.16 13.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.8 116.03 28.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -52.1 165.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.6 p -147.1 -173.05 4.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.405 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -25.68 62.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.4 59.16 3.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.2 m -147.25 10.11 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.9 m-85 -94.93 152.18 18.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.1 m-85 -150.04 116.59 5.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -69.31 127.42 33.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.01 96.52 10.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HE ' HH22 ' A' ' 116' ' ' ARG . 0.0 OUTLIER -91.96 114.31 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.2 128.54 34.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -91.71 -177.44 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -92.62 45.06 1.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.9 m-20 -146.89 28.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.27 -0.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.897 . . . . 0.0 109.711 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.6 m-85 -96.61 130.98 43.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.373 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.56 168.71 11.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.4 p -145.8 119.6 9.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.12 106.31 18.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.751 HH22 ' HE ' ' A' ' 106' ' ' ARG . 33.5 ttm180 -93.87 146.5 23.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -72.21 151.73 42.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.9 ttt180 -91.29 -75.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 13.9 tttp -51.14 -9.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.863 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 118' ' ' ARG . 14.7 m-85 -143.08 64.06 1.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.7 p -62.11 1.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 15.4 m -89.97 11.33 20.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.493 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.04 140.54 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.943 . . . . 0.0 109.783 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.479 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 26.8 m-85 -106.37 165.4 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -91.41 119.88 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.697 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -150.56 147.17 27.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.56 178.36 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -95.53 -169.45 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -93.77 -13.87 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -92.9 8.37 39.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.427 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.33 3.65 84.35 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.85 173.14 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -1.128 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.0 p90 -92.82 120.32 33.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -69.95 131.49 44.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.395 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.599 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.34 133.16 12.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -58.97 -2.3 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.599 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.0 p -92.36 -57.43 2.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.193 . . . . 0.0 109.498 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 137' ' ' SER . 23.1 mtpp -61.05 -8.19 3.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -71.06 158.14 36.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.81 179.65 34.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.97 175.77 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.833 1.688 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.63 -56.14 5.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.86 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -1.151 . . . . 0.0 109.357 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.608 ' CB ' HD21 ' A' ' 36' ' ' ASN . 8.6 mtmp? -85.03 3.48 38.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.697 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.12 -10.47 31.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.588 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -5.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -83.94 87.98 7.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -92.94 167.75 11.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.5 70.63 32.12 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.446 -0.784 . . . . 0.0 109.391 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.38 99.6 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.852 1.701 . . . . 0.0 110.335 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.6 mtm -96.25 122.3 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.425 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.7 t -62.23 148.66 44.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.51 57.05 4.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -74.45 -85.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.441 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.478 179.989 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.96 -87.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.69 -170.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.18 -66.01 1.74 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -158.42 -141.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -1.109 . . . . 0.0 109.483 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.449 HD13 ' OXT' ' A' ' 155' ' ' SER . 8.0 mt -47.39 149.67 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -59.13 153.28 18.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.411 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -91.11 57.21 3.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.2 mt -51.43 150.04 6.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.808 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.23 76.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.051 1.167 . . . . 0.0 110.238 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 42.4 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.133 -0.979 . . . . 0.0 110.199 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -91.61 -47.07 0.35 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.0 Cg_endo -66.86 97.23 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.035 1.156 . . . . 0.0 110.17 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -172.83 83.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.37 -41.02 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.6 -147.51 18.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.84 -179.78 27.81 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.3 m -134.75 -126.88 0.16 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.37 1.081 . . . . 0.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.22 -57.75 5.49 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 -88.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -1.136 . . . . 0.0 109.338 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.72 64.91 8.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.865 . . . . 0.0 109.916 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.79 167.9 16.41 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.451 1.434 . . . . 0.0 109.754 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -61.32 92.14 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.636 1.557 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 23' ' ' PRO . . . -61.99 -128.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.629 ' CD2' ' CB ' ' A' ' 152' ' ' SER . 0.1 OUTLIER -99.8 64.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.544 -0.974 . . . . 0.0 109.349 -179.959 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -88.14 4.92 43.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -99.43 -13.64 19.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.78 -179.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -114.75 152.32 46.24 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.664 . . . . 0.0 109.247 -179.825 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.02 157.65 24.2 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.264 1.309 . . . . 0.0 110.204 179.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' HE2' HD22 ' A' ' 64' ' ' LEU . 2.4 mtmt -135.8 131.97 36.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.679 . . . . 0.0 109.19 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -84.96 118.67 24.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.526 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 41' ' ' LEU . 23.9 mt -84.87 98.01 10.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 117.61 30.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.99 102.58 12.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.31 -27.97 50.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 23.9 m-80 -76.95 103.2 6.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.21 4.73 89.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.97 85.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.2 m-85 -143.39 132.82 23.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.078 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -93.28 129.02 39.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD23 HD12 ' A' ' 32' ' ' LEU . 53.8 tp -60.53 142.25 55.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 109.245 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 48.5 ttt180 -146.85 115.62 6.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.65 115.5 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.284 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -75.42 151.74 85.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.007 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.05 -28.79 71.35 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 121.202 1.268 . . . . 0.0 110.468 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.56 4.06 10.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.87 -31.44 5.29 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -46.96 114.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -1.112 . . . . 0.0 109.519 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.23 129.53 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -155.61 149.89 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 155.39 22.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.54 152.92 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -82.51 -12.0 58.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.534 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.33 101.57 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.96 -5.01 59.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -20.19 22.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.536 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -51.95 112.3 3.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.925 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.57 3.72 0.45 Allowed 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 120.638 0.892 . . . . 0.0 110.129 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 41.9 m80 -86.92 -15.25 39.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -76.76 -2.37 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -82.48 86.02 6.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.02 135.28 33.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.45 108.48 19.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -94.08 149.14 21.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.707 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -141.62 134.54 28.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.371 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.76 131.68 38.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -97.13 -76.72 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -95.85 -121.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -94.03 -96.6 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.1 3.38 46.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.0 125.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -1.188 . . . . 0.0 109.424 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.76 169.59 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 109.452 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -142.88 128.42 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.7 149.74 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -147.12 117.93 7.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.56 130.1 11.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.88 -74.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -1.121 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.419 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 14.3 t -49.12 -55.31 12.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.38 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -26.82 67.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.392 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m120 51.34 50.31 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 93' ' ' ALA . 8.7 mtp180 -146.68 147.2 30.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.948 . . . . 0.0 109.598 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.18 130.98 36.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.15 140.94 58.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.01 139.65 21.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -97.45 131.46 44.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.47 -0.769 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -73.2 -174.19 1.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.78 -16.79 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.5 p30 -90.23 -38.86 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.04 -10.88 2.31 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -72.8 124.8 26.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.1 mp -93.32 137.74 32.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.556 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -149.74 -174.23 4.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 179.931 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' ' 81' ' ' ARG . . . -143.67 132.18 22.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.295 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -110.24 168.77 9.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -84.51 -1.13 55.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.14 136.77 52.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.723 -0.611 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.9 p -80.98 109.02 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 p -97.53 179.12 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.415 -0.803 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.13 -21.58 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -93.09 53.16 1.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 51.0 m -141.61 5.6 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.8 . . . . 0.0 109.529 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 77.3 m-85 -93.2 153.52 18.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.9 m-85 -149.03 115.1 5.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -61.62 107.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -86.54 94.1 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -94.98 124.1 38.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.671 HD12 HD22 ' A' ' 113' ' ' ASN . 3.9 tt -91.43 133.23 35.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.613 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 110' ' ' ASN . 2.1 mt-10 -94.71 151.2 19.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.513 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 m -63.58 1.9 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.496 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 36.1 t-20 -93.38 25.77 3.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER 61.64 -3.63 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.887 179.98 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.1 m-85 -94.59 -174.87 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.671 HD22 HD12 ' A' ' 107' ' ' LEU . 5.8 m120 -147.64 164.83 32.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 p -143.82 120.63 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -93.8 105.43 17.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -93.25 139.16 30.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -70.27 147.93 49.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 120' ' ' TYR . 45.6 ttt180 -81.75 -73.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.0 tptt -51.64 -9.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 13.6 m-85 -139.12 68.6 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.713 . . . . 0.0 109.176 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.3 p -63.75 -16.36 60.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.4 m -89.92 18.85 5.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.983 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -148.47 123.54 10.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.848 . . . . 0.0 109.636 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 35.4 m-85 -100.7 164.48 11.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.18 139.64 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.02 -175.25 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -141.14 166.39 24.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -94.21 177.86 5.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -91.69 -7.52 49.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 109.315 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.81 -0.68 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.4 -0.54 65.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -90.42 166.3 13.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 109.369 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.532 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 21.6 p90 -85.42 120.08 26.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.35 123.0 20.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 135' ' ' LEU . 13.4 tp -47.92 160.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.178 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.02 -42.41 19.87 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -59.03 -17.58 26.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.689 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.31 -9.72 46.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.802 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.7 p -80.51 177.51 8.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -0.975 . . . . 0.0 109.565 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.8 178.69 22.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.77 165.41 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.864 1.709 . . . . 0.0 110.16 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.16 -37.6 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -66.52 121.82 16.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -1.142 . . . . 0.0 109.501 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 21.1 mtmt -80.97 -7.85 59.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.75 -6.46 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.3 pt -95.06 8.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.603 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.14 98.39 10.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.04 164.67 11.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.66 -0.65 . . . . 0.0 109.495 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -141.93 70.29 24.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.41 -0.806 . . . . 0.0 109.389 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.58 107.73 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.88 1.72 . . . . 0.0 110.478 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.1 mtt -98.41 117.14 32.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.501 -0.749 . . . . 0.0 109.38 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.629 ' CB ' ' CD2' ' A' ' 25' ' ' HIS . 31.3 t -69.95 142.65 52.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.04 58.86 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -55.43 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.95 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.449 ' OXT' HD13 ' A' ' 6' ' ' ILE . 6.1 t . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.74 170.58 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.114 1.21 . . . . 0.0 110.109 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HE3' HD22 ' A' ' 64' ' ' LEU . 6.4 mtmp? -142.78 132.42 23.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 5.3 mtm-85 -84.83 122.52 29.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.64 98.94 10.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 109.485 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -97.85 117.15 31.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.5 t -82.18 137.71 34.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -26.38 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.956 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.7 m-20 -74.43 105.01 5.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 109.801 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.53 5.85 88.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.73 83.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 46.3 m-85 -142.32 137.52 30.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -1.083 . . . . 0.0 109.505 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 29.1 m-85 -94.46 145.96 24.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.556 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -80.26 145.3 32.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.255 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.417 HH11 ' CG ' ' A' ' 57' ' ' ASP . 2.9 ttt180 -148.4 122.29 9.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.499 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -90.04 109.1 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.172 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -66.13 152.26 94.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.147 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.85 -28.88 79.12 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.203 1.269 . . . . 0.0 110.242 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.82 6.55 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.29 -31.97 3.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -47.65 120.99 3.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -1.12 . . . . 0.0 109.461 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.533 HG21 ' CD1' ' A' ' 83' ' ' LEU . 62.5 t -91.34 129.77 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -147.87 -159.62 1.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.57 151.61 23.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.8 151.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' LYS . 25.1 mtm180 -77.66 -31.39 52.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 56' ' ' SER . 2.2 mm-40 -50.52 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.555 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -76.38 -1.29 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.4 p -91.37 -20.2 22.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -44.47 107.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 0.0 109.462 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.55 5.54 0.33 Allowed 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 120.797 0.998 . . . . 0.0 110.54 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.1 m80 -93.39 -18.19 22.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.77 -3.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -74.82 84.62 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.25 134.93 33.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -91.65 104.92 17.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.336 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.38 152.69 19.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.68 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.13 149.16 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.39 149.39 22.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -149.03 143.04 25.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 52.95 -119.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.377 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -147.45 113.24 5.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.74 -18.46 55.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 72' ' ' VAL . 69.0 t -92.51 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -1.163 . . . . 0.0 109.477 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 72' ' ' VAL . 19.7 m -146.42 131.17 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -92.42 118.29 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.24 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -145.56 144.77 30.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.46 137.52 13.64 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.98 -68.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -1.132 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 t -66.62 -48.88 68.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.91 -24.38 66.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.38 46.43 26.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.915 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.04 149.36 34.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -93.16 137.46 32.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.533 ' CD1' HG21 ' A' ' 49' ' ' VAL . 57.4 tp -65.14 143.84 57.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.896 . . . . 0.0 109.29 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.22 18.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.591 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.6 ttm -95.22 150.47 20.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -92.64 -170.01 2.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.592 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.4 mp0 -93.46 -32.02 14.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -79.89 -37.63 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 142.55 -5.01 2.03 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -73.26 117.87 15.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -91.76 133.14 35.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.0 pp -149.96 172.95 14.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.598 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -114.87 164.84 13.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.414 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -150.02 169.74 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -84.01 -35.83 23.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -94.13 138.69 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.1 p -90.26 117.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.403 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 11.0 p -103.08 173.62 6.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -15.64 23.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.339 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.83 51.24 1.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 98' ' ' THR . 7.7 m -140.89 5.23 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -93.12 160.46 14.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -150.0 114.85 5.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -65.41 118.83 9.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -93.4 98.18 11.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.611 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.13 100.34 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.337 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 113' ' ' ASN . 4.4 tt -77.6 129.45 35.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.71 -171.34 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -91.34 2.96 56.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.9 m-80 -94.78 24.78 4.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.21 -2.35 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.975 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.6 m-85 -91.55 -175.79 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 109.491 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.499 HD21 HD12 ' A' ' 107' ' ' LEU . 5.2 m120 -146.95 158.13 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.565 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 p -134.29 118.38 17.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.64 -0.662 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.03 105.28 17.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -92.91 142.61 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.355 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 t -71.36 147.81 47.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -88.77 -66.67 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 tptp -49.1 -18.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.6 m-85 -144.31 77.69 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 82.3 p -66.01 5.96 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 3.9 m -89.52 5.38 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.526 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 5.3 m-90 -148.39 170.45 17.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.028 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 17.0 m-85 -137.09 162.67 32.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.96 122.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.688 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -153.12 138.17 17.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.35 171.94 8.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -87.64 -115.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -143.18 7.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 109.546 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.22 11.23 8.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.57 64.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -93.13 159.23 15.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 38.1 p90 -91.15 120.06 31.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -69.88 132.28 45.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.638 ' O ' HG23 ' A' ' 139' ' ' THR . 13.5 tp -47.8 150.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -70.94 -10.43 68.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.557 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.1 p -91.03 -32.22 15.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.155 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -81.16 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 135' ' ' LEU . 70.4 p -79.4 156.32 27.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.14 -179.75 38.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.91 171.48 3.7 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.894 1.729 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.29 -50.54 3.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.07 134.28 40.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 14.1 mtmt -83.96 6.52 21.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.688 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.05 -6.46 8.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 113' ' ' ASN . 21.0 pt -90.45 -6.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.16 97.51 9.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -98.86 159.65 14.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.6 tp -139.13 71.53 40.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.504 -0.748 . . . . 0.0 108.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HB2' ' HZ2' ' A' ' 30' ' ' LYS . 5.9 Cg_exo -61.83 116.45 3.45 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.877 1.718 . . . . 0.0 110.715 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.8 mtt -95.99 121.2 37.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 0.0 109.168 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.9 t -69.23 135.72 50.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 109.479 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.51 168.53 2.13 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.134 1.223 . . . . 0.0 110.097 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.9 mtmt -138.9 139.84 38.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -91.52 120.07 32.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 22.8 mt -84.63 101.98 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -95.56 115.83 27.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.544 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.89 111.31 17.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.213 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -59.09 -30.39 68.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.6 m-80 -78.64 105.23 9.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 110.122 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 81.65 4.63 90.31 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 86.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.1 m-85 -142.66 134.5 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -94.14 123.84 37.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 51.7 tp -57.79 141.83 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.491 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 25.4 ttt180 -147.28 117.93 7.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.5 mt -93.17 110.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -71.75 151.81 93.35 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.145 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.0 Cg_exo -57.04 -27.83 75.68 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.126 1.218 . . . . 0.0 110.238 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -74.95 0.45 15.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -29.62 7.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.59 114.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -1.153 . . . . 0.0 109.429 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.56 129.95 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 109.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 2.9 p30 -166.46 151.01 7.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.99 159.0 24.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 m -146.17 148.63 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -1.17 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -76.82 -9.84 58.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.43 84.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.477 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 2.51 3.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.89 -20.37 20.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -49.89 111.2 1.95 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.67 5.38 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.663 0.909 . . . . 0.0 110.245 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 47.3 m80 -94.24 -14.79 25.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.35 9.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 59' ' ' HIS . 2.9 mmmm -91.12 88.0 6.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' A' ' 32' ' ' LEU . 11.0 mt -90.08 134.99 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -95.03 110.23 22.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.581 HD22 ' HE2' ' A' ' 30' ' ' LYS . 10.2 mp -95.47 144.57 25.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.813 . . . . 0.0 109.491 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.86 134.16 47.35 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 121.79 31.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.59 -85.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.6 mt-10 -94.86 149.57 21.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.883 . . . . 0.0 109.318 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.7 mtt-85 -57.58 84.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 140.82 -1.83 2.07 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -138.86 145.57 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -1.046 . . . . 0.0 109.414 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.7 m -138.9 133.83 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -94.61 127.07 40.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.452 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 mt -93.41 144.49 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -146.52 143.47 28.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.68 135.59 12.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.92 -83.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -1.141 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.9 t -48.88 -43.99 39.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.88 65.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 49.65 50.14 18.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.4 mtp180 -146.0 147.08 31.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.95 127.29 36.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.9 144.85 31.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 109.33 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -145.17 170.14 16.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.16 134.65 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.5 -169.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -91.75 -11.16 37.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.413 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -92.6 -42.54 9.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA3' ' H ' ' A' ' 136' ' ' GLY . . . 146.86 -9.97 1.38 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -66.98 127.56 33.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -1.167 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.9 mp -93.47 134.51 35.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.7 pp -150.07 143.74 25.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.897 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.96 158.47 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.763 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.71 161.85 38.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.98 -47.35 37.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 m -85.07 139.42 31.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.23 152.16 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -148.01 -163.65 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.489 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -55.39 -51.64 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 85' ' ' MET . 71.7 mt-10 -74.2 77.23 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 36.9 m -155.2 -33.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 38.2 m-85 -84.68 156.05 21.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 68.4 m-85 -145.08 122.85 11.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.17 119.82 8.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.1 146.42 24.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.065 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 118.94 9.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.368 -0.832 . . . . 0.0 109.677 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.11 119.86 31.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.251 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.92 -178.74 6.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 m -86.43 -12.14 49.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 54.6 m-80 -89.48 16.94 6.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 1.0 OUTLIER 65.2 57.75 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.649 -0.657 . . . . 0.0 110.323 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 60.1 m-85 -145.49 123.42 12.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.605 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -89.96 124.48 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.736 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.8 p -97.74 168.8 10.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.752 . . . . 0.0 109.382 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -143.59 105.87 4.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 134.38 38.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -63.94 131.41 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.141 -0.974 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 120' ' ' TYR . 40.7 ttp180 -69.22 -69.88 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.626 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 17.8 tttt -51.65 -10.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 122' ' ' SER . 36.3 m-85 -147.01 69.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -65.9 4.96 0.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.1 m -95.08 9.38 39.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.587 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.21 139.15 17.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.7 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -100.2 156.43 17.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.98 128.99 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.208 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.04 149.27 26.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -102.03 176.24 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.602 -0.686 . . . . 0.0 109.458 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -95.08 -167.42 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -11.2 30.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 132' ' ' GLN . 1.6 t -91.47 0.12 57.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.47 -2.53 70.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.4 mp0 -84.97 176.41 8.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 32.6 p90 -92.8 120.4 33.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.63 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -71.02 136.09 48.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.97 164.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.061 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -93.17 -1.7 66.76 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -97.33 -20.82 17.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.245 -1.15 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -90.06 -4.91 57.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 p -79.51 155.23 28.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.004 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.63 178.71 42.92 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.4 Cg_endo -60.97 169.58 5.76 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.925 1.75 . . . . 0.0 110.274 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 -20.51 2.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' A' ' 145' ' ' ALA . 10.2 mt-30 -90.16 109.51 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -1.15 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 15.9 mtmt -65.05 2.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.35 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.06 -9.13 19.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.1 pt -94.54 5.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.482 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 144' ' ' LYS . 87.0 mt -94.67 85.67 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -94.9 169.64 9.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.227 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.73 70.43 30.56 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.41 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.89 104.13 0.37 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.848 1.699 . . . . 0.0 110.411 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.4 mtt -95.12 125.59 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.3 t -70.02 132.62 46.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.95 165.3 8.66 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.118 1.212 . . . . 0.0 110.45 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -147.26 122.14 9.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -86.27 122.62 30.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.85 101.08 12.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -91.95 124.34 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.286 -0.883 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.55 127.52 35.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.421 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -74.7 -19.56 60.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.669 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.21 105.16 15.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.73 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.69 5.14 90.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 84.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.5 m-85 -143.64 135.68 26.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -1.107 . . . . 0.0 109.518 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.48 129.43 43.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 tp -55.47 144.77 24.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.953 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.471 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 17.0 ttt180 -149.08 114.63 5.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.581 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.85 114.27 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.269 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.508 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 66.8 m-70 -69.34 151.27 96.95 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.034 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.526 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.8 Cg_endo -57.27 -27.92 77.32 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.301 1.334 . . . . 0.0 110.764 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.96 -3.0 29.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 109.742 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.69 -13.29 65.47 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -67.83 126.1 28.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.043 -1.269 . . . . 0.0 109.243 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.72 135.7 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 17.8 p-10 -153.93 -163.8 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.53 146.2 16.17 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.44 153.26 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -94.21 2.3 55.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.376 -0.828 . . . . 0.0 109.275 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.81 86.61 4.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.482 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -61.68 -5.17 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 t -87.16 25.75 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.039 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.471 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-20 -112.71 95.97 35.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.26 0.7 0.63 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.864 1.043 . . . . 0.0 110.271 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.52 ' CD2' ' HG ' ' A' ' 78' ' ' SER . 45.3 m80 -78.48 -26.77 46.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -70.37 -1.75 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.281 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -75.66 88.33 2.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.255 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.77 135.43 33.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.573 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 16.0 tp60 -89.85 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -94.32 128.23 40.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -114.21 147.08 39.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.18 139.71 30.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.65 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' GLU . 1.9 tm-20 -145.55 129.36 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.263 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . 2.1 tt0 52.16 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 109.285 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -96.24 118.92 33.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.815 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.37 19.0 31.46 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -147.84 146.94 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.62 137.34 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -93.68 116.38 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.65 144.33 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -145.6 145.87 31.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.05 131.5 10.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.24 -85.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.44 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.52 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 22.8 t -50.18 -22.85 1.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.08 -26.64 19.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 51.19 52.21 15.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.949 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.62 HH21 ' HZ1' ' A' ' 95' ' ' LYS . 91.4 mtt180 -149.9 147.71 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.362 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -91.49 132.72 36.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.3 tp -63.36 147.77 50.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.226 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -150.03 132.83 15.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.409 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 11.1 ttm -100.87 132.71 46.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.408 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 92' ' ' LEU . 11.1 mmtm -90.98 169.3 11.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.084 -1.01 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.55 -23.51 58.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.2 -3.97 48.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.96 71.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -79.77 118.23 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.334 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -91.39 134.84 34.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.488 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -145.71 -174.13 4.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.471 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.67 154.6 49.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.319 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -145.85 170.16 17.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.62 ' HZ1' HH21 ' A' ' 81' ' ' ARG . 0.8 OUTLIER -81.54 -35.0 30.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 132.84 35.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.83 164.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -147.3 -173.1 4.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.0 -14.39 59.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 85' ' ' MET . 25.8 mt-10 -90.89 8.58 34.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.7 m -92.54 -5.88 50.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 56.1 m-85 -94.32 153.2 18.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 85.0 m-85 -149.1 121.67 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -55.66 114.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.323 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.45 95.1 9.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -94.18 118.96 32.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.433 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 tt -93.39 123.4 36.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' ASN . 14.6 mt-10 -90.8 161.68 15.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.89 3.81 1.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -93.02 20.26 6.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.02 -1.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.0 m-85 -98.07 141.31 31.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.659 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -94.47 166.12 12.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.605 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 5.5 p -144.62 112.11 6.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.326 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.83 135.65 33.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 124' ' ' TYR . 3.2 ttm180 -127.13 145.75 50.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -68.85 146.03 53.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.708 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -88.53 -72.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.9 tttp -50.65 -10.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 20.4 m-85 -145.25 68.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.516 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 71.8 p -64.37 5.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.639 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.4 m -89.9 9.29 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.6 m-90 -150.3 141.16 22.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 109.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 116' ' ' ARG . 71.4 m-85 -104.09 165.7 10.88 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.711 . . . . 0.0 109.569 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.3 t -94.54 121.3 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.79 144.38 21.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.149 -0.969 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.83 -175.93 3.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.462 -0.773 . . . . 0.0 109.478 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -93.78 -119.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -146.35 8.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.534 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -125.39 6.46 7.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.09 12.86 51.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HG2' HG23 ' A' ' 130' ' ' THR . 84.4 mm-40 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.4 p90 -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -70.95 142.62 51.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 6.1 tp -63.71 -153.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -109.12 -43.66 1.17 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -61.39 -22.51 65.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 109.725 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -89.8 -15.63 31.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.59 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 135' ' ' LEU . 80.6 p -90.1 154.49 19.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.85 179.72 38.32 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.68 169.01 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.888 1.725 . . . . 0.0 110.187 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.03 -58.09 3.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 134.45 54.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -1.153 . . . . 0.0 109.441 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HB3' HD12 ' A' ' 147' ' ' LEU . 31.5 mtmt -83.6 5.77 23.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.13 -7.13 11.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.575 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.14 -6.73 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 144' ' ' LYS . 63.1 mt -80.1 85.16 5.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -89.87 169.24 11.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.6 tp -142.32 70.08 22.01 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.809 . . . . 0.0 109.418 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.98 103.5 0.29 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.844 1.696 . . . . 0.0 110.356 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.3 mtt -97.73 119.12 35.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.761 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.7 t -70.0 119.09 13.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.384 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.46 177.62 0.21 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 121.267 1.312 . . . . 0.0 110.25 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -146.25 138.44 25.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.2 mtt-85 -92.66 120.97 33.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 0.0 109.321 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.82 102.01 12.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -93.5 118.95 31.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.98 101.4 12.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -51.78 -34.51 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.691 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 5.1 m-80 -73.73 105.18 4.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.994 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.03 4.31 89.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.65 85.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.9 m-85 -142.72 133.77 25.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.496 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -95.39 123.68 39.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.3 tp -54.29 146.21 15.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.276 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 24.5 ttt180 -149.25 117.51 6.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.8 mt -92.87 130.94 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.172 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -91.71 151.4 42.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.163 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.491 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.47 -27.46 82.08 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.304 1.336 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -74.83 12.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.702 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -41.11 3.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.32 153.75 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.37 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -138.11 141.93 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.341 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 3.9 p-10 -153.85 -150.02 0.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -146.2 148.08 19.52 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.56 149.57 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -1.12 . . . . 0.0 109.466 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 53' ' ' ARG . 20.5 mtm-85 -90.25 -15.79 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.27 103.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.43 44.42 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -144.19 20.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.265 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.4 m-20 -105.77 104.97 51.39 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.74 2.66 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.786 0.991 . . . . 0.0 110.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.3 m80 -82.63 -5.75 58.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.257 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt -90.23 -5.18 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -76.64 86.53 3.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.12 134.92 34.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.84 114.08 26.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.838 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -93.2 113.14 25.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.0 143.07 26.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.92 120.93 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -95.0 -42.43 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.2 mt-10 -151.77 158.78 43.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.466 -0.772 . . . . 0.0 109.296 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -60.75 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 141.93 -2.82 1.93 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.35 142.43 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -1.122 . . . . 0.0 109.596 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.91 130.7 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 109.239 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -91.51 131.13 37.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -89.95 142.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -146.96 121.77 9.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.573 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 139.56 27.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 78' ' ' SER . 79.2 t -75.06 -87.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.547 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 77' ' ' VAL . 13.1 t -47.18 -33.33 5.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.44 -29.64 47.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 50.8 53.98 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.3 mtt180 -146.88 148.79 32.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -91.5 132.07 36.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.39 142.62 58.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.06 148.81 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.9 ttp -106.7 143.89 34.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HZ3' HH21 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.15 148.9 25.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.34 -19.06 7.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.401 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.5 p30 -87.65 -44.65 11.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.81 -9.59 1.37 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 ' HZ3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -71.65 128.65 36.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -1.148 . . . . 0.0 109.449 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -95.06 135.34 36.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.43 -173.72 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.28 42.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.455 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -146.97 155.84 42.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -71.32 -19.09 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.44 139.92 30.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 97' ' ' VAL . 4.5 t -86.25 107.81 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -94.68 156.09 16.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.37 -23.92 6.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -93.93 53.09 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 97.0 m -134.24 -2.18 2.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 87.4 m-85 -95.44 153.98 17.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 71.2 m-85 -146.04 121.13 10.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.01 93.92 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 115' ' ' TYR . 31.4 tt0 -78.15 93.19 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -93.47 137.85 32.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.85 140.46 29.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.361 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.84 -171.72 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' ASN . 43.1 t -93.78 -33.28 13.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -74.27 20.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.142 -0.973 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.5 m-20 65.24 56.05 1.04 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.714 . . . . 0.0 109.916 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -142.42 137.31 30.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.393 -0.817 . . . . 0.0 109.286 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.91 153.99 20.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 146' ' ' ILE . 12.5 p -137.18 114.92 11.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 105' ' ' GLU . 98.5 m-85 -89.93 104.5 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.506 ' NH2' ' O ' ' A' ' 121' ' ' THR . 23.8 ttt180 -93.92 134.37 36.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.205 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.9 t -60.95 153.36 25.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 120' ' ' TYR . 56.3 ttt180 -90.83 -77.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -51.13 -9.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 122' ' ' SER . 32.3 m-85 -138.85 59.33 1.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.506 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 26.5 p -59.55 -0.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.737 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.6 m -90.04 10.07 25.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 3.3 m-90 -155.13 144.01 20.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.849 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 28.0 m-85 -104.85 167.21 9.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.658 -0.652 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.0 128.32 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.57 145.64 24.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.632 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.28 178.86 5.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 109.447 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -96.23 -167.9 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 109.401 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -93.24 -13.47 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 109.42 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -93.46 2.32 56.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.41 0.32 67.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -85.06 172.26 11.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -1.144 . . . . 0.0 109.512 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 37.8 p90 -92.63 120.22 32.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -71.99 131.59 43.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.496 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.3 tp -47.98 155.04 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.309 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.84 -1.45 58.98 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.496 ' OG ' HD23 ' A' ' 135' ' ' LEU . 60.1 p -92.79 -58.25 2.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -55.15 -7.62 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 137' ' ' SER . 11.4 p -85.57 155.44 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.81 39.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.98 170.79 4.37 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.905 1.736 . . . . 0.0 110.162 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.01 -51.18 4.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.75 135.05 50.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -1.106 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.5 mtpp -84.81 1.61 46.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 109.565 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.64 -3.58 0.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.693 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 114' ' ' THR . 20.3 pt -98.13 2.61 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 109.681 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 144' ' ' LYS . 79.3 mt -90.48 110.23 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -117.23 168.28 10.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.51 70.17 17.5 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.318 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.33 105.98 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.794 1.662 . . . . 0.0 110.387 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.7 mtt -97.59 118.61 34.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 109.397 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.5 t -62.19 145.81 52.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.868 . . . . 0.0 109.498 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.2 165.96 6.45 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.229 1.286 . . . . 0.0 110.364 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HD2' HD22 ' A' ' 64' ' ' LEU . 57.8 mttt -146.36 127.02 14.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.0 109.198 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -84.96 124.52 31.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 41' ' ' LEU . 23.3 mt -84.8 98.25 10.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -92.76 119.66 32.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -86.89 112.23 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -63.34 -17.36 62.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.64 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.8 m-80 -88.03 104.92 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.91 4.79 89.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.12 84.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 47.1 m-85 -142.98 130.94 21.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.13 120.65 34.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 32' ' ' LEU . 49.1 tp -50.83 144.41 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.259 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.474 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 33.2 ttt180 -147.78 120.58 8.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 49' ' ' VAL . 76.0 mt -95.73 130.82 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.795 . . . . 0.0 109.11 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -91.29 150.89 42.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.49 -25.63 74.76 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.244 1.296 . . . . 0.0 110.312 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.1 p30 -74.92 7.56 3.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.7 -41.83 2.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.8 mmm180 -47.28 157.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.488 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 43' ' ' ILE . 84.2 t -138.77 134.17 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.4 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -146.09 -150.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.24 149.92 22.11 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -145.79 145.99 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -1.118 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.4 -6.46 58.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.49 108.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.486 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 21.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.36 -20.24 3.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.642 . . . . 0.0 109.692 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -44.75 108.19 0.71 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 109.62 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.09 5.26 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 110.152 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' ASP . 50.0 m80 -93.71 -3.14 52.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.68 -1.48 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 14.7 mmtt -78.14 86.25 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.93 130.85 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.82 111.4 22.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -90.25 153.58 20.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.902 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -144.9 130.96 19.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.338 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 123.77 28.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.572 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.15 -95.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -89.48 -173.9 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 112.4 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.43 24.65 20.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 t -145.92 142.54 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' VAL . 31.3 m -140.63 125.79 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.523 -0.735 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -93.51 128.26 39.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.54 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.78 149.62 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 14.6 tttp -146.51 134.34 21.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.23 136.25 18.25 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 60.1 t -77.98 -57.01 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -1.154 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -17.82 48.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.43 -23.55 19.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 2.2 m120 51.13 49.64 20.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -146.43 148.52 32.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.551 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 75.1 m-85 -91.63 132.81 36.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.545 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 tp -65.02 139.55 58.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.25 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.74 134.92 18.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.579 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -95.12 126.38 40.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.66 -175.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.14 -16.41 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -90.2 -40.21 12.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.55 -9.26 1.41 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 90' ' ' ARG . 1.8 mtt-85 -73.55 123.62 24.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -1.165 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -92.56 132.95 36.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.3 pp -148.7 -172.67 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.611 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.07 44.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.291 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 170.04 17.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -84.6 -37.31 21.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 m -85.01 149.64 25.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 98' ' ' THR . 54.8 t -77.21 162.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.385 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.531 ' N ' HG12 ' A' ' 97' ' ' VAL . 71.6 p -147.27 177.81 8.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -76.14 -26.34 56.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 27.0 mp0 -92.87 19.64 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 2.1 m -93.98 -11.8 30.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 66.2 m-85 -93.17 159.55 15.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 76.0 m-85 -148.78 116.18 6.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -54.89 142.35 29.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -125.15 141.64 51.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -146.96 142.02 27.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.97 137.35 35.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.31 -175.92 3.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.2 p -94.67 38.28 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 59.1 m-80 -146.86 31.14 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 m120 60.99 -1.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 40.6 m-85 -95.12 126.83 40.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.468 HD22 ' H ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -93.67 168.83 10.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -137.64 161.47 36.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.731 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -137.8 109.87 7.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.72 149.17 22.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -75.52 162.79 28.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.7 ttt-85 -93.5 -77.95 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.885 . . . . 0.0 109.303 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.2 tptt -51.24 -9.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.547 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.7 m-85 -141.97 59.68 1.47 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.435 -0.791 . . . . 0.0 109.374 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p -62.07 0.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 12.3 m -90.17 15.0 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.522 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 11.1 m-90 -155.14 143.56 20.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 109.713 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.0 m-85 -107.54 158.76 16.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.663 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -84.77 131.16 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.303 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.62 -175.75 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.55 161.52 37.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.772 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.21 173.74 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.8 19.15 7.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 16.63 8.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.74 -0.6 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.47 42.87 47.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -134.68 154.8 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.944 . . . . 0.0 109.323 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -80.87 120.17 24.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.76 127.67 33.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.678 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.8 tp -50.35 142.57 10.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.75 14.55 2.58 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 135' ' ' LEU . 84.7 p -102.61 -38.65 7.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.508 -0.995 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -90.11 -8.65 50.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 135' ' ' LEU . 41.0 p -69.91 145.21 52.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 109.495 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.11 -179.76 42.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.8 Cg_endo -61.07 -174.71 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.924 1.749 . . . . 0.0 110.164 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.27 -35.23 0.94 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 141' ' ' PRO . 18.2 mm-40 -93.14 134.52 35.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -1.131 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 39.4 mtmt -78.51 -0.49 29.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.19 -7.05 1.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.2 pt -95.32 1.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 109.652 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.2 mt -90.99 110.06 21.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -116.79 165.36 13.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.1 tp -144.4 70.75 15.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 109.21 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -62.23 112.78 1.65 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.89 1.727 . . . . 0.0 110.617 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 35.3 mtt -96.72 129.69 44.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.342 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.4 t -70.11 128.71 37.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.538 -179.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.11 176.13 0.27 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 120.99 1.127 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.6 ' HD2' HD22 ' A' ' 64' ' ' LEU . 47.0 mttt -144.89 175.06 10.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.8 mtm-85 -125.35 117.48 23.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' CD1' HD12 ' A' ' 62' ' ' LEU . 20.7 mt -84.83 102.0 12.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -94.47 117.9 30.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.26 99.38 11.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -51.5 -35.01 38.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.736 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 12.1 m-80 -71.86 105.05 3.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.751 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.4 4.56 89.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.25 83.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.4 m-85 -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -93.51 119.73 32.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.11 138.72 37.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -147.44 123.64 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 109.715 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.1 mt -93.96 118.08 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -69.3 150.92 97.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.092 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.0 Cg_endo -58.86 -23.96 69.91 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.175 1.25 . . . . 0.0 110.542 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.64 -15.47 51.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.67 -34.01 4.56 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -47.27 114.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.243 . . . . 0.0 109.497 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.42 143.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -170.15 -150.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.58 156.47 26.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 m -145.7 139.13 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -1.077 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.492 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.9 mtm-85 -76.61 6.52 5.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -94.87 103.45 15.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -81.59 6.35 15.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.2 t -90.24 7.29 38.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' HIS . 5.8 m-20 -93.01 113.53 60.11 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.051 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.88 2.6 0.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.675 0.917 . . . . 0.0 110.216 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.472 ' CD2' ' HG ' ' A' ' 78' ' ' SER . 42.4 m80 -84.57 -20.47 31.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.82 0.07 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 22.3 mttt -87.58 87.55 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.524 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.1 mt -90.42 135.22 33.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -91.1 117.1 29.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.6 HD22 ' HD2' ' A' ' 30' ' ' LYS . 10.6 mp -90.51 158.66 16.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.51 138.84 26.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.311 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.91 157.99 16.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.01 -91.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.16 -155.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -88.64 105.02 17.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.5 -7.8 77.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.76 136.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.88 126.94 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -94.74 130.94 41.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -0.824 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.35 151.87 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -150.06 145.54 26.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.03 138.96 17.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 40.2 t -75.74 -62.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -1.134 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.472 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -73.84 -46.89 42.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.26 68.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.416 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.94 49.7 20.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 11.9 mtt180 -141.99 150.03 40.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -92.33 130.07 38.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.93 150.99 46.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.34 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.65 32.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.6 ttm -126.8 134.92 50.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -92.58 178.4 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -78.13 -34.19 50.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.21 -3.43 20.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.49 66.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.422 ' C ' HD12 ' A' ' 91' ' ' LEU . 58.0 mtm180 -80.54 119.01 22.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.442 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.9 mp -93.4 134.52 35.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 92' ' ' LEU . 4.3 pp -148.74 164.95 32.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.82 157.78 16.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.06 149.42 30.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -73.03 -31.95 64.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -92.96 142.04 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.3 t -79.25 156.43 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.453 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 46.2 p -146.88 156.75 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.34 -29.71 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.409 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -93.92 57.71 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.472 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 67.9 m -140.95 3.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -101.19 160.25 14.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.466 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.98 112.07 4.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -60.06 126.04 25.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.626 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -95.55 93.48 7.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.474 HH11 ' NH1' ' A' ' 116' ' ' ARG . 60.1 ttt180 -89.89 125.16 35.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.57 132.33 36.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.79 -173.22 3.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.97 -7.0 50.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -93.73 24.11 4.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 63.59 -5.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 109.889 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 110' ' ' ASN . 51.0 m-85 -91.64 128.51 37.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.124 -0.985 . . . . 0.0 109.26 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -89.91 166.91 13.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.913 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 p -141.85 122.91 14.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 109.177 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -92.57 110.97 22.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.767 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.474 ' NH1' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.75 137.82 37.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.273 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.87 157.98 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -93.78 -64.39 1.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 109.587 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -53.74 -49.73 67.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.678 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 122' ' ' SER . 7.0 m-85 -110.47 68.87 0.68 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.7 -0.625 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 121' ' ' THR . 14.8 p -59.76 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.8 m -89.14 10.37 22.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.085 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.3 m-90 -149.69 141.7 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 109.696 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.5 m-85 -109.22 150.81 27.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.688 -0.632 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.24 131.3 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.307 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.03 171.52 15.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.7 mt -132.13 165.15 24.7 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -93.37 -172.71 3.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -93.0 -13.25 28.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 9.92 35.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.59 6.02 86.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -92.43 166.54 12.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 37.7 p90 -92.74 120.21 32.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -69.83 131.65 44.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.661 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.55 135.5 11.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.278 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.12 2.85 1.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.661 ' OG ' HD23 ' A' ' 135' ' ' LEU . 59.8 p -92.21 -38.76 11.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 109.56 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -79.79 -5.0 54.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.1 p -77.25 149.62 35.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.477 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.43 179.73 45.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.94 164.83 13.23 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 121.873 1.715 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.65 -43.16 3.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 143' ' ' GLN . 1.6 mp0 -68.35 132.42 47.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -1.115 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -84.81 -5.25 59.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.69 -0.73 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 10.8 pt -99.97 6.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.99 110.05 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.643 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -119.6 168.0 11.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.659 -0.65 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -142.8 70.43 19.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -61.97 105.87 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.68 141.56 32.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.513 -0.742 . . . . 0.0 109.319 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -70.04 173.47 6.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.2 175.02 1.17 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.22 1.28 . . . . 0.0 110.321 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -145.28 175.35 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 4.2 mtm-85 -133.58 119.98 20.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.532 -0.73 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.57 102.35 12.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.584 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -96.48 115.89 28.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 t -83.26 106.03 14.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.513 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -28.33 24.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.685 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.2 m-80 -77.47 105.09 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.615 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.35 4.88 87.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.57 62.67 3.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -111.64 132.46 54.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.639 -0.918 . . . . 0.0 109.785 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -93.02 115.73 28.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.844 . . . . 0.0 109.265 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.513 HD23 HD12 ' A' ' 32' ' ' LEU . 41.6 tp -48.77 143.1 5.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 0.0 109.292 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 34.0 ttt180 -149.57 118.31 6.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -89.94 106.17 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.193 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -67.02 151.21 97.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 0.0 109.038 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.1 Cg_exo -57.16 -26.18 68.06 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.045 1.163 . . . . 0.0 110.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -75.21 -0.15 18.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.51 -30.46 6.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -52.8 121.55 7.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 83' ' ' LEU . 95.1 t -92.57 138.33 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -165.37 151.35 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.81 159.41 22.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.03 141.77 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -86.37 16.08 4.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.93 88.32 5.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.621 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -62.03 -5.2 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 p -90.99 31.02 1.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.848 . . . . 0.0 109.08 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 30.2 m-20 -113.87 93.5 29.51 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.96 1.6 0.42 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 120.94 1.094 . . . . 0.0 110.382 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.486 ' H ' ' C ' ' A' ' 57' ' ' ASP . 37.2 m80 -81.41 -15.61 54.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.69 2.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -76.43 82.12 3.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 109.147 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.1 mt -89.86 135.07 33.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.166 -0.959 . . . . 0.0 109.391 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.94 104.18 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -90.79 148.31 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 125.35 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.69 28.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.86 -76.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.459 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -94.62 -90.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -142.54 -31.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.529 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.25 -18.88 6.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.98 147.81 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -1.104 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.3 127.43 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.469 -0.769 . . . . 0.0 109.453 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.8 m -93.22 112.11 23.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.6 mt -91.91 144.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -144.24 145.66 32.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.454 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.33 135.27 12.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.04 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 109.428 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.5 t -61.42 -47.26 86.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -27.76 69.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.888 . . . . 0.0 109.472 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.8 m120 51.34 50.58 18.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.7 mtt180 -149.84 147.96 28.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.04 129.34 36.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 49' ' ' VAL . 40.8 tp -57.65 145.14 35.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.57 170.09 17.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.01 140.17 29.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -87.08 170.37 11.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.76 -14.09 61.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 3.1 p30 -83.11 -47.45 11.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 144.52 -7.56 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -72.43 125.37 27.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -92.23 138.12 31.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.02 -171.63 3.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.755 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.28 159.45 42.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.446 -0.784 . . . . 0.0 109.272 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.5 t -146.69 170.09 17.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -83.85 -35.16 24.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -92.18 135.04 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -83.82 106.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.6 p -95.14 -179.11 4.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -16.68 63.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -93.54 48.0 1.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -139.9 3.27 2.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 84.1 m-85 -95.75 162.07 13.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 87.0 m-85 -150.03 114.38 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -59.12 112.96 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.06 141.74 37.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -137.78 90.83 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.549 -0.719 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.0 tp -68.19 126.72 30.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.373 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.03 -172.5 3.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -93.9 -13.43 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.2 m120 -88.0 28.97 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 109.489 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER 60.19 -0.15 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.2 m-85 -95.26 126.97 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -93.23 166.21 12.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.636 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.8 p -144.6 120.77 10.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.315 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -90.69 113.8 25.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -96.38 144.95 26.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.435 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -70.81 153.88 42.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.466 ' C ' ' H ' ' A' ' 120' ' ' TYR . 47.8 ttt180 -91.69 -75.72 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -51.37 -9.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 122' ' ' SER . 20.5 m-85 -141.78 62.52 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -62.06 2.04 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.683 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 120' ' ' TYR . 48.7 m -90.91 11.31 23.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.408 ' HD1' ' HG1' ' A' ' 139' ' ' THR . 2.4 m-90 -155.05 142.35 19.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.6 m-85 -106.76 170.04 8.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.4 t -90.73 126.75 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -151.58 148.37 27.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.51 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.11 172.61 6.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.551 -0.718 . . . . 0.0 109.44 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -93.95 -169.48 2.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.449 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -92.78 -12.31 31.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 t -93.69 -4.01 51.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 9.92 59.92 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -92.75 141.17 28.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.133 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 26.0 p90 -62.03 120.14 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.77 126.69 30.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.58 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -47.78 140.92 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.36 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.35 -4.9 39.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.6 p -87.82 -28.34 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -1.18 . . . . 0.0 109.436 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.92 -4.93 57.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.408 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 28.6 p -70.45 162.03 29.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.574 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 179.99 22.61 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.01 167.3 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.94 1.76 . . . . 0.0 110.17 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.32 -48.39 2.64 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -79.51 129.27 34.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -1.186 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -82.64 2.8 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.736 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.92 -2.73 2.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 pt -93.28 1.34 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.47 87.65 7.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.387 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.66 162.94 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.6 tp -138.46 71.83 44.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.92 103.76 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.911 1.741 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.26 35.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.2 t -70.03 175.17 4.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.458 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.14 160.07 16.98 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 121.066 1.177 . . . . 0.0 110.126 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.51 ' HD2' HD22 ' A' ' 64' ' ' LEU . 21.7 mttt -140.43 138.4 34.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.465 -0.772 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.2 mtm-85 -88.57 129.06 35.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.9 mt -93.91 101.09 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -95.1 121.67 36.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 t -88.56 105.13 17.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -15.24 8.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 16.3 m120 -86.38 104.38 15.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 75.31 4.94 75.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.7 89.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.8 m-85 -145.64 130.78 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -1.13 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -93.59 123.82 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.65 136.55 56.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.928 . . . . 0.0 109.219 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 57' ' ' ASP . 40.4 ttp180 -146.04 118.03 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.637 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mt -92.62 126.31 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -87.4 152.02 51.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.14 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.63 -26.59 65.69 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.236 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.95 1.7 12.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.965 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -25.09 10.88 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -57.55 114.96 2.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -1.19 . . . . 0.0 109.384 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.26 142.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -171.35 151.92 3.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.8 155.29 23.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 m -146.43 155.08 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.402 HH11 ' HB3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -92.23 9.07 35.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.53 102.17 14.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -83.38 -4.96 58.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.358 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -78.74 13.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.25 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -105.59 104.93 50.73 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.84 1.06 0.91 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 120.77 0.98 . . . . 0.0 110.2 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 57' ' ' ASP . 40.6 m80 -76.15 -26.69 56.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.273 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -65.65 -5.33 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -75.9 87.41 2.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.92 135.23 33.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.857 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 6.8 tt0 -89.73 114.32 25.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.325 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -86.6 153.07 22.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.0 109.628 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -144.68 131.91 20.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.93 119.78 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.57 -73.2 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -90.56 -143.85 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.482 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -93.94 -26.62 16.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.78 -9.38 2.54 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.45 104.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -1.204 . . . . 0.0 109.38 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.08 177.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.537 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -145.82 118.44 8.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.04 149.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' NZ ' ' NE2' ' A' ' 63' ' ' GLN . 11.0 tttm -146.59 144.35 29.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.44 133.65 11.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.4 -74.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -61.75 -26.03 67.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.95 -26.6 31.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 51.11 50.0 19.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -147.76 146.95 29.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -94.5 134.37 37.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.92 143.49 57.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.223 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.37 134.21 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.9 ttm -97.63 139.33 33.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.385 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HE3' HD21 ' A' ' 92' ' ' LEU . 25.4 mmtt -92.1 173.87 7.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.427 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -77.67 -27.09 50.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 6.4 p-10 -73.19 -49.4 28.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.486 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 145.67 -13.19 1.76 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -72.62 123.61 23.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.567 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -92.36 137.15 32.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -147.87 -172.41 4.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.09 156.71 45.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 m -145.88 153.48 40.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CG ' ' NH1' ' A' ' 81' ' ' ARG . 9.1 mtmp? -68.62 -29.77 68.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.529 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.48 148.33 23.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.3 t -92.37 149.54 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.428 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 38.2 p -146.51 157.43 43.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.45 -17.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 44.82 1.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.428 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 3.8 m -144.62 8.12 1.31 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 81.1 m-85 -100.0 159.7 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 75.3 m-85 -149.37 140.53 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.49 125.61 33.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 109.448 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -90.25 135.04 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.281 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -141.3 126.03 17.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.387 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tt -92.51 125.45 37.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.292 -0.88 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -90.67 -173.87 3.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.408 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 m -93.34 63.85 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 34.1 p30 -169.26 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.36 -7.52 0.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 50.3 m-85 -93.75 135.85 34.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -95.38 166.44 11.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.785 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 22.9 p -139.82 119.9 13.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -98.75 117.07 32.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -95.05 161.47 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 109.272 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.56 159.77 30.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.871 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.66 -61.84 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.399 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -83.28 -36.44 24.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' SER . 16.5 m-85 -89.29 50.54 1.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -49.0 -14.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -90.03 17.54 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 13.1 m-90 -155.05 141.33 18.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.913 . . . . 0.0 109.62 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.4 m-85 -112.04 169.98 8.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.683 -0.636 . . . . 0.0 109.587 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.75 133.17 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.377 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.01 154.86 33.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HA ' ' H ' ' A' ' 134' ' ' LYS . 31.8 mt -115.66 172.75 6.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.4 -169.23 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -94.97 -17.04 22.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -91.33 3.34 55.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.525 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.81 2.91 66.55 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.4 163.47 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -1.177 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 33.7 p90 -79.23 120.27 23.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 0.0 109.489 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 127' ' ' LEU . 16.8 tttt -72.05 128.66 36.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.581 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.6 tp -47.83 140.65 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.95 22.35 1.21 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.581 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.08 -27.25 7.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.598 -0.942 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -90.02 -9.27 49.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.682 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 p -69.97 152.28 44.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.22 -179.14 40.47 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.1 151.81 75.95 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.85 1.7 . . . . 0.0 110.185 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.43 -28.3 9.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -86.74 119.76 27.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -73.56 -3.45 27.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.78 -3.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -96.43 2.96 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.05 110.12 21.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.51 163.13 17.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 109.434 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.4 tp -137.79 72.34 48.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.49 -0.756 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.63 108.0 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.836 1.691 . . . . 0.0 110.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.458 -0.776 . . . . 0.0 109.584 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.4 t -70.16 147.65 49.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.231 -0.918 . . . . 0.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.461 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.43 164.07 11.6 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.187 1.258 . . . . 0.0 110.431 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -149.11 129.91 14.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.9 mtt-85 -87.34 117.18 25.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD12 HD23 ' A' ' 41' ' ' LEU . 19.0 mt -84.83 99.73 11.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.564 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -94.82 121.48 36.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.0 t -91.28 113.28 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.269 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.29 -19.96 63.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 0.0 109.617 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.452 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.6 m-80 -82.86 104.99 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.17 4.96 87.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.1 86.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 43.8 m-85 -143.49 131.36 21.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 109.651 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -94.33 119.06 32.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 32' ' ' LEU . 46.6 tp -47.8 140.78 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.271 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 44.5 ttt180 -145.97 115.98 7.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.01 104.15 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.066 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -64.89 150.55 94.73 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.109 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.7 Cg_endo -57.68 -26.67 73.99 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.142 1.228 . . . . 0.0 110.057 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -75.45 3.15 9.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.83 -30.74 5.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -50.48 114.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -1.152 . . . . 0.0 109.358 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.7 142.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.471 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -173.4 154.6 2.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.54 160.11 25.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -148.1 141.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -1.115 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.7 mtm-85 -84.54 2.12 42.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.95 112.97 20.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 109.771 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -85.21 -5.83 59.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.71 27.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' HIS . 88.3 m-20 -115.16 90.44 23.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.65 1.95 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.035 1.157 . . . . 0.0 110.64 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' ASP . 44.2 m80 -80.12 -10.74 59.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.279 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -79.81 -2.19 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -75.64 87.85 2.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.83 135.92 33.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -88.94 106.19 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.274 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.86 153.46 19.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.95 135.94 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.533 -0.729 . . . . 0.0 109.039 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 153.09 28.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -150.15 146.62 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.81 . . . . 0.0 109.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 53.06 -146.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 62.15 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.674 -0.642 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.28 1.67 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 72' ' ' VAL . 90.1 t -93.48 156.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -1.095 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 72' ' ' VAL . 5.6 m -145.32 123.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.355 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 m -93.32 123.98 36.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 mt -97.08 145.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.454 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -146.75 152.15 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.464 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.47 132.09 11.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -73.52 -62.61 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -40.26 62.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 109.532 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.73 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 51.72 44.71 29.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.785 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 43.4 mtp180 -141.58 144.23 34.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.92 136.47 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.6 tp -64.13 149.47 47.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.119 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 131.37 14.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 50.6 ttm -97.67 132.58 43.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 109.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -91.5 176.02 6.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -83.29 -22.62 32.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.432 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.497 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 23.8 p30 -77.16 -4.76 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.948 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.89 4.61 65.0 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 91' ' ' LEU . 9.5 mtp180 -88.77 122.16 31.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -1.175 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.685 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.0 mp -93.34 132.12 37.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.86 178.02 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -119.03 163.26 17.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.748 -0.595 . . . . 0.0 109.418 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -150.24 161.61 42.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.368 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -79.37 -34.57 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.75 164.55 13.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 98' ' ' THR . 46.2 t -90.15 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.505 ' N ' HG12 ' A' ' 97' ' ' VAL . 74.8 p -147.52 177.14 9.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -22.5 62.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.15 13.26 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 88.8 m -93.69 -9.97 35.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 69.4 m-85 -96.21 153.18 17.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 73.8 m-85 -146.35 137.18 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -77.17 124.19 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -0.984 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.44 145.35 24.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 108' ' ' GLU . 19.3 ttp180 -147.51 116.32 6.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.04 134.26 34.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 106' ' ' ARG . 3.7 mm-40 -93.07 176.7 6.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.1 p -85.2 -4.02 59.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.513 ' N ' HD22 ' A' ' 110' ' ' ASN . 1.0 OUTLIER -93.38 28.48 2.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.28 -4.64 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.8 m-85 -88.95 -172.13 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -146.81 167.67 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.77 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 p -142.98 169.49 17.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -0.76 . . . . 0.0 109.184 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -145.27 110.7 5.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -92.58 140.18 29.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.364 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -61.63 147.69 44.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 121' ' ' THR . 6.1 ttp180 -75.87 -57.93 3.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.591 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -75.61 -42.25 52.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 122' ' ' SER . 44.3 m-85 -92.91 52.69 1.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 118' ' ' ARG . 65.0 p -53.81 -5.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.813 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.2 m -89.92 10.23 24.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.68 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.16 146.09 22.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.811 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -104.65 165.27 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 109.573 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.0 118.76 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.56 143.62 23.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.982 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.31 175.4 6.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.431 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -91.01 -142.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.341 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -128.77 -16.83 4.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.66 . . . . 0.0 109.519 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.2 t -94.85 37.79 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.35 51.72 56.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -142.63 162.01 36.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -1.054 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.7 p90 -92.17 120.28 32.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.444 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.53 129.73 40.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.668 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.1 tp -55.42 157.9 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.152 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -80.28 24.31 3.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.668 ' OG ' HD23 ' A' ' 135' ' ' LEU . 51.8 p -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.957 . . . . 0.0 109.539 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -89.64 -5.14 57.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.654 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 135' ' ' LEU . 74.5 p -76.18 155.12 34.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.19 -179.93 35.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.73 179.61 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.857 1.705 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.91 -50.98 3.74 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.66 135.1 41.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.452 ' CB ' HD21 ' A' ' 36' ' ' ASN . 7.8 mtpt -83.99 7.44 18.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.86 -6.25 7.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.67 -2.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 144' ' ' LYS . 61.9 mt -88.16 90.48 8.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -97.58 167.94 10.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 0.0 109.418 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -140.44 70.35 32.49 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.3 101.37 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.777 1.651 . . . . 0.0 110.507 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.3 mtt -96.71 129.18 44.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.1 t -70.08 140.54 52.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.412 ' HB1' HH22 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.78 150.3 71.9 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.979 1.119 . . . . 0.0 110.228 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.8 mtmt -138.26 141.21 39.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.178 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -94.93 128.17 41.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.424 ' CD1' HD12 ' A' ' 62' ' ' LEU . 17.9 mt -84.91 124.66 31.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -115.23 114.46 25.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.0 t -86.82 106.02 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -47.55 -35.32 8.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.43 -0.794 . . . . 0.0 109.922 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.08 105.04 2.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.21 5.55 76.99 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.33 54.04 10.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.95 134.02 45.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.594 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 24.6 m-85 -93.8 117.06 29.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.15 136.94 23.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.244 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 5.9 ttt180 -147.54 124.51 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.749 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.65 122.44 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.086 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.77 151.38 73.81 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 109.173 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.529 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.8 Cg_endo -59.14 -23.41 69.08 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.176 1.251 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.4 p30 -74.98 3.26 8.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.52 3.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 mmm180 -46.94 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 109.534 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -141.38 134.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.394 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -166.9 152.13 7.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.41 21.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.73 144.86 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -1.137 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . 19.9 mmm-85 -64.93 -36.6 84.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -85.43 -1.31 56.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.428 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.1 p -94.03 15.2 17.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.1 m-20 -92.01 114.57 62.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.157 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.9 -2.14 2.0 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 120.601 0.867 . . . . 0.0 110.113 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.0 m80 -79.49 -28.8 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.312 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.57 -6.32 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.424 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -74.84 86.82 2.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.424 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.3 mt -90.15 135.26 33.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -89.7 109.31 20.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -87.67 156.56 19.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.628 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -140.68 -175.24 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.476 -0.765 . . . . 0.0 109.279 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.09 144.24 51.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.683 . . . . 0.0 109.523 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.3 mm-40 -145.46 144.41 30.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 48.17 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.085 -1.01 . . . . 0.0 109.22 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.88 62.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.78 -18.29 1.43 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLU . 21.4 t -92.51 119.25 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.236 . . . . 0.0 109.678 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 103' ' ' PHE . 3.6 m -94.12 179.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.339 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 m -145.87 116.87 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.62 145.51 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.92 129.23 12.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.41 133.86 12.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.94 -74.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -1.167 . . . . 0.0 109.53 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.5 m -47.13 -52.56 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.97 -22.37 65.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.9 m120 51.76 38.75 23.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 33.4 mtt180 -137.03 154.76 50.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.441 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.459 ' CG ' HG22 ' A' ' 97' ' ' VAL . 79.5 m-85 -94.28 134.72 36.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.26 144.93 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.19 132.43 15.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.668 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -98.7 142.38 30.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.815 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 92' ' ' LEU . 4.9 mmtm -94.93 177.93 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.53 -12.59 48.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.28 -2.54 58.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.85 64.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -88.81 118.58 28.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -1.118 . . . . 0.0 109.499 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.1 mp -92.36 132.17 36.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.4 pp -146.08 -170.45 3.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.848 . . . . 0.0 109.464 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.97 151.72 44.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 109.476 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -145.43 170.06 17.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -83.87 -23.38 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 t -92.44 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 97' ' ' VAL . 25.2 t -82.46 94.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.558 ' N ' ' SG ' ' A' ' 101' ' ' CYS . 3.3 p -76.45 -175.72 3.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.04 -11.23 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 9.16 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 98' ' ' THR . 3.7 m -94.32 -0.35 55.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.579 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 96.7 m-85 -94.94 151.15 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -0.841 . . . . 0.0 109.716 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.4 m-85 -147.55 134.82 20.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -80.17 159.35 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.98 . . . . 0.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -123.71 139.83 53.6 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.16 77.84 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.83 151.99 10.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.29 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -129.4 168.72 15.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.661 -0.649 . . . . 0.0 109.324 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.7 p -77.2 58.05 1.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.501 ' C ' ' H ' ' A' ' 112' ' ' TYR . 40.8 p30 -155.3 17.79 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 63.51 -7.75 0.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.526 -0.734 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 110' ' ' ASN . 49.9 m-85 -95.35 128.65 42.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.86 170.16 10.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.61 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 p -144.32 111.8 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -102.19 126.69 49.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -116.18 157.16 25.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 109.634 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -65.15 160.61 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.873 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 121' ' ' THR . 53.9 ttt180 -90.7 -73.99 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 8.4 tptm -58.11 -9.72 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -136.39 57.77 1.76 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.529 -0.732 . . . . 0.0 109.445 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' ARG . 21.8 p -61.26 1.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.687 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.6 m -89.96 11.52 20.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.99 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 14.5 m-90 -146.92 132.71 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -98.65 153.0 19.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.596 -0.69 . . . . 0.0 109.946 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.76 134.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.39 171.42 19.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.5 mt -132.32 172.03 12.96 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 128' ' ' LYS . 14.5 mtpp -94.49 -163.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -93.79 -24.94 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.707 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -77.22 -1.35 29.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.05 69.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.5 mp0 -85.11 179.1 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 31.6 p90 -94.11 120.77 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.67 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.611 ' NZ ' ' NE2' ' A' ' 143' ' ' GLN . 26.0 tttt -69.72 138.66 53.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.571 HD23 ' OG ' ' A' ' 137' ' ' SER . 15.2 tp -47.65 142.56 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.0 19.3 1.27 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.571 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.18 -27.0 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.914 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -90.06 -4.94 57.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.749 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 p -70.89 135.93 48.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.45 179.72 47.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.6 Cg_endo -61.23 179.08 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.88 1.72 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.8 -30.75 1.28 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.611 ' NE2' ' NZ ' ' A' ' 134' ' ' LYS . 15.1 mt-30 -92.48 134.08 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.18 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -85.06 1.85 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.545 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.36 -11.59 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.2 pt -92.59 -2.8 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.6 mt -88.63 86.79 7.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 109.503 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -91.29 164.43 13.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.56 70.48 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.35 109.97 1.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.803 1.669 . . . . 0.0 110.303 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.0 mtt -98.04 128.37 44.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -68.57 160.57 29.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.647 -0.658 . . . . 0.0 109.393 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 166.46 7.62 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.075 1.183 . . . . 0.0 110.27 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HD2' HD22 ' A' ' 64' ' ' LEU . 39.3 mttp -143.51 127.27 17.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.215 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -84.9 124.67 31.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.543 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.52 104.87 16.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -99.09 126.68 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.509 -0.744 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 43.8 t -89.45 130.74 35.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.19 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -79.8 -15.7 56.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.0 OUTLIER -88.21 104.82 17.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.67 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.56 4.94 89.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.4 88.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.449 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 44.7 m-85 -145.42 132.17 20.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.733 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -94.73 120.69 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.402 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.4 tp -47.53 142.64 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 12.8 ttt180 -150.32 114.74 5.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 117.32 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.476 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 90.8 m-70 -79.71 150.24 72.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.913 . . . . 0.0 109.031 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.5 -23.96 58.92 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.075 1.183 . . . . 0.0 110.259 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 4.8 p30 -75.01 -2.49 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.72 -31.51 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.2 mtm-85 -56.76 117.7 4.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -1.153 . . . . 0.0 109.528 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 83' ' ' LEU . 48.8 t -94.09 140.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 43.0 p30 -164.14 153.27 13.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.06 160.44 24.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -146.84 149.77 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -1.155 . . . . 0.0 109.478 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -80.78 4.6 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 57' ' ' ASP . 20.7 tt0 -88.01 91.6 8.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.383 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -77.84 48.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 p -163.49 20.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.715 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -77.7 141.36 64.44 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.991 . . . . 0.0 108.991 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.89 22.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.191 1.261 . . . . 0.0 111.073 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.5 m80 -132.61 -10.2 3.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.173 -0.954 . . . . 0.0 109.99 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.3 -3.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.046 -1.033 . . . . 0.0 109.338 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.95 86.7 7.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.01 135.0 33.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -93.59 110.5 22.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.07 136.47 26.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.77 123.17 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.13 -30.12 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -165.45 -159.93 0.44 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 10.5 ptt180 -89.18 118.54 28.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.01 66.96 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 t -145.75 99.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -1.09 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -93.19 174.83 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 m -145.48 119.72 9.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.324 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.67 147.59 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.594 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -147.01 132.01 18.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.374 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.91 132.9 12.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 78' ' ' SER . 57.0 t -72.52 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -1.155 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 77' ' ' VAL . 24.7 t -53.83 -47.56 70.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.7 70.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.35 46.35 26.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 81' ' ' ARG . 2.8 mtt-85 -136.09 142.63 44.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 109.305 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -89.93 116.4 27.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 49' ' ' VAL . 49.2 tp -50.69 149.7 3.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.18 128.34 11.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.7 ttm -94.16 138.11 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -83.44 166.88 17.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -20.57 60.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.498 ' CG ' ' HE ' ' A' ' 90' ' ' ARG . 1.7 p30 -87.02 -45.14 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 147.69 -10.67 1.26 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HE ' ' CG ' ' A' ' 88' ' ' ASP . 75.5 mtm180 -68.65 122.01 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -1.2 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -90.87 129.55 36.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.698 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.6 pp -147.53 150.93 35.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.264 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -101.2 157.32 16.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.748 . . . . 0.0 109.504 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.85 146.21 27.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.454 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -70.99 -21.43 62.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 t -89.69 151.59 21.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.16 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -147.43 162.01 39.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -11.55 31.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.46 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -94.12 4.96 53.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -91.52 -8.81 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.498 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 90.3 m-85 -95.03 153.03 17.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 69.2 m-85 -145.69 127.02 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.93 116.21 5.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.64 89.2 7.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.275 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.95 127.7 36.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.1 134.21 35.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -93.77 -177.78 4.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -93.63 40.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.5 m120 -148.15 30.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.57 -0.39 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.7 m-85 -97.36 125.34 41.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 0.0 109.284 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.2 m-20 -94.54 167.18 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 109.855 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -142.61 122.13 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.448 -0.782 . . . . 0.0 109.235 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -94.2 115.14 27.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 151.93 20.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.65 152.3 35.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.105 -0.997 . . . . 0.0 109.591 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -87.59 -75.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 21.7 tptt -49.69 -10.97 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 10.7 m-85 -143.91 66.37 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -64.71 5.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 33.6 m -91.59 10.49 27.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.692 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -151.35 144.62 24.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 24.1 m-85 -108.26 166.25 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.35 132.94 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.85 166.28 33.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -132.7 175.77 9.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 0.0 109.336 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -95.21 -169.64 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.389 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.43 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 6.6 ptm180 -91.65 -12.72 33.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -93.68 1.44 56.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.4 64.88 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.42 ' HG2' HG23 ' A' ' 130' ' ' THR . 49.1 mm-40 -85.34 161.84 19.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 109.509 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.8 p90 -91.98 120.51 32.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.502 ' HZ2' ' HB2' ' A' ' 138' ' ' LYS . 13.8 ttpp -72.98 134.92 44.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.404 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.532 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.7 tp -47.3 136.79 8.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.888 . . . . 0.0 109.224 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.92 -8.75 74.17 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.532 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.0 p -83.45 -29.62 27.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.492 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 134' ' ' LYS . 8.5 mtpp -89.98 -4.8 57.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.424 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 5.3 p -69.87 153.87 42.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.64 -179.75 43.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.94 162.62 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.803 1.669 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.57 -29.46 7.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.28 127.74 34.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -1.145 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -84.1 -2.88 57.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.606 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -63.23 -5.13 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.425 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.57 0.45 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.95 91.86 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -95.77 167.59 11.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.656 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.72 73.54 54.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.291 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.38 106.49 0.49 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.861 1.707 . . . . 0.0 110.608 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.1 mtp -97.41 130.24 44.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.463 -0.773 . . . . 0.0 109.409 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.5 t -70.04 137.01 50.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.47 164.0 6.07 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.096 1.197 . . . . 0.0 110.266 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 64' ' ' LEU . 26.3 mtmt -136.61 136.68 39.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.603 -0.685 . . . . 0.0 109.266 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.8 mtt-85 -87.46 121.87 30.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.482 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.528 HD12 HD23 ' A' ' 41' ' ' LEU . 27.6 mt -86.6 97.67 10.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.25 120.46 33.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.61 107.17 19.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.15 -22.07 60.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.9 m-80 -80.13 96.42 6.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.928 . . . . 0.0 109.488 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 85.7 4.62 85.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 84.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -143.02 132.4 23.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -1.041 . . . . 0.0 109.515 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -94.13 124.67 38.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 32' ' ' LEU . 56.2 tp -56.81 140.25 48.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.28 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -147.41 121.48 9.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.418 HG23 HG22 ' A' ' 49' ' ' VAL . 62.6 mt -94.36 121.53 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 89.1 m-70 -86.44 150.29 51.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.029 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -57.98 -22.41 54.86 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.105 1.203 . . . . 0.0 110.109 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 14.1 p30 -75.04 1.04 14.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -39.33 3.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.479 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.1 mtm-85 -54.51 119.91 5.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 43' ' ' ILE . 39.5 t -102.02 130.58 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -149.71 163.5 37.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.399 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.16 157.5 23.35 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -146.07 141.96 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -1.12 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -79.79 3.89 18.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm-40 -91.14 91.85 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 56.26 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -149.94 9.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.017 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' HIS . 2.6 p-10 -92.07 140.06 24.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.55 6.36 0.2 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.935 1.09 . . . . 0.0 110.564 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . 78.0 m80 -94.76 -34.54 12.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.78 -6.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 109.414 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 84.47 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.91 135.12 33.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tm0? -91.67 112.72 24.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.114 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.47 152.03 19.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.657 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -138.03 123.99 20.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.585 -0.697 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.1 134.18 35.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.622 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -100.28 -89.65 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 109.349 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.19 -155.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.38 54.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 165.15 -30.32 0.22 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 72' ' ' VAL . 55.3 t -89.95 154.89 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 109.537 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 71' ' ' VAL . 18.0 m -142.32 166.25 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -137.16 124.75 22.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.33 148.29 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -148.08 129.95 15.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.61 138.0 16.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.17 -68.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -58.0 -54.36 47.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.77 67.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 50.66 51.75 16.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.631 ' HE ' ' HZ3' ' A' ' 95' ' ' LYS . 91.1 mtt180 -147.6 149.2 32.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.87 130.21 36.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.21 141.54 58.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 109.268 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 156.25 41.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.6 tpp -112.29 143.75 42.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.67 -0.644 . . . . 0.0 109.383 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -80.17 -169.31 2.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -19.11 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.3 p30 -91.14 -38.47 12.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 109.62 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.14 -7.87 1.88 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -70.05 127.51 33.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.7 mp -91.9 139.02 31.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -150.04 -175.95 5.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.579 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.34 155.06 46.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -145.64 170.02 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.631 ' HZ3' ' HE ' ' A' ' 81' ' ' ARG . 9.9 mttm -80.38 -42.38 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 126.68 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.4 p -65.53 120.09 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 p -92.21 -174.1 3.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 101' ' ' CYS . 52.7 t0 -80.03 -31.97 39.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.79 16.52 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.464 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' A' ' 99' ' ' ASP . 64.4 m -94.85 1.72 55.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.6 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.1 m-85 -96.76 148.66 22.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 61.6 m-85 -145.92 115.59 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.309 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -60.85 117.02 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.087 -1.008 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -81.09 148.29 29.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' NH2' HH21 ' A' ' 116' ' ' ARG . 36.0 ttp180 -148.2 108.95 4.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.97 121.23 34.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -90.22 -177.67 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.428 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 3.31 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -91.03 18.24 6.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.463 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.46 -0.67 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.1 m-85 -99.17 136.28 39.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 113' ' ' ASN . 2.0 m-80 -93.72 162.65 13.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.771 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.5 p -143.41 122.8 13.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -95.26 109.17 21.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.856 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.598 HH21 ' NH2' ' A' ' 106' ' ' ARG . 37.9 ttm180 -93.36 149.22 21.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.983 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -80.19 167.74 19.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -93.78 -87.1 0.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.412 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -48.54 -13.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -126.26 56.8 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 118' ' ' ARG . 52.9 p -57.91 -19.75 32.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.727 . . . . 0.0 110.418 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.9 m -89.55 19.95 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.917 -1.114 . . . . 0.0 108.989 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -139.83 151.89 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.512 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 28.3 m-85 -131.54 152.57 50.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.712 . . . . 0.0 109.522 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.09 135.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -154.2 -178.45 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.11 165.96 26.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.87 175.33 7.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -87.02 -13.12 45.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -93.09 1.01 57.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.55 7.75 61.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -92.59 166.22 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 27.8 p90 -83.19 120.25 25.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 135' ' ' LEU . 38.9 tttm -71.51 137.42 48.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.487 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 5.7 tp -61.65 -152.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.487 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -127.71 -36.87 0.47 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.466 ' HG ' ' HZ3' ' A' ' 138' ' ' LYS . 27.0 p -52.91 -29.93 31.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.221 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HZ3' ' HG ' ' A' ' 137' ' ' SER . 2.4 mptp? -90.18 -20.08 23.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.4 p -69.93 136.7 50.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.14 179.81 48.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.74 153.97 58.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.874 1.716 . . . . 0.0 110.238 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.19 32.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -1.115 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 2.4 mtmp? -74.92 -7.76 54.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -58.12 -3.21 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -99.8 6.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.89 110.2 22.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.841 . . . . 0.0 109.614 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.14 163.72 16.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.684 -0.635 . . . . 0.0 109.402 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 tp -141.43 70.92 26.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.466 -0.771 . . . . 0.0 109.243 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.9 109.3 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.923 1.749 . . . . 0.0 110.559 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.2 mtt -95.92 125.7 40.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.1 t -68.72 141.57 55.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.562 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.72 167.72 3.81 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.138 1.225 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.7 mttt -145.77 133.46 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.232 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -85.03 120.96 27.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 mt -84.91 95.97 9.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -91.79 115.03 27.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.0 t -81.83 125.12 30.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -78.96 -14.88 58.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.903 . . . . 0.0 109.761 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 29.9 m-80 -88.32 92.49 9.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 93.02 4.92 64.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.75 82.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.4 m-85 -142.7 132.97 24.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.364 -1.08 . . . . 0.0 109.552 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -93.55 129.4 39.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.96 146.46 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 6.8 ttt180 -145.52 159.12 43.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.51 104.97 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.23 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.9 m-70 -66.92 150.58 97.75 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.079 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.2 Cg_exo -57.07 -24.05 55.95 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.157 1.238 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 23.8 p30 -74.98 -1.7 23.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.82 -32.04 6.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.4 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -52.15 119.94 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -1.209 . . . . 0.0 109.458 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.4 150.43 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 109.507 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 16.3 p-10 -174.57 151.35 1.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.92 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 155.25 21.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.87 139.54 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.0 mtm-85 -71.52 -7.12 45.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.04 98.04 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -84.98 7.15 22.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 t -91.34 -20.12 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -63.58 116.14 23.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.128 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.36 0.39 1.03 Allowed 'Trans proline' 0 C--O 1.213 -0.737 0 C-N-CA 120.632 0.888 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . 49.4 m80 -77.72 -6.63 54.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.86 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -87.63 6.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.3 87.41 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -91.77 135.28 34.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -89.75 105.39 17.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.51 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.5 mp -89.7 153.04 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -144.7 137.92 26.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.73 122.96 32.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -95.47 -76.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -95.96 -124.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -92.7 -76.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 5.44 81.24 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.08 140.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 30.9 m -141.02 127.32 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -91.47 121.1 32.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.611 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.32 145.12 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.321 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -146.84 143.81 28.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.13 139.98 18.81 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.449 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 58.5 t -80.02 -58.24 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -1.164 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.5 -43.78 18.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.12 67.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 3.1 m-80 51.25 50.84 18.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.57 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 94.1 mtt180 -148.5 149.3 31.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -93.17 129.79 39.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.937 . . . . 0.0 109.585 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.4 142.6 51.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.17 133.35 18.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.1 ttm -92.43 145.53 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HE3' HD21 ' A' ' 92' ' ' LEU . 17.2 mmtt -92.99 -177.34 4.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 21.2 mm-40 -79.62 -40.43 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.7 p30 -69.95 -37.14 75.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 135.8 1.75 2.94 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 90' ' ' ARG . 3.9 mtm-85 -76.45 119.15 19.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.8 134.87 34.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD21 ' HE3' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -149.17 178.04 9.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.708 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -111.88 158.12 19.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.687 -0.633 . . . . 0.0 109.449 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -150.06 134.46 17.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -54.84 -49.97 69.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -85.0 130.55 34.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.521 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -85.66 160.43 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 p -147.49 -172.98 4.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -13.0 62.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -95.91 50.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.1 m -147.43 9.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 63.0 m-85 -96.16 152.67 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.672 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.7 m-85 -150.25 115.77 5.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.897 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -57.56 152.56 14.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.42 137.34 54.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -142.8 134.52 26.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.438 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.17 128.57 46.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 109.679 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -86.33 171.42 11.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.277 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -76.21 -5.04 45.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.58 17.91 10.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.01 61.71 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -0.778 . . . . 0.0 110.205 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.452 ' C ' ' ND2' ' A' ' 113' ' ' ASN . 48.7 m-85 -144.6 -171.93 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 112' ' ' TYR . 4.3 m-80 -147.91 114.55 6.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 109.804 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -95.36 124.06 39.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.264 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -96.32 109.16 21.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -97.57 147.54 24.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.192 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 t -78.99 158.88 27.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.676 ' O ' HG23 ' A' ' 121' ' ' THR . 0.2 OUTLIER -93.22 -78.01 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.449 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -47.86 -34.81 9.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.2 m-85 -112.22 65.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 118' ' ' ARG . 67.6 p -64.08 3.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 120' ' ' TYR . 54.4 m -93.47 11.72 27.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.2 161.24 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 19.4 m-85 -123.91 169.91 11.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -87.92 122.52 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.48 144.45 22.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.615 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -95.86 -176.29 3.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -94.33 -108.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.86 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -148.17 -35.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 109.457 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -81.25 10.54 5.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.68 10.62 60.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -93.93 166.82 11.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -1.172 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -89.99 120.45 31.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.428 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -69.83 139.08 53.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.713 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.4 tp -58.64 141.94 50.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -66.46 5.16 2.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 135' ' ' LEU . 96.4 p -93.48 -32.37 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -90.0 -16.95 28.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.554 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 126' ' ' ALA . 38.8 p -69.91 161.41 30.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.36 179.33 31.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.1 Cg_endo -61.7 178.38 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.88 1.72 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 -33.21 0.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 141' ' ' PRO . 17.2 mt-30 -87.65 128.11 35.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -1.207 . . . . 0.0 109.601 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 37.8 mtmt -74.96 -2.82 28.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.16 -3.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.45 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.1 pt -97.49 3.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.1 109.95 21.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -116.05 163.75 15.46 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.1 tp -140.85 72.41 28.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.141 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.55 115.18 2.5 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.853 1.702 . . . . 0.0 110.711 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.4 mtt -97.13 121.84 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.8 t -69.98 139.86 52.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.254 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.928 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.61 150.6 60.03 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 121.13 1.22 . . . . 0.0 110.289 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HE2' HD22 ' A' ' 64' ' ' LEU . 40.4 mtmt -143.31 141.86 31.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.198 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' NH2' ' O ' ' A' ' 55' ' ' LYS . 7.8 mtp180 -92.97 128.28 38.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 HD23 ' A' ' 41' ' ' LEU . 17.3 mt -85.03 128.78 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -115.31 114.51 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.1 105.7 17.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -48.51 -35.14 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 109.908 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 105.01 3.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 109.715 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.02 5.91 85.41 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.27 52.49 13.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -99.17 137.64 37.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.492 -1.005 . . . . 0.0 109.746 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -95.61 112.12 23.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD12 ' A' ' 32' ' ' LEU . 37.3 tp -46.51 145.18 1.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 64.0 ttt180 -144.26 154.26 42.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.679 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -134.74 127.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -91.65 149.41 39.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.124 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -58.26 -22.02 55.21 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.241 1.294 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.82 -11.62 60.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 109.677 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.84 15.02 38.06 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -93.8 115.55 27.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.107 -1.231 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.87 131.4 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -148.32 -163.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.383 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.86 127.18 2.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.72 155.61 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.468 -1.019 . . . . 0.0 108.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LYS . 16.7 mtm-85 -91.64 -16.42 27.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.986 -1.071 . . . . 0.0 109.451 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.8 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 53' ' ' ARG . 18.4 pttp -83.48 -2.71 56.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.88 10.02 20.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.142 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -104.56 106.03 52.71 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.56 2.48 0.52 Allowed 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 120.744 0.963 . . . . 0.0 110.273 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.5 m80 -76.99 -28.01 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.456 HD11 ' NH2' ' A' ' 31' ' ' ARG . 2.2 pt -72.27 -8.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.83 92.05 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.448 HD12 HD11 ' A' ' 32' ' ' LEU . 8.2 mt -91.31 135.61 33.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.22 108.95 19.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.224 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.9 mp -91.26 153.15 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -147.88 133.99 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.303 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 169.25 18.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 67' ' ' GLU . 3.1 tm-20 -145.04 -34.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -154.01 -163.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 80.7 mtm180 -84.88 58.82 5.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.575 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.47 -26.84 1.68 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.64 138.6 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -1.181 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.97 179.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.276 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 m -145.38 121.84 11.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.635 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.9 mt -93.96 147.7 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -146.46 140.09 25.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.399 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.48 138.71 19.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 41.2 t -80.0 -68.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.47 -15.6 59.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.7 24.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 77' ' ' VAL . 44.5 m-20 51.16 45.69 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.594 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 73.1 mtt180 -147.43 148.06 30.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -94.61 130.95 40.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -60.4 147.83 39.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.294 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.02 137.15 19.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.636 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.8 ttm -100.43 132.41 45.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.467 -0.771 . . . . 0.0 109.341 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -78.82 157.46 28.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -21.08 66.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 2.7 p-10 -84.77 -42.58 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.36 -7.48 1.8 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -72.54 122.3 21.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 109.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -92.59 129.79 38.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -146.59 -174.58 4.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.01 154.07 44.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -146.46 163.93 34.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -70.14 -33.01 71.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.92 127.3 34.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 97' ' ' VAL . 8.4 p -82.64 85.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.6 p -68.3 -167.26 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 101' ' ' CYS . 55.3 m-20 -80.0 -26.81 39.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.81 7.34 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.473 ' H ' ' C ' ' A' ' 99' ' ' ASP . 85.8 m -96.72 -3.04 43.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -86.64 149.87 24.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -150.03 117.74 6.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CB ' ' HE ' ' A' ' 116' ' ' ARG . 33.0 m-85 -64.06 128.09 34.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -97.89 134.99 40.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -145.05 131.33 19.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.558 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.9 tp -95.91 120.16 35.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.63 170.88 12.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.4 t -78.29 53.27 1.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 112' ' ' TYR . 11.2 t-20 -150.84 22.86 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.25 0.23 0.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 109.568 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.6 m-85 -101.78 138.13 39.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -90.71 164.01 14.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.71 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 p -142.44 117.95 10.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -98.43 118.63 35.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.416 -0.802 . . . . 0.0 109.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -102.07 148.07 25.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.549 -0.72 . . . . 0.0 109.301 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -73.66 156.25 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 120' ' ' TYR . 1.1 ttt-85 -89.76 -77.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 5.7 tptt -48.35 -12.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 12.0 m-85 -143.82 67.12 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -65.27 5.02 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 37.0 m -90.39 9.75 27.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.578 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -151.51 142.77 23.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.8 m-85 -110.65 163.84 13.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 109.561 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -80.82 138.46 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -155.04 -177.67 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 127' ' ' LEU . 79.8 mt -142.64 169.21 18.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -95.07 -178.12 4.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -11.45 32.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 130' ' ' THR . 1.9 t -93.58 2.64 56.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.75 4.93 67.04 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.6 mp0 -93.32 169.7 10.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.129 . . . . 0.0 109.473 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.5 p90 -92.54 120.46 33.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -69.78 135.59 49.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.469 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.3 tp -47.65 123.78 6.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.47 -23.97 29.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.469 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.2 p -80.17 -20.79 43.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -1.195 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -90.07 -8.89 50.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 45.2 p -73.02 157.75 36.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.68 179.74 42.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 172.11 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.876 1.717 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.99 -37.95 2.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -83.55 131.88 34.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -1.19 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -83.35 -0.49 50.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.571 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.02 -8.81 3.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.56 2.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 144' ' ' LYS . 60.9 mt -93.32 90.62 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.14 166.99 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -146.21 71.03 13.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.242 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.3 112.9 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.842 1.694 . . . . 0.0 110.501 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.9 mtt -103.86 142.65 34.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.3 t -69.94 149.86 47.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 -179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.02 116.63 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 120.862 1.041 . . . . 0.0 110.165 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -95.1 143.18 26.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.392 -0.818 . . . . 0.0 109.666 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.2 mtt-85 -87.43 135.86 33.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.21 120.59 26.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 109.764 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -109.53 107.47 17.59 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -76.47 103.32 6.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -45.35 -31.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.538 HD21 ' CB ' ' A' ' 144' ' ' LYS . 2.0 m-80 -66.95 105.14 1.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.02 4.65 36.14 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.21 83.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -124.42 128.73 49.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.932 . . . . 0.0 109.255 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -90.31 114.07 26.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.216 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.9 tp -48.91 141.67 7.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.526 HH11 ' CG ' ' A' ' 57' ' ' ASP . 39.8 ttp180 -147.55 112.48 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.2 mt -89.96 112.75 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -74.35 151.93 87.78 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.121 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.7 Cg_exo -56.92 -26.42 67.55 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.163 1.242 . . . . 0.0 110.24 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.46 0.37 17.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.56 4.36 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.3 mtm-85 -50.63 115.24 1.4 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.13 146.09 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 14.0 p30 -169.06 148.13 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.26 151.53 20.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -146.35 153.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -89.91 -0.7 57.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.28 88.1 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -68.91 -5.04 18.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 22.65 1.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.6 OUTLIER -110.18 99.92 41.79 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.61 3.62 0.36 Allowed 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 120.912 1.075 . . . . 0.0 110.522 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.9 m80 -84.23 -4.64 58.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.65 1.85 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -77.01 100.45 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.29 135.2 43.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.79 107.33 19.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -85.85 150.72 24.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.532 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.04 132.93 16.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.4 135.44 33.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 -38.32 8.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.639 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -151.34 -117.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -83.85 -110.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.687 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.53 6.26 17.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.76 129.89 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.79 168.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -142.47 118.99 10.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.448 -0.783 . . . . 0.0 109.401 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 74' ' ' ILE . 4.8 mt -91.07 152.33 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -148.65 117.99 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.506 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 131.91 51.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.08 -60.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -68.2 -34.28 75.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.17 -21.92 33.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 51.25 55.21 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 6.6 mtp180 -146.8 149.29 33.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.399 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -94.97 129.63 41.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.06 139.66 58.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.267 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.82 133.31 16.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -97.12 133.0 42.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 88' ' ' ASP . 32.8 mmtt -73.45 164.24 26.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.893 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.78 24.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.1 p30 -130.24 -42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.663 -0.648 . . . . 0.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.41 -9.61 1.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.2 mtt-85 -78.53 115.93 18.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -1.162 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.67 131.02 38.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.412 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.569 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.94 -171.83 3.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.16 151.43 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 109.383 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.21 151.33 38.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.481 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -63.86 -28.92 70.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.77 127.38 38.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.94 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 p -148.25 -165.37 2.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -68.01 -19.43 64.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.961 . . . . 0.0 109.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.63 54.1 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 58.3 m -146.71 9.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -94.32 156.41 16.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.89 105.56 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -58.39 103.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.512 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -87.06 94.56 9.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -89.92 126.85 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.454 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.29 132.26 34.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.56 -178.92 4.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -89.15 -11.41 43.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.1 m-20 -89.59 28.55 1.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER 60.42 -0.7 0.25 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.75 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.2 m-85 -95.48 130.14 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.92 169.97 10.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.3 p -142.39 120.45 12.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.791 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -93.15 99.05 11.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -93.49 145.15 24.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -72.02 155.57 40.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.6 ttt180 -92.45 -76.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.6 -9.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 13.4 m-85 -140.47 60.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 40.1 p -61.0 0.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 4.0 m -90.51 10.68 24.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.08 142.33 19.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -105.55 170.13 8.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.0 t -90.68 69.95 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 145' ' ' ALA . . . -94.01 141.59 28.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.5 mt -95.97 179.6 5.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -92.65 -171.68 2.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -93.64 -11.77 30.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 2.51 55.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.43 0.4 67.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -88.43 171.01 10.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.6 p90 -89.6 120.41 30.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -70.14 139.34 52.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.483 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.4 tp -47.68 125.07 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.226 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.45 -16.5 7.04 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.483 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.3 p -90.1 -20.45 23.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.053 -1.263 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -89.98 -11.03 42.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.2 p -69.93 175.07 4.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.83 25.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.2 170.95 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.893 1.729 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.91 -55.07 2.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -75.15 134.87 41.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' CB ' HD21 ' A' ' 36' ' ' ASN . 33.9 mtmt -82.76 4.39 25.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . . . -61.21 -3.85 0.99 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.1 pt -93.12 -9.63 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.9 mt -81.87 91.64 6.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -94.07 157.28 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.5 tp -138.12 71.95 47.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.21 115.0 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.775 1.65 . . . . 0.0 110.732 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.3 mtt -97.43 130.59 44.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 109.22 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.0 t -68.32 144.31 54.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' HH12 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.48 156.7 30.05 Favored 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.236 1.291 . . . . 0.0 110.341 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -141.12 133.77 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.436 -0.79 . . . . 0.0 109.424 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.1 mtt-85 -90.76 133.86 34.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.65 126.35 38.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -115.19 119.46 36.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.5 t -93.82 106.66 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.09 -35.04 10.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.656 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.633 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -67.95 103.28 1.45 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.92 4.93 83.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 55.16 8.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -102.14 143.05 32.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.978 . . . . 0.0 109.795 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.02 110.14 22.46 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 127' ' ' LEU . 13.6 tp -46.95 144.66 2.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.119 -0.988 . . . . 0.0 109.716 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -143.55 155.4 44.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.89 131.83 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.199 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -93.17 149.68 37.86 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.067 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.06 -21.75 52.15 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.224 1.283 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -74.85 4.79 5.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -38.54 3.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -48.1 164.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.7 t -137.83 148.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.587 -0.696 . . . . 0.0 109.258 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' ' CG1' ' A' ' 52' ' ' VAL . 3.1 p-10 -154.17 -160.02 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 131' ' ' GLY . . . -143.1 126.38 2.82 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.407 ' CG1' ' OD2' ' A' ' 50' ' ' ASP . 1.8 m -142.55 151.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.456 -1.026 . . . . 0.0 108.457 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 55' ' ' LYS . 35.4 mtm180 -89.04 -21.54 23.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.091 -1.006 . . . . 0.0 109.341 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -44.93 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.764 . . . . 0.0 109.705 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' ARG . 6.9 pttp -81.27 1.33 32.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.3 p -88.28 5.12 43.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.214 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -99.27 110.35 57.85 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.177 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.73 3.18 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.717 0.944 . . . . 0.0 110.238 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -74.85 -33.23 62.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.334 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.96 0.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.459 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.612 ' NZ ' ' NH1' ' A' ' 31' ' ' ARG . 8.6 tptt -77.1 96.71 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.453 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 131.75 45.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.503 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.02 109.54 20.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -92.61 150.01 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.553 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.73 137.9 21.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.1 160.21 25.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.952 . . . . 0.0 109.581 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -142.94 -84.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.79 -151.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -85.87 117.72 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 -3.11 13.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.41 139.34 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -1.16 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.5 m -140.86 128.23 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.535 -0.728 . . . . 0.0 109.577 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 m -94.47 118.74 32.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.06 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 82' ' ' TYR . 58.4 tttp -145.71 144.18 30.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.44 134.17 12.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.47 -77.75 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -27.18 7.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.95 -25.46 20.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.0 m120 50.99 48.3 23.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -146.37 150.76 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 75' ' ' LYS . 80.9 m-85 -94.86 127.8 41.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.3 147.92 24.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -145.88 167.87 22.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.0 ttm -134.17 141.12 46.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.675 -0.64 . . . . 0.0 109.407 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -92.84 160.79 14.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.46 -29.41 70.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -45.53 26.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.08 -6.72 1.81 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.52 ' NH1' ' OH ' ' A' ' 133' ' ' TYR . 2.1 mmt180 -63.84 120.08 11.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -1.222 . . . . 0.0 109.471 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.16 -175.31 5.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.08 150.6 38.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.315 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -146.6 156.52 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -73.44 -18.56 61.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.25 112.97 25.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.96 142.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.464 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.2 p -147.31 -163.35 1.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.58 -14.8 63.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.504 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -94.07 42.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 64.6 m -144.03 6.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 60.7 m-85 -94.36 151.44 19.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 96.0 m-85 -150.22 111.94 4.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CD2' ' NH1' ' A' ' 116' ' ' ARG . 32.2 m-85 -54.89 157.81 3.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.27 95.26 4.41 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 109.307 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -89.96 108.57 19.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.66 117.86 30.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.93 -175.58 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -1.25 57.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 41.3 t-20 -91.44 27.49 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.95 -3.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 109.88 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.9 m-85 -94.31 156.49 16.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.242 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -123.9 165.38 17.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 109.758 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -141.0 120.13 12.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.321 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -89.9 107.77 19.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.479 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.513 ' NH1' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -99.07 133.65 43.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.499 -0.751 . . . . 0.0 109.133 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t -61.41 161.8 8.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.968 . . . . 0.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -95.45 -79.12 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 0.0 109.199 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -50.33 -11.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -130.19 52.53 2.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 118' ' ' ARG . 79.9 p -52.72 -12.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 m -93.51 20.51 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.928 . . . . 0.0 109.635 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -152.29 130.75 12.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.72 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.5 m-85 -103.99 167.97 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.581 -0.699 . . . . 0.0 109.591 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.52 148.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.887 . . . . 0.0 109.362 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.58 -177.96 6.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 41' ' ' LEU . 29.5 mt -144.86 171.28 14.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -90.27 174.03 7.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -93.79 11.71 28.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -125.08 5.55 7.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.7 -0.625 . . . . 0.0 109.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 95.27 0.28 63.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -85.09 172.95 10.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -1.166 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 20.9 p90 -93.62 120.55 34.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.592 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -72.71 132.82 44.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.364 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.72 158.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.76 -39.01 18.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -67.49 -15.37 63.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -1.159 . . . . 0.0 109.585 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -90.02 -5.05 57.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -74.38 165.68 24.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.57 179.47 21.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.86 168.71 6.74 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.849 1.7 . . . . 0.0 110.237 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.87 -47.9 2.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.14 131.52 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.633 ' CB ' HD21 ' A' ' 36' ' ' ASN . 36.3 mtmt -85.1 -1.94 57.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.522 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.18 -0.14 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.6 pt -93.66 -10.45 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.599 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 91.47 8.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.35 168.39 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.6 tp -144.27 70.44 16.09 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.58 112.97 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.796 1.664 . . . . 0.0 110.305 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 29.8 mtt -98.12 115.61 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.307 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.5 t -65.16 157.32 29.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.1 166.43 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.215 1.277 . . . . 0.0 110.525 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HD2' HD22 ' A' ' 64' ' ' LEU . 36.8 mttp -150.02 131.05 14.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.235 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.53 118.73 28.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.427 ' CD1' HD12 ' A' ' 62' ' ' LEU . 24.0 mt -84.92 100.65 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -98.6 125.42 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.472 -0.767 . . . . 0.0 109.571 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.66 121.46 33.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -15.13 62.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.705 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -84.66 105.07 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 53' ' ' ARG . . . 75.87 4.91 78.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.67 88.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.2 m-85 -144.84 132.97 21.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -1.076 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -94.92 131.56 40.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.388 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.77 143.52 57.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.268 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 57' ' ' ASP . 42.5 ttt180 -146.47 119.32 8.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.669 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.13 120.22 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -82.93 151.74 64.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.38 -27.29 75.05 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.121 1.214 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 p30 -74.91 0.88 14.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -25.11 11.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -55.95 114.96 2.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -1.154 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -92.69 142.1 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.406 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 12.7 p-10 -170.91 150.09 3.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.09 155.23 22.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.67 140.57 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 37' ' ' GLY . 8.5 mmt180 -69.27 -12.54 61.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.78 98.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' O ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.12 -5.49 59.34 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.264 -0.897 . . . . 0.0 108.943 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -97.09 23.74 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -102.85 107.55 55.12 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.187 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.5 -3.28 3.21 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 120.718 0.945 . . . . 0.0 110.154 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -76.04 -25.64 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.271 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.49 -5.52 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -76.09 87.27 2.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.959 . . . . 0.0 109.424 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 32' ' ' LEU . 8.4 mt -89.92 135.38 33.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -89.62 111.19 22.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.256 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -91.3 148.97 21.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.718 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 73' ' ' SER . 7.4 tt0 -145.36 148.25 33.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.87 163.68 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 102' ' ' PHE . 3.2 tt0 -138.01 -51.13 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.489 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -147.77 -139.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -91.51 101.26 13.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.0 -14.63 52.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.03 106.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -1.174 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 103' ' ' PHE . 3.3 m -95.74 -178.0 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 65' ' ' GLN . 5.9 m -144.84 112.39 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.37 -0.831 . . . . 0.0 109.236 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.97 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.65 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -146.27 143.68 29.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.398 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.29 142.42 16.39 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 78' ' ' SER . 55.0 t -78.93 -87.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 109.368 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 77' ' ' VAL . 10.0 t -47.6 -39.68 17.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.42 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.445 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 51.25 53.95 12.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.672 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -147.17 156.25 42.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.92 130.37 40.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.76 143.12 51.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.559 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -147.91 170.2 18.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.5 ttp -139.29 122.08 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.487 -0.758 . . . . 0.0 109.372 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -59.57 -175.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.26 -11.75 45.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -92.55 -38.02 12.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 143.44 -9.45 2.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -66.36 124.55 23.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.64 HD11 ' SD ' ' A' ' 85' ' ' MET . 11.0 mp -92.71 134.33 35.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.09 -171.53 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.599 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.64 150.39 40.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.26 147.78 31.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -66.33 -17.3 64.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.895 . . . . 0.0 109.543 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -90.24 140.81 29.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.493 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 97' ' ' VAL . 24.9 t -92.98 94.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.48 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.2 p -91.71 157.02 17.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.428 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.97 -21.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.87 48.52 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.2 m -138.61 1.02 2.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.455 -0.778 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 67' ' ' GLU . 99.2 m-85 -98.79 159.75 14.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.84 . . . . 0.0 109.412 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.2 m-85 -150.13 115.65 5.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.593 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.03 149.38 12.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.25 90.09 3.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -94.87 126.04 39.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.18 125.79 39.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -92.59 170.09 10.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.432 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -79.81 62.95 4.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 13.0 p30 -159.94 21.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.488 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.4 -6.77 0.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 110.037 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.3 m-85 -97.62 134.55 40.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 109.365 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.4 170.01 9.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.877 . . . . 0.0 109.822 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -140.27 114.62 9.24 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -90.63 115.33 27.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.876 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 150.9 22.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.556 -0.715 . . . . 0.0 109.161 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.3 163.44 20.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.896 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -94.83 -61.65 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 109.242 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.51 -54.07 23.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -96.1 62.62 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 p -56.89 2.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 120' ' ' TYR . 19.4 m -89.33 15.17 9.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.898 -1.126 . . . . 0.0 109.443 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.04 146.55 23.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 14.4 m-85 -104.71 169.45 8.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.17 125.61 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.55 156.4 42.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.1 mt -112.75 -178.36 3.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.771 -0.581 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.99 -129.45 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.533 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -139.84 4.52 2.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.502 -0.749 . . . . 0.0 109.408 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.31 14.82 8.32 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.61 6.46 60.91 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -92.91 162.74 13.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -1.121 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.0 p90 -93.32 120.3 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.666 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.686 ' NZ ' HE21 ' A' ' 143' ' ' GLN . 22.7 ttmt -70.03 135.41 49.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.493 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.677 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.66 160.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.27 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.3 24.52 7.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.677 ' OG ' HD23 ' A' ' 135' ' ' LEU . 33.7 p -115.07 -45.73 2.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.701 -0.882 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -4.86 28.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.684 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -73.16 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.66 179.46 31.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.95 171.57 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.885 1.723 . . . . 0.0 110.237 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.26 -44.34 3.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.686 HE21 ' NZ ' ' A' ' 134' ' ' LYS . 2.5 mm100 -85.39 133.82 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.461 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.628 ' CB ' HD21 ' A' ' 36' ' ' ASN . 36.9 mtmt -81.39 3.95 22.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.25 -9.95 5.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 pt -92.56 1.82 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 144' ' ' LYS . 71.1 mt -94.3 90.56 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.398 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.56 168.65 10.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 tp -141.02 70.61 28.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.329 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.54 103.83 0.41 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.8 1.667 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.6 mtt -95.4 125.35 39.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.354 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.4 t -70.02 135.33 49.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.416 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.45 167.24 2.85 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.204 1.269 . . . . 0.0 110.244 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -140.7 127.0 19.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -86.76 124.95 33.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.559 HD12 HD23 ' A' ' 41' ' ' LEU . 10.9 mt -84.72 102.03 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.562 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.94 116.2 23.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.21 61.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.691 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.5 m-80 -90.0 105.21 17.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.37 4.91 87.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 84.17 0.02 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.63 134.68 30.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.413 -1.051 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -95.25 133.35 39.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 32' ' ' LEU . 39.9 tp -67.53 143.25 56.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.209 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.651 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 1.5 ttt180 -155.99 125.05 6.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.98 . . . . 0.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 49' ' ' VAL . 38.1 mt -94.13 127.17 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.256 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.792 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 86.8 m-70 -83.58 148.86 56.08 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.7 Cg_endo -59.25 -21.12 58.59 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.203 1.268 . . . . 0.0 110.466 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.71 7.73 2.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.708 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.63 -39.29 3.13 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -52.0 162.04 0.51 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -1.141 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 43' ' ' ILE . 70.0 t -139.4 141.35 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.46 -0.775 . . . . 0.0 109.366 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.792 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 39.4 p-10 -159.46 -149.77 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.88 155.94 26.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m -145.49 139.13 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -1.068 . . . . 0.0 109.401 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -77.83 -17.78 57.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.18 110.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 34.65 0.55 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -129.63 -20.4 3.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.655 -0.653 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -45.48 108.71 0.82 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.837 . . . . 0.0 109.485 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.86 5.44 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.674 0.916 . . . . 0.0 110.152 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.651 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 47.6 m80 -94.13 -15.42 24.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -70.05 -4.72 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.506 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.0 mtpt -76.94 79.38 3.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.06 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.86 110.41 21.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -87.72 159.0 18.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -141.28 176.33 8.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.222 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 72' ' ' VAL . . . -132.64 142.07 48.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.608 -0.682 . . . . 0.0 109.574 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.19 143.0 28.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 50.81 -127.22 2.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -147.81 137.8 22.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.23 10.33 81.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.25 143.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.476 -1.014 . . . . 0.0 109.324 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 66' ' ' ALA . 2.4 m -136.83 -176.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.479 -0.763 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -141.53 126.34 18.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -95.48 148.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.36 136.75 23.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.41 136.81 15.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 78' ' ' SER . 51.3 t -74.97 -86.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -1.198 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.551 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -47.51 -53.63 13.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.359 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.55 63.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.9 m120 51.08 45.24 28.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 0.0 109.55 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -137.24 145.67 43.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 109.332 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.95 129.41 36.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.887 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.45 150.19 19.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -144.03 165.74 26.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 109.476 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.7 ttm -137.47 126.86 24.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.378 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -91.4 -173.04 3.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.92 -29.47 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.9 1.18 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.07 78.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -91.27 117.67 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -90.04 137.34 32.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.612 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.13 177.46 9.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.736 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.18 164.64 12.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.692 -0.63 . . . . 0.0 109.417 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -149.33 159.13 44.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 109.509 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -88.44 -0.5 57.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.93 123.75 16.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.496 -0.753 . . . . 0.0 109.423 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.07 154.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -150.93 168.39 24.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -47.51 -24.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.9 49.27 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -143.38 5.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -97.4 157.61 15.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -150.01 112.94 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' ARG . 34.1 m-85 -54.92 149.14 12.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.98 . . . . 0.0 109.231 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.96 92.14 3.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.657 -0.652 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 114' ' ' THR . 10.5 ttp180 -91.47 120.19 32.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.68 126.56 32.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.91 -177.19 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.7 m -93.67 55.92 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.568 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 17.2 p-10 -165.78 31.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.95 -4.29 0.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.6 m-85 -91.31 127.61 36.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.72 167.21 11.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 14.2 p -136.17 120.57 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.85 104.18 16.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -98.45 145.82 26.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.38 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -62.56 161.34 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 0.0 109.277 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -87.15 -61.67 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.68 -44.38 56.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.504 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -92.63 57.91 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -58.25 -0.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.5 m -89.71 11.81 18.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.07 -1.019 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.03 152.59 29.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 11.4 m-85 -120.65 163.19 18.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.63 130.06 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.23 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.86 143.49 21.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.96 167.78 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -93.75 -165.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.86 -10.16 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -4.77 53.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.97 34.22 9.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.3 176.38 5.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.769 -0.842 . . . . 0.0 109.374 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.8 p90 -87.02 120.06 27.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -71.39 131.84 43.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.715 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -52.15 140.5 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.52 4.08 1.61 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.715 ' OG ' HD23 ' A' ' 135' ' ' LEU . 88.9 p -91.89 -34.61 14.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.17 . . . . 0.0 109.604 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.02 -10.76 43.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 p -70.0 145.33 51.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.5 178.96 38.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.49 166.54 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.938 1.759 . . . . 0.0 110.222 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.62 -50.47 2.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -80.41 135.08 36.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 40.6 mtmt -85.01 9.28 15.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.07 -2.54 2.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 pt -97.13 -3.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 109.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.93 91.75 8.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.632 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.54 165.51 12.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.1 tp -141.87 70.45 24.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.392 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.16 104.9 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.752 1.635 . . . . 0.0 110.36 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.7 mtt -95.31 136.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 130.4 42.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 179.911 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.1 153.61 57.27 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.148 1.232 . . . . 0.0 110.384 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -137.41 124.46 21.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -85.26 118.97 25.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.638 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.01 100.91 11.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -94.58 125.17 39.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.7 t -90.18 123.27 33.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -72.44 -13.91 61.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.575 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.3 m-80 -90.34 105.12 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.98 5.8 88.88 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.47 85.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 43.6 m-85 -143.15 136.21 27.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -1.089 . . . . 0.0 109.568 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -98.13 122.76 41.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.403 -0.811 . . . . 0.0 109.493 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.13 145.53 20.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.179 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 59' ' ' HIS . 20.2 ttt180 -150.63 128.62 11.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.06 131.35 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.416 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 49.9 m-70 -90.5 152.09 44.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.105 -0.997 . . . . 0.0 109.193 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.56 -27.34 76.38 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.198 1.265 . . . . 0.0 110.368 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -74.88 9.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.525 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -33.73 3.28 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -47.51 166.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -1.176 . . . . 0.0 109.405 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.44 134.01 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 32.8 p-10 -159.4 155.93 27.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.33 152.19 20.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.64 149.13 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -1.108 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -82.25 -10.07 59.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.51 83.78 0.41 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -84.66 49.63 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.552 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.95 6.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 109.914 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 139.57 21.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.039 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.21 -4.37 3.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.022 1.148 . . . . 0.0 110.317 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CB ' ' NE ' ' A' ' 42' ' ' ARG . 70.1 m80 -75.0 -25.79 59.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.911 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.41 -1.95 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.322 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 77' ' ' VAL . 11.7 mmtp -83.96 87.0 7.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.93 135.64 33.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.42 104.37 16.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.341 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.82 154.8 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.22 141.25 35.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.74 136.08 33.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -140.57 122.18 15.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 60.01 164.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 108.935 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.77 32.97 0.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.77 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.23 16.76 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.742 -1.218 . . . . 0.0 110.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.54 155.67 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -1.231 . . . . 0.0 109.575 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' VAL . 4.3 m -144.07 130.02 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -92.84 125.33 37.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.828 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -104.05 142.61 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.757 . . . . 0.0 109.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -147.23 151.57 36.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.75 139.42 14.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 61' ' ' LYS . 54.4 t -78.24 -65.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -71.92 -42.54 66.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.6 65.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 49.98 51.29 16.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -146.06 145.98 30.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.377 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -89.8 133.55 34.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.579 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 44.1 tp -63.56 146.82 52.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.55 132.7 16.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.1 ttm -97.51 120.16 37.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.96 176.54 9.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.32 -26.33 30.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.18 -2.62 22.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 92.48 -14.98 63.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.6 mtt-85 -71.43 123.33 22.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.478 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -90.2 136.2 33.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.579 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -146.4 -175.44 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.65 158.7 43.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 p -145.17 170.11 16.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.321 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -79.97 -36.9 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -93.23 126.0 38.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -71.06 118.85 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 p -97.88 161.57 13.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.66 -21.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.37 55.47 2.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -139.29 3.69 2.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 79.3 m-85 -96.87 162.89 13.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 92.5 m-85 -150.15 121.94 8.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -62.18 97.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -73.17 95.37 2.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -92.51 123.64 35.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.75 134.32 35.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.24 -170.69 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -95.81 -17.54 21.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.659 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 4.1 p30 -94.39 26.0 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.769 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 71.52 2.61 4.34 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.726 -0.609 . . . . 0.0 110.697 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -90.29 140.58 29.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.918 -1.114 . . . . 0.0 109.443 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -95.4 164.16 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 p -141.8 119.89 12.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.332 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -91.77 105.47 17.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -96.15 145.5 25.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -68.34 148.8 50.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -80.55 -56.73 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -70.01 -46.64 64.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.1 m-85 -95.94 59.44 2.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -57.03 -2.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.9 m -89.85 10.34 24.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.678 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.08 153.02 30.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 13.8 m-85 -117.02 168.98 9.77 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.303 0.573 . . . . 0.0 109.464 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.78 133.24 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.87 177.48 9.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.1 158.36 39.86 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -93.19 170.63 9.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -78.49 -11.93 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 130' ' ' THR . 1.7 t -91.87 26.1 2.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.77 50.01 69.31 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -137.47 167.01 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.974 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.2 p90 -90.33 120.58 31.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -69.63 132.62 46.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 139' ' ' THR . 13.8 tp -54.04 160.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -78.62 -0.61 80.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.1 p -95.01 -47.23 6.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -1.12 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -72.46 -6.74 45.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 135' ' ' LEU . 3.1 p -69.95 153.52 43.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.01 -179.87 28.21 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.33 -174.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.779 1.652 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.57 -43.1 1.81 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -92.21 119.46 31.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.575 ' CB ' HD21 ' A' ' 36' ' ' ASN . 36.6 mtpt -71.05 4.53 2.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.24 -9.2 10.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.349 -0.844 . . . . 0.0 109.542 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -93.15 0.53 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.525 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 144' ' ' LYS . 70.5 mt -92.35 91.39 7.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.39 168.84 10.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.5 tp -143.07 70.43 18.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.16 107.7 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.791 1.661 . . . . 0.0 110.246 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.0 mtt -93.88 111.13 22.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.805 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 t -66.2 145.37 55.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 179.939 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.8 175.57 0.29 Allowed 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 121.251 1.301 . . . . 0.0 110.243 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -146.28 175.11 10.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.427 HH11 ' HG3' ' A' ' 31' ' ' ARG . 17.9 mtm-85 -131.01 128.1 39.67 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.45 111.0 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.774 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -101.42 114.52 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.81 108.31 17.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.491 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.737 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.1 m-80 -77.25 105.0 8.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.65 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . . . 72.3 7.05 66.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 73.98 0.27 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -118.27 129.88 55.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.73 -0.865 . . . . 0.0 109.571 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.82 113.2 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.2 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 32' ' ' LEU . 43.8 tp -49.07 133.83 18.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 109.187 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 57' ' ' ASP . 41.2 ttp180 -142.5 122.98 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.7 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.54 133.76 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.202 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -89.92 151.24 45.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.09 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.15 -18.15 28.23 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.161 1.24 . . . . 0.0 110.516 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.89 -7.88 54.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.19 55.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -94.05 163.09 13.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -1.132 . . . . 0.0 109.363 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 83' ' ' LEU . 74.5 t -129.66 126.59 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.568 -0.707 . . . . 0.0 109.315 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.61 149.99 24.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.27 151.85 22.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.25 146.12 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -1.149 . . . . 0.0 109.704 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 37' ' ' GLY . 28.2 mtt-85 -77.02 1.16 18.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.01 88.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -85.11 33.37 0.54 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.602 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -143.64 21.8 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.66 124.41 55.02 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.041 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.1 1.86 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.668 0.912 . . . . 0.0 110.28 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.4 m80 -94.07 -13.81 26.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.54 9.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.612 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -93.26 87.48 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -90.1 135.16 33.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -89.82 110.33 21.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.01 118.51 31.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.14 146.57 27.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.305 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.98 139.36 30.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' GLU . 28.1 tt0 -146.64 142.05 27.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . 1.5 mt-10 48.3 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -100.97 113.28 26.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 109.541 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.63 25.56 17.78 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.75 152.54 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -1.103 . . . . 0.0 109.418 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.7 m -144.49 133.41 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -92.08 118.75 31.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.554 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.89 138.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -147.04 139.6 24.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.66 142.36 20.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.44 -72.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -45.19 91.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.31 -27.35 68.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.96 50.15 19.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.421 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 5.5 mtp180 -145.89 150.05 35.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -95.29 134.31 38.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.323 -0.861 . . . . 0.0 109.766 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HG21 ' A' ' 49' ' ' VAL . 42.9 tp -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.249 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.08 148.5 29.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 47.2 ttm -106.27 132.91 51.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.371 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -72.45 -170.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.0 -45.54 26.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.707 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 1.4 p-10 -69.96 -82.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -171.18 24.61 0.09 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -89.61 124.27 34.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.2 mp -94.01 128.7 40.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.54 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.81 -173.53 4.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -140.2 152.55 46.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.404 -0.81 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.61 155.03 42.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -61.09 -36.81 80.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 99.0 p -84.93 137.55 33.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -89.08 118.12 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.9 p -93.98 -169.82 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 101' ' ' CYS . 1.7 m-20 -80.06 -30.75 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.99 15.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.448 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 99' ' ' ASP . 93.8 m -95.1 -9.32 33.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -86.74 148.8 25.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.935 . . . . 0.0 109.435 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.27 116.48 7.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -59.51 122.43 14.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.93 97.79 9.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 116.82 29.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.76 120.3 31.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.493 ' OE1' HG23 ' A' ' 114' ' ' THR . 19.4 mt-10 -84.7 -171.29 3.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.5 p -93.37 -4.35 51.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.7 m-20 -93.06 25.84 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.55 -1.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.79 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.2 m-85 -95.93 130.94 42.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -91.61 163.05 14.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.742 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.493 HG23 ' OE1' ' A' ' 108' ' ' GLU . 6.6 p -139.09 114.66 9.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.124 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -89.84 114.71 26.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.806 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.82 139.82 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.295 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -67.68 137.01 55.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.5 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 120' ' ' TYR . 25.5 ttt180 -77.98 -70.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.589 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 3.2 tptt -51.55 -10.08 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 27.6 m-85 -146.2 70.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.7 p -64.88 4.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 120' ' ' TYR . 11.2 m -94.25 10.23 34.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.88 . . . . 0.0 109.603 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 10.4 m-90 -154.97 137.37 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 22.6 m-85 -100.98 165.39 11.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.574 -0.704 . . . . 0.0 109.388 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.67 125.86 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.665 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -152.2 143.4 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -95.39 176.21 6.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -93.07 173.19 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -84.92 -4.84 59.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.434 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.596 HG23 HE21 ' A' ' 132' ' ' GLN . 0.7 OUTLIER -93.94 -5.16 48.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.26 -0.66 55.95 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.596 HE21 HG23 ' A' ' 130' ' ' THR . 1.5 mp0 -93.13 172.6 8.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -1.184 . . . . 0.0 109.532 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.9 p90 -91.61 120.22 32.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -70.2 131.84 44.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 139' ' ' THR . 13.2 tp -48.5 160.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.11 2.05 53.05 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' THR . 84.5 p -93.69 -68.17 0.82 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' N ' ' OG ' ' A' ' 137' ' ' SER . 12.3 mptt -48.18 -14.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 135' ' ' LEU . 22.3 p -69.93 150.36 46.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.42 179.84 30.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.51 158.46 31.86 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.69 -28.78 8.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -90.4 113.89 25.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.411 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -65.93 -2.25 3.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.665 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.99 -10.36 28.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 1.9 pt -90.67 2.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.499 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.4 mt -91.01 87.31 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.99 159.62 15.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.672 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 149' ' ' LEU . 19.5 tp -140.84 70.91 29.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.018 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 109.35 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.888 1.726 . . . . 0.0 110.641 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 20.6 mtt -97.5 130.94 44.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.397 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.0 t -70.08 167.99 16.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.134 -0.979 . . . . 0.0 109.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.413 -179.965 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.806 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.07 160.1 13.54 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.988 1.125 . . . . 0.0 110.174 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.69 ' HG3' HD22 ' A' ' 64' ' ' LEU . 24.8 mmtp -122.47 174.16 7.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.7 mtm-85 -136.84 110.89 8.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 41' ' ' LEU . 9.5 mt -84.06 101.28 11.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.927 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.22 115.68 27.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.7 t -78.87 111.43 15.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.576 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -20.2 66.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.3 m-80 -88.13 100.93 13.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.597 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 86.71 4.55 82.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 84.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 48.7 m-85 -142.2 131.3 23.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -1.062 . . . . 0.0 109.477 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -92.64 121.92 34.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.47 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 32' ' ' LEU . 49.2 tp -53.0 145.25 13.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.0 109.187 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 22.4 ttt180 -148.7 158.95 44.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.576 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.6 mt -136.27 123.37 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -88.15 149.69 45.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.116 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.89 -23.72 60.82 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.294 1.33 . . . . 0.0 110.699 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.476 ' OD2' ' CD ' ' A' ' 48' ' ' ARG . 36.4 p-10 -74.63 3.87 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.739 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.42 -35.31 4.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' CD ' ' OD2' ' A' ' 46' ' ' ASP . 27.0 mtp180 -47.8 152.86 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.92 144.18 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.468 -0.77 . . . . 0.0 109.428 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -167.04 -146.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.91 161.12 28.25 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.8 m -147.1 138.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.465 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 53' ' ' ARG . 4.5 mtm-85 -82.25 5.43 20.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.38 106.61 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -84.0 38.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.96 17.5 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -99.13 110.16 56.92 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.795 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 1.63 0.63 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.68 0.92 . . . . 0.0 110.127 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.1 m80 -80.6 -13.29 59.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.391 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.21 -0.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.18 87.48 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.97 131.68 35.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.454 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -89.98 102.95 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.69 HD22 ' HG3' ' A' ' 30' ' ' LYS . 10.7 mp -86.21 149.66 24.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.98 139.1 28.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.69 111.74 22.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -92.11 -91.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -84.34 180.0 7.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.8 mtt-85 -76.62 110.7 11.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.41 26.02 26.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.52 96.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -1.127 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.87 126.65 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 m -94.31 129.02 41.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.443 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.78 146.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.96 117.68 8.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.46 48.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 55.2 t -80.0 -80.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -1.086 . . . . 0.0 109.435 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -58.6 -35.01 71.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.79 -25.83 61.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.479 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 5.0 m-80 51.21 52.69 14.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.8 mtt-85 -147.63 143.32 27.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.9 126.78 35.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -59.88 147.49 38.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.51 170.14 17.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -140.03 128.89 23.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -73.12 -169.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -92.78 -17.5 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.4 p30 -85.44 -40.87 15.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.49 2.16 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -70.56 126.35 29.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -93.09 138.47 31.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.05 -176.56 5.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.89 157.1 44.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m -145.49 170.14 16.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.831 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -42.88 33.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 p -89.43 142.86 27.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.5 p -85.23 116.99 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.417 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -96.01 178.88 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -22.81 67.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -94.08 54.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.814 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.2 m -137.43 0.56 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 83.9 m-85 -94.87 153.17 17.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.386 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 82.2 m-85 -147.84 120.14 8.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -59.74 154.19 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -125.25 97.24 5.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.684 -0.635 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.98 116.74 28.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.89 112.33 24.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -84.89 167.72 15.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.883 . . . . 0.0 109.528 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.0 t -81.49 66.39 7.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.654 ' ND2' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -167.58 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.49 -7.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.517 -0.739 . . . . 0.0 110.057 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.654 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 54.8 m-85 -98.32 120.12 38.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -93.25 170.05 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.833 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 p -134.08 121.64 21.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.344 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.44 105.01 16.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 121' ' ' THR . 27.9 ttt180 -94.78 147.06 23.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.855 . . . . 0.0 109.454 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -74.01 158.26 34.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -93.67 -75.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 10.4 tptm -51.44 -9.93 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.1 m-85 -142.97 63.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.467 -0.771 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.521 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 30.2 p -63.27 2.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 57.8 m -91.01 11.97 21.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.06 145.27 21.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 116' ' ' ARG . 27.9 m-85 -109.96 168.16 9.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.741 -0.6 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.7 t -92.93 131.43 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.4 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -148.26 -172.54 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 95.5 mt -138.49 149.8 45.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -61.09 -102.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.5 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 31.3 ptt180 -173.76 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.417 -0.802 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 130' ' ' THR . 1.8 t -92.53 22.11 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.616 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.75 6.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -136.4 158.7 43.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.956 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 31.0 p90 -95.02 120.46 35.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.816 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -69.74 135.26 49.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.606 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.2 tp -58.06 157.34 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.279 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -79.39 22.19 3.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.606 ' OG ' HD23 ' A' ' 135' ' ' LEU . 3.5 p -98.57 -60.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.362 -1.081 . . . . 0.0 109.554 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -71.93 -7.5 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 135' ' ' LEU . 23.7 p -70.12 146.84 50.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.89 179.77 42.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.84 172.71 2.71 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.864 1.709 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.1 -42.11 2.5 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -72.52 134.68 45.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.0 mtpp -85.09 -4.13 59.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -61.48 -3.72 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 144' ' ' LYS . 3.0 pt -99.2 -3.23 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.2 mt -82.24 93.95 7.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 109.591 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.26 161.06 13.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.808 . . . . 0.0 109.529 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.4 tp -133.32 75.73 69.74 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.672 . . . . 0.0 109.23 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.25 111.08 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.712 1.608 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.3 mtt -96.37 114.99 26.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 9.6 t -70.2 129.07 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.414 179.936 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.09 174.41 0.33 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.115 1.21 . . . . 0.0 110.08 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' HD22 ' A' ' 64' ' ' LEU . 9.7 mtpp -147.22 131.04 17.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.9 mtt-85 -85.89 121.18 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.056 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 41' ' ' LEU . 19.7 mt -84.5 104.91 14.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.98 117.14 33.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.585 -0.697 . . . . 0.0 109.6 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.39 116.45 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.164 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -65.48 -24.5 67.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.06 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.82 105.14 14.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 83.24 4.34 89.69 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.41 83.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.563 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 47.8 m-85 -141.48 140.53 33.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -1.103 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -100.88 134.24 44.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 32' ' ' LEU . 44.7 tp -70.13 144.12 52.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 41.1 ttp180 -152.82 129.1 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -103.33 136.28 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.518 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 5.5 m-70 -91.73 148.89 38.16 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.066 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.14 -17.66 46.93 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.095 1.197 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 7.4 p30 -74.84 -10.48 59.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.776 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 15.15 29.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.6 mtt-85 -92.65 167.44 11.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -1.19 . . . . 0.0 109.333 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.7 t -142.94 117.73 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.402 -0.811 . . . . 0.0 109.274 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 4.3 p-10 -158.23 160.29 36.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.637 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.11 152.99 20.94 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.7 155.06 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.481 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -75.26 -30.66 60.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.461 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.421 ' OE2' ' OD1' ' A' ' 57' ' ' ASP . 2.6 mt-10 -47.26 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 53' ' ' ARG . 8.8 pttp -85.24 33.82 0.56 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.946 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -165.23 43.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.09 -1.006 . . . . 0.0 110.007 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.2 156.88 38.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.957 . . . . 0.0 109.188 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -66.15 22.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 121.508 1.472 . . . . 0.0 111.051 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . 61.7 m80 -141.71 -15.51 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.029 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -64.81 -5.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -88.39 90.81 8.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.434 HD12 ' CD1' ' A' ' 32' ' ' LEU . 15.4 mt -89.96 135.38 33.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 64' ' ' LEU . 2.4 tp-100 -89.67 106.49 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -86.92 155.59 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.72 121.8 12.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.847 . . . . 0.0 109.246 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.83 157.57 26.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.93 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -148.06 135.42 20.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 50.75 -112.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -153.52 124.64 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.11 -17.87 35.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.29 146.02 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.669 -0.9 . . . . 0.0 109.332 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 m -146.43 175.34 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -143.97 128.77 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.73 147.84 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.565 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 5.7 tttp -147.49 134.27 20.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.62 130.85 10.3 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.36 -74.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -1.13 . . . . 0.0 109.496 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.1 t -66.42 -45.25 80.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -27.55 39.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 78' ' ' SER . 11.2 m120 49.79 47.48 22.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.513 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 92.4 mtt180 -147.28 144.67 29.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 70.7 m-85 -90.15 131.69 35.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.602 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.33 142.63 56.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.206 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -148.29 134.49 19.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 53.7 ttm -96.65 126.58 41.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.395 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -72.25 178.8 3.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 -31.59 45.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -70.98 -48.26 54.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.06 -9.11 1.52 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -71.27 124.71 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.489 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.3 mp -92.74 133.87 35.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.553 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -147.59 177.78 8.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -116.83 156.64 26.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.626 . . . . 0.0 109.373 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -145.34 162.91 36.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -82.98 -39.79 20.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.1 t -92.63 122.76 35.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.14 154.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -147.53 -177.12 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -22.55 64.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -87.68 44.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 22.0 m -143.17 5.45 1.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 59.7 m-85 -93.42 151.89 19.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 0.0 109.563 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 84.1 m-85 -150.16 110.59 4.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.882 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -56.96 155.14 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.137 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -125.19 95.35 4.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.369 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' NH2' ' OE1' ' A' ' 108' ' ' GLU . 6.2 ttp180 -90.76 132.36 35.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.21 132.45 36.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' OE1' ' NH2' ' A' ' 106' ' ' ARG . 4.5 mm-40 -88.35 -174.67 4.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -16.46 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.908 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.404 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 5.7 m-80 -93.44 24.24 4.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 64.11 57.32 1.28 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 110.056 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 52.7 m-85 -143.02 126.39 16.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.257 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.73 120.36 34.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 146' ' ' ILE . 66.8 p -98.1 129.06 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.405 -0.809 . . . . 0.0 109.224 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -95.89 113.03 24.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -100.81 144.89 29.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.378 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -76.24 139.95 41.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 109.582 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.474 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.2 ttt-85 -76.47 -70.63 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -51.37 -9.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.409 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.474 ' N ' ' C ' ' A' ' 118' ' ' ARG . 49.7 m-85 -143.86 68.22 1.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.5 p -67.06 3.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 120' ' ' TYR . 73.5 m -95.63 10.55 36.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.82 . . . . 0.0 109.652 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 5.1 m-90 -155.13 145.18 21.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.848 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.3 m-85 -112.01 161.47 16.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.75 -0.594 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.74 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.199 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 -171.37 3.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.808 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 133' ' ' TYR . 19.4 mt -140.78 159.46 42.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.523 -0.736 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -87.56 -173.54 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.86 -15.53 26.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.613 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.542 HG23 ' OE1' ' A' ' 132' ' ' GLN . 1.5 t -89.09 3.5 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.05 76.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 130' ' ' THR . 3.6 mp0 -86.11 174.76 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -1.175 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 35.5 p90 -95.02 120.43 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.68 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -69.85 135.42 49.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.396 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -49.31 149.35 2.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.245 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.21 0.28 59.66 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 35.7 p -93.99 -37.96 11.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -1.123 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -76.82 -8.2 56.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -71.95 160.32 32.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 153.3 179.69 28.98 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -61.11 -176.62 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.922 1.748 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.46 -36.78 0.98 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 145' ' ' ALA . 5.2 mt-30 -93.34 113.46 25.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -1.084 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 146' ' ' ILE . 19.5 mtmt -65.83 2.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.6 2.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.644 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' THR . 5.6 pt -100.66 6.35 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.35 94.81 8.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -98.3 164.3 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.811 . . . . 0.0 109.37 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -142.01 70.82 23.66 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.841 . . . . 0.0 109.52 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.81 107.84 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.929 1.753 . . . . 0.0 110.324 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 8.8 mtt -96.18 128.99 43.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.516 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.9 t -70.12 153.2 43.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.578 ' CB ' HH22 ' A' ' 31' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.14 171.45 2.27 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.21 1.273 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -145.15 126.93 15.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.04 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.5 mtt-85 -84.81 117.09 23.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.653 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 41' ' ' LEU . 18.7 mt -84.63 99.07 10.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.97 124.2 36.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 t -90.51 120.31 31.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.212 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -67.94 -14.87 63.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 8.3 m-20 -88.63 105.22 17.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.642 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.21 4.94 87.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.85 86.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.2 m-85 -144.77 138.26 27.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.302 -1.116 . . . . 0.0 109.65 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.48 121.63 38.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.0 109.423 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 32' ' ' LEU . 41.4 tp -49.36 150.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.203 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -156.61 119.51 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 mt -92.55 129.18 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.191 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.99 151.99 45.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.8 -26.75 75.12 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.27 1.313 . . . . 0.0 110.378 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -74.79 10.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -37.41 2.98 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.621 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.8 mtt-85 -47.17 154.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -1.187 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 83' ' ' LEU . 95.7 t -134.16 130.42 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -146.24 -149.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.42 150.44 22.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.16 144.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -77.64 -16.67 58.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -59.97 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.384 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.12 12.36 3.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.554 -179.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -108.92 10.91 26.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 109.597 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -95.05 123.48 57.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.18 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.13 4.92 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 120.636 0.891 . . . . 0.0 110.331 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 57' ' ' ASP . 24.1 m80 -82.53 -38.41 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.879 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -65.52 4.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.577 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 59' ' ' HIS . 14.5 mttt -87.24 84.08 7.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.37 134.28 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.83 108.23 19.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.371 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -144.2 144.51 31.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.412 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.27 126.36 36.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.948 . . . . 0.0 109.505 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -97.48 -30.21 13.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -153.67 -171.88 4.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -0.926 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -82.95 23.53 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.579 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.63 23.72 0.1 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.31 151.0 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.3 m -145.2 127.18 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -94.5 122.22 36.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.583 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 74' ' ' ILE . 8.3 mt -94.4 145.75 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -147.37 130.78 16.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.32 133.81 13.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 88.4 t -76.19 -65.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -1.15 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -61.64 -34.19 75.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.64 34.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 31.6 m120 50.97 50.82 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -148.11 148.53 30.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -89.95 134.89 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 49' ' ' VAL . 39.5 tp -65.09 147.75 52.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.65 170.3 17.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.7 ttm -139.11 129.05 25.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.529 -0.732 . . . . 0.0 109.409 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -75.07 178.71 5.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.39 -7.84 59.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.7 p30 -92.72 -46.29 7.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.33 -9.16 1.46 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -71.93 127.86 33.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.9 mp -91.68 139.16 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.662 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.08 -176.06 5.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.57 160.08 40.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.291 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 76.8 p -147.14 170.02 18.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -80.98 -36.86 30.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 p -91.23 126.17 36.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.7 p -72.98 116.31 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.51 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.7 p -93.64 -170.16 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.92 -10.85 59.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -93.78 12.55 25.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 59.2 m -95.68 8.93 42.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.627 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -97.74 148.65 23.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 63.2 m-85 -150.13 113.37 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -55.26 152.02 8.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 108.928 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -125.07 94.71 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -92.69 128.42 38.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.936 . . . . 0.0 109.4 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.29 137.99 32.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.664 ' OE2' HG23 ' A' ' 114' ' ' THR . 2.5 mp0 -92.67 -178.34 4.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -94.24 47.74 1.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -156.14 23.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 65.13 49.77 1.95 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.53 -0.731 . . . . 0.0 110.012 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' ' OE2' ' A' ' 108' ' ' GLU . 52.3 m-85 -140.63 129.87 23.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.6 OUTLIER -94.6 154.6 17.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.631 -179.826 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.664 HG23 ' OE2' ' A' ' 108' ' ' GLU . 23.3 p -131.38 119.32 21.51 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -93.32 107.74 19.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -101.53 148.12 25.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.294 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -72.57 157.11 38.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.965 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.96 -76.52 0.48 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -51.29 -10.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 118' ' ' ARG . 31.2 m-85 -142.89 63.78 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 p -63.32 3.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.775 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.7 m -89.86 11.68 19.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.606 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.14 145.36 22.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 109.839 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.2 m-85 -113.79 167.51 10.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.766 -0.584 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.49 129.37 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.32 149.38 26.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 19.7 mt -107.11 176.56 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.535 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.46 -166.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 109.28 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -17.29 23.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.366 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.1 1.96 55.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.423 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.25 12.21 56.46 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -93.52 142.63 27.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -1.192 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 24.5 p90 -69.09 120.67 15.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 127' ' ' LEU . 2.8 ttpm? -69.65 130.5 42.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.418 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.5 148.34 1.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.38 -31.68 81.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.418 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -77.46 -15.55 59.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -1.174 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -89.31 -4.96 57.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.0 p -87.33 156.68 19.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 167.34 179.94 40.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.93 166.52 10.29 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.866 1.711 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.32 1.9 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.25 106.46 6.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -66.42 -3.0 5.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.528 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.593 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -61.5 -6.27 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.408 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 146' ' ' ILE . 4.9 pt -93.75 -1.52 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.497 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.11 90.35 8.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -94.92 167.98 11.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.7 tp -144.49 73.87 15.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.446 -0.784 . . . . 0.0 109.251 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.97 115.16 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.75 1.633 . . . . 0.0 110.629 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.0 mtt -96.33 107.01 19.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -63.97 147.02 53.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.898 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.75 168.66 2.2 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 121.147 1.231 . . . . 0.0 110.168 179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -144.86 128.75 17.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.825 . . . . 0.0 109.376 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.35 118.82 25.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 20.7 mt -84.86 98.84 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 40' ' ' PHE . 37.3 t80 -94.98 122.13 37.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.685 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.24 131.48 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.184 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.57 -18.78 58.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.756 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 3.0 m120 -82.15 105.08 12.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 109.608 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.84 4.92 88.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 84.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.6 m-85 -143.17 134.95 26.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -1.112 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 22.8 m-85 -96.68 126.27 41.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 49.7 tp -51.22 149.3 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.35 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 17.7 ttt180 -158.26 116.02 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.0 mt -91.81 128.97 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.236 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -89.44 151.64 46.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 0.0 109.055 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.18 -24.02 64.72 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.113 1.208 . . . . 0.0 110.254 179.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -74.9 2.5 10.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.602 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.4 -32.25 5.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -47.36 162.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -1.114 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -143.6 128.33 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -155.99 -150.28 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.419 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.38 27.7 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.73 149.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -1.083 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -81.92 -15.72 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 99.87 3.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.379 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -80.61 12.26 3.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -92.26 -20.11 21.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.542 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.7 OUTLIER -60.02 115.01 11.23 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.256 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.94 3.45 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.633 0.889 . . . . 0.0 110.185 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.7 m80 -85.07 -12.33 53.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.4 9.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.9 mmmm -92.53 84.57 5.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.27 134.48 34.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.59 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -91.65 109.77 21.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.56 114.88 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -99.01 142.85 29.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.6 161.56 14.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -145.21 -102.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.31 -154.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -90.43 106.61 18.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.88 -9.19 73.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.82 133.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.1 129.03 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.382 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.1 m -93.65 123.76 37.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.87 141.47 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -146.13 146.65 30.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.69 14.84 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' LYS . 99.1 t -79.94 -46.25 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -1.163 . . . . 0.0 109.558 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -88.67 -43.37 11.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.23 66.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 51.31 49.16 21.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.3 mtt180 -147.99 147.5 29.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.32 135.26 34.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.3 tp -64.95 145.19 56.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.203 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.86 135.34 18.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.9 ttm -98.18 138.89 34.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.455 -0.778 . . . . 0.0 109.453 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HE2' HD21 ' A' ' 92' ' ' LEU . 10.4 mmtm -92.48 178.0 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 4.6 pm0 -80.54 -25.49 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.6 p30 -83.16 -1.56 53.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.475 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 93.69 2.26 65.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -78.36 115.18 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -90.63 132.24 35.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.549 HD21 ' HE2' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -146.55 -172.04 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.483 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.31 152.66 47.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -145.03 170.01 16.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -83.47 -23.49 32.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 63.5 m -93.12 151.85 19.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.64 113.8 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -93.18 177.02 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.46 -17.74 61.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 22.9 mp0 -93.17 16.67 12.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.3 m -92.94 -7.18 46.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 68.1 m-85 -93.01 153.41 18.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 74.1 m-85 -146.47 116.38 7.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -56.11 159.4 3.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -125.13 141.77 51.9 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 97.86 3.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.72 131.33 42.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.39 -170.87 2.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.842 . . . . 0.0 109.385 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.87 -4.65 52.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.465 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -94.48 26.42 3.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.44 -0.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.4 m-85 -93.7 137.21 33.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.84 165.81 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 109.757 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.8 p -143.92 119.38 10.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.434 -0.791 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.66 113.54 25.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.75 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -97.21 143.23 28.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 109.302 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -60.67 162.18 6.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 109.383 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 121' ' ' THR . 61.2 ttt180 -92.68 -62.88 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -48.1 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.1 m-85 -93.89 60.46 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 118' ' ' ARG . 80.4 p -56.96 -0.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.56 11.38 19.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.01 146.47 23.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.769 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.2 m-85 -109.31 169.82 8.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.656 -0.652 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.65 133.55 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.372 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.35 -175.69 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.09 165.82 26.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -94.24 177.72 5.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -92.88 -14.15 28.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.3 t -93.32 32.69 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.6 50.96 60.88 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -142.26 166.53 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -1.078 . . . . 0.0 109.513 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -90.62 120.25 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -69.88 132.48 46.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -53.34 134.45 39.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.0 109.352 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.57 -0.55 1.99 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -93.04 -29.65 15.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.586 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -89.73 -4.88 57.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.3 p -72.98 144.1 47.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.15 -179.96 45.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.05 169.92 5.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.883 1.722 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.25 -53.61 3.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.53 134.74 43.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -1.172 . . . . 0.0 109.523 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -83.44 7.67 16.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.437 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.1 -9.37 16.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.2 pt -90.14 -5.51 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.351 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' ' 144' ' ' LYS . 52.3 mt -87.1 90.03 8.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -94.78 164.55 12.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 149' ' ' LEU . 39.8 tp -141.82 70.98 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 109.17 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 106.35 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.953 1.769 . . . . 0.0 110.448 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.9 mtt -95.95 123.45 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.312 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.7 t -67.41 157.67 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.963 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 168.02 3.09 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.098 1.199 . . . . 0.0 110.247 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.9 mttt -141.96 139.0 32.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.362 -0.836 . . . . 0.0 109.249 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -89.91 122.26 32.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.1 mt -84.95 97.24 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.621 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -95.75 113.8 25.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.31 118.07 23.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 109.377 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.85 -16.5 63.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.494 HD21 ' CB ' ' A' ' 144' ' ' LYS . 14.2 m120 -86.31 104.13 15.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.01 4.84 89.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 83.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -142.82 132.57 23.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.358 -1.083 . . . . 0.0 109.533 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.79 114.96 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.6 tp -47.65 143.09 4.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 17.1 ttt180 -150.15 117.1 5.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 126.34 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.137 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -87.97 152.02 50.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.23 -22.77 58.79 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.126 1.217 . . . . 0.0 110.266 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -74.75 8.8 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.23 -36.18 3.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.4 mtt-85 -47.15 164.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -138.35 123.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -152.61 151.38 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.84 162.77 25.42 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -146.69 148.97 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -1.127 . . . . 0.0 109.549 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -82.18 10.26 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.425 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -93.71 94.84 8.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.714 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -75.33 -5.14 43.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 p -94.48 16.72 14.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -91.14 114.28 61.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.14 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.88 2.5 0.58 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.615 0.877 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 42.8 m80 -86.29 -11.38 52.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.47 -4.73 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 77' ' ' VAL . 20.8 mmtm -76.65 83.76 3.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.947 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.75 135.1 33.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.17 113.07 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -92.17 153.78 19.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.416 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -145.55 149.72 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.88 150.71 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.12 130.84 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.43 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 50.84 -107.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 6.7 ptm180 -154.91 129.79 9.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.77 29.12 73.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.95 96.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -1.16 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 72' ' ' VAL . 2.4 m -94.58 129.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -92.69 121.69 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -89.95 148.44 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -148.77 140.98 24.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.73 145.64 20.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 78' ' ' SER . 76.2 t -79.5 -86.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 109.488 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.464 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -47.36 -55.07 9.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -30.33 64.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 78' ' ' SER . 73.9 m-80 51.32 44.62 28.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 30.2 mtt180 -137.2 145.26 43.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.56 -0.713 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.17 136.21 33.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.416 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 55.2 tp -63.73 151.5 41.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.277 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.4 158.08 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.42 ' CE ' HD21 ' A' ' 91' ' ' LEU . 41.5 ttm -139.26 130.45 26.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HE3' HD21 ' A' ' 92' ' ' LEU . 3.1 mptp? -94.18 -171.22 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.44 -15.39 25.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.56 -5.51 59.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 94.36 7.78 60.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 91' ' ' LEU . 98.9 mtt180 -85.15 108.21 17.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.384 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.757 ' N ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -94.18 131.55 39.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.8 pp -150.07 173.14 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.567 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -105.03 159.62 15.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.702 . . . . 0.0 109.497 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -150.13 163.4 38.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.0 109.454 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -88.55 -34.18 17.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -93.66 130.71 39.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.7 p -81.93 103.5 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.42 ' C ' ' N ' ' A' ' 100' ' ' GLU . 69.7 p -96.0 165.2 12.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.43 -17.77 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.42 ' N ' ' C ' ' A' ' 98' ' ' THR . 2.5 mp0 -92.72 49.61 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -143.4 6.49 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -96.66 154.23 17.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 0.0 109.464 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 90.0 m-85 -150.02 115.68 5.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.95 152.27 7.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.201 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -125.13 89.86 3.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.626 . . . . 0.0 109.4 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -89.92 120.87 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.358 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 tp -91.6 119.92 31.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.311 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -84.92 -172.84 4.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 111' ' ' ASN . 13.0 p -92.78 -20.27 20.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.2 m120 -74.32 25.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.562 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.3 m120 60.65 -0.7 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.726 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 46.4 m-85 -98.71 133.45 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.1 m120 -93.14 170.14 9.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 p -141.25 113.26 7.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.429 -0.795 . . . . 0.0 109.277 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -89.96 105.98 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 121' ' ' THR . 13.7 ttt180 -96.17 151.04 19.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -76.13 155.62 34.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -91.24 -74.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.4 tptt -52.34 -9.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.656 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 17.5 m-85 -142.96 67.19 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.371 -0.83 . . . . 0.0 109.495 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.523 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 23.4 p -65.12 5.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 68.0 m -89.73 7.16 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.745 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.1 m-90 -154.62 167.59 29.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.76 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 12.7 m-85 -131.52 168.28 17.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.727 -0.608 . . . . 0.0 109.375 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.0 t -86.07 125.5 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 109.338 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.11 163.57 39.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.0 mt -119.56 161.69 20.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -79.27 -99.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.154 -0.966 . . . . 0.0 109.492 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.91 -36.7 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.735 HG23 ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -78.27 10.33 3.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 6.54 67.94 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.735 ' OE1' HG23 ' A' ' 130' ' ' THR . 1.9 mp0 -84.82 167.54 15.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.536 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.5 p90 -93.73 120.1 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.619 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -69.91 126.42 29.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -46.73 145.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -71.28 8.23 5.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -91.0 -34.65 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -90.0 -7.43 54.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 p -70.27 151.78 44.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 158.11 -179.31 33.9 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.95 169.99 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.848 1.699 . . . . 0.0 110.137 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.47 -49.63 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.605 ' N ' HE21 ' A' ' 143' ' ' GLN . 3.9 mm-40 -72.44 131.58 42.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.494 ' CB ' HD21 ' A' ' 36' ' ' ASN . 3.5 mtpt -85.02 3.68 37.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.44 -2.53 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 23.2 pt -97.29 -3.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.798 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.84 99.39 9.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 109.53 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.37 159.29 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.08 72.17 46.98 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.64 117.67 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.824 1.683 . . . . 0.0 110.538 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 15.1 mtt -96.54 127.19 42.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 0.0 109.263 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 t -70.09 161.82 29.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.961 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.7 171.73 1.87 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.177 1.251 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -138.54 130.88 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.217 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.6 mtm-85 -84.99 116.95 23.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 41' ' ' LEU . 25.0 mt -84.78 95.66 9.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -91.47 116.2 28.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 t -83.61 105.0 14.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 109.169 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -57.65 -23.61 52.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.601 -179.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 15.4 m-80 -78.15 104.95 9.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 77.79 4.73 85.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.54 86.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' CZ ' ' NH1' ' A' ' 53' ' ' ARG . 48.3 m-85 -144.26 135.46 25.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 109.285 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -92.34 137.27 32.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 32' ' ' LEU . 50.9 tp -75.4 143.42 42.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.734 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 30.9 ttm180 -146.48 122.52 10.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.04 107.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.447 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 61.1 m-70 -66.95 151.95 96.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.098 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.04 -29.57 74.74 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.118 1.212 . . . . 0.0 110.398 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.97 5.59 4.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.461 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 -26.27 5.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -51.53 115.99 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -1.145 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.63 127.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 7.2 p-10 -154.13 152.25 30.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.32 25.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 42' ' ' ARG . 33.8 m -149.1 152.49 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.607 ' NH1' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -76.13 -27.87 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.277 179.847 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -47.86 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -85.19 25.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.733 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 p -152.15 35.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.026 . . . . 0.0 109.991 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.41 140.02 25.41 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 108.911 179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.11 -4.68 4.07 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 121.1 1.2 . . . . 0.0 110.453 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 61' ' ' LYS . 69.4 m80 -94.49 -23.66 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.241 -179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 60' ' ' ILE . 1.3 pt -69.1 8.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 59' ' ' HIS . 3.2 mmmm -94.4 87.86 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 109.425 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.2 mt -93.84 135.08 35.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.24 109.53 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.84 151.06 19.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.27 150.4 36.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' OE1' ' A' ' 65' ' ' GLN . . . -94.31 150.76 19.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.78 -83.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.552 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.32 -147.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -92.29 127.03 37.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.412 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.55 33.99 68.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.57 101.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.69 -0.888 . . . . 0.0 109.372 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.1 m -103.09 126.03 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.686 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 m -89.84 122.99 33.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.93 148.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -146.15 139.99 26.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.9 133.6 11.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 26.1 t -77.79 -72.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.4 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -62.88 -39.97 96.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.61 63.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 18.5 m-80 50.95 50.82 18.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -147.44 147.97 30.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -91.54 127.93 37.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.58 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.64 149.82 20.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.366 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.32 170.25 18.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.404 ' CE ' HD11 ' A' ' 91' ' ' LEU . 23.9 ttm -138.29 131.37 30.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.0 109.433 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -85.86 -166.46 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -90.1 -33.88 16.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.56 -1.74 11.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.89 70.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.22 125.99 29.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -1.215 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 mp -92.13 135.83 33.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.675 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -149.42 -173.06 4.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.46 158.94 43.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.78 169.94 18.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -82.49 -27.98 31.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.8 m -92.87 160.13 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.516 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.1 t -92.83 156.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 72.1 p -147.35 160.06 42.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.59 -16.19 35.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -93.99 8.17 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.5 -4.57 50.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 109.79 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 93.5 m-85 -92.2 159.92 15.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 91.7 m-85 -150.94 119.13 6.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.32 147.57 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.974 -1.079 . . . . 0.0 109.334 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -125.33 97.77 5.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.674 -0.641 . . . . 0.0 109.318 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.72 128.42 41.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.568 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 112' ' ' TYR . 17.5 tp -94.67 121.51 36.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.77 -175.72 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -92.98 -25.06 18.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.635 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -74.17 18.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 109' ' ' SER . 2.5 m120 63.92 65.17 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.401 ' O ' HD12 ' A' ' 107' ' ' LEU . 40.5 m-85 -144.92 -168.87 3.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.133 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -146.64 113.34 6.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.755 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -94.62 111.71 23.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.264 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.51 109.01 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -100.27 150.88 22.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.75 166.89 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -95.3 -57.82 2.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.388 179.913 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -82.08 -49.29 10.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.1 m-85 -91.7 61.25 4.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -57.11 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 0.0 110.711 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 120' ' ' TYR . 45.6 m -89.02 11.02 19.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.78 -1.2 . . . . 0.0 109.619 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.4 m-90 -152.48 159.38 43.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 21.2 m-85 -123.06 169.83 10.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.716 -0.615 . . . . 0.0 109.413 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.55 133.27 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -150.13 178.09 9.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 109.673 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.0 157.68 46.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.646 -0.659 . . . . 0.0 109.383 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -93.94 -166.58 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.334 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -93.87 -10.08 35.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.5 t -90.1 -7.86 52.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.97 60.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -93.77 173.95 7.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -1.11 . . . . 0.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 38.4 p90 -92.6 120.35 32.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -70.01 136.4 50.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 137' ' ' SER . 13.8 tp -59.78 127.49 32.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -49.16 -10.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 135' ' ' LEU . 21.4 p -75.51 -36.55 60.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -1.211 . . . . 0.0 109.642 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -89.96 -5.19 56.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.675 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.5 p -83.7 138.73 33.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.9 179.5 48.65 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.96 165.62 11.83 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.874 1.716 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.34 -58.87 3.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 145' ' ' ALA . 26.2 mm-40 -70.75 120.83 16.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -1.191 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 19.1 mtmm -63.51 1.68 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.1 -4.66 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -99.86 4.75 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.9 mt -91.86 109.82 21.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -113.0 162.06 16.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.6 tp -140.2 70.69 34.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.73 111.37 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.93 1.753 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.1 mtt -94.37 99.88 12.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.325 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 t -56.75 133.41 54.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.977 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.07 172.04 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.197 1.265 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 64' ' ' LEU . 34.9 mttm -148.03 128.1 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.16 120.47 26.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.78 104.81 15.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.671 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -104.47 123.08 46.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.54 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.44 136.86 32.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -82.4 -25.77 33.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 36' ' ' ASN . 1.2 m-80 -74.95 105.07 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.704 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.38 4.93 89.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.45 87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.0 m-85 -143.81 136.44 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -1.067 . . . . 0.0 109.689 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -95.54 124.6 39.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.318 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.52 144.43 26.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.151 -0.968 . . . . 0.0 109.149 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 19.6 ttt180 -148.01 119.77 8.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.743 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -94.44 128.37 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.082 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -91.66 151.89 42.8 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.216 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.35 -27.79 77.11 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.178 1.252 . . . . 0.0 110.317 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -74.91 1.84 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.63 -31.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -50.2 118.5 3.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.463 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 148.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -169.57 -162.9 0.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.32 158.48 27.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.87 143.6 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -1.087 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -74.39 -1.39 20.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.66 92.55 8.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -85.17 56.42 3.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.2 p -155.49 13.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 110.096 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.6 m-20 -93.25 145.68 30.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.983 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.56 0.82 1.25 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.106 1.204 . . . . 0.0 110.338 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 57' ' ' ASP . 77.5 m80 -91.35 -29.21 17.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 110.187 -179.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -69.16 4.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.971 -1.08 . . . . 0.0 109.351 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 59' ' ' HIS . 10.7 mtpt -93.02 82.87 4.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -93.39 134.04 36.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.387 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -94.04 123.27 37.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.94 156.34 17.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -144.94 125.04 13.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.04 165.29 22.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.56 -98.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.391 -0.818 . . . . 0.0 109.206 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 2.3 mt-10 -84.67 -172.62 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.049 -1.032 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 10.9 mpt_? -72.96 107.74 5.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.9 68.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 68' ' ' GLU . 12.5 t -92.97 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.22 170.63 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.505 ' OG ' ' CD2' ' A' ' 102' ' ' PHE . 4.6 m -148.94 134.99 19.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 75' ' ' LYS . 82.1 mt -93.14 155.94 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.501 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.425 ' N ' HG22 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -149.36 139.8 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.62 127.33 9.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.94 -61.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.461 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -27.05 68.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.88 -23.98 21.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 51.66 51.2 17.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -148.08 145.96 28.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.516 ' CG ' HG22 ' A' ' 97' ' ' VAL . 86.8 m-85 -96.03 125.09 40.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -58.98 145.1 42.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.244 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.1 130.83 14.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 ttm -90.5 104.25 16.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.546 ' HG3' HD21 ' A' ' 92' ' ' LEU . 23.6 mmtt -62.91 166.46 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.527 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -78.51 -22.07 47.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -73.63 -5.85 43.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.95 -7.75 70.12 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -77.95 123.91 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.344 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.8 mp -89.77 124.26 34.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.209 -0.932 . . . . 0.0 109.128 179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -148.43 -170.33 3.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 109.611 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.16 161.13 39.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 p -146.49 153.19 40.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -59.11 -38.37 79.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.87 157.67 20.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' CG ' ' A' ' 82' ' ' TYR . 28.1 t -93.1 117.45 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.7 p -89.19 173.01 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.46 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -94.13 24.89 4.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.558 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 18.0 m -93.87 -8.81 39.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.583 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' OG ' ' A' ' 73' ' ' SER . 77.8 m-85 -93.99 158.56 15.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.593 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 86.7 m-85 -148.13 116.58 6.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.35 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -55.1 124.56 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -88.48 147.94 24.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -148.1 120.13 8.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.515 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.9 131.0 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -175.69 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -90.96 -4.48 56.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.466 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 112' ' ' TYR . 12.8 m-80 -93.48 27.89 2.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.501 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 63.64 -7.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.488 -0.758 . . . . 0.0 110.126 179.807 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.5 m-85 -84.14 -173.06 4.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.27 167.12 24.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -142.43 169.96 16.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.301 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -143.83 110.93 5.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.359 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -94.94 145.52 24.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -63.98 162.12 14.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 121' ' ' THR . 1.7 ttt-85 -92.36 -63.71 1.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.714 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -64.9 -47.8 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.731 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.5 m-85 -99.59 63.85 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.57 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -59.76 2.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.9 m -89.81 14.02 13.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.041 -1.037 . . . . 0.0 109.772 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.07 145.75 22.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.948 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -107.71 166.93 10.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.36 125.49 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.595 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.67 159.06 40.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.8 mt -108.1 179.39 4.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.658 -0.651 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -95.24 -112.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CB ' HH11 ' A' ' 129' ' ' ARG . 0.0 OUTLIER -147.38 -32.59 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 -179.889 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -79.31 3.6 17.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.492 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.64 56.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -94.12 167.5 11.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -86.64 120.36 27.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.669 ' NZ ' HE21 ' A' ' 143' ' ' GLN . 63.8 tttt -69.84 133.71 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -59.15 138.04 57.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.227 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -70.95 11.9 2.39 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.686 ' OG ' HD23 ' A' ' 135' ' ' LEU . 99.4 p -94.57 -37.78 11.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -1.15 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -88.78 -6.05 57.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.3 p -70.97 158.01 37.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.508 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 161.35 -179.47 36.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.89 159.5 29.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.883 1.722 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.43 -27.48 9.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.669 HE21 ' NZ ' ' A' ' 134' ' ' LYS . 38.2 mt-30 -84.82 128.28 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 144' ' ' LYS . 6.7 mtmp? -82.78 -3.75 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.419 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.595 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.16 -14.84 41.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pt -84.76 2.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 144' ' ' LYS . 73.7 mt -91.62 90.52 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.83 166.91 11.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.6 tp -141.93 70.42 24.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.722 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.01 105.75 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.791 1.661 . . . . 0.0 110.418 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.6 mtt -94.81 125.36 39.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.378 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 137.57 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.517 179.967 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.01 154.96 41.51 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.178 1.252 . . . . 0.0 110.243 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -124.67 122.61 37.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.95 118.62 24.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 41' ' ' LEU . 16.2 mt -84.82 102.89 13.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.586 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -95.82 123.45 39.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.322 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -91.88 117.56 29.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.4 -14.68 57.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.0 m-20 -83.4 105.02 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.32 4.86 65.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.92 75.65 0.21 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.41 133.0 51.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.698 -0.883 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.77 117.86 30.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 32' ' ' LEU . 36.6 tp -48.74 137.58 12.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.249 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 7.2 ttt180 -148.23 119.97 8.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.645 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.8 113.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.103 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -76.18 149.47 82.17 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.525 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.1 Cg_endo -58.52 -24.05 67.63 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.13 1.22 . . . . 0.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 18.6 p30 -74.9 2.22 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.39 -33.76 4.61 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.14 114.75 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.4 125.03 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 4.7 p-10 -155.37 -152.96 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -144.07 161.34 27.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.29 142.63 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 109.505 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -77.1 1.48 17.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.31 83.84 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 55.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 m -145.43 6.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 109.872 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 59' ' ' HIS . 28.2 m-20 -94.27 138.93 22.34 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.91 . . . . 0.0 109.12 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -1.36 1.76 Allowed 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 121.069 1.179 . . . . 0.0 110.373 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.513 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 78.1 m80 -83.37 -22.12 32.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 110.036 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -75.95 7.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -95.81 87.36 4.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.44 135.27 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.11 109.6 21.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 109.266 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.85 154.46 19.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -139.03 142.04 38.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.495 -0.753 . . . . 0.0 109.143 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.26 28.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.551 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 69' ' ' ARG . 1.1 tp10 -144.42 143.42 30.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 51.4 -90.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.405 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.0 ttm180 -147.82 -91.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.85 9.16 57.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.59 97.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -1.193 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.42 126.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -94.85 130.18 41.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.56 150.1 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.558 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -148.84 130.27 14.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.75 135.74 14.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.05 -80.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -1.103 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.7 t -47.66 -57.27 5.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.74 -25.81 63.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.9 m120 51.24 45.54 27.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -136.98 148.66 47.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.327 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -91.02 130.84 36.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.1 138.03 58.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.139 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.0 144.59 25.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.35 144.16 28.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.767 . . . . 0.0 109.357 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.9 174.18 11.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -78.69 -15.88 57.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.29 -42.51 9.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.517 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.13 -8.93 1.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' HD12 ' A' ' 91' ' ' LEU . 46.3 mtp180 -75.15 125.94 30.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -1.105 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.63 141.22 28.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.928 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.22 -171.31 3.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 179.922 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -135.91 114.79 12.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 p -98.2 170.09 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -38.4 14.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.448 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.34 159.73 15.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 t -93.02 149.11 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 p -147.1 172.46 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -47.88 -35.79 11.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 19.4 mt-10 -88.73 67.03 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 74.6 m -153.39 15.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 46.4 m-85 -124.6 158.4 33.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.706 -0.621 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 35.1 m-85 -144.74 122.9 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.398 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.59 109.48 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.458 ' OE2' ' CE1' ' A' ' 115' ' ' TYR . 37.4 tt0 -85.64 150.2 24.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -146.42 98.36 3.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.24 131.9 48.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.421 ' HB2' HD21 ' A' ' 110' ' ' ASN . 3.2 mm-40 -94.48 -166.82 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.4 m -94.64 -20.9 19.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.786 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.568 ' N ' HD22 ' A' ' 110' ' ' ASN . 0.0 OUTLIER -80.23 25.92 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 62.94 -7.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.463 -0.773 . . . . 0.0 110.466 179.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.556 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 42.7 m-85 -89.9 135.75 33.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.881 -1.137 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.616 HD22 ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -93.75 168.74 10.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.1 p -143.66 122.69 12.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.458 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 85.1 m-85 -94.19 114.94 27.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 19.0 ttt180 -98.19 142.57 29.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.416 ' C ' ' N ' ' A' ' 120' ' ' TYR . 34.7 ttt180 -94.99 -72.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -54.64 -9.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.7 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.8 m-85 -140.9 60.79 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 16.8 p -58.33 -1.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.726 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.88 10.3 24.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.53 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.08 142.49 19.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 109.737 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.9 m-85 -106.48 169.7 8.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.7 t -89.52 134.51 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.44 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.63 162.19 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.05 161.27 23.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.522 ' HZ2' ' HG3' ' A' ' 134' ' ' LYS . 33.0 mttp -85.85 -170.02 2.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -92.44 -29.71 16.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -73.75 1.62 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.48 66.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -86.69 168.65 13.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -1.158 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.2 p90 -92.21 120.2 32.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HG3' ' HZ2' ' A' ' 128' ' ' LYS . 48.1 tttt -69.94 135.76 49.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.54 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.54 160.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.202 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.83 16.81 55.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.54 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.9 p -115.07 -27.74 7.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.683 -0.892 . . . . 0.0 109.638 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -87.64 -4.98 58.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.694 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 p -70.71 166.69 20.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 154.26 179.58 29.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.93 166.35 10.57 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.85 1.7 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.81 -56.12 2.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.48 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.8 mt-30 -70.35 133.91 47.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 109.464 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.503 ' C ' HD21 ' A' ' 36' ' ' ASN . 15.3 mtpp -85.14 3.84 37.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.594 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.75 -4.24 1.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.2 pt -93.99 -4.36 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -0.845 . . . . 0.0 109.557 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.67 107.97 17.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.02 162.77 16.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.1 tp -140.29 71.18 33.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.96 105.09 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.901 1.734 . . . . 0.0 110.435 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.4 mtm -100.68 128.96 46.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.791 . . . . 0.0 109.408 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 t -70.22 120.75 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.999 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.54 171.64 1.31 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.233 1.289 . . . . 0.0 110.278 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.51 ' HD2' HD22 ' A' ' 64' ' ' LEU . 83.7 mttt -149.98 139.41 21.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.3 mtm-85 -92.98 114.47 27.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.5 mt -85.0 91.25 8.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -86.29 125.52 33.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.5 t -89.68 123.67 33.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -72.5 -14.55 61.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.608 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -86.2 104.99 16.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.797 -179.66 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.53 6.23 80.31 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.38 77.68 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -134.29 138.15 44.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.598 -0.942 . . . . 0.0 109.606 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -96.47 158.81 15.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 41' ' ' LEU . 17.9 tp -85.23 139.21 31.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -146.33 111.69 5.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.9 mt -89.85 133.89 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.194 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.524 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.8 m-70 -89.01 149.65 43.71 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 109.184 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.4 Cg_endo -59.94 -23.27 72.16 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.166 1.244 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -15.3 57.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.818 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 117.78 -37.12 3.39 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.5 mtt-85 -46.4 114.89 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -1.159 . . . . 0.0 109.79 -179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 47' ' ' GLY . 97.3 t -100.1 128.56 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.531 -0.731 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.524 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 3.1 p30 -155.69 -150.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -146.89 163.63 28.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.42 154.46 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -81.1 -14.35 57.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.95 87.6 4.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -81.99 17.84 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 109.421 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 p -100.58 3.32 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.86 133.71 28.65 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 109.164 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -4.16 4.21 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.84 1.026 . . . . 0.0 110.257 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -74.83 -10.95 59.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' LYS . 3.2 pt -89.26 -7.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.35 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -80.0 90.16 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.88 135.2 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.96 104.92 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -89.13 153.34 21.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.44 126.93 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.94 121.92 26.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.97 -29.37 14.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.492 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.03 -167.59 2.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -82.42 -0.79 47.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.92 28.92 1.27 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 t -145.49 145.12 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -1.101 . . . . 0.0 109.431 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.1 m -143.01 121.67 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -93.28 123.34 36.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.451 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.1 mt -91.44 147.46 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -145.8 132.53 19.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.85 137.65 17.6 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.78 -65.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.471 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 t -63.3 -49.8 72.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.918 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.06 -21.55 66.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 47.65 45.0 17.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.842 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 40.7 mtp180 -141.08 146.82 37.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.464 -0.773 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.84 136.8 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.03 149.23 45.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.24 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.64 129.26 13.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 ttm -96.41 130.85 43.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.88 -175.38 4.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -92.72 -23.47 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 p30 -82.78 -40.35 20.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 143.57 -7.92 2.02 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -75.57 120.64 21.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.555 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -92.42 136.34 33.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -147.01 -171.9 3.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.14 164.36 30.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.371 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 m -149.92 170.02 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -83.09 -46.16 13.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.8 116.03 28.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -52.1 165.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.6 p -147.1 -173.05 4.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.405 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -25.68 62.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.4 59.16 3.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.2 m -147.25 10.11 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.9 m-85 -94.93 152.18 18.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.1 m-85 -150.04 116.59 5.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -69.31 127.42 33.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.01 96.52 10.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HE ' HH22 ' A' ' 116' ' ' ARG . 0.0 OUTLIER -91.96 114.31 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.2 128.54 34.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -91.71 -177.44 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -92.62 45.06 1.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.9 m-20 -146.89 28.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.27 -0.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.897 . . . . 0.0 109.711 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.6 m-85 -96.61 130.98 43.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.373 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.56 168.71 11.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.4 p -145.8 119.6 9.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.12 106.31 18.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.751 HH22 ' HE ' ' A' ' 106' ' ' ARG . 33.5 ttm180 -93.87 146.5 23.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -72.21 151.73 42.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.9 ttt180 -91.29 -75.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 13.9 tttp -51.14 -9.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.863 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 118' ' ' ARG . 14.7 m-85 -143.08 64.06 1.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.7 p -62.11 1.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 15.4 m -89.97 11.33 20.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.493 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.04 140.54 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.943 . . . . 0.0 109.783 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.479 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 26.8 m-85 -106.37 165.4 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -91.41 119.88 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.697 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -150.56 147.17 27.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.56 178.36 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -95.53 -169.45 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -93.77 -13.87 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -92.9 8.37 39.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.427 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.33 3.65 84.35 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.85 173.14 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -1.128 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.0 p90 -92.82 120.32 33.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -69.95 131.49 44.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.395 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.599 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.34 133.16 12.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -58.97 -2.3 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.599 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.0 p -92.36 -57.43 2.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.193 . . . . 0.0 109.498 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 137' ' ' SER . 23.1 mtpp -61.05 -8.19 3.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -71.06 158.14 36.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.81 179.65 34.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.97 175.77 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.833 1.688 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.63 -56.14 5.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.86 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -1.151 . . . . 0.0 109.357 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.608 ' CB ' HD21 ' A' ' 36' ' ' ASN . 8.6 mtmp? -85.03 3.48 38.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.697 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.12 -10.47 31.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.588 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -5.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -83.94 87.98 7.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -92.94 167.75 11.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.5 70.63 32.12 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.446 -0.784 . . . . 0.0 109.391 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.38 99.6 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.852 1.701 . . . . 0.0 110.335 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.6 mtm -96.25 122.3 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.425 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.7 t -62.23 148.66 44.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.498 -179.951 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.02 157.65 24.2 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.264 1.309 . . . . 0.0 110.204 179.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.552 ' HE2' HD22 ' A' ' 64' ' ' LEU . 2.4 mtmt -135.8 131.97 36.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.679 . . . . 0.0 109.19 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -84.96 118.67 24.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.526 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 41' ' ' LEU . 23.9 mt -84.87 98.01 10.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 117.61 30.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.99 102.58 12.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.31 -27.97 50.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 14.8 m120 -76.95 103.2 6.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.21 4.73 89.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.97 85.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.2 m-85 -143.39 132.82 23.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.078 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -93.28 129.02 39.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD23 HD12 ' A' ' 32' ' ' LEU . 53.8 tp -60.53 142.25 55.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 109.245 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 48.5 ttt180 -146.85 115.62 6.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.65 115.5 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.284 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -75.42 151.74 85.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.007 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.05 -28.79 71.35 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 121.202 1.268 . . . . 0.0 110.468 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.56 4.06 10.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.87 -31.44 5.29 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -46.96 114.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -1.112 . . . . 0.0 109.519 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.23 129.53 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -155.61 149.89 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 155.39 22.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.54 152.92 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -82.51 -12.0 58.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.534 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.33 101.57 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.96 -5.01 59.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -20.19 22.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.536 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -51.95 112.3 3.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.57 3.72 0.45 Allowed 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 120.638 0.892 . . . . 0.0 110.129 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 41.9 m80 -86.92 -15.25 39.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -76.76 -2.37 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -82.48 86.02 6.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.02 135.28 33.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.45 108.48 19.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -94.08 149.14 21.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.707 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -141.62 134.54 28.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.371 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.76 131.68 38.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -97.13 -76.72 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -95.85 -121.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -94.03 -96.6 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.1 3.38 46.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.0 125.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -1.188 . . . . 0.0 109.424 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.76 169.59 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 109.452 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -142.88 128.42 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.7 149.74 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -147.12 117.93 7.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.56 130.1 11.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.88 -74.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -1.121 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.419 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 14.3 t -49.12 -55.31 12.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.38 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -26.82 67.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.392 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m120 51.34 50.31 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 93' ' ' ALA . 8.7 mtp180 -146.68 147.2 30.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.948 . . . . 0.0 109.598 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.18 130.98 36.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.15 140.94 58.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.01 139.65 21.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -97.45 131.46 44.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.47 -0.769 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -73.2 -174.19 1.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.78 -16.79 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.5 p30 -90.23 -38.86 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.04 -10.88 2.31 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -72.8 124.8 26.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.1 mp -93.32 137.74 32.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.556 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -149.74 -174.23 4.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 179.931 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' ' 81' ' ' ARG . . . -143.67 132.18 22.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.295 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -110.24 168.77 9.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -84.51 -1.13 55.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.14 136.77 52.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.723 -0.611 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.9 p -80.98 109.02 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 p -97.53 179.12 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.415 -0.803 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.13 -21.58 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -93.09 53.16 1.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 51.0 m -141.61 5.6 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.8 . . . . 0.0 109.529 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 77.3 m-85 -93.2 153.52 18.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.9 m-85 -149.03 115.1 5.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -61.62 107.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -86.54 94.1 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -94.98 124.1 38.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.43 133.23 35.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.613 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 110' ' ' ASN . 2.1 mt-10 -94.71 151.2 19.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.513 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 m -63.58 1.9 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.496 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 36.1 t-20 -93.38 25.77 3.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER 61.64 -3.63 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.887 179.98 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.1 m-85 -94.59 -174.87 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 112' ' ' TYR . 3.9 m-80 -147.64 164.83 32.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 p -143.82 120.63 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -93.8 105.43 17.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -93.25 139.16 30.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -70.27 147.93 49.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 120' ' ' TYR . 45.6 ttt180 -81.75 -73.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.0 tptt -51.64 -9.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 13.6 m-85 -139.12 68.6 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.713 . . . . 0.0 109.176 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.3 p -63.75 -16.36 60.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.4 m -89.92 18.85 5.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.983 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -148.47 123.54 10.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.848 . . . . 0.0 109.636 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 35.4 m-85 -100.7 164.48 11.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.18 139.64 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.02 -175.25 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -141.14 166.39 24.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -94.21 177.86 5.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -91.69 -7.52 49.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 109.315 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.81 -0.68 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.4 -0.54 65.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -90.42 166.3 13.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 109.369 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.532 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 21.6 p90 -85.42 120.08 26.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.35 123.0 20.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 135' ' ' LEU . 13.4 tp -47.92 160.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.178 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.02 -42.41 19.87 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -59.03 -17.58 26.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.689 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.31 -9.72 46.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.802 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.7 p -80.51 177.51 8.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -0.975 . . . . 0.0 109.565 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.8 178.69 22.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.77 165.41 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.864 1.709 . . . . 0.0 110.16 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.16 -37.6 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -66.52 121.82 16.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -1.142 . . . . 0.0 109.501 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 21.1 mtmt -80.97 -7.85 59.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.75 -6.46 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.3 pt -95.06 8.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.603 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.14 98.39 10.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.04 164.67 11.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.66 -0.65 . . . . 0.0 109.495 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -141.93 70.29 24.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.41 -0.806 . . . . 0.0 109.389 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.58 107.73 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.88 1.72 . . . . 0.0 110.478 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.1 mtt -98.41 117.14 32.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.501 -0.749 . . . . 0.0 109.38 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.3 t -69.95 142.65 52.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -70.19 1.12 5.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.479 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -48.43 92.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.917 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . 162.57 -164.62 35.8 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.63 -98.47 0.09 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -1.144 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' C ' HG23 ' A' ' 7' ' ' THR . 6.9 mt -145.43 142.37 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.485 HG23 ' C ' ' A' ' 6' ' ' ILE . 1.6 p 61.48 143.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.03 127.58 12.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.437 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 7.7 mt -90.11 -32.15 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.224 -0.923 . . . . 0.0 112.025 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.645 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.8 Cg_endo -68.98 98.54 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.689 0.926 . . . . 0.0 110.208 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -174.94 161.5 2.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.39 68.15 53.88 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.564 -0.71 . . . . 0.0 110.028 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.25 161.73 25.9 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.642 1.561 . . . . 0.0 110.217 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 48.43 73.26 0.22 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.62 -13.79 6.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.357 -0.839 . . . . 0.0 109.575 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 168.97 -85.62 0.09 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.17 36.72 80.5 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 p 47.51 86.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -1.165 . . . . 0.0 109.457 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.63 107.97 0.28 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.81 -35.07 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -1.172 . . . . 0.0 109.462 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -89.96 -47.18 0.39 Allowed Pre-proline 0 N--CA 1.488 1.43 0 O-C-N 121.284 -0.885 . . . . 0.0 110.746 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.3 Cg_endo -66.62 168.08 17.5 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 120.995 1.13 . . . . 0.0 109.795 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.71 135.17 67.64 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 121.639 1.559 . . . . 0.0 110.137 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' ND1' ' A' ' 25' ' ' HIS . . . 171.54 -5.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.429 ' ND1' ' O ' ' A' ' 24' ' ' GLY . 64.1 m-70 -146.68 8.83 1.01 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.299 -1.118 . . . . 0.0 109.647 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -95.6 29.64 2.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.22 -27.24 16.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -0.897 . . . . 0.0 109.51 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -114.8 152.62 46.57 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -55.74 170.58 0.92 Allowed 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.114 1.21 . . . . 0.0 110.109 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' HE3' HD22 ' A' ' 64' ' ' LEU . 6.4 mtmp? -142.78 132.42 23.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.803 . . . . 0.0 109.488 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 5.3 mtm-85 -84.83 122.52 29.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.378 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -84.64 98.94 10.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 0.0 109.485 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -97.85 117.15 31.53 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.775 . . . . 0.0 109.452 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 37.5 t -82.18 137.71 34.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.339 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -26.38 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 0.0 109.956 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.587 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.7 m-20 -74.43 105.01 5.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 0.0 109.801 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.53 5.85 88.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.73 83.48 0.03 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 46.3 m-85 -142.32 137.52 30.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.36 -1.083 . . . . 0.0 109.505 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 29.1 m-85 -94.46 145.96 24.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 109.556 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -80.26 145.3 32.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.255 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.417 HH11 ' CG ' ' A' ' 57' ' ' ASP . 2.9 ttt180 -148.4 122.29 9.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.499 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.5 mt -90.04 109.1 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.172 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -66.13 152.26 94.18 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.147 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.85 -28.88 79.12 Favored 'Trans proline' 0 C--N 1.323 -0.799 0 C-N-CA 121.203 1.269 . . . . 0.0 110.242 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.82 6.55 3.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.598 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.29 -31.97 3.68 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -47.65 120.99 3.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.296 -1.12 . . . . 0.0 109.461 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.533 HG21 ' CD1' ' A' ' 83' ' ' LEU . 62.5 t -91.34 129.77 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.311 -0.868 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -147.87 -159.62 1.05 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -148.57 151.61 23.77 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.8 151.69 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -1.124 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' ' N ' ' A' ' 55' ' ' LYS . 25.1 mtm180 -77.66 -31.39 52.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.211 -0.931 . . . . 0.0 109.404 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' OE2' ' OG ' ' A' ' 56' ' ' SER . 2.2 mm-40 -50.52 96.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -0.882 . . . . 0.0 109.555 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -76.38 -1.29 26.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.413 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.422 ' OG ' ' OE2' ' A' ' 54' ' ' GLU . 5.4 p -91.37 -20.2 22.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -44.47 107.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 0.0 109.462 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.55 5.54 0.33 Allowed 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 120.797 0.998 . . . . 0.0 110.54 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.479 ' H ' ' C ' ' A' ' 57' ' ' ASP . 46.1 m80 -93.39 -18.19 22.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.127 -0.983 . . . . 0.0 109.566 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -71.77 -3.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -74.82 84.62 2.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.6 mt -90.25 134.93 33.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -91.65 104.92 17.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.336 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.38 152.69 19.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.885 . . . . 0.0 109.68 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.13 149.16 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.39 149.39 22.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.568 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -149.03 143.04 25.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 52.95 -119.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.905 . . . . 0.0 109.377 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -147.45 113.24 5.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.74 -18.46 55.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 72' ' ' VAL . 69.0 t -92.51 157.71 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -1.163 . . . . 0.0 109.477 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 72' ' ' VAL . 19.7 m -146.42 131.17 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.905 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -92.42 118.29 30.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mt -91.24 144.42 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.316 -0.865 . . . . 0.0 109.399 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -145.56 144.77 30.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.46 137.52 13.64 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.6 t -79.98 -68.03 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -1.132 . . . . 0.0 109.457 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.4 t -66.62 -48.88 68.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.181 -0.949 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.91 -24.38 66.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 109.489 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.0 m120 51.38 46.43 26.49 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.915 . . . . 0.0 109.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -145.04 149.36 34.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 109.424 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -93.16 137.46 32.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.54 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.533 ' CD1' HG21 ' A' ' 49' ' ' VAL . 57.4 tp -65.14 143.84 57.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.267 -0.896 . . . . 0.0 109.29 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.22 18.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.591 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.6 ttm -95.22 150.47 20.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -92.64 -170.01 2.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.968 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.592 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 1.4 mp0 -93.46 -32.02 14.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -79.89 -37.63 34.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.213 -0.93 . . . . 0.0 109.581 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.486 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 142.55 -5.01 2.03 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -73.26 117.87 15.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -91.76 133.14 35.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.522 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.646 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.0 pp -149.96 172.95 14.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.598 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -114.87 164.84 13.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.618 -0.676 . . . . 0.0 109.414 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.6 m -150.02 169.74 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -84.01 -35.83 23.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.367 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 t -94.13 138.69 31.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.424 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.1 p -90.26 117.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.219 -0.926 . . . . 0.0 109.407 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.403 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 11.0 p -103.08 173.62 6.22 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -15.64 23.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.339 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -93.83 51.24 1.52 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.515 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 98' ' ' THR . 7.7 m -140.89 5.23 1.94 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.449 -0.782 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -93.12 160.46 14.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.0 109.54 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -150.0 114.85 5.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.425 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -65.41 118.83 9.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.37 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -93.4 98.18 11.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.873 . . . . 0.0 109.64 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.611 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.13 100.34 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -0.865 . . . . 0.0 109.337 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD12 HD21 ' A' ' 113' ' ' ASN . 4.4 tt -77.6 129.45 35.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -93.71 -171.34 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.325 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 t -91.34 2.96 56.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.484 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.9 m-80 -94.78 24.78 4.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.21 -2.35 0.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 109.975 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.6 m-85 -91.55 -175.79 4.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -0.964 . . . . 0.0 109.491 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.499 HD21 HD12 ' A' ' 107' ' ' LEU . 5.2 m120 -146.95 158.13 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.565 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.1 p -134.29 118.38 17.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.64 -0.662 . . . . 0.0 109.318 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -90.03 105.28 17.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.21 -0.931 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.472 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -92.91 142.61 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.885 . . . . 0.0 109.355 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 t -71.36 147.81 47.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.276 -0.89 . . . . 0.0 109.495 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -88.77 -66.67 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.1 tptp -49.1 -18.89 0.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.511 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.6 m-85 -144.31 77.69 1.55 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.458 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 82.3 p -66.01 5.96 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.517 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 3.9 m -89.52 5.38 45.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.918 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.526 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 5.3 m-90 -148.39 170.45 17.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.055 -1.028 . . . . 0.0 109.739 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 17.0 m-85 -137.09 162.67 32.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.501 -0.749 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 37.5 t -83.96 122.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.326 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.688 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -153.12 138.17 17.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -92.35 171.94 8.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.299 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -87.64 -115.23 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -143.18 7.07 1.56 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -0.873 . . . . 0.0 109.546 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.22 11.23 8.13 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.13 10.57 64.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -93.13 159.23 15.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.503 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.512 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 38.1 p90 -91.15 120.06 31.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 ttmt -69.88 132.28 45.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.638 ' O ' HG23 ' A' ' 139' ' ' THR . 13.5 tp -47.8 150.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.297 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -70.94 -10.43 68.16 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.557 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.1 p -91.03 -32.22 15.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.155 . . . . 0.0 109.52 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -81.16 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.579 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 135' ' ' LEU . 70.4 p -79.4 156.32 27.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.433 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 164.14 -179.75 38.84 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.91 171.48 3.7 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 121.894 1.729 . . . . 0.0 110.163 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.29 -50.54 3.61 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.07 134.28 40.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -1.153 . . . . 0.0 109.425 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' C ' ' ND2' ' A' ' 36' ' ' ASN . 14.1 mtmt -83.96 6.52 21.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.441 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.688 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.05 -6.46 8.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.598 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 113' ' ' ASN . 21.0 pt -90.45 -6.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 69.6 mt -85.16 97.51 9.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -98.86 159.65 14.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.6 tp -139.13 71.53 40.42 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.504 -0.748 . . . . 0.0 108.994 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HB2' ' HZ2' ' A' ' 30' ' ' LYS . 5.9 Cg_exo -61.83 116.45 3.45 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.877 1.718 . . . . 0.0 110.715 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.8 mtt -95.99 121.2 37.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 0.0 109.168 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 17.9 t -69.23 135.72 50.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.149 -0.969 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.92 57.15 4.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 109.479 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -74.5 -85.03 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 54.1 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.41 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.64 176.61 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.413 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.95 -99.76 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . 62.67 172.72 1.74 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' OE2' ' O ' ' A' ' 56' ' ' SER . 56.4 mm-40 -74.49 -46.87 36.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 0.0 109.452 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.18 172.38 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.803 . . . . 0.0 109.455 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -59.57 174.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' O ' ' A' ' 7' ' ' THR . 51.7 m 47.36 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -75.6 -47.15 4.16 Favored Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.223 -0.923 . . . . 0.0 110.682 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.7 Cg_endo -67.46 95.88 0.4 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.091 1.194 . . . . 0.0 110.075 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' LEU . . . -105.69 51.11 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.524 -0.735 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' ALA . 6.1 mt -38.43 102.81 0.25 Allowed Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 119.13 -0.462 . . . . 0.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -66.58 86.05 0.28 Allowed 'Trans proline' 0 C--N 1.326 -0.617 0 C-N-CA 120.769 0.979 . . . . 0.0 110.044 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 16' ' ' GLY . 3.5 mm-40 45.26 80.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.757 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' OD1' HD22 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -63.01 0.65 0.53 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.466 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 14' ' ' GLU . . . -81.34 -34.38 26.15 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.28 121.35 7.5 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.09 101.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.245 -1.15 . . . . 0.0 109.464 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.97 -52.72 0.02 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.17 -81.28 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -1.17 . . . . 0.0 109.522 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -146.89 62.91 7.89 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.467 -0.771 . . . . 0.0 109.936 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.58 113.57 2.01 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 121.735 1.624 . . . . 0.0 110.274 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.74 98.1 0.34 Allowed 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 120.76 0.973 . . . . 0.0 109.928 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 25' ' ' HIS . . . -174.35 48.11 0.14 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 96.6 m-70 -157.15 46.52 0.4 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -1.127 . . . . 0.0 109.359 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 90.9 m-85 -137.8 5.58 2.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 109.538 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.84 -36.2 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -0.946 . . . . 0.0 109.526 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.97 152.69 46.77 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.51 168.53 2.13 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 C-N-CA 121.134 1.223 . . . . 0.0 110.097 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.581 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.9 mtmt -138.9 139.84 38.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.506 -0.746 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.471 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -91.52 120.07 32.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 109.378 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 22.8 mt -84.63 101.98 12.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -95.56 115.83 27.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.544 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.89 111.31 17.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.354 -0.841 . . . . 0.0 109.213 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -59.09 -30.39 68.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.196 -0.94 . . . . 0.0 110.21 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.6 m-80 -78.64 105.23 9.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.975 . . . . 0.0 110.122 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 81.65 4.63 90.31 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 86.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.506 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.1 m-85 -142.66 134.5 26.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -1.11 . . . . 0.0 109.55 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -94.14 123.84 37.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.515 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 51.7 tp -57.79 141.83 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.321 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 25.4 ttt180 -147.28 117.93 7.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.5 mt -93.17 110.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.336 -0.852 . . . . 0.0 109.233 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -71.75 151.81 93.35 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.145 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.0 Cg_exo -57.04 -27.83 75.68 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.126 1.218 . . . . 0.0 110.238 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -74.95 0.45 15.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.34 -29.62 7.53 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.59 114.78 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -1.153 . . . . 0.0 109.429 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.56 129.95 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 109.439 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 2.9 p30 -166.46 151.01 7.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 0.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.99 159.0 24.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.2 m -146.17 148.63 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -1.17 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -76.82 -9.84 58.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -72.43 84.85 1.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.928 . . . . 0.0 109.477 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.47 2.51 3.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.491 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.429 ' O ' ' OE2' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -92.89 -20.37 20.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.4 OUTLIER -49.89 111.2 1.95 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.67 5.38 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.663 0.909 . . . . 0.0 110.245 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 47.3 m80 -94.24 -14.79 25.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.703 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -72.35 9.68 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.145 -0.972 . . . . 0.0 109.53 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 59' ' ' HIS . 2.9 mmmm -91.12 88.0 6.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 109.426 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.432 HD12 ' CD1' ' A' ' 32' ' ' LEU . 11.0 mt -90.08 134.99 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.461 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -95.03 110.23 22.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 0.0 109.479 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.581 HD22 ' HE2' ' A' ' 30' ' ' LYS . 10.2 mp -95.47 144.57 25.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.4 -0.813 . . . . 0.0 109.491 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.86 134.16 47.35 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -88.98 121.79 31.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.581 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -97.59 -85.33 0.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.6 mt-10 -94.86 149.57 21.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.883 . . . . 0.0 109.318 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.7 mtt-85 -57.58 84.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.387 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 140.82 -1.83 2.07 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.0 t -138.86 145.57 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -1.046 . . . . 0.0 109.414 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.7 m -138.9 133.83 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.479 -0.763 . . . . 0.0 109.536 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -94.61 127.07 40.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.452 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 mt -93.41 144.49 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.509 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -146.52 143.47 28.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.421 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -92.68 135.59 12.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.9 t -74.92 -83.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -1.141 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.9 t -48.88 -43.99 39.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.59 -26.88 65.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -0.853 . . . . 0.0 109.504 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 49.65 50.14 18.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.4 mtp180 -146.0 147.08 31.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.527 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -89.95 127.29 36.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 109.418 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 tp -56.9 144.85 31.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 109.33 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 92' ' ' LEU . . . -145.17 170.14 16.82 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.853 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.16 134.65 24.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 109.568 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.5 -169.61 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.183 -0.948 . . . . 0.0 109.512 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -91.75 -11.16 37.52 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.413 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -92.6 -42.54 9.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA3' ' H ' ' A' ' 136' ' ' GLY . . . 146.86 -9.97 1.38 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -66.98 127.56 33.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -1.167 . . . . 0.0 109.507 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.9 mp -93.47 134.51 35.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.7 pp -150.07 143.74 25.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.897 . . . . 0.0 109.314 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.96 158.47 15.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.48 -0.763 . . . . 0.0 109.433 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.71 161.85 38.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -73.98 -47.35 37.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.526 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 42.1 m -85.07 139.42 31.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.1 p -86.23 152.16 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 p -148.01 -163.65 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.155 -0.966 . . . . 0.0 109.489 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -55.39 -51.64 66.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' O ' ' A' ' 85' ' ' MET . 71.7 mt-10 -74.2 77.23 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 36.9 m -155.2 -33.58 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.441 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 38.2 m-85 -84.68 156.05 21.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 109.563 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 68.4 m-85 -145.08 122.85 11.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.17 119.82 8.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.689 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.1 146.42 24.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.065 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 118.94 9.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.368 -0.832 . . . . 0.0 109.677 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.8 tp -91.11 119.86 31.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.865 . . . . 0.0 109.251 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.92 -178.74 6.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.8 m -86.43 -12.14 49.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.236 -0.915 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.43 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 54.6 m-80 -89.48 16.94 6.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.476 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 1.0 OUTLIER 65.2 57.75 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.649 -0.657 . . . . 0.0 110.323 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 60.1 m-85 -145.49 123.42 12.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.605 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -89.96 124.48 34.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.736 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.8 p -97.74 168.8 10.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.752 . . . . 0.0 109.382 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -143.59 105.87 4.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.376 -0.828 . . . . 0.0 109.553 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.59 134.38 38.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -63.94 131.41 47.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.141 -0.974 . . . . 0.0 109.51 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 120' ' ' TYR . 40.7 ttp180 -69.22 -69.88 0.31 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.626 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.469 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 17.8 tttt -51.65 -10.02 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.571 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.483 ' C ' ' H ' ' A' ' 122' ' ' SER . 36.3 m-85 -147.01 69.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.599 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -65.9 4.96 0.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.1 m -95.08 9.38 39.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.352 -0.843 . . . . 0.0 109.587 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.21 139.15 17.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.156 -0.965 . . . . 0.0 109.7 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -100.2 156.43 17.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.7 t -81.98 128.99 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.208 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.04 149.27 26.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.764 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.6 mt -102.03 176.24 5.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.602 -0.686 . . . . 0.0 109.458 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -95.08 -167.42 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.464 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -11.2 30.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.295 -0.878 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 132' ' ' GLN . 1.6 t -91.47 0.12 57.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.47 -2.53 70.78 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.51 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.4 mp0 -84.97 176.41 8.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 32.6 p90 -92.8 120.4 33.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.63 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -71.02 136.09 48.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.1 tp -47.97 164.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.061 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -93.17 -1.7 66.76 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.0 p -97.33 -20.82 17.59 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.245 -1.15 . . . . 0.0 109.69 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -90.06 -4.91 57.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.761 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 p -79.51 155.23 28.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.093 -1.004 . . . . 0.0 109.527 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.63 178.71 42.92 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.4 Cg_endo -60.97 169.58 5.76 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.925 1.75 . . . . 0.0 110.274 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.54 -20.51 2.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' A' ' 145' ' ' ALA . 10.2 mt-30 -90.16 109.51 20.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -1.15 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 15.9 mtmt -65.05 2.37 0.77 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.35 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.714 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.06 -9.13 19.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.1 pt -94.54 5.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.482 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 144' ' ' LYS . 87.0 mt -94.67 85.67 4.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -94.9 169.64 9.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.227 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.73 70.43 30.56 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.41 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -62.89 104.13 0.37 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.848 1.699 . . . . 0.0 110.411 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.4 mtt -95.12 125.59 39.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.31 -0.869 . . . . 0.0 109.426 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.3 t -70.02 132.62 46.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.8 57.04 3.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.202 -0.936 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -63.11 -61.46 2.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.469 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.344 0.592 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.71 -102.31 0.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.532 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -92.96 74.25 4.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.533 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.09 -142.67 18.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -90.02 -101.92 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -1.116 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' C ' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -91.78 -166.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.515 HG23 ' C ' ' A' ' 6' ' ' ILE . 1.6 p 64.07 49.82 2.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.562 -0.711 . . . . 0.0 109.752 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -81.09 -3.17 51.06 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 108.974 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.4 tp -116.35 88.01 22.01 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.36 99.52 0.1 Allowed 'Trans proline' 0 C--N 1.32 -0.924 0 C-N-CA 121.084 1.189 . . . . 0.0 110.457 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.55 -168.78 2.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 149' ' ' LEU . 1.2 tp -142.27 68.64 21.83 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.396 -0.815 . . . . 0.0 109.901 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.2 89.07 0.25 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.772 1.648 . . . . 0.0 110.014 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 179.53 100.76 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.061 -1.025 . . . . 0.0 109.445 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -20.54 66.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 18' ' ' SER . . . 68.19 -77.87 0.23 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 18' ' ' SER . . . -61.38 79.14 0.02 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m -168.19 95.93 0.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -1.145 . . . . 0.0 109.426 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.77 -5.93 60.16 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.11 92.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -1.082 . . . . 0.0 109.742 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 45.49 68.05 3.68 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 0.0 109.879 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.63 113.78 2.27 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.777 1.651 . . . . 0.0 109.963 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 124.8 14.73 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.715 0.943 . . . . 0.0 109.991 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 147.02 -57.67 0.5 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.83 6.1 1.3 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.152 . . . . 0.0 109.413 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.479 ' CG ' ' HB2' ' A' ' 66' ' ' ALA . 78.1 m-85 -85.83 16.6 3.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 0.0 109.171 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.7 mmtt -92.16 35.6 0.99 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.847 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.81 148.72 28.54 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 108.841 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.95 165.3 8.66 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.118 1.212 . . . . 0.0 110.45 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -147.26 122.14 9.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.331 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -86.27 122.62 30.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.8 mt -84.85 101.08 12.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -91.95 124.34 35.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.286 -0.883 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.8 t -89.55 127.52 35.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.421 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -74.7 -19.56 60.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.327 -0.858 . . . . 0.0 109.669 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -85.21 105.16 15.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.208 -0.933 . . . . 0.0 109.73 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.69 5.14 90.15 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 84.46 0.02 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.5 m-85 -143.64 135.68 26.66 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -1.107 . . . . 0.0 109.518 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -96.48 129.43 43.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.385 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 43.5 tp -55.47 144.77 24.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.176 -0.953 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.471 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 17.0 ttt180 -149.08 114.63 5.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.946 . . . . 0.0 109.581 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.5 mt -89.85 114.27 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.269 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.508 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 66.8 m-70 -69.34 151.27 96.95 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 109.034 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.8 Cg_endo -57.27 -27.92 77.32 Favored 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 121.301 1.334 . . . . 0.0 110.764 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.96 -3.0 29.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.024 . . . . 0.0 109.742 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.69 -13.29 65.47 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -67.83 126.1 28.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.043 -1.269 . . . . 0.0 109.243 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.72 135.7 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 17.8 p-10 -153.93 -163.8 1.72 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.53 146.2 16.17 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.44 153.26 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.541 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 -94.21 2.3 55.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.376 -0.828 . . . . 0.0 109.275 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.81 86.61 4.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 109.482 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -61.68 -5.17 1.75 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.381 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 t -87.16 25.75 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.039 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.471 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.3 m-20 -112.71 95.97 35.19 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.26 0.7 0.63 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 120.864 1.043 . . . . 0.0 110.271 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.52 ' CD2' ' HG ' ' A' ' 78' ' ' SER . 45.3 m80 -78.48 -26.77 46.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.219 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -70.37 -1.75 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 109.281 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -75.66 88.33 2.75 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.336 -0.853 . . . . 0.0 109.255 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -89.77 135.43 33.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.573 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 16.0 tp60 -89.85 105.25 17.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.882 . . . . 0.0 109.464 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -94.32 128.23 40.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.301 -0.874 . . . . 0.0 109.504 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -114.21 147.08 39.51 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.479 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . . . -88.18 139.71 30.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -0.935 . . . . 0.0 109.65 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 68' ' ' GLU . 1.9 tm-20 -145.55 129.36 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.263 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . 2.1 tt0 52.16 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.962 . . . . 0.0 109.285 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -96.24 118.92 33.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.397 -0.815 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.37 19.0 31.46 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -147.84 146.94 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.185 -1.185 . . . . 0.0 109.546 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.62 137.34 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.367 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 m -93.68 116.38 28.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.375 -0.828 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.65 144.33 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 109.473 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -145.6 145.87 31.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.05 131.5 10.77 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.24 -85.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.44 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.52 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 22.8 t -50.18 -22.85 1.87 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.08 -26.64 19.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.0 109.421 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 51.19 52.21 15.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.181 -0.949 . . . . 0.0 109.602 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.62 HH21 ' HZ1' ' A' ' 95' ' ' LYS . 91.4 mtt180 -149.9 147.71 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.362 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -91.49 132.72 36.07 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.3 tp -63.36 147.77 50.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.226 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -150.03 132.83 15.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.176 -0.953 . . . . 0.0 109.661 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.409 ' O ' ' OE1' ' A' ' 100' ' ' GLU . 11.1 ttm -100.87 132.71 46.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.534 -0.729 . . . . 0.0 109.408 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 92' ' ' LEU . 11.1 mmtm -90.98 169.3 11.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.084 -1.01 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -74.55 -23.51 58.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.521 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.2 -3.97 48.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.209 -0.932 . . . . 0.0 109.446 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.85 -1.96 71.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -79.77 118.23 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -1.159 . . . . 0.0 109.334 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -91.39 134.84 34.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.488 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -145.71 -174.13 4.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 109.471 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.67 154.6 49.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.319 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 m -145.85 170.16 17.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.62 ' HZ1' HH21 ' A' ' 81' ' ' ARG . 0.8 OUTLIER -81.54 -35.0 30.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -0.941 . . . . 0.0 109.506 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.93 132.84 35.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.503 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -72.83 164.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -147.3 -173.1 4.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.0 -14.39 59.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 85' ' ' MET . 25.8 mt-10 -90.89 8.58 34.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.138 -0.976 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 75.7 m -92.54 -5.88 50.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 56.1 m-85 -94.32 153.2 18.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.481 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 85.0 m-85 -149.1 121.67 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.887 . . . . 0.0 109.354 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -55.66 114.39 1.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.323 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -92.45 95.1 9.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.944 . . . . 0.0 109.59 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 106' ' ' ARG . 0.3 OUTLIER -94.18 118.96 32.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 109.433 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 tt -93.39 123.4 36.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 110' ' ' ASN . 14.6 mt-10 -90.8 161.68 15.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.89 3.81 1.39 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -93.02 20.26 6.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m120 61.02 -1.68 0.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.0 109.77 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.0 m-85 -98.07 141.31 31.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.659 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -94.47 166.12 12.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.605 -179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 5.5 p -144.62 112.11 6.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.326 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.83 135.65 33.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.534 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 124' ' ' TYR . 3.2 ttm180 -127.13 145.75 50.63 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -68.85 146.03 53.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 0.0 109.708 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -88.53 -72.05 0.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.9 tttp -50.65 -10.69 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.508 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 20.4 m-85 -145.25 68.84 1.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.516 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 71.8 p -64.37 5.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.226 -0.921 . . . . 0.0 109.639 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.4 m -89.9 9.29 28.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.787 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.6 m-90 -150.3 141.16 22.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.022 -1.049 . . . . 0.0 109.933 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.561 ' CZ ' ' CZ ' ' A' ' 116' ' ' ARG . 71.4 m-85 -104.09 165.7 10.88 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.562 -0.711 . . . . 0.0 109.569 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 68.3 t -94.54 121.3 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -0.828 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.67 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.79 144.38 21.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.149 -0.969 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.7 mt -98.83 -175.93 3.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.462 -0.773 . . . . 0.0 109.478 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -93.78 -119.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.135 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -146.35 8.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.358 -0.839 . . . . 0.0 109.534 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.7 OUTLIER -125.39 6.46 7.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.57 -0.706 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.09 12.86 51.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HG2' HG23 ' A' ' 130' ' ' THR . 84.4 mm-40 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -1.108 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.4 p90 -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -70.95 142.62 51.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.572 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 6.1 tp -63.71 -153.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -109.12 -43.66 1.17 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 24.7 p -61.39 -22.51 65.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 109.725 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -89.8 -15.63 31.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.96 . . . . 0.0 109.59 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 135' ' ' LEU . 80.6 p -90.1 154.49 19.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.532 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 163.85 179.72 38.32 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.68 169.01 6.04 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.888 1.725 . . . . 0.0 110.187 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.03 -58.09 3.61 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 134.45 54.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -1.153 . . . . 0.0 109.441 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HB3' HD12 ' A' ' 147' ' ' LEU . 31.5 mtmt -83.6 5.77 23.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.316 -0.865 . . . . 0.0 109.461 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.67 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.13 -7.13 11.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.575 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.14 -6.73 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.474 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 144' ' ' LYS . 63.1 mt -80.1 85.16 5.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.407 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -89.87 169.24 11.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.491 HD11 HD11 ' A' ' 12' ' ' LEU . 21.6 tp -142.32 70.08 22.01 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.405 -0.809 . . . . 0.0 109.418 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.98 103.5 0.29 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.844 1.696 . . . . 0.0 110.356 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.3 mtt -97.73 119.12 35.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.482 -0.761 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.7 t -70.0 119.09 13.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.84 55.3 3.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.384 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -56.38 -87.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.494 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.41 148.13 4.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.243 -0.911 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -77.87 104.9 8.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' GLU . . . -92.93 -44.96 3.73 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -54.08 -172.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.188 -1.184 . . . . 0.0 109.54 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 57.0 mt -82.79 119.35 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.91 . . . . 0.0 109.523 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.1 p -49.47 100.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.457 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 m -144.82 61.59 1.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.407 -0.808 . . . . 0.0 109.208 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.477 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.1 mt -56.09 -49.36 93.59 Favored Pre-proline 0 C--N 1.305 -1.353 0 O-C-N 121.196 -0.94 . . . . 0.0 110.744 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.3 Cg_endo -65.25 -173.0 0.25 Allowed 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 120.887 1.058 . . . . 0.0 110.062 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' ' SD ' ' A' ' 151' ' ' MET . . . -173.44 113.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tp -165.04 67.82 1.27 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.885 . . . . 0.0 109.725 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.51 154.86 66.08 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.732 1.621 . . . . 0.0 110.126 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 48.72 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.522 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -63.69 -26.68 68.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.352 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.71 82.34 0.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -55.84 106.6 0.64 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.9 p -170.89 68.88 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.413 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.625 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . 148.73 -44.29 0.76 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 71.59 -13.2 0.57 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.32 -1.106 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' H ' ' C ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -157.47 66.66 3.76 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.19 114.27 2.58 Favored 'Trans proline' 0 CA--C 1.549 1.244 0 C-N-CA 121.837 1.691 . . . . 0.0 110.11 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.53 176.69 2.05 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 120.734 0.956 . . . . 0.0 110.154 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 47.11 50.56 15.93 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 25' ' ' HIS . 18.8 t60 -130.38 -9.17 4.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.648 -0.913 . . . . 0.0 109.479 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CE1' ' HB2' ' A' ' 66' ' ' ALA . 55.9 m-85 -78.22 34.6 0.2 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 109.422 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 25' ' ' HIS . 15.2 tttm -66.02 0.33 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.871 . . . . 0.0 109.523 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 26' ' ' PHE . 7.1 m-20 -149.61 152.2 34.55 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.9 . . . . 0.0 109.051 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.46 177.62 0.21 Allowed 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 121.267 1.312 . . . . 0.0 110.25 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HZ2' ' HB2' ' A' ' 152' ' ' SER . 43.0 mttm -146.25 138.44 25.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.373 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.2 mtt-85 -92.66 120.97 33.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 0.0 109.321 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.82 102.01 12.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -93.5 118.95 31.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 109.5 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -85.98 101.4 12.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -51.78 -34.51 40.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.691 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 5.1 m-80 -73.73 105.18 4.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.994 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.03 4.31 89.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.65 85.48 0.01 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.9 m-85 -142.72 133.77 25.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -1.103 . . . . 0.0 109.496 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -95.39 123.68 39.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.404 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.3 tp -54.29 146.21 15.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 109.276 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 24.5 ttt180 -149.25 117.51 6.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.8 mt -92.87 130.94 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.172 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -91.71 151.4 42.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.946 . . . . 0.0 109.163 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.491 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.47 -27.46 82.08 Favored 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 121.304 1.336 . . . . 0.0 110.419 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -74.83 12.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 109.702 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -41.11 3.02 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -47.32 153.75 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.284 -1.127 . . . . 0.0 109.37 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.3 t -138.11 141.93 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.553 -0.717 . . . . 0.0 109.341 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 3.9 p-10 -153.85 -150.02 0.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.349 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.43 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -146.2 148.08 19.52 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.56 149.57 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.296 -1.12 . . . . 0.0 109.466 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' ' 53' ' ' ARG . 20.5 mtm-85 -90.25 -15.79 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -54.27 103.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.43 44.42 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -144.19 20.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.265 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.4 m-20 -105.77 104.97 51.39 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.665 -0.647 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -61.74 2.66 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.786 0.991 . . . . 0.0 110.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.487 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.3 m80 -82.63 -5.75 58.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.257 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pt -90.23 -5.18 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -76.64 86.53 3.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -91.12 134.92 34.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.195 -0.94 . . . . 0.0 109.459 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.84 114.08 26.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.36 -0.838 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.4 mp -93.2 113.14 25.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.0 143.07 26.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . . . -93.92 120.93 34.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -95.0 -42.43 8.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.365 -0.834 . . . . 0.0 109.276 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 70' ' ' GLY . 5.2 mt-10 -151.77 158.78 43.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.466 -0.772 . . . . 0.0 109.296 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 -60.75 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.394 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . 141.93 -2.82 1.93 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.35 142.43 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -1.122 . . . . 0.0 109.596 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.91 130.7 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.521 -0.737 . . . . 0.0 109.239 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -91.51 131.13 37.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.4 mt -89.95 142.5 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -146.96 121.77 9.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.342 -0.849 . . . . 0.0 109.573 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.3 139.56 27.01 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 78' ' ' SER . 79.2 t -75.06 -87.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.547 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 77' ' ' VAL . 13.1 t -47.18 -33.33 5.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.44 -29.64 47.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 50.8 53.98 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.491 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 5.3 mtt180 -146.88 148.79 32.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.441 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -91.5 132.07 36.51 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.618 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 tp -64.39 142.62 58.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.298 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.06 148.81 29.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.615 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.9 ttp -106.7 143.89 34.15 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.609 -0.682 . . . . 0.0 109.421 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.568 ' HZ3' HH21 ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.15 148.9 25.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.873 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.34 -19.06 7.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.401 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.5 p30 -87.65 -44.65 11.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.81 -9.59 1.37 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.568 HH21 ' HZ3' ' A' ' 86' ' ' LYS . 0.5 OUTLIER -71.65 128.65 36.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -1.148 . . . . 0.0 109.449 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -95.06 135.34 36.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.535 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -149.43 -173.72 4.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.03 151.28 42.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.455 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.9 t -146.97 155.84 42.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.0 109.408 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -71.32 -19.09 62.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.44 139.92 30.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 97' ' ' VAL . 4.5 t -86.25 107.81 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.426 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 66.9 p -94.68 156.09 16.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -52.37 -23.92 6.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -93.93 53.09 1.74 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 97.0 m -134.24 -2.18 2.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.59 -0.694 . . . . 0.0 109.47 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 87.4 m-85 -95.44 153.98 17.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.34 -0.85 . . . . 0.0 109.438 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 71.2 m-85 -146.04 121.13 10.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -67.01 93.92 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.197 -0.939 . . . . 0.0 109.318 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' OE2' ' CZ ' ' A' ' 115' ' ' TYR . 31.4 tt0 -78.15 93.19 4.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.502 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -93.47 137.85 32.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.491 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 tp -88.85 140.46 29.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.361 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -91.84 -171.72 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 111' ' ' ASN . 43.1 t -93.78 -33.28 13.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.593 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -74.27 20.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.142 -0.973 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 109' ' ' SER . 1.5 m-20 65.24 56.05 1.04 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.558 -0.714 . . . . 0.0 109.916 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -142.42 137.31 30.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.393 -0.817 . . . . 0.0 109.286 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -89.91 153.99 20.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.711 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 146' ' ' ILE . 12.5 p -137.18 114.92 11.28 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 109.239 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.423 ' CZ ' ' OE2' ' A' ' 105' ' ' GLU . 98.5 m-85 -89.93 104.5 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.506 ' NH2' ' O ' ' A' ' 121' ' ' THR . 23.8 ttt180 -93.92 134.37 36.37 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.205 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.9 t -60.95 153.36 25.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 120' ' ' TYR . 56.3 ttt180 -90.83 -77.51 0.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.627 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -51.13 -9.86 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 122' ' ' SER . 32.3 m-85 -138.85 59.33 1.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.395 -0.816 . . . . 0.0 109.212 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.506 ' O ' ' NH2' ' A' ' 116' ' ' ARG . 26.5 p -59.55 -0.13 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.737 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.6 m -90.04 10.07 25.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.505 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 3.3 m-90 -155.13 144.01 20.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.849 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 28.0 m-85 -104.85 167.21 9.86 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.658 -0.652 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.0 128.32 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -0.868 . . . . 0.0 109.251 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.57 145.64 24.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.173 -0.955 . . . . 0.0 109.632 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.8 mt -97.28 178.86 5.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.825 . . . . 0.0 109.447 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -96.23 -167.9 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 109.401 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -93.24 -13.47 28.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.369 -0.832 . . . . 0.0 109.42 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -93.46 2.32 56.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.413 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.41 0.32 67.52 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -85.06 172.26 11.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -1.144 . . . . 0.0 109.512 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 37.8 p90 -92.63 120.22 32.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.422 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -71.99 131.59 43.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.496 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.3 tp -47.98 155.04 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.309 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.84 -1.45 58.98 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.496 ' OG ' HD23 ' A' ' 135' ' ' LEU . 60.1 p -92.79 -58.25 2.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.553 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -55.15 -7.62 0.22 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.237 -0.914 . . . . 0.0 109.533 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 137' ' ' SER . 11.4 p -85.57 155.44 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.133 -0.979 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.22 179.81 39.3 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.98 170.79 4.37 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 121.905 1.736 . . . . 0.0 110.162 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.01 -51.18 4.54 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -68.75 135.05 50.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -1.106 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.5 mtpp -84.81 1.61 46.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.919 . . . . 0.0 109.565 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.728 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.64 -3.58 0.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.881 . . . . 0.0 109.693 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 114' ' ' THR . 20.3 pt -98.13 2.61 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 109.681 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 144' ' ' LYS . 79.3 mt -90.48 110.23 21.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.684 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -117.23 168.28 10.45 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.51 70.17 17.5 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.434 -0.791 . . . . 0.0 109.318 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.33 105.98 0.45 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.794 1.662 . . . . 0.0 110.387 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 11' ' ' ALA . 9.7 mtt -97.59 118.61 34.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.45 -0.781 . . . . 0.0 109.397 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.405 ' HB2' ' HZ2' ' A' ' 30' ' ' LYS . 46.5 t -62.19 145.81 52.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.446 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -90.78 58.63 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.868 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -86.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.49 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.58 -79.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 11.9 mp0 48.8 35.24 6.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.67 168.12 27.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.29 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -1.148 . . . . 0.0 109.439 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -85.01 137.11 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -88.22 59.6 5.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.3 m -146.7 60.9 1.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.45 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -59.48 -47.71 97.32 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.264 -0.898 . . . . 0.0 110.794 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.1 Cg_endo -66.52 113.18 2.61 Favored 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 120.988 1.126 . . . . 0.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.7 149.65 2.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -0.888 . . . . 0.0 109.432 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.6 67.52 51.7 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.455 -0.778 . . . . 0.0 110.163 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.81 112.36 1.62 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 121.653 1.568 . . . . 0.0 110.213 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 49.26 88.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.381 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -66.59 -31.75 72.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 47.24 -122.88 7.59 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 63.7 -146.27 50.28 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 m 61.37 56.14 2.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -1.144 . . . . 0.0 109.525 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.14 -85.47 0.16 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.93 -106.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -1.114 . . . . 0.0 109.457 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -174.01 70.44 0.33 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.0 109.439 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -65.22 168.0 15.15 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.716 1.611 . . . . 0.0 109.85 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.92 -170.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.668 1.579 . . . . 0.0 110.189 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.17 77.42 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -147.76 14.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -1.083 . . . . 0.0 109.338 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -128.67 31.08 5.03 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -93.05 18.28 9.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -150.1 151.98 32.93 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.098 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.2 165.96 6.45 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.229 1.286 . . . . 0.0 110.364 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.5 ' HD2' HD22 ' A' ' 64' ' ' LEU . 57.8 mttt -146.36 127.02 14.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.0 109.198 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -84.96 124.52 31.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.919 . . . . 0.0 109.538 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 41' ' ' LEU . 23.3 mt -84.8 98.25 10.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.364 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -92.76 119.66 32.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.55 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -86.89 112.23 21.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.271 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -63.34 -17.36 62.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.64 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.8 m-80 -88.03 104.92 17.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.91 4.79 89.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.12 84.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 47.1 m-85 -142.98 130.94 21.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 0.0 109.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -94.13 120.65 34.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.39 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 32' ' ' LEU . 49.1 tp -50.83 144.41 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.259 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.474 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 33.2 ttt180 -147.78 120.58 8.68 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -0.99 . . . . 0.0 109.802 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 49' ' ' VAL . 76.0 mt -95.73 130.82 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.795 . . . . 0.0 109.11 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -91.29 150.89 42.24 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.49 -25.63 74.76 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.244 1.296 . . . . 0.0 110.312 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.1 p30 -74.92 7.56 3.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.7 -41.83 2.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.8 mmm180 -47.28 157.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.488 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 43' ' ' ILE . 84.2 t -138.77 134.17 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.457 -0.777 . . . . 0.0 109.4 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -146.09 -150.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.24 149.92 22.11 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -145.79 145.99 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -1.118 . . . . 0.0 109.322 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -80.4 -6.46 58.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.49 108.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.486 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.05 21.83 1.55 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.587 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.36 -20.24 3.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.642 . . . . 0.0 109.692 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -44.75 108.19 0.71 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.423 -0.798 . . . . 0.0 109.62 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.09 5.26 0.41 Allowed 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 110.152 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.482 ' H ' ' C ' ' A' ' 57' ' ' ASP . 50.0 m80 -93.71 -3.14 52.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.608 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -90.68 -1.48 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.196 -0.94 . . . . 0.0 109.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 14.7 mmtt -78.14 86.25 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -91.93 130.85 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.82 111.4 22.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -90.25 153.58 20.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.902 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -144.9 130.96 19.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 109.338 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.48 123.77 28.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.572 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -97.15 -95.82 0.21 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.406 -0.809 . . . . 0.0 109.47 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -89.48 -173.9 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.413 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 112.4 13.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.467 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.43 24.65 20.89 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.3 t -145.92 142.54 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -1.132 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' VAL . 31.3 m -140.63 125.79 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.523 -0.735 . . . . 0.0 109.519 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -93.51 128.26 39.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.54 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 mt -93.78 149.62 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 14.6 tttp -146.51 134.34 21.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.528 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.23 136.25 18.25 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.49 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 60.1 t -77.98 -57.01 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -1.154 . . . . 0.0 109.505 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -17.82 48.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.957 . . . . 0.0 109.512 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.43 -23.55 19.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.468 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 2.2 m120 51.13 49.64 20.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.423 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -146.43 148.52 32.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.551 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 75.1 m-85 -91.63 132.81 36.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.545 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.2 tp -65.02 139.55 58.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.858 . . . . 0.0 109.25 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.46 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.74 134.92 18.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.579 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -95.12 126.38 40.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.66 -175.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.14 -16.41 26.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.411 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 p-10 -90.2 -40.21 12.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.55 -9.26 1.41 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.613 ' CG ' HH11 ' A' ' 90' ' ' ARG . 1.8 mtt-85 -73.55 123.62 24.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -1.165 . . . . 0.0 109.465 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.579 HD11 ' SD ' ' A' ' 85' ' ' MET . 9.8 mp -92.56 132.95 36.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.506 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.588 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.3 pp -148.7 -172.67 4.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.611 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.1 158.07 44.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.428 -0.795 . . . . 0.0 109.291 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 170.04 17.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.537 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 mttp -84.6 -37.31 21.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 21.2 m -85.01 149.64 25.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 98' ' ' THR . 54.8 t -77.21 162.21 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.385 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.531 ' N ' HG12 ' A' ' 97' ' ' VAL . 71.6 p -147.27 177.81 8.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -76.14 -26.34 56.21 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 27.0 mp0 -92.87 19.64 7.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.156 -0.965 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 2.1 m -93.98 -11.8 30.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 109.609 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 66.2 m-85 -93.17 159.55 15.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 109.535 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 76.0 m-85 -148.78 116.18 6.18 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -54.89 142.35 29.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -125.15 141.64 51.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.714 -0.616 . . . . 0.0 109.492 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -146.96 142.02 27.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.97 137.35 35.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.31 -175.92 3.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -0.839 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.2 p -94.67 38.28 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 59.1 m-80 -146.86 31.14 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.2 -0.937 . . . . 0.0 109.57 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 m120 60.99 -1.73 0.23 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 40.6 m-85 -95.12 126.83 40.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.383 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.468 HD22 ' H ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -93.67 168.83 10.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.769 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -137.64 161.47 36.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.531 -0.731 . . . . 0.0 109.297 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -137.8 109.87 7.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 0.0 109.483 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.72 149.17 22.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.457 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -75.52 162.79 28.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.528 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.7 ttt-85 -93.5 -77.95 0.44 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.283 -0.885 . . . . 0.0 109.303 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.2 tptt -51.24 -9.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.927 . . . . 0.0 109.547 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.7 m-85 -141.97 59.68 1.47 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.435 -0.791 . . . . 0.0 109.374 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p -62.07 0.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.336 -0.853 . . . . 0.0 109.526 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 12.3 m -90.17 15.0 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.522 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 11.1 m-90 -155.14 143.56 20.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.094 -1.004 . . . . 0.0 109.713 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.0 m-85 -107.54 158.76 16.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.639 -0.663 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 t -84.77 131.16 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.303 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.62 -175.75 4.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.657 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.6 mt -140.55 161.52 37.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.466 -0.772 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.21 173.74 8.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -92.8 19.15 7.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.23 -0.919 . . . . 0.0 109.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.12 16.63 8.45 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.74 -0.6 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.47 42.87 47.06 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -134.68 154.8 51.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.944 . . . . 0.0 109.323 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -80.87 120.17 24.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.955 . . . . 0.0 109.485 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.76 127.67 33.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.466 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.678 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.8 tp -50.35 142.57 10.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.302 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.522 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.75 14.55 2.58 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.678 ' OG ' HD23 ' A' ' 135' ' ' LEU . 84.7 p -102.61 -38.65 7.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.508 -0.995 . . . . 0.0 109.544 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -90.11 -8.65 50.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 109.623 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 135' ' ' LEU . 41.0 p -69.91 145.21 52.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 109.495 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.11 -179.76 42.76 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.8 Cg_endo -61.07 -174.71 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 121.924 1.749 . . . . 0.0 110.164 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.27 -35.23 0.94 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.45 ' H ' ' C ' ' A' ' 141' ' ' PRO . 18.2 mm-40 -93.14 134.52 35.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -1.131 . . . . 0.0 109.527 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 39.4 mtmt -78.51 -0.49 29.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.707 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.19 -7.05 1.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.538 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.2 pt -95.32 1.96 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.345 -0.847 . . . . 0.0 109.652 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.2 mt -90.99 110.06 21.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -116.79 165.36 13.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.641 -0.662 . . . . 0.0 109.444 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.1 tp -144.4 70.75 15.9 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 109.21 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -62.23 112.78 1.65 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.89 1.727 . . . . 0.0 110.617 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 35.3 mtt -96.72 129.69 44.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.342 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.4 t -70.11 128.71 37.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.423 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.38 53.76 2.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.138 -0.976 . . . . 0.0 109.538 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -93.18 -66.73 0.9 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.498 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.372 0.606 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.03 -91.71 0.13 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 53.98 34.45 19.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.2 130.97 1.4 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.64 178.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -1.136 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -70.77 73.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.288 -0.883 . . . . 0.0 109.501 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 ' OG1' HD12 ' A' ' 9' ' ' LEU . 76.4 p -88.95 156.2 19.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' LEU . 27.0 p -75.51 -3.7 35.58 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.334 -0.854 . . . . 0.0 109.567 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' THR . 6.0 mp 58.23 158.23 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.13 115.13 2.25 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.124 1.216 . . . . 0.0 110.138 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -147.14 -166.92 2.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 109.491 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tt -140.6 69.41 31.47 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.58 -0.7 . . . . 0.0 109.422 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -64.23 -165.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.793 1.662 . . . . 0.0 110.317 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' GLY . 3.5 mt-10 -76.89 53.86 0.96 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.428 -0.795 . . . . 0.0 109.52 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 25.27 0.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.458 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' GLU . . . -47.95 125.91 12.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.31 70.58 0.33 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.5 p -93.2 59.79 3.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 0.0 109.434 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.12 -86.36 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -153.27 35.28 0.46 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.487 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.496 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 3.2 p90 39.2 67.43 2.41 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.807 -0.558 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.8 168.39 10.36 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.597 1.531 . . . . 0.0 109.872 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.16 111.67 0.88 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.696 1.598 . . . . 0.0 110.206 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -171.38 4.9 0.04 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -146.59 9.36 1.04 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -1.107 . . . . 0.0 109.456 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.71 11.21 32.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 9.51 8.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.544 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -149.94 149.77 28.46 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 108.806 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.11 176.13 0.27 Allowed 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 120.99 1.127 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.6 ' HD2' HD22 ' A' ' 64' ' ' LEU . 47.0 mttt -144.89 175.06 10.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.384 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.8 mtm-85 -125.35 117.48 23.84 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' CD1' HD12 ' A' ' 62' ' ' LEU . 20.7 mt -84.83 102.0 12.73 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.908 . . . . 0.0 109.575 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -94.47 117.9 30.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.0 t -85.26 99.38 11.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -51.5 -35.01 38.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.736 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 12.1 m-80 -71.86 105.05 3.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.321 -0.862 . . . . 0.0 109.751 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.4 4.56 89.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.25 83.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.4 m-85 -141.99 132.73 25.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -1.072 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -93.51 119.73 32.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.473 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.6 tp -54.11 138.72 37.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.203 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -147.44 123.64 10.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 109.715 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.1 mt -93.96 118.08 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.372 -0.83 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -69.3 150.92 97.11 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.092 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.0 Cg_endo -58.86 -23.96 69.91 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.175 1.25 . . . . 0.0 110.542 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.64 -15.47 51.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.968 . . . . 0.0 109.766 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.67 -34.01 4.56 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -47.27 114.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.243 . . . . 0.0 109.497 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.42 143.26 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.487 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -170.15 -150.12 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.417 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.58 156.47 26.97 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.4 m -145.7 139.13 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.369 -1.077 . . . . 0.0 109.431 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.492 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.9 mtm-85 -76.61 6.52 5.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.575 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -94.87 103.45 15.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 0.0 109.55 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -81.59 6.35 15.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.249 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.2 t -90.24 7.29 38.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.372 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' HIS . 5.8 m-20 -93.01 113.53 60.11 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.372 -0.83 . . . . 0.0 109.051 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.88 2.6 0.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.675 0.917 . . . . 0.0 110.216 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.472 ' CD2' ' HG ' ' A' ' 78' ' ' SER . 42.4 m80 -84.57 -20.47 31.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.475 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 pt -71.82 0.07 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 22.3 mttt -87.58 87.55 7.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.914 . . . . 0.0 109.524 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.1 mt -90.42 135.22 33.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -91.1 117.1 29.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.433 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.6 HD22 ' HD2' ' A' ' 30' ' ' LYS . 10.6 mp -90.51 158.66 16.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.512 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -145.51 138.84 26.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.311 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.91 157.99 16.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.248 -0.908 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.01 -91.82 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.16 -155.33 0.19 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.0 mtt180 -88.64 105.02 17.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.5 -7.8 77.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.3 t -91.76 136.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.289 -1.124 . . . . 0.0 109.499 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.88 126.94 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.426 -0.796 . . . . 0.0 109.475 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 m -94.74 130.94 41.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -0.824 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.35 151.87 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -150.06 145.54 26.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -85.03 138.96 17.25 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 61' ' ' LYS . 40.2 t -75.74 -62.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -1.134 . . . . 0.0 109.49 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.472 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -73.84 -46.89 42.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.73 -26.26 68.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.416 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.8 m120 50.94 49.7 20.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.338 -0.851 . . . . 0.0 109.438 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.432 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 11.9 mtt180 -141.99 150.03 40.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -92.33 130.07 38.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.93 150.99 46.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.34 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.65 32.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.581 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.6 ttm -126.8 134.92 50.46 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -92.58 178.4 5.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -78.13 -34.19 50.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.21 -3.43 20.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.49 3.49 66.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.422 ' C ' HD12 ' A' ' 91' ' ' LEU . 58.0 mtm180 -80.54 119.01 22.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.442 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.9 mp -93.4 134.52 35.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 92' ' ' LEU . 4.3 pp -148.74 164.95 32.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.429 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.82 157.78 16.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.741 . . . . 0.0 109.548 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.06 149.42 30.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -73.03 -31.95 64.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -92.96 142.04 27.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.3 t -79.25 156.43 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.91 . . . . 0.0 109.453 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 46.2 p -146.88 156.75 43.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.389 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.34 -29.71 2.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.409 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -93.92 57.71 2.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.472 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 67.9 m -140.95 3.45 1.82 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.373 -0.829 . . . . 0.0 109.672 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -101.19 160.25 14.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 0.0 109.466 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -149.98 112.07 4.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.45 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -60.06 126.04 25.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.626 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -95.55 93.48 7.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 0.0 109.423 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.474 HH11 ' NH1' ' A' ' 116' ' ' ARG . 60.1 ttt180 -89.89 125.16 35.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.57 132.33 36.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -93.79 -173.22 3.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.97 -7.0 50.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -93.73 24.11 4.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 63.59 -5.4 0.27 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.491 -0.756 . . . . 0.0 109.889 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 110' ' ' ASN . 51.0 m-85 -91.64 128.51 37.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.124 -0.985 . . . . 0.0 109.26 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -89.91 166.91 13.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 109.913 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 p -141.85 122.91 14.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 109.177 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -92.57 110.97 22.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.767 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.474 ' NH1' HH11 ' A' ' 106' ' ' ARG . 0.0 OUTLIER -99.75 137.82 37.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.467 -0.771 . . . . 0.0 109.273 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.87 157.98 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -93.78 -64.39 1.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -0.895 . . . . 0.0 109.587 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -53.74 -49.73 67.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.221 -0.924 . . . . 0.0 109.678 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.543 ' C ' ' H ' ' A' ' 122' ' ' SER . 7.0 m-85 -110.47 68.87 0.68 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.7 -0.625 . . . . 0.0 109.426 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 121' ' ' THR . 14.8 p -59.76 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.0 110.229 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.8 m -89.14 10.37 22.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.963 -1.085 . . . . 0.0 109.655 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.3 m-90 -149.69 141.7 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 0.0 109.696 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.5 m-85 -109.22 150.81 27.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.688 -0.632 . . . . 0.0 109.388 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.24 131.3 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.307 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -147.03 171.52 15.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 35.7 mt -132.13 165.15 24.7 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -93.37 -172.71 3.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -93.0 -13.25 28.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 0.0 109.476 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.07 9.92 35.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.59 6.02 86.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -92.43 166.54 12.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.422 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 37.7 p90 -92.74 120.21 32.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.943 . . . . 0.0 109.479 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -69.83 131.65 44.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.33 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.661 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.55 135.5 11.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.278 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.12 2.85 1.27 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.661 ' OG ' HD23 ' A' ' 135' ' ' LEU . 59.8 p -92.21 -38.76 11.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.213 -1.169 . . . . 0.0 109.56 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -79.79 -5.0 54.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.1 p -77.25 149.62 35.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.477 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.43 179.73 45.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.94 164.83 13.23 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 121.873 1.715 . . . . 0.0 110.186 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.65 -43.16 3.19 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 143' ' ' GLN . 1.6 mp0 -68.35 132.42 47.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -1.115 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -84.81 -5.25 59.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.265 -0.897 . . . . 0.0 109.457 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.566 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.69 -0.73 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.914 . . . . 0.0 109.578 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 10.8 pt -99.97 6.33 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.3 mt -92.99 110.05 21.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 0.0 109.643 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -119.6 168.0 11.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.659 -0.65 . . . . 0.0 109.407 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.8 tp -142.8 70.43 19.56 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.468 -0.77 . . . . 0.0 109.241 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -61.97 105.87 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.855 1.703 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.68 141.56 32.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.513 -0.742 . . . . 0.0 109.319 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -70.04 173.47 6.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.423 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.7 65.6 1.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -75.93 -76.79 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.479 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.66 173.88 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.72 89.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.9 133.63 6.53 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.586 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 1.2 mp0 -46.84 -24.83 0.64 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -1.098 . . . . 0.0 109.398 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.63 HG22 ' N ' ' A' ' 7' ' ' THR . 2.8 mp -131.17 168.2 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.693 -0.629 . . . . 0.0 109.419 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.63 ' N ' HG22 ' A' ' 6' ' ' ILE . 11.7 t -138.59 -170.93 2.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 0.0 109.326 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 8' ' ' THR . 95.6 m 51.39 46.62 26.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.892 . . . . 0.0 109.294 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -70.53 -47.89 17.73 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.311 -0.868 . . . . 0.0 110.957 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 3.2 Cg_exo -64.67 109.74 1.3 Allowed 'Trans proline' 0 C--N 1.322 -0.838 0 C-N-CA 120.977 1.118 . . . . 0.0 110.239 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.09 -167.22 1.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.386 -0.821 . . . . 0.0 109.357 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.67 68.02 36.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.34 -169.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.75 1.634 . . . . 0.0 110.238 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.9 OUTLIER -84.87 57.45 4.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.254 -0.903 . . . . 0.0 109.448 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.24 -16.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.658 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . 83.92 -103.19 2.55 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.78 57.74 1.49 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.34 37.83 0.75 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -1.216 . . . . 0.0 109.41 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 39.99 40.27 1.67 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.32 96.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.025 -1.279 . . . . 0.0 110.103 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 44.27 68.35 3.21 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.461 -0.775 . . . . 0.0 110.202 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.491 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 3.9 Cg_exo -56.96 -44.51 43.88 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.779 1.652 . . . . 0.0 112.798 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 22' ' ' PRO . 3.6 Cg_exo -65.58 105.86 0.81 Allowed 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 120.833 1.022 . . . . 0.0 110.257 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.38 -17.39 0.12 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -94.53 60.99 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.339 -1.095 . . . . 0.0 109.296 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' A' ' 28' ' ' ASP . 38.7 m-85 -73.26 35.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 25' ' ' HIS . 0.2 OUTLIER -74.94 16.57 0.29 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.311 -0.868 . . . . 0.0 109.778 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 27' ' ' LYS . 4.0 m-20 -148.71 148.8 29.07 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.278 -0.888 . . . . 0.0 109.125 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.2 175.02 1.17 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 121.22 1.28 . . . . 0.0 110.321 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -145.28 175.35 10.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.338 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 4.2 mtm-85 -133.58 119.98 20.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.532 -0.73 . . . . 0.0 109.111 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.57 102.35 12.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.584 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -96.48 115.89 28.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.498 -0.751 . . . . 0.0 109.268 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.6 t -83.26 106.03 14.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.513 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -28.33 24.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.685 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.2 m-80 -77.47 105.09 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 0.0 109.615 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.35 4.88 87.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.57 62.67 3.5 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -111.64 132.46 54.57 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.639 -0.918 . . . . 0.0 109.785 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -93.02 115.73 28.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.349 -0.844 . . . . 0.0 109.265 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.513 HD23 HD12 ' A' ' 32' ' ' LEU . 41.6 tp -48.77 143.1 5.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.181 -0.949 . . . . 0.0 109.292 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 34.0 ttt180 -149.57 118.31 6.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.0 mt -89.94 106.17 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.193 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -67.02 151.21 97.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.907 . . . . 0.0 109.038 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.1 Cg_exo -57.16 -26.18 68.06 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 121.045 1.163 . . . . 0.0 110.256 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.5 p30 -75.21 -0.15 18.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.182 -0.949 . . . . 0.0 109.494 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.51 -30.46 6.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -52.8 121.55 7.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.442 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 83' ' ' LEU . 95.1 t -92.57 138.33 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -165.37 151.35 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.885 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.81 159.41 22.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.0 m -148.03 141.77 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -1.19 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 mtp180 -86.37 16.08 4.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.372 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -94.93 88.32 5.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 109.621 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 ptpt -62.03 -5.2 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.943 . . . . 0.0 109.21 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.1 p -90.99 31.02 1.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.848 . . . . 0.0 109.08 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 30.2 m-20 -113.87 93.5 29.51 Favored Pre-proline 0 N--CA 1.494 1.735 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.96 1.6 0.42 Allowed 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 120.94 1.094 . . . . 0.0 110.382 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.486 ' H ' ' C ' ' A' ' 57' ' ' ASP . 37.2 m80 -81.41 -15.61 54.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.247 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.69 2.39 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -76.43 82.12 3.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.177 -0.952 . . . . 0.0 109.147 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 62' ' ' LEU . 7.1 mt -89.86 135.07 33.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.166 -0.959 . . . . 0.0 109.391 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -89.94 104.18 16.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -90.79 148.31 22.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.59 125.35 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.337 -0.852 . . . . 0.0 109.444 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.69 28.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.86 -76.95 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 0.0 109.459 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -94.62 -90.96 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -0.825 . . . . 0.0 109.392 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -142.54 -31.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.529 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -113.25 -18.88 6.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 65.0 t -89.98 147.81 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -1.104 . . . . 0.0 109.524 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.3 127.43 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.469 -0.769 . . . . 0.0 109.453 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.8 m -93.22 112.11 23.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.6 mt -91.91 144.81 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -144.24 145.66 32.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.454 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.33 135.27 12.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -74.04 -74.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -1.128 . . . . 0.0 109.428 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.5 t -61.42 -47.26 86.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.323 -0.86 . . . . 0.0 109.465 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -27.76 69.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.888 . . . . 0.0 109.472 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.8 m120 51.34 50.58 18.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.645 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.7 mtt180 -149.84 147.96 28.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -90.04 129.34 36.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.856 . . . . 0.0 109.474 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 49' ' ' VAL . 40.8 tp -57.65 145.14 35.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 0.0 109.315 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.57 170.09 17.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.57 ' SD ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -144.01 140.17 29.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.367 -0.833 . . . . 0.0 109.411 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.4 mmtt -87.08 170.37 11.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -73.76 -14.09 61.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.303 -0.873 . . . . 0.0 109.518 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 3.1 p30 -83.11 -47.45 11.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.462 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 144.52 -7.56 1.77 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -72.43 125.37 27.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -92.23 138.12 31.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 0.0 109.359 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.02 -171.63 3.96 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.755 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.28 159.45 42.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.446 -0.784 . . . . 0.0 109.272 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.5 t -146.69 170.09 17.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 0.0 109.491 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -83.85 -35.16 24.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.438 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -92.18 135.04 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.721 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -83.82 106.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.495 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.6 p -95.14 -179.11 4.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 109.471 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -16.68 63.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.249 -0.907 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -93.54 48.0 1.27 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -139.9 3.27 2.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 84.1 m-85 -95.75 162.07 13.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 87.0 m-85 -150.03 114.38 5.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.44 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -59.12 112.96 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -79.06 141.74 37.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.282 -0.886 . . . . 0.0 109.449 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -137.78 90.83 2.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.549 -0.719 . . . . 0.0 109.316 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.0 tp -68.19 126.72 30.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.373 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.03 -172.5 3.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t -93.9 -13.43 27.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.2 m120 -88.0 28.97 0.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.902 . . . . 0.0 109.489 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER 60.19 -0.15 0.26 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.762 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.2 m-85 -95.26 126.97 40.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 109.477 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -93.23 166.21 12.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.636 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.8 p -144.6 120.77 10.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.315 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -90.69 113.8 25.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.629 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -96.38 144.95 26.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -0.847 . . . . 0.0 109.435 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -70.81 153.88 42.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.118 -0.989 . . . . 0.0 109.589 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.466 ' C ' ' H ' ' A' ' 120' ' ' TYR . 47.8 ttt180 -91.69 -75.72 0.47 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.55 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -51.37 -9.9 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 122' ' ' SER . 20.5 m-85 -141.78 62.52 1.44 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.367 -0.833 . . . . 0.0 109.287 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -62.06 2.04 0.25 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.683 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 120' ' ' TYR . 48.7 m -90.91 11.31 23.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.221 -0.924 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.408 ' HD1' ' HG1' ' A' ' 139' ' ' THR . 2.4 m-90 -155.05 142.35 19.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.6 m-85 -106.76 170.04 8.17 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.599 -0.688 . . . . 0.0 109.521 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 92.4 t -90.73 126.75 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.736 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -151.58 148.37 27.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.51 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -108.11 172.61 6.73 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.551 -0.718 . . . . 0.0 109.44 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -93.95 -169.48 2.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 109.449 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -92.78 -12.31 31.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.94 . . . . 0.0 109.466 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.2 t -93.69 -4.01 51.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 9.92 59.92 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -92.75 141.17 28.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -1.133 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 26.0 p90 -62.03 120.14 10.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.2 ttpt -71.77 126.69 30.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.58 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -47.78 140.92 6.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.36 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.35 -4.9 39.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.58 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.6 p -87.82 -28.34 21.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -1.18 . . . . 0.0 109.436 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -89.92 -4.93 57.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.408 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 28.6 p -70.45 162.03 29.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.574 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 179.99 22.61 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.01 167.3 9.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.94 1.76 . . . . 0.0 110.17 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.32 -48.39 2.64 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -79.51 129.27 34.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -1.186 . . . . 0.0 109.399 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -82.64 2.8 31.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.736 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.92 -2.73 2.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.499 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 21.3 pt -93.28 1.34 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.457 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -89.47 87.65 7.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.387 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -94.66 162.94 13.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.631 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.6 tp -138.46 71.83 44.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.601 -0.687 . . . . 0.0 109.253 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.92 103.76 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.911 1.741 . . . . 0.0 110.416 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -96.41 137.26 35.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 0.0 109.447 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 33.2 t -70.03 175.17 4.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.41 77.64 1.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 109.458 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -93.77 -81.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.429 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.29 130.54 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.513 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 50.38 -99.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -0.872 . . . . 0.0 109.472 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.84 -86.54 0.06 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -172.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -1.184 . . . . 0.0 109.437 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 81.27 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 109.516 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 7' ' ' THR . 14.0 m 50.91 87.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.173 -0.954 . . . . 0.0 109.579 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 8' ' ' THR . 8.8 t -82.95 128.62 34.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 109.373 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.873 HD23 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -163.42 160.27 18.01 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 108.647 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.65 145.14 96.63 Favored 'Trans proline' 0 C--N 1.319 -0.983 0 C-N-CA 121.292 1.328 . . . . 0.0 110.237 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.59 91.53 2.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.604 -0.685 . . . . 0.0 109.315 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -74.31 -47.56 5.87 Favored Pre-proline 0 N--CA 1.486 1.369 0 O-C-N 121.314 -0.866 . . . . 0.0 110.752 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.5 Cg_endo -67.34 96.58 0.41 Allowed 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.025 1.15 . . . . 0.0 110.056 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -173.64 46.21 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -104.76 -19.53 13.9 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.59 19.51 0.49 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 15' ' ' ASP . . . -177.79 -130.15 1.36 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.0 t -101.26 -123.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 122.345 1.069 . . . . 0.0 109.119 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.47 56.07 0.49 Allowed Glycine 0 C--N 1.28 -2.581 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -147.0 -111.96 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 109.393 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -179.3 68.95 0.18 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.876 . . . . 0.0 109.629 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.94 168.14 16.13 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.661 1.574 . . . . 0.0 109.819 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.16 -171.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 121.639 1.559 . . . . 0.0 110.149 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.25 78.87 0.09 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.618 ' CE1' ' NZ ' ' A' ' 30' ' ' LYS . 16.5 t60 -172.13 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -1.111 . . . . 0.0 109.531 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.626 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 8.4 m-85 -88.13 33.79 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.626 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.22 10.23 22.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -151.77 149.58 24.18 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 108.91 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.14 160.07 16.98 Favored 'Trans proline' 0 C--N 1.324 -0.749 0 C-N-CA 121.066 1.177 . . . . 0.0 110.126 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.618 ' NZ ' ' CE1' ' A' ' 25' ' ' HIS . 21.7 mttt -140.43 138.4 34.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.465 -0.772 . . . . 0.0 109.394 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.2 mtm-85 -88.57 129.06 35.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 46.9 mt -93.91 101.09 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -95.1 121.67 36.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.407 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.9 t -88.56 105.13 17.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.26 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.12 -15.24 8.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.863 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 16.3 m120 -86.38 104.38 15.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.367 -0.833 . . . . 0.0 109.46 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 75.31 4.94 75.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.7 89.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.427 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.8 m-85 -145.64 130.78 18.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -1.13 . . . . 0.0 109.598 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -93.59 123.82 37.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.438 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 50.4 tp -57.65 136.55 56.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.928 . . . . 0.0 109.219 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.52 HH11 ' CG ' ' A' ' 57' ' ' ASP . 40.4 ttp180 -146.04 118.03 8.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.215 -0.928 . . . . 0.0 109.637 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 mt -92.62 126.31 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -87.4 152.02 51.75 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.14 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.63 -26.59 65.69 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.236 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.95 1.7 12.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.155 -0.965 . . . . 0.0 109.501 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.18 -25.09 10.88 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -57.55 114.96 2.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -1.19 . . . . 0.0 109.384 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -97.26 142.17 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -171.35 151.92 3.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.8 155.29 23.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.7 m -146.43 155.08 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -1.127 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 HH11 ' HB3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -92.23 9.07 35.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.53 102.17 14.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.519 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -83.38 -4.96 58.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.358 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -78.74 13.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.25 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -105.59 104.93 50.73 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.84 1.06 0.91 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 120.77 0.98 . . . . 0.0 110.2 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.456 ' H ' ' C ' ' A' ' 57' ' ' ASP . 40.6 m80 -76.15 -26.69 56.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.274 -0.891 . . . . 0.0 109.273 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -65.65 -5.33 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -75.9 87.41 2.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.354 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.92 135.23 33.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.857 . . . . 0.0 109.457 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' NE2' ' NZ ' ' A' ' 75' ' ' LYS . 6.8 tt0 -89.73 114.32 25.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.325 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.605 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.9 mp -86.6 153.07 22.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -0.92 . . . . 0.0 109.628 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -144.68 131.91 20.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.834 . . . . 0.0 109.351 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.626 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . . . -88.93 119.78 29.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.57 -73.2 0.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -90.56 -143.85 0.17 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.382 -0.824 . . . . 0.0 109.482 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -93.94 -26.62 16.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.78 -9.38 2.54 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.45 104.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.153 -1.204 . . . . 0.0 109.38 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.08 177.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.537 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -145.82 118.44 8.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.344 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.04 149.28 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' NZ ' ' NE2' ' A' ' 63' ' ' GLN . 11.0 tttm -146.59 144.35 29.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.372 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.44 133.65 11.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -78.4 -74.8 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -61.75 -26.03 67.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.862 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.95 -26.6 31.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.448 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 51.11 50.0 19.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -147.76 146.95 29.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 109.512 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -94.5 134.37 37.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 tp -64.92 143.49 57.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.0 109.223 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.37 134.21 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.234 -0.916 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 44.9 ttm -97.63 139.33 33.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.385 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.453 ' HE3' HD21 ' A' ' 92' ' ' LEU . 25.4 mmtt -92.1 173.87 7.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.151 -0.968 . . . . 0.0 109.427 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -77.67 -27.09 50.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.502 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 6.4 p-10 -73.19 -49.4 28.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 0.0 109.486 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.463 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 145.67 -13.19 1.76 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -72.62 123.61 23.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -1.166 . . . . 0.0 109.567 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.2 mp -92.36 137.15 32.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.421 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -147.87 -172.41 4.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.56 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.457 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.09 156.71 45.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.349 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 m -145.88 153.48 40.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CG ' ' NH1' ' A' ' 81' ' ' ARG . 9.1 mtmp? -68.62 -29.77 68.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 0.0 109.529 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.48 148.33 23.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.526 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.3 t -92.37 149.54 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.428 ' OG1' ' SG ' ' A' ' 101' ' ' CYS . 38.2 p -146.51 157.43 43.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.45 -17.59 0.83 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.404 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 44.82 1.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' SG ' ' OG1' ' A' ' 98' ' ' THR . 3.8 m -144.62 8.12 1.31 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.351 -0.843 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 81.1 m-85 -100.0 159.7 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -0.822 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 75.3 m-85 -149.37 140.53 23.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -85.49 125.61 33.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.184 -0.947 . . . . 0.0 109.448 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -90.25 135.04 33.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.281 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -141.3 126.03 17.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 0.0 109.387 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.8 tt -92.51 125.45 37.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.292 -0.88 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -90.67 -173.87 3.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.408 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.5 m -93.34 63.85 3.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 34.1 p30 -169.26 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 63.36 -7.52 0.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.447 -0.783 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 50.3 m-85 -93.75 135.85 34.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.429 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -95.38 166.44 11.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.785 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 22.9 p -139.82 119.9 13.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 109.285 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -98.75 117.07 32.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.853 . . . . 0.0 109.703 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -95.05 161.47 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.342 -0.849 . . . . 0.0 109.272 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.56 159.77 30.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.156 -0.965 . . . . 0.0 109.871 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -80.66 -61.84 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.399 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -83.28 -36.44 24.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.782 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' SER . 16.5 m-85 -89.29 50.54 1.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.616 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -49.0 -14.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -90.03 17.54 6.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 13.1 m-90 -155.05 141.33 18.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.913 . . . . 0.0 109.62 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.4 m-85 -112.04 169.98 8.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.683 -0.636 . . . . 0.0 109.587 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.8 t -84.75 133.17 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.377 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.01 154.86 33.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.648 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HA ' ' H ' ' A' ' 134' ' ' LYS . 31.8 mt -115.66 172.75 6.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -89.4 -169.23 2.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.958 . . . . 0.0 109.437 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -94.97 -17.04 22.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.335 -0.853 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -91.33 3.34 55.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.525 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.81 2.91 66.55 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.4 163.47 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -1.177 . . . . 0.0 109.463 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 33.7 p90 -79.23 120.27 23.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.889 . . . . 0.0 109.489 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.409 ' H ' ' HA ' ' A' ' 127' ' ' LEU . 16.8 tttt -72.05 128.66 36.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.581 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.6 tp -47.83 140.65 6.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.327 -0.858 . . . . 0.0 109.276 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.95 22.35 1.21 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.581 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.08 -27.25 7.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.598 -0.942 . . . . 0.0 109.551 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -90.02 -9.27 49.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 109.682 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.4 p -69.97 152.28 44.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 166.22 -179.14 40.47 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.1 151.81 75.95 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.85 1.7 . . . . 0.0 110.185 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.43 -28.3 9.24 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -86.74 119.76 27.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.291 -1.123 . . . . 0.0 109.44 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -73.56 -3.45 27.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.586 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.78 -3.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -96.43 2.96 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.374 -0.829 . . . . 0.0 109.616 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.7 mt -93.05 110.12 21.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.543 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -118.51 163.13 17.24 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.686 -0.634 . . . . 0.0 109.434 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.4 tp -137.79 72.34 48.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.49 -0.756 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.63 108.0 0.67 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.836 1.691 . . . . 0.0 110.257 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.458 -0.776 . . . . 0.0 109.584 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.4 t -70.16 147.65 49.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.231 -0.918 . . . . 0.0 109.406 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.64 58.29 4.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.461 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -55.02 -65.6 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.403 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.475 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 tpp . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -88.77 167.74 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.528 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 50.87 -96.07 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.478 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' GLU . . . 170.62 -160.42 33.05 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLY . 19.9 pt-20 35.95 -155.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.067 -0.666 . . . . 0.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -75.53 130.0 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.452 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -91.74 51.75 1.91 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 m -144.84 67.69 1.25 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.128 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.6 OUTLIER -59.05 -47.85 97.78 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.336 -0.852 . . . . 0.0 110.61 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 1.9 Cg_endo -66.72 110.96 2.01 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.04 1.16 . . . . 0.0 110.103 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.53 153.81 3.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 tp -169.39 67.95 0.63 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.583 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.24 179.38 0.86 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.773 1.649 . . . . 0.0 110.278 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 1.6 mp0 49.81 81.74 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -95.77 -30.14 13.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 109.449 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.15 132.76 45.59 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.65 124.41 3.82 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -151.52 65.82 0.88 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.334 -1.098 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.35 -101.27 0.27 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -81.56 -105.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -1.146 . . . . 0.0 109.449 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -177.52 69.51 0.22 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.649 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.44 168.18 13.43 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.654 1.569 . . . . 0.0 109.864 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.5 95.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.525 1.484 . . . . 0.0 110.163 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.7 -85.47 1.76 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.487 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -157.27 53.64 0.49 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -1.146 . . . . 0.0 109.425 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -66.31 5.94 0.49 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.5 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -79.33 40.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.912 . . . . 0.0 109.595 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -148.22 151.68 37.77 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.362 -0.836 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.43 164.07 11.6 Favored 'Trans proline' 0 C--N 1.323 -0.801 0 C-N-CA 121.187 1.258 . . . . 0.0 110.431 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -149.11 129.91 14.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.9 mtt-85 -87.34 117.18 25.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 109.53 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD12 HD23 ' A' ' 41' ' ' LEU . 19.0 mt -84.83 99.73 11.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.564 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -94.82 121.48 36.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.391 -0.818 . . . . 0.0 109.498 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.0 t -91.28 113.28 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -0.921 . . . . 0.0 109.269 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.29 -19.96 63.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 0.0 109.617 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.452 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.6 m-80 -82.86 104.99 13.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 78.17 4.96 87.07 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.1 86.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 43.8 m-85 -143.49 131.36 21.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 109.651 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -94.33 119.06 32.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD23 HD12 ' A' ' 32' ' ' LEU . 46.6 tp -47.8 140.78 6.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.96 . . . . 0.0 109.271 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 44.5 ttt180 -145.97 115.98 7.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.642 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 78.8 mt -93.01 104.15 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.066 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -64.89 150.55 94.73 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.109 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.7 Cg_endo -57.68 -26.67 73.99 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.142 1.228 . . . . 0.0 110.057 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -75.45 3.15 9.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.511 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.83 -30.74 5.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -50.48 114.94 1.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -1.152 . . . . 0.0 109.358 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 96.8 t -93.7 142.27 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.903 . . . . 0.0 109.471 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.9 p30 -173.4 154.6 2.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 109.442 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.54 160.11 25.36 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.9 m -148.1 141.39 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.305 -1.115 . . . . 0.0 109.498 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.7 mtm-85 -84.54 2.12 42.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -83.95 112.97 20.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.898 . . . . 0.0 109.771 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -85.21 -5.83 59.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.069 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.71 27.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 59' ' ' HIS . 88.3 m-20 -115.16 90.44 23.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.65 1.95 0.34 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.035 1.157 . . . . 0.0 110.64 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.491 ' H ' ' C ' ' A' ' 57' ' ' ASP . 44.2 m80 -80.12 -10.74 59.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.156 -0.965 . . . . 0.0 109.279 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -79.81 -2.19 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -75.64 87.85 2.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mt -89.83 135.92 33.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.406 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -88.94 106.19 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.274 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.86 153.46 19.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 0.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.95 135.94 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.533 -0.729 . . . . 0.0 109.039 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 153.09 28.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.208 -0.933 . . . . 0.0 109.644 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -150.15 146.62 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.403 -0.81 . . . . 0.0 109.269 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 53.06 -146.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.263 -0.898 . . . . 0.0 109.431 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 62.15 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.674 -0.642 . . . . 0.0 109.412 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.28 1.67 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 72' ' ' VAL . 90.1 t -93.48 156.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -1.095 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 72' ' ' VAL . 5.6 m -145.32 123.15 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.355 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.6 m -93.32 123.98 36.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.5 mt -97.08 145.13 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.331 -0.856 . . . . 0.0 109.454 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -146.75 152.15 38.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.139 -0.976 . . . . 0.0 109.464 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.47 132.09 11.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.1 t -73.52 -62.61 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.46 -40.26 62.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 109.532 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.23 -25.73 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.897 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 51.72 44.71 29.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.785 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 43.4 mtp180 -141.58 144.23 34.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.366 -0.834 . . . . 0.0 109.364 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.92 136.47 33.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.19 -0.944 . . . . 0.0 109.609 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.6 tp -64.13 149.47 47.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.119 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 131.37 14.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 50.6 ttm -97.67 132.58 43.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -0.799 . . . . 0.0 109.396 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -91.5 176.02 6.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -83.29 -22.62 32.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.432 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.497 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 23.8 p30 -77.16 -4.76 46.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -0.948 . . . . 0.0 109.425 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.89 4.61 65.0 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.429 ' C ' HD12 ' A' ' 91' ' ' LEU . 9.5 mtp180 -88.77 122.16 31.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -1.175 . . . . 0.0 109.456 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.685 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.0 mp -93.34 132.12 37.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.156 -0.965 . . . . 0.0 109.502 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.86 178.02 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -119.03 163.26 17.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.748 -0.595 . . . . 0.0 109.418 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.1 t -150.24 161.61 42.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.368 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -79.37 -34.57 41.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.925 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.75 164.55 13.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.45 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 98' ' ' THR . 46.2 t -90.15 162.05 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.456 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.505 ' N ' HG12 ' A' ' 97' ' ' VAL . 74.8 p -147.52 177.14 9.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -22.5 62.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 0.0 109.463 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -92.15 13.26 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 88.8 m -93.69 -9.97 35.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.562 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 69.4 m-85 -96.21 153.18 17.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.47 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 73.8 m-85 -146.35 137.18 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.913 . . . . 0.0 109.489 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -77.17 124.19 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.125 -0.984 . . . . 0.0 109.429 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -93.44 145.35 24.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.491 HH21 ' CD ' ' A' ' 108' ' ' GLU . 19.3 ttp180 -147.51 116.32 6.78 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.04 134.26 34.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.574 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 106' ' ' ARG . 3.7 mm-40 -93.07 176.7 6.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.441 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 85.1 p -85.2 -4.02 59.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 109.521 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' N ' HD22 ' A' ' 110' ' ' ASN . 1.0 OUTLIER -93.38 28.48 2.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 62.28 -4.64 0.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.818 . . . . 0.0 109.976 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.8 m-85 -88.95 -172.13 3.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -146.81 167.67 23.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.77 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.0 p -142.98 169.49 17.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.484 -0.76 . . . . 0.0 109.184 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -145.27 110.7 5.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.472 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.6 ttp180 -92.58 140.18 29.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.212 -0.93 . . . . 0.0 109.364 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -61.63 147.69 44.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.459 ' O ' HG23 ' A' ' 121' ' ' THR . 6.1 ttp180 -75.87 -57.93 3.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.591 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -75.61 -42.25 52.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.584 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 122' ' ' SER . 44.3 m-85 -92.91 52.69 1.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 118' ' ' ARG . 65.0 p -53.81 -5.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.813 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.496 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.2 m -89.92 10.23 24.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.68 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.16 146.09 22.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.811 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -104.65 165.27 11.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.66 -0.65 . . . . 0.0 109.573 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.5 t -90.0 118.76 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.314 -0.866 . . . . 0.0 109.345 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -152.56 143.62 23.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.982 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.4 mt -96.31 175.4 6.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.402 -0.811 . . . . 0.0 109.431 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -91.01 -142.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.341 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -128.77 -16.83 4.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.644 -0.66 . . . . 0.0 109.519 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.2 t -94.85 37.79 1.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.35 51.72 56.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -142.63 162.01 36.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -1.054 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 28.7 p90 -92.17 120.28 32.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.444 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -69.53 129.73 40.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.668 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.1 tp -55.42 157.9 3.54 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.152 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.521 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -80.28 24.31 3.61 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.668 ' OG ' HD23 ' A' ' 135' ' ' LEU . 51.8 p -112.94 -34.64 5.68 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.573 -0.957 . . . . 0.0 109.539 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -89.64 -5.14 57.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 109.654 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 135' ' ' LEU . 74.5 p -76.18 155.12 34.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 160.19 -179.93 35.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.73 179.61 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.857 1.705 . . . . 0.0 110.194 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.91 -50.98 3.74 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.66 135.1 41.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' CB ' HD21 ' A' ' 36' ' ' ASN . 7.8 mtpt -83.99 7.44 18.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.73 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.86 -6.25 7.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.552 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.2 pt -94.67 -2.0 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.335 -0.853 . . . . 0.0 109.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.429 HD12 ' HB3' ' A' ' 144' ' ' LYS . 61.9 mt -88.16 90.48 8.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -97.58 167.94 10.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.815 . . . . 0.0 109.418 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -140.44 70.35 32.49 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.449 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.3 101.37 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.777 1.651 . . . . 0.0 110.507 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.3 mtt -96.71 129.18 44.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.387 -0.821 . . . . 0.0 109.37 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.1 t -70.08 140.54 52.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.412 ' HB1' HH22 ' A' ' 31' ' ' ARG . . . -92.17 53.18 2.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.508 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.435 ' HG3' ' HZ3' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -75.04 -83.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.492 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.46 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.84 104.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.235 -0.915 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -55.91 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.72 154.44 0.88 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -89.22 -83.78 0.23 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.243 -1.151 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' CD1' ' H ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -80.34 166.27 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.123 -0.985 . . . . 0.0 109.355 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 6' ' ' ILE . 1.7 p -48.03 172.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.287 -0.883 . . . . 0.0 109.388 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.24 -28.54 27.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.936 . . . . 0.0 109.477 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.9 OUTLIER -93.36 151.51 40.34 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 108.663 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.99 139.21 89.59 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.943 1.096 . . . . 0.0 110.125 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' LEU . . . -96.19 47.08 1.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.39 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 11' ' ' ALA . 5.4 mt 40.94 69.96 1.76 Allowed Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.91 -0.494 . . . . 0.0 110.242 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.84 72.79 0.33 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.773 1.649 . . . . 0.0 109.979 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 46.31 86.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.023 -1.048 . . . . 0.0 109.69 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -37.22 12.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.78 84.02 0.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -149.79 -157.12 7.55 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.3 m -151.72 77.93 1.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -1.144 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -160.62 59.76 0.3 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.19 -90.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -1.139 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -59.67 -47.61 97.18 Favored Pre-proline 0 N--CA 1.487 1.421 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.1 Cg_endo -66.7 168.04 17.77 Favored 'Trans proline' 0 C--N 1.321 -0.901 0 C-N-CA 120.994 1.129 . . . . 0.0 109.736 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -56.96 156.17 25.06 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.57 1.513 . . . . 0.0 110.242 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.5 -25.71 0.2 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -145.83 57.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -1.082 . . . . 0.0 109.391 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.73 42.57 2.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.0 109.352 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 3.4 ttpt -139.61 21.96 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.566 -0.709 . . . . 0.0 109.489 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -149.89 149.21 27.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.798 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.78 150.3 71.9 Favored 'Trans proline' 0 C--N 1.323 -0.768 0 C-N-CA 120.979 1.119 . . . . 0.0 110.228 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HE2' HD22 ' A' ' 64' ' ' LEU . 31.8 mtmt -138.26 141.21 39.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.471 -0.768 . . . . 0.0 109.178 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -94.93 128.17 41.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.524 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.424 ' CD1' HD12 ' A' ' 62' ' ' LEU . 17.9 mt -84.91 124.66 31.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 109.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -115.23 114.46 25.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.748 -0.595 . . . . 0.0 109.5 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.0 t -86.82 106.02 17.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -47.55 -35.32 8.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.43 -0.794 . . . . 0.0 109.922 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.08 105.04 2.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.21 5.55 76.99 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.33 54.04 10.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -101.95 134.02 45.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.594 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 24.6 m-85 -93.8 117.06 29.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.7 tp -51.15 136.94 23.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.182 -0.949 . . . . 0.0 109.244 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 5.9 ttt180 -147.54 124.51 11.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.963 . . . . 0.0 109.749 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.7 mt -94.65 122.44 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.086 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -79.77 151.38 73.81 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 109.173 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.529 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.8 Cg_endo -59.14 -23.41 69.08 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.176 1.251 . . . . 0.0 110.25 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.475 ' OD1' ' CG ' ' A' ' 48' ' ' ARG . 1.4 p30 -74.98 3.26 8.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.68 -36.52 3.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' CG ' ' OD1' ' A' ' 46' ' ' ASP . 12.0 mmm180 -46.94 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -1.129 . . . . 0.0 109.534 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -141.38 134.01 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.399 -0.813 . . . . 0.0 109.394 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 p30 -166.9 152.13 7.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.511 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.32 153.41 21.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 m -145.73 144.86 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.267 -1.137 . . . . 0.0 109.517 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . 19.9 mmm-85 -64.93 -36.6 84.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.274 -0.891 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.94 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 109.595 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -85.43 -1.31 56.9 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.89 . . . . 0.0 109.428 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.1 p -94.03 15.2 17.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 1.1 m-20 -92.01 114.57 62.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.157 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.9 -2.14 2.0 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 120.601 0.867 . . . . 0.0 110.113 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.0 m80 -79.49 -28.8 41.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.312 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -72.57 -6.32 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.887 . . . . 0.0 109.424 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -74.84 86.82 2.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.424 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.3 mt -90.15 135.26 33.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.375 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -89.7 109.31 20.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -87.67 156.56 19.4 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.628 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -140.68 -175.24 4.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.476 -0.765 . . . . 0.0 109.279 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.09 144.24 51.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.606 -0.683 . . . . 0.0 109.523 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 71' ' ' VAL . 2.3 mm-40 -145.46 144.41 30.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 48.17 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.085 -1.01 . . . . 0.0 109.22 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -98.88 62.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.78 -18.29 1.43 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 67' ' ' GLU . 21.4 t -92.51 119.25 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.236 . . . . 0.0 109.678 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 103' ' ' PHE . 3.6 m -94.12 179.19 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.339 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 m -145.87 116.87 7.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.584 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -96.62 145.51 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.92 129.23 12.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.927 . . . . 0.0 109.484 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.41 133.86 12.55 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.94 -74.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -1.167 . . . . 0.0 109.53 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.5 m -47.13 -52.56 15.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.97 -22.37 65.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.9 m120 51.76 38.75 23.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 33.4 mtt180 -137.03 154.76 50.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.445 -0.784 . . . . 0.0 109.441 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.459 ' CG ' HG22 ' A' ' 97' ' ' VAL . 79.5 m-85 -94.28 134.72 36.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.26 144.93 56.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.299 -0.875 . . . . 0.0 109.144 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.19 132.43 15.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.196 -0.94 . . . . 0.0 109.573 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.668 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -98.7 142.38 30.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.395 -0.815 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE2' HD21 ' A' ' 92' ' ' LEU . 4.9 mmtm -94.93 177.93 5.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.451 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -86.53 -12.59 48.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.926 . . . . 0.0 109.428 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -88.28 -2.54 58.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.85 64.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -88.81 118.58 28.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -1.118 . . . . 0.0 109.499 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 85' ' ' MET . 10.1 mp -92.36 132.17 36.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.477 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.4 pp -146.08 -170.45 3.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.848 . . . . 0.0 109.464 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.97 151.72 44.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.471 -0.768 . . . . 0.0 109.476 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -145.43 170.06 17.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.867 . . . . 0.0 109.504 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -83.87 -23.38 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.585 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.3 t -92.44 136.73 32.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.212 -0.93 . . . . 0.0 109.53 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 97' ' ' VAL . 25.2 t -82.46 94.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.558 ' N ' ' SG ' ' A' ' 101' ' ' CYS . 3.3 p -76.45 -175.72 3.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.04 -11.23 59.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.606 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.46 9.16 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.273 -0.892 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.558 ' SG ' ' N ' ' A' ' 98' ' ' THR . 3.7 m -94.32 -0.35 55.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -0.901 . . . . 0.0 109.579 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 96.7 m-85 -94.94 151.15 19.44 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.355 -0.841 . . . . 0.0 109.716 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.4 m-85 -147.55 134.82 20.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -80.17 159.35 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.131 -0.98 . . . . 0.0 109.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -123.71 139.83 53.6 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -139.16 77.84 1.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.569 -0.707 . . . . 0.0 109.43 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.83 151.99 10.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.29 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -129.4 168.72 15.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.661 -0.649 . . . . 0.0 109.324 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 97.7 p -77.2 58.05 1.53 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.501 ' C ' ' H ' ' A' ' 112' ' ' TYR . 40.8 p30 -155.3 17.79 0.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m120 63.51 -7.75 0.17 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.526 -0.734 . . . . 0.0 110.277 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' H ' ' C ' ' A' ' 110' ' ' ASN . 49.9 m-85 -95.35 128.65 42.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -91.86 170.16 10.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.61 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 p -144.32 111.8 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -102.19 126.69 49.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.559 -0.713 . . . . 0.0 109.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -116.18 157.16 25.27 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.73 -0.606 . . . . 0.0 109.634 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -65.15 160.61 20.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.873 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 121' ' ' THR . 53.9 ttt180 -90.7 -73.99 0.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 8.4 tptm -58.11 -9.72 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.596 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.477 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -136.39 57.77 1.76 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.529 -0.732 . . . . 0.0 109.445 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' ARG . 21.8 p -61.26 1.47 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.189 -0.945 . . . . 0.0 109.687 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 5.6 m -89.96 11.52 20.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.115 -0.99 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 14.5 m-90 -146.92 132.71 18.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 109.586 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -98.65 153.0 19.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.596 -0.69 . . . . 0.0 109.946 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.76 134.15 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.545 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.39 171.42 19.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.5 mt -132.32 172.03 12.96 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' HZ2' ' HB3' ' A' ' 128' ' ' LYS . 14.5 mtpp -94.49 -163.48 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -93.79 -24.94 17.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.912 . . . . 0.0 109.707 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -77.22 -1.35 29.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.05 69.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' A' ' 132' ' ' GLN . 3.5 mp0 -85.11 179.1 7.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -1.166 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 31.6 p90 -94.11 120.77 34.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.337 -0.852 . . . . 0.0 109.67 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.611 ' NZ ' ' NE2' ' A' ' 143' ' ' GLN . 26.0 tttt -69.72 138.66 53.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.571 HD23 ' OG ' ' A' ' 137' ' ' SER . 15.2 tp -47.65 142.56 4.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.332 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -73.0 19.3 1.27 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.571 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.3 p -115.18 -27.0 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.646 -0.914 . . . . 0.0 109.581 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -90.06 -4.94 57.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 109.749 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 p -70.89 135.93 48.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.911 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -176.45 179.72 47.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.6 Cg_endo -61.23 179.08 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 121.88 1.72 . . . . 0.0 110.251 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 75.8 -30.75 1.28 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.611 ' NE2' ' NZ ' ' A' ' 134' ' ' LYS . 15.1 mt-30 -92.48 134.08 35.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -1.18 . . . . 0.0 109.538 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -85.06 1.85 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -0.914 . . . . 0.0 109.479 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.545 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.36 -11.59 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.271 -0.893 . . . . 0.0 109.446 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.2 pt -92.59 -2.8 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.6 mt -88.63 86.79 7.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 109.503 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -91.29 164.43 13.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.2 tp -143.56 70.48 17.47 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 109.462 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.35 109.97 1.11 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.803 1.669 . . . . 0.0 110.303 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.0 mtt -98.04 128.37 44.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 29.3 t -68.57 160.57 29.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -128.97 72.88 1.48 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.647 -0.658 . . . . 0.0 109.393 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -75.55 -69.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 83.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.476 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.84 128.63 1.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.433 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -60.11 121.53 12.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -0.911 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.37 -178.41 39.97 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.24 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -1.145 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -91.62 178.72 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.493 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.55 104.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.938 . . . . 0.0 109.406 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 m -77.93 -76.6 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 tp 54.28 68.44 2.72 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 2.6 Cg_endo -63.31 151.4 85.08 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.713 1.609 . . . . 0.0 110.219 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 10' ' ' PRO . . . 175.89 87.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mp 42.32 70.39 1.76 Allowed Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 121.574 -0.704 . . . . 0.0 110.039 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.85 136.17 47.8 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.854 1.702 . . . . 0.0 110.173 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 47.43 74.87 0.14 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 109.513 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.29 88.02 6.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.324 -0.86 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -166.21 56.26 0.24 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.99 153.11 25.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.6 p -163.16 52.2 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -1.138 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.29 -78.55 0.24 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.43 -110.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.1 p90 -150.43 67.62 8.21 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.79 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.96 168.31 12.39 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.643 1.562 . . . . 0.0 109.809 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.36 157.26 22.62 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.603 1.535 . . . . 0.0 110.038 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.18 -113.48 0.33 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.456 ' C ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -93.48 43.11 1.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -1.136 . . . . 0.0 109.646 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -75.01 18.48 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.395 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 25' ' ' HIS . 24.0 tttm -93.88 10.3 33.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.871 . . . . 0.0 109.661 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -114.9 149.52 42.59 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.38 166.46 7.62 Favored 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 121.075 1.183 . . . . 0.0 110.27 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.454 ' HD2' HD22 ' A' ' 64' ' ' LEU . 39.3 mttp -143.51 127.27 17.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.374 -0.829 . . . . 0.0 109.215 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.1 mtm-85 -84.9 124.67 31.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.181 -0.949 . . . . 0.0 109.543 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -95.52 104.87 16.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.649 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -99.09 126.68 44.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.509 -0.744 . . . . 0.0 109.506 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 43.8 t -89.45 130.74 35.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.247 -0.908 . . . . 0.0 109.19 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -79.8 -15.7 56.94 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.812 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.0 OUTLIER -88.21 104.82 17.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.67 -179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 79.56 4.94 89.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.4 88.13 0.01 OUTLIER Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.449 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 44.7 m-85 -145.42 132.17 20.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -1.115 . . . . 0.0 109.733 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -94.73 120.69 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.402 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 46.4 tp -47.53 142.64 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.431 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 12.8 ttt180 -150.32 114.74 5.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 117.32 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.302 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.476 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 90.8 m-70 -79.71 150.24 72.38 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.913 . . . . 0.0 109.031 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.5 -23.96 58.92 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.075 1.183 . . . . 0.0 110.259 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.482 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 4.8 p30 -75.01 -2.49 27.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.495 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.72 -31.51 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.483 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.2 mtm-85 -56.76 117.7 4.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -1.153 . . . . 0.0 109.528 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 83' ' ' LEU . 48.8 t -94.09 140.06 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.491 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 43.0 p30 -164.14 153.27 13.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 0.0 109.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.06 160.44 24.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.3 m -146.84 149.77 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -1.155 . . . . 0.0 109.478 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -80.78 4.6 18.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.148 -0.97 . . . . 0.0 109.443 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' OE2' ' OD2' ' A' ' 57' ' ' ASP . 20.7 tt0 -88.01 91.6 8.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.383 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -77.84 48.83 0.73 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -0.939 . . . . 0.0 109.437 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.0 p -163.49 20.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.88 . . . . 0.0 109.715 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -77.7 141.36 64.44 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.115 -0.991 . . . . 0.0 108.991 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.89 22.8 0.08 OUTLIER 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 121.191 1.261 . . . . 0.0 111.073 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.5 m80 -132.61 -10.2 3.16 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.173 -0.954 . . . . 0.0 109.99 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt -72.3 -3.56 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.046 -1.033 . . . . 0.0 109.338 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -86.95 86.7 7.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.438 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.01 135.0 33.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.226 -0.921 . . . . 0.0 109.425 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 63' ' ' GLN . 0.5 OUTLIER -93.59 110.5 22.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.66 149.53 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -144.07 136.47 26.75 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.4 -0.813 . . . . 0.0 109.505 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.77 123.17 30.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.408 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.13 -30.12 15.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -165.45 -159.93 0.44 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 10.5 ptt180 -89.18 118.54 28.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.01 66.96 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.8 t -145.75 99.47 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -1.09 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -93.19 174.83 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 m -145.48 119.72 9.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.324 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.67 147.59 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.594 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -147.01 132.01 18.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.296 -0.877 . . . . 0.0 109.374 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.91 132.9 12.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 78' ' ' SER . 57.0 t -72.52 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -1.155 . . . . 0.0 109.454 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 77' ' ' VAL . 24.7 t -53.83 -47.56 70.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.72 -30.7 70.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 51.35 46.35 26.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.595 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' HG2' HH11 ' A' ' 81' ' ' ARG . 2.8 mtt-85 -136.09 142.63 44.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 109.305 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -89.93 116.4 27.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 49' ' ' VAL . 49.2 tp -50.69 149.7 3.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.236 -0.915 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.18 128.34 11.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.127 -0.983 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 15.7 ttm -94.16 138.11 32.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -83.44 166.88 17.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.29 -20.57 60.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.498 ' CG ' ' HE ' ' A' ' 90' ' ' ARG . 1.7 p30 -87.02 -45.14 11.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.496 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.453 ' N ' ' CG ' ' A' ' 88' ' ' ASP . . . 147.69 -10.67 1.26 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HE ' ' CG ' ' A' ' 88' ' ' ASP . 75.5 mtm180 -68.65 122.01 17.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -1.2 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -90.87 129.55 36.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.484 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.698 ' C ' HD12 ' A' ' 92' ' ' LEU . 3.6 pp -147.53 150.93 35.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.264 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -101.2 157.32 16.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.503 -0.748 . . . . 0.0 109.504 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.85 146.21 27.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.454 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -70.99 -21.43 62.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.4 t -89.69 151.59 21.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 t -89.16 151.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.1 p -147.43 162.01 39.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -11.55 31.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.46 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -94.12 4.96 53.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -91.52 -8.81 46.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.498 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 90.3 m-85 -95.03 153.03 17.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.468 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 69.2 m-85 -145.69 127.02 14.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -0.854 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -62.93 116.21 5.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.154 -0.966 . . . . 0.0 109.386 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.64 89.2 7.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.275 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.95 127.7 36.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.1 134.21 35.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -93.77 -177.78 4.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -93.63 40.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.292 -0.88 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 112' ' ' TYR . 7.5 m120 -148.15 30.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.57 -0.39 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.7 m-85 -97.36 125.34 41.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.855 . . . . 0.0 109.284 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.2 m-20 -94.54 167.18 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.888 . . . . 0.0 109.855 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -142.61 122.13 13.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.448 -0.782 . . . . 0.0 109.235 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -94.2 115.14 27.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.742 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 151.93 20.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.434 -0.791 . . . . 0.0 109.38 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -76.65 152.3 35.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.105 -0.997 . . . . 0.0 109.591 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -87.59 -75.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 0.0 109.416 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.518 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 21.7 tptt -49.69 -10.97 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.718 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 10.7 m-85 -143.91 66.37 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 11.7 p -64.71 5.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.955 . . . . 0.0 109.633 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 33.6 m -91.59 10.49 27.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.692 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -151.35 144.62 24.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.931 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 24.1 m-85 -108.26 166.25 10.89 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.287 0.565 . . . . 0.0 109.476 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 87.4 t -88.35 132.94 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.357 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.606 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.85 166.28 33.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.195 -0.941 . . . . 0.0 109.692 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 29.2 mt -132.7 175.77 9.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.629 -0.669 . . . . 0.0 109.336 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -95.21 -169.64 2.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.389 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.43 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 6.6 ptm180 -91.65 -12.72 33.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.434 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -93.68 1.44 56.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.4 64.88 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.42 ' HG2' HG23 ' A' ' 130' ' ' THR . 49.1 mm-40 -85.34 161.84 19.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 109.509 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.8 p90 -91.98 120.51 32.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.497 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.502 ' HZ2' ' HB2' ' A' ' 138' ' ' LYS . 13.8 ttpp -72.98 134.92 44.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.962 . . . . 0.0 109.404 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.532 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.7 tp -47.3 136.79 8.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.278 -0.888 . . . . 0.0 109.224 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -72.92 -8.75 74.17 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.532 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.0 p -83.45 -29.62 27.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.492 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 134' ' ' LYS . 8.5 mtpp -89.98 -4.8 57.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.424 ' HG1' ' HD1' ' A' ' 123' ' ' TRP . 5.3 p -69.87 153.87 42.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.908 . . . . 0.0 109.431 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.64 -179.75 43.18 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.94 162.62 18.5 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.803 1.669 . . . . 0.0 110.186 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.57 -29.46 7.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -86.28 127.74 34.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -1.145 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 27.7 mtmt -84.1 -2.88 57.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.606 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -63.23 -5.13 2.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.915 . . . . 0.0 109.425 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.0 pt -93.57 0.45 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.329 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 mt -89.95 91.86 8.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -95.77 167.59 11.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -0.882 . . . . 0.0 109.656 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.9 tp -136.72 73.54 54.01 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.527 -0.733 . . . . 0.0 109.291 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.38 106.49 0.49 Allowed 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.861 1.707 . . . . 0.0 110.608 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 2.1 mtp -97.41 130.24 44.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.463 -0.773 . . . . 0.0 109.409 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 36.5 t -70.04 137.01 50.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -88.76 58.19 4.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.236 -0.915 . . . . 0.0 109.41 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -54.93 -89.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.472 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.492 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.324 0.583 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.91 102.51 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -92.66 99.45 12.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.475 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.74 56.16 3.83 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 47.2 -103.82 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -1.173 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 mm -90.65 101.44 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.228 -0.92 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 ' H ' HG23 ' A' ' 7' ' ' THR . 9.1 p -56.58 -173.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 8' ' ' THR . 87.7 m -92.17 57.78 3.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 mt -85.26 152.49 58.28 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.83 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.13 153.23 33.72 Favored 'Trans proline' 0 C--N 1.322 -0.868 0 C-N-CA 121.13 1.22 . . . . 0.0 110.222 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.42 156.61 43.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.383 -0.823 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 15' ' ' ASP . 7.1 tp -171.07 68.14 0.48 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 109.656 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.99 159.64 45.4 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.924 1.749 . . . . 0.0 110.475 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER 45.49 86.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.411 -0.806 . . . . 0.0 109.779 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 12' ' ' LEU . 1.0 OUTLIER 36.33 -87.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.218 0.532 . . . . 0.0 110.722 179.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . -164.65 -29.64 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.05 -166.56 6.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m 47.38 71.12 0.35 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -1.127 . . . . 0.0 109.308 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -49.74 -82.04 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.22 26.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -1.109 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -76.46 -49.66 2.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.02 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 1.4 Cg_endo -66.81 167.35 19.71 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 120.779 0.986 . . . . 0.0 109.786 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.78 122.21 10.89 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 121.593 1.529 . . . . 0.0 109.984 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.29 20.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -145.76 8.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -1.15 . . . . 0.0 109.514 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.727 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 42.4 m-85 -109.02 4.89 23.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.641 -0.662 . . . . 0.0 109.429 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.33 -6.94 59.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.421 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.19 149.8 36.17 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.799 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.47 164.0 6.07 Favored 'Trans proline' 0 C--N 1.322 -0.832 0 C-N-CA 121.096 1.197 . . . . 0.0 110.266 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 64' ' ' LEU . 26.3 mtmt -136.61 136.68 39.4 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.603 -0.685 . . . . 0.0 109.266 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.8 mtt-85 -87.46 121.87 30.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.482 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD12 HD23 ' A' ' 41' ' ' LEU . 27.6 mt -86.6 97.67 10.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.459 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.25 120.46 33.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.0 t -90.61 107.17 19.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.385 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.15 -22.07 60.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.862 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 9.9 m-80 -80.13 96.42 6.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.928 . . . . 0.0 109.488 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 85.7 4.62 85.07 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.61 84.89 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.522 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -143.02 132.4 23.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -1.041 . . . . 0.0 109.515 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -94.13 124.67 38.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.468 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 HD12 ' A' ' 32' ' ' LEU . 56.2 tp -56.81 140.25 48.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 0.0 109.28 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -147.41 121.48 9.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.418 HG23 HG22 ' A' ' 49' ' ' VAL . 62.6 mt -94.36 121.53 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.517 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 89.1 m-70 -86.44 150.29 51.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.182 -0.949 . . . . 0.0 109.029 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -57.98 -22.41 54.86 Favored 'Trans proline' 0 C--N 1.322 -0.818 0 C-N-CA 121.105 1.203 . . . . 0.0 110.109 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' OD2' ' NH1' ' A' ' 48' ' ' ARG . 14.1 p30 -75.04 1.04 14.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.47 -39.33 3.07 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.479 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.1 mtm-85 -54.51 119.91 5.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 43' ' ' ILE . 39.5 t -102.02 130.58 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.5 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -149.71 163.5 37.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 0.0 109.399 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.16 157.5 23.35 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.5 m -146.07 141.96 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -1.12 . . . . 0.0 109.364 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.3 mtm180 -79.79 3.89 18.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 mm-40 -91.14 91.85 8.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.905 . . . . 0.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 56.26 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.9 p -149.94 9.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.073 -1.017 . . . . 0.0 110.127 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' HIS . 2.6 p-10 -92.07 140.06 24.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.043 -1.036 . . . . 0.0 109.233 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.55 6.36 0.2 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.935 1.09 . . . . 0.0 110.564 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . 78.0 m80 -94.76 -34.54 12.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.215 -0.928 . . . . 0.0 110.427 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -64.78 -6.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.886 -1.134 . . . . 0.0 109.414 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mtpt -85.15 84.47 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.072 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.91 135.12 33.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.76 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 9.9 tm0? -91.67 112.72 24.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.114 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.566 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.2 mp -92.47 152.03 19.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -0.931 . . . . 0.0 109.657 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -138.03 123.99 20.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.585 -0.697 . . . . 0.0 109.367 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -81.1 134.18 35.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -0.845 . . . . 0.0 109.622 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -100.28 -89.65 0.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.488 -0.757 . . . . 0.0 109.349 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.19 -155.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.3 -0.875 . . . . 0.0 109.357 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.38 54.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.533 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 165.15 -30.32 0.22 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 72' ' ' VAL . 55.3 t -89.95 154.89 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 109.537 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 71' ' ' VAL . 18.0 m -142.32 166.25 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.499 -0.751 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -137.16 124.75 22.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.575 -0.703 . . . . 0.0 109.416 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.33 148.29 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.358 -0.839 . . . . 0.0 109.577 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -148.08 129.95 15.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.61 138.0 16.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.17 -68.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -1.147 . . . . 0.0 109.469 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.3 t -58.0 -54.36 47.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.332 -0.855 . . . . 0.0 109.466 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.04 -24.77 67.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.362 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 50.66 51.75 16.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.912 . . . . 0.0 109.47 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.631 ' HE ' ' HZ3' ' A' ' 95' ' ' LYS . 91.1 mtt180 -147.6 149.2 32.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.199 -0.938 . . . . 0.0 109.451 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -89.87 130.21 36.13 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.216 -0.928 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.7 tp -65.21 141.54 58.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.418 -0.801 . . . . 0.0 109.268 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.11 156.25 41.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.196 -0.94 . . . . 0.0 109.456 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 91' ' ' LEU . 1.6 tpp -112.29 143.75 42.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.67 -0.644 . . . . 0.0 109.383 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -80.17 -169.31 2.0 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.439 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.98 -19.11 22.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.171 -0.955 . . . . 0.0 109.497 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.3 p30 -91.14 -38.47 12.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.909 . . . . 0.0 109.62 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.14 -7.87 1.88 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 62.4 mtm180 -70.05 127.51 33.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -1.173 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 91' ' ' LEU . 7.7 mp -91.9 139.02 31.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.565 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -150.04 -175.95 5.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 0.0 109.579 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -140.34 155.06 46.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.183 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -145.64 170.02 17.3 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.631 ' HZ3' ' HE ' ' A' ' 81' ' ' ARG . 9.9 mttm -80.38 -42.38 22.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -0.892 . . . . 0.0 109.505 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 126.68 33.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.4 p -65.53 120.09 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 p -92.21 -174.1 3.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 101' ' ' CYS . 52.7 t0 -80.03 -31.97 39.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.79 16.52 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.464 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' A' ' 99' ' ' ASP . 64.4 m -94.85 1.72 55.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.6 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.1 m-85 -96.76 148.66 22.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 61.6 m-85 -145.92 115.59 7.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.309 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -60.85 117.02 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.087 -1.008 . . . . 0.0 109.33 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -81.09 148.29 29.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.401 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' NH2' HH21 ' A' ' 116' ' ' ARG . 36.0 ttp180 -148.2 108.95 4.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 tt -92.97 121.23 34.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -90.22 -177.67 5.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.428 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.53 3.31 29.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -0.896 . . . . 0.0 109.52 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -91.03 18.24 6.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.463 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.46 -0.67 0.25 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.696 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.1 m-85 -99.17 136.28 39.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.372 -0.83 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 113' ' ' ASN . 2.0 m-80 -93.72 162.65 13.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.771 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.5 p -143.41 122.8 13.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -95.26 109.17 21.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.34 -0.85 . . . . 0.0 109.856 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.598 HH21 ' NH2' ' A' ' 106' ' ' ARG . 37.9 ttm180 -93.36 149.22 21.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.294 -0.879 . . . . 0.0 108.983 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -80.19 167.74 19.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -93.78 -87.1 0.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.423 -0.798 . . . . 0.0 109.412 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -48.54 -13.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.215 -0.928 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -126.26 56.8 1.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 118' ' ' ARG . 52.9 p -57.91 -19.75 32.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.536 -0.727 . . . . 0.0 110.418 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.9 m -89.55 19.95 4.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.917 -1.114 . . . . 0.0 108.989 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.3 m-90 -139.83 151.89 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.512 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 28.3 m-85 -131.54 152.57 50.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.712 . . . . 0.0 109.522 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.09 135.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.0 109.203 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -154.2 -178.45 7.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.11 165.96 26.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -89.87 175.33 7.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.441 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -87.02 -13.12 45.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -93.09 1.01 57.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.55 7.75 61.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -92.59 166.22 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 27.8 p90 -83.19 120.25 25.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.223 -0.923 . . . . 0.0 109.473 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 135' ' ' LEU . 38.9 tttm -71.51 137.42 48.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.493 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.487 ' HG ' ' H ' ' A' ' 136' ' ' GLY . 5.7 tp -61.65 -152.98 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.487 ' H ' ' HG ' ' A' ' 135' ' ' LEU . . . -127.71 -36.87 0.47 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.466 ' HG ' ' HZ3' ' A' ' 138' ' ' LYS . 27.0 p -52.91 -29.93 31.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.221 . . . . 0.0 109.5 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' HZ3' ' HG ' ' A' ' 137' ' ' SER . 2.4 mptp? -90.18 -20.08 23.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.4 p -69.93 136.7 50.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.51 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.14 179.81 48.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.74 153.97 58.6 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.874 1.716 . . . . 0.0 110.238 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.19 32.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -92.86 129.72 38.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -1.115 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 2.4 mtmp? -74.92 -7.76 54.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.178 -0.951 . . . . 0.0 109.373 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.713 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -58.12 -3.21 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.685 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 144' ' ' LYS . 2.2 pt -99.8 6.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 mt -96.89 110.2 22.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.354 -0.841 . . . . 0.0 109.614 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -119.14 163.72 16.62 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.684 -0.635 . . . . 0.0 109.402 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.0 tp -141.43 70.92 26.61 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.466 -0.771 . . . . 0.0 109.243 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.9 109.3 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.923 1.749 . . . . 0.0 110.559 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 3.2 mtt -95.92 125.7 40.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.1 t -68.72 141.57 55.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.562 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.47 56.7 2.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.33 -0.856 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.19 -60.57 3.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.092 -0.956 . . . . 0.0 109.444 -179.982 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.92 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.495 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 51.37 -125.95 2.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.91 -177.3 46.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -65.68 -109.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -1.128 . . . . 0.0 109.499 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.534 ' H ' HH22 ' A' ' 31' ' ' ARG . 71.2 mt -73.53 140.47 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.88 . . . . 0.0 109.567 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 t -56.99 164.91 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 109.579 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.564 HG23 ' H ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -94.68 -81.32 0.39 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.355 -0.84 . . . . 0.0 109.54 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 8' ' ' THR . 9.1 mt 51.57 76.53 0.53 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.155 -0.965 . . . . 0.0 109.704 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.1 -175.18 0.47 Allowed 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.704 1.602 . . . . 0.0 110.2 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 55.66 78.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.498 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER 179.26 -50.38 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.611 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 2.1 Cg_endo -65.34 120.76 8.03 Favored 'Trans proline' 0 C--N 1.325 -0.675 0 C-N-CA 120.827 1.018 . . . . 0.0 110.301 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 48.61 88.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.475 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -94.18 91.4 6.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.543 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.25 44.74 3.7 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -151.0 48.84 0.56 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 p -146.15 63.1 1.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -1.156 . . . . 0.0 109.609 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 21' ' ' PHE . . . -81.8 -100.79 0.41 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.58 22.97 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -1.195 . . . . 0.0 109.188 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 19' ' ' GLY . 4.0 m-85 53.48 63.03 8.66 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.412 -0.805 . . . . 0.0 110.091 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.82 158.6 50.05 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.425 1.417 . . . . 0.0 109.387 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.18 103.17 0.35 Allowed 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 121.329 1.353 . . . . 0.0 109.926 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -144.06 -82.33 0.05 OUTLIER Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.3 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -100.98 66.18 1.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.315 -1.109 . . . . 0.0 109.888 -179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 35.7 m-85 -122.58 4.81 9.56 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -95.71 23.84 5.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.426 -0.796 . . . . 0.0 109.448 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -147.56 152.36 41.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.836 . . . . 0.0 109.202 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.72 167.72 3.81 Favored 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.138 1.225 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.7 mttt -145.77 133.46 21.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.232 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.534 HH22 ' H ' ' A' ' 6' ' ' ILE . 23.4 mtt180 -85.03 120.96 27.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.662 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.3 mt -84.91 95.97 9.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -91.79 115.03 27.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.627 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 54.0 t -81.83 125.12 30.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -78.96 -14.88 58.95 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.254 -0.903 . . . . 0.0 109.761 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 29.9 m-80 -88.32 92.49 9.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.522 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 93.02 4.92 64.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.75 82.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 49.4 m-85 -142.7 132.97 24.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.364 -1.08 . . . . 0.0 109.552 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -93.55 129.4 39.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 109.351 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.5 tp -64.96 146.46 54.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.47 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 6.8 ttt180 -145.52 159.12 43.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.0 mt -133.51 104.97 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.568 -0.708 . . . . 0.0 109.23 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.9 m-70 -66.92 150.58 97.75 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.209 -0.932 . . . . 0.0 109.079 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.2 Cg_exo -57.07 -24.05 55.95 Favored 'Trans proline' 0 C--N 1.324 -0.75 0 C-N-CA 121.157 1.238 . . . . 0.0 110.344 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 23.8 p30 -74.98 -1.7 23.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.564 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 93.82 -32.04 6.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' N ' ' OD1' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -52.15 119.94 4.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -1.209 . . . . 0.0 109.458 -179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.4 150.43 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.864 . . . . 0.0 109.507 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.529 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 16.3 p-10 -174.57 151.35 1.49 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.92 . . . . 0.0 109.447 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 155.25 21.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.87 139.54 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -1.141 . . . . 0.0 109.497 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.48 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.0 mtm-85 -71.52 -7.12 45.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.43 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.04 98.04 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.582 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -84.98 7.15 22.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.471 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 t -91.34 -20.12 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 0.0 109.541 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' CG ' ' NH1' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -63.58 116.14 23.83 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.872 . . . . 0.0 109.128 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.36 0.39 1.03 Allowed 'Trans proline' 0 C--O 1.213 -0.737 0 C-N-CA 120.632 0.888 . . . . 0.0 110.182 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . 49.4 m80 -77.72 -6.63 54.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -0.86 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 pt -87.63 6.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.3 87.41 7.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.481 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -91.77 135.28 34.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.877 . . . . 0.0 109.452 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -89.75 105.39 17.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.955 . . . . 0.0 109.51 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 64' ' ' LEU . 9.5 mp -89.7 153.04 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -144.7 137.92 26.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 109.498 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -87.73 122.96 32.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.432 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -95.47 -76.43 0.5 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.381 -0.825 . . . . 0.0 109.537 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -95.96 -124.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.379 -0.825 . . . . 0.0 109.542 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -92.7 -76.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.535 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.21 5.44 81.24 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.7 t -90.08 140.29 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -1.127 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 30.9 m -141.02 127.32 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.466 -0.771 . . . . 0.0 109.303 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -91.47 121.1 32.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.611 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -92.32 145.12 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.321 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -146.84 143.81 28.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.382 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.13 139.98 18.81 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.449 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 58.5 t -80.02 -58.24 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -1.164 . . . . 0.0 109.448 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.5 -43.78 18.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.299 -0.875 . . . . 0.0 109.478 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.12 67.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.505 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 3.1 m-80 51.25 50.84 18.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.57 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 94.1 mtt180 -148.5 149.3 31.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -93.17 129.79 39.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.937 . . . . 0.0 109.585 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.1 tp -59.4 142.6 51.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -148.17 133.35 18.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.1 ttm -92.43 145.53 24.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.241 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HE3' HD21 ' A' ' 92' ' ' LEU . 17.2 mmtt -92.99 -177.34 4.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 21.2 mm-40 -79.62 -40.43 29.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.3 -0.875 . . . . 0.0 109.623 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.7 p30 -69.95 -37.14 75.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.498 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.476 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 135.8 1.75 2.94 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' HG3' HH11 ' A' ' 90' ' ' ARG . 3.9 mtm-85 -76.45 119.15 19.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.638 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.8 134.87 34.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.297 -0.877 . . . . 0.0 109.459 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD21 ' HE3' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -149.17 178.04 9.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.708 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -111.88 158.12 19.82 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.687 -0.633 . . . . 0.0 109.449 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 p -150.06 134.46 17.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -54.84 -49.97 69.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 109.534 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.6 m -85.0 130.55 34.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.885 . . . . 0.0 109.521 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.4 p -85.66 160.43 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 p -147.49 -172.98 4.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.281 -0.887 . . . . 0.0 109.428 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -13.0 62.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -95.91 50.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.507 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.1 m -147.43 9.56 0.94 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.973 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 63.0 m-85 -96.16 152.67 18.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 0.0 109.672 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.7 m-85 -150.25 115.77 5.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.897 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -57.56 152.56 14.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.239 -0.913 . . . . 0.0 109.593 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -125.42 137.34 54.0 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.8 ttm180 -142.8 134.52 26.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 109.438 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.17 128.57 46.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.462 -0.774 . . . . 0.0 109.679 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -86.33 171.42 11.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.353 -0.842 . . . . 0.0 109.277 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.0 t -76.21 -5.04 45.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.59 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -93.58 17.91 10.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.542 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m120 64.01 61.71 0.92 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.455 -0.778 . . . . 0.0 110.205 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.452 ' C ' ' ND2' ' A' ' 113' ' ' ASN . 48.7 m-85 -144.6 -171.93 3.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.368 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 112' ' ' TYR . 4.3 m-80 -147.91 114.55 6.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 0.0 109.804 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -95.36 124.06 39.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.264 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -96.32 109.16 21.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -97.57 147.54 24.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.47 -0.768 . . . . 0.0 109.192 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 t -78.99 158.88 27.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.637 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.676 ' O ' HG23 ' A' ' 121' ' ' THR . 0.2 OUTLIER -93.22 -78.01 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.449 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -47.86 -34.81 9.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.389 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.463 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.2 m-85 -112.22 65.35 0.63 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.659 -0.651 . . . . 0.0 109.531 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 118' ' ' ARG . 67.6 p -64.08 3.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 0.0 109.554 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 120' ' ' TYR . 54.4 m -93.47 11.72 27.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.799 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.2 161.24 41.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.144 -0.973 . . . . 0.0 109.991 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 19.4 m-85 -123.91 169.91 11.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -87.92 122.52 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.309 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.48 144.45 22.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.615 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.2 mt -95.86 -176.29 3.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 109.503 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -94.33 -108.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.86 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -148.17 -35.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 0.0 109.457 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.3 t -81.25 10.54 5.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 92.68 10.62 60.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -93.93 166.82 11.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -1.172 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.6 p90 -89.99 120.45 31.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.293 -0.879 . . . . 0.0 109.428 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -69.83 139.08 53.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.523 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.713 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.4 tp -58.64 141.94 50.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -66.46 5.16 2.37 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 135' ' ' LEU . 96.4 p -93.48 -32.37 14.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.145 . . . . 0.0 109.635 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -90.0 -16.95 28.78 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.554 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.539 HG22 ' HB3' ' A' ' 126' ' ' ALA . 38.8 p -69.91 161.41 30.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.975 . . . . 0.0 109.428 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.36 179.33 31.29 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.1 Cg_endo -61.7 178.38 0.72 Allowed 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.88 1.72 . . . . 0.0 110.203 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.17 -33.21 0.78 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 141' ' ' PRO . 17.2 mt-30 -87.65 128.11 35.28 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.148 -1.207 . . . . 0.0 109.601 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 37.8 mtmt -74.96 -2.82 28.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.506 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.16 -3.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.974 . . . . 0.0 109.45 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 144' ' ' LYS . 5.1 pt -97.49 3.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.688 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -91.1 109.95 21.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.125 -0.984 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -116.05 163.75 15.46 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 26.1 tp -140.85 72.41 28.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.407 -0.808 . . . . 0.0 109.141 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -60.55 115.18 2.5 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.853 1.702 . . . . 0.0 110.711 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 10.4 mtt -97.13 121.84 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.469 -0.77 . . . . 0.0 109.291 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.8 t -69.98 139.86 52.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.126 -0.984 . . . . 0.0 109.254 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.85 56.5 3.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -64.22 -84.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.45 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.449 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . -89.66 -33.89 16.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.604 ' OE2' HG21 ' A' ' 7' ' ' THR . 39.8 mt-10 -57.88 -162.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.254 -0.904 . . . . 0.0 109.507 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.76 ' N ' ' HZ1' ' A' ' 55' ' ' LYS . . . -151.22 -137.73 2.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' ILE . 5.1 mt-10 -93.42 160.56 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -1.143 . . . . 0.0 109.501 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' GLU . 3.3 mt 46.21 94.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.626 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.604 HG21 ' OE2' ' A' ' 3' ' ' GLU . 86.5 m -144.94 60.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' LEU . 5.3 t -146.38 44.29 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' THR . 9.6 mt 60.39 148.77 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.46 176.14 0.23 Allowed 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 121.016 1.144 . . . . 0.0 110.315 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.41 -171.48 3.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.72 67.81 12.76 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.66 -171.74 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.714 1.61 . . . . 0.0 110.166 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.28 91.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -58.98 -57.16 14.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 0.0 109.389 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 46.67 84.8 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.04 26.04 16.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.33 101.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.209 -1.171 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.3 108.4 0.22 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.74 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -1.089 . . . . 0.0 109.702 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' N ' ' HD3' ' A' ' 22' ' ' PRO . 2.0 t80 -143.98 59.05 6.6 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.481 -0.762 . . . . 0.0 110.42 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 21' ' ' PHE . 1.5 Cg_endo -63.84 168.19 12.42 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.604 1.536 . . . . 0.0 109.836 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -59.63 -169.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 121.517 1.478 . . . . 0.0 109.765 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 154.34 -105.87 0.28 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.411 ' CE1' ' NZ ' ' A' ' 154' ' ' LYS . 32.9 m-70 -73.44 28.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -1.162 . . . . 0.0 109.791 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 24' ' ' GLY . 71.1 m-85 -92.48 27.52 2.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -145.25 -7.39 0.62 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.362 -0.836 . . . . 0.0 109.431 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -114.79 152.44 46.38 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.61 150.6 60.03 Favored 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 121.13 1.22 . . . . 0.0 110.289 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.559 ' HE2' HD22 ' A' ' 64' ' ' LEU . 40.4 mtmt -143.31 141.86 31.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -0.764 . . . . 0.0 109.198 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' NH2' ' O ' ' A' ' 55' ' ' LYS . 7.8 mtp180 -92.97 128.28 38.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.283 -0.886 . . . . 0.0 109.273 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.554 HD12 HD23 ' A' ' 41' ' ' LEU . 17.3 mt -85.03 128.78 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -115.31 114.51 25.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.1 105.7 17.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.19 -0.944 . . . . 0.0 109.541 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 ttpp -48.51 -35.14 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 0.0 109.908 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 105.01 3.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.131 -0.98 . . . . 0.0 109.715 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.02 5.91 85.41 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.27 52.49 13.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -99.17 137.64 37.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.492 -1.005 . . . . 0.0 109.746 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -95.61 112.12 23.91 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD12 ' A' ' 32' ' ' LEU . 37.3 tp -46.51 145.18 1.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.009 -1.057 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 64.0 ttt180 -144.26 154.26 42.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.84 . . . . 0.0 109.679 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 97.0 mt -134.74 127.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -91.65 149.41 39.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 109.124 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.457 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.3 Cg_endo -58.26 -22.02 55.21 Favored 'Trans proline' 0 C--N 1.325 -0.678 0 C-N-CA 121.241 1.294 . . . . 0.0 110.614 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.82 -11.62 60.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 109.677 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.84 15.02 38.06 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -93.8 115.55 27.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.107 -1.231 . . . . 0.0 109.305 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.87 131.4 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.438 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -148.32 -163.0 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.871 . . . . 0.0 109.383 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -143.86 127.18 2.94 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -142.72 155.61 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.468 -1.019 . . . . 0.0 108.495 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' LYS . 16.7 mtm-85 -91.64 -16.42 27.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.986 -1.071 . . . . 0.0 109.451 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.8 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.76 ' HZ1' ' N ' ' A' ' 4' ' ' GLY . 18.4 pttp -83.48 -2.71 56.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -0.906 . . . . 0.0 109.445 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -87.88 10.02 20.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.142 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -104.56 106.03 52.71 Favored Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.56 2.48 0.52 Allowed 'Trans proline' 0 C--N 1.325 -0.677 0 C-N-CA 120.744 0.963 . . . . 0.0 110.273 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.5 m80 -76.99 -28.01 54.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.456 HD11 ' NH2' ' A' ' 31' ' ' ARG . 2.2 pt -72.27 -8.11 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.884 . . . . 0.0 109.334 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.83 92.05 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.563 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.448 HD12 HD11 ' A' ' 32' ' ' LEU . 8.2 mt -91.31 135.61 33.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.22 108.95 19.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 0.0 109.224 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.642 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.9 mp -91.26 153.15 20.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -147.88 133.99 19.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.303 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.11 169.25 18.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.545 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 67' ' ' GLU . 3.1 tm-20 -145.04 -34.27 0.35 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 0.0 109.513 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -154.01 -163.51 1.65 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 80.7 mtm180 -84.88 58.82 5.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.575 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.47 -26.84 1.68 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.64 138.6 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -1.181 . . . . 0.0 109.52 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.97 179.74 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.632 -0.667 . . . . 0.0 109.276 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 55.1 m -145.38 121.84 11.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.229 -0.919 . . . . 0.0 109.635 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.9 mt -93.96 147.7 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -146.46 140.09 25.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.399 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.48 138.71 19.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 41.2 t -80.0 -68.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.47 -15.6 59.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.561 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -87.21 -23.7 24.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.201 -0.937 . . . . 0.0 109.493 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 77' ' ' VAL . 44.5 m-20 51.16 45.69 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.594 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 73.1 mtt180 -147.43 148.06 30.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.439 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -94.61 130.95 40.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.607 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.4 tp -60.4 147.83 39.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.294 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.02 137.15 19.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.636 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.8 ttm -100.43 132.41 45.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.467 -0.771 . . . . 0.0 109.341 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -78.82 157.46 28.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.81 -21.08 66.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' CG ' ' N ' ' A' ' 89' ' ' GLY . 2.7 p-10 -84.77 -42.58 15.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.863 . . . . 0.0 109.488 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 144.36 -7.48 1.8 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -72.54 122.3 21.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.217 -1.167 . . . . 0.0 109.599 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -92.59 129.79 38.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.457 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.561 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -146.59 -174.58 4.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.01 154.07 44.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 81.0 p -146.46 163.93 34.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -70.14 -33.01 71.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.92 127.3 34.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 97' ' ' VAL . 8.4 p -82.64 85.29 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 46.6 p -68.3 -167.26 0.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 101' ' ' CYS . 55.3 m-20 -80.0 -26.81 39.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 109.522 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.81 7.34 0.53 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -0.956 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.473 ' H ' ' C ' ' A' ' 99' ' ' ASP . 85.8 m -96.72 -3.04 43.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -86.64 149.87 24.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.23 -0.919 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -150.03 117.74 6.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.396 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' CB ' ' HE ' ' A' ' 116' ' ' ARG . 33.0 m-85 -64.06 128.09 34.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.675 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -97.89 134.99 40.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.291 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -145.05 131.33 19.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.558 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.9 tp -95.91 120.16 35.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.385 -0.822 . . . . 0.0 109.29 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.63 170.88 12.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.4 t -78.29 53.27 1.22 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 112' ' ' TYR . 11.2 t-20 -150.84 22.86 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.25 0.23 0.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 109.568 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.6 m-85 -101.78 138.13 39.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 0.0 109.351 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -90.71 164.01 14.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.246 -0.908 . . . . 0.0 109.71 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 p -142.44 117.95 10.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 109.353 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -98.43 118.63 35.53 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.416 -0.802 . . . . 0.0 109.716 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.491 ' HE ' ' CB ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -102.07 148.07 25.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.549 -0.72 . . . . 0.0 109.301 179.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -73.66 156.25 38.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' A' ' 120' ' ' TYR . 1.1 ttt-85 -89.76 -77.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 5.7 tptt -48.35 -12.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 12.0 m-85 -143.82 67.12 1.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.343 -0.848 . . . . 0.0 109.609 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.1 p -65.27 5.02 0.42 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 120' ' ' TYR . 37.0 m -90.39 9.75 27.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.578 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.5 m-90 -151.51 142.77 23.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.8 m-85 -110.65 163.84 13.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.719 -0.613 . . . . 0.0 109.561 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.5 t -80.82 138.46 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -155.04 -177.67 6.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 127' ' ' LEU . 79.8 mt -142.64 169.21 18.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -95.07 -178.12 4.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.358 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.07 -11.45 32.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.424 ' H ' HG22 ' A' ' 130' ' ' THR . 1.9 t -93.58 2.64 56.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.256 -0.903 . . . . 0.0 109.48 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.75 4.93 67.04 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.471 ' N ' ' CD ' ' A' ' 132' ' ' GLN . 1.6 mp0 -93.32 169.7 10.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.129 . . . . 0.0 109.473 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.524 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.5 p90 -92.54 120.46 33.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -0.879 . . . . 0.0 109.523 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -69.78 135.59 49.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.438 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.469 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.3 tp -47.65 123.78 6.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.47 -23.97 29.25 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.469 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.2 p -80.17 -20.79 43.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.169 -1.195 . . . . 0.0 109.647 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -90.07 -8.89 50.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.938 . . . . 0.0 109.537 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 45.2 p -73.02 157.75 36.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.68 179.74 42.19 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.85 172.11 3.17 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.876 1.717 . . . . 0.0 110.251 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.99 -37.95 2.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -83.55 131.88 34.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.177 -1.19 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -83.35 -0.49 50.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.527 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.571 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.02 -8.81 3.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.55 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pt -94.56 2.79 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 109.468 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 144' ' ' LYS . 60.9 mt -93.32 90.62 6.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.552 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -100.14 166.99 10.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.3 tp -146.21 71.03 13.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.307 -0.87 . . . . 0.0 109.242 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.3 112.9 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.842 1.694 . . . . 0.0 110.501 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.9 mtt -103.86 142.65 34.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.545 -0.722 . . . . 0.0 109.256 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 38.3 t -69.94 149.86 47.33 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.0 59.06 3.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.411 ' NZ ' ' CE1' ' A' ' 25' ' ' HIS . 53.2 mttp -73.31 -69.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.549 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.532 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.271 0.558 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.59 -98.82 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 50.96 -169.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -0.909 . . . . 0.0 109.498 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.68 -107.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.556 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 11.8 pm0 -85.58 -165.25 1.17 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -1.15 . . . . 0.0 109.422 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 7' ' ' THR . 3.1 mt -59.49 81.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -0.922 . . . . 0.0 109.425 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 70.39 142.14 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.5 m -157.37 52.59 0.48 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.938 . . . . 0.0 109.512 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mt -91.69 152.08 42.95 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 108.845 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.3 161.24 9.51 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.1 1.2 . . . . 0.0 110.158 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.66 177.48 2.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 tt -148.27 68.67 10.37 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.31 -166.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.661 1.574 . . . . 0.0 110.257 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -77.29 53.66 1.04 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -80.23 40.85 0.5 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 173.26 29.91 0.03 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.44 -55.94 2.49 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -169.33 70.44 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -1.19 . . . . 0.0 109.489 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.93 108.82 0.58 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' H ' ' HD2' ' A' ' 22' ' ' PRO . . . -148.62 -39.59 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.509 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -93.46 -47.65 0.29 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.427 -0.796 . . . . 0.0 110.738 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.4 Cg_endo -66.29 167.92 17.3 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.004 1.136 . . . . 0.0 109.902 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.55 -169.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.676 1.584 . . . . 0.0 110.244 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.1 -48.14 3.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.8 t60 -96.21 61.89 2.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.38 -1.071 . . . . 0.0 109.325 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 20.6 m-85 -139.97 4.84 2.1 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.46 -0.775 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -85.72 48.75 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -162.78 94.81 1.17 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 0.0 109.106 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.02 116.63 3.4 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 120.862 1.041 . . . . 0.0 110.165 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -95.1 143.18 26.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.392 -0.818 . . . . 0.0 109.666 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.2 mtt-85 -87.43 135.86 33.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.339 -0.851 . . . . 0.0 108.918 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.21 120.59 26.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.134 -0.978 . . . . 0.0 109.764 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -109.53 107.47 17.59 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -76.47 103.32 6.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.329 -0.857 . . . . 0.0 109.571 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -45.35 -31.54 1.67 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.538 HD21 ' CB ' ' A' ' 144' ' ' LYS . 2.0 m-80 -66.95 105.14 1.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.737 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.02 4.65 36.14 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.21 83.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -124.42 128.73 49.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.616 -0.932 . . . . 0.0 109.255 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -90.31 114.07 26.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.216 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.9 tp -48.91 141.67 7.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 109.553 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.526 HH11 ' CG ' ' A' ' 57' ' ' ASP . 39.8 ttp180 -147.55 112.48 5.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.583 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 79.2 mt -89.96 112.75 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.856 . . . . 0.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -74.35 151.93 87.78 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.121 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 3.7 Cg_exo -56.92 -26.42 67.55 Favored 'Trans proline' 0 C--N 1.323 -0.807 0 C-N-CA 121.163 1.242 . . . . 0.0 110.24 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -75.46 0.37 17.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.11 -34.56 4.36 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 48' ' ' ARG . 3.3 mtm-85 -50.63 115.24 1.4 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 0.0 109.612 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.13 146.09 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 14.0 p30 -169.06 148.13 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.26 151.53 20.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -146.35 153.3 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -89.91 -0.7 57.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -80.28 88.1 5.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.625 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -68.91 -5.04 18.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.257 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.6 22.65 1.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.6 OUTLIER -110.18 99.92 41.79 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.61 3.62 0.36 Allowed 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 120.912 1.075 . . . . 0.0 110.522 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.471 ' H ' ' C ' ' A' ' 57' ' ' ASP . 39.9 m80 -84.23 -4.64 58.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.65 1.85 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.51 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -77.01 100.45 5.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.29 135.2 43.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.529 -0.732 . . . . 0.0 109.503 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -89.79 107.33 19.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.373 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -85.85 150.72 24.34 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.532 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -150.04 132.93 16.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -91.4 135.44 33.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 109.466 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.73 -38.32 8.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.501 -0.749 . . . . 0.0 109.639 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -151.34 -117.74 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -83.85 -110.32 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.687 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.53 6.26 17.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.7 t -89.76 129.89 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -1.165 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.79 168.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 109.507 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -142.47 118.99 10.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.448 -0.783 . . . . 0.0 109.401 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 74' ' ' ILE . 4.8 mt -91.07 152.33 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -148.65 117.99 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 0.0 109.506 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 131.91 51.45 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.08 -60.19 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -1.126 . . . . 0.0 109.467 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.1 p -68.2 -34.28 75.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.546 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.17 -21.92 33.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 51.25 55.21 9.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.507 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 6.6 mtp180 -146.8 149.29 33.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 109.399 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -94.97 129.63 41.95 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 109.653 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 tp -65.06 139.66 58.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -0.905 . . . . 0.0 109.267 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.82 133.31 16.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.188 -0.945 . . . . 0.0 109.524 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.614 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.0 ttp -97.12 133.0 42.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.86 . . . . 0.0 109.499 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 88' ' ' ASP . 32.8 mmtt -73.45 164.24 26.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.893 . . . . 0.0 109.458 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.78 24.93 0.28 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.467 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.1 p30 -130.24 -42.38 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.663 -0.648 . . . . 0.0 109.346 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.41 -9.61 1.46 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.2 mtt-85 -78.53 115.93 18.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -1.162 . . . . 0.0 109.524 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.664 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.67 131.02 38.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.205 -0.934 . . . . 0.0 109.412 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.569 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -146.94 -171.83 3.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.288 -0.882 . . . . 0.0 109.553 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -141.16 151.43 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.447 -0.783 . . . . 0.0 109.383 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.21 151.33 38.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.885 . . . . 0.0 109.481 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -63.86 -28.92 70.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.295 -0.878 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.77 127.38 38.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.509 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.1 p -92.94 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 p -148.25 -165.37 2.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -68.01 -19.43 64.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -0.961 . . . . 0.0 109.448 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.63 54.1 2.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 58.3 m -146.71 9.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -94.32 156.41 16.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.0 109.555 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.89 105.56 3.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.912 . . . . 0.0 109.428 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -58.39 103.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.512 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -87.06 94.56 9.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.399 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -89.92 126.85 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.454 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 tp -88.29 132.26 34.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.326 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -93.56 -178.92 4.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.92 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 p -89.15 -11.41 43.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.227 -0.921 . . . . 0.0 109.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.1 m-20 -89.59 28.55 1.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER 60.42 -0.7 0.25 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.327 -0.858 . . . . 0.0 109.75 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 35.2 m-85 -95.48 130.14 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.873 . . . . 0.0 109.461 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.92 169.97 10.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.467 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 42.3 p -142.39 120.45 12.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.435 -0.791 . . . . 0.0 109.472 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -93.15 99.05 11.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 17.2 ttt180 -93.49 145.15 24.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.529 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.7 t -72.02 155.57 40.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.432 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.6 ttt180 -92.45 -76.28 0.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.187 -0.946 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -51.6 -9.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 13.4 m-85 -140.47 60.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.381 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 40.1 p -61.0 0.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.594 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 4.0 m -90.51 10.68 24.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.621 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.08 142.33 19.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -0.976 . . . . 0.0 109.812 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -105.55 170.13 8.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.559 -0.713 . . . . 0.0 109.375 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.0 t -90.68 69.95 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 145' ' ' ALA . . . -94.01 141.59 28.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.5 mt -95.97 179.6 5.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -0.812 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -92.65 -171.68 2.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.476 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -93.64 -11.77 30.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -0.87 . . . . 0.0 109.411 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.65 2.51 55.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.534 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.43 0.4 67.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -88.43 171.01 10.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 29.6 p90 -89.6 120.41 30.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.961 . . . . 0.0 109.483 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -70.14 139.34 52.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.376 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.483 HD23 ' OG ' ' A' ' 137' ' ' SER . 14.4 tp -47.68 125.07 7.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.226 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -54.45 -16.5 7.04 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.483 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.3 p -90.1 -20.45 23.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.053 -1.263 . . . . 0.0 109.58 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -89.98 -11.03 42.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.684 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.2 p -69.93 175.07 4.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 149.08 179.83 25.29 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.2 170.95 4.45 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.893 1.729 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.91 -55.07 2.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -75.15 134.87 41.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -1.153 . . . . 0.0 109.471 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' CB ' HD21 ' A' ' 36' ' ' ASN . 33.9 mtmt -82.76 4.39 25.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.798 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . . . -61.21 -3.85 0.99 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 109.485 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.412 ' H ' ' C ' ' A' ' 144' ' ' LYS . 21.1 pt -93.12 -9.63 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 144' ' ' LYS . 62.9 mt -81.87 91.64 6.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.274 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -94.07 157.28 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.844 . . . . 0.0 109.724 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.5 tp -138.12 71.95 47.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.21 115.0 2.45 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.775 1.65 . . . . 0.0 110.732 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.3 mtt -97.43 130.59 44.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.483 -0.76 . . . . 0.0 109.22 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 31.0 t -68.32 144.31 54.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.648 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' HH12 ' A' ' 31' ' ' ARG . . . -85.1 53.43 2.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.451 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.22 -77.44 0.19 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.324 0.583 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.69 115.75 22.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.947 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' GLY . 2.7 mt-10 -91.6 97.31 10.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.288 -0.883 . . . . 0.0 109.442 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 58.62 158.9 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.62 -120.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -1.179 . . . . 0.0 109.437 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.38 107.35 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.389 -0.819 . . . . 0.0 109.65 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -62.42 139.03 58.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 109.189 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 13.5 t -145.86 156.42 43.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.637 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.92 98.23 41.09 Favored Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.31 115.56 2.82 Favored 'Trans proline' 0 C--N 1.325 -0.68 0 C-N-CA 120.924 1.082 . . . . 0.0 110.543 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.1 52.11 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.482 -0.761 . . . . 0.0 109.176 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tt 54.16 68.74 2.53 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.359 -0.838 . . . . 0.0 109.499 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.95 156.84 60.17 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.697 1.598 . . . . 0.0 110.273 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 50.45 90.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.19 -0.944 . . . . 0.0 109.486 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -77.48 52.93 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . -55.37 -43.51 84.79 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . 62.02 119.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.7 OUTLIER 73.18 102.16 0.07 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -1.114 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.18 91.6 2.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.91 7.29 1.42 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.437 -1.037 . . . . 0.0 109.474 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.537 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -95.79 -46.17 0.26 Allowed Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.441 -0.787 . . . . 0.0 111.036 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 3.9 Cg_exo -65.45 167.89 15.82 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.096 1.197 . . . . 0.0 109.96 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.82 170.51 1.38 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.64 1.56 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.34 -20.37 0.08 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -177.45 32.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.189 -1.183 . . . . 0.0 109.469 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -87.51 17.15 4.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.4 41.28 1.09 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.887 . . . . 0.0 109.823 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.3 152.07 32.58 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.937 . . . . 0.0 109.285 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.48 156.7 30.05 Favored 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.236 1.291 . . . . 0.0 110.341 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -141.12 133.77 28.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.436 -0.79 . . . . 0.0 109.424 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.615 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.1 mtt-85 -90.76 133.86 34.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.65 126.35 38.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -115.19 119.46 36.44 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.5 t -93.82 106.66 18.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.09 -35.04 10.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 0.0 109.656 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.633 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -67.95 103.28 1.45 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -0.913 . . . . 0.0 109.504 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.92 4.93 83.82 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.73 55.16 8.41 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -102.14 143.05 32.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.537 -0.978 . . . . 0.0 109.795 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -100.02 110.14 22.46 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD13 HD11 ' A' ' 127' ' ' LEU . 13.6 tp -46.95 144.66 2.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.119 -0.988 . . . . 0.0 109.716 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -143.55 155.4 44.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.517 -0.739 . . . . 0.0 109.415 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 96.4 mt -128.89 131.83 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.606 -0.684 . . . . 0.0 109.199 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -93.17 149.68 37.86 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.067 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.06 -21.75 52.15 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.224 1.283 . . . . 0.0 110.399 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -74.85 4.79 5.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -38.54 3.2 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -48.1 164.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 109.477 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.7 t -137.83 148.13 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.587 -0.696 . . . . 0.0 109.258 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' ' CG1' ' A' ' 52' ' ' VAL . 3.1 p-10 -154.17 -160.02 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.131 -0.981 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 131' ' ' GLY . . . -143.1 126.38 2.82 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.407 ' CG1' ' OD2' ' A' ' 50' ' ' ASP . 1.8 m -142.55 151.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.456 -1.026 . . . . 0.0 108.457 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 55' ' ' LYS . 35.4 mtm180 -89.04 -21.54 23.4 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.091 -1.006 . . . . 0.0 109.341 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -44.93 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.478 -0.764 . . . . 0.0 109.705 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 53' ' ' ARG . 6.9 pttp -81.27 1.33 32.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.3 p -88.28 5.12 43.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.214 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.3 m-20 -99.27 110.35 57.85 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.488 -0.758 . . . . 0.0 109.177 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.73 3.18 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.717 0.944 . . . . 0.0 110.238 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.6 m80 -74.85 -33.23 62.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.334 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -68.96 0.12 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.459 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.612 ' NZ ' ' NH1' ' A' ' 31' ' ' ARG . 8.6 tptt -77.1 96.71 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 0.0 109.453 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.02 131.75 45.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.401 -0.812 . . . . 0.0 109.503 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -90.02 109.54 20.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -0.901 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -92.61 150.01 20.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.94 . . . . 0.0 109.553 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.73 137.9 21.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.1 160.21 25.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.952 . . . . 0.0 109.581 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -142.94 -84.86 0.16 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -91.79 -151.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.124 -0.985 . . . . 0.0 109.412 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -85.87 117.72 24.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 70.86 -3.11 13.78 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 78.4 t -92.41 139.34 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -1.16 . . . . 0.0 109.486 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.5 m -140.86 128.23 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.535 -0.728 . . . . 0.0 109.577 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 m -94.47 118.74 32.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.542 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.06 147.56 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 109.429 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' NZ ' ' CE1' ' A' ' 82' ' ' TYR . 58.4 tttp -145.71 144.18 30.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.44 134.17 12.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.47 -77.75 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -51.12 -27.18 7.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.95 -25.46 20.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.912 . . . . 0.0 109.449 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.0 m120 50.99 48.3 23.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -0.992 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -146.37 150.76 36.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.551 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.619 ' CE1' ' NZ ' ' A' ' 75' ' ' LYS . 80.9 m-85 -94.86 127.8 41.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 109.535 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.1 tp -57.3 147.92 24.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.69 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -145.88 167.87 22.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.467 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 46.0 ttm -134.17 141.12 46.96 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.675 -0.64 . . . . 0.0 109.407 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -92.84 160.79 14.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.46 -29.41 70.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.0 109.443 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -45.53 26.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.489 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.08 -6.72 1.81 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.52 ' NH1' ' OH ' ' A' ' 133' ' ' TYR . 2.1 mmt180 -63.84 120.08 11.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.122 -1.222 . . . . 0.0 109.471 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.97 133.1 34.99 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.311 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.69 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.16 -175.31 5.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.08 150.6 38.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.315 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -146.6 156.52 43.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -73.44 -18.56 61.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.25 112.97 25.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.442 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.96 142.58 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.927 . . . . 0.0 109.464 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.2 p -147.31 -163.35 1.74 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -68.58 -14.8 63.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.504 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.8 mt-10 -94.07 42.03 1.09 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.537 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 64.6 m -144.03 6.99 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 60.7 m-85 -94.36 151.44 19.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.554 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 96.0 m-85 -150.22 111.94 4.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.434 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.513 ' CD2' ' NH1' ' A' ' 116' ' ' ARG . 32.2 m-85 -54.89 157.81 3.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.45 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -125.27 95.26 4.41 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.669 -0.644 . . . . 0.0 109.307 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -89.96 108.57 19.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 16.4 tp -92.66 117.86 30.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.93 -175.58 5.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.407 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.43 -1.25 57.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.458 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 41.3 t-20 -91.44 27.49 1.95 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 0.0 109.41 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 61.95 -3.87 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.449 -0.782 . . . . 0.0 109.88 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.9 m-85 -94.31 156.49 16.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.242 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -123.9 165.38 17.47 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 109.758 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.4 p -141.0 120.13 12.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.578 -0.701 . . . . 0.0 109.321 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -89.9 107.77 19.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.479 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.513 ' NH1' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -99.07 133.65 43.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.499 -0.751 . . . . 0.0 109.133 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.5 t -61.41 161.8 8.84 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.152 -0.968 . . . . 0.0 110.197 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.1 OUTLIER -95.45 -79.12 0.44 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 0.0 109.199 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -50.33 -11.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.473 ' N ' ' O ' ' A' ' 118' ' ' ARG . 6.1 m-85 -130.19 52.53 2.01 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 118' ' ' ARG . 79.9 p -52.72 -12.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.94 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 m -93.51 20.51 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.928 . . . . 0.0 109.635 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -152.29 130.75 12.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.72 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 26.5 m-85 -103.99 167.97 9.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.581 -0.699 . . . . 0.0 109.591 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.52 148.24 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.887 . . . . 0.0 109.362 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.58 -177.96 6.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 0.0 109.579 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 HD13 ' A' ' 41' ' ' LEU . 29.5 mt -144.86 171.28 14.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.481 -0.762 . . . . 0.0 109.464 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -90.27 174.03 7.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.414 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -93.79 11.71 28.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -125.08 5.55 7.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.7 -0.625 . . . . 0.0 109.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . 95.27 0.28 63.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -85.09 172.95 10.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -1.166 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.534 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 20.9 p90 -93.62 120.55 34.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.592 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -72.71 132.82 44.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.364 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.72 158.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.279 -0.888 . . . . 0.0 109.164 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.76 -39.01 18.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -67.49 -15.37 63.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -1.159 . . . . 0.0 109.585 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -90.02 -5.05 57.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.608 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.2 p -74.38 165.68 24.77 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.504 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.57 179.47 21.0 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.86 168.71 6.74 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.849 1.7 . . . . 0.0 110.237 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.87 -47.9 2.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -82.14 131.52 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.31 -1.112 . . . . 0.0 109.484 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.633 ' CB ' HD21 ' A' ' 36' ' ' ASN . 36.3 mtmt -85.1 -1.94 57.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.248 -0.908 . . . . 0.0 109.522 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.18 -0.14 0.31 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.431 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 144' ' ' LYS . 23.6 pt -93.66 -10.45 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.599 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 91.47 8.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.35 168.39 10.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.396 -0.815 . . . . 0.0 109.442 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 31.6 tp -144.27 70.44 16.09 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.392 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -62.58 112.97 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.796 1.664 . . . . 0.0 110.305 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 29.8 mtt -98.12 115.61 28.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 0.0 109.307 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 42.5 t -65.16 157.32 29.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 109.602 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.99 56.21 3.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -56.13 -58.02 9.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.487 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.26 -96.99 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -142.77 -91.69 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.427 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.29 -176.67 14.62 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' O ' ' O ' ' A' ' 6' ' ' ILE . 8.6 mt-10 -90.15 134.35 34.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -1.134 . . . . 0.0 109.487 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.666 HG22 ' N ' ' A' ' 7' ' ' THR . 74.0 mt 53.09 172.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.396 -0.815 . . . . 0.0 109.541 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.666 ' N ' HG22 ' A' ' 6' ' ' ILE . 3.2 p -77.64 165.86 23.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.091 -1.006 . . . . 0.0 109.541 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.14 147.73 3.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 11' ' ' ALA . 4.4 mp -138.13 149.01 62.21 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.3 Cg_endo -58.47 76.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.709 0 C-N-CA 120.985 1.123 . . . . 0.0 110.243 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 43.15 65.68 0.92 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.167 -0.958 . . . . 0.0 110.184 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -90.17 -47.46 0.39 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 110.779 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.2 Cg_endo -66.49 167.1 19.7 Favored 'Trans proline' 0 C--N 1.321 -0.919 0 C-N-CA 121.09 1.193 . . . . 0.0 110.205 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 16' ' ' GLY . 10.5 tt0 64.33 50.35 2.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER 41.84 -90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.737 -0.602 . . . . 0.0 110.128 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' GLU . . . 149.86 11.82 0.11 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.21 -175.47 9.6 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.0 m 177.13 79.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.45 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.32 -58.79 5.3 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -145.78 9.68 1.17 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -1.087 . . . . 0.0 109.461 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 2.7 p90 38.09 67.19 2.17 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.822 -0.549 . . . . 0.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.35 168.18 11.63 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.645 1.563 . . . . 0.0 109.853 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.63 168.53 3.06 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 121.614 1.543 . . . . 0.0 110.171 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.15 39.46 6.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -166.69 30.49 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -1.152 . . . . 0.0 109.5 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -135.86 28.28 3.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.553 -0.717 . . . . 0.0 109.323 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.88 3.0 56.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.668 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -114.86 151.94 45.96 Favored Pre-proline 0 N--CA 1.495 1.822 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -60.1 166.43 8.96 Favored 'Trans proline' 0 C--N 1.323 -0.814 0 C-N-CA 121.215 1.277 . . . . 0.0 110.525 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HD2' HD22 ' A' ' 64' ' ' LEU . 36.8 mttp -150.02 131.05 14.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 109.235 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -88.53 118.73 28.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.508 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.427 ' CD1' HD12 ' A' ' 62' ' ' LEU . 24.0 mt -84.92 100.65 11.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -98.6 125.42 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.472 -0.767 . . . . 0.0 109.571 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.6 t -91.66 121.46 33.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.31 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -15.13 62.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.705 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.9 m-80 -84.66 105.07 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.714 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH2' ' A' ' 53' ' ' ARG . . . 75.87 4.91 78.32 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 50.67 88.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.407 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 42.2 m-85 -144.84 132.97 21.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.371 -1.076 . . . . 0.0 109.62 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -94.92 131.56 40.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.388 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.3 tp -62.77 143.52 57.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.268 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH1' ' OD1' ' A' ' 57' ' ' ASP . 42.5 ttt180 -146.47 119.32 8.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -0.928 . . . . 0.0 109.669 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.13 120.22 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 109.155 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -82.93 151.74 64.45 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.06 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.38 -27.29 75.05 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.121 1.214 . . . . 0.0 110.225 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.9 p30 -74.91 0.88 14.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.41 -25.11 11.37 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -55.95 114.96 2.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -1.154 . . . . 0.0 109.441 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 70.2 t -92.69 142.1 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.406 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 12.7 p-10 -170.91 150.09 3.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 109.582 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.09 155.23 22.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.4 m -147.67 140.57 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -1.129 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH2' ' O ' ' A' ' 37' ' ' GLY . 8.5 mmt180 -69.27 -12.54 61.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 0.0 109.22 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.78 98.6 0.1 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.429 ' O ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -85.12 -5.49 59.34 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.264 -0.897 . . . . 0.0 108.943 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.4 ' O ' ' OG ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -97.09 23.74 7.02 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.285 179.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' OD1' ' NH1' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -102.85 107.55 55.12 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.514 -0.741 . . . . 0.0 109.187 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.5 -3.28 3.21 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 120.718 0.945 . . . . 0.0 110.154 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -76.04 -25.64 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.271 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.49 -5.52 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.363 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -76.09 87.27 2.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.165 -0.959 . . . . 0.0 109.424 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.427 HD12 ' CD1' ' A' ' 32' ' ' LEU . 8.4 mt -89.92 135.38 33.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -89.62 111.19 22.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.256 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -91.3 148.97 21.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.718 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' O ' ' N ' ' A' ' 73' ' ' SER . 7.4 tt0 -145.36 148.25 33.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.87 163.68 22.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.87 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 102' ' ' PHE . 3.2 tt0 -138.01 -51.13 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.521 -0.737 . . . . 0.0 109.489 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -147.77 -139.82 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -91.51 101.26 13.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.0 -14.63 52.39 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.03 106.06 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.205 -1.174 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 103' ' ' PHE . 3.3 m -95.74 -178.0 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 65' ' ' GLN . 5.9 m -144.84 112.39 6.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.37 -0.831 . . . . 0.0 109.236 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mt -89.97 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.271 -0.893 . . . . 0.0 109.65 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -146.27 143.68 29.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.398 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.29 142.42 16.39 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 78' ' ' SER . 55.0 t -78.93 -87.61 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 109.368 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 77' ' ' VAL . 10.0 t -47.6 -39.68 17.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.71 -29.42 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.445 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 51.25 53.95 12.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.672 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -147.17 156.25 42.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.529 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -93.92 130.37 40.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.548 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.76 143.12 51.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.302 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.559 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -147.91 170.2 18.19 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HD11 ' A' ' 91' ' ' LEU . 2.5 ttp -139.29 122.08 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.487 -0.758 . . . . 0.0 109.372 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -59.57 -175.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -0.835 . . . . 0.0 109.434 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.26 -11.75 45.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.52 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 2.5 p30 -92.55 -38.02 12.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 143.44 -9.45 2.16 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -66.36 124.55 23.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.549 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.64 HD11 ' SD ' ' A' ' 85' ' ' MET . 11.0 mp -92.71 134.33 35.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.09 -171.53 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.599 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.64 150.39 40.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.395 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.26 147.78 31.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -66.33 -17.3 64.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.267 -0.895 . . . . 0.0 109.543 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -90.24 140.81 29.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.493 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.466 ' O ' HG12 ' A' ' 97' ' ' VAL . 24.9 t -92.98 94.6 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.48 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.2 p -91.71 157.02 17.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.428 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -48.97 -21.74 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.87 48.52 1.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 48.2 m -138.61 1.02 2.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.455 -0.778 . . . . 0.0 109.553 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 67' ' ' GLU . 99.2 m-85 -98.79 159.75 14.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.84 . . . . 0.0 109.412 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 77.2 m-85 -150.13 115.65 5.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 109.593 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -55.03 149.38 12.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.245 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.25 90.09 3.17 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -94.87 126.04 39.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.24 -0.913 . . . . 0.0 109.55 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.7 tt -94.18 125.79 39.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -92.59 170.09 10.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.432 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -79.81 62.95 4.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.449 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.504 ' C ' ' H ' ' A' ' 112' ' ' TYR . 13.0 p30 -159.94 21.63 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.944 . . . . 0.0 109.488 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.4 -6.77 0.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.488 -0.758 . . . . 0.0 110.037 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' H ' ' C ' ' A' ' 110' ' ' ASN . 41.3 m-85 -97.62 134.55 40.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 109.365 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -95.4 170.01 9.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.877 . . . . 0.0 109.822 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.0 p -140.27 114.62 9.24 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -90.63 115.33 27.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.876 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.57 150.9 22.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.556 -0.715 . . . . 0.0 109.161 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.3 163.44 20.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.896 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -94.83 -61.65 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.341 -0.85 . . . . 0.0 109.242 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -67.51 -54.07 23.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.764 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -96.1 62.62 2.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.9 p -56.89 2.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 0.0 110.305 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 120' ' ' TYR . 19.4 m -89.33 15.17 9.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.898 -1.126 . . . . 0.0 109.443 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -155.04 146.55 23.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.635 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 14.4 m-85 -104.71 169.45 8.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.642 -0.661 . . . . 0.0 109.495 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.17 125.61 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.434 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.55 156.4 42.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.683 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 27.1 mt -112.75 -178.36 3.37 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.771 -0.581 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -86.99 -129.45 0.05 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.533 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -139.84 4.52 2.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.502 -0.749 . . . . 0.0 109.408 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.31 14.82 8.32 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.61 6.46 60.91 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -92.91 162.74 13.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -1.121 . . . . 0.0 109.452 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.0 p90 -93.32 120.3 33.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.666 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.686 ' NZ ' HE21 ' A' ' 143' ' ' GLN . 22.7 ttmt -70.03 135.41 49.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.493 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.677 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.66 160.05 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.27 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -85.3 24.52 7.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.677 ' OG ' HD23 ' A' ' 135' ' ' LEU . 33.7 p -115.07 -45.73 2.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.701 -0.882 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.38 -4.86 28.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.221 -0.924 . . . . 0.0 109.684 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 p -73.16 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.167 -0.958 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.66 179.46 31.65 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.95 171.57 3.66 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.885 1.723 . . . . 0.0 110.237 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.26 -44.34 3.19 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.686 HE21 ' NZ ' ' A' ' 134' ' ' LYS . 2.5 mm100 -85.39 133.82 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -1.179 . . . . 0.0 109.461 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.628 ' CB ' HD21 ' A' ' 36' ' ' ASN . 36.9 mtmt -81.39 3.95 22.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -61.25 -9.95 5.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.202 -0.936 . . . . 0.0 109.485 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.0 pt -92.56 1.82 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 144' ' ' LYS . 71.1 mt -94.3 90.56 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.398 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -93.56 168.65 10.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 tp -141.02 70.61 28.68 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.329 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.54 103.83 0.41 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.8 1.667 . . . . 0.0 110.485 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.6 mtt -95.4 125.35 39.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.405 -0.809 . . . . 0.0 109.354 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.4 t -70.02 135.33 49.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.571 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -96.86 61.98 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.447 -0.783 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.8 mttm -54.9 -77.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.485 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.403 ' OXT' HG21 ' A' ' 6' ' ' ILE . 41.8 p . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.424 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.61 123.88 7.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' CD ' ' N ' ' A' ' 3' ' ' GLU . 2.5 mp0 -88.18 -169.91 2.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . 50.49 95.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.22 -98.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -1.119 . . . . 0.0 109.431 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.48 ' CG1' ' NH2' ' A' ' 31' ' ' ARG . 0.5 OUTLIER -89.64 -176.5 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -66.18 178.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.458 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -145.6 -98.89 0.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.798 ' H ' HG23 ' A' ' 8' ' ' THR . 11.8 mt 60.18 148.86 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.559 -0.713 . . . . 0.0 109.215 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -56.13 -173.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.754 0 C-N-CA 120.991 1.127 . . . . 0.0 110.188 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.79 156.5 30.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.534 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.48 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.7 OUTLIER 179.18 -50.76 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.288 -0.882 . . . . 0.0 110.573 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.48 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 2.2 Cg_endo -64.62 144.65 85.11 Favored 'Trans proline' 0 C--N 1.324 -0.723 0 C-N-CA 120.717 0.945 . . . . 0.0 110.111 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 49.65 74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.484 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.5 -28.29 23.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 48.95 -130.63 23.51 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -155.26 -40.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 78.4 p -145.69 48.47 1.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -1.122 . . . . 0.0 109.347 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.11 66.39 0.24 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.319 -1.513 . . . . 0.0 109.319 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB1' ' CD1' ' A' ' 21' ' ' PHE . . . -46.45 -79.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 109.688 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.499 ' CD1' ' HB1' ' A' ' 20' ' ' ALA . 2.3 p90 -153.99 67.14 5.74 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.852 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.61 167.78 11.05 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.565 1.51 . . . . 0.0 109.65 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' HIS . 2.5 Cg_endo -58.45 173.96 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 121.667 1.578 . . . . 0.0 110.259 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.13 3.08 2.41 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' A' ' 23' ' ' PRO . 81.6 t60 -87.59 -23.07 24.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -1.173 . . . . 0.0 109.473 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 7.4 m-85 -93.02 31.23 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -0.879 . . . . 0.0 109.614 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -73.27 -28.6 62.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.349 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.91 152.64 46.67 Favored Pre-proline 0 N--CA 1.494 1.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -56.45 167.24 2.85 Favored 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.204 1.269 . . . . 0.0 110.244 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -140.7 127.0 19.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.45 -0.781 . . . . 0.0 109.352 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' NH2' ' CG1' ' A' ' 6' ' ' ILE . 53.6 mtt180 -86.76 124.95 33.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD12 HD23 ' A' ' 41' ' ' LEU . 10.9 mt -84.72 102.03 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.562 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -94.86 120.27 34.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.94 116.2 23.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.21 61.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.313 -0.867 . . . . 0.0 109.691 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 1.5 m-80 -90.0 105.21 17.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.37 4.91 87.49 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.88 84.17 0.02 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -140.63 134.68 30.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.413 -1.051 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -95.25 133.35 39.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 32' ' ' LEU . 39.9 tp -67.53 143.25 56.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.209 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.651 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 1.5 ttt180 -155.99 125.05 6.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.98 . . . . 0.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG23 HG22 ' A' ' 49' ' ' VAL . 38.1 mt -94.13 127.17 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.256 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.792 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 86.8 m-70 -83.58 148.86 56.08 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.7 Cg_endo -59.25 -21.12 58.59 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.203 1.268 . . . . 0.0 110.466 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -74.71 7.73 2.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.708 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.63 -39.29 3.13 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -52.0 162.04 0.51 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -1.141 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG22 HG23 ' A' ' 43' ' ' ILE . 70.0 t -139.4 141.35 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.46 -0.775 . . . . 0.0 109.366 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.792 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 39.4 p-10 -159.46 -149.77 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.88 155.94 26.74 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.441 HG21 ' OD2' ' A' ' 57' ' ' ASP . 3.3 m -145.49 139.13 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -1.068 . . . . 0.0 109.401 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -77.83 -17.78 57.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.18 110.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.229 -0.92 . . . . 0.0 109.456 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.0 34.65 0.55 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.545 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -129.63 -20.4 3.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.655 -0.653 . . . . 0.0 109.59 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.6 OUTLIER -45.48 108.71 0.82 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.36 -0.837 . . . . 0.0 109.485 179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.86 5.44 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 120.674 0.916 . . . . 0.0 110.152 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.651 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 47.6 m80 -94.13 -15.42 24.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 pt -70.05 -4.72 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.506 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' HG23 ' A' ' 77' ' ' VAL . 32.0 mtpt -76.94 79.38 3.5 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.874 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.92 135.06 33.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.86 110.41 21.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.289 -0.882 . . . . 0.0 109.272 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -87.72 159.0 18.66 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -141.28 176.33 8.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.222 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.492 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . . . -132.64 142.07 48.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.608 -0.682 . . . . 0.0 109.574 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -146.19 143.0 28.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.416 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 50.81 -127.22 2.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.317 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -147.81 137.8 22.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.23 10.33 81.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.2 t -141.25 143.38 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.476 -1.014 . . . . 0.0 109.324 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 66' ' ' ALA . 2.4 m -136.83 -176.77 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.479 -0.763 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.1 m -141.53 126.34 18.1 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.612 -0.68 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 mt -95.48 148.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.36 136.75 23.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -83.41 136.81 15.49 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 78' ' ' SER . 51.3 t -74.97 -86.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -1.198 . . . . 0.0 109.47 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.551 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -47.51 -53.63 13.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.359 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.51 -28.55 63.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' OD1' ' O ' ' A' ' 78' ' ' SER . 18.9 m120 51.08 45.24 28.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 0.0 109.55 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.521 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -137.24 145.67 43.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 109.332 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.95 129.41 36.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.887 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.8 tp -57.45 150.19 19.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.334 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -144.03 165.74 26.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 109.476 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 28.7 ttm -137.47 126.86 24.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.526 -0.734 . . . . 0.0 109.378 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -91.4 -173.04 3.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.393 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -87.92 -29.47 20.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.253 -0.905 . . . . 0.0 109.513 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -69.9 1.18 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.86 13.07 78.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 90' ' ' ARG . 0.7 OUTLIER -91.27 117.67 29.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -1.155 . . . . 0.0 109.411 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.692 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.1 mp -90.04 137.34 32.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.612 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.13 177.46 9.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 0.0 109.736 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -110.18 164.64 12.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.692 -0.63 . . . . 0.0 109.417 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.2 m -149.33 159.13 44.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.0 109.509 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -88.44 -0.5 57.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.93 123.75 16.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.496 -0.753 . . . . 0.0 109.423 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.9 p -65.07 154.42 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.345 -0.847 . . . . 0.0 109.552 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -150.93 168.39 24.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -47.51 -24.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.9 49.27 1.32 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.446 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -143.38 5.99 1.47 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.352 -0.843 . . . . 0.0 109.612 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -97.4 157.61 15.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.453 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -150.01 112.94 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 116' ' ' ARG . 34.1 m-85 -54.92 149.14 12.06 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.133 -0.98 . . . . 0.0 109.231 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -124.96 92.14 3.58 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.657 -0.652 . . . . 0.0 109.503 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' O ' ' OG1' ' A' ' 114' ' ' THR . 10.5 ttp180 -91.47 120.19 32.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.68 126.56 32.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.501 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -86.91 -177.19 6.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.7 m -93.67 55.92 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.29 -0.881 . . . . 0.0 109.568 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 112' ' ' TYR . 17.2 p-10 -165.78 31.48 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.95 -4.29 0.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.426 -0.796 . . . . 0.0 110.227 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.488 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.6 m-85 -91.31 127.61 36.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -93.72 167.21 11.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.653 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 14.2 p -136.17 120.57 18.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 109.273 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -92.85 104.18 16.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.539 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -98.45 145.82 26.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.421 -0.8 . . . . 0.0 109.38 179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -62.56 161.34 12.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 0.0 109.277 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -87.15 -61.67 1.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.671 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -73.68 -44.38 56.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.5 m-85 -92.63 57.91 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.508 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.8 p -58.25 -0.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 0.0 109.94 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 120' ' ' TYR . 10.5 m -89.71 11.81 18.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.07 -1.019 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.03 152.59 29.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 11.4 m-85 -120.65 163.19 18.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.748 -0.595 . . . . 0.0 109.535 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.7 t -84.63 130.06 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.23 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.86 143.49 21.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.73 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.96 167.78 11.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.471 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.8 mtmt -93.75 -165.74 1.38 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -87.86 -10.16 51.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.366 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 -4.77 53.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.97 34.22 9.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.3 176.38 5.66 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.769 -0.842 . . . . 0.0 109.374 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.526 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.8 p90 -87.02 120.06 27.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.505 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -71.39 131.84 43.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.715 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -52.15 140.5 20.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -0.87 . . . . 0.0 109.337 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.52 4.08 1.61 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.715 ' OG ' HD23 ' A' ' 135' ' ' LEU . 88.9 p -91.89 -34.61 14.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -1.17 . . . . 0.0 109.604 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.02 -10.76 43.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.158 -0.964 . . . . 0.0 109.553 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.6 p -70.0 145.33 51.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.953 . . . . 0.0 109.544 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 165.5 178.96 38.96 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.49 166.54 9.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.938 1.759 . . . . 0.0 110.222 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.62 -50.47 2.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -80.41 135.08 36.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.522 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 40.6 mtmt -85.01 9.28 15.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.0 109.503 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.656 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -65.07 -2.54 2.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.482 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.4 pt -97.13 -3.16 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.42 -0.8 . . . . 0.0 109.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -86.93 91.75 8.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.119 -0.988 . . . . 0.0 109.632 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -95.54 165.51 12.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.418 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.1 tp -141.87 70.45 24.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.396 -0.815 . . . . 0.0 109.392 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.16 104.9 0.43 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.752 1.635 . . . . 0.0 110.36 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 5.7 mtt -95.31 136.27 35.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.852 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 130.4 42.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 109.559 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.47 59.73 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.385 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -55.08 -91.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.494 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.43 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ptm . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.22 -18.28 35.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.487 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -90.93 83.34 5.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.4 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.81 136.27 2.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.521 ' OE2' ' NE ' ' A' ' 31' ' ' ARG . 4.7 mp0 -82.56 -142.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -1.176 . . . . 0.0 109.502 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 8' ' ' THR . 0.6 OUTLIER -66.19 86.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.944 . . . . 0.0 109.424 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.9 m -53.12 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -92.2 16.16 12.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.478 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 9' ' ' LEU . 3.3 mm? 57.29 150.44 0.06 OUTLIER Pre-proline 0 N--CA 1.497 1.91 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.99 142.0 96.45 Favored 'Trans proline' 0 C--N 1.324 -0.756 0 C-N-CA 120.825 1.017 . . . . 0.0 110.066 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.27 -175.98 5.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.183 -0.948 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 tp -148.12 69.95 10.87 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.359 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.49 -163.2 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.823 1.682 . . . . 0.0 110.382 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -76.24 52.64 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.456 -0.777 . . . . 0.0 109.749 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -83.44 -26.92 29.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.5 -63.1 1.8 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.45 -160.03 48.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 p -149.02 53.72 0.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -1.174 . . . . 0.0 109.454 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.61 37.58 0.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 50.61 90.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -1.096 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.514 ' CZ ' ' O ' ' A' ' 105' ' ' GLU . 52.6 m-85 45.69 67.98 3.77 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.893 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.61 114.06 2.57 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.775 1.65 . . . . 0.0 109.857 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.61 115.25 2.78 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 120.7 0.934 . . . . 0.0 110.158 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -170.58 -21.43 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.583 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -159.83 91.58 0.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -1.154 . . . . 0.0 109.519 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' CG ' ' HB2' ' A' ' 66' ' ' ALA . 46.1 m-85 -144.11 19.08 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -94.77 21.16 7.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 0.0 109.683 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.5 OUTLIER -114.9 149.23 42.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.1 153.61 57.27 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 121.148 1.232 . . . . 0.0 110.384 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -137.41 124.46 21.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' NE ' ' OE2' ' A' ' 5' ' ' GLU . 2.1 mtm-85 -85.26 118.97 25.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.638 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.01 100.91 11.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.213 -0.93 . . . . 0.0 109.367 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -94.58 125.17 39.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.268 -0.895 . . . . 0.0 109.616 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.7 t -90.18 123.27 33.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -72.44 -13.91 61.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.335 -0.853 . . . . 0.0 109.854 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.575 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.3 m-80 -90.34 105.12 17.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.98 5.8 88.88 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.47 85.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.452 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 43.6 m-85 -143.15 136.21 27.97 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.349 -1.089 . . . . 0.0 109.568 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -98.13 122.76 41.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.403 -0.811 . . . . 0.0 109.493 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.13 145.53 20.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 109.179 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.413 ' NE ' ' CB ' ' A' ' 59' ' ' HIS . 20.2 ttt180 -150.63 128.62 11.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.097 -1.002 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.7 mt -95.06 131.35 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 109.131 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.416 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 49.9 m-70 -90.5 152.09 44.92 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.105 -0.997 . . . . 0.0 109.193 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.56 -27.34 76.38 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 121.198 1.265 . . . . 0.0 110.368 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -74.88 9.87 1.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.525 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -33.73 3.28 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -47.51 166.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.202 -1.176 . . . . 0.0 109.405 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.44 134.01 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.382 -0.824 . . . . 0.0 109.339 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 32.8 p-10 -159.4 155.93 27.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.33 152.19 20.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 m -145.64 149.13 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.317 -1.108 . . . . 0.0 109.431 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -82.25 -10.07 59.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -69.51 83.78 0.41 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.908 . . . . 0.0 109.309 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -84.66 49.63 1.74 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.271 -0.893 . . . . 0.0 109.552 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.95 6.19 1.02 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 109.914 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 139.57 21.71 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.293 -0.879 . . . . 0.0 109.039 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.21 -4.37 3.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.022 1.148 . . . . 0.0 110.317 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' CB ' ' NE ' ' A' ' 42' ' ' ARG . 70.1 m80 -75.0 -25.79 59.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.911 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 pt -79.41 -1.95 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 0.0 109.322 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' HG23 ' A' ' 77' ' ' VAL . 11.7 mmtp -83.96 87.0 7.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.346 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mt -90.93 135.64 33.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.362 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.42 104.37 16.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.918 . . . . 0.0 109.341 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.82 154.8 19.24 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.22 141.25 35.93 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HB2' ' CG ' ' A' ' 26' ' ' PHE . . . -90.74 136.08 33.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 0.0 109.803 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -140.57 122.18 15.21 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 60.01 164.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 108.935 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.77 32.97 0.65 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.77 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.23 16.76 0.13 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.742 -1.218 . . . . 0.0 110.201 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.54 155.67 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -1.231 . . . . 0.0 109.575 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 72' ' ' VAL . 4.3 m -144.07 130.02 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.838 . . . . 0.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 m -92.84 125.33 37.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.828 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -104.05 142.61 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.757 . . . . 0.0 109.393 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -147.23 151.57 36.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.75 139.42 14.5 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 61' ' ' LYS . 54.4 t -78.24 -65.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -1.19 . . . . 0.0 109.471 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 m -71.92 -42.54 66.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.6 65.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -0.939 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 49.98 51.29 16.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -146.06 145.98 30.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.326 -0.859 . . . . 0.0 109.377 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -89.8 133.55 34.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.579 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.494 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 44.1 tp -63.56 146.82 52.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.291 -0.881 . . . . 0.0 109.347 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.432 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -149.55 132.7 16.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.1 ttm -97.51 120.16 37.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.409 -0.807 . . . . 0.0 109.383 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.96 176.54 9.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.927 . . . . 0.0 109.429 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -83.32 -26.33 30.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.213 -0.93 . . . . 0.0 109.463 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.18 -2.62 22.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 92.48 -14.98 63.45 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 90' ' ' ARG . 2.6 mtt-85 -71.43 123.33 22.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.478 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.6 mp -90.2 136.2 33.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.579 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -146.4 -175.44 4.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.65 158.7 43.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.439 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.0 p -145.17 170.11 16.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.321 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -79.97 -36.9 35.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -93.23 126.0 38.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.533 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.6 p -71.06 118.85 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.514 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 p -97.88 161.57 13.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.358 -0.839 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.66 -21.86 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.37 55.47 2.0 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.505 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -139.29 3.69 2.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.46 -0.775 . . . . 0.0 109.551 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 79.3 m-85 -96.87 162.89 13.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 109.467 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 92.5 m-85 -150.15 121.94 8.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -62.18 97.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.514 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 34.9 tt0 -73.17 95.37 2.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.361 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -92.51 123.64 35.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.554 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.75 134.32 35.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.304 -0.872 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.24 -170.69 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.954 . . . . 0.0 109.325 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.3 p -95.81 -17.54 21.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.659 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 4.1 p30 -94.39 26.0 3.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.769 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 71.52 2.61 4.34 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.726 -0.609 . . . . 0.0 110.697 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -90.29 140.58 29.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.918 -1.114 . . . . 0.0 109.443 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -95.4 164.16 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.679 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 3.2 p -141.8 119.89 12.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 0.0 109.332 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -91.77 105.47 17.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -96.15 145.5 25.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.436 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -68.34 148.8 50.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.133 -0.979 . . . . 0.0 109.397 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.609 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -80.55 -56.73 3.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.924 . . . . 0.0 109.571 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -70.01 -46.64 64.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.1 m-85 -95.94 59.44 2.0 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -57.03 -2.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 27.9 m -89.85 10.34 24.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.158 -0.964 . . . . 0.0 109.678 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.471 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.08 153.02 30.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.816 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 13.8 m-85 -117.02 168.98 9.77 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.303 0.573 . . . . 0.0 109.464 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.78 133.24 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 109.145 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.87 177.48 9.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.1 158.36 39.86 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -93.19 170.63 9.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.421 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -78.49 -11.93 59.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 130' ' ' THR . 1.7 t -91.87 26.1 2.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.532 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.77 50.01 69.31 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -137.47 167.01 22.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.543 -0.974 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.2 p90 -90.33 120.58 31.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.899 . . . . 0.0 109.571 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -69.63 132.62 46.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 139' ' ' THR . 13.8 tp -54.04 160.73 1.43 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.471 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -78.62 -0.61 80.52 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.1 p -95.01 -47.23 6.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -1.12 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -72.46 -6.74 45.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 0.0 109.477 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 135' ' ' LEU . 3.1 p -69.95 153.52 43.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 152.01 -179.87 28.21 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.33 -174.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.779 1.652 . . . . 0.0 110.2 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.57 -43.1 1.81 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -92.21 119.46 31.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.481 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.575 ' CB ' HD21 ' A' ' 36' ' ' ASN . 36.6 mtpt -71.05 4.53 2.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 109.387 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.597 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.24 -9.2 10.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.349 -0.844 . . . . 0.0 109.542 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -93.15 0.53 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.525 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 144' ' ' LYS . 70.5 mt -92.35 91.39 7.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -0.92 . . . . 0.0 109.635 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.39 168.84 10.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.0 109.191 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.5 tp -143.07 70.43 18.39 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.336 -0.852 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -62.16 107.7 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.791 1.661 . . . . 0.0 110.246 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.0 mtt -93.88 111.13 22.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.413 -0.805 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.0 t -66.2 145.37 55.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.08 56.21 3.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.459 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 mtpp -74.84 -83.45 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.0 109.526 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.5 161.08 2.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.98 103.47 16.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 109.488 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.91 134.68 2.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -92.02 -81.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -1.202 . . . . 0.0 109.587 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -99.16 135.44 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.83 . . . . 0.0 109.672 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -58.04 -161.03 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.519 179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 7' ' ' THR . 94.6 m 53.33 96.93 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.2 mt -44.87 153.12 0.51 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.288 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.65 173.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.774 0 C-N-CA 121.23 1.286 . . . . 0.0 110.542 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -179.12 -167.52 0.11 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mt -142.41 70.81 21.64 Favored Pre-proline 0 C--N 1.301 -1.522 0 O-C-N 121.506 -0.746 . . . . 0.0 109.517 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' O ' ' CB ' ' A' ' 14' ' ' GLU . 2.2 Cg_endo -65.49 114.04 2.73 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.858 1.705 . . . . 0.0 110.165 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 13' ' ' PRO . 14.5 tt0 71.0 101.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.366 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.06 -26.04 0.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.33 -0.856 . . . . 0.0 109.545 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 47.09 74.91 0.21 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.22 108.86 0.31 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.3 p -171.15 55.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -1.143 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.75 -87.82 0.12 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.468 ' C ' ' CD1' ' A' ' 21' ' ' PHE . . . -146.3 -110.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -1.13 . . . . 0.0 109.412 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 20' ' ' ALA . 72.7 m-85 -152.37 67.51 6.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 109.775 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.15 167.8 13.68 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 121.591 1.527 . . . . 0.0 109.749 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.82 152.67 55.63 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 121.594 1.53 . . . . 0.0 110.097 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 26' ' ' PHE . . . 143.02 -52.33 0.64 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.509 ' O ' ' NZ ' ' A' ' 30' ' ' LYS . 63.4 m-70 -75.08 28.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -1.128 . . . . 0.0 109.538 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 52.1 m-85 -131.92 29.72 4.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.74 . . . . 0.0 109.224 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -95.21 -14.96 23.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.793 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -150.27 152.52 33.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.001 . . . . 0.0 109.338 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.8 175.57 0.29 Allowed 'Trans proline' 0 C--N 1.324 -0.739 0 C-N-CA 121.251 1.301 . . . . 0.0 110.243 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 25' ' ' HIS . 9.6 mttp -146.28 175.11 10.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.427 HH11 ' HG3' ' A' ' 31' ' ' ARG . 17.9 mtm-85 -131.01 128.1 39.67 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD12 HD23 ' A' ' 41' ' ' LEU . 10.4 mt -84.45 111.0 19.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.965 . . . . 0.0 109.774 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -101.42 114.52 28.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.345 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.8 t -84.81 108.31 17.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.193 -0.942 . . . . 0.0 109.491 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -51.86 -23.77 5.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.737 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 36' ' ' ASN . 1.1 m-80 -77.25 105.0 8.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.171 -0.955 . . . . 0.0 109.65 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 53' ' ' ARG . . . 72.3 7.05 66.79 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.04 73.98 0.27 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -118.27 129.88 55.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.73 -0.865 . . . . 0.0 109.571 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -91.82 113.2 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 109.2 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 32' ' ' LEU . 43.8 tp -49.07 133.83 18.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 0.0 109.187 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.516 HH11 ' CG ' ' A' ' 57' ' ' ASP . 41.2 ttp180 -142.5 122.98 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 0.0 109.7 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.2 mt -94.54 133.76 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.328 -0.858 . . . . 0.0 109.202 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -89.92 151.24 45.06 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.075 -1.016 . . . . 0.0 109.09 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.15 -18.15 28.23 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.161 1.24 . . . . 0.0 110.516 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -74.89 -7.88 54.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.106 -0.996 . . . . 0.0 109.562 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 13.19 55.46 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -94.05 163.09 13.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -1.132 . . . . 0.0 109.363 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 83' ' ' LEU . 74.5 t -129.66 126.59 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.568 -0.707 . . . . 0.0 109.315 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -156.61 149.99 24.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 109.506 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.27 151.85 22.3 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.25 146.12 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -1.149 . . . . 0.0 109.704 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 37' ' ' GLY . 28.2 mtt-85 -77.02 1.16 18.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 109.26 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.01 88.14 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -85.11 33.37 0.54 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.959 . . . . 0.0 109.602 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 m -143.64 21.8 1.82 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 109.614 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' HH11 ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.66 124.41 55.02 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 109.041 179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.1 1.86 0.55 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.668 0.912 . . . . 0.0 110.28 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 57' ' ' ASP . 38.4 m80 -94.07 -13.81 26.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -81.54 9.7 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.07 -1.019 . . . . 0.0 109.612 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -93.26 87.48 5.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -90.1 135.16 33.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.558 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -89.82 110.33 21.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.01 118.51 31.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -102.14 146.57 27.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.305 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 26' ' ' PHE . . . -88.98 139.36 30.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.194 -0.941 . . . . 0.0 109.552 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' GLU . 28.1 tt0 -146.64 142.05 27.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . 1.5 mt-10 48.3 -174.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.885 . . . . 0.0 109.563 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -100.97 113.28 26.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 109.541 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.63 25.56 17.78 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.75 152.54 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.325 -1.103 . . . . 0.0 109.418 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.7 m -144.49 133.41 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 m -92.08 118.75 31.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.332 -0.855 . . . . 0.0 109.554 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.89 138.66 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.142 -0.974 . . . . 0.0 109.391 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -147.04 139.6 24.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.66 142.36 20.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.44 -72.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -1.141 . . . . 0.0 109.484 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -45.19 91.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.621 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.31 -27.35 68.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 50.96 50.15 19.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 5.5 mtp180 -145.89 150.05 35.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.413 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -95.29 134.31 38.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.323 -0.861 . . . . 0.0 109.766 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HG21 ' A' ' 49' ' ' VAL . 42.9 tp -64.98 141.79 58.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.249 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.08 148.5 29.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.137 -0.977 . . . . 0.0 109.634 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 47.2 ttm -106.27 132.91 51.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.508 -0.745 . . . . 0.0 109.371 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -72.45 -170.58 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.515 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -77.0 -45.54 26.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 0.0 109.707 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 89' ' ' GLY . 1.4 p-10 -69.96 -82.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' A' ' 88' ' ' ASP . . . -171.18 24.61 0.09 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -89.61 124.27 34.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.2 mp -94.01 128.7 40.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.502 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.54 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.81 -173.53 4.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.395 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -140.2 152.55 46.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.404 -0.81 . . . . 0.0 109.487 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.61 155.03 42.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 109.377 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -61.09 -36.81 80.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.481 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 99.0 p -84.93 137.55 33.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 97' ' ' VAL . 12.0 p -89.08 118.12 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.9 p -93.98 -169.82 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 109.534 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 101' ' ' CYS . 1.7 m-20 -80.06 -30.75 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -71.99 15.06 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.215 -0.928 . . . . 0.0 109.448 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 99' ' ' ASP . 93.8 m -95.1 -9.32 33.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 0.0 109.664 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -86.74 148.8 25.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.935 . . . . 0.0 109.435 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -146.27 116.48 7.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.418 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -59.51 122.43 14.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.93 97.79 9.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.48 116.82 29.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.0 tp -90.76 120.3 31.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' OE1' HG23 ' A' ' 114' ' ' THR . 19.4 mt-10 -84.7 -171.29 3.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.5 p -93.37 -4.35 51.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 109.559 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.7 m-20 -93.06 25.84 3.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -0.866 . . . . 0.0 109.557 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.55 -1.01 0.24 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.378 -0.826 . . . . 0.0 109.79 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 110' ' ' ASN . 39.2 m-85 -95.93 130.94 42.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -91.61 163.05 14.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -0.954 . . . . 0.0 109.742 -179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.493 HG23 ' OE1' ' A' ' 108' ' ' GLU . 6.6 p -139.09 114.66 9.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.575 -0.703 . . . . 0.0 109.124 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -89.84 114.71 26.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.264 -0.898 . . . . 0.0 109.806 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.82 139.82 33.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.461 -0.774 . . . . 0.0 109.295 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -67.68 137.01 55.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.181 -0.949 . . . . 0.0 109.5 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 120' ' ' TYR . 25.5 ttt180 -77.98 -70.32 0.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.298 -0.876 . . . . 0.0 109.589 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 3.2 tptt -51.55 -10.08 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.526 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 27.6 m-85 -146.2 70.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 30.7 p -64.88 4.01 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 120' ' ' TYR . 11.2 m -94.25 10.23 34.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.88 . . . . 0.0 109.603 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 10.4 m-90 -154.97 137.37 14.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 22.6 m-85 -100.98 165.39 11.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.574 -0.704 . . . . 0.0 109.388 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.67 125.86 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.216 -0.927 . . . . 0.0 109.293 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.665 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -152.2 143.4 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.6 mt -95.39 176.21 6.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.393 -0.817 . . . . 0.0 109.333 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -93.07 173.19 7.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.383 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -84.92 -4.84 59.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 109.434 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.596 HG23 HE21 ' A' ' 132' ' ' GLN . 0.7 OUTLIER -93.94 -5.16 48.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 100.26 -0.66 55.95 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.596 HE21 HG23 ' A' ' 130' ' ' THR . 1.5 mp0 -93.13 172.6 8.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -1.184 . . . . 0.0 109.532 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.9 p90 -91.61 120.22 32.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -70.2 131.84 44.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 139' ' ' THR . 13.2 tp -48.5 160.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.174 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.11 2.05 53.05 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 139' ' ' THR . 84.5 p -93.69 -68.17 0.82 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' N ' ' OG ' ' A' ' 137' ' ' SER . 12.3 mptt -48.18 -14.09 0.05 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 135' ' ' LEU . 22.3 p -69.93 150.36 46.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.506 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 155.42 179.84 30.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.51 158.46 31.86 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.883 1.722 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.69 -28.78 8.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -90.4 113.89 25.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.411 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -65.93 -2.25 3.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.665 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -64.99 -10.36 28.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.411 ' H ' HG12 ' A' ' 146' ' ' ILE . 1.9 pt -90.67 2.68 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.499 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.4 mt -91.01 87.31 6.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -93.99 159.62 15.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.672 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 149' ' ' LEU . 19.5 tp -140.84 70.91 29.85 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.481 -0.762 . . . . 0.0 109.018 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.99 109.35 0.59 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.888 1.726 . . . . 0.0 110.641 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 20.6 mtt -97.5 130.94 44.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.774 . . . . 0.0 109.397 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.0 t -70.08 167.99 16.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.134 -0.979 . . . . 0.0 109.171 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.9 50.05 1.85 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -93.79 -73.83 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.887 . . . . 0.0 109.433 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.513 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.97 146.71 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.935 . . . . 0.0 109.496 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -78.25 -131.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.523 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.68 132.54 0.09 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -66.19 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -1.158 . . . . 0.0 109.502 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 6' ' ' ILE . 2.4 mp -78.32 139.63 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.325 -0.859 . . . . 0.0 109.419 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.594 ' OG1' HD13 ' A' ' 9' ' ' LEU . 79.2 p -51.94 160.81 0.66 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER -77.37 -60.37 2.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.486 -179.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.594 HD13 ' OG1' ' A' ' 7' ' ' THR . 6.3 mp 57.84 157.62 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -57.16 174.8 0.4 Allowed 'Trans proline' 0 C--N 1.321 -0.894 0 C-N-CA 121.173 1.249 . . . . 0.0 110.144 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.28 -172.43 4.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.527 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' O ' ' OD2' ' A' ' 15' ' ' ASP . 1.5 tt 52.25 69.04 2.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.451 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.15 177.37 2.02 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 121.769 1.646 . . . . 0.0 110.168 -179.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.56 51.81 13.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 0.0 109.472 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 12' ' ' LEU . 1.2 m-20 -71.54 94.89 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 17' ' ' GLY . . . -172.77 58.59 0.15 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . . . 58.05 161.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 166.91 105.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -1.114 . . . . 0.0 109.453 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -46.2 -79.07 0.07 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -150.7 81.05 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.198 -1.178 . . . . 0.0 109.53 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.492 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 2.9 p90 37.17 66.47 2.12 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.997 -0.439 . . . . 0.0 110.597 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.9 168.13 12.64 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.561 1.507 . . . . 0.0 109.766 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.62 103.01 0.15 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.583 1.522 . . . . 0.0 110.213 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.506 ' O ' ' ND1' ' A' ' 25' ' ' HIS . . . 148.88 47.1 0.02 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 24' ' ' GLY . 46.7 m-70 -155.96 16.78 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.385 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 27.9 m-85 -120.14 27.25 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.689 -0.632 . . . . 0.0 109.45 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.3 mmtp -93.01 10.82 29.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.903 . . . . 0.0 109.572 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.07 149.93 26.16 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 108.822 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -57.07 160.1 13.54 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.988 1.125 . . . . 0.0 110.174 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.69 ' HG3' HD22 ' A' ' 64' ' ' LEU . 24.8 mmtp -122.47 174.16 7.22 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.482 HH11 ' HG3' ' A' ' 31' ' ' ARG . 3.7 mtm-85 -136.84 110.89 8.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD12 HD23 ' A' ' 41' ' ' LEU . 9.5 mt -84.06 101.28 11.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.927 -179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.22 115.68 27.74 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 109.185 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.7 t -78.87 111.43 15.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.576 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -20.2 66.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 2.3 m-80 -88.13 100.93 13.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.597 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 86.71 4.55 82.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.03 84.13 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 48.7 m-85 -142.2 131.3 23.26 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.394 -1.062 . . . . 0.0 109.477 179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -92.64 121.92 34.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -0.946 . . . . 0.0 109.47 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 32' ' ' LEU . 49.2 tp -53.0 145.25 13.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.0 109.187 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 22.4 ttt180 -148.7 158.95 44.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.576 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 82.6 mt -136.27 123.37 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -88.15 149.69 45.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.116 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.89 -23.72 60.82 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 121.294 1.33 . . . . 0.0 110.699 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' OD2' ' CD ' ' A' ' 48' ' ' ARG . 36.4 p-10 -74.63 3.87 7.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.739 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.42 -35.31 4.17 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' CD ' ' OD2' ' A' ' 46' ' ' ASP . 27.0 mtp180 -47.8 152.86 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -1.177 . . . . 0.0 109.344 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -137.92 144.18 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.468 -0.77 . . . . 0.0 109.428 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -167.04 -146.98 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.545 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -145.91 161.12 28.25 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.8 m -147.1 138.36 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.465 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.475 HH11 ' HG3' ' A' ' 53' ' ' ARG . 4.5 mtm-85 -82.25 5.43 20.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -83.38 106.61 15.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.877 . . . . 0.0 109.548 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 9.7 pttp -84.0 38.46 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.96 17.5 2.12 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.529 -0.732 . . . . 0.0 109.268 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -99.13 110.16 56.92 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.427 -0.795 . . . . 0.0 109.152 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 1.63 0.63 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.68 0.92 . . . . 0.0 110.127 -179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 57' ' ' ASP . 23.1 m80 -80.6 -13.29 59.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.391 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -87.21 -0.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.874 . . . . 0.0 109.451 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -75.18 87.48 2.45 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.97 131.68 35.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.912 . . . . 0.0 109.454 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -89.98 102.95 15.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.69 HD22 ' HG3' ' A' ' 30' ' ' LYS . 10.7 mp -86.21 149.66 24.93 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.204 -0.935 . . . . 0.0 109.435 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -143.98 139.1 28.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' HB2' ' CE2' ' A' ' 26' ' ' PHE . . . -88.69 111.74 22.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -92.11 -91.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.47 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -84.34 180.0 7.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.847 . . . . 0.0 109.511 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 69' ' ' ARG . 2.8 mtt-85 -76.62 110.7 11.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.488 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.41 26.02 26.66 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -145.52 96.67 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.284 -1.127 . . . . 0.0 109.484 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -92.87 126.65 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.6 m -94.31 129.02 41.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.443 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.78 146.84 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -0.859 . . . . 0.0 109.545 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.96 117.68 8.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.0 137.46 48.27 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.517 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 55.2 t -80.0 -80.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -1.086 . . . . 0.0 109.435 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.413 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.3 OUTLIER -58.6 -35.01 71.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.895 . . . . 0.0 109.449 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.79 -25.83 61.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.479 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 5.0 m-80 51.21 52.69 14.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.615 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.8 mtt-85 -147.63 143.32 27.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -89.9 126.78 35.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.4 tp -59.88 147.49 38.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.664 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.51 170.14 17.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -140.03 128.89 23.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.516 -0.74 . . . . 0.0 109.379 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -73.12 -169.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -92.78 -17.5 24.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 3.4 p30 -85.44 -40.87 15.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.665 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.56 -6.49 2.16 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -70.56 126.35 29.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.9 mp -93.09 138.47 31.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.664 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.05 -176.56 5.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.89 157.1 44.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.361 -0.837 . . . . 0.0 109.362 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 m -145.49 170.14 16.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.831 . . . . 0.0 109.415 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.6 -42.88 33.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -0.924 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 p -89.43 142.86 27.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.5 p -85.23 116.99 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.347 -0.846 . . . . 0.0 109.417 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.5 p -96.01 178.88 5.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.448 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.19 -22.81 67.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.426 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -94.08 54.67 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.814 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.2 m -137.43 0.56 2.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.48 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 83.9 m-85 -94.87 153.17 17.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.386 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 82.2 m-85 -147.84 120.14 8.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.458 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -59.74 154.19 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.227 -0.921 . . . . 0.0 109.284 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -125.25 97.24 5.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.684 -0.635 . . . . 0.0 109.403 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.98 116.74 28.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.085 -1.009 . . . . 0.0 109.441 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 13.2 tp -90.89 112.33 24.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.211 -0.93 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -84.89 167.72 15.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.883 . . . . 0.0 109.528 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.0 t -81.49 66.39 7.02 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.654 ' ND2' ' H ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -167.58 24.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m120 63.49 -7.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.517 -0.739 . . . . 0.0 110.057 179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.654 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 54.8 m-85 -98.32 120.12 38.19 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.917 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.3 m120 -93.25 170.05 9.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.281 -0.887 . . . . 0.0 109.833 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 p -134.08 121.64 21.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.344 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -94.44 105.01 16.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 121' ' ' THR . 27.9 ttt180 -94.78 147.06 23.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.331 -0.855 . . . . 0.0 109.454 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -74.01 158.26 34.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.156 -0.965 . . . . 0.0 109.686 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -93.67 -75.62 0.5 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.255 -0.903 . . . . 0.0 109.483 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.486 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 10.4 tptm -51.44 -9.93 0.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 11.1 m-85 -142.97 63.68 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.467 -0.771 . . . . 0.0 109.435 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.521 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 30.2 p -63.27 2.74 0.34 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -0.891 . . . . 0.0 109.576 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 57.8 m -91.01 11.97 21.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.06 145.27 21.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.727 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.468 ' OH ' ' CZ ' ' A' ' 116' ' ' ARG . 27.9 m-85 -109.96 168.16 9.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.741 -0.6 . . . . 0.0 109.44 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 69.7 t -92.93 131.43 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 109.4 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -148.26 -172.54 4.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 95.5 mt -138.49 149.8 45.77 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.553 -0.717 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -61.09 -102.97 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.34 -0.85 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.5 ' O ' ' CZ ' ' A' ' 39' ' ' PHE . 31.3 ptt180 -173.76 -30.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.417 -0.802 . . . . 0.0 109.353 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 130' ' ' THR . 1.8 t -92.53 22.11 4.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.616 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 88.99 40.75 6.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -136.4 158.7 43.82 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.574 -0.956 . . . . 0.0 109.509 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 31.0 p90 -95.02 120.46 35.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.816 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -69.74 135.26 49.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.606 HD23 ' OG ' ' A' ' 137' ' ' SER . 8.2 tp -58.06 157.34 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.279 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.523 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -79.39 22.19 3.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.606 ' OG ' HD23 ' A' ' 135' ' ' LEU . 3.5 p -98.57 -60.71 1.49 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.362 -1.081 . . . . 0.0 109.554 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -71.93 -7.5 48.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.122 -0.986 . . . . 0.0 109.641 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 135' ' ' LEU . 23.7 p -70.12 146.84 50.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.89 179.77 42.32 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.84 172.71 2.71 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.864 1.709 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.1 -42.11 2.5 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -72.52 134.68 45.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.379 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.517 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 16.0 mtpp -85.09 -4.13 59.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.611 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -61.48 -3.72 1.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.544 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.419 ' H ' ' C ' ' A' ' 144' ' ' LYS . 3.0 pt -99.2 -3.23 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.39 -0.819 . . . . 0.0 109.66 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.2 mt -82.24 93.95 7.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.915 . . . . 0.0 109.591 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -99.26 161.06 13.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.408 -0.808 . . . . 0.0 109.529 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.4 tp -133.32 75.73 69.74 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.624 -0.672 . . . . 0.0 109.23 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.25 111.08 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.712 1.608 . . . . 0.0 110.503 -179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 40.3 mtt -96.37 114.99 26.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.455 -0.778 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.497 ' CB ' ' HZ2' ' A' ' 154' ' ' LYS . 9.6 t -70.2 129.07 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -0.919 . . . . 0.0 109.455 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.94 56.34 3.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.414 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.497 ' HZ2' ' CB ' ' A' ' 152' ' ' SER . 63.4 mttp -66.78 -73.87 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.228 -0.92 . . . . 0.0 109.493 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptt? . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.28 0.562 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.74 120.73 9.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.472 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -82.15 135.92 35.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.461 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.476 ' O ' ' C ' ' A' ' 5' ' ' GLU . . . 93.49 51.51 2.16 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 4' ' ' GLY . 1.4 pm0 29.48 -131.62 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.313 -0.522 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.622 HG22 HG23 ' A' ' 7' ' ' THR . 2.4 mp -78.46 115.66 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.622 HG23 HG22 ' A' ' 6' ' ' ILE . 11.8 p 51.94 178.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 8' ' ' THR . 8.3 t -165.34 94.13 0.62 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.55 151.85 44.07 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 108.956 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.97 99.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.07 1.18 . . . . 0.0 110.133 179.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.29 143.4 47.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.92 . . . . 0.0 109.531 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 tp -148.82 68.07 9.59 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.68 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.86 131.66 33.94 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.736 1.624 . . . . 0.0 110.176 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 16' ' ' GLY . 2.2 mp0 52.59 91.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.293 -0.879 . . . . 0.0 109.443 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.6 OUTLIER -54.23 -7.42 0.14 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.462 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -145.4 -49.39 0.03 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 46.8 -93.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 16' ' ' GLY . 20.6 m -146.58 51.25 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.095 . . . . 0.0 109.425 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . 66.02 -6.13 1.66 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.86 101.01 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -1.166 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' H ' ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER 177.98 -51.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.222 -0.924 . . . . 0.0 110.801 -179.993 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' A' ' 21' ' ' PHE . 3.9 Cg_exo -62.46 167.87 10.67 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 120.65 0.9 . . . . 0.0 109.829 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.73 -168.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 121.687 1.591 . . . . 0.0 110.368 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.28 -48.54 1.19 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -93.85 44.89 1.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -1.118 . . . . 0.0 109.486 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -140.91 14.23 2.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.431 -0.793 . . . . 0.0 109.563 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -94.09 23.91 4.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 109.695 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -162.8 152.56 13.29 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.09 174.41 0.33 Allowed 'Trans proline' 0 C--N 1.322 -0.844 0 C-N-CA 121.115 1.21 . . . . 0.0 110.08 179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HD3' HD22 ' A' ' 64' ' ' LEU . 9.7 mtpp -147.22 131.04 17.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.665 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.9 mtt-85 -85.89 121.18 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.056 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 41' ' ' LEU . 19.7 mt -84.5 104.91 14.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -0.917 . . . . 0.0 109.428 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.98 117.14 33.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.585 -0.697 . . . . 0.0 109.6 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.39 116.45 23.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.164 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -65.48 -24.5 67.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 110.06 -179.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -83.82 105.14 14.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 83.24 4.34 89.69 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 45.41 83.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.563 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 47.8 m-85 -141.48 140.53 33.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -1.103 . . . . 0.0 109.534 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -100.88 134.24 44.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.529 -0.732 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 32' ' ' LEU . 44.7 tp -70.13 144.12 52.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 41.1 ttp180 -152.82 129.1 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.3 mt -103.33 136.28 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.518 ' HE2' ' CG ' ' A' ' 50' ' ' ASP . 5.5 m-70 -91.73 148.89 38.16 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.066 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.14 -17.66 46.93 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.095 1.197 . . . . 0.0 110.423 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 7.4 p30 -74.84 -10.48 59.54 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.776 -179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 15.15 29.79 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.6 mtt-85 -92.65 167.44 11.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -1.19 . . . . 0.0 109.333 179.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 16.7 t -142.94 117.73 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.402 -0.811 . . . . 0.0 109.274 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' CG ' ' HE2' ' A' ' 44' ' ' HIS . 4.3 p-10 -158.23 160.29 36.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.223 -0.923 . . . . 0.0 109.637 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -94.11 152.99 20.94 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.7 155.06 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.345 -1.091 . . . . 0.0 109.481 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -75.26 -30.66 60.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.461 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.421 ' OE2' ' OD1' ' A' ' 57' ' ' ASP . 2.6 mt-10 -47.26 94.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 53' ' ' ARG . 8.8 pttp -85.24 33.82 0.56 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.946 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.424 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 1.1 t -165.23 43.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.09 -1.006 . . . . 0.0 110.007 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -94.2 156.88 38.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.957 . . . . 0.0 109.188 179.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_endo -66.15 22.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.321 -0.911 0 C-N-CA 121.508 1.472 . . . . 0.0 111.051 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . 61.7 m80 -141.71 -15.51 0.82 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.053 -1.029 . . . . 0.0 110.928 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 pt -64.81 -5.2 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.761 -1.212 . . . . 0.0 109.408 -179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -88.39 90.81 8.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.374 -0.829 . . . . 0.0 109.449 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.434 HD12 ' CD1' ' A' ' 32' ' ' LEU . 15.4 mt -89.96 135.38 33.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.47 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' OE1' ' N ' ' A' ' 64' ' ' LEU . 2.4 tp-100 -89.67 106.49 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -86.92 155.59 20.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.542 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -143.72 121.8 12.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.847 . . . . 0.0 109.246 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.83 157.57 26.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.93 . . . . 0.0 109.596 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -148.06 135.42 20.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 109.385 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 50.75 -112.01 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -153.52 124.64 7.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.299 -0.876 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.11 -17.87 35.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.29 146.02 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.669 -0.9 . . . . 0.0 109.332 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 m -146.43 175.34 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 m -143.97 128.77 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.73 147.84 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.29 -0.881 . . . . 0.0 109.565 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' NZ ' ' CZ ' ' A' ' 82' ' ' TYR . 5.7 tttp -147.49 134.27 20.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.62 130.85 10.3 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.36 -74.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -1.13 . . . . 0.0 109.496 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 80' ' ' ASN . 2.1 t -66.42 -45.25 80.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -27.55 39.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 78' ' ' SER . 11.2 m120 49.79 47.48 22.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.285 -0.885 . . . . 0.0 109.439 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.513 ' HB3' ' HB1' ' A' ' 93' ' ' ALA . 92.4 mtt180 -147.28 144.67 29.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.436 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CZ ' ' NZ ' ' A' ' 75' ' ' LYS . 70.7 m-85 -90.15 131.69 35.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.602 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.33 142.63 56.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.938 . . . . 0.0 109.206 179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.554 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -148.29 134.49 19.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 53.7 ttm -96.65 126.58 41.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.371 -0.831 . . . . 0.0 109.395 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -72.25 178.8 3.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.82 -31.59 45.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.503 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -70.98 -48.26 54.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.514 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 146.06 -9.11 1.52 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -71.27 124.71 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.154 -1.203 . . . . 0.0 109.489 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.3 mp -92.74 133.87 35.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.484 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.553 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.8 OUTLIER -147.59 177.78 8.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -116.83 156.64 26.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.699 -0.626 . . . . 0.0 109.373 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.7 t -145.34 162.91 36.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -82.98 -39.79 20.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.1 t -92.63 122.76 35.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.179 -0.951 . . . . 0.0 109.493 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.14 154.73 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.201 -0.937 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -147.53 -177.12 5.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.18 -0.95 . . . . 0.0 109.511 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.75 -22.55 64.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -87.68 44.26 1.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.496 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 22.0 m -143.17 5.45 1.48 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.419 -0.801 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 59.7 m-85 -93.42 151.89 19.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.965 . . . . 0.0 109.563 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 84.1 m-85 -150.16 110.59 4.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.288 -0.882 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -56.96 155.14 8.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 109.137 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -125.19 95.35 4.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.369 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' NH2' ' OE1' ' A' ' 108' ' ' GLU . 6.2 ttp180 -90.76 132.36 35.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.21 132.45 36.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 109.493 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' OE1' ' NH2' ' A' ' 106' ' ' ARG . 4.5 mm-40 -88.35 -174.67 4.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.395 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.14 -16.46 24.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.908 . . . . 0.0 109.452 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.404 ' O ' ' CD2' ' A' ' 112' ' ' TYR . 5.7 m-80 -93.44 24.24 4.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.537 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 m120 64.11 57.32 1.28 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.503 -0.748 . . . . 0.0 110.056 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.404 ' CD2' ' O ' ' A' ' 110' ' ' ASN . 52.7 m-85 -143.02 126.39 16.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 109.257 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -94.73 120.36 34.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 146' ' ' ILE . 66.8 p -98.1 129.06 44.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.405 -0.809 . . . . 0.0 109.224 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -95.89 113.03 24.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.341 -0.849 . . . . 0.0 109.725 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -100.81 144.89 29.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 109.378 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 t -76.24 139.95 41.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 109.582 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.474 ' C ' ' N ' ' A' ' 120' ' ' TYR . 1.2 ttt-85 -76.47 -70.63 0.44 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.346 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -51.37 -9.87 0.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 109.409 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.474 ' N ' ' C ' ' A' ' 118' ' ' ARG . 49.7 m-85 -143.86 68.22 1.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.387 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 82.5 p -67.06 3.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 120' ' ' TYR . 73.5 m -95.63 10.55 36.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.82 . . . . 0.0 109.652 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 5.1 m-90 -155.13 145.18 21.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.848 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 23.3 m-85 -112.01 161.47 16.42 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.75 -0.594 . . . . 0.0 109.457 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 56.3 t -83.74 140.64 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 0.0 109.199 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.01 -171.37 3.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.808 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 133' ' ' TYR . 19.4 mt -140.78 159.46 42.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.523 -0.736 . . . . 0.0 109.3 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -87.56 -173.54 4.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 109.433 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -92.86 -15.53 26.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -0.895 . . . . 0.0 109.613 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.542 HG23 ' OE1' ' A' ' 132' ' ' GLN . 1.5 t -89.09 3.5 51.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.0 109.538 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.2 -1.05 76.37 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' OE1' HG23 ' A' ' 130' ' ' THR . 3.6 mp0 -86.11 174.76 8.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -1.175 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 35.5 p90 -95.02 120.43 35.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 109.68 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -69.85 135.42 49.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.396 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -49.31 149.35 2.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.245 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.524 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -75.21 0.28 59.66 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 35.7 p -93.99 -37.96 11.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -1.123 . . . . 0.0 109.553 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -76.82 -8.2 56.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.1 p -71.95 160.32 32.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 153.3 179.69 28.98 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' GLN . 2.7 Cg_endo -61.11 -176.62 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.922 1.748 . . . . 0.0 110.235 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 74.46 -36.78 0.98 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.457 ' C ' ' H ' ' A' ' 145' ' ' ALA . 5.2 mt-30 -93.34 113.46 25.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -1.084 . . . . 0.0 109.549 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 146' ' ' ILE . 19.5 mtmt -65.83 2.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.457 ' H ' ' C ' ' A' ' 143' ' ' GLN . . . -64.6 2.08 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.644 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 114' ' ' THR . 5.6 pt -100.66 6.35 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 109.638 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.7 mt -94.35 94.81 8.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 0.0 109.802 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -98.3 164.3 12.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.402 -0.811 . . . . 0.0 109.37 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 tp -142.01 70.82 23.66 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.355 -0.841 . . . . 0.0 109.52 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.81 107.84 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.929 1.753 . . . . 0.0 110.324 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 8.8 mtt -96.18 128.99 43.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.855 . . . . 0.0 109.516 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.9 t -70.12 153.2 43.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.888 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.578 ' CB ' HH22 ' A' ' 31' ' ' ARG . . . -91.36 58.84 3.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.53 -78.57 0.41 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.231 -0.918 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.503 -179.973 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.264 0.554 . . . . 0.0 109.528 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -47.71 129.15 13.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.23 -0.919 . . . . 0.0 109.517 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.85 99.48 12.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.02 -18.7 74.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -140.36 -168.48 2.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -1.01 . . . . 0.0 109.351 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.32 99.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -0.883 . . . . 0.0 109.42 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.1 m -92.52 116.54 29.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.539 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.4 t -147.53 -3.28 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mp 46.77 68.8 3.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.765 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.07 99.01 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.799 1.666 . . . . 0.0 110.21 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -151.79 58.23 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.711 ' H ' ' HD2' ' A' ' 13' ' ' PRO . 0.8 OUTLIER 178.65 -37.26 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.584 -0.697 . . . . 0.0 111.308 179.561 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 12' ' ' LEU . 1.8 Cg_endo -70.01 127.0 13.78 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 120.488 0.792 . . . . 0.0 110.277 -179.159 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 51.32 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -66.05 -8.53 23.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.91 -113.02 3.87 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.92 -149.64 5.01 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -84.69 52.63 2.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -1.111 . . . . 0.0 109.501 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.15 88.93 0.01 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.88 8.09 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -1.113 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.429 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 12.7 m-85 46.46 66.88 4.95 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.979 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.37 113.95 2.48 Favored 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 121.767 1.645 . . . . 0.0 110.073 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.88 109.9 1.19 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.778 0.985 . . . . 0.0 110.096 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -173.03 -64.82 0.05 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.436 ' CD2' ' H ' ' A' ' 25' ' ' HIS . 0.4 OUTLIER -88.68 27.3 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.667 -179.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.572 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 24.7 m-85 -87.04 10.11 17.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.415 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 12.8 tttm -93.43 34.45 1.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.331 -0.856 . . . . 0.0 109.506 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -148.83 151.92 36.1 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.073 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.14 171.45 2.27 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 121.21 1.273 . . . . 0.0 110.369 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.572 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 30.2 mttt -145.15 126.93 15.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.04 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.599 ' CG ' HH11 ' A' ' 31' ' ' ARG . 1.5 mtt-85 -84.81 117.09 23.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.653 -179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD12 HD23 ' A' ' 41' ' ' LEU . 18.7 mt -84.63 99.07 10.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.97 124.2 36.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.312 -0.867 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 t -90.51 120.31 31.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 0.0 109.212 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -67.94 -14.87 63.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.356 -0.84 . . . . 0.0 109.865 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.593 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 8.3 m-20 -88.63 105.22 17.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.15 -0.969 . . . . 0.0 109.642 -179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.21 4.94 87.14 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.85 86.83 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 47.2 m-85 -144.77 138.26 27.02 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.302 -1.116 . . . . 0.0 109.65 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.48 121.63 38.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.0 109.423 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.426 HD23 HD12 ' A' ' 32' ' ' LEU . 41.4 tp -49.36 150.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 0.0 109.203 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -156.61 119.51 4.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.2 mt -92.55 129.18 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.191 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -89.99 151.99 45.8 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.123 -0.986 . . . . 0.0 109.19 -179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -57.8 -26.75 75.12 Favored 'Trans proline' 0 C--N 1.323 -0.804 0 C-N-CA 121.27 1.313 . . . . 0.0 110.378 179.685 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -74.79 10.73 1.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.92 -37.41 2.98 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.621 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.8 mtt-85 -47.17 154.07 0.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.183 -1.187 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG21 ' CD1' ' A' ' 83' ' ' LEU . 95.7 t -134.16 130.42 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.365 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -146.24 -149.23 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.903 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -150.42 150.44 22.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.16 144.06 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.474 HH11 ' HG3' ' A' ' 53' ' ' ARG . 3.6 mtm-85 -77.64 -16.67 58.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.436 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -59.97 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.384 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -81.12 12.36 3.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.554 -179.908 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -108.92 10.91 26.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.631 -0.668 . . . . 0.0 109.597 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -95.05 123.48 57.2 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.18 -179.923 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.13 4.92 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 120.636 0.891 . . . . 0.0 110.331 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 57' ' ' ASP . 24.1 m80 -82.53 -38.41 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.062 -1.024 . . . . 0.0 109.879 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -65.52 4.82 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.577 -179.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 59' ' ' HIS . 14.5 mttt -87.24 84.08 7.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -90.37 134.28 34.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.898 . . . . 0.0 109.53 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -89.83 108.23 19.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.371 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.4 mp -93.21 150.85 20.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 -179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -144.2 144.51 31.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 0.0 109.412 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.27 126.36 36.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.184 -0.948 . . . . 0.0 109.505 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -97.48 -30.21 13.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.487 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -153.67 -171.88 4.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.219 -0.926 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -82.95 23.53 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.579 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -169.63 23.72 0.1 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 92.1 t -149.31 151.0 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.422 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.3 m -145.2 127.18 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.503 179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.6 m -94.5 122.22 36.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.583 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 74' ' ' ILE . 8.3 mt -94.4 145.75 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.462 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -147.37 130.78 16.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -78.32 133.81 13.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 88.4 t -76.19 -65.41 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -1.15 . . . . 0.0 109.462 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -61.64 -34.19 75.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.474 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.88 -25.64 34.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.425 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 31.6 m120 50.97 50.82 18.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -148.11 148.53 30.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -89.95 134.89 33.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' CD1' HG21 ' A' ' 49' ' ' VAL . 39.5 tp -65.09 147.75 52.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.662 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -146.65 170.3 17.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 109.388 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 34.7 ttm -139.11 129.05 25.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.529 -0.732 . . . . 0.0 109.409 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -75.07 178.71 5.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.592 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -84.39 -7.84 59.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 89' ' ' GLY . 1.7 p30 -92.72 -46.29 7.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 88' ' ' ASP . . . 146.33 -9.16 1.46 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -71.93 127.86 33.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.9 mp -91.68 139.16 30.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.662 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -150.08 -176.06 5.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.582 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.57 160.08 40.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 109.291 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 76.8 p -147.14 170.02 18.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -80.98 -36.86 30.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.509 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.9 p -91.23 126.17 36.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 97' ' ' VAL . 11.7 p -72.98 116.31 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.51 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.7 p -93.64 -170.16 2.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -79.92 -10.85 59.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -93.78 12.55 25.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.491 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 59.2 m -95.68 8.93 42.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -0.86 . . . . 0.0 109.627 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -97.74 148.65 23.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.384 -0.822 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.458 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 63.2 m-85 -150.13 113.37 4.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -55.26 152.02 8.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 108.928 179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.429 ' OE2' ' CE1' ' A' ' 21' ' ' PHE . 10.6 tt0 -125.07 94.71 4.25 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -92.69 128.42 38.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.936 . . . . 0.0 109.4 179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 tp -93.29 137.99 32.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.664 ' OE2' HG23 ' A' ' 114' ' ' THR . 2.5 mp0 -92.67 -178.34 4.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.434 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.1 m -94.24 47.74 1.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -156.14 23.24 0.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' ND2' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 65.13 49.77 1.95 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.53 -0.731 . . . . 0.0 110.012 179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.423 ' O ' ' OE2' ' A' ' 108' ' ' GLU . 52.3 m-85 -140.63 129.87 23.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.385 -0.822 . . . . 0.0 109.325 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 113' ' ' ASN . 0.6 OUTLIER -94.6 154.6 17.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.631 -179.826 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.664 HG23 ' OE2' ' A' ' 108' ' ' GLU . 23.3 p -131.38 119.32 21.51 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -93.32 107.74 19.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 -179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -101.53 148.12 25.58 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 109.294 179.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -72.57 157.11 38.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.169 -0.957 . . . . 0.0 109.965 -179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.2 OUTLIER -93.96 -76.52 0.48 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.349 -0.844 . . . . 0.0 109.43 -179.956 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -51.29 -10.03 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.34 -0.85 . . . . 0.0 109.6 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 118' ' ' ARG . 31.2 m-85 -142.89 63.78 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.875 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 19.7 p -63.32 3.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.875 . . . . 0.0 109.775 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' TYR . 16.7 m -89.86 11.68 19.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.606 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -154.14 145.36 22.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 109.839 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 27.2 m-85 -113.79 167.51 10.57 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.766 -0.584 . . . . 0.0 109.447 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.49 129.37 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.585 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.32 149.38 26.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.941 . . . . 0.0 109.656 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.453 ' O ' ' NZ ' ' A' ' 134' ' ' LYS . 19.7 mt -107.11 176.56 5.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.615 -0.678 . . . . 0.0 109.535 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -95.46 -166.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.38 -0.825 . . . . 0.0 109.28 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -17.29 23.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.366 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.1 1.96 55.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -0.887 . . . . 0.0 109.423 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.25 12.21 56.46 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -93.52 142.63 27.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -1.192 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.523 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 24.5 p90 -69.09 120.67 15.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.857 . . . . 0.0 109.59 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.453 ' NZ ' ' O ' ' A' ' 127' ' ' LEU . 2.8 ttpm? -69.65 130.5 42.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.146 -0.971 . . . . 0.0 109.405 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.418 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.5 148.34 1.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.935 . . . . 0.0 109.403 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.52 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -64.38 -31.68 81.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.418 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -77.46 -15.55 59.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -1.174 . . . . 0.0 109.55 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -89.31 -4.96 57.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.539 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.0 p -87.33 156.68 19.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 167.34 179.94 40.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.93 166.52 10.29 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 121.866 1.711 . . . . 0.0 110.231 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.78 -33.32 1.9 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.25 106.46 6.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.402 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -66.42 -3.0 5.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.528 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.593 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -61.5 -6.27 2.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.408 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 146' ' ' ILE . 4.9 pt -93.75 -1.52 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.425 -0.797 . . . . 0.0 109.497 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.5 mt -87.11 90.35 8.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.308 -0.87 . . . . 0.0 109.476 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -94.92 167.98 11.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.361 -0.837 . . . . 0.0 109.562 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.7 tp -144.49 73.87 15.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.446 -0.784 . . . . 0.0 109.251 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.97 115.16 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 121.75 1.633 . . . . 0.0 110.629 -179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 6.0 mtt -96.33 107.01 19.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.442 -0.786 . . . . 0.0 109.324 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -63.97 147.02 53.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.345 179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.99 56.76 4.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -55.21 -86.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.49 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.535 179.98 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.315 0.578 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 -15.71 0.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -59.73 167.93 1.91 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 109.415 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.92 172.08 42.85 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -73.05 -106.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.449 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 8' ' ' THR . 9.5 mm -90.93 105.31 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 0.0 109.536 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -47.95 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 109.267 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -79.42 87.2 5.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 11' ' ' ALA . 83.4 mt -84.51 150.57 57.22 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 0.0 108.657 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 2.5 Cg_endo -56.7 87.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.761 0 C-N-CA 120.98 1.12 . . . . 0.0 110.007 179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 10' ' ' PRO . . . 165.4 73.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.298 -0.876 . . . . 0.0 109.227 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.963 ' H ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -101.15 163.23 18.35 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.37 -0.831 . . . . 0.0 108.946 -179.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.39 101.36 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.458 1.439 . . . . 0.0 110.222 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -162.45 51.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.888 . . . . 0.0 109.457 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -96.35 -31.55 12.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -0.809 . . . . 0.0 109.386 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.67 86.63 1.35 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.09 152.01 24.17 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -77.78 52.27 1.01 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -1.12 . . . . 0.0 109.459 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.29 15.02 36.17 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -144.73 -112.45 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -1.081 . . . . 0.0 109.216 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 21' ' ' PHE . 13.6 p90 -165.41 66.87 1.16 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.207 -0.933 . . . . 0.0 109.804 179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.76 167.93 11.05 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.587 1.524 . . . . 0.0 109.837 -179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.63 133.74 58.56 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.637 1.558 . . . . 0.0 110.204 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' ' CG ' ' A' ' 25' ' ' HIS . . . 149.21 27.93 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 24' ' ' GLY . 91.5 m-70 -156.64 56.09 0.55 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -1.151 . . . . 0.0 109.417 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -140.87 14.94 2.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 tttt -92.5 -16.84 25.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.595 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.84 152.63 46.61 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.75 168.66 2.2 Favored 'Trans proline' 0 C--N 1.322 -0.864 0 C-N-CA 121.147 1.231 . . . . 0.0 110.168 179.474 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -144.86 128.75 17.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.381 -0.825 . . . . 0.0 109.376 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.608 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.35 118.82 25.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.94 . . . . 0.0 109.509 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 41' ' ' LEU . 20.7 mt -84.86 98.84 10.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 40' ' ' PHE . 37.3 t80 -94.98 122.13 37.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.685 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.24 131.48 35.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.857 . . . . 0.0 109.184 179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.57 -18.78 58.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.756 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 3.0 m120 -82.15 105.08 12.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 109.608 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.515 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 78.84 4.92 88.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 48.33 84.02 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.6 m-85 -143.17 134.95 26.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -1.112 . . . . 0.0 109.545 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 22.8 m-85 -96.68 126.27 41.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 32' ' ' LEU . 49.7 tp -51.22 149.3 3.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.35 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.511 ' NH2' ' OD1' ' A' ' 57' ' ' ASP . 17.7 ttt180 -158.26 116.02 2.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.582 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.0 mt -91.81 128.97 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.236 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -89.44 151.64 46.44 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 0.0 109.055 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.518 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.18 -24.02 64.72 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 121.113 1.208 . . . . 0.0 110.254 179.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -74.9 2.5 10.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.602 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.4 -32.25 5.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -47.36 162.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -1.114 . . . . 0.0 109.446 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.5 t -143.6 128.33 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.862 . . . . 0.0 109.457 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -155.99 -150.28 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 109.419 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.38 27.7 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -145.73 149.5 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -1.083 . . . . 0.0 109.433 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -81.92 -15.72 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.247 -0.908 . . . . 0.0 109.49 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 99.87 3.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.379 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -80.61 12.26 3.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.555 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 t -92.26 -20.11 21.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.542 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.511 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 0.7 OUTLIER -60.02 115.01 11.23 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.256 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.94 3.45 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.633 0.889 . . . . 0.0 110.185 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' H ' ' C ' ' A' ' 57' ' ' ASP . 59.7 m80 -85.07 -12.33 53.26 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -0.871 . . . . 0.0 109.544 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.4 9.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.487 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.9 mmmm -92.53 84.57 5.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -91.27 134.48 34.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.59 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -91.65 109.77 21.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.56 114.88 27.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -99.01 142.85 29.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.428 -0.795 . . . . 0.0 109.595 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.6 161.56 14.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -145.21 -102.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -0.865 . . . . 0.0 109.431 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -76.31 -154.53 0.05 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -90.43 106.61 18.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.88 -9.19 73.34 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.82 133.18 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -1.156 . . . . 0.0 109.528 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.1 129.03 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.382 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.1 m -93.65 123.76 37.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.334 -0.854 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.87 141.47 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -146.13 146.65 30.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -91.81 139.69 14.84 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 61' ' ' LYS . 99.1 t -79.94 -46.25 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -1.163 . . . . 0.0 109.558 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -88.67 -43.37 11.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.539 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.54 -23.23 66.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.506 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 51.31 49.16 21.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 91.3 mtt180 -147.99 147.5 29.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.32 135.26 34.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.334 -0.854 . . . . 0.0 109.656 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.3 tp -64.95 145.19 56.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.337 -0.852 . . . . 0.0 109.203 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.86 135.34 18.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 42.9 ttm -98.18 138.89 34.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.455 -0.778 . . . . 0.0 109.453 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HE2' HD21 ' A' ' 92' ' ' LEU . 10.4 mmtm -92.48 178.0 5.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.931 . . . . 0.0 109.529 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 4.6 pm0 -80.54 -25.49 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.6 p30 -83.16 -1.56 53.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.475 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 93.69 2.26 65.25 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -78.36 115.18 17.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -1.139 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.666 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -90.63 132.24 35.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.493 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.549 HD21 ' HE2' ' A' ' 86' ' ' LYS . 0.7 OUTLIER -146.55 -172.04 3.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.284 -0.885 . . . . 0.0 109.483 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.31 152.66 47.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.468 -0.77 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -145.03 170.01 16.99 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 109.402 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -83.47 -23.49 32.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.597 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 63.5 m -93.12 151.85 19.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -93.64 113.8 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -93.18 177.02 6.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.524 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -73.46 -17.74 61.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.432 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 22.9 mp0 -93.17 16.67 12.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.923 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.3 m -92.94 -7.18 46.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.193 -0.942 . . . . 0.0 109.529 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 68.1 m-85 -93.01 153.41 18.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.627 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 74.1 m-85 -146.47 116.38 7.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -56.11 159.4 3.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -125.13 141.77 51.9 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.33 97.86 3.11 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.393 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.4 tt -72.72 131.33 42.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.641 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -93.39 -170.87 2.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.352 -0.842 . . . . 0.0 109.385 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.87 -4.65 52.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.465 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.3 m-20 -94.48 26.42 3.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.44 -0.76 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 33.4 m-85 -93.7 137.21 33.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.168 -0.957 . . . . 0.0 109.445 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -95.84 165.81 12.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.348 -0.845 . . . . 0.0 109.757 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.8 p -143.92 119.38 10.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.434 -0.791 . . . . 0.0 109.279 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.66 113.54 25.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.75 -179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -97.21 143.23 28.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.478 -0.764 . . . . 0.0 109.302 179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -60.67 162.18 6.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.14 -0.975 . . . . 0.0 109.383 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 121' ' ' THR . 61.2 ttt180 -92.68 -62.88 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 109.592 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -48.1 65.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -0.9 . . . . 0.0 109.618 -179.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' SER . 9.1 m-85 -93.89 60.46 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 109.493 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 118' ' ' ARG . 80.4 p -56.96 -0.99 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.968 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.56 11.38 19.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.113 -0.992 . . . . 0.0 109.652 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.01 146.47 23.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 0.0 109.769 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.2 m-85 -109.31 169.82 8.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.656 -0.652 . . . . 0.0 109.522 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.65 133.55 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.372 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -149.35 -175.69 5.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -140.09 165.82 26.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.521 -0.737 . . . . 0.0 109.284 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -94.24 177.72 5.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.445 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -92.88 -14.15 28.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.456 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.3 t -93.32 32.69 1.3 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.318 -0.864 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 57.6 50.96 60.88 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -142.26 166.53 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.367 -1.078 . . . . 0.0 109.513 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -90.62 120.25 31.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -69.88 132.48 46.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -53.34 134.45 39.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.195 -0.941 . . . . 0.0 109.352 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -61.57 -0.55 1.99 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.61 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.7 p -93.04 -29.65 15.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -1.161 . . . . 0.0 109.586 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -89.73 -4.88 57.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.228 -0.92 . . . . 0.0 109.564 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.3 p -72.98 144.1 47.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 174.15 -179.96 45.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.05 169.92 5.47 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.883 1.722 . . . . 0.0 110.164 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.25 -53.61 3.53 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.53 134.74 43.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -1.172 . . . . 0.0 109.523 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HB3' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -83.44 7.67 16.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.437 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.632 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -64.1 -9.37 16.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.467 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.2 pt -90.14 -5.51 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.351 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.468 HD12 ' HB3' ' A' ' 144' ' ' LYS . 52.3 mt -87.1 90.03 8.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -94.78 164.55 12.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.347 -0.845 . . . . 0.0 109.496 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 149' ' ' LEU . 39.8 tp -141.82 70.98 24.65 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.434 -0.791 . . . . 0.0 109.17 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -63.39 106.35 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 121.953 1.769 . . . . 0.0 110.448 -179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 12.9 mtt -95.95 123.45 39.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.312 179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.7 t -67.41 157.67 33.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -144.29 82.69 1.71 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -62.37 -66.06 0.6 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.499 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.48 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.81 24.53 1.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -92.2 116.06 28.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.462 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.14 -81.53 0.05 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -146.84 -94.33 0.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -1.137 . . . . 0.0 109.408 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.73 ' N ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -62.71 177.56 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.893 . . . . 0.0 109.3 -179.958 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -147.1 62.38 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -0.87 . . . . 0.0 109.339 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 8' ' ' THR . 5.9 t -145.19 66.17 1.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 109.381 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER -57.22 -48.84 96.69 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.891 . . . . 0.0 110.708 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 9' ' ' LEU . 2.5 Cg_endo -65.04 -169.57 0.13 Allowed 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 120.918 1.079 . . . . 0.0 110.059 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -144.99 86.18 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.329 -0.857 . . . . 0.0 109.541 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -89.23 -47.54 0.41 Allowed Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.249 -0.907 . . . . 0.0 110.679 179.927 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.8 Cg_endo -67.47 113.97 3.1 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.085 1.19 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -171.65 97.68 0.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.196 -0.94 . . . . 0.0 109.431 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.0 -85.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.83 71.14 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.05 -129.44 3.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 25.2 t 50.43 89.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.185 -1.185 . . . . 0.0 109.466 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 151.71 -63.45 0.38 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' C ' ' CG ' ' A' ' 21' ' ' PHE . . . -129.19 -11.17 4.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.657 -0.908 . . . . 0.0 109.555 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CG ' ' C ' ' A' ' 20' ' ' ALA . 3.2 p90 38.05 66.94 2.25 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.74 -0.6 . . . . 0.0 110.445 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.71 168.24 10.48 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.6 1.533 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -57.19 145.22 87.88 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.61 1.54 . . . . 0.0 110.177 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.34 -74.6 0.22 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -66.63 -6.6 15.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -1.153 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.36 41.78 0.48 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.308 -0.87 . . . . 0.0 109.509 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -129.96 13.57 5.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.698 -0.626 . . . . 0.0 109.327 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.55 149.64 29.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.893 . . . . 0.0 108.781 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 168.02 3.09 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 121.098 1.199 . . . . 0.0 110.247 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD2' HD22 ' A' ' 64' ' ' LEU . 54.9 mttt -141.96 139.0 32.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.362 -0.836 . . . . 0.0 109.249 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.4 mtm-85 -89.91 122.26 32.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.403 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.1 mt -84.95 97.24 9.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 0.0 109.621 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -95.75 113.8 25.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 109.439 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.31 118.07 23.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.225 -0.922 . . . . 0.0 109.377 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -68.85 -16.5 63.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.494 HD21 ' CB ' ' A' ' 144' ' ' LYS . 14.2 m120 -86.31 104.13 15.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.161 -0.962 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.01 4.84 89.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.48 83.67 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.8 m-85 -142.82 132.57 23.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.358 -1.083 . . . . 0.0 109.533 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.79 114.96 26.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.864 . . . . 0.0 109.396 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 45.6 tp -47.65 143.09 4.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.343 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.627 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 17.1 ttt180 -150.15 117.1 5.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.509 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.99 126.34 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.137 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -87.97 152.02 50.33 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.128 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.2 Cg_endo -58.23 -22.77 58.79 Favored 'Trans proline' 0 C--N 1.322 -0.819 0 C-N-CA 121.126 1.217 . . . . 0.0 110.266 179.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.3 p30 -74.75 8.8 2.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.92 . . . . 0.0 109.596 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.567 ' HA2' ' HB3' ' A' ' 93' ' ' ALA . . . 85.23 -36.18 3.09 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' CG ' HH11 ' A' ' 48' ' ' ARG . 2.4 mtt-85 -47.15 164.19 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -1.133 . . . . 0.0 109.442 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.7 t -138.35 123.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -152.61 151.38 30.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.84 162.77 25.42 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -146.69 148.97 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -1.127 . . . . 0.0 109.549 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.3 mtm180 -82.18 10.26 7.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 0.0 109.425 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -93.71 94.84 8.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.714 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -75.33 -5.14 43.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 p -94.48 16.72 14.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.415 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -91.14 114.28 61.05 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.14 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.88 2.5 0.58 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.615 0.877 . . . . 0.0 110.252 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.627 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 42.8 m80 -86.29 -11.38 52.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 pt -85.47 -4.73 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 77' ' ' VAL . 20.8 mmtm -76.65 83.76 3.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.947 . . . . 0.0 109.406 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.75 135.1 33.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.434 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.17 113.07 24.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -0.925 . . . . 0.0 109.47 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -92.17 153.78 19.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.416 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -145.55 149.72 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.88 150.71 22.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.481 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -146.12 130.84 17.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.43 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 50.84 -107.42 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.466 -179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 69' ' ' ARG . 6.7 ptm180 -154.91 129.79 9.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.77 29.12 73.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.7 t -146.95 96.31 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -1.16 . . . . 0.0 109.472 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 72' ' ' VAL . 2.4 m -94.58 129.95 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.351 -0.843 . . . . 0.0 109.596 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -92.69 121.69 34.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.346 -0.846 . . . . 0.0 109.406 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.9 mt -89.95 148.44 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.581 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -148.77 140.98 24.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.73 145.64 20.23 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 78' ' ' SER . 76.2 t -79.5 -86.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -1.188 . . . . 0.0 109.488 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.464 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -47.36 -55.07 9.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -30.33 64.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' ND2' ' O ' ' A' ' 78' ' ' SER . 73.9 m-80 51.32 44.62 28.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 30.2 mtt180 -137.2 145.26 43.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.56 -0.713 . . . . 0.0 109.45 179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -90.17 136.21 33.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.266 -0.896 . . . . 0.0 109.555 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 55.2 tp -63.73 151.5 41.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.877 . . . . 0.0 109.277 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.4 158.08 44.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.42 ' CE ' HD21 ' A' ' 91' ' ' LEU . 41.5 ttm -139.26 130.45 26.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.455 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.576 ' HE3' HD21 ' A' ' 92' ' ' LEU . 3.1 mptp? -94.18 -171.22 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.44 -15.39 25.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -83.56 -5.51 59.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.488 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 94.36 7.78 60.37 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 91' ' ' LEU . 98.9 mtt180 -85.15 108.21 17.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -1.157 . . . . 0.0 109.384 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.757 ' N ' HD12 ' A' ' 91' ' ' LEU . 6.3 mp -94.18 131.55 39.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.509 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.8 pp -150.07 173.14 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.567 ' HB3' ' HA2' ' A' ' 47' ' ' GLY . . . -105.03 159.62 15.69 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.702 . . . . 0.0 109.497 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 p -150.13 163.4 38.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.862 . . . . 0.0 109.454 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -88.55 -34.18 17.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.468 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -93.66 130.71 39.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.334 -0.854 . . . . 0.0 109.448 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 97' ' ' VAL . 10.7 p -81.93 103.5 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.42 ' C ' ' N ' ' A' ' 100' ' ' GLU . 69.7 p -96.0 165.2 12.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 109.486 179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.43 -17.77 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.42 ' N ' ' C ' ' A' ' 98' ' ' THR . 2.5 mp0 -92.72 49.61 1.48 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 83' ' ' LEU . 18.2 m -143.4 6.49 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.5 m-85 -96.66 154.23 17.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 0.0 109.464 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 90.0 m-85 -150.02 115.68 5.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.279 -0.888 . . . . 0.0 109.486 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.95 152.27 7.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.201 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -125.13 89.86 3.13 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.626 . . . . 0.0 109.4 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -89.92 120.87 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 0.0 109.358 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 18.1 tp -91.6 119.92 31.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.314 -0.866 . . . . 0.0 109.311 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -84.92 -172.84 4.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 111' ' ' ASN . 13.0 p -92.78 -20.27 20.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 112' ' ' TYR . 1.2 m120 -74.32 25.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.562 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 109' ' ' SER . 5.3 m120 60.65 -0.7 0.26 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.322 -0.861 . . . . 0.0 109.726 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 110' ' ' ASN . 46.4 m-85 -98.71 133.45 43.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.407 -0.808 . . . . 0.0 109.404 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 1.1 m120 -93.14 170.14 9.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -0.871 . . . . 0.0 109.737 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 p -141.25 113.26 7.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.429 -0.795 . . . . 0.0 109.277 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -89.96 105.98 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 121' ' ' THR . 13.7 ttt180 -96.17 151.04 19.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -76.13 155.62 34.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 109.679 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.619 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.3 OUTLIER -91.24 -74.31 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.521 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 9.4 tptt -52.34 -9.87 0.12 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.656 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 17.5 m-85 -142.96 67.19 1.31 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.371 -0.83 . . . . 0.0 109.495 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.523 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 23.4 p -65.12 5.26 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 0.0 109.519 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 123' ' ' TRP . 68.0 m -89.73 7.16 38.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 0.0 109.745 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.494 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.1 m-90 -154.62 167.59 29.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.76 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 12.7 m-85 -131.52 168.28 17.93 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.727 -0.608 . . . . 0.0 109.375 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.0 t -86.07 125.5 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.875 . . . . 0.0 109.338 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -153.11 163.57 39.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.0 mt -119.56 161.69 20.19 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.3 mtmm -79.27 -99.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.154 -0.966 . . . . 0.0 109.492 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.91 -36.7 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.267 -0.895 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.735 HG23 ' OE1' ' A' ' 132' ' ' GLN . 0.1 OUTLIER -78.27 10.33 3.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.444 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 90.56 6.54 67.94 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.735 ' OE1' HG23 ' A' ' 130' ' ' THR . 1.9 mp0 -84.82 167.54 15.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.536 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.5 p90 -93.73 120.1 33.56 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.859 . . . . 0.0 109.619 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -69.91 126.42 29.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.367 179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 13.7 tp -46.73 145.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.325 -0.859 . . . . 0.0 109.545 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -71.28 8.23 5.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.7 p -91.0 -34.65 15.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -1.142 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -90.0 -7.43 54.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.9 p -70.27 151.78 44.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.217 -0.927 . . . . 0.0 109.352 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 158.11 -179.31 33.9 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.95 169.99 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 121.848 1.699 . . . . 0.0 110.137 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.47 -49.63 4.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.605 ' N ' HE21 ' A' ' 143' ' ' GLN . 3.9 mm-40 -72.44 131.58 42.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -1.171 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.494 ' CB ' HD21 ' A' ' 36' ' ' ASN . 3.5 mtpt -85.02 3.68 37.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.722 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -63.44 -2.53 1.59 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -0.895 . . . . 0.0 109.556 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 23.2 pt -97.29 -3.99 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.798 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.84 99.39 9.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.983 . . . . 0.0 109.53 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.37 159.29 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.587 -0.696 . . . . 0.0 109.534 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.3 tp -138.08 72.17 46.98 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.64 117.67 4.5 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.824 1.683 . . . . 0.0 110.538 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 15.1 mtt -96.54 127.19 42.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.488 -0.758 . . . . 0.0 109.263 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.6 t -70.09 161.82 29.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.359 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -146.59 85.09 1.63 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 12.6 mttp -72.87 -65.12 0.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 85.4 p . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.493 179.948 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.6 -134.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.137 -0.977 . . . . 0.0 109.445 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 47.58 67.08 0.87 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.5 141.2 0.39 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.31 174.39 0.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -1.166 . . . . 0.0 109.462 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -56.16 95.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.7 151.61 35.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.477 ' O ' HG22 ' A' ' 8' ' ' THR . 56.5 m -166.39 -1.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.215 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.9 mt -123.78 80.31 56.06 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' O ' ' N ' ' A' ' 12' ' ' LEU . 6.2 Cg_exo -61.21 -170.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.395 1.397 . . . . 0.0 110.37 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.94 95.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.831 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 10' ' ' PRO . 4.8 tp -171.46 66.82 0.43 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.723 179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.34 -168.49 0.1 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 121.744 1.629 . . . . 0.0 110.215 -179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -171.28 70.26 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 12.4 t70 -150.31 6.63 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.3 -116.86 5.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.22 1.08 0.5 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -88.61 57.51 4.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -168.07 25.46 0.12 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 69.46 24.4 5.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -1.121 . . . . 0.0 109.446 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 56.8 67.9 2.4 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.718 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.48 168.13 11.94 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.647 1.565 . . . . 0.0 109.736 -179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.17 146.4 81.75 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 121.535 1.49 . . . . 0.0 110.204 179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -175.25 -38.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' N ' ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -147.58 13.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.257 -1.143 . . . . 0.0 109.526 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.2 21.89 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.446 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 25' ' ' HIS . 9.5 mttm -93.32 -13.73 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 0.0 109.617 -179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -114.9 152.31 46.35 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.7 171.73 1.87 Allowed 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.177 1.251 . . . . 0.0 110.391 179.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 50.8 mttt -138.54 130.88 28.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.542 -0.724 . . . . 0.0 109.217 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.484 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.6 mtm-85 -84.99 116.95 23.68 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.912 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 41' ' ' LEU . 25.0 mt -84.78 95.66 9.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -91.47 116.2 28.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.705 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.7 t -83.61 105.0 14.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 109.169 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -57.65 -23.61 52.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.601 -179.71 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 15.4 m-80 -78.15 104.95 9.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 77.79 4.73 85.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.802 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.54 86.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' CZ ' ' NH1' ' A' ' 53' ' ' ARG . 48.3 m-85 -144.26 135.46 25.44 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.327 -1.102 . . . . 0.0 109.285 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -92.34 137.27 32.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.956 . . . . 0.0 109.304 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 32' ' ' LEU . 50.9 tp -75.4 143.42 42.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.973 . . . . 0.0 109.307 -180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.734 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 30.9 ttm180 -146.48 122.52 10.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -92.04 107.48 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.231 179.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' CD2' ' OD1' ' A' ' 50' ' ' ASP . 61.1 m-70 -66.95 151.95 96.45 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.921 . . . . 0.0 109.098 -179.72 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.04 -29.57 74.74 Favored 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.118 1.212 . . . . 0.0 110.398 179.634 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -74.97 5.59 4.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.461 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.14 -26.27 5.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 34.5 mtt180 -51.53 115.99 1.88 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -1.145 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -90.63 127.5 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD1' ' CD2' ' A' ' 44' ' ' HIS . 7.2 p-10 -154.13 152.25 30.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.513 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -92.75 160.32 25.24 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.734 HG21 ' CZ ' ' A' ' 42' ' ' ARG . 33.8 m -149.1 152.49 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -1.165 . . . . 0.0 109.531 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.607 ' NH1' ' CZ ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -76.13 -27.87 57.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.277 179.847 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -47.86 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 109.518 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.6 OUTLIER -85.19 25.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.733 -179.896 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.4 p -152.15 35.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.058 -1.026 . . . . 0.0 109.991 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.41 140.02 25.41 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 108.911 179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.11 -4.68 4.07 Favored 'Trans proline' 0 C--N 1.324 -0.72 0 C-N-CA 121.1 1.2 . . . . 0.0 110.453 179.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 61' ' ' LYS . 69.4 m80 -94.49 -23.66 17.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.241 -179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 60' ' ' ILE . 1.3 pt -69.1 8.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.97 -1.081 . . . . 0.0 109.4 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 59' ' ' HIS . 3.2 mmmm -94.4 87.86 5.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.397 -0.814 . . . . 0.0 109.425 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 32' ' ' LEU . 10.2 mt -93.84 135.08 35.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.618 -179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.24 109.53 20.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -93.84 151.06 19.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' OE1' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -145.27 150.4 36.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 109.592 -179.939 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' OE1' ' A' ' 65' ' ' GLN . . . -94.31 150.76 19.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.78 -83.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.537 -0.727 . . . . 0.0 109.552 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -94.32 -147.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -92.29 127.03 37.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.412 -179.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.55 33.99 68.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.57 101.86 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.69 -0.888 . . . . 0.0 109.372 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 72' ' ' VAL . 25.1 m -103.09 126.03 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.686 . . . . 0.0 109.494 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.0 m -89.84 122.99 33.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.93 148.84 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.517 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -146.15 139.99 26.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.436 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.9 133.6 11.94 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 26.1 t -77.79 -72.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -1.153 . . . . 0.0 109.472 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.4 ' N ' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -62.88 -39.97 96.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 109.415 179.951 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.07 -24.61 63.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.369 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 77' ' ' VAL . 18.5 m-80 50.95 50.82 18.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.456 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -147.44 147.97 30.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.503 179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -91.54 127.93 37.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.58 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 tp -57.64 149.82 20.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.366 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.675 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.32 170.25 18.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.404 ' CE ' HD11 ' A' ' 91' ' ' LEU . 23.9 ttm -138.29 131.37 30.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.0 109.433 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.0 mmtp -85.86 -166.46 1.53 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -90.1 -33.88 16.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.432 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.56 -1.74 11.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.182 -0.949 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.77 1.89 70.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.22 125.99 29.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.135 -1.215 . . . . 0.0 109.516 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 91' ' ' LEU . 9.2 mp -92.13 135.83 33.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.475 179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.675 ' CD1' ' HB3' ' A' ' 84' ' ' ALA . 0.7 OUTLIER -149.42 -173.06 4.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.96 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -144.46 158.94 43.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.78 169.94 18.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -82.49 -27.98 31.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.486 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.8 m -92.87 160.13 15.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.9 . . . . 0.0 109.516 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 98' ' ' THR . 25.1 t -92.83 156.44 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.418 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' ' CG1' ' A' ' 97' ' ' VAL . 72.1 p -147.35 160.06 42.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -60.59 -16.19 35.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.164 -0.96 . . . . 0.0 109.429 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -93.99 8.17 42.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.387 -0.82 . . . . 0.0 109.477 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 76.8 m -93.5 -4.57 50.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.309 -0.869 . . . . 0.0 109.79 -179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.463 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 93.5 m-85 -92.2 159.92 15.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 91.7 m-85 -150.94 119.13 6.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.879 . . . . 0.0 109.578 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -55.32 147.57 16.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.974 -1.079 . . . . 0.0 109.334 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -125.33 97.77 5.35 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.674 -0.641 . . . . 0.0 109.318 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -94.72 128.42 41.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.568 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 112' ' ' TYR . 17.5 tp -94.67 121.51 36.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.436 -0.79 . . . . 0.0 109.166 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -84.77 -175.72 5.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -92.98 -25.06 18.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.903 . . . . 0.0 109.635 -179.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -74.17 18.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 0.0 109.492 -179.915 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 109' ' ' SER . 2.5 m120 63.92 65.17 0.72 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.463 -0.773 . . . . 0.0 110.317 179.551 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.401 ' O ' HD12 ' A' ' 107' ' ' LEU . 40.5 m-85 -144.92 -168.87 3.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.0 109.133 179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -146.64 113.34 6.03 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 109.755 -179.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.4 p -94.62 111.71 23.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.319 -0.863 . . . . 0.0 109.264 179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.51 109.01 20.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 -179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -100.27 150.88 22.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 109.142 179.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -59.75 166.89 2.34 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.182 -179.398 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 118' ' ' ARG . 0.0 OUTLIER -95.3 -57.82 2.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.435 -0.791 . . . . 0.0 109.388 179.913 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -82.08 -49.29 10.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.833 -179.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' C ' ' H ' ' A' ' 122' ' ' SER . 8.1 m-85 -91.7 61.25 4.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.34 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 3.1 p -57.11 5.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.433 -0.792 . . . . 0.0 110.711 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 120' ' ' TYR . 45.6 m -89.02 11.02 19.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.78 -1.2 . . . . 0.0 109.619 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 122' ' ' SER . 5.4 m-90 -152.48 159.38 43.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -0.96 . . . . 0.0 109.637 179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 21.2 m-85 -123.06 169.83 10.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.716 -0.615 . . . . 0.0 109.413 -179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.55 133.27 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.249 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -150.13 178.09 9.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 109.673 -179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.0 157.68 46.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.646 -0.659 . . . . 0.0 109.383 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -93.94 -166.58 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 109.334 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -93.87 -10.08 35.12 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.5 t -90.1 -7.86 52.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 93.34 8.97 60.82 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -93.77 173.95 7.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -1.11 . . . . 0.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.514 ' CD2' ' O ' ' A' ' 133' ' ' TYR . 38.4 p90 -92.6 120.35 32.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.484 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -70.01 136.4 50.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 137' ' ' SER . 13.8 tp -59.78 127.49 32.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.0 109.304 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -49.16 -10.41 0.16 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 135' ' ' LEU . 21.4 p -75.51 -36.55 60.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.142 -1.211 . . . . 0.0 109.642 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -89.96 -5.19 56.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.675 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 70.5 p -83.7 138.73 33.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.9 179.5 48.65 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.96 165.62 11.83 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.874 1.716 . . . . 0.0 110.228 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.34 -58.87 3.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' C ' ' H ' ' A' ' 145' ' ' ALA . 26.2 mm-40 -70.75 120.83 16.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.176 -1.191 . . . . 0.0 109.484 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.514 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 19.1 mtmm -63.51 1.68 0.53 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 0.0 109.445 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.765 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -60.1 -4.66 0.83 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.72 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 144' ' ' LYS . 1.6 pt -99.86 4.75 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.428 -0.795 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 144' ' ' LYS . 84.9 mt -91.86 109.82 21.16 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.154 -0.966 . . . . 0.0 109.673 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -113.0 162.06 16.31 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.6 tp -140.2 70.69 34.02 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 109.414 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.73 111.37 1.5 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.93 1.753 . . . . 0.0 110.419 -179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 28.1 mtt -94.37 99.88 12.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.325 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.3 t -56.75 133.41 54.11 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 109.567 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.05 59.47 3.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.415 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -54.97 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.492 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.57 114.52 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER -91.18 59.14 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.58 179.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 3' ' ' GLU . . . -61.69 -144.86 0.01 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -92.64 -83.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -1.174 . . . . 0.0 109.488 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 6' ' ' ILE . 2.7 mp -98.0 62.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.353 -0.842 . . . . 0.0 109.389 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 1.2 p 48.49 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.838 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.517 ' C ' HD23 ' A' ' 9' ' ' LEU . 10.3 m -140.06 108.48 5.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.802 . . . . 0.0 109.433 -179.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.749 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -103.55 163.85 16.61 Favored Pre-proline 0 N--CA 1.494 1.762 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.822 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -57.22 109.51 0.47 Allowed 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 121.383 1.389 . . . . 0.0 110.296 179.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.69 -172.45 3.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.23 68.35 5.31 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 109.668 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.3 149.64 90.74 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.784 1.656 . . . . 0.0 110.241 -179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -174.78 90.55 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -91.36 -28.08 17.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 109.526 179.936 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.29 55.03 2.82 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -61.34 -109.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.3 t 59.2 55.9 4.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.182 -1.187 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . 79.05 -39.28 2.04 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 19' ' ' GLY . . . 67.27 1.22 2.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -1.11 . . . . 0.0 109.488 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -82.57 -47.45 0.89 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 110.728 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 2.1 Cg_endo -66.93 168.05 18.15 Favored 'Trans proline' 0 C--N 1.321 -0.883 0 C-N-CA 120.96 1.107 . . . . 0.0 109.777 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.23 -170.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.234 0 C-N-CA 121.648 1.565 . . . . 0.0 110.216 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 41.24 35.1 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -158.0 21.65 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.258 -1.142 . . . . 0.0 109.387 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -133.34 40.25 3.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.581 -0.699 . . . . 0.0 109.259 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -90.92 16.19 9.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -154.91 152.09 24.7 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.187 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.07 172.04 1.42 Allowed 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 121.197 1.265 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.503 ' HD2' HD22 ' A' ' 64' ' ' LEU . 34.9 mttm -148.03 128.1 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 31' ' ' ARG . 2.7 mtt-85 -85.16 120.47 26.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.0 mt -84.78 104.81 15.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 109.671 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -104.47 123.08 46.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.597 -0.689 . . . . 0.0 109.54 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.44 136.86 32.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.925 . . . . 0.0 109.289 179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -82.4 -25.77 33.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.965 . . . . 0.0 109.705 -179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 36' ' ' ASN . 1.2 m-80 -74.95 105.07 5.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.184 -0.947 . . . . 0.0 109.704 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' O ' ' CD2' ' A' ' 39' ' ' PHE . . . 79.38 4.93 89.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.837 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.45 87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 37' ' ' GLY . 44.0 m-85 -143.81 136.44 27.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.387 -1.067 . . . . 0.0 109.689 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -95.54 124.6 39.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.318 179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.52 144.43 26.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.151 -0.968 . . . . 0.0 109.149 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 19.6 ttt180 -148.01 119.77 8.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.743 -179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.9 mt -94.44 128.37 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.082 179.659 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -91.66 151.89 42.8 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.216 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.35 -27.79 77.11 Favored 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 121.178 1.252 . . . . 0.0 110.317 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -74.91 1.84 11.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -179.834 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.63 -31.5 5.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -50.2 118.5 3.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -1.145 . . . . 0.0 109.463 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 148.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.504 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -169.57 -162.9 0.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -146.32 158.48 27.71 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.897 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.87 143.6 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.351 -1.087 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.9 mtp180 -74.39 -1.39 20.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -84.66 92.55 8.2 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.397 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 pttp -85.17 56.42 3.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.244 -0.91 . . . . 0.0 109.721 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.2 p -155.49 13.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 110.096 -179.845 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 59' ' ' HIS . 1.6 m-20 -93.25 145.68 30.49 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.983 . . . . 0.0 109.095 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -62.56 0.82 1.25 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 121.106 1.204 . . . . 0.0 110.338 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 57' ' ' ASP . 77.5 m80 -91.35 -29.21 17.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 110.187 -179.233 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt -69.16 4.92 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.971 -1.08 . . . . 0.0 109.351 -179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 59' ' ' HIS . 10.7 mtpt -93.02 82.87 4.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.321 -0.862 . . . . 0.0 109.654 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.5 mt -93.39 134.04 36.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.387 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -94.04 123.27 37.3 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.295 -0.878 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.6 mp -91.94 156.34 17.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -144.94 125.04 13.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.04 165.29 22.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.0 109.558 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -143.56 -98.76 0.11 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.391 -0.818 . . . . 0.0 109.206 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 2.3 mt-10 -84.67 -172.62 4.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.049 -1.032 . . . . 0.0 109.393 179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 10.9 mpt_? -72.96 107.74 5.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 109.575 -179.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.9 68.86 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' HB ' ' H ' ' A' ' 68' ' ' GLU . 12.5 t -92.97 140.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.1 m -144.22 170.63 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.398 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.505 ' OG ' ' CD2' ' A' ' 102' ' ' PHE . 4.6 m -148.94 134.99 19.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 75' ' ' LYS . 82.1 mt -93.14 155.94 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.501 179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.425 ' N ' HG22 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -149.36 139.8 22.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.507 179.972 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.62 127.33 9.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.1 t -76.94 -61.77 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.461 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.91 -27.05 68.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.88 -23.98 21.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.196 -0.94 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 51.66 51.2 17.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.618 HH11 ' CG ' ' A' ' 81' ' ' ARG . 1.9 mtt-85 -148.08 145.96 28.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.428 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.516 ' CG ' HG22 ' A' ' 97' ' ' VAL . 86.8 m-85 -96.03 125.09 40.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.34 -0.85 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.9 tp -58.98 145.1 42.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.244 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 101' ' ' CYS . . . -150.1 130.83 14.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.8 ttm -90.5 104.25 16.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.26 -0.9 . . . . 0.0 109.346 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.546 ' HG3' HD21 ' A' ' 92' ' ' LEU . 23.6 mmtt -62.91 166.46 5.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 0.0 109.527 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -78.51 -22.07 47.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.525 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -73.63 -5.85 43.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.451 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.95 -7.75 70.12 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -77.95 123.91 27.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -1.154 . . . . 0.0 109.344 -179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.8 mp -89.77 124.26 34.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.209 -0.932 . . . . 0.0 109.128 179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.578 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -148.43 -170.33 3.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 109.611 -179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.16 161.13 39.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.458 -0.776 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 p -146.49 153.19 40.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.416 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -59.11 -38.37 79.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.87 157.67 20.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' CG ' ' A' ' 82' ' ' TYR . 28.1 t -93.1 117.45 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.7 p -89.19 173.01 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.46 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -69.96 -22.97 63.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.466 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -94.13 24.89 4.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.558 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 84' ' ' ALA . 18.0 m -93.87 -8.81 39.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.583 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.505 ' CD2' ' OG ' ' A' ' 73' ' ' SER . 77.8 m-85 -93.99 158.56 15.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.593 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 86.7 m-85 -148.13 116.58 6.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.869 . . . . 0.0 109.35 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -55.1 124.56 17.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 0.0 109.534 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -88.48 147.94 24.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 109.377 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -148.1 120.13 8.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.515 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.9 131.0 37.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.09 -175.69 4.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -90.96 -4.48 56.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.902 . . . . 0.0 109.466 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 112' ' ' TYR . 12.8 m-80 -93.48 27.89 2.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.889 . . . . 0.0 109.501 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 63.64 -7.53 0.19 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.488 -0.758 . . . . 0.0 110.126 179.807 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.5 m-85 -84.14 -173.06 4.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.04 -1.037 . . . . 0.0 109.463 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.27 167.12 24.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.68 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 p -142.43 169.96 16.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 0.0 109.301 179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -143.83 110.93 5.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.444 -0.785 . . . . 0.0 109.359 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -94.94 145.52 24.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.612 -179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -63.98 162.12 14.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.494 ' O ' HG23 ' A' ' 121' ' ' THR . 1.7 ttt-85 -92.36 -63.71 1.2 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.714 -179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -64.9 -47.8 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.731 -179.779 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.5 m-85 -99.59 63.85 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.57 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 118' ' ' ARG . 3.0 p -59.76 2.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.955 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 120' ' ' TYR . 3.9 m -89.81 14.02 13.0 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.041 -1.037 . . . . 0.0 109.772 -179.843 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' A' ' 136' ' ' GLY . 2.3 m-90 -155.07 145.75 22.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.948 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -107.71 166.93 10.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.696 -0.627 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.9 t -91.36 125.49 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 109.359 179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.595 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -154.67 159.06 40.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.253 -0.904 . . . . 0.0 109.53 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.8 mt -108.1 179.39 4.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.658 -0.651 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -95.24 -112.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CB ' HH11 ' A' ' 129' ' ' ARG . 0.0 OUTLIER -147.38 -32.59 0.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.575 -179.889 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -79.31 3.6 17.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.492 179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.74 11.64 56.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -94.12 167.5 11.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -1.126 . . . . 0.0 109.52 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.518 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 34.3 p90 -86.64 120.36 27.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.474 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.669 ' NZ ' HE21 ' A' ' 143' ' ' GLN . 63.8 tttt -69.84 133.71 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.9 tp -59.15 138.04 57.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.227 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 123' ' ' TRP . . . -70.95 11.9 2.39 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.686 ' OG ' HD23 ' A' ' 135' ' ' LEU . 99.4 p -94.57 -37.78 11.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -1.15 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -88.78 -6.05 57.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 32.3 p -70.97 158.01 37.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.95 . . . . 0.0 109.496 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.508 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 161.35 -179.47 36.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.89 159.5 29.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.883 1.722 . . . . 0.0 110.15 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.43 -27.48 9.47 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.669 HE21 ' NZ ' ' A' ' 134' ' ' LYS . 38.2 mt-30 -84.82 128.28 34.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -1.171 . . . . 0.0 109.519 179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 144' ' ' LYS . 6.7 mtmp? -82.78 -3.75 57.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.419 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.595 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -62.16 -14.84 41.53 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 -179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pt -84.76 2.31 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.489 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 144' ' ' LYS . 73.7 mt -91.62 90.52 7.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -94.83 166.91 11.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.205 -0.935 . . . . 0.0 109.413 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.6 tp -141.93 70.42 24.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.546 -0.722 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -63.01 105.75 0.48 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.791 1.661 . . . . 0.0 110.418 -179.391 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 7.6 mtt -94.81 125.36 39.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.816 . . . . 0.0 109.378 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.2 t -69.75 137.57 52.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.26 56.8 3.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.517 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 154' ' ' LYS . 9.7 mtpm? -81.67 -57.34 3.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.561 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.296 0.569 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.13 -50.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 53.57 85.17 0.05 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.504 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 5' ' ' GLU . . . -79.03 65.38 3.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.415 ' O ' ' O ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 48.15 -173.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.154 . . . . 0.0 109.446 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 6' ' ' ILE . 2.5 mp -49.67 142.11 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.403 HG22 ' H ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -47.24 121.6 3.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.82 127.29 31.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.933 . . . . 0.0 109.54 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD13 ' HD2' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -94.51 116.78 66.78 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 108.963 179.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HD2' HD13 ' A' ' 9' ' ' LEU . 5.0 Cg_exo -59.99 -178.4 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.563 0.842 . . . . 0.0 110.211 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.44 52.86 0.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.296 -0.877 . . . . 0.0 109.65 -179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' N ' ' CD ' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -89.69 -47.42 0.4 Allowed Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.192 -0.943 . . . . 0.0 110.595 179.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 1.2 Cg_endo -68.69 86.9 0.44 Allowed 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 120.994 1.129 . . . . 0.0 109.894 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -172.81 53.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.359 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.83 -24.05 63.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.87 6.04 73.07 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.87 17.85 14.72 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.9 p -90.5 58.42 3.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -1.141 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.65 -85.15 0.06 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.29 -76.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.153 . . . . 0.0 109.481 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -143.16 68.66 17.79 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.52 114.23 2.62 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.728 1.618 . . . . 0.0 109.843 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.48 99.89 0.21 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 120.693 0.929 . . . . 0.0 110.154 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.54 36.21 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 25' ' ' HIS . 84.2 t60 -146.4 53.65 1.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -1.125 . . . . 0.0 109.395 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -140.23 33.2 1.91 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 109.396 -179.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -95.52 19.03 11.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.825 -179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.85 149.29 25.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.152 -0.967 . . . . 0.0 109.051 179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.01 154.96 41.51 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.178 1.252 . . . . 0.0 110.243 179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -124.67 122.61 37.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.95 118.62 24.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 41' ' ' LEU . 16.2 mt -84.82 102.89 13.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.586 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -95.82 123.45 39.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.322 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -91.88 117.56 29.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -64.4 -14.68 57.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.366 -0.834 . . . . 0.0 109.588 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' ND2' ' N ' ' A' ' 145' ' ' ALA . 4.0 m-20 -83.4 105.02 14.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.165 -0.959 . . . . 0.0 109.646 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.32 4.86 65.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.92 75.65 0.21 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -126.41 133.0 51.39 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.698 -0.883 . . . . 0.0 109.487 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -94.77 117.86 30.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.484 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD23 HD12 ' A' ' 32' ' ' LEU . 36.6 tp -48.74 137.58 12.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.926 . . . . 0.0 109.249 179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HE ' ' CB ' ' A' ' 59' ' ' HIS . 7.2 ttt180 -148.23 119.97 8.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.187 -0.946 . . . . 0.0 109.645 -179.817 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.8 113.89 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.103 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -76.18 149.47 82.17 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.05 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.525 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 2.1 Cg_endo -58.52 -24.05 67.63 Favored 'Trans proline' 0 C--N 1.324 -0.733 0 C-N-CA 121.13 1.22 . . . . 0.0 110.251 179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 48' ' ' ARG . 18.6 p30 -74.9 2.22 10.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 109.523 -179.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.39 -33.76 4.61 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -48.14 114.75 1.0 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -1.153 . . . . 0.0 109.367 -179.99 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.1 t -96.4 125.03 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' CG ' ' N ' ' A' ' 51' ' ' GLY . 4.7 p-10 -155.37 -152.96 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG ' ' A' ' 50' ' ' ASP . . . -144.07 161.34 27.86 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.8 m -147.29 142.63 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.224 -1.162 . . . . 0.0 109.505 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -77.1 1.48 17.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.336 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -87.31 83.84 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.41 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.85 55.01 1.65 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 0.0 109.412 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.7 m -145.43 6.64 1.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.415 -0.803 . . . . 0.0 109.872 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 59' ' ' HIS . 28.2 m-20 -94.27 138.93 22.34 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.91 . . . . 0.0 109.12 -179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -1.36 1.76 Allowed 'Trans proline' 0 C--N 1.326 -0.628 0 C-N-CA 121.069 1.179 . . . . 0.0 110.373 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' CB ' ' HE ' ' A' ' 42' ' ' ARG . 78.1 m80 -83.37 -22.12 32.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 110.036 -179.413 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 pt -75.95 7.84 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.087 -1.008 . . . . 0.0 109.473 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 mtpp -95.81 87.36 4.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.4 mt -92.44 135.27 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -93.11 109.6 21.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.28 -0.888 . . . . 0.0 109.266 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.7 mp -90.85 154.46 19.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.855 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -139.03 142.04 38.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.495 -0.753 . . . . 0.0 109.143 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -85.13 144.26 28.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.551 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 69' ' ' ARG . 1.1 tp10 -144.42 143.42 30.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.294 179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 51.4 -90.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.405 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 67' ' ' GLU . 8.0 ttm180 -147.82 -91.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.491 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.85 9.16 57.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.59 97.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -1.193 . . . . 0.0 109.539 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -94.42 126.14 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 m -94.85 130.18 41.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.7 mt -94.56 150.1 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.558 179.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -148.84 130.27 14.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.75 135.74 14.83 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.5 t -80.05 -80.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -1.103 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.7 t -47.66 -57.27 5.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.438 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.74 -25.81 63.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.211 -0.93 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.9 m120 51.24 45.54 27.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.572 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 29.5 mtt180 -136.98 148.66 47.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 109.327 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -91.02 130.84 36.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.26 -0.9 . . . . 0.0 109.491 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.1 138.03 58.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 109.139 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.0 144.59 25.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 45.5 ttm -98.35 144.16 28.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.472 -0.767 . . . . 0.0 109.357 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.9 174.18 11.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.468 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -78.69 -15.88 57.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.29 -42.51 9.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.841 . . . . 0.0 109.517 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.13 -8.93 1.49 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' C ' HD12 ' A' ' 91' ' ' LEU . 46.3 mtp180 -75.15 125.94 30.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.322 -1.105 . . . . 0.0 109.501 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.637 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.5 mp -92.63 141.22 28.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.216 -0.928 . . . . 0.0 109.5 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -146.22 -171.31 3.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.338 -0.851 . . . . 0.0 109.521 179.922 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' HB1' ' HB3' ' A' ' 81' ' ' ARG . . . -135.91 114.79 12.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 p -98.2 170.09 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.517 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -38.4 14.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.448 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.34 159.73 15.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.891 . . . . 0.0 109.435 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 t -93.02 149.11 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.4 p -147.1 172.46 13.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -47.88 -35.79 11.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' O ' ' SG ' ' A' ' 101' ' ' CYS . 19.4 mt-10 -88.73 67.03 8.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.338 -0.851 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 100' ' ' GLU . 74.6 m -153.39 15.17 0.52 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 46.4 m-85 -124.6 158.4 33.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.706 -0.621 . . . . 0.0 109.419 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 35.1 m-85 -144.74 122.9 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.398 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -68.59 109.48 3.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.383 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.458 ' OE2' ' CE1' ' A' ' 115' ' ' TYR . 37.4 tt0 -85.64 150.2 24.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.304 -0.872 . . . . 0.0 109.585 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -146.42 98.36 3.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.24 131.9 48.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.421 ' HB2' HD21 ' A' ' 110' ' ' ASN . 3.2 mm-40 -94.48 -166.82 1.55 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.853 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 74.4 m -94.64 -20.9 19.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.786 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.568 ' N ' HD22 ' A' ' 110' ' ' ASN . 0.0 OUTLIER -80.23 25.92 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.927 . . . . 0.0 109.618 -179.826 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 62.94 -7.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.463 -0.773 . . . . 0.0 110.466 179.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.556 ' H ' ' ND2' ' A' ' 110' ' ' ASN . 42.7 m-85 -89.9 135.75 33.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.881 -1.137 . . . . 0.0 109.337 179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.616 HD22 ' N ' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -93.75 168.74 10.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.871 -179.733 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.1 p -143.66 122.69 12.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.519 -0.738 . . . . 0.0 109.286 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.458 ' CE1' ' OE2' ' A' ' 105' ' ' GLU . 85.1 m-85 -94.19 114.94 27.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.507 ' NE ' ' O ' ' A' ' 121' ' ' THR . 19.0 ttt180 -98.19 142.57 29.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 179.748 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 t -67.81 158.75 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.583 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.416 ' C ' ' N ' ' A' ' 120' ' ' TYR . 34.7 ttt180 -94.99 -72.46 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.641 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -54.64 -9.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.7 -179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 122' ' ' SER . 10.8 m-85 -140.9 60.79 1.51 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.398 -0.814 . . . . 0.0 109.51 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' NE ' ' A' ' 116' ' ' ARG . 16.8 p -58.33 -1.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.726 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 120' ' ' TYR . 6.6 m -89.88 10.3 24.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.53 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -155.08 142.49 19.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.0 109.737 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 25.9 m-85 -106.48 169.7 8.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.661 -0.649 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.7 t -89.52 134.51 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.44 179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.53 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -147.63 162.19 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.05 161.27 23.32 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.522 ' HZ2' ' HG3' ' A' ' 134' ' ' LYS . 33.0 mttp -85.85 -170.02 2.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -92.44 -29.71 16.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.468 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -73.75 1.62 10.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 91.65 5.48 66.7 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -86.69 168.65 13.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -1.158 . . . . 0.0 109.548 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 36.2 p90 -92.21 120.2 32.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HG3' ' HZ2' ' A' ' 128' ' ' LYS . 48.1 tttt -69.94 135.76 49.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.193 -0.942 . . . . 0.0 109.353 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.54 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.5 tp -47.54 160.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.202 -180.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.83 16.81 55.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.54 ' OG ' HD23 ' A' ' 135' ' ' LEU . 21.9 p -115.07 -27.74 7.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.683 -0.892 . . . . 0.0 109.638 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -87.64 -4.98 58.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.694 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.7 p -70.71 166.69 20.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 154.26 179.58 29.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.93 166.35 10.57 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.85 1.7 . . . . 0.0 110.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.81 -56.12 2.6 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.48 ' OE1' ' NZ ' ' A' ' 134' ' ' LYS . 1.8 mt-30 -70.35 133.91 47.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 109.464 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.503 ' C ' HD21 ' A' ' 36' ' ' ASN . 15.3 mtpp -85.14 3.84 37.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.903 . . . . 0.0 109.526 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.594 ' N ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.75 -4.24 1.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.2 pt -93.99 -4.36 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.349 -0.845 . . . . 0.0 109.557 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.8 mt -84.67 107.97 17.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.521 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -115.02 162.77 16.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.683 -0.635 . . . . 0.0 109.37 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.1 tp -140.29 71.18 33.28 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.469 -0.769 . . . . 0.0 109.404 -179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.96 105.09 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.901 1.734 . . . . 0.0 110.435 -179.556 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 11.4 mtm -100.68 128.96 46.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.435 -0.791 . . . . 0.0 109.408 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.3 t -70.22 120.75 16.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.425 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.08 59.89 2.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -55.01 -91.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.545 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.451 -179.941 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.09 100.0 3.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 3' ' ' GLU . 1.6 mm-40 -57.64 105.19 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.364 -0.835 . . . . 0.0 109.551 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.09 -151.41 0.63 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -79.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -1.181 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 7' ' ' THR . 95.2 mt -84.57 166.02 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.614 ' N ' HG22 ' A' ' 6' ' ' ILE . 8.5 p -47.54 141.76 4.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.407 ' H ' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER -72.73 16.81 0.13 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.98 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 7' ' ' THR . 9.1 mt -92.01 152.39 42.79 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.189 -0.944 . . . . 0.0 108.86 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -56.57 -175.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 121.119 1.212 . . . . 0.0 110.163 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.27 151.82 3.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 mt -139.93 68.48 35.61 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.463 -0.773 . . . . 0.0 109.607 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.43 -171.86 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.74 1.626 . . . . 0.0 110.219 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 57.35 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.33 -0.856 . . . . 0.0 109.457 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -66.88 -30.47 70.64 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.473 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.16 -106.09 0.36 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.64 -172.64 34.49 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.9 t -146.99 65.68 1.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -1.139 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.59 36.86 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.1 21.85 6.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -1.117 . . . . 0.0 109.529 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.502 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -77.67 -48.47 2.26 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.314 -0.866 . . . . 0.0 110.789 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 21' ' ' PHE . 1.7 Cg_endo -67.12 168.08 18.39 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 120.909 1.073 . . . . 0.0 109.747 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.79 133.52 56.69 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.644 1.563 . . . . 0.0 110.055 179.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -147.18 -45.63 0.03 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' C ' ' H ' ' A' ' 27' ' ' LYS . 4.9 p80 -146.82 28.66 1.03 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -1.144 . . . . 0.0 109.464 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CD2' ' NZ ' ' A' ' 30' ' ' LYS . 51.2 m-85 -72.56 16.12 0.16 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 25' ' ' HIS . 12.3 mttp -90.75 30.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -149.01 152.18 36.01 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.027 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.54 171.64 1.31 Allowed 'Trans proline' 0 C--N 1.322 -0.821 0 C-N-CA 121.233 1.289 . . . . 0.0 110.278 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.554 ' NZ ' ' CD2' ' A' ' 26' ' ' PHE . 83.7 mttt -149.98 139.41 21.45 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.316 -0.865 . . . . 0.0 109.264 179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.491 HH11 ' HG3' ' A' ' 31' ' ' ARG . 2.3 mtm-85 -92.98 114.47 27.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.595 -179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.5 mt -85.0 91.25 8.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.38 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -86.29 125.52 33.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.901 . . . . 0.0 109.645 -179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.5 t -89.68 123.67 33.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -72.5 -14.55 61.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.608 HD21 ' CB ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -86.2 104.99 16.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.797 -179.66 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.53 6.23 80.31 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 51.38 77.68 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -134.29 138.15 44.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.598 -0.942 . . . . 0.0 109.606 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -96.47 158.81 15.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.221 179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 41' ' ' LEU . 17.9 tp -85.23 139.21 31.83 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.896 . . . . 0.0 109.299 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -146.33 111.69 5.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.635 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 52.9 mt -89.85 133.89 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.273 -0.892 . . . . 0.0 109.194 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.524 ' NE2' ' OD2' ' A' ' 50' ' ' ASP . 81.8 m-70 -89.01 149.65 43.71 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.977 . . . . 0.0 109.184 -179.593 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' O ' ' NH1' ' A' ' 81' ' ' ARG . 1.4 Cg_endo -59.94 -23.27 72.16 Favored 'Trans proline' 0 C--N 1.323 -0.769 0 C-N-CA 121.166 1.244 . . . . 0.0 110.367 179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.61 -15.3 57.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.818 -179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 49' ' ' VAL . . . 117.78 -37.12 3.39 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 48' ' ' ARG . 1.5 mtt-85 -46.4 114.89 0.89 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -1.159 . . . . 0.0 109.79 -179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 47' ' ' GLY . 97.3 t -100.1 128.56 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.531 -0.731 . . . . 0.0 109.459 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.524 ' OD2' ' NE2' ' A' ' 44' ' ' HIS . 3.1 p30 -155.69 -150.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.351 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.489 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -146.89 163.63 28.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.42 154.46 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -81.1 -14.35 57.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.95 87.6 4.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.446 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -81.99 17.84 1.48 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.945 . . . . 0.0 109.421 179.945 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 p -100.58 3.32 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 109.76 -179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -92.86 133.71 28.65 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 0.0 109.164 -179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.64 -4.16 4.21 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.84 1.026 . . . . 0.0 110.257 179.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -74.83 -10.95 59.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 55' ' ' LYS . 3.2 pt -89.26 -7.78 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.35 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -80.0 90.16 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.928 . . . . 0.0 109.41 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mt -90.88 135.2 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -89.96 104.92 17.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.3 mp -89.13 153.34 21.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.582 180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.44 126.93 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.94 121.92 26.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.97 -29.37 14.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.492 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -151.03 -167.59 2.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.31 -0.868 . . . . 0.0 109.472 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -82.42 -0.79 47.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.347 -0.846 . . . . 0.0 109.484 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.92 28.92 1.27 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 t -145.49 145.12 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.329 -1.101 . . . . 0.0 109.431 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 72' ' ' VAL . 29.1 m -143.01 121.67 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.356 -0.84 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -93.28 123.34 36.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.451 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.1 mt -91.44 147.46 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -145.8 132.53 19.98 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.85 137.65 17.6 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.4 t -78.78 -65.86 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -1.178 . . . . 0.0 109.471 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 t -63.3 -49.8 72.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.918 . . . . 0.0 109.45 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.06 -21.55 66.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.472 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.2 m120 47.65 45.0 17.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.352 -0.842 . . . . 0.0 109.529 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' A' ' 45' ' ' PRO . 40.7 mtp180 -141.08 146.82 37.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.464 -0.773 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -89.84 136.8 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.574 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.2 tp -63.03 149.23 45.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.24 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.526 ' HB3' ' CD1' ' A' ' 92' ' ' LEU . . . -149.64 129.26 13.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 109.532 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 21.4 ttm -96.41 130.85 43.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 109.45 179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -78.88 -175.38 4.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.159 -0.963 . . . . 0.0 109.509 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -92.72 -23.47 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 109.564 -179.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.524 ' N ' ' OE1' ' A' ' 87' ' ' GLU . 3.4 p30 -82.78 -40.35 20.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' CD1' ' A' ' 91' ' ' LEU . . . 143.57 -7.92 2.02 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -75.57 120.64 21.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -1.161 . . . . 0.0 109.555 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.645 ' N ' HD12 ' A' ' 91' ' ' LEU . 8.6 mp -92.42 136.34 33.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' C ' HD12 ' A' ' 92' ' ' LEU . 1.1 pp -147.01 -171.9 3.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -139.14 164.36 30.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.554 -0.716 . . . . 0.0 109.371 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 m -149.92 170.02 19.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.936 . . . . 0.0 109.384 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -83.09 -46.16 13.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.354 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.8 116.03 28.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 p -52.1 165.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.6 p -147.1 -173.05 4.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.322 -0.861 . . . . 0.0 109.405 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -25.68 62.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -92.4 59.16 3.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.2 m -147.25 10.11 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 64.9 m-85 -94.93 152.18 18.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.1 m-85 -150.04 116.59 5.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -69.31 127.42 33.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.01 96.52 10.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.876 . . . . 0.0 109.496 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HE ' HH22 ' A' ' 116' ' ' ARG . 0.0 OUTLIER -91.96 114.31 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -85.2 128.54 34.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -91.71 -177.44 4.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.5 p -92.62 45.06 1.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.489 ' C ' ' H ' ' A' ' 112' ' ' TYR . 70.9 m-20 -146.89 28.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -0.879 . . . . 0.0 109.446 179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 m120 60.27 -0.03 0.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.897 . . . . 0.0 109.711 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 110' ' ' ASN . 36.6 m-85 -96.61 130.98 43.7 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.373 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.493 ' OD1' ' N ' ' A' ' 113' ' ' ASN . 0.9 OUTLIER -92.56 168.71 11.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.4 p -145.8 119.6 9.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -93.12 106.31 18.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.498 -179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.751 HH22 ' HE ' ' A' ' 106' ' ' ARG . 33.5 ttm180 -93.87 146.5 23.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.5 t -72.21 151.73 42.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.153 -0.967 . . . . 0.0 109.374 179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 120' ' ' TYR . 12.9 ttt180 -91.29 -75.03 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.607 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 13.9 tttp -51.14 -9.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.32 -0.863 . . . . 0.0 109.471 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.484 ' H ' ' C ' ' A' ' 118' ' ' ARG . 14.7 m-85 -143.08 64.06 1.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.7 p -62.11 1.81 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.591 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' TYR . 15.4 m -89.97 11.33 20.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.529 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.493 ' CG ' ' O ' ' A' ' 136' ' ' GLY . 2.4 m-90 -155.04 140.54 17.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.943 . . . . 0.0 109.783 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.479 ' OH ' ' NE ' ' A' ' 116' ' ' ARG . 26.8 m-85 -106.37 165.4 11.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.64 -0.663 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.9 t -91.41 119.88 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.697 ' HB1' ' CB ' ' A' ' 145' ' ' ALA . . . -150.56 147.17 27.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 109.627 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.8 mt -96.56 178.36 5.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 0.0 109.464 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -95.53 -169.45 1.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.39 -0.819 . . . . 0.0 109.364 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -93.77 -13.87 26.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -0.886 . . . . 0.0 109.434 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -92.9 8.37 39.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.427 179.948 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.33 3.65 84.35 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -89.85 173.14 8.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -1.128 . . . . 0.0 109.471 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.528 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 30.0 p90 -92.82 120.32 33.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -69.95 131.49 44.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.395 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.599 HD23 ' OG ' ' A' ' 137' ' ' SER . 13.7 tp -47.34 133.16 12.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.375 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' ' CG ' ' A' ' 123' ' ' TRP . . . -58.97 -2.3 1.21 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.599 ' OG ' HD23 ' A' ' 135' ' ' LEU . 22.0 p -92.36 -57.43 2.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.171 -1.193 . . . . 0.0 109.498 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' N ' ' OG ' ' A' ' 137' ' ' SER . 23.1 mtpp -61.05 -8.19 3.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.6 p -71.06 158.14 36.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 159.81 179.65 34.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.97 175.77 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.833 1.688 . . . . 0.0 110.201 179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.63 -56.14 5.04 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.54 134.86 54.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -1.151 . . . . 0.0 109.357 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.608 ' CB ' HD21 ' A' ' 36' ' ' ASN . 8.6 mtmp? -85.03 3.48 38.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.697 ' CB ' ' HB1' ' A' ' 126' ' ' ALA . . . -65.12 -10.47 31.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.9 . . . . 0.0 109.588 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.26 -5.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -83.94 87.98 7.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -92.94 167.75 11.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.4 tp -140.5 70.63 32.12 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.446 -0.784 . . . . 0.0 109.391 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.38 99.6 0.2 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 121.852 1.701 . . . . 0.0 110.335 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 18.6 mtm -96.25 122.3 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.425 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 41.7 t -62.23 148.66 44.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.952 . . . . 0.0 109.445 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.51 57.05 4.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 109.498 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -74.45 -85.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.36 -0.838 . . . . 0.0 109.441 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.478 179.989 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.96 -87.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.42 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 50.69 -170.34 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.18 -66.01 1.74 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -158.42 -141.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -1.109 . . . . 0.0 109.483 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.449 HD13 ' OXT' ' A' ' 155' ' ' SER . 8.0 mt -47.39 149.67 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 109.51 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -59.13 153.28 18.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.411 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 t -91.11 57.21 3.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.0 109.579 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.615 ' HB3' HD13 ' A' ' 12' ' ' LEU . 1.2 mt -51.43 150.04 6.95 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.808 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -58.23 76.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.051 1.167 . . . . 0.0 110.238 179.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 42.4 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.133 -0.979 . . . . 0.0 110.199 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -91.61 -47.07 0.35 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.187 -0.946 . . . . 0.0 110.692 179.818 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 12' ' ' LEU . 2.0 Cg_endo -66.86 97.23 0.39 Allowed 'Trans proline' 0 C--N 1.321 -0.895 0 C-N-CA 121.035 1.156 . . . . 0.0 110.17 -179.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -172.83 83.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.597 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.37 -41.02 94.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.442 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.6 -147.51 18.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.84 -179.78 27.81 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.3 m -134.75 -126.88 0.16 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.37 1.081 . . . . 0.0 108.954 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.22 -57.75 5.49 Favored Glycine 0 C--N 1.278 -2.681 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -146.51 -88.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -1.136 . . . . 0.0 109.338 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.72 64.91 8.8 Favored Pre-proline 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.865 . . . . 0.0 109.916 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.79 167.9 16.41 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 121.451 1.434 . . . . 0.0 109.754 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -61.32 92.14 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.636 1.557 . . . . 0.0 109.751 179.248 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 23' ' ' PRO . . . -61.99 -128.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.721 ' CD2' ' H ' ' A' ' 25' ' ' HIS . 0.1 OUTLIER -99.8 64.12 1.25 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.544 -0.974 . . . . 0.0 109.349 -179.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -88.14 4.92 43.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -99.43 -13.64 19.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.448 -0.782 . . . . 0.0 109.78 -179.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -114.75 152.32 46.24 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.638 -0.664 . . . . 0.0 109.247 -179.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.02 157.65 24.2 Favored 'Trans proline' 0 C--N 1.323 -0.796 0 C-N-CA 121.264 1.309 . . . . 0.0 110.204 179.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.552 ' HE2' HD22 ' A' ' 64' ' ' LEU . 2.4 mtmt -135.8 131.97 36.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.679 . . . . 0.0 109.19 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -84.96 118.67 24.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.526 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 41' ' ' LEU . 23.9 mt -84.87 98.01 10.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.419 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 117.61 30.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.99 102.58 12.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -55.31 -27.97 50.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 14.8 m120 -76.95 103.2 6.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 109.641 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' O ' ' CE2' ' A' ' 39' ' ' PHE . . . 80.21 4.73 89.87 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 46.97 85.01 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' A' ' 37' ' ' GLY . 48.2 m-85 -143.39 132.82 23.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -1.078 . . . . 0.0 109.517 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -93.28 129.02 39.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD23 HD12 ' A' ' 32' ' ' LEU . 53.8 tp -60.53 142.25 55.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 109.245 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 57' ' ' ASP . 48.5 ttt180 -146.85 115.62 6.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.544 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.65 115.5 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.887 . . . . 0.0 109.284 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -75.42 151.74 85.43 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.007 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.05 -28.79 71.35 Favored 'Trans proline' 0 C--N 1.323 -0.795 0 C-N-CA 121.202 1.268 . . . . 0.0 110.468 179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -76.56 4.06 10.08 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 109.557 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.87 -31.44 5.29 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -46.96 114.89 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -1.112 . . . . 0.0 109.519 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.23 129.53 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -155.61 149.89 25.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.909 . . . . 0.0 109.473 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 155.39 22.27 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.7 m -146.54 152.92 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -1.152 . . . . 0.0 109.456 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -82.51 -12.0 58.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.187 -0.946 . . . . 0.0 109.534 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -66.33 101.57 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -0.928 . . . . 0.0 109.413 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.96 -5.01 59.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 109.633 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.15 -20.19 22.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.536 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -51.95 112.3 3.14 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.57 3.72 0.45 Allowed 'Trans proline' 0 C--O 1.216 -0.583 0 C-N-CA 120.638 0.892 . . . . 0.0 110.129 -179.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . 41.9 m80 -86.92 -15.25 39.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.974 . . . . 0.0 109.539 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 pt -76.76 -2.37 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.538 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.3 mtpt -82.48 86.02 6.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -90.02 135.28 33.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.45 108.48 19.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 64' ' ' LEU . 10.5 mp -94.08 149.14 21.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.707 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -141.62 134.54 28.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.371 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.76 131.68 38.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.389 -0.819 . . . . 0.0 109.564 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -97.13 -76.72 0.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.396 -0.815 . . . . 0.0 109.462 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -95.85 -121.07 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.445 -0.784 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -94.03 -96.6 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.338 -0.851 . . . . 0.0 109.488 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.1 3.38 46.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -90.0 125.43 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -1.188 . . . . 0.0 109.424 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.76 169.59 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.53 -0.731 . . . . 0.0 109.452 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.1 m -142.88 128.42 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 109.323 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.6 mt -92.7 149.74 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 0.0 109.718 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ttpt -147.12 117.93 7.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.266 -0.896 . . . . 0.0 109.411 179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -74.56 130.1 11.71 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.88 -74.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -1.121 . . . . 0.0 109.467 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.419 ' HG ' ' CD2' ' A' ' 59' ' ' HIS . 14.3 t -49.12 -55.31 12.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.38 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.71 -26.82 67.44 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.209 -0.932 . . . . 0.0 109.392 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.4 m120 51.34 50.31 19.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.599 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.495 ' NE ' ' O ' ' A' ' 93' ' ' ALA . 8.7 mtp180 -146.68 147.2 30.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.948 . . . . 0.0 109.598 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -90.18 130.98 36.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.241 -0.912 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.0 tp -65.15 140.94 58.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.339 -0.851 . . . . 0.0 109.319 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.01 139.65 21.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 109.545 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 29.2 ttm -97.45 131.46 44.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.47 -0.769 . . . . 0.0 109.306 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -73.2 -174.19 1.51 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 109.443 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -92.78 -16.79 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 3.5 p30 -90.23 -38.86 13.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 0.0 109.617 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.04 -10.88 2.31 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -72.8 124.8 26.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -1.177 . . . . 0.0 109.557 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 91' ' ' LEU . 10.1 mp -93.32 137.74 32.34 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.418 179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.556 ' C ' HD12 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -149.74 -174.23 4.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.141 -0.975 . . . . 0.0 109.665 179.931 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.495 ' O ' ' NE ' ' A' ' 81' ' ' ARG . . . -143.67 132.18 22.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.295 -179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -110.24 168.77 9.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.671 -0.643 . . . . 0.0 109.626 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.6 mtpt -84.51 -1.13 55.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.14 136.77 52.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.723 -0.611 . . . . 0.0 109.405 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 97' ' ' VAL . 14.9 p -80.98 109.02 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.501 -179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.7 p -97.53 179.12 4.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.415 -0.803 . . . . 0.0 109.457 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -63.13 -21.58 66.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -93.09 53.16 1.92 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 51.0 m -141.61 5.6 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.419 -0.8 . . . . 0.0 109.529 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 103' ' ' PHE . 77.3 m-85 -93.2 153.52 18.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 88.9 m-85 -149.03 115.1 5.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.475 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -61.62 107.5 0.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.465 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -86.54 94.1 9.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 mtt180 -94.98 124.1 38.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.364 -0.835 . . . . 0.0 109.464 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.43 133.23 35.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.613 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 110' ' ' ASN . 2.1 mt-10 -94.71 151.2 19.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.318 -0.864 . . . . 0.0 109.513 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.3 m -63.58 1.9 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.496 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 112' ' ' TYR . 36.1 t-20 -93.38 25.77 3.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.47 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.6 OUTLIER 61.64 -3.63 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 109.887 179.98 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.492 ' H ' ' C ' ' A' ' 110' ' ' ASN . 37.1 m-85 -94.59 -174.87 3.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.401 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 112' ' ' TYR . 3.9 m-80 -147.64 164.83 32.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.194 -0.941 . . . . 0.0 109.622 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.2 p -143.82 120.63 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -93.8 105.43 17.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -93.25 139.16 30.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.348 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 t -70.27 147.93 49.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.513 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 120' ' ' TYR . 45.6 ttt180 -81.75 -73.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 109.499 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 7.0 tptt -51.64 -9.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.363 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 119' ' ' LYS . 13.6 m-85 -139.12 68.6 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.56 -0.713 . . . . 0.0 109.176 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 68.3 p -63.75 -16.36 60.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.873 -179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.4 m -89.92 18.85 5.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.128 -0.983 . . . . 0.0 109.4 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -148.47 123.54 10.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.848 . . . . 0.0 109.636 179.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 124' ' ' TYR . 35.4 m-85 -100.7 164.48 11.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 0.0 109.44 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.18 139.64 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.325 -0.859 . . . . 0.0 109.333 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 145' ' ' ALA . . . -155.02 -175.25 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.622 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -141.14 166.39 24.91 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.413 -0.805 . . . . 0.0 109.295 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -94.21 177.86 5.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 109.319 179.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -91.69 -7.52 49.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.162 -0.961 . . . . 0.0 109.315 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.81 -0.68 55.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 94.4 -0.54 65.92 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -90.42 166.3 13.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 109.369 -179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.532 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 21.6 p90 -85.42 120.08 26.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.35 123.0 20.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 135' ' ' LEU . 13.4 tp -47.92 160.1 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.178 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.02 -42.41 19.87 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 21.6 p -59.03 -17.58 26.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.689 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.31 -9.72 46.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.802 -179.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.7 p -80.51 177.51 8.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.141 -0.975 . . . . 0.0 109.565 -179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.8 178.69 22.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.77 165.41 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.864 1.709 . . . . 0.0 110.16 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 77.16 -37.6 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -66.52 121.82 16.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -1.142 . . . . 0.0 109.501 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 21.1 mtmt -80.97 -7.85 59.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.384 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.612 ' HB1' ' HB1' ' A' ' 126' ' ' ALA . . . -59.75 -6.46 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 0.0 109.574 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 146' ' ' ILE . 2.3 pt -95.06 8.55 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.37 -0.831 . . . . 0.0 109.603 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.4 mt -95.14 98.39 10.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.04 164.67 11.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.66 -0.65 . . . . 0.0 109.495 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 tp -141.93 70.29 24.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.41 -0.806 . . . . 0.0 109.389 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -62.58 107.73 0.63 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 121.88 1.72 . . . . 0.0 110.478 -179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 9.1 mtt -98.41 117.14 32.14 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.501 -0.749 . . . . 0.0 109.38 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.427 ' CB ' ' ND1' ' A' ' 25' ' ' HIS . 31.3 t -69.95 142.65 52.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.04 58.86 2.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.361 -0.837 . . . . 0.0 109.496 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -55.43 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.179 -0.95 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.449 ' OXT' HD13 ' A' ' 6' ' ' ILE . 6.1 t . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.537 -179.99 . . . . . . . . 1 1 . 1 stop_ save_